Citrus Sinensis ID: 002908
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 867 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.311 | 0.289 | 0.381 | 3e-48 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.292 | 0.309 | 0.395 | 2e-45 | |
| A7J1T2 | 961 | Mitogen-activated protein | N/A | no | 0.284 | 0.257 | 0.394 | 5e-45 | |
| Q1HKZ5 | 959 | Mitogen-activated protein | yes | no | 0.284 | 0.257 | 0.387 | 1e-44 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.295 | 0.279 | 0.390 | 2e-44 | |
| O43283 | 966 | Mitogen-activated protein | yes | no | 0.284 | 0.255 | 0.387 | 2e-44 | |
| A7J1T0 | 961 | Mitogen-activated protein | N/A | no | 0.284 | 0.257 | 0.383 | 2e-44 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.304 | 0.109 | 0.397 | 3e-44 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.288 | 0.194 | 0.384 | 5e-44 | |
| Q5R8X7 | 966 | Mitogen-activated protein | yes | no | 0.284 | 0.255 | 0.383 | 6e-44 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 194 bits (492), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 110/288 (38%), Positives = 161/288 (55%), Gaps = 18/288 (6%)
Query: 565 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE 624
L + D+ +I N DL + +G G++G VYH W GT+VA+K+ F+G +
Sbjct: 653 VLDDADVGECEIPWN-DLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA---- 707
Query: 625 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 684
EF E I+ +L HPNVV F G V P L+ VTEF+ GSL +L + H+D
Sbjct: 708 --LAEFRSEVRIMRRLRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHID 763
Query: 685 RRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742
R+R+ +A+D A GM LH+ IVH DLK NLLV+ + KVGDFGLS++K N
Sbjct: 764 ERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNV----KVGDFGLSRLKHN 819
Query: 743 TLVTG-GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 801
T ++ GT WMAPE+L S +EK DV+SFG++LWE+ T P+ M+ ++G
Sbjct: 820 TFLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLRLPWRGMNPMQVVG 877
Query: 802 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
+ R +P D ++ +CW DP +RPSF ++ L+ ++
Sbjct: 878 AVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLN 925
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 185 bits (469), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 108/273 (39%), Positives = 159/273 (58%), Gaps = 19/273 (6%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
DL +++G+G+FGTV+ +W G+DVA+K + + F ER+ EF RE I+ +L
Sbjct: 550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-----HAERVN-EFLREVAIMKRL 603
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMDAAFG 698
HPN+V F G V P L+ VTE++ GSL +L LD R+RL +A D A G
Sbjct: 604 RHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 699 MEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG-GVRGTLPW 755
M YLH++N IVH DLK NLLV+ K + KV DFGLS++K +T ++ GT W
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKYTV----KVCDFGLSRLKASTFLSSKSAAGTPEW 717
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
MAPE+L S +EK DV+SFG++LWE+ T ++P+ N++ ++ + R +P
Sbjct: 718 MAPEVLRDEPS--NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 775
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+ + ++E CW +P RPSF I LR +
Sbjct: 776 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A7J1T2|M313A_XENLA Mitogen-activated protein kinase kinase kinase 13-A OS=Xenopus laevis GN=map3k13-a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 183 bits (464), Expect = 5e-45, Method: Compositional matrix adjust.
Identities = 107/271 (39%), Positives = 153/271 (56%), Gaps = 24/271 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E++ EL+ LGSG G V+ GK+RG +VAIK+++ EQ+ ++ R K
Sbjct: 167 EEISELQWLGSGAQGAVFLGKFRGEEVAIKKVR---------EQKETDIKHLR------K 211
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
L HPN++AF GV P L + E+ +G L VL + R + R + + A GM
Sbjct: 212 LKHPNIIAFKGVCTQAPCYCL--IMEYCAHGQLYEVLRAG-RKVSPRLLVDWSNGIASGM 268
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 759
YLH I+H DLK N+LV D + K+ DFG SK + GT+ WMAPE
Sbjct: 269 NYLHLHKIIHRDLKSPNVLVTHTDTV----KISDFGTSKELSDKSTKMSFAGTVAWMAPE 324
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 819
++ + VSEKVD++SFG++LWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 325 VIR--NEPVSEKVDIWSFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 382
Query: 820 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850
+++LM+Q W P RPSF +I L + SA
Sbjct: 383 FKILMKQTWHSKPRNRPSFRQILMHLDIASA 413
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q1HKZ5|M3K13_MOUSE Mitogen-activated protein kinase kinase kinase 13 OS=Mus musculus GN=Map3k13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (461), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 105/271 (38%), Positives = 149/271 (54%), Gaps = 24/271 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E++ EL+ LGSG G V+ GK+R +VAIK+++ EQ ++ R K
Sbjct: 165 EEISELQWLGSGAQGAVFLGKFRAEEVAIKKVR---------EQNETDIKHLR------K 209
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
L HPN++AF GV P + E+ +G L VL + R + R + + A GM
Sbjct: 210 LKHPNIIAFKGVCTQAP--CYCIIMEYCAHGQLYEVLRAG-RKITPRLLVDWSTGIASGM 266
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 759
YLH I+H DLK N+LV D + K+ DFG SK + GT+ WMAPE
Sbjct: 267 NYLHLHKIIHRDLKSPNVLVTHTDAV----KISDFGTSKELSDKSTKMSFAGTVAWMAPE 322
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 819
++ + VSEKVD++SFG+VLWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 323 VIR--NEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 380
Query: 820 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850
+++LM+Q W P RPSF + L + SA
Sbjct: 381 FKILMKQTWQSKPRNRPSFRQTLMHLDIASA 411
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 105/269 (39%), Positives = 151/269 (56%), Gaps = 13/269 (4%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
I +L+ +LG GTFG VY G WRG+ VAIK+IK + ++ EF +E I
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN-----EDVNNQVLEEFRKELTI 711
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
LS+L HPN+V P L +TE++ GSL L SK+ ++ + +A+ A
Sbjct: 712 LSRLRHPNIVLLMAACTAPP--NLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIA 769
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
GM YLH ++H D+K NLL++ ++ IC DFGLSK+K + G+ WM
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLDEHMNVK-IC---DFGLSKLKSKSTEMTKSIGSPIWM 825
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
+PELL G +EKVDV++FGI+LWE+ TGE PY+ + + + +LRPP+P
Sbjct: 826 SPELLMGED--YTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAW 883
Query: 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
+ L++ CW DP+ RPSFTEI L
Sbjct: 884 PYQLSHLIQACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O43283|M3K13_HUMAN Mitogen-activated protein kinase kinase kinase 13 OS=Homo sapiens GN=MAP3K13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 105/271 (38%), Positives = 149/271 (54%), Gaps = 24/271 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E++ EL+ LGSG G V+ GK+R +VAIK+++ EQ ++ R K
Sbjct: 166 EEISELQWLGSGAQGAVFLGKFRAEEVAIKKVR---------EQNETDIKHLR------K 210
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
L HPN++AF GV P + E+ +G L VL + R + R + + A GM
Sbjct: 211 LKHPNIIAFKGVCTQAP--CYCIIMEYCAHGQLYEVLRAG-RKITPRLLVDWSTGIASGM 267
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 759
YLH I+H DLK N+LV D + K+ DFG SK + GT+ WMAPE
Sbjct: 268 NYLHLHKIIHRDLKSPNVLVTHTDAV----KISDFGTSKELSDKSTKMSFAGTVAWMAPE 323
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 819
++ + VSEKVD++SFG+VLWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 324 VIR--NEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 381
Query: 820 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850
+++LM+Q W P RPSF + L + SA
Sbjct: 382 FKILMKQTWQSKPRNRPSFRQTLMHLDIASA 412
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis GN=map3k13-b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 104/271 (38%), Positives = 151/271 (55%), Gaps = 24/271 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E++ EL+ LGSG G V+ GK+RG +VAIK+++ EQ+ ++ R K
Sbjct: 169 EEISELQWLGSGAQGAVFLGKFRGEEVAIKKVR---------EQKETDIKHLR------K 213
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
L HPN++AF GV P + E+ G L VL + R + + + + A GM
Sbjct: 214 LKHPNIIAFKGVCTQAP--CYCILMEYCAQGQLYEVLRAG-RKVTPKLLVEWSTGIASGM 270
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 759
YLH I+H DLK N+LV D + K+ DFG SK + GT+ WMAPE
Sbjct: 271 NYLHLHKIIHRDLKSPNVLVTHADTV----KISDFGTSKELSDKSTKMSFAGTVAWMAPE 326
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 819
++ + VSEKVD++SFG++LWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 327 VIR--NEPVSEKVDIWSFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 384
Query: 820 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850
+++LM+Q W P RPSF +I L + +A
Sbjct: 385 FKILMKQTWQSKPRNRPSFRQILMHLDIAAA 415
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 114/287 (39%), Positives = 159/287 (55%), Gaps = 23/287 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
I +LE + +G G FG V G WR TDVAIK I + F +SS + F E I
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK--RLIIAMD 694
LSKL HPNVV F G G VTE+M GSLR L L++ RL +A+D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 695 AAFGMEYLH--SKNIVHFDLKCDNLLVNLK-DPIRPI--------CKVGDFGLSKIK--R 741
A GM YLH + I+H DL N+L++ DP P+ CK+ DFGLS++K +
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 801
+ +T V G +P+MAPE+ G S+ SEK DV+S+G+VL+E+LT +EP +M +
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDSN--SEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 802 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+ RPP+P S+W+ ++ QCW +P RP+F +I L+ M
Sbjct: 2342 LAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVHLKEM 2388
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 103/268 (38%), Positives = 151/268 (56%), Gaps = 18/268 (6%)
Query: 588 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647
+G G +G V+ G WRGT+VA+K + + +L + +E ++L KL HPN+V
Sbjct: 857 IGRGGYGQVFRGSWRGTEVAVKML------FNDNVNLKLISDLRKEVDLLCKLRHPNIVL 910
Query: 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN- 706
F G + + VTE++ GSL ++LL + +D RL + D A GM YLHS+N
Sbjct: 911 FMGACTEP--SSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP 968
Query: 707 -IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 765
I+H DLK DNLLV+ D + KV DFGL+ +K +T + GT W+APE+L +
Sbjct: 969 IIIHRDLKTDNLLVD--DSWQ--VKVADFGLATVKSHTFA-KTMCGTTGWVAPEVL--AE 1021
Query: 766 SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLME 825
+EK DV+S+ IVLWE+LT PYA + ++ I + R P+P +C ++ LM
Sbjct: 1022 EGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI-DRGERLPMPAWCPPKYAALMN 1080
Query: 826 QCWAPDPVVRPSFTEIARRLRVMSAACQ 853
+CW DP RPSF EI + M + Q
Sbjct: 1081 RCWETDPTHRPSFPEILPIMEGMISEFQ 1108
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8X7|M3K13_PONAB Mitogen-activated protein kinase kinase kinase 13 OS=Pongo abelii GN=MAP3K13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 104/271 (38%), Positives = 149/271 (54%), Gaps = 24/271 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E++ EL+ LGSG G V+ GK+R +VAIK+++ EQ ++ R K
Sbjct: 166 EEISELQWLGSGAQGAVFLGKFRAEEVAIKKVR---------EQNETDIKHLR------K 210
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
L HPN++AF GV P + E+ +G L VL + R + R + + A GM
Sbjct: 211 LKHPNIIAFKGVCTQAP--CYCIIMEYCAHGQLYEVLRAG-RKITPRLLVDWSTGIASGM 267
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 759
YLH I+H DLK N+LV D + K+ DFG SK + GT+ W+APE
Sbjct: 268 NYLHLHKIIHRDLKSPNVLVTHTDAV----KISDFGTSKELSDKSTKMSFAGTVAWLAPE 323
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 819
++ + VSEKVD++SFG+VLWE+LTGE PY ++ AII G+ +N+L PVP C
Sbjct: 324 VIR--NEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 381
Query: 820 WRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850
+++LM+Q W P RPSF + L + SA
Sbjct: 382 FKILMKQTWQSKPRNRPSFRQTLMHLDIASA 412
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 867 | ||||||
| 359472758 | 1338 | PREDICTED: uncharacterized protein LOC10 | 0.989 | 0.641 | 0.669 | 0.0 | |
| 297737995 | 1238 | unnamed protein product [Vitis vinifera] | 0.965 | 0.676 | 0.657 | 0.0 | |
| 449454768 | 1291 | PREDICTED: uncharacterized protein LOC10 | 0.957 | 0.642 | 0.603 | 0.0 | |
| 449503359 | 1291 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.957 | 0.642 | 0.602 | 0.0 | |
| 225462248 | 1207 | PREDICTED: uncharacterized protein LOC10 | 0.881 | 0.632 | 0.540 | 0.0 | |
| 255544604 | 1240 | serine/threonine protein kinase, putativ | 0.871 | 0.609 | 0.553 | 0.0 | |
| 255544602 | 1240 | serine/threonine protein kinase, putativ | 0.874 | 0.611 | 0.551 | 0.0 | |
| 449470682 | 1199 | PREDICTED: uncharacterized protein LOC10 | 0.851 | 0.615 | 0.573 | 0.0 | |
| 356528667 | 1245 | PREDICTED: uncharacterized protein LOC10 | 0.855 | 0.595 | 0.547 | 0.0 | |
| 356555219 | 1243 | PREDICTED: uncharacterized protein LOC10 | 0.862 | 0.601 | 0.540 | 0.0 |
| >gi|359472758|ref|XP_002276237.2| PREDICTED: uncharacterized protein LOC100242423 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1149 bits (2973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 580/866 (66%), Positives = 684/866 (78%), Gaps = 8/866 (0%)
Query: 1 MYSGFHA--DDSEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKIN 58
MYS H E A+E K K D+ + K+ E EK RSL+KEAS KE KIK D S+ K+N
Sbjct: 463 MYSDVHVHVQGLEVSAKEDKLKRDNSSQKMNEPEKNRSLEKEASVKEAKIKTDSSVQKMN 522
Query: 59 EIDNIRRSENDHVVSSHSYVSSVSNYIPREEVSVVSSSPGI-VPSLLPSKSNKMAQEPIQ 117
E++ IR E++H VSSH + SV NYIPR+E SVV+S+ I VP LLP K++K E +Q
Sbjct: 523 ELEKIRSLESEHNVSSHPHDGSVPNYIPRDEASVVNSTADIGVPMLLP-KTSKKHLESVQ 581
Query: 118 NSMPLEAVNEGRKNN-DDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQ 175
S P EAV++G+ N + D F SGGAF+ G+GDSEA+PT SY + IP R +HSE+
Sbjct: 582 ISKPPEAVSDGKINTFNGDGHFHTSGGAFSPGYGDSEADPTEVSYPEQTLIPPRVFHSER 641
Query: 176 IPREQTEKNRLSKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQ 235
IPREQ E NRLSKSDDSFGSQFL+S SD S+ + ES+DKLH GN+ S++EQ+ +
Sbjct: 642 IPREQAELNRLSKSDDSFGSQFLMSHTRSDVSQQVAESIDKLHGGNVTSQSEQAASSTTA 701
Query: 236 QYTNLQKVEDGHAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVT 295
YTN + VEDG Q K+K+ AD I K+NSN SEDGL L KSE P S DD E+
Sbjct: 702 LYTNPKTVEDGLTQFEKYKDVADDIKKLNSNISEDGLGPKLLKSESKWPAPTSVDDHEIA 761
Query: 296 KIRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKG 355
+R+ KD +++D EAAGL + TA+ GTS K +DS K + + W+E+A KNN ++ KG
Sbjct: 762 GVRDGNKDPAVSDREAAGLNNLTASQGTSSKPHDDSPSKPTGFHWDEMAVKKNNDDNTKG 821
Query: 356 QAQSLAQKENSVRAVSPGDSSIAVVSPEG-DILIDINDRFPRDFLSDIFTKARISENIAG 414
AQ +A EN +R+V G+SS+ V +PEG DILIDINDRFPRDFLSDIF+KAR SE G
Sbjct: 822 HAQPMAWTENPLRSVPGGESSVGVGAPEGGDILIDINDRFPRDFLSDIFSKARTSEGPPG 881
Query: 415 VSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGA 474
+SP+HGDG LS N+ENH+P+ WS+F+ LAQ+EF RK VSLMDQDHLG+ S L NIEEG
Sbjct: 882 ISPLHGDGTGLSLNLENHEPKHWSFFQKLAQEEFIRKGVSLMDQDHLGYPSSLMNIEEGT 941
Query: 475 TVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQ 534
+DYS+PPLK DG + SRINF+E Q+ESSS+V P+T++ H DY S +K +ES+Q
Sbjct: 942 PIDYSFPPLKSDGVALGPMDSRINFEEEIQQESSSMVRPNTIDMHEDYDPSPVKRDESVQ 1001
Query: 535 SE-VVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTF 593
+ + N R +SDYEE + ++ G P VD +LG+ DISTLQIIKNEDLEEL+ELGSGTF
Sbjct: 1002 MDGMANPRTPDSDYEEVKFEIQNTGAPFVDPSLGDIDISTLQIIKNEDLEELRELGSGTF 1061
Query: 594 GTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653
GTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLT+EFWREA+ILSKLHHPNVVAFYGVVQ
Sbjct: 1062 GTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWREADILSKLHHPNVVAFYGVVQ 1121
Query: 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLK 713
DGPGGTLATVTEFMVNGSLRHVL+SK+RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLK
Sbjct: 1122 DGPGGTLATVTEFMVNGSLRHVLVSKDRHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLK 1181
Query: 714 CDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVD 773
CDNLLVNLKDP+RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS+VSEKVD
Sbjct: 1182 CDNLLVNLKDPLRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSRVSEKVD 1241
Query: 774 VFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPV 833
VFSFGIVLWEILTGEEPYA+MHYGAIIGGIVNNTLRPPVP +CDSEW+LLMEQCWAPDP+
Sbjct: 1242 VFSFGIVLWEILTGEEPYAHMHYGAIIGGIVNNTLRPPVPSYCDSEWKLLMEQCWAPDPI 1301
Query: 834 VRPSFTEIARRLRVMSAACQTKSHGH 859
RPSFTEIARRLR MSAACQTK G+
Sbjct: 1302 GRPSFTEIARRLRAMSAACQTKPQGY 1327
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737995|emb|CBI27196.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1115 bits (2883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 567/863 (65%), Positives = 667/863 (77%), Gaps = 26/863 (3%)
Query: 2 YSGFHADDSEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEID 61
Y G EA +VK + K+ E EK RSL+KEAS KE KIK D S+ K+NE++
Sbjct: 386 YQGQKMRHGEAEQHQVKSGSYASPWKMNEPEKNRSLEKEASVKEAKIKTDSSVQKMNELE 445
Query: 62 NIRRSENDHVVSSHSYVSSVSNYIPREEVSVVSSSPGI-VPSLLPSKSNKMAQEPIQNSM 120
IR E++H VSSH + SV NYIPR+E SVV+S+ I VP LLP K++K E +Q S
Sbjct: 446 KIRSLESEHNVSSHPHDGSVPNYIPRDEASVVNSTADIGVPMLLP-KTSKKHLESVQISK 504
Query: 121 PLEAVNEGRKNN-DDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPR 178
P EAV++G+ N + D F SGGAF+ G+GDSEA+PT SY + IP R +HSE+IPR
Sbjct: 505 PPEAVSDGKINTFNGDGHFHTSGGAFSPGYGDSEADPTEVSYPEQTLIPPRVFHSERIPR 564
Query: 179 EQTEKNRLSKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYT 238
EQ E NRLSKSDDSFGSQFL+S SD S+ + ES+DKLH GN+ S++EQ+ + YT
Sbjct: 565 EQAELNRLSKSDDSFGSQFLMSHTRSDVSQQVAESIDKLHGGNVTSQSEQAASSTTALYT 624
Query: 239 NLQKVEDGHAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIR 298
N + VEDG Q K+K+ AD I K+NSN SEDGL L KSE P S DD E+ +R
Sbjct: 625 NPKTVEDGLTQFEKYKDVADDIKKLNSNISEDGLGPKLLKSESKWPAPTSVDDHEIAGVR 684
Query: 299 ETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQ 358
+ KD +++D EAAGL + TA+ GTS K +DS K + + W+E+A
Sbjct: 685 DGNKDPAVSDREAAGLNNLTASQGTSSKPHDDSPSKPTGFHWDEMA-------------- 730
Query: 359 SLAQKENSVRAVSPGDSSIAVVSPEG-DILIDINDRFPRDFLSDIFTKARISENIAGVSP 417
N +R+V G+SS+ V +PEG DILIDINDRFPRDFLSDIF+KAR SE G+SP
Sbjct: 731 ------NPLRSVPGGESSVGVGAPEGGDILIDINDRFPRDFLSDIFSKARTSEGPPGISP 784
Query: 418 MHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVD 477
+HGDG LS N+ENH+P+ WS+F+ LAQ+EF RK VSLMDQDHLG+ S L NIEEG +D
Sbjct: 785 LHGDGTGLSLNLENHEPKHWSFFQKLAQEEFIRKGVSLMDQDHLGYPSSLMNIEEGTPID 844
Query: 478 YSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSE- 536
YS+PPLK DG + SRINF+E Q+ESSS+V P+T++ H DY S +K +ES+Q +
Sbjct: 845 YSFPPLKSDGVALGPMDSRINFEEEIQQESSSMVRPNTIDMHEDYDPSPVKRDESVQMDG 904
Query: 537 VVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTV 596
+ N R +SDYEE + ++ G P VD +LG+ DISTLQIIKNEDLEEL+ELGSGTFGTV
Sbjct: 905 MANPRTPDSDYEEVKFEIQNTGAPFVDPSLGDIDISTLQIIKNEDLEELRELGSGTFGTV 964
Query: 597 YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656
YHGKWRGTDVAIKRIKKSCFTGRSSEQERLT+EFWREA+ILSKLHHPNVVAFYGVVQDGP
Sbjct: 965 YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTVEFWREADILSKLHHPNVVAFYGVVQDGP 1024
Query: 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 716
GGTLATVTEFMVNGSLRHVL+SK+RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN
Sbjct: 1025 GGTLATVTEFMVNGSLRHVLVSKDRHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 1084
Query: 717 LLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFS 776
LLVNLKDP+RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS+VSEKVDVFS
Sbjct: 1085 LLVNLKDPLRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSRVSEKVDVFS 1144
Query: 777 FGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRP 836
FGIVLWEILTGEEPYA+MHYGAIIGGIVNNTLRPPVP +CDSEW+LLMEQCWAPDP+ RP
Sbjct: 1145 FGIVLWEILTGEEPYAHMHYGAIIGGIVNNTLRPPVPSYCDSEWKLLMEQCWAPDPIGRP 1204
Query: 837 SFTEIARRLRVMSAACQTKSHGH 859
SFTEIARRLR MSAACQTK G+
Sbjct: 1205 SFTEIARRLRAMSAACQTKPQGY 1227
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454768|ref|XP_004145126.1| PREDICTED: uncharacterized protein LOC101217445 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 959 bits (2478), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/868 (60%), Positives = 633/868 (72%), Gaps = 38/868 (4%)
Query: 3 SGFHADDSEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDN 62
SGFH D ++ ++E K S + K+ E ++I+SL+KE S + ++KR+ SL KI+E +
Sbjct: 459 SGFHTQDPDSSSREGKITEISTS-KLSEPDEIQSLEKEVSFNDAQMKRESSLHKIDEANE 517
Query: 63 IRRSENDHVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPL 122
E++ VSS+ +SV NY + + V++S + SLL +K+NK Q+P S+ L
Sbjct: 518 SPNFEHECGVSSNLNDASVLNYNTKG-MQVINSDTDVGSSLLLTKNNK-HQDPAPESVSL 575
Query: 123 EAVNEGRKNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQT 181
EA NEG + +D +F +S TSG G S+A+ T FSY P +PQR +HSE+IPREQ
Sbjct: 576 EASNEGNRGTKED-KF-SSDELPTSGFGASKADETGFSYLEP-ILPQRVFHSERIPREQA 632
Query: 182 EKNRLSKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQ 241
E NRLSKSDDSFGSQFL +Q SD S+ I ES + L GNM E+EQ V+ +K N Q
Sbjct: 633 ELNRLSKSDDSFGSQFLRTQGNSDYSQTIIESAETLLDGNMTLESEQFVSSSKLPCGNHQ 692
Query: 242 KVEDGHAQLRKHKEFADKINK-INSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRET 300
+EDG K+K ADK +K +N +G DG SE++ +
Sbjct: 693 TIEDGLEPFEKYKTSADKNSKTMNISGEHDG-------SEVSDM--------------SN 731
Query: 301 VKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSL 360
+K S +EA GL H TA K+ E+S + E W E + N+GN+ + Q +
Sbjct: 732 IKSPSACRKEAEGLAHLTAGEEVPDKHKEESLMGPLESGWIEGSTHNNHGNETQEQPEPS 791
Query: 361 AQKENSVRAVSPGDSSIAVVSPE-GDILIDINDRFPRDFLSDIFTKARISENIAGVSPMH 419
+ EN + + + + + + E GDILIDINDRFPRDFLSDIF+KAR SENI+G++P+H
Sbjct: 792 SLTENPGKNATQVEPGVGIGTSEHGDILIDINDRFPRDFLSDIFSKARNSENISGINPLH 851
Query: 420 GDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYS 479
G+GA LS NVENH+P+RWSYFRNLAQ+EF +DVSLMDQDHLGFSS L N+EEG TV+
Sbjct: 852 GNGAGLSVNVENHEPKRWSYFRNLAQEEFVGRDVSLMDQDHLGFSSSLGNVEEGGTVN-R 910
Query: 480 YPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVN 539
+P L D + + S NFD+ Q ES + GPST + +Y+ S+LKGNE++ +
Sbjct: 911 FPLLNSDVGAIYEKESH-NFDDNIQPESRLLTGPSTTNLYTEYNSSQLKGNETMHEP--S 967
Query: 540 HRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHG 599
+ + + + +LD G+PLVD L +FDISTLQIIKNEDLEE +ELGSGTFGTVYHG
Sbjct: 968 SKSPQDENVDAKLDGQDIGVPLVDFYLKDFDISTLQIIKNEDLEEQRELGSGTFGTVYHG 1027
Query: 600 KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659
KWRGTDVAIKRIKKSCFT RSSEQERLT+EFWREAEILSKLHHPNVVAFYGVVQDGPGGT
Sbjct: 1028 KWRGTDVAIKRIKKSCFTCRSSEQERLTIEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1087
Query: 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 719
LATVTEFMVNGSLR+VLLSKER+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV
Sbjct: 1088 LATVTEFMVNGSLRNVLLSKERYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1147
Query: 720 NLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGI 779
NLKDP RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGI
Sbjct: 1148 NLKDPFRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGI 1207
Query: 780 VLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFT 839
VLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP FCD +WRLLMEQCW+PDPV RPSFT
Sbjct: 1208 VLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPSFCDPDWRLLMEQCWSPDPVARPSFT 1267
Query: 840 EIARRLRVMSAACQTKSHGHQVQNQVPK 867
+IARRLRVMS A QT+S QNQ+PK
Sbjct: 1268 DIARRLRVMSTAAQTRS----PQNQMPK 1291
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503359|ref|XP_004161963.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101223789 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2472), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/868 (60%), Positives = 631/868 (72%), Gaps = 38/868 (4%)
Query: 3 SGFHADDSEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDN 62
SGFH D ++ ++E K S + K+ E ++I+SL+KE S + ++KR+ SL KI+E +
Sbjct: 459 SGFHTQDPDSSSREGKITEISTS-KLSEPDEIQSLEKEVSFNDAQMKRESSLHKIDEANE 517
Query: 63 IRRSENDHVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPL 122
E++ VSS+ +SV NY + + V++S + SLL +K+NK Q+P S+ L
Sbjct: 518 SPNFEHECGVSSNLNDASVLNYNTKG-MQVINSDTDVGSSLLLTKNNK-HQDPAPESVSL 575
Query: 123 EAVNEGRKNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQT 181
EA NEG + +D +F +S TSG G S+A+ T FSY P +PQR +HSE+IPREQ
Sbjct: 576 EASNEGNRGTKED-KF-SSDELPTSGFGASKADETGFSYLEP-ILPQRVFHSERIPREQA 632
Query: 182 EKNRLSKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQ 241
E NRLSKSDDSFGSQFL +Q SD S+ I ES + L GNM E+EQ V+ +K N Q
Sbjct: 633 ELNRLSKSDDSFGSQFLRTQGNSDYSQTIIESAETLLDGNMTLESEQFVSSSKLPCGNHQ 692
Query: 242 KVEDGHAQLRKHKEFADKINK-INSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRET 300
+EDG K+K ADK +K +N +G DG SE++ +
Sbjct: 693 TIEDGLEPFEKYKTSADKNSKTMNISGEHDG-------SEVSDM--------------SN 731
Query: 301 VKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSL 360
+K S +EA GL H TA K+ E+S + E W E + N+GN+ + Q +
Sbjct: 732 IKSPSACRKEAEGLAHLTAGEEVPDKHKEESLMGPLESGWIEGSTHNNHGNETQEQPEPS 791
Query: 361 AQKENSVRAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMH 419
+ EN + + + + + S GDILIDINDRFPRDFLSDIF+KAR SENI+G++P+H
Sbjct: 792 SLTENPGKNATQVEPGVGIGTSEHGDILIDINDRFPRDFLSDIFSKARNSENISGINPLH 851
Query: 420 GDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYS 479
G+GA LS NVENH+P+RWSYFRNLAQ+EF +DVSLMDQDHLGFSS L N+EEG TV+
Sbjct: 852 GNGAGLSVNVENHEPKRWSYFRNLAQEEFVGRDVSLMDQDHLGFSSSLGNVEEGGTVN-R 910
Query: 480 YPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVN 539
+P L D + + S NFD+ Q ES + GPST + +Y+ S+LKGNE++ +
Sbjct: 911 FPLLNSDVGAIYEKESH-NFDDNIQPESRLLTGPSTTNLYTEYNSSQLKGNETMHEP--S 967
Query: 540 HRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHG 599
+ + + + +LD G+PLVD L +FDISTLQIIKNEDLEE +ELGSGTFGTVYHG
Sbjct: 968 SKSPQDENVDAKLDGQDIGVPLVDFYLKDFDISTLQIIKNEDLEEQRELGSGTFGTVYHG 1027
Query: 600 KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659
KWRGTDVAIKRIKKSCFT RSSEQERLT+EFWREAEILSKLHHPNVVAFYGVVQDGPGGT
Sbjct: 1028 KWRGTDVAIKRIKKSCFTCRSSEQERLTIEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1087
Query: 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 719
LATVTEFMVNGSLR+VLLSKER+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV
Sbjct: 1088 LATVTEFMVNGSLRNVLLSKERYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1147
Query: 720 NLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGI 779
NLKDP RPICKVGDFGLSK KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGI
Sbjct: 1148 NLKDPFRPICKVGDFGLSKXKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGI 1207
Query: 780 VLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFT 839
VLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP FCD +WRLLMEQCW+PDPV RPSFT
Sbjct: 1208 VLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPSFCDPDWRLLMEQCWSPDPVARPSFT 1267
Query: 840 EIARRLRVMSAACQTKSHGHQVQNQVPK 867
+IARRLRVMS A QT+S QNQ+PK
Sbjct: 1268 DIARRLRVMSTAAQTRS----PQNQMPK 1291
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462248|ref|XP_002263264.1| PREDICTED: uncharacterized protein LOC100257013 [Vitis vinifera] gi|147772468|emb|CAN65102.1| hypothetical protein VITISV_021043 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2105), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/834 (54%), Positives = 552/834 (66%), Gaps = 70/834 (8%)
Query: 38 DKEASTKEQKIKRDHSLPKINEIDNIRRSENDHVVSSHSYVSSVSNYIPREEVSVVSSSP 97
D KE +K D S+ + N +NI S+ND ++ S V + IP EE V SS
Sbjct: 432 DPSVLVKEVTLKNDASIQQENIPENISPSKNDCLIPSQPSDGEVMDRIPVEEALVSISSL 491
Query: 98 GIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGRKNNDDDVRFQASGGAFTSGHGDSEAEPT 157
PS++ +P++ S ++A+N+ + D AS F + D +
Sbjct: 492 ----DQFPSENKGKHHKPVEISSSVDAMNQAQVPKSDYDHHPASSSPFAPVYADPGSGLM 547
Query: 158 NFSYNGPSAIPQR-YHSEQIPREQTEK-NRLSKSDDSFGSQFLISQALSDGSK--PIRES 213
+ SY P +PQR Y+SE++PREQ E NRLSKSDDS GSQFLIS + SD K + ES
Sbjct: 548 DLSYLEPPVLPQRVYYSERVPREQAELLNRLSKSDDSLGSQFLISHSRSDIEKQDSVAES 607
Query: 214 VDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFADKINKINSNGSEDGLQ 273
DKL +GN+A +TEQS+
Sbjct: 608 TDKLRNGNLAPQTEQSI------------------------------------------- 624
Query: 274 SSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSL 333
S G++ + + K+ D T ++ + L ++ G P N S K+ +D
Sbjct: 625 -STGEAMVEDMAVKA--DHGTTGTKDIPRKLLLHGTTEPGSELPAMNQVASVKHCQDPLS 681
Query: 334 KQSEYEWNEIAA--IKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIAVVSPE-GDILIDI 390
E + E++ +N G AQ+ A SS+ V +PE GDILIDI
Sbjct: 682 TPPELDQGEMSGKDFTSNNTLGVGDAQTFAWT----------GSSVGVSTPEQGDILIDI 731
Query: 391 NDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSR 450
NDRFPRDFLSDIF+KA + +S DGA LS N+EN +P+ WSYF+ LAQ F +
Sbjct: 732 NDRFPRDFLSDIFSKAVHFADSPDISKPQKDGAGLSLNMENREPKHWSYFQKLAQGGFVQ 791
Query: 451 KDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESS-S 509
DVSLMDQDHLGFSS LT +EE + Y + PL D ++ Q SRI+F E +Q+ES
Sbjct: 792 NDVSLMDQDHLGFSSVLTKVEEEVSKPYQFTPLMADEVLIGQLESRISFGEENQKESPPG 851
Query: 510 IVGPSTMETHPDYSRSELKGNESLQSE--VVNHRIQESDYEEGRLDLPTAGIPLVDLALG 567
+ + + H DYS SE+K ++S+Q + + N R +S+ E+G+++ G P +D ++G
Sbjct: 852 RIAADSTDLHSDYSPSEIKESDSVQFDRMIENLRTPDSEGEDGKMETKNIGRPPLDPSIG 911
Query: 568 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLT 627
+FDI+TLQIIKNEDLEELKELGSGTFGTVYHGKWRG+DVAIKRIKK CFT RSSEQERLT
Sbjct: 912 DFDINTLQIIKNEDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKICFTSRSSEQERLT 971
Query: 628 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
+EFWREA+ILSKLHHPNVVAFYGVV DGPG TLATVTE+MV+GSLRHVLL K+R+LDRRK
Sbjct: 972 IEFWREADILSKLHHPNVVAFYGVVHDGPGATLATVTEYMVDGSLRHVLLRKDRYLDRRK 1031
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747
RL+IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP+RPICKVGDFGLSKIKRNTLV+G
Sbjct: 1032 RLLIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPLRPICKVGDFGLSKIKRNTLVSG 1091
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807
GVRGTLPWMAPELLNGSS+KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV+NT
Sbjct: 1092 GVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVSNT 1151
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQV 861
LRP VP CD EWR LMEQCWAP+P VRPSFTEI RLRVMSAA QTK+ GH+
Sbjct: 1152 LRPTVPSSCDPEWRTLMEQCWAPNPAVRPSFTEITGRLRVMSAAAQTKTPGHKA 1205
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544604|ref|XP_002513363.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547271|gb|EEF48766.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2035), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/782 (55%), Positives = 539/782 (68%), Gaps = 26/782 (3%)
Query: 85 IPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR-KNNDDDVRFQASGG 143
+P +E S+ G + SL PSK+ QE + S +AVN + N+ +D AS G
Sbjct: 470 VPVDEASLAVGLQGDLHSL-PSKNEGWDQETEKVSSSADAVNSSQVPNSSEDGPCSASDG 528
Query: 144 AFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEK-NRLSKSDDSFGSQFLISQ 201
+ +G+ D + + SY PS PQR Y+SE+IPREQ E NRLSKSDDS G Q L S
Sbjct: 529 TYGTGNADPVSNLIDLSYLEPSVPPQRVYYSERIPREQAELLNRLSKSDDSLGPQLLNS- 587
Query: 202 ALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFADKIN 261
I ES +KL S N+AS + S + +KQ + + + DG AQL+K KEFAD ++
Sbjct: 588 --------IAESTEKLSSSNLASHAKDSTSTSKQS-ADTRTINDGLAQLQKFKEFADAVS 638
Query: 262 KINS--NGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPTA 319
+N + SED L+S + K D I D A HP
Sbjct: 639 LMNKKPSDSEDVLESGFKHPVSGNLADK--DSVHRDGILRGDSDTDYTTGIKAESEHPAG 696
Query: 320 NHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIAV 379
TS + D + SE E+ GN+N G + + E+S + +S G S+ V
Sbjct: 697 GKVTSVMHQMDPASIHSESTRAEMTGKDFTGNNNLGHSLPFSGIESSAKDISQGIPSVGV 756
Query: 380 -VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWS 438
+ + DI +DINDRFPRDFLS+IF+ +E+ GVS MH DG +S +++NH+P+ WS
Sbjct: 757 PATKQADITVDINDRFPRDFLSEIFSSGVFAED-PGVSTMHKDGVGVSVHMKNHEPKHWS 815
Query: 439 YFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRIN 498
YF+ LAQ+ F ++DVSL+DQD +G S N EG Y + PL D + S++N
Sbjct: 816 YFQKLAQEGFVQRDVSLIDQDSVGTPSAPAN-AEGDQKSYHFEPLT-DVMSISHEYSQLN 873
Query: 499 FDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQ--SEVVNHRIQESDYEEGRLDLPT 556
F E ++++ ++G + PD+ S++K +ES+Q + + N + +S YE +L+
Sbjct: 874 FGEDNKKDLPGVIGADSA-VLPDFGHSQVKDSESMQFGAMIENLKSPDSVYEGAKLENRN 932
Query: 557 AGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCF 616
G+P +D +L +FDI+TLQ+IKN+DLEEL+ELGSGTFGTVYHGKWRG+DVAIKR+KK CF
Sbjct: 933 VGLPPLDPSLVDFDINTLQVIKNDDLEELRELGSGTFGTVYHGKWRGSDVAIKRLKKICF 992
Query: 617 TGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 676
+GRSSEQERLT EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV E+MV+GSLRHVL
Sbjct: 993 SGRSSEQERLTSEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVAEYMVDGSLRHVL 1052
Query: 677 LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736
L K+R+LDRRKRL+IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP RPICKVGDFGL
Sbjct: 1053 LKKDRYLDRRKRLLIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPQRPICKVGDFGL 1112
Query: 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 796
SKIKRNTLV+GGVRGTLPWMAPELLNGSS+KVSEKVDVFSFGIVLWEILTGEEPYANMHY
Sbjct: 1113 SKIKRNTLVSGGVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLWEILTGEEPYANMHY 1172
Query: 797 GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS-AACQTK 855
GAIIGGIVNNTLRP +P CD+EW++LMEQCWAP+P RPSFTEIA RLRVMS AA QTK
Sbjct: 1173 GAIIGGIVNNTLRPTIPSNCDAEWKMLMEQCWAPNPAARPSFTEIAGRLRVMSIAAGQTK 1232
Query: 856 SH 857
H
Sbjct: 1233 GH 1234
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544602|ref|XP_002513362.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547270|gb|EEF48765.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2026), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/787 (55%), Positives = 533/787 (67%), Gaps = 29/787 (3%)
Query: 85 IPREEVSV-VSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR-KNNDDDVRFQASG 142
+P +E+SV V++ G + S+ PSK+ + S ++A++ N+ +D +F S
Sbjct: 471 VPVDEISVAVAAQEGALHSM-PSKNEGKQRGSESISFSVDAIDPVHVPNSCEDDQFSTSS 529
Query: 143 GAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTE-KNRLSKSDDSFGSQFLIS 200
F DS + + SY PSA PQR Y+SE+IPREQ E NRLSKSDDS GSQFLI
Sbjct: 530 SIFGFDCADSVSNLIDLSYVEPSAPPQRVYYSERIPREQAELMNRLSKSDDSLGSQFLIP 589
Query: 201 QALSDGS--KPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFAD 258
+ D + K S +KL N+ +TE A+ + Q + +G AQ +K+ E A
Sbjct: 590 HSRPDIAEQKSTTASAEKLIQSNLLPQTEDPSTTAEPLLIDPQPI-NGLAQPQKYIELAA 648
Query: 259 KINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPT 318
+ +N N S + V K+ DC ++ V++ A +P
Sbjct: 649 P-DDVNDNDSVN-----------RNAVLKADHDCAAGNHKKPVEETG-----EARFGNPA 691
Query: 319 ANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIA 378
A T G D ++ EI N+N G + + E+S VS I
Sbjct: 692 APQTTPGMYHRDPVSDHPGHKLGEITGKVFASNENVGYSLPYSLTESSTNDVSQEVPPIF 751
Query: 379 V-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRW 437
V + GDI IDINDRFPRDFLS+IF++ ++E+ AGV+P+H DGA +S +ENH+P+ W
Sbjct: 752 VSATKPGDISIDINDRFPRDFLSEIFSRGILTEDRAGVNPLHKDGAGMSVIMENHEPKHW 811
Query: 438 SYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRI 497
SYF+ LAQ+EF +KD SLMDQDHLG + +EG Y + LK +G M Q SR
Sbjct: 812 SYFQKLAQEEFVQKDFSLMDQDHLGTPPLIAKFKEGDQNSYHFARLKTEGVSMDQKYSRP 871
Query: 498 NFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVV--NHRIQESDYEEGRLDLP 555
NF EG+ ++ + + + + S +KG+ES+Q VV N + E E G LD
Sbjct: 872 NFVEGTNQKVLAGLRAADSTILSGFDHSHVKGSESMQFGVVMDNLKTPEPRAEGGNLDNR 931
Query: 556 TAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSC 615
+G+P V L++ +FDI TLQIIKNEDLEEL+ELGSGTFGTVYHGKWRG+DVAIKR+KK C
Sbjct: 932 NSGLPPVGLSVVDFDIDTLQIIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRLKKIC 991
Query: 616 FTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV 675
FTGRSSEQERLT+EFW EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE+MV+GSLRHV
Sbjct: 992 FTGRSSEQERLTIEFWHEAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEYMVDGSLRHV 1051
Query: 676 LLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735
LL K+R+LDRRKRL+IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP RPICKVGDFG
Sbjct: 1052 LLKKDRYLDRRKRLLIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPQRPICKVGDFG 1111
Query: 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 795
LSKIKRNTLV+GGVRGTLPWMAPELLNG S+KVSEKVDVFSFGIVLWEILTGEEPYANMH
Sbjct: 1112 LSKIKRNTLVSGGVRGTLPWMAPELLNGGSNKVSEKVDVFSFGIVLWEILTGEEPYANMH 1171
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS-AACQT 854
YGAIIGGIVNNTLRP +P FCD EW+ LMEQCWAP+P RP+FTEIA RLR+MS AA Q
Sbjct: 1172 YGAIIGGIVNNTLRPAIPNFCDPEWKRLMEQCWAPNPAARPAFTEIAGRLRIMSTAASQN 1231
Query: 855 KSHGHQV 861
K GH+
Sbjct: 1232 KGQGHKA 1238
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470682|ref|XP_004153045.1| PREDICTED: uncharacterized protein LOC101213632, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2020), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/772 (57%), Positives = 546/772 (70%), Gaps = 34/772 (4%)
Query: 3 SGFHADDSEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDN 62
SGFH D ++ ++E K S + K+ E ++I+SL+KE S + ++KR+ SL KI+E +
Sbjct: 459 SGFHTQDPDSSSREGKITEISTS-KLSEPDEIQSLEKEVSFNDAQMKRESSLHKIDEANE 517
Query: 63 IRRSENDHVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPL 122
E++ VSS+ +SV NY + + V++S + SLL +K+NK Q+P S+ L
Sbjct: 518 SPNFEHECGVSSNLNDASVLNYNTKG-MQVINSDTDVGSSLLLTKNNKH-QDPAPESVSL 575
Query: 123 EAVNEGRKNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQT 181
EA NEG + +D +F +S TSG G S+A+ T FSY P +PQR +HSE+IPREQ
Sbjct: 576 EASNEGNRGTKED-KF-SSDELPTSGFGASKADETGFSYLEP-ILPQRVFHSERIPREQA 632
Query: 182 EKNRLSKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQ 241
E NRLSKSDDSFGSQFL +Q SD S+ I ES + L GNM E+EQ V+ +K N Q
Sbjct: 633 ELNRLSKSDDSFGSQFLRTQGNSDYSQTIIESAETLLDGNMTLESEQFVSSSKLPCGNHQ 692
Query: 242 KVEDGHAQLRKHKEFADKINK-INSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRET 300
+EDG K+K ADK +K +N +G DG SE++ +
Sbjct: 693 TIEDGLEPFEKYKTSADKNSKTMNISGEHDG-------SEVSDM--------------SN 731
Query: 301 VKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSL 360
+K S +EA GL H TA K+ E+S + E W E + N+GN+ + Q +
Sbjct: 732 IKSPSACRKEAEGLAHLTAGEEVPDKHKEESLMGPLESGWIEGSTHNNHGNETQEQPEPS 791
Query: 361 AQKENSVRAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMH 419
+ EN + + + + + S GDILIDINDRFPRDFLSDIF+KAR SENI+G++P+H
Sbjct: 792 SLTENPGKNATQVEPGVGIGTSEHGDILIDINDRFPRDFLSDIFSKARNSENISGINPLH 851
Query: 420 GDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYS 479
G+GA LS NVENH+P+RWSYFRNLAQ+EF +DVSLMDQDHLGFSS L N+EEG TV+
Sbjct: 852 GNGAGLSVNVENHEPKRWSYFRNLAQEEFVGRDVSLMDQDHLGFSSSLGNVEEGGTVN-R 910
Query: 480 YPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVN 539
+P L D + + S NFD+ Q ES + GPST + +Y+ S+LKGNE++ +
Sbjct: 911 FPLLNSDVGAIYEKESH-NFDDNIQPESRLLTGPSTTNLYTEYNSSQLKGNETMHEP--S 967
Query: 540 HRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHG 599
+ + + + +LD G+PLVD L +FDISTLQIIKNEDLEE +ELGSGTFGTVYHG
Sbjct: 968 SKSPQDENVDAKLDGQDIGVPLVDFYLKDFDISTLQIIKNEDLEEQRELGSGTFGTVYHG 1027
Query: 600 KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659
KWRGTDVAIKRIKKSCFT RSSEQERLT+EFWREAEILSKLHHPNVVAFYGVVQDGPGGT
Sbjct: 1028 KWRGTDVAIKRIKKSCFTCRSSEQERLTIEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1087
Query: 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 719
LATVTEFMVNGSLR+VLLSKER+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV
Sbjct: 1088 LATVTEFMVNGSLRNVLLSKERYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1147
Query: 720 NLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 771
NLKDP RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK
Sbjct: 1148 NLKDPFRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1199
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528667|ref|XP_003532921.1| PREDICTED: uncharacterized protein LOC100799118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/776 (54%), Positives = 535/776 (68%), Gaps = 34/776 (4%)
Query: 96 SPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR--KNNDDDVRFQASGGAFTSGHGDSE 153
S G+ P+L PSK+ Q+ S + ++N + K+ +DD F + AF+ H D+E
Sbjct: 492 SEGLHPAL-PSKNKGKHQQSEDASSLISSMNPTQTPKSVEDDF-FTTATDAFSHAHVDAE 549
Query: 154 AEPTNFSYNGPSAIPQR-YHSEQIPREQTEK-NRLSKSDDSFGSQFLISQALSDGSKP-- 209
+ +FSY P +P R Y+SE+IPREQ + NR +KSDD+ GS L+S LSD S+
Sbjct: 550 SNVIDFSYLEPPPLPNRVYYSERIPREQADLLNRSTKSDDAHGSHLLMSDLLSDFSQKNS 609
Query: 210 IRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFADKINKINSNGSE 269
I ES D LH+GN ++ S + K + ++DG A + +K+ D K+N S+
Sbjct: 610 ITESTDMLHNGNTSNLNMMSSSAGKPLQADGHTIDDGFAPPQTYKQLPDTTIKVNPKLSQ 669
Query: 270 DGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPTANHGTSGKNPE 329
SE QV+ +D +V++ + V LS ++ E G H + S + +
Sbjct: 670 HV------NSESKQVL----EDNKVSRNEDQV--LS-SENETKGTEHLAFHQVPSVEQNQ 716
Query: 330 DSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIAVVSP-EGDILI 388
+ + K + E++ + + ND K Q+Q+ N+ + VS A P +GDILI
Sbjct: 717 NLASKLPDLNLAEVST-RESDNDTKVQSQTFPLTGNTGQDVSQDFPPEAKSRPTQGDILI 775
Query: 389 DINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEF 448
DI DRFPRDFL D+F+KA ISE+ + + P+ D A LS N++NH+P+RWSYF+NLA + F
Sbjct: 776 DIEDRFPRDFLYDMFSKAIISEDSSSIGPLPTDRAGLSLNMDNHEPKRWSYFQNLALEGF 835
Query: 449 SRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESS 508
+VSL+DQD+LGFSS + ++EG + P G + ++ S +N E +Q+
Sbjct: 836 D--NVSLIDQDNLGFSSAVRKVQEGDSKSQPSAPQPAGGVLAGRTDSHLNIGEENQKNVP 893
Query: 509 SIVGPSTMETHPDYSRSELKGNESLQSEVV--NHRIQESDYEEGRLDLPTAGIPLVDLAL 566
H Y S+LKGNE+ + + N R QES+Y++ + + P +
Sbjct: 894 VATKTEASIFHQKYEHSQLKGNENKNMDAIMENIRPQESEYQDDKNE------PRNVVVA 947
Query: 567 GNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERL 626
G FD ST+Q IKNEDLEEL+ELGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQERL
Sbjct: 948 GEFDTSTVQFIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERL 1007
Query: 627 TLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 686
T+EFWREA+ILSKLHHPNVVAFYGVVQDGPG TLATVTEFMV+GSLR+VLL K+R+LDRR
Sbjct: 1008 TIEFWREADILSKLHHPNVVAFYGVVQDGPGATLATVTEFMVDGSLRNVLLRKDRYLDRR 1067
Query: 687 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 746
KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV+
Sbjct: 1068 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVS 1127
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806
GGVRGTLPWMAPELLNGSS+KVSEKVDVFSFGIVLWEILTG+EPYANMHYGAIIGGIVNN
Sbjct: 1128 GGVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLWEILTGDEPYANMHYGAIIGGIVNN 1187
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC-QTKSHGHQV 861
TLRP +P +CD EW+ LMEQCWAP+P VRPSF EIARRLRVMSAA Q K GH+
Sbjct: 1188 TLRPTIPSYCDLEWKTLMEQCWAPNPAVRPSFAEIARRLRVMSAAASQIKGQGHKA 1243
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555219|ref|XP_003545932.1| PREDICTED: uncharacterized protein LOC100802996 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/784 (54%), Positives = 530/784 (67%), Gaps = 36/784 (4%)
Query: 88 EEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR--KNNDDDVRFQASGGAF 145
E + + S G+ P+L PSK+ Q+ S ++N + K+ +DD F S AF
Sbjct: 484 EASATTAISEGLHPAL-PSKNKGKHQQSEDASSLFSSMNPTQTPKSVEDDF-FTTSNDAF 541
Query: 146 TSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEK-NRLSKSDDSFGSQFLISQAL 203
+ H D+E+ +FSY P +P R Y+SE+IPREQ + NR +KSDD+ GS L+S L
Sbjct: 542 SRAHVDAESNVIDFSYLEPPPLPNRVYYSERIPREQADLLNRSTKSDDAHGSHLLMSDLL 601
Query: 204 SDGSK--PIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFADKIN 261
SD S+ I ES D LHSGNM++ S + AK + + D Q +K+ D +
Sbjct: 602 SDFSQKNSITESSDILHSGNMSNLNMMSSSAAKPLQADGHTINDVLPQ--TYKQLPDTTS 659
Query: 262 KINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPTANH 321
K+NS L V +S E K+ + ++ G H +
Sbjct: 660 KVNS-------------KLLQHVNSESKQVLEDNKVSRNEDQVLSSENRTKGAEHLAFHR 706
Query: 322 GTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIAVVS 381
S ++ ++ + K + +E++ + + ND K Q+Q+ N+ + VS A
Sbjct: 707 VPSVEHNQNLTSKLPDLNLSEVST-RESDNDTKVQSQTFPLTGNTGQDVSQEFPPEAKSR 765
Query: 382 P-EGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYF 440
P +GDILIDI DRFPRDFL D+F+KA ISE+ + + P+ D A LS N+ NH+P+RWSYF
Sbjct: 766 PTQGDILIDIEDRFPRDFLYDMFSKAIISEDSSSIGPLPTDRAGLSLNMGNHEPKRWSYF 825
Query: 441 RNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFD 500
+NLA++ F +VSL+DQD+LGFSS + ++EG + PL G + + S +N
Sbjct: 826 QNLAKEGFD--NVSLIDQDNLGFSSAVRKVQEGDSKSQPSAPLPAAGVLAGHTESHLNVG 883
Query: 501 EGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQ--ESDYEEGRLDLPTAG 558
E SQ+ H Y S+LKGNE+ + V IQ ES+Y++G+ +
Sbjct: 884 EESQKNVPVATKTEATIFHQKYEHSQLKGNENKNMDAVMENIQPQESEYQDGKDE----- 938
Query: 559 IPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTG 618
P + G FD ST+Q IKNEDLEEL+ELGSGTFGTVYHGKWRG+DVAIKRIKKSCF G
Sbjct: 939 -PRNVVVAGEFDTSTVQFIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAG 997
Query: 619 RSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS 678
RSSEQERLT+EFWREA+ILSKLHHPNVVAFYGVVQDGPG TLATV E+MV+GSLR+VLL
Sbjct: 998 RSSEQERLTIEFWREADILSKLHHPNVVAFYGVVQDGPGATLATVAEYMVDGSLRNVLLR 1057
Query: 679 KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
K+R+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP+RPICKVGDFGLSK
Sbjct: 1058 KDRYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPMRPICKVGDFGLSK 1117
Query: 739 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 798
IKRNTLV+GGVRGTLPWMAPELLNGSS+KVSEKVDVFSFGIVLWEILTG+EPYANMHYGA
Sbjct: 1118 IKRNTLVSGGVRGTLPWMAPELLNGSSNKVSEKVDVFSFGIVLWEILTGDEPYANMHYGA 1177
Query: 799 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC-QTKSH 857
IIGGIVNNTLRP +P +CD +W+ LMEQCWAP+P VRPSFTEIARRLRVMSAA Q K
Sbjct: 1178 IIGGIVNNTLRPTIPSYCDLDWKTLMEQCWAPNPAVRPSFTEIARRLRVMSAAASQIKGQ 1237
Query: 858 GHQV 861
GH+
Sbjct: 1238 GHKA 1241
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 867 | ||||||
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.409 | 0.282 | 0.746 | 9.4e-195 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.762 | 0.529 | 0.531 | 7.4e-169 | |
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.416 | 0.314 | 0.740 | 3.8e-168 | |
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.326 | 0.253 | 0.809 | 6.4e-130 | |
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.380 | 0.316 | 0.717 | 4.2e-127 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.336 | 0.249 | 0.715 | 1.5e-120 | |
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.400 | 0.329 | 0.600 | 1.6e-117 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.291 | 0.330 | 0.427 | 6.1e-46 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.309 | 0.287 | 0.388 | 1.5e-43 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.302 | 0.254 | 0.4 | 2e-43 |
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1395 (496.1 bits), Expect = 9.4e-195, Sum P(3) = 9.4e-195
Identities = 274/367 (74%), Positives = 306/367 (83%)
Query: 503 SQRESSSIVGPSTM---ETHPDYSRSELKGNESL--QSEVVNHRIQESDYEEGRLDLPTA 557
S++ +SS + P PD S + ++ Q + +I+ ++ + L+ A
Sbjct: 893 SEKVASSQIHPQIHFDGNIKPDVSTITIPDLNTVDTQEDYSQSQIKGAESTDATLN---A 949
Query: 558 GIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFT 617
G+PL+D + + +LQ+IKN+DLEELKELGSGTFGTVYHGKWRGTDVAIKRIK+SCF
Sbjct: 950 GVPLIDFMAADSGMRSLQVIKNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKRSCFI 1009
Query: 618 GRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL 677
GRSSEQERLT EFW EAEILSKLHHPNV+AFYGVV+DGPGGTLATVTE+MVNGSLRHVLL
Sbjct: 1010 GRSSEQERLTSEFWHEAEILSKLHHPNVMAFYGVVKDGPGGTLATVTEYMVNGSLRHVLL 1069
Query: 678 SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737
S RHLDRRKRLIIAMDAAFGMEYLHSK+IVHFDLKCDNLLVNLKDP RPICKVGDFGLS
Sbjct: 1070 SN-RHLDRRKRLIIAMDAAFGMEYLHSKSIVHFDLKCDNLLVNLKDPARPICKVGDFGLS 1128
Query: 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 797
KIKRNTLVTGGVRGTLPWMAPELL+GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG
Sbjct: 1129 KIKRNTLVTGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1188
Query: 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA-ACQTKS 856
AIIGGIVNNTLRP VP +CD EWR+LMEQCWAPDP VRP+F EIARRLR MS+ A TK
Sbjct: 1189 AIIGGIVNNTLRPTVPNYCDPEWRMLMEQCWAPDPFVRPAFPEIARRLRTMSSSAVHTKP 1248
Query: 857 HG--HQV 861
H HQ+
Sbjct: 1249 HAVNHQI 1255
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1642 (583.1 bits), Expect = 7.4e-169, P = 7.4e-169
Identities = 370/696 (53%), Positives = 458/696 (65%)
Query: 177 PREQTEKNRLSKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQ 236
PR+ T + D Q +S + D + +HS + ++ + + P +Q
Sbjct: 573 PRQNTTAKPATYRDAVITGQVPLS-GIEDQLSTSSSTYAPVHSDSESNLIDLNY-PEPEQ 630
Query: 237 YTNLQKVEDGHAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTK 296
+ Q+V R+ E ++++K +++ S + S + Q K A V K
Sbjct: 631 SS--QRVYCSERIPREQLELLNRLSKSDNSLSSQFVTSESPANTAQQDSGKEA----VGK 684
Query: 297 IRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQ 356
+ K ++ND+ H T H E + E + I N + NK +
Sbjct: 685 SHDEFK--TVNDDAN----HHT--HKDVETIFEKVGVSDETLESEPLHKIVNPDDANKNR 736
Query: 357 AQSLAQKENSVRAVSPGDSSIAVVSPE------GDILIDINDRFPRDFLSDIFTKARISE 410
+ A E V +S +++++ V PE GDILIDINDRFPRDFLS+IF++A ISE
Sbjct: 737 VVNGADTEIGVSNLSHVNAAMSHVIPEEQASLQGDILIDINDRFPRDFLSEIFSQA-ISE 795
Query: 411 NIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNI 470
+ + V P DGA +S NV+NHD + WSYF+ LA+D+F ++DV ++DQ S +
Sbjct: 796 DTSTVRPYPHDGAAVSMNVQNHDRKNWSYFQQLAEDQFIQRDV-VLDQADSRIPSDRKDG 854
Query: 471 EEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530
E + + Y PL DG + ++ + S G T P ++K
Sbjct: 855 GESSRLPY-VSPLSRDGISTNLANPQLTLGQDYGGNFSEKDGGGTGSIPPALENEQMKVT 913
Query: 531 ESLQ--SEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGN-FDISTLQIIKNEDLEELKE 587
ES + + V N R +S+ ++ + + A +P LG+ FD S LQIIKNEDLEEL+E
Sbjct: 914 ESEEFGAMVENLRTPDSEPKDEKTETRHAALP----PLGSEFDYSGLQIIKNEDLEELRE 969
Query: 588 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647
LGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQERLT EFW EAEILSKLHHPNVVA
Sbjct: 970 LGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEILSKLHHPNVVA 1029
Query: 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI 707
FYGVV+DGPGGTLATVTE+MV+GSLRHVL+ K+RHLDRRKRLIIAMDAAFGMEYLHSKN
Sbjct: 1030 FYGVVKDGPGGTLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAAFGMEYLHSKNT 1089
Query: 708 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 767
VHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTLV+GGVRGTLPWMAPELLNGSSSK
Sbjct: 1090 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNGSSSK 1149
Query: 768 VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQC 827
VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP +PGFCD EWR LME+C
Sbjct: 1150 VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPGFCDDEWRTLMEEC 1209
Query: 828 WAPDPVVRPSFTEIARRLRVMSAAC---QTKSHGHQ 860
WAP+P+ RPSFTEIA RLRVMS+A Q+K H+
Sbjct: 1210 WAPNPMARPSFTEIAGRLRVMSSAATSTQSKPSAHR 1245
|
|
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1400 (497.9 bits), Expect = 3.8e-168, Sum P(2) = 3.8e-168
Identities = 271/366 (74%), Positives = 306/366 (83%)
Query: 498 NFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTA 557
+ ++G + V P T E D + ++ +E + V N R + + E+ + + A
Sbjct: 781 DMEDGGEIARLHQVAPLT-ENRVD-PQMKVTESEEFDAMVENLRTSDCEQEDEKSETRNA 838
Query: 558 GIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFT 617
G+P V +L ++D S LQII N+DLEELKELGSGTFGTVYHGKWRG+DVAIKRIKKSCF
Sbjct: 839 GLPPVGPSLADYDTSGLQIIMNDDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKSCFA 898
Query: 618 GRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL 677
GRSSEQERLT EFW EAEILSKLHHPNVVAFYGVV+DGPG TLATVTE+MV+GSLRHVL+
Sbjct: 899 GRSSEQERLTGEFWGEAEILSKLHHPNVVAFYGVVKDGPGATLATVTEYMVDGSLRHVLV 958
Query: 678 SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737
K+RHLDRRKRLIIAMDAAFGMEYLH+KNIVHFDLKCDNLLVNLKDP RPICKVGDFGLS
Sbjct: 959 RKDRHLDRRKRLIIAMDAAFGMEYLHAKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 1018
Query: 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 797
KIKRNTLV+GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG
Sbjct: 1019 KIKRNTLVSGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 1078
Query: 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC---QT 854
AIIGGIVNNTLRP +P +CDS+WR+LME+CWAP+P RPSFTEIA RLRVMS A Q+
Sbjct: 1079 AIIGGIVNNTLRPTIPSYCDSDWRILMEECWAPNPTARPSFTEIAGRLRVMSTAATSNQS 1138
Query: 855 KSHGHQ 860
K H+
Sbjct: 1139 KPPAHK 1144
|
|
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1216 (433.1 bits), Expect = 6.4e-130, Sum P(3) = 6.4e-130
Identities = 229/283 (80%), Positives = 249/283 (87%)
Query: 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWRE 633
LQIIKN DLE+L ELGSGT+GTVYHG WRGTDVAIKRI+ SCF GRSSEQERLT +FWRE
Sbjct: 828 LQIIKNADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWRE 887
Query: 634 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
A+ILS LHHPNVVAFYG+V DG GGTLATVTEFMVNGSLRH LL K+R LD RK++IIAM
Sbjct: 888 AQILSNLHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIAM 947
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 753
DAAFGMEYLHSKNIVHFDLKC+NLLVNL+DP RPICKVGD GLS+IKRNTLV+GGVRGTL
Sbjct: 948 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGTL 1007
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813
PWMAPELLNGSS++VSEKVDVFS+GI LWEILTGEEPYA+MH GAIIGGIV NTLRPP+P
Sbjct: 1008 PWMAPELLNGSSTRVSEKVDVFSYGISLWEILTGEEPYADMHCGAIIGGIVKNTLRPPIP 1067
Query: 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKS 856
C EW+ LMEQCW+ DP RP FTEI RLR MS TKS
Sbjct: 1068 KSCSPEWKKLMEQCWSVDPDSRPPFTEITCRLRSMSMEVVTKS 1110
|
|
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1248 (444.4 bits), Expect = 4.2e-127, P = 4.2e-127
Identities = 244/340 (71%), Positives = 278/340 (81%)
Query: 517 ETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGR-LDLPTAGIPLVDLALGNFDISTLQ 575
+ H Y+R + N +SE+ E Y++ R D + +V++ G I LQ
Sbjct: 709 DDHKSYTREKEITNADHESEM------EEKYKKSRNTDDSFSEAAMVEIEAG---IYGLQ 759
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
IIKN DLE+L ELGSGTFGTVY+GKWRGTDVAIKRIK SCF+G SSEQ R T +FWREA
Sbjct: 760 IIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNSCFSGGSSEQARQTKDFWREAR 819
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
IL+ LHHPNVVAFYGVV DGPGGT+ATVTE+MVNGSLRHVL K+R LDRRK+L+I +D+
Sbjct: 820 ILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRHVLQRKDRLLDRRKKLMITLDS 879
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 755
AFGMEYLH KNIVHFDLKCDNLLVNL+DP RPICKVGDFGLS+IKRNTLV+GGVRGTLPW
Sbjct: 880 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPW 939
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
MAPELLNGSS++VSEKVDVFSFGIV+WEILTGEEPYAN+H GAIIGGIVNNTLRPPVP
Sbjct: 940 MAPELLNGSSNRVSEKVDVFSFGIVMWEILTGEEPYANLHCGAIIGGIVNNTLRPPVPER 999
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 855
C++EWR LMEQCW+ DP VRPSFTEI RLR M+ A Q K
Sbjct: 1000 CEAEWRKLMEQCWSFDPGVRPSFTEIVERLRSMTVALQPK 1039
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1132 (403.5 bits), Expect = 1.5e-120, Sum P(3) = 1.5e-120
Identities = 209/292 (71%), Positives = 241/292 (82%)
Query: 567 GNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERL 626
G+ + LQIIK+ DLEEL+ELGSGTFGTVYHGKWRGTDVAIKRI CF G+ SEQER+
Sbjct: 873 GSDSLDQLQIIKDSDLEELRELGSGTFGTVYHGKWRGTDVAIKRINDRCFAGKPSEQERM 932
Query: 627 TLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 686
+FW EA+ L+ LHHPNVVAFYGVV D PGG++ATVTE+MVNGSLR+ L R+ DR
Sbjct: 933 IDDFWNEAQNLAGLHHPNVVAFYGVVLDSPGGSVATVTEYMVNGSLRNALQKNVRNFDRC 992
Query: 687 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 746
KR +IAMD AFGMEYLH K IVHFDLK DNLLVNL+DP RPICKVGD GLSK+K TL++
Sbjct: 993 KRQLIAMDIAFGMEYLHGKKIVHFDLKSDNLLVNLRDPHRPICKVGDLGLSKVKCQTLIS 1052
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806
GGVRGTLPWMAPELLNG+SS VSEKVDVFSFGIVLWE+ TGEEPYA++HYGAIIGGIV+N
Sbjct: 1053 GGVRGTLPWMAPELLNGTSSLVSEKVDVFSFGIVLWELFTGEEPYADLHYGAIIGGIVSN 1112
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHG 858
TLRP +P FCD +W+LLME+CW+ +P RPSFTEI LR M+ +K G
Sbjct: 1113 TLRPQIPDFCDMDWKLLMERCWSAEPSERPSFTEIVNELRTMATKLPSKEQG 1164
|
|
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1133 (403.9 bits), Expect = 1.6e-117, Sum P(2) = 1.6e-117
Identities = 209/348 (60%), Positives = 270/348 (77%)
Query: 508 SSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALG 567
+++ G + ++ HP+ ++ +++ E +++E + Q+ + D P A
Sbjct: 708 AALEGAAEVKAHPEEAKDQVRP-ELVENESEHMNAQDEPEIDSDSDNPNNFKIEQTKAEA 766
Query: 568 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLT 627
LQ I+N+DLEE++ELG GT+G+VYHGKW+G+DVAIKRIK SCF G+ SE+ERL
Sbjct: 767 EAKSRGLQSIRNDDLEEIRELGHGTYGSVYHGKWKGSDVAIKRIKASCFAGKPSERERLI 826
Query: 628 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
+FW+EA +LS LHHPNVV+FYG+V+DGP G+LATV EFMVNGSL+ L K+R +DRRK
Sbjct: 827 EDFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVAEFMVNGSLKQFLQKKDRTIDRRK 886
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747
RLIIAMD AFGMEYLH KNIVHFDLKC+NLLVN++DP RPICK+GD GLSK+K+ TLV+G
Sbjct: 887 RLIIAMDTAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQKTLVSG 946
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807
GVRGTLPWMAPELL+G S+ VSEK+DV+SFGIV+WE+LTGEEPYA+MH +IIGGIVNN
Sbjct: 947 GVRGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGEEPYADMHCASIIGGIVNNA 1006
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 855
LRP +P +CD EW+ LME CW +P RPSFTEI+++LR M+AA K
Sbjct: 1007 LRPKIPQWCDPEWKGLMESCWTSEPTERPSFTEISQKLRTMAAAMNLK 1054
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 6.1e-46, Sum P(3) = 6.1e-46
Identities = 115/269 (42%), Positives = 157/269 (58%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
EDL +++G G+ GTVYHG W G+DVA+K K ++ E + F +E ++ +
Sbjct: 485 EDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYS------EEIITSFKQEVSLMKR 538
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
L HPNV+ F G V P L VTEF+ GSL +L + LD R+R+ +A D A GM
Sbjct: 539 LRHPNVLLFMGAVAS-PQ-RLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGM 596
Query: 700 EYLH--SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
YLH S I+H DLK NLLV+ + KV DFGLS+IK T +T RGT WMA
Sbjct: 597 NYLHHCSPPIIHRDLKSSNLLVDRNWTV----KVADFGLSRIKHETYLTTNGRGTPQWMA 652
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817
PE+L ++ EK DV+SFG+VLWE++T + P+ N++ +IG + R VP D
Sbjct: 653 PEVLRNEAA--DEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVD 710
Query: 818 SEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
+W LME CW +P RPSF E+ +LR
Sbjct: 711 PQWIALMESCWHSEPQCRPSFQELMDKLR 739
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 1.5e-43, Sum P(2) = 1.5e-43
Identities = 112/288 (38%), Positives = 163/288 (56%)
Query: 566 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 625
L + D+ +I N DL + +G G++G VYH W GT+VA+K+ F+G +
Sbjct: 654 LDDADVGECEIPWN-DLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA----- 707
Query: 626 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR 685
EF E I+ +L HPNVV F G V P L+ VTEF+ GSL +L + H+D
Sbjct: 708 -LAEFRSEVRIMRRLRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHIDE 764
Query: 686 RKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743
R+R+ +A+D A GM LH+ IVH DLK NLLV+ + KVGDFGLS++K NT
Sbjct: 765 RRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNV----KVGDFGLSRLKHNT 820
Query: 744 LVTG-GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 802
++ GT WMAPE+L S +EK DV+SFG++LWE+ T P+ M+ ++G
Sbjct: 821 FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLRLPWRGMNPMQVVGA 878
Query: 803 IVNNTLRPPVPGFCDSE-WRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
+ R +P D R+++E CW DP +RPSF ++ L+ ++
Sbjct: 879 VGFQNRRLEIPKELDPVVGRIILE-CWQTDPNLRPSFAQLTEVLKPLN 925
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 496 (179.7 bits), Expect = 2.0e-43, Sum P(2) = 2.0e-43
Identities = 112/280 (40%), Positives = 162/280 (57%)
Query: 570 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 629
D+S +I+ E++ + +G G++G VY G W GT+VA+K+ TG + E E
Sbjct: 737 DVSDCEILW-EEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALE------E 789
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
F E I+ KL HPN+V F G V P L+ VTEF+ GSL ++ LD R+RL
Sbjct: 790 FRSEVRIMKKLRHPNIVLFMGAVTRPPN--LSIVTEFLPRGSLYRLIHRPNNQLDERRRL 847
Query: 690 IIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747
+A+DAA GM YLHS N IVH DLK NLLV+ K+ + +C DFGLS++K +T ++
Sbjct: 848 RMALDAARGMNYLHSCNPMIVHRDLKSPNLLVD-KNWVVKVC---DFGLSRMKHSTYLSS 903
Query: 748 -GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806
GT WMAPE+L + EK DV+S+G++LWE+ T ++P+ M+ ++G +
Sbjct: 904 KSTAGTAEWMAPEVLRNEPA--DEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQ 961
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
R +P F D L+ +CW D +RPSF EI L+
Sbjct: 962 HRRLDIPDFVDPAIADLISKCWQTDSKLRPSFAEIMASLK 1001
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 867 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-80 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-78 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-78 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-72 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-59 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-51 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-49 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-47 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-46 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-45 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-45 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-45 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-45 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-44 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-43 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-43 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-42 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-41 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-40 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-40 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-40 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-40 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-39 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-38 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-38 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-37 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-37 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-37 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-37 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-37 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-37 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-37 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-36 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-35 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-35 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-35 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-34 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-34 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-33 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-32 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-32 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-32 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-32 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-32 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-32 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-31 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-30 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-29 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-29 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-29 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-29 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-29 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-29 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-28 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-28 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-28 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-27 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-26 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-26 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-26 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-25 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-24 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-24 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-24 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-23 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-21 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-20 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-18 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-17 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-15 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-14 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-11 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 8e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 4e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-04 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 260 bits (666), Expect = 1e-80
Identities = 112/278 (40%), Positives = 139/278 (50%), Gaps = 34/278 (12%)
Query: 582 LEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
LE K+LG G FG VY G +G T VA+K +K+ +SE+ER EF EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-----ASEEERE--EFLEEAS 53
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
I+ KL HPN+V GV G L VTE+M G L L L + L +A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGT 752
A GMEYL SKN VH DL N LV + K+ DFGLS+ GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTEN----LVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIVNNT 807
+ WMAPE L K + K DV+SFG++LWEI T GE+PY M + G
Sbjct: 168 IKWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG----- 220
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
R P P C E LM QCWA DP RP+F+E+ L
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 253 bits (650), Expect = 2e-78
Identities = 111/274 (40%), Positives = 139/274 (50%), Gaps = 27/274 (9%)
Query: 582 LEELKELGSGTFGTVYHGKWRGT------DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
L K+LG G FG VY GK +G +VA+K +K+ SEQ+ EF REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-----SEQQIE--EFLREAR 53
Query: 636 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
I+ KL HPNVV GV ++ P L V E+M G L L L L A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEP---LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ 110
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
A GMEYL SKN +H DL N LV + K+ DFGLS+ + G LP
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
WMAPE L K + K DV+SFG++LWEI T GE+PY M ++ + N R P
Sbjct: 167 IRWMAPESLK--EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLP 223
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C E LM QCWA DP RP+F+E+ L
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 253 bits (649), Expect = 3e-78
Identities = 106/274 (38%), Positives = 135/274 (49%), Gaps = 26/274 (9%)
Query: 582 LEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
L K+LG G FG VY G +G +VA+K +K+ +SEQ+ EF REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIE--EFLREAR 53
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMD 694
I+ KL HPN+V GV + + V E+M G L L L L A+
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMI--VMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
A GMEYL SKN +H DL N LV + K+ DFGLS+ + G LP
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
WMAPE L K + K DV+SFG++LWEI T GEEPY M ++ + P
Sbjct: 168 IRWMAPESLK--EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK 225
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C E LM QCWA DP RP+F+E+ L
Sbjct: 226 PPN-CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 4e-72
Identities = 104/279 (37%), Positives = 138/279 (49%), Gaps = 35/279 (12%)
Query: 586 KELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
K+LG G FG VY GK +G T+VA+K +K+ +SE+ER +F +EA ++ KL
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----ASEEERK--DFLKEARVMKKL 53
Query: 641 HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------ERHLDRRKRLII 691
HPNVV GV ++ P L V E+M G L L + L + L
Sbjct: 54 GHPNVVRLLGVCTEEEP---LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV-TGGVR 750
A+ A GMEYL SK VH DL N LV + K+ DFGLS+ +
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGED----LVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 751 GTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807
G LP WMAPE L + K DV+SFG++LWEI T G PY + ++ +
Sbjct: 167 GKLPIRWMAPESLK--DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-YLRKG 223
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
R P P +C E LM CW DP RP+F+E+ RL
Sbjct: 224 YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 6e-62
Identities = 86/263 (32%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E L++LG G+FG VY + + T VAIK IKK ++ER RE +IL KL
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK---KIKKDRER----ILREIKILKKL 54
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
HPN+V Y V +D L V E+ G L +L + R + R + +E
Sbjct: 55 KHPNIVRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR-QILSALE 111
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPEL 760
YLHSK IVH DLK +N+L++ + K+ DFGL++ GT +MAPE+
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHV----KLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPPVPGF-CDS 818
L G + VD++S G++L+E+LTG+ P+ + I P P +
Sbjct: 168 LLG--KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP 225
Query: 819 EWRLLMEQCWAPDPVVRPSFTEI 841
E + L+ + DP R + E
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 1e-60
Identities = 94/270 (34%), Positives = 145/270 (53%), Gaps = 26/270 (9%)
Query: 582 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E L++LGSG+FGTVY K +GT VA+K +KK S++++ RE IL +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR---SEKSKKDQ---TARREIRILRR 54
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
L HPN+V +D L V E+ G L LS+ L + IA+ G+
Sbjct: 55 LSHPNIVRLIDAFEDK--DHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGL 111
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMA 757
EYLHS I+H DLK +N+L++ + K+ DFGL+K +K ++ +T V GT +MA
Sbjct: 112 EYLHSNGIIHRDLKPENILLDEN----GVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMA 166
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817
PE+L G + KVDV+S G++L+E+LTG+ P++ + + ++ L PP+
Sbjct: 167 PEVLLG-GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL-QLIRRILGPPLEFDEP 224
Query: 818 ------SEWRLLMEQCWAPDPVVRPSFTEI 841
E + L+++C DP RP+ EI
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 7e-59
Identities = 89/257 (34%), Positives = 123/257 (47%), Gaps = 49/257 (19%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G FGTVY + + T VAIK IKK + L E RE EIL KL+HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE-------DSSSLLEELLREIEILKKLNHPNI 53
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 705
V YGV +D L V E+ GSL+ +L E L + L I + G+EYLHS
Sbjct: 54 VKLYGVFEDENHLYL--VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLNGS 764
I+H DLK +N+L++ + K+ DFGLSK + + + + GT +MAPE+L G
Sbjct: 112 GIIHRDLKPENILLDSDN---GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG- 167
Query: 765 SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM 824
SEK D++S G++L+E+ E + L+
Sbjct: 168 KGYYSEKSDIWSLGVILYEL---------------------------------PELKDLI 194
Query: 825 EQCWAPDPVVRPSFTEI 841
+ DP RPS EI
Sbjct: 195 RKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 6e-51
Identities = 98/273 (35%), Positives = 136/273 (49%), Gaps = 26/273 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
I +++L+ +G G FG V G +RG VA+K +K ++ F EA +
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA---------FLAEASV 53
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDA 695
++ L HPN+V GVV G L VTE+M GSL L S+ R + ++L A+D
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP- 754
GMEYL KN VH DL N+LV+ + KV DFGL+K + G LP
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDS----GKLPV 163
Query: 755 -WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812
W APE L K S K DV+SFGI+LWEI + G PY + ++ + R
Sbjct: 164 KWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEA 220
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C E +M+ CW DP RP+F ++ +L
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 95/272 (34%), Positives = 136/272 (50%), Gaps = 25/272 (9%)
Query: 586 KELGSGTFGTVYHGKWRGT-----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
K +G G FG V G+ + DVAIK +K S+++RL +F EA I+ +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----SDKQRL--DFLTEASIMGQF 62
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
HPN++ GVV + +TE+M NGSL L + + + + A GM+
Sbjct: 63 DHPNIIRLEGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMA 757
YL N VH DL N+LVN +CKV DFGLS+ + T T G + + W A
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNL----VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
PE + + K + DV+SFGIV+WE+++ GE PY +M +I + + R P P C
Sbjct: 177 PEAI--AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDC 233
Query: 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
S LM CW D RP+F++I L M
Sbjct: 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 8e-49
Identities = 87/266 (32%), Positives = 129/266 (48%), Gaps = 29/266 (10%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ LG G+FG+VY + T +A+K ++ S + E LE RE ILS L HP
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA----LE--REIRILSSLQHP 59
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-----RRKRLIIAMDAAFG 698
N+V +YG +D TL E++ GSL LL K L + R I+ G
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE-----G 113
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---RNTLVTGGVRGTLPW 755
+ YLHS IVH D+K N+LV+ + K+ DFG +K TG VRGT W
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGIVNNTLRPPVPG 814
MAPE++ G + D++S G + E+ TG+ P++ + A + I ++ P +P
Sbjct: 170 MAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227
Query: 815 FCDSEWRLLMEQCWAPDPVVRPSFTE 840
E + + +C DP RP+ E
Sbjct: 228 HLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 95/270 (35%), Positives = 137/270 (50%), Gaps = 24/270 (8%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
+L LKELGSG FG V+ GKWRG DVAIK I++ G SE + F EA+++ K
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSEDD-----FIEEAKVMMK 55
Query: 640 LHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 698
L HPN+V YGV + P + VTE+M NG L + L ++ L L + D
Sbjct: 56 LSHPNLVQLYGVCTKQRP---IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPWM 756
MEYL S +H DL N LV + KV DFGL++ + T G + + W
Sbjct: 113 MEYLESNGFIHRDLAARNCLVGE----DNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
PE+ + S+ S K DV+SFG+++WE+ + G+ PY ++ + R P
Sbjct: 169 PPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKL 225
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
+E +M CW P RP+F ++ +L
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-46
Identities = 96/268 (35%), Positives = 136/268 (50%), Gaps = 25/268 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E L+ ++LG+G FG V+ G W G T VA+K +K + + F +EA+
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---------FLQEAQ 53
Query: 636 ILSKLHHPNVVAFYGVVQDG-PGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAM 693
I+ KL H +V Y V + P + VTE+M GSL L S E + L + + +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEP---IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRG 751
A GM YL S+N +H DL N+LV +CK+ DFGL+++ + T G +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGEN----LVCKIADFGLARLIEDDEYTAREGAKF 166
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810
+ W APE N + + K DV+SFGI+L EI+T G PY M ++ + R
Sbjct: 167 PIKWTAPEAAN--YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRM 223
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSF 838
P P C E LM QCW DP RP+F
Sbjct: 224 PRPPNCPEELYDLMLQCWDKDPEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 89/287 (31%), Positives = 140/287 (48%), Gaps = 31/287 (10%)
Query: 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLT 627
L+I+K +LE++K LGSG FGTVY G W VAIK +++ T + +E L
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEIL- 57
Query: 628 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRR 686
EA +++ + HP+VV G+ + +T+ M G L +V K+ + +
Sbjct: 58 ----DEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQ 109
Query: 687 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNT 743
L + A GM YL K +VH DL N+LV K P K+ DFGL+K+
Sbjct: 110 YLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTP--QHVKITDFGLAKLLDVDEKE 165
Query: 744 LVTGGVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIG 801
G + + WMA E +L+ + K DV+S+G+ +WE++T G +PY + I
Sbjct: 166 YHAEGGKVPIKWMALESILHR---IYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIP 221
Query: 802 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
++ R P P C + +++ +CW D RP+F E+ M
Sbjct: 222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 103/267 (38%), Positives = 143/267 (53%), Gaps = 25/267 (9%)
Query: 586 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 644
+++G G FG VY G + T+VA+K +C RS+ L +F +EAEIL + HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TC---RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 645 VVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+V GV VQ P + V E + GSL L K+ L +K L +++DAA GMEYL
Sbjct: 54 IVKLIGVCVQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLP--WMAPE 759
SKN +H DL N LV + + K+ DFG+S+ + + V+ G +P W APE
Sbjct: 111 SKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPE 165
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 818
LN + + + DV+S+GI+LWE + G+ PY M + + R P P C
Sbjct: 166 ALN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMS-NQQTRERIESGYRMPAPQLCPE 222
Query: 819 EWRLLMEQCWAPDPVVRPSFTEIARRL 845
E LM QCWA DP RPSF+EI L
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 8e-45
Identities = 94/275 (34%), Positives = 135/275 (49%), Gaps = 25/275 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I ++ L++LG+G FG V+ G W T VA+K +K G ++ F EA+
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKD-----FLAEAQ 53
Query: 636 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAM 693
I+ KL HP ++ Y V + P + VTE M GSL L R L + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP---IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 753
A GM YL ++N +H DL N+LV + ICKV DFGL+++ + +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENN----ICKVADFGLARVIKEDIYEAREGAKF 166
Query: 754 P--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810
P W APE ++ S K DV+SFGI+L EI+T G PY M ++ V+ R
Sbjct: 167 PIKWTAPEAAL--YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-QQVDQGYRM 223
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P P C E +M CW DP RP+F + +L
Sbjct: 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 9e-45
Identities = 98/294 (33%), Positives = 138/294 (46%), Gaps = 44/294 (14%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTL 628
+ E + ++ELG G+FG VY G +G T VAIK + +S +ER+
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENASMRERI-- 54
Query: 629 EFWREAEILSKLHHPNVVAFYGVVQDG-PGGTLATVTEFMVNGSLRHVLLS---KERH-- 682
EF EA ++ + + +VV GVV G P TL V E M G L+ L S + +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQP--TL-VVMELMAKGDLKSYLRSRRPEAENNP 111
Query: 683 ----LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
+K + +A + A GM YL +K VH DL N +V K+GDFG+++
Sbjct: 112 GLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKIGDFGMTR 167
Query: 739 -IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY--- 791
I G +G LP WMAPE L + K DV+SFG+VLWE+ T E+PY
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225
Query: 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
+N + L P C + LM CW +P +RP+F EI L
Sbjct: 226 SNEEVLKFVID--GGHLDLPEN--CPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 97/270 (35%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I +DL LKELG+G FG V +GKWRG DVAIK IK+ G SE E F EA+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDE-----FIEEAK 51
Query: 636 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++ KL H +V YGV + P + VTE+M NG L + L + + L + D
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRP---IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
GM YL SK +H DL N LV+ + KV DFGLS+ + T V P
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQG----CVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W PE+L SK S K DV++FG+++WE+ + G+ PY + + + LR
Sbjct: 165 VRWSPPEVLL--YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLY 221
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P + +M CW RP+F ++
Sbjct: 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 91/272 (33%), Positives = 135/272 (49%), Gaps = 25/272 (9%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
E+ ++LGSG FG V+ G W+ VAIK +K S+ +F +E + L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK--------SDDLLKQQDFQKEVQALK 57
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAF 697
+L H ++++ + V G + +TE M GSL L S E + L + +A A
Sbjct: 58 RLRHKHLISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115
Query: 698 GMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP 754
GM YL +N +H DL N+LV +L +CKV DFGL++ IK + ++ +
Sbjct: 116 GMAYLEEQNSIHRDLAARNILVGEDL------VCKVADFGLARLIKEDVYLSSDKKIPYK 169
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 813
W APE + S K DV+SFGI+L+E+ T G+ PY M+ + I R P P
Sbjct: 170 WTAPEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCP 226
Query: 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
C E +M +CWA +P RPSF + L
Sbjct: 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 95/273 (34%), Positives = 130/273 (47%), Gaps = 32/273 (11%)
Query: 586 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
KELG G FG+V G + +VA+K +K+ + ++ EF REA ++++L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ----EHIAAGKK---EFLREASVMAQL 53
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
HP +V GV + G L V E G L L K R + +A A GM
Sbjct: 54 DHPCIVRLIGVCK-GEPLML--VMELAPLGPL-LKYLKKRREIPVSDLKELAHQVAMGMA 109
Query: 701 YLHSKNIVHFDLKCDN-LLVNLKDPIRPICKVGDFGLSKIKRN-----TLVTGGVRGTLP 754
YL SK+ VH DL N LLVN R K+ DFG+S+ T G R L
Sbjct: 110 YLESKHFVHRDLAARNVLLVN-----RHQAKISDFGMSRALGAGSDYYRATTAG-RWPLK 163
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 813
W APE +N K S K DV+S+G+ LWE + G +PY M GA + ++ + R P P
Sbjct: 164 WYAPECIN--YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLESGERLPRP 220
Query: 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
C E +M CW P RP+F+E+ R
Sbjct: 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 94/298 (31%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTL 628
++ + + +ELG G FG V+ G+ VA+K +K++
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARK 53
Query: 629 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------ 682
+F REAE+L+ H N+V FYGV + G V E+M +G L L S
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 683 -------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGD 733
L + L IA+ A GM YL S++ VH DL N LV +L + K+GD
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL------VVKIGD 165
Query: 734 FGLSK-IKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GE 788
FG+S+ + G LP WM PE ++ K + + DV+SFG+VLWEI T G+
Sbjct: 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVVLWEIFTYGK 222
Query: 789 EPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
+P+ + +I I L P C SE +M CW DP R + +I RL+
Sbjct: 223 QPWYGLSNEEVIECITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 6e-42
Identities = 85/272 (31%), Positives = 129/272 (47%), Gaps = 37/272 (13%)
Query: 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
E L+++G G FG VY + + G +VAIK IK ++E++ E +IL
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKII----NEIQILK 52
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 698
K HPN+V +YG L V EF GSL+ +L S + L + + + G
Sbjct: 53 KCKHPNIVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-----RNTLVTGGVRGTL 753
+EYLHS I+H D+K N+L+ + K+ DFGLS RNT+V GT
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDGEV----KLIDFGLSAQLSDTKARNTMV-----GTP 161
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813
WMAPE++NG K D++S GI E+ G+ PY+ + + I N P
Sbjct: 162 YWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN----GPP 215
Query: 814 GFCDSEW-----RLLMEQCWAPDPVVRPSFTE 840
G + E + +++C +P RP+ +
Sbjct: 216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 88/288 (30%), Positives = 134/288 (46%), Gaps = 37/288 (12%)
Query: 582 LEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
L+ +K+LG G FG V ++ G VA+K + S S+ F RE E
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-------FEREIE 58
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
IL L H N+V + GV + G +L + E++ +GSLR L ++ ++ L+ +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTL 753
GM+YL S+ +H DL N+LV +D + K+ DFGL+K+ + G
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLV----KISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 754 P--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN----- 805
P W APE L +SK S DV+SFG+ L+E+ T G+ + + GI
Sbjct: 175 PIFWYAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232
Query: 806 ----NTLRP----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
L+ P P C E LM+ CW +P RPSF ++ +
Sbjct: 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 1e-40
Identities = 95/276 (34%), Positives = 139/276 (50%), Gaps = 28/276 (10%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I +L +KELGSG FG V+ GKWR VAIK I + G SE++ F EA+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEED-----FIEEAK 51
Query: 636 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++ KL HP +V YGV Q P L VTEFM NG L + L ++ L + L + D
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGT 752
GMEYL + +H DL N LV+ + KV DFG+++ + + G +
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTG----VVKVSDFGMTRYVLDDEYTSSSGAKFP 164
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV--NNTLR 809
+ W PE+ N SK S K DV+SFG+++WE+ T G+ P+ ++ I R
Sbjct: 165 VKWSPPEVFN--FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR 222
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P + + + ++ CW P RP+F E+ R +
Sbjct: 223 PKLA--SMTVYEVMY-SCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 87/267 (32%), Positives = 124/267 (46%), Gaps = 27/267 (10%)
Query: 586 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
K+LG G+FG V G+W + VA+K +K + + F +EA I+ L
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-------FLKEAAIMHSL 53
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMDAAFGM 699
H N++ YGVV P L VTE GSL L H A+ A GM
Sbjct: 54 DHENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGTLPW 755
YL SK +H DL N+L+ D + K+GDFGL + + + ++ ++ W
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKV----KIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 814
APE L + S DV+ FG+ LWE+ T GEEP+A + I+ I R P
Sbjct: 167 CAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE 224
Query: 815 FCDSEWRLLMEQCWAPDPVVRPSFTEI 841
C + +M QCWA +P RP+F +
Sbjct: 225 ACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-40
Identities = 90/268 (33%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 587 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 644
+LG G +G VY G W+ VA+K +K E EF +EA ++ ++ HPN
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEAAVMKEIKHPN 63
Query: 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLH 703
+V GV P +TEFM G+L L R ++ L +A + MEYL
Sbjct: 64 LVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRGTLPWMAPELL 761
KN +H DL N LV + KV DFGLS++ T G + + W APE L
Sbjct: 122 KKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 177
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 820
+ +K S K DV++FG++LWEI T G PY + + ++ R P C +
Sbjct: 178 --AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRMERPEGCPPKV 234
Query: 821 RLLMEQCWAPDPVVRPSFTEIARRLRVM 848
LM CW +P RPSF EI + M
Sbjct: 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 6e-40
Identities = 98/274 (35%), Positives = 140/274 (51%), Gaps = 26/274 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ ++L+ L+ +G G FG V G +RG VA+K IK T ++ F EA +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQA---------FLAEASV 52
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDA 695
+++L H N+V GV+ + GG L VTE+M GSL L S+ R + L+ ++D
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP- 754
MEYL + N VH DL N+LV+ + + KV DFGL+K +T T G LP
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDT----GKLPV 163
Query: 755 -WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812
W APE L K S K DV+SFGI+LWEI + G PY + ++ V +
Sbjct: 164 KWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDA 220
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
P C +M+QCW D RPSF ++ +L
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 99/292 (33%), Positives = 144/292 (49%), Gaps = 39/292 (13%)
Query: 582 LEELKELGSGTFGTV----YH--GKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
L+ +++LG G FG+V Y G VA+K+++ S ++E R +F RE E
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLR---DFEREIE 57
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
IL L H N+V + GV L V E++ GSLR L LD RK L+ A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTGGVRG 751
GMEYL SK VH DL N+LV ++ + K+GDFGL+K+ K V
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVESENRV----KIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MHYGAIIGG------- 802
+ W APE L SK S DV+SFG+VL+E+ T + + + ++G
Sbjct: 174 PIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231
Query: 803 ------IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
++ N R P P C +E +M++CW DP RPSF+E+A ++ +
Sbjct: 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 5e-39
Identities = 92/274 (33%), Positives = 135/274 (49%), Gaps = 24/274 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I +L ++E+GSG FG V+ G W VAIK I++ G SE++ F EA+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEED-----FIEEAQ 51
Query: 636 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++ KL HP +V YGV + P + V EFM +G L L ++ + L + +D
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSP---ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
GM YL S N++H DL N LV + KV DFG+++ + T P
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQ----VVKVSDFGMTRFVLDDQYTSSTGTKFP 164
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W +PE+ S SK S K DV+SFG+++WE+ + G+ PY N ++ I N R
Sbjct: 165 VKWSSPEVF--SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLY 221
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P LM+ CW P RPSF+ + +L
Sbjct: 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 78/260 (30%), Positives = 128/260 (49%), Gaps = 31/260 (11%)
Query: 587 ELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 644
+G G FG VY G G VAIK+I + + + E ++L L HPN
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEI----DLLKNLKHPN 60
Query: 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF------G 698
+V + G ++ +L + E+ NGSLR ++ ++ + L+ A + G
Sbjct: 61 IVKYIGSIETS--DSLYIILEYAENGSLRQII---KKFGPFPESLV----AVYVYQVLQG 111
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMA 757
+ YLH + ++H D+K N+L KD + K+ DFG++ K+ + V GT WMA
Sbjct: 112 LAYLHEQGVIHRDIKAANILTT-KD---GVVKLADFGVATKLNDVSKDDASVVGTPYWMA 167
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817
PE++ S S D++S G + E+LTG PY +++ A + IV + PP+P
Sbjct: 168 PEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGIS 224
Query: 818 SEWRLLMEQCWAPDPVVRPS 837
E + + QC+ DP +RP+
Sbjct: 225 PELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 93/267 (34%), Positives = 136/267 (50%), Gaps = 24/267 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
+ E L+ +K+LG+G FG V+ G + G T VAIK +K+ + + F EA
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---------FLAEAN 53
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMD 694
++ +L HP +V Y VV P + +TE+M NGSL L + E L K + +A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRGT 752
A GM ++ KN +H DL+ N+LV+ CK+ DFGL+++ + T G +
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSET----LCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
+ W APE +N + + K DV+SFGI+L EI+T G PY M +I + R P
Sbjct: 167 IKWTAPEAINYGTFTI--KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMP 223
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSF 838
P C E LM CW P RP+F
Sbjct: 224 RPDNCPEELYELMRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 98/291 (33%), Positives = 142/291 (48%), Gaps = 36/291 (12%)
Query: 570 DISTLQIIKNEDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQE 624
D+S ++I EE+ +G+G FG V G+ R VAIK +K +G + +Q
Sbjct: 2 DVSCVKI------EEV--IGAGEFGEVCRGRLKLPGKREIFVAIKTLK----SGYTEKQR 49
Query: 625 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 684
R +F EA I+ + HPN++ GVV + +TEFM NG+L L +
Sbjct: 50 R---DFLSEASIMGQFDHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQFT 104
Query: 685 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----K 740
+ + + A GM+YL N VH DL N+LVN +CKV DFGLS+
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN----LVCKVSDFGLSRFLEDDT 160
Query: 741 RNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 797
+ T + G +P W APE + + K + DV+S+GIV+WE+++ GE PY +M
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
Query: 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+I I + PP P C + LM CW D RP F +I L M
Sbjct: 219 DVINAIEQDYRLPP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 94/267 (35%), Positives = 138/267 (51%), Gaps = 24/267 (8%)
Query: 586 KELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ +G G FG V+ G+ R T VA+K SC R + L +F +EA IL + HP
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK----SC---RETLPPDLKAKFLQEARILKQYSHP 53
Query: 644 NVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
N+V GV Q P + V E + G L ++ L ++ + + +AA GMEYL
Sbjct: 54 NIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGT-LPWMAPE 759
SK+ +H DL N LV K+ + K+ DFG+S+ + + + TGG++ + W APE
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVL----KISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 818
LN + S + DV+SFGI+LWE + G PYAN+ + +R P P C
Sbjct: 167 ALN--YGRYSSESDVWSFGILLWEAFSLGAVPYANLS-NQQTREAIEQGVRLPCPELCPD 223
Query: 819 EWRLLMEQCWAPDPVVRPSFTEIARRL 845
LME+CW DP RPSF+ + + L
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 93/288 (32%), Positives = 135/288 (46%), Gaps = 34/288 (11%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 629
+ + + L+ LG G FG VY G +RG D VA+K + +SC SEQ+ +
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-----SEQDES--D 55
Query: 630 FWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR--- 685
F EA I+SK +H N+V GV + P + E M G L+ L +R
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSFERLP---RFILLELMAGGDLKSFLRENRPRPERPSS 112
Query: 686 ---RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR 741
+ L A D A G +YL + +H D+ N L+ K P R + K+ DFG+++ I R
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMARDIYR 171
Query: 742 NTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 797
+ G R LP WM PE L+G + K DV+SFG++LWEI + G PY
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGI---FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
Query: 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
++ + P G +R+ M CW P RP+F I R+
Sbjct: 229 EVMEFVTGGGRLDPPKGCPGPVYRI-MTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 87/274 (31%), Positives = 132/274 (48%), Gaps = 36/274 (13%)
Query: 588 LGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
+G G FG VYHG +D A+K + R ++ E + +F +E I+ H
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN------RITDLEEVE-QFLKEGIIMKDFSH 55
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDAAFGMEY 701
PNV++ G+ G L V +M +G LR+ + E H K LI + A GMEY
Sbjct: 56 PNVLSLLGICLPSEGSPL-VVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS---------KIKRNTLVTGGVRGT 752
L SK VH DL N +++ + KV DFGL+ + +T G +
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTV----KVADFGLARDIYDKEYYSVHNHT----GAKLP 165
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
+ WMA E L + K + K DV+SFG++LWE++T G PY ++ I ++ R
Sbjct: 166 VKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLL 222
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P +C +M CW P P +RP+F+E+ R+
Sbjct: 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 99/295 (33%), Positives = 138/295 (46%), Gaps = 44/295 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
+ L+ELG G FG VY G+ G T VAIK +K++ + ++ EF +
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-------AEPKVQQEFRQ 57
Query: 633 EAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERH--------- 682
EAE++S L HPN+V GV ++ P + E++ +G L L+ H
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQP---TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 683 ------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736
LD L IA+ A GMEYL S + VH DL N LV + K+ DFGL
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV----KISDFGL 170
Query: 737 SK-IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 792
S+ I + LP WM PE + K + + D++SFG+VLWEI + G +PY
Sbjct: 171 SRDIYSADYYRVQSKSLLPVRWMPPEAI--LYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
Query: 793 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847
+I I + L P P C + LM +CW P RP F +I RLR
Sbjct: 229 GFSNQEVIEMIRSRQLL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 4e-37
Identities = 98/270 (36%), Positives = 136/270 (50%), Gaps = 30/270 (11%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E L+ +K+LG+G FG V+ G W G T VA+K +K + S F EA+
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---------FLEEAQ 53
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMD 694
I+ KL H +V Y VV + P + VTE+M GSL L E R L + +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTLVTG--GVR 750
A GM Y+ N +H DL+ N+LV L +CK+ DFGL+++ + T G +
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVGDGL------VCKIADFGLARLIEDNEYTARQGAK 164
Query: 751 GTLPWMAPEL-LNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808
+ W APE L G + + K DV+SFGI+L E++T G PY M+ ++ V
Sbjct: 165 FPIKWTAPEAALYG---RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGY 220
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSF 838
R P P C LM QCW DP RP+F
Sbjct: 221 RMPCPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 90/277 (32%), Positives = 134/277 (48%), Gaps = 25/277 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
I+ ED+ + +G G FG VY G + VA+K K + +F
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFL 55
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
+EA I+ + HP++V GV+ + P + V E G LR L + LD ++
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLILY 112
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 751
+ + + YL SK VH D+ N+LV+ D + K+GDFGLS+ + +G
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPDCV----KLGDFGLSRYLEDESYYKASKG 168
Query: 752 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808
LP WMAPE +N + + DV+ FG+ +WEIL G +P+ + +IG I N
Sbjct: 169 KLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE- 225
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
R P+P C LM +CWA DP RP FTE+ +L
Sbjct: 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 8e-37
Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 582 LEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
+ L+++G G G VY R T +VAIK+++ + + L + E I+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------QNKELII---NEILIMKD 71
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
HPN+V +Y G L V E+M GSL ++ ++ + + + G+
Sbjct: 72 CKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRGTL 753
EYLHS+N++H D+K DN+L++ + K+ DFG + K KRN++V GT
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSV----KLADFGFAAQLTKEKSKRNSVV-----GTP 180
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV- 812
WMAPE++ KVD++S GI+ E+ GE PY + I + PP+
Sbjct: 181 YWMAPEVI--KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLK 237
Query: 813 -PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKS 856
P E++ + +C DP RPS E+ + + AC +
Sbjct: 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP-FLKKACPKEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 92/272 (33%), Positives = 140/272 (51%), Gaps = 31/272 (11%)
Query: 581 DLEEL---KELGSGTFGTVYHGKWRGTDVAIKRIKKSC-FTGRSSEQERLTLEFWREAEI 636
+L++L + +G G FG V G++ G VA+K IK C T ++ F E +
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK--CDVTAQA---------FLEETAV 52
Query: 637 LSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 694
++KLHH N+V GV+ +G L V E M G+L + L ++ R L +L+ ++D
Sbjct: 53 MTKLHHKNLVRLLGVILHNG----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD 108
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
A GMEYL SK +VH DL N+LV+ + KV DFGL+++ + + +
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDG----VAKVSDFGLARVGSMGVDNS--KLPVK 162
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 813
W APE L K S K DV+S+G++LWE+ + G PY M + V R P
Sbjct: 163 WTAPEALK--HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-VKECVEKGYRMEPP 219
Query: 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
C ++ +LM CW +P RPSF ++ +L
Sbjct: 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E +K++G G+FG VY + R +D +K I S SE+ER E +IL K
Sbjct: 3 EIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLS----NMSEKEREDAL--NEVKILKK 55
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAA 696
L+HPN++ +Y ++ G L V E+ G L + ++ + + L +
Sbjct: 56 LNHPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGTLPW 755
++YLHS+ I+H D+K N+ + + K+GDFG+SK+ +T+ + V GT +
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNG----LVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR---PPV 812
++PEL + K D++S G VL+E+ T + P+ G + + L+ PP+
Sbjct: 170 LSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPF----EGENLLELALKILKGQYPPI 223
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
P SE R L+ DP RPS +I +
Sbjct: 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-35
Identities = 96/278 (34%), Positives = 137/278 (49%), Gaps = 33/278 (11%)
Query: 588 LGSGTFGTVYHGKWRGTD--------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
LGSG FG VY G VA+K ++K +++QE+ EF +EA ++S
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-----ATDQEKK--EFLKEAHLMSN 55
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS--KERH----LDRRKRLIIAM 693
+HPN+V GV + + E M G L L ER L ++ L I +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP-ICKVGDFGLSK-IKRNTLVTGGVRG 751
D A G YL + +H DL N LV+ K + K+GDFGL++ I ++ G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 752 TLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807
LP WMAPE LL+G K + + DV+SFG+++WEILT G++PY ++ ++ V
Sbjct: 174 LLPVRWMAPESLLDG---KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ-HVTAG 229
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
R P C + LM CWA DP RP+F I L
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-35
Identities = 87/290 (30%), Positives = 134/290 (46%), Gaps = 45/290 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWR 632
+L+E+ LG G FG V+ K +G + V +K ++K+ + E L EF R
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRR 57
Query: 633 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLD 684
E ++ KL H NVV G+ ++ + + E+ G L+ L K L
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 685 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---- 740
++++ + A GM++L + VH DL N LV+ + KV LSK
Sbjct: 116 TKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR----EVKVSLLSLSKDVYNSE 171
Query: 741 ----RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795
RN L+ L W+APE + S K DV+SFG+++WE+ T GE P+ +
Sbjct: 172 YYKLRNALIP------LRWLAPEAV--QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
++ + L PVP C S LM +CWA +P RPSF+E+ L
Sbjct: 224 DEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 5e-35
Identities = 94/270 (34%), Positives = 134/270 (49%), Gaps = 26/270 (9%)
Query: 586 KELGSGTFGTVYHG--KWRG---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
K +G+G FG V+ G K G VAIK +K +E++R +F EA I+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-----YTEKQRQ--DFLSEASIMGQF 63
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
H N++ GVV + +TE+M NG+L L + + + + A GM+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN----TLVTGGVRGTLPWM 756
YL N VH DL N+LVN CKV DFGLS++ + T T G + + W
Sbjct: 122 YLSDMNYVHRDLAARNILVNSN----LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
APE + + K + DV+SFGIV+WE+++ GE PY +M ++ I N+ R P P
Sbjct: 178 APEAI--AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMD 234
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
C S LM QCW D RP F +I L
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 86/274 (31%), Positives = 125/274 (45%), Gaps = 35/274 (12%)
Query: 580 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
DLE +K LG G+ G VY H K G A+K+I G +++L RE +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIH---VDGDEEFRKQLL----RELKT 52
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
L P VV YG G ++ V E+M GSL LL K + IA
Sbjct: 53 LRSCESPYVVKCYGAFYKE--GEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQIL 109
Query: 697 FGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGV 749
G++YLH+K +I+H D+K NLL+N K + K+ DFG+SK+ + NT V
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFV---- 161
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA---NMHYGAIIGGIVNN 806
GT+ +M+PE + G S S D++S G+ L E G+ P+ + ++ I +
Sbjct: 162 -GTVTYMSPERIQGESY--SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG 218
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTE 840
E+R + C DP RPS E
Sbjct: 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-34
Identities = 92/270 (34%), Positives = 129/270 (47%), Gaps = 26/270 (9%)
Query: 586 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
K +G+G FG V G+ R VAIK +K G + +Q R +F EA I+ +
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRR---DFLSEASIMGQF 62
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
HPN++ GVV + VTE+M NGSL L + + + + A GM+
Sbjct: 63 DHPNIIHLEGVVTKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN----TLVTGGVRGTLPWM 756
YL VH DL N+LVN +CKV DFGLS++ + T G + + W
Sbjct: 121 YLSDMGYVHRDLAARNILVNSN----LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
APE + + K + DV+S+GIV+WE+++ GE PY M +I I R P P
Sbjct: 177 APEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMD 233
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
C + LM CW D RP F +I L
Sbjct: 234 CPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 95/272 (34%), Positives = 133/272 (48%), Gaps = 28/272 (10%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E L +LG G FG V+ G W GT VAIK +K + F +EA+
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---------FLQEAQ 53
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMD 694
I+ KL H +V Y VV + P + VTEFM GSL L + ++L + + +A
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ 110
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTLVTG--GVR 750
A GM Y+ N +H DL+ N+LV NL +CK+ DFGL+++ + T G +
Sbjct: 111 IADGMAYIERMNYIHRDLRAANILVGDNL------VCKIADFGLARLIEDNEYTARQGAK 164
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 809
+ W APE + + K DV+SFGI+L E++T G PY M ++ V R
Sbjct: 165 FPIKWTAPEA--ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERGYR 221
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P P C LM+ CW DP RP+F I
Sbjct: 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 97/270 (35%), Positives = 133/270 (49%), Gaps = 30/270 (11%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E L +LG G FG V+ G W GT VAIK +K + + F +EA+
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQ 53
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 694
++ KL H +V Y VV + P + VTE+M GSL L + R +L+ +A
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 110
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTLVTG--GVR 750
A GM Y+ N VH DL+ N+LV NL +CKV DFGL+++ + T G +
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGENL------VCKVADFGLARLIEDNEYTARQGAK 164
Query: 751 GTLPWMAPEL-LNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808
+ W APE L G + + K DV+SFGI+L E+ T G PY M ++ V
Sbjct: 165 FPIKWTAPEAALYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGY 220
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSF 838
R P P C LM QCW +P RP+F
Sbjct: 221 RMPCPPECPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 74/259 (28%), Positives = 118/259 (45%), Gaps = 19/259 (7%)
Query: 588 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647
LGSG+FG+VY G D +K+ + + +E +LSKL HPN+V
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-----KRLIIAMDAAFGMEYL 702
+ G ++ L E + GSL LL K R I+ G+EYL
Sbjct: 67 YLGTEREE--DNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILL-----GLEYL 118
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLN 762
H +N VH D+K N+LV+ + K+ DFG++K +G+ WMAPE++
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVV----KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 763 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822
D++S G + E+ TG+ P++ + A + I + PP+P E +
Sbjct: 175 -QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233
Query: 823 LMEQCWAPDPVVRPSFTEI 841
+ +C DP +RP+ E+
Sbjct: 234 FILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 89/278 (32%), Positives = 124/278 (44%), Gaps = 31/278 (11%)
Query: 586 KELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
K LG G FG+V G+ D VA+K +K T E EF EA +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE------EFLSEAACMKDF 58
Query: 641 HHPNVVAFYGV-VQDGPGGTLAT---VTEFMVNGSLRHVLLSKE-----RHLDRRKRLII 691
HPNV+ GV + + + FM +G L LL L + L
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVR 750
+D A GMEYL ++N +H DL N + L++ + +C V DFGLS KI G
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCM--LREDMT-VC-VADFGLSKKIYSGDYYRQGRI 174
Query: 751 GTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807
+P W+A E L + + K DV++FG+ +WEI T G+ PY + I + +
Sbjct: 175 AKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
R P C E LM CW DP RP+FT++ L
Sbjct: 233 -RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 80/275 (29%), Positives = 128/275 (46%), Gaps = 41/275 (14%)
Query: 580 EDLEELKE-LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
E++ ++ E LG G++G+VY + G VAIK + E++ + +E I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--------PVEEDLQEII--KEISI 51
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
L + P +V +YG L V E+ GS+ ++ + L + I
Sbjct: 52 LKQCDSPYIVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL 109
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVR 750
G+EYLHS +H D+K N+L+N + K+ DFG+S KRNT++
Sbjct: 110 KGLEYLHSNKKIHRDIKAGNILLNEEG----QAKLADFGVSGQLTDTMAKRNTVI----- 160
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
GT WMAPE++ + K D++S GI E+ G+ PY+++H I I N +P
Sbjct: 161 GTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KP 215
Query: 811 PVPGFCD-SEWRL----LMEQCWAPDPVVRPSFTE 840
P P D +W +++C DP RPS +
Sbjct: 216 P-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 93/276 (33%), Positives = 131/276 (47%), Gaps = 30/276 (10%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
+L K LG+G FG V G VA+K +K T SSE+E L E
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP---TAHSSEREALMSEL-- 89
Query: 633 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLI 690
+I+S L +H N+V G G G + +TE+ G L + L K E L L
Sbjct: 90 --KIMSHLGNHENIVNLLGACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR--NTLVTG 747
+ A GM +L SKN +H DL N+L+ I K+ DFGL++ I N +V G
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK----IVKICDFGLARDIMNDSNYVVKG 201
Query: 748 GVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805
R + WMAPE + N + S DV+S+GI+LWEI + G PY M + ++
Sbjct: 202 NARLPVKWMAPESIFNCVYTFES---DVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258
Query: 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
R P +E +M+ CW DP+ RP+F +I
Sbjct: 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 98/284 (34%), Positives = 139/284 (48%), Gaps = 41/284 (14%)
Query: 588 LGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
LG G FG+V + + D VA+K +K F+ SS+ E EF REA + + H
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIE----EFLREAACMKEFDH 60
Query: 643 PNVVAFYGV-VQDGPGGTLA---TVTEFMVNGSLRHVLLSKER------HLDRRKRLIIA 692
PNV+ GV ++ G L + FM +G L H L R L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL-HTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRG 751
+D A GMEYL SKN +H DL N ++N +C V DFGLS KI G
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN---MTVC-VADFGLSKKIYSGDYYRQGCAS 175
Query: 752 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIV 804
LP W+A E L + + + DV++FG+ +WEI+T G+ PYA + Y +I G
Sbjct: 176 KLPVKWLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-- 231
Query: 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
N L+ P C + LM QCW+P+P RPSF + +L ++
Sbjct: 232 -NRLKQPPD--CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 90/268 (33%), Positives = 137/268 (51%), Gaps = 25/268 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E ++ +K+LG+G FG V+ G + T VA+K +K G S Q F EA
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP----GTMSVQA-----FLEEAN 53
Query: 636 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAM 693
++ L H +V Y VV ++ P + +TE+M GSL L S E +LI +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEP---IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRG 751
A GM Y+ KN +H DL+ N+LV+ + + +CK+ DFGL+++ + T G +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS--ESL--MCKIADFGLARVIEDNEYTAREGAKF 166
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810
+ W APE +N S + K DV+SFGI+L+EI+T G+ PY M ++ + R
Sbjct: 167 PIKWTAPEAINFGSFTI--KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRM 223
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSF 838
P C E +M+ CW RP+F
Sbjct: 224 PRMENCPDELYDIMKTCWKEKAEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 89/271 (32%), Positives = 126/271 (46%), Gaps = 30/271 (11%)
Query: 587 ELGSGTFGTVYHG----KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
ELGSG FG V G + + DVAIK +K + ++ + E REAEI+ +L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK-------NENEKSVRDEMMREAEIMHQLDN 54
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
P +V GV + L V E G L L K+ + + + + GM+YL
Sbjct: 55 PYIVRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 703 HSKNIVHFDLKCDN-LLVNLKDPIRPICKVGDFGLSKI-----KRNTLVTGGVRGTLPWM 756
KN VH DL N LLVN + K+ DFGLSK + G + L W
Sbjct: 112 EGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWY 165
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
APE +N K S + DV+S+GI +WE + G++PY M ++ I R P
Sbjct: 166 APECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPAE 222
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
C E LM+ CW RP+F ++ R+R
Sbjct: 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 84/276 (30%), Positives = 123/276 (44%), Gaps = 44/276 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E L+ +G G+FG VY + T+ VAIK I +E E ++ +E + L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQ--QEIQFL 53
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
S+ P + +YG G L + E+ GS +L K LD I +
Sbjct: 54 SQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRG 751
G+EYLH + +H D+K N+L++ + + K+ DFG+S KRNT V G
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDV----KLADFGVSGQLTSTMSKRNTFV-----G 160
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
T WMAPE++ S EK D++S GI E+ GE P +++H ++ I N PP
Sbjct: 161 TPFWMAPEVI--KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--NPP 216
Query: 812 V-------PGFCDSEWRLLMEQCWAPDPVVRPSFTE 840
F D + C DP RPS E
Sbjct: 217 SLEGNKFSKPFKD-----FVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 87/263 (33%), Positives = 127/263 (48%), Gaps = 22/263 (8%)
Query: 588 LGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 646
LG G FG V+ G + T VA+K K+ + L ++F EA IL + HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIV 55
Query: 647 AFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 705
GV Q P + V E + G L K+ L ++ + A+DAA GM YL SK
Sbjct: 56 KLIGVCTQRQP---IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLNG 763
N +H DL N LV + + K+ DFG+S+ + + + + +P W APE LN
Sbjct: 113 NCIHRDLAARNCLVGENN----VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN- 167
Query: 764 SSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822
+ S + DV+S+GI+LWE + G PY M V R P C +
Sbjct: 168 -YGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRMSCPQKCPDDVYK 225
Query: 823 LMEQCWAPDPVVRPSFTEIARRL 845
+M++CW P RP F+E+ + L
Sbjct: 226 VMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 5e-31
Identities = 90/292 (30%), Positives = 136/292 (46%), Gaps = 41/292 (14%)
Query: 582 LEELKELGSGTFGTV----YHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWR-EA 634
L++++ LG G FG V Y GT VA+K +K+ C +Q W+ E
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-----GQQNT---SGWKKEI 57
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
IL L+H N+V + G + G L + E++ GSLR L + L+ + L+ A
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQ 115
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR--GT 752
GM YLHS++ +H DL N+L++ + K+GDFGL+K VR G
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 753 LP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MHYGAIIG---GIVN 805
P W A E L +K S DV+SFG+ L+E+LT + + + +IG G +
Sbjct: 172 SPVFWYAVECLK--ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 806 ---------NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+R P P C E +LM+ CW + RP+F + L+ M
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 84/270 (31%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 586 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
ELGSG FGTV G ++ VA+K +K + L E REA ++ +L
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKND------NNDPALKDELLREANVMQQLD 54
Query: 642 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
+P +V G+ + + V E G L + L K +H+ + + + GM+Y
Sbjct: 55 NPYIVRMIGICE---AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLP--WMA 757
L N VH DL N+L+ + K+ DFGLSK G P W A
Sbjct: 111 LEETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
PE +N K S K DV+SFG+++WE + G++PY M G + ++ + R P C
Sbjct: 167 PECMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-GNEVTQMIESGERMECPQRC 223
Query: 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
E LM+ CW RP F + RLR
Sbjct: 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 77/269 (28%), Positives = 130/269 (48%), Gaps = 22/269 (8%)
Query: 588 LGSGTFGTVYHG--KWRGTDVAIKRIK-KSCFTGRSSEQERLTLEFWR-EAEILSKLHHP 643
+G GT+G VY G +A+K+++ + GR +++ ++ R E E L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGMEY 701
N+V + G + L+ E++ GS+ L + ++L+ G+ Y
Sbjct: 69 NIVQYLGF-ETTEE-YLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMAP 758
LHSK I+H DLK DNLLV+ ICK+ DFG+SK + ++G++ WMAP
Sbjct: 124 LHSKGILHRDLKADNLLVDADG----ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP----G 814
E+++ S S KVD++S G V+ E+ G P+++ A + + N PP+P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239
Query: 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+ C+ +P RP+ E+ +
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 6e-30
Identities = 86/285 (30%), Positives = 134/285 (47%), Gaps = 27/285 (9%)
Query: 575 QIIKNEDLEELKELGSGTFGTVYHGKW--RGTD----VAIKRIKKSCFTGRSSEQERLTL 628
+I+K +L +LK LGSG FGTV+ G W G VAIK I+ +GR + Q
Sbjct: 2 RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQ----- 54
Query: 629 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 688
E + L H +V G+ PG +L VT+ GSL + LD ++
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 689 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLV 745
L + A GM YL +VH +L N+L LK I ++ DFG++ +
Sbjct: 112 LNWCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKKYF 167
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 804
+ + WMA E + + + + DV+S+G+ +WE+++ G EPYA M + ++
Sbjct: 168 YSEHKTPIKWMALESIL--FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLL 224
Query: 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
R P C + ++M +CW D VRP+F E+A M+
Sbjct: 225 EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 79/259 (30%), Positives = 117/259 (45%), Gaps = 25/259 (9%)
Query: 588 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G+FG V + + T A+K +KK + + + E ILS+++HP +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK-----KKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR-RKRLIIAMDAAFGMEYLHS 704
V + Q L V E+ G L LSKE R R A + +EYLHS
Sbjct: 56 VKLHYAFQTE--EKLYLVLEYAPGGELFS-HLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGVRGTLPWMAPELLNG 763
I++ DLK +N+L++ I K+ DFGL+K T GT ++APE+L G
Sbjct: 112 LGIIYRDLKPENILLDADGHI----KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 764 SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PGFCDSEWR 821
+ VD +S G++L+E+LTG+ P+ Y I L+ P+ P F E R
Sbjct: 168 --KGYGKAVDWWSLGVLLYEMLTGKPPF----YAEDRKEIYEKILKDPLRFPEFLSPEAR 221
Query: 822 LLMEQCWAPDPVVRPSFTE 840
L+ DP R
Sbjct: 222 DLISGLLQKDPTKRLGSGG 240
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 88/267 (32%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E L+ K+LG+G FG V+ + + T VA+K +K + + F EA
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---------FLAEAN 53
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 694
++ L H +V + VV P + +TEFM GSL L S E +LI +
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRGT 752
A GM ++ +N +H DL+ N+LV+ +CK+ DFGL+++ + T G +
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVSAS----LVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
+ W APE +N S + K DV+SFGI+L EI+T G PY M +I + R P
Sbjct: 167 IKWTAPEAINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMP 223
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSF 838
P C E +M +CW P RP+F
Sbjct: 224 RPENCPEELYNIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 93/295 (31%), Positives = 135/295 (45%), Gaps = 56/295 (18%)
Query: 585 LKELGSGTFGTVYHGKWR--GTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
++ELG FG +Y G G D VAIK +K ++ Q+ EF +EA +++
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-----NNPQQ--WGEFQQEASLMA 62
Query: 639 KLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERH--------------- 682
+LHHPN+V GVV Q+ P + + E++ G L L+ + H
Sbjct: 63 ELHHPNIVCLLGVVTQEQP---VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 683 -LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS---- 737
LD L IA+ A GMEYL S VH DL N+L+ + + K+ D GLS
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV----KISDLGLSREIY 175
Query: 738 -----KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 791
+++ +L+ + WM PE + K S D++SFG+VLWEI + G +PY
Sbjct: 176 SADYYRVQPKSLL------PIRWMPPEAI--MYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
+I + L P C LM +CW P RP F +I RLR
Sbjct: 228 YGFSNQEVIEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 86/269 (31%), Positives = 122/269 (45%), Gaps = 24/269 (8%)
Query: 588 LGSGTFGTVYHG-----KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
LG+G FG + G R VAI ++ C S +Q R F EA L + H
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRR---GFLAEALTLGQFDH 65
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
N+V GV+ G T+ VTE+M NG+L L E L + + + A GM+YL
Sbjct: 66 SNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPEL 760
VH L +LVN +CK+ F + ++ + + G P W APE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSD----LVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 819
+ S DV+SFGIV+WE+++ GE PY +M +I V + R P P C +
Sbjct: 180 IQ--YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VEDGFRLPAPRNCPNL 236
Query: 820 WRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
LM CW + RP F++I L M
Sbjct: 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 97/295 (32%), Positives = 134/295 (45%), Gaps = 42/295 (14%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
IK D+ ELG G FG V+ + VA+K +K++ SE R +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 53
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS---KERHLDRR 686
F REAE+L+ L H ++V FYGV +G L V E+M +G L L S + L
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 687 K-----------RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735
+ L IA A GM YL S + VH DL N LV + K+GDFG
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG----LVVKIGDFG 167
Query: 736 LSK-IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 791
+S+ I G R LP WM PE + K + + D++SFG+VLWEI T G++P+
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
Query: 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
+ I I P C E +M+ CW +P R +I RL+
Sbjct: 226 YQLSNTEAIECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 97/295 (32%), Positives = 140/295 (47%), Gaps = 46/295 (15%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
+ E + L+ELG G+FG VY G R T VA+K + +S +S +ER+ E
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-----ASLRERI--E 55
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS--------KER 681
F EA ++ +VV GVV G TL V E M +G L+ L S R
Sbjct: 56 FLNEASVMKGFTCHHVVRLLGVVSKGQP-TL-VVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 682 HLDRRKRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-I 739
+ +I +A + A GM YL++K VH DL N +V + K+GDFG+++ I
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV----KIGDFGMTRDI 169
Query: 740 KRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 796
G +G LP WMAPE L + D++SFG+VLWEI + E+PY +
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
Query: 797 GAII-----GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
++ GG ++ P C LM CW +P +RP+F EI L+
Sbjct: 228 EQVLKFVMDGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 82/284 (28%), Positives = 139/284 (48%), Gaps = 60/284 (21%)
Query: 588 LGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLE-FWREAEILSKLHHPN 644
+GSG+FG+VY G G +A+K+++ + S +++R L+ RE +L +L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 645 VVAFYGVVQDG----------PGGTLATV-------TEFMVNGSLRHVLLSKERHLDRRK 687
+V + G D PGG++A + E +V +R +L
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK---------- 117
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVT 746
G+ YLH++ I+H D+K N+LV+ K I K+ DFG+S K++ N+L T
Sbjct: 118 ----------GLNYLHNRGIIHRDIKGANILVDNKGGI----KISDFGISKKLEANSLST 163
Query: 747 G------GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAI 799
++G++ WMAPE++ +S + K D++S G ++ E+LTG+ P+ + AI
Sbjct: 164 KTNGARPSLQGSVFWMAPEVVKQTSY--TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI 221
Query: 800 --IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
IG P +P SE +E+ + D RP+ E+
Sbjct: 222 FKIGENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 80/218 (36%), Positives = 114/218 (52%), Gaps = 22/218 (10%)
Query: 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 643
L++LG G+FG VY + VA+K + K +S E ER F RE +IL+ L H P
Sbjct: 5 LRKLGEGSFGEVYLAR-DRKLVALKVLAKK-LESKSKEVER----FLREIQILASLNHPP 58
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLIIAMDAAFGMEY 701
N+V Y QD L V E++ GSL +L R L + L I +EY
Sbjct: 59 NIVKLYDFFQDEGSLYL--VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-------GTLP 754
LHSK I+H D+K +N+L+ D + K+ DFGL+K+ + T + GT
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 755 WMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPY 791
+MAPE+L G S + S D++S GI L+E+LTG P+
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211
|
Length = 384 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 93/304 (30%), Positives = 126/304 (41%), Gaps = 64/304 (21%)
Query: 582 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTL------------- 628
L +++LG G FG V+ + D +K+ +++ L
Sbjct: 7 LNFVEKLGEGQFGEVHLCE---ADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 629 -EFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKE------ 680
+F +E +ILS+L PN+ GV D P L + E+M NG L L
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPP---LCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 681 ----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736
+ L L +A A GM YL S N VH DL N LV I K+ DFG+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI----KIADFGM 176
Query: 737 SKIKRNTLVTGG---VRGTLP----WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-- 786
S L + V+G P WMA E +L G K + K DV++FG+ LWEILT
Sbjct: 177 S----RNLYSSDYYRVQGRAPLPIRWMAWESVLLG---KFTTKSDVWAFGVTLWEILTLC 229
Query: 787 GEEPYA---------NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPS 837
E+PY N + G RPP C + LM +CW D RP+
Sbjct: 230 REQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPN---CPKDIYELMLECWRRDEEDRPT 286
Query: 838 FTEI 841
F EI
Sbjct: 287 FREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 98/305 (32%), Positives = 137/305 (44%), Gaps = 51/305 (16%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 629
IK D+ +ELG G FG V+ + VA+K +K R +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--------D 53
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL------------- 676
F REAE+L+ L H ++V FYGV D G L V E+M +G L L
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 677 --LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVG 732
+ L + L IA A GM YL S++ VH DL N LV NL + K+G
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL------LVKIG 165
Query: 733 DFGLSK-IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GE 788
DFG+S+ + G LP WM PE + K + + DV+SFG++LWEI T G+
Sbjct: 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGK 223
Query: 789 EPYANMHYGAIIGGIVNNTL--RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
+P+ + +I I + RP V C E +M CW +P R + EI + L
Sbjct: 224 QPWFQLSNTEVIECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280
Query: 847 VMSAA 851
+ A
Sbjct: 281 ALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 5e-29
Identities = 95/295 (32%), Positives = 142/295 (48%), Gaps = 46/295 (15%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
+ E + +ELG G+FG VY G +G T VAIK + ++ +S +ER+ E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-----ASMRERI--E 55
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR---- 685
F EA ++ + + +VV GVV G TL + E M G L+ L S ++
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQP-TL-VIMELMTRGDLKSYLRSLRPEMENNPVQ 113
Query: 686 -----RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-I 739
+K + +A + A GM YL++ VH DL N +V + K+GDFG+++ I
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV----KIGDFGMTRDI 169
Query: 740 KRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 796
G +G LP WM+PE L + DV+SFG+VLWEI T E+PY M
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227
Query: 797 GAII-----GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
++ GG+++ P C LM CW +P +RPSF EI ++
Sbjct: 228 EQVLRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 83/268 (30%), Positives = 129/268 (48%), Gaps = 21/268 (7%)
Query: 581 DLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
D E L ++G G+FG V+ K A+K+I S R E E EA +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE------EAIDEARVLA 54
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAA 696
KL ++ +Y D G L V E+ NG L H LL +R + + +
Sbjct: 55 KLDSSYIIRYYESFLDK--GKLNIVMEYAENGDL-HKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGVRGTLPW 755
G+ +LHSK I+H D+K NL ++ D + K+GD G++K+ NT + GT +
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNV----KIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
++PEL +EK DV++ G+VL+E TG+ P+ + GA+I I+ PPV
Sbjct: 168 LSPELC--EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-PPVSQM 224
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+ L++QC D RP ++ R
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 19/268 (7%)
Query: 583 EELKELGSGTFG--TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
++ LG G FG T+Y + V K + T S ++ R L E ILS L
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN---LTRLSEKERRDALN---EIVILSLL 56
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAMDAAFGM 699
HPN++A+Y D TL E+ G+L ++ K + + L +
Sbjct: 57 QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGVRGTLPWMAP 758
Y+H I+H D+K N+ + I K+GDFG+SKI + V GT +M+P
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAGLI----KLGDFGISKILGSEYSMAETVVGTPYYMSP 170
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 818
EL G K + K D+++ G VL+E+LT + + + ++ IV PV S
Sbjct: 171 ELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSS 227
Query: 819 EWRLLMEQCWAPDPVVRPSFTEIARRLR 846
E L+ DP RP+ E+ +
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 88/287 (30%), Positives = 145/287 (50%), Gaps = 29/287 (10%)
Query: 574 LQIIKNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLT 627
L+I+K +L+ +K LGSG FGTVY G W VAIK + ++ TG +
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TG-----PKAN 53
Query: 628 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
+EF EA I++ + HP++V GV T+ VT+ M +G L + + ++ +
Sbjct: 54 VEFMDEALIMASMDHPHLVRLLGVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQL 110
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNT 743
L + A GM YL + +VH DL N+LV + + K+ DFGL+++ ++
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHV----KITDFGLARLLEGDEKEY 166
Query: 744 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 802
GG + + WMA E ++ K + + DV+S+G+ +WE++T G +PY + I
Sbjct: 167 NADGG-KMPIKWMALECIH--YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPD 222
Query: 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
++ R P P C + ++M +CW D RP F E+A M+
Sbjct: 223 LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 41/279 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED E ++ +GSGT+G VY + T VAIK IK + +E +L
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-------LEPGDDFE-IIQQEISML 54
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+ HPN+VA++G L V E+ GSL+ + L + + +
Sbjct: 55 KECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVRG 751
G+ YLH +H D+K N+L+ + K+ DFG+S KR + + G
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTEDGDV----KLADFGVSAQLTATIAKRKSFI-----G 163
Query: 752 TLPWMAPELL-NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
T WMAPE+ K D+++ GI E+ + P ++H + I + P
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP 223
Query: 811 PV--------PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P P F D +++C DP RP+ T++
Sbjct: 224 PKLKDKEKWSPVFHD-----FIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 83/288 (28%), Positives = 130/288 (45%), Gaps = 45/288 (15%)
Query: 582 LEELKELGSGTFGTVY------HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
L+ +++LG G FG V G G VA+K +K + +E E
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-------PESGGNHIADLKKEIE 58
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
IL L+H N+V + G+ + G + + EF+ +GSL+ L + ++ +++L A+
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT---LVTGGVRG 751
GM+YL S+ VH DL N+LV + + K+GDFGL+K I+ + V +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQV----KIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------AIIG---- 801
+ W APE L SK DV+SFG+ L+E+LT Y + +IG
Sbjct: 175 PVFWYAPECL--IQSKFYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHG 228
Query: 802 --------GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
++ R P P C E LM +CW P R +F +
Sbjct: 229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 92/308 (29%), Positives = 128/308 (41%), Gaps = 61/308 (19%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 629
+ + L K LG G FG V + G D VA+K +K +E++ +
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKD--LSD 61
Query: 630 FWREAEILSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVL----------- 676
E E++ + H N++ GV Q+GP L V E+ +G+LR L
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP---LYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 677 ----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732
E L ++ + A A GME+L SK +H DL N+LV + K+
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH----VMKIA 174
Query: 733 DFGLSK-IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GE 788
DFGL++ I G LP WMAPE L + + DV+SFG++LWEI T G
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 789 EPYANMHYGAIIGGIVNNTL--------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTE 840
PY GI L R P C E LM CW P RP+F +
Sbjct: 233 SPYP---------GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283
Query: 841 IARRLRVM 848
+ L M
Sbjct: 284 LVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
N+ E + ELG G FG VY + + T + K E E +F E +ILS
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGL--FAAAKIIQIESEEELE----DFMVEIDILS 57
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 698
+ HPN+V Y L + EF G+L ++L ER L + +
Sbjct: 58 ECKHPNIVGLYEAYFYEN--KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRGT 752
+ +LHS ++H DLK N+L+ L + K+ DFG+S KR+T + GT
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDV----KLADFGVSAKNKSTLQKRDTFI-----GT 166
Query: 753 LPWMAPELLNGSSSK---VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809
WMAPE++ + K K D++S GI L E+ E P+ ++ ++ I+ +
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--E 224
Query: 810 PPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
PP P S + ++ C DP RP+ E+
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 89/308 (28%), Positives = 133/308 (43%), Gaps = 68/308 (22%)
Query: 581 DLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWRE 633
++E ++++G G FG V+ + G T VA+K +K+ +S + +F RE
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-----ASAD--MQADFQRE 58
Query: 634 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-------LSKERHLDRR 686
A ++++ HPN+V GV G + + E+M G L L H
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 687 KR--------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732
R L IA A GM YL + VH DL N LV + K+
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVV----KIA 172
Query: 733 DFGLSKIKRNTLVTGGVRGT----LP--WMAPE--LLNGSSSKVSEKVDVFSFGIVLWEI 784
DFGLS RN + + +P WM PE N + + + DV+++G+VLWEI
Sbjct: 173 DFGLS---RNIYSADYYKASENDAIPIRWMPPESIFYN----RYTTESDVWAYGVVLWEI 225
Query: 785 LT-GEEPYANMHYGAII-----GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSF 838
+ G +PY M + +I G +++ P C E LM CW+ P RPSF
Sbjct: 226 FSYGMQPYYGMAHEEVIYYVRDGNVLS------CPDNCPLELYNLMRLCWSKLPSDRPSF 279
Query: 839 TEIARRLR 846
I R L+
Sbjct: 280 ASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 91/273 (33%), Positives = 133/273 (48%), Gaps = 30/273 (10%)
Query: 580 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+DLE L ELG+G G V H + G +A+K I+ + Q+++ RE +I
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTIR---LEINEAIQKQIL----RELDI 52
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
L K + P +V FYG + G ++ E+M GSL +L + + R IA+
Sbjct: 53 LHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL 110
Query: 697 FGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 755
G+ YLH K I+H D+K N+LVN + I K+ DFG+S N+L V GT +
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQI----KLCDFGVSGQLVNSLAKTFV-GTSSY 165
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA--NMHYGAII---GGIVNNTLRP 810
MAPE + G+ V K D++S G+ L E+ TG PY N I IVN P
Sbjct: 166 MAPERIQGNDYSV--KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--P 221
Query: 811 PV--PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P G +++ + C DP RPS+ E+
Sbjct: 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 21/283 (7%)
Query: 574 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFW 631
L+I+K + +++K LGSG FGTVY G W G V I K R + + E
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEIL 57
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
EA +++ + +P+V G+ T+ +T+ M G L + + ++ + L
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 114
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTG 747
+ A GM YL + +VH DL N+LV K P K+ DFGL+K+ ++ G
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEYHAEG 170
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806
G + + WMA E + + + DV+S+G+ +WE++T G +PY + + I I+
Sbjct: 171 G-KVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEK 226
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
R P P C + ++M +CW D RP F E+ M+
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 80/265 (30%), Positives = 117/265 (44%), Gaps = 25/265 (9%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
+ G +G V+ K + T AIK IKK+ ++ + LT E +ILS+ P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-----ERDILSQAQSPYV 55
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 705
V Y Q L V E++ G L LL LD I + +EYLHS
Sbjct: 56 VKLYYSFQGK--KNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLV------TGGVRGTLPWM 756
I+H DLK DN+L++ + K+ DFGLSK ++R + + GT ++
Sbjct: 113 GIIHRDLKPDNILIDSNGHL----KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
APE++ G S+ VD +S G +L+E L G P+ I I+N + P
Sbjct: 169 APEVILGQGH--SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226
Query: 817 DSEWRLLMEQCWAPDPVVRPSFTEI 841
E L+ + PDP R I
Sbjct: 227 SDEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 69/218 (31%), Positives = 115/218 (52%), Gaps = 32/218 (14%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E++ ++G GT+G VY + + T VA+K+I+ +E+E + RE ++L KL
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGFPITAIREIKLLQKL 55
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFM---VNGSLRHVL----LSKERHLDRRKRLIIAM 693
HPN+V +V G++ V E+M + G L S+ + K+L+
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY--MKQLLE-- 111
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLV-TGGVR 750
G++YLHS I+H D+K N+L+N + K+ DFGL++ KRN+ T V
Sbjct: 112 ----GLQYLHSNGILHRDIKGSNILINNDGVL----KLADFGLARPYTKRNSADYTNRVI 163
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
TL + PELL G +++ +VD++S G +L E+ G+
Sbjct: 164 -TLWYRPPELLLG-ATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 19/224 (8%)
Query: 585 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
L+ +G G FG V + R T A+K + K + S + L E IL +L+H
Sbjct: 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL-----NERRILQELNH 59
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
P +V + QD + V + ++ G LR+ L K + + + + I + +EYL
Sbjct: 60 PFLVNLWYSFQDEE--NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYL 116
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 761
HSK I+H D+K DN+L++ + + DF ++ K+ +TL T GT +MAPE+L
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGH----VHITDFNIATKVTPDTLTTSTS-GTPGYMAPEVL 171
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805
V+ VD +S G+ +E L G+ PY H I I
Sbjct: 172 CRQGYSVA--VDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRA 212
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 4e-27
Identities = 100/300 (33%), Positives = 137/300 (45%), Gaps = 50/300 (16%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
IK ED+ +G G FG V + + AIK +K+ +SE + +F
Sbjct: 4 IKFEDV-----IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-----ASENDHR--DFAG 51
Query: 633 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-----------LSKE 680
E E+L KL HHPN++ G ++ G L E+ G+L L +KE
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKE 109
Query: 681 R----HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDF 734
L ++ L A D A GM+YL K +H DL N+LV NL K+ DF
Sbjct: 110 HGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL------ASKIADF 163
Query: 735 GLSKIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 791
GLS+ + + G LP WMA E LN S + K DV+SFG++LWEI++ G PY
Sbjct: 164 GLSRGEE--VYVKKTMGRLPVRWMAIESLN--YSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
Query: 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851
M + + R P CD E LM QCW P RP F +I+ +L M A
Sbjct: 220 CGMTCAELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 26/268 (9%)
Query: 586 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LG G FG VY + G ++A+K++ +++E LE E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVP-FDPDSPETKKEVNALE--CEIQLLKNLQHE 64
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 699
+V +YG ++D TL+ E+M GS++ L + E + R I+ G+
Sbjct: 65 RIVQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-----GV 117
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGTLPW 755
EYLHS IVH D+K N+L + + K+GDFG SK I + V GT W
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNV----KLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
M+PE+++G K DV+S G + E+LT + P+A A I I P +P
Sbjct: 174 MSPEVISGEGY--GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH 231
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+ R + + + + RPS E+ R
Sbjct: 232 VSPDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 96/305 (31%), Positives = 136/305 (44%), Gaps = 66/305 (21%)
Query: 586 KELGSGTFGTV-----YHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
K LG G FG V + K R T VA+K +K++ SSE L EF +L
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEF----NLLK 58
Query: 639 KLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVL-LSK----------------- 679
+++HP+V+ YG QDGP L + E+ GSLR L S+
Sbjct: 59 QVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 680 -----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734
ER L + A + GM+YL +VH DL N+LV K+ DF
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR----KMKISDF 171
Query: 735 GLSK--------IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEI 784
GLS+ +KR+ +G +P WMA E L + + DV+SFG++LWEI
Sbjct: 172 GLSRDVYEEDSYVKRS-------KGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEI 222
Query: 785 LT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+T G PY + + ++ R P C E LM CW +P RP+F +I++
Sbjct: 223 VTLGGNPYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
Query: 844 RLRVM 848
L M
Sbjct: 282 ELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 94/285 (32%), Positives = 129/285 (45%), Gaps = 43/285 (15%)
Query: 588 LGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 642
+G G FG V + + D AIKR+K+ S + R +F E E+L KL HH
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHR---DFAGELEVLCKLGHH 67
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD----------------RR 686
PN++ G + G L E+ +G+L L K R L+ +
Sbjct: 68 PNIINLLGACEHR--GYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 687 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 746
+ L A D A GM+YL K +H DL N+LV + K+ DFGLS+ + +
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN----YVAKIADFGLSRGQE--VYV 178
Query: 747 GGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 803
G LP WMA E LN S + DV+S+G++LWEI++ G PY M + +
Sbjct: 179 KKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
Query: 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
R P CD E LM QCW P RPSF +I L M
Sbjct: 237 PQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 21/283 (7%)
Query: 574 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFW 631
++I+K +L+++K LGSG FGTVY G W G +V +I + R + + E
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENV---KIPVAIKVLRENTSPKANKEIL 57
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGS-LRHVLLSKERHLDRRKRLI 690
EA +++ + P V G+ T+ VT+ M G L +V +K+R + + L
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLN 113
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTG 747
+ A GM YL +VH DL N+LV K P K+ DFGL++ I
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEYHAD 169
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806
G + + WMA E + + + + DV+S+G+ +WE++T G +PY + I ++
Sbjct: 170 GGKVPIKWMALESI--LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-AREIPDLLEK 226
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
R P P C + ++M +CW D RP F E+ M+
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 94/287 (32%), Positives = 130/287 (45%), Gaps = 47/287 (16%)
Query: 588 LGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 642
+G G FG V + + D AIKR+K+ +S+ + +F E E+L KL HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDHR--DFAGELEVLCKLGHH 55
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD----------------RR 686
PN++ G + G L E+ +G+L L K R L+ +
Sbjct: 56 PNIINLLGACEHR--GYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQ 112
Query: 687 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTL 744
+ L A D A GM+YL K +H DL N+LV N K+ DFGLS+ + +
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA------KIADFGLSRGQE--V 164
Query: 745 VTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIG 801
G LP WMA E LN S + DV+S+G++LWEI++ G PY M +
Sbjct: 165 YVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222
Query: 802 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+ R P CD E LM QCW P RPSF +I L M
Sbjct: 223 KLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 96/300 (32%), Positives = 142/300 (47%), Gaps = 44/300 (14%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
IK ++ +ELG G FG V+ + VA+K +K + R +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK--------D 53
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRH---------VLLSK- 679
F REAE+L+ L H ++V FYGV + G L V E+M +G L VL+++
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 680 --ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFG 735
L + + L IA A GM YL S++ VH DL N LV NL + K+GDFG
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL------LVKIGDFG 165
Query: 736 LSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 791
+S+ +T V G + WM PE + K + + DV+S G+VLWEI T G++P+
Sbjct: 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
Query: 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851
+ +I I + P C E LM CW +P +R + EI L+ ++ A
Sbjct: 224 YQLSNNEVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 79/266 (29%), Positives = 119/266 (44%), Gaps = 41/266 (15%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
++L ++G GT+G VY + + T VAIK+IK E E + RE ++L +L
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKEL 55
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
+HPN++ V G L V EFM + L ++ ++R L G+
Sbjct: 56 NHPNIIKLLDVF--RHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLPWMAP 758
+ HS I+H DLK +NLL+N + + K+ DFGL++ T V T + AP
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVL----KLADFGLARSFGSPVRPYTHYV-VTRWYRAP 167
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD- 817
ELL G S VD++S G + E+L+ RP PG +
Sbjct: 168 ELLLG-DKGYSTPVDIWSVGCIFAELLSR---------------------RPLFPGKSEI 205
Query: 818 SEWRLLMEQCWAPDPVVRPSFTEIAR 843
+ + PDP V P FT +AR
Sbjct: 206 DQLFKIFRTLGTPDPEVWPKFTSLAR 231
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 73/271 (26%), Positives = 134/271 (49%), Gaps = 35/271 (12%)
Query: 583 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E+++ +G G FG V+ K V IK+I + ++ ERL + E ++L L
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP----VEQMTKDERLAAQ--NECQVLKLL 56
Query: 641 HHPNVVAFYG----------VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
HPN++ +Y V++ PGGTLA + + LL ++ L +++
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ-----KRCNSLLDEDTILHFFVQIL 111
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
+A+ ++H+K I+H DLK N+L++ + + K+GDFG+SKI + V
Sbjct: 112 LAL------HHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVV 162
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
GT +++PEL G ++K D+++ G VL+E+ + + + + A++ I++ T
Sbjct: 163 GTPCYISPELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA- 219
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P+ + R L+ DP RP ++I
Sbjct: 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 75/267 (28%), Positives = 120/267 (44%), Gaps = 22/267 (8%)
Query: 586 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
++LG+G F + Y + GT +A+K++ SSEQE + +E ++++L+HP
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+++ G + E+M GS+ H LLSK + G+ YLH
Sbjct: 64 HIIRMLGATCED--SHFNLFVEWMAGGSVSH-LLSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-----SKIKRNTLVTGGVRGTLPWMAP 758
I+H D+K NLL+ D ++ DFG +K G + GT+ +MAP
Sbjct: 121 ENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM----HYGAIIGGIVNNTLRPPVPG 814
E+L G S DV+S G V+ E+ T + P+ H A+I I + T P +P
Sbjct: 178 EVLRGEQYGRS--CDVWSVGCVIIEMATAKPPWNAEKHSNHL-ALIFKIASATTAPSIPE 234
Query: 815 FCDSEWRLLMEQCWAPDPVVRPSFTEI 841
R + +C P RP E+
Sbjct: 235 HLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 81/289 (28%), Positives = 126/289 (43%), Gaps = 51/289 (17%)
Query: 580 EDLEELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR-EAEI 636
+D E ++ +G G VY VAIKRI E+ + +++ R E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI--------DLEKCQTSVDELRKEVQA 52
Query: 637 LSKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLIIA 692
+S+ +HPNVV +Y VV D L V ++ GSL ++ S LD +
Sbjct: 53 MSQCNHPNVVKYYTSFVVGD----ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS----------KIKRN 742
+ G+EYLHS +H D+K N+L+ + K+ DFG+S + R
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSV----KIADFGVSASLADGGDRTRKVRK 164
Query: 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 802
T V GT WMAPE++ K D++SFGI E+ TG PY+ Y +
Sbjct: 165 TFV-----GTPCWMAPEVME-QVHGYDFKADIWSFGITAIELATGAAPYS--KYPPM--K 214
Query: 803 IVNNTLRPPVPGF--------CDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
++ TL+ P +R ++ C DP RP+ E+ +
Sbjct: 215 VLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 35/288 (12%)
Query: 568 NFDISTLQIIKNEDLEELKEL--GSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 625
I+ ++ I+++D+++ + ++Y G + +V I+ KK +
Sbjct: 6 RSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKF-----HKGHKV 60
Query: 626 LTLEFWREAEILSKLHHPNVVAFYG----VVQDGPGGTLATVTEFMVNGSLRHVLLSKER 681
L E + L ++ N++ YG +V D P +L + E+ G LR VL KE+
Sbjct: 61 LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL--ILEYCTRGYLREVL-DKEK 117
Query: 682 HLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI- 739
L + +L +A+D G+ L+ N + +L + LV K+ GL KI
Sbjct: 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY----KLKIICHGLEKIL 173
Query: 740 ------KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
N +V + + ++LN S+ + K D++S G+VLWEI TG+ P+ N
Sbjct: 174 SSPPFKNVNFMV---------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
Query: 794 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ I I+N +P C E + ++E C + D + RP+ EI
Sbjct: 225 LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 80/262 (30%), Positives = 121/262 (46%), Gaps = 19/262 (7%)
Query: 588 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG GT+G VY + T V AIK I + R S + E E + S L H N+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHE---EIALHSYLKHRNI 67
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF--GMEYLH 703
V + G D G E + GSL +L SK L ++ II G++YLH
Sbjct: 68 VQYLG--SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLN 762
IVH D+K DN+LVN + K+ DFG SK + T GTL +MAPE+++
Sbjct: 126 DNQIVHRDIKGDNVLVN---TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 763 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPPVPGFCDSEWR 821
D++S G + E+ TG+ P+ + A + + + P +P +E +
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK 242
Query: 822 LLMEQCWAPDPVVRPSFTEIAR 843
+ +C+ PDP R S ++ +
Sbjct: 243 NFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 31/216 (14%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E+L++LG GT+G VY + + T VA+K+I+ +E+E + RE +L +L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLKEL 55
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRL---IIAMDA 695
HPN+V V+ L V E+ + L+ L + L K + ++
Sbjct: 56 KHPNIVKLLDVIHTE--RKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLR--- 109
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGT 752
G+ Y HS I+H DLK N+L+N + K+ DFGL++ I T V T
Sbjct: 110 --GLAYCHSHRILHRDLKPQNILINRD----GVLKLADFGLARAFGIPLRTYTHEVV--T 161
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
L + APE+L G S S VD++S G + E++TG+
Sbjct: 162 LWYRAPEILLG-SKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 86/296 (29%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 586 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
K LG G FG V + G D VA+K +K + ++ + E E+
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-------DNATDKDLADLISEMEL 70
Query: 637 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 679
+ + H N++ GV Q+GP L + E+ G+LR L ++
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGP---LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 680 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK- 738
E L + + A A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIADFGLARG 183
Query: 739 IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795
+ G LP WMAPE L + + DV+SFGI++WEI T G PY +
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851
+ ++ R P C E +LM +CW P RP+F ++ L + AA
Sbjct: 242 VEELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 588 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G FG V K + + A+K +KK ++ + E EIL + +HP +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH-----IFSEKEILEECNHPFI 55
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK-RLIIAMDAAFGMEYLHS 704
V Y +D + + E+ + G L +L D R IA EYLH+
Sbjct: 56 VKLYRTFKDKK--YIYMLMEYCLGGELWTIL-RDRGLFDEYTARFYIAC-VVLAFEYLHN 111
Query: 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 764
+ I++ DLK +NLL++ + K+ DFG +K ++ T GT ++APE++
Sbjct: 112 RGIIYRDLKPENLLLDSNGYV----KLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK 167
Query: 765 SSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
S VD +S GI+L+E+LTG P+
Sbjct: 168 GYDFS--VDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 91/295 (30%), Positives = 132/295 (44%), Gaps = 56/295 (18%)
Query: 585 LKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
++ELG FG VY G GT VAIK +K + L EF EA +
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMR 62
Query: 638 SKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERH-------------- 682
S+L HPN+V GVV ++ P L+ + + + L L+ + H
Sbjct: 63 SRLQHPNIVCLLGVVTKEQP---LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 683 -LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL----- 736
L+ + I A GME+L S ++VH DL N+LV K + K+ D GL
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV----KISDLGLFREVY 175
Query: 737 ----SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 791
K+ N+L+ + WM+PE + K S D++S+G+VLWE+ + G +PY
Sbjct: 176 AADYYKLMGNSLLP------IRWMSPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
Query: 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
+I I N + P P C + LM +CW P RP F +I RLR
Sbjct: 228 CGYSNQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 91/278 (32%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 586 KELGSGTFGTVYHGKWRGTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
K LG G FG+V G+ D VA+K +K + T SE E +F EA + +
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEME----DFLSEAVCMKEFD 58
Query: 642 HPNVVAFYGVVQDGPGG----TLATVTEFMVNGSLRHVLL-----SKERHLDRRKRLIIA 692
HPNV+ GV + + FM +G L LL ++L + +
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRG 751
D A GMEYL SK+ +H DL N ++N +C V DFGLS KI G
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNEN---MNVC-VADFGLSKKIYNGDYYRQGRIA 174
Query: 752 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN-NT 807
+P W+A E L + + K DV+SFG+ +WEI T G+ PY + I + N
Sbjct: 175 KMPVKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR 232
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
L+ P P D + LM CW +P RPSF + L
Sbjct: 233 LKQP-PDCLDGLYS-LMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 97/307 (31%), Positives = 129/307 (42%), Gaps = 59/307 (19%)
Query: 581 DLEELKE-LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTL----------- 628
KE LG G FG V+ + G + K + K S Q L
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGME---KFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61
Query: 629 ---EFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLS---KER 681
+F +E +I+S+L PN++ V + P L +TE+M NG L L +E
Sbjct: 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP---LCMITEYMENGDLNQFLSRHEPQEA 118
Query: 682 HLDRRKRLI-------IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734
I +A A GM+YL S N VH DL N LV I K+ DF
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTI----KIADF 174
Query: 735 GLSKIKRNTLVTGGV-----RGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT 786
G+S RN L +G R LP WM+ E +L G + S DV++FG+ LWEILT
Sbjct: 175 GMS---RN-LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS---DVWAFGVTLWEILT 227
Query: 787 --GEEPYANMHYGAII---GGIVNNTLRP---PVPGFCDSEWRLLMEQCWAPDPVVRPSF 838
E+PY+ + +I G + R P P C LM CW + RPSF
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287
Query: 839 TEIARRL 845
EI L
Sbjct: 288 QEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 40/274 (14%)
Query: 585 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
L+ +G G +G VY GK T VA+K I + + ++ + RE +LS+L
Sbjct: 6 LELIGRGAYGAVYRGKHVPTGRVVALKIIN------LDTPDDDVS-DIQREVALLSQLRQ 58
Query: 643 ---PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
PN+ +YG GP L + E+ GS+R L K + + +I + +
Sbjct: 59 SQPPNITKYYGSYLKGP--RLWIIMEYAEGGSVR--TLMKAGPIAEKYISVIIREVLVAL 114
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRGTL 753
+Y+H ++H D+K N+LV ++ +C DFG++ KR+T V GT
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVK-LC---DFGVAALLNQNSSKRSTFV-----GTP 165
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813
WMAPE++ K D++S GI ++E+ TG PY+++ + I + +P P
Sbjct: 166 YWMAPEVITEGKY-YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KP--P 220
Query: 814 GFCDSEWRLLMEQ----CWAPDPVVRPSFTEIAR 843
D+ + L+ + C +P R S E+ +
Sbjct: 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 79/286 (27%), Positives = 114/286 (39%), Gaps = 58/286 (20%)
Query: 588 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE------------RLTLEFWREAE 635
LG GTF +Y G R +S QE R +L F+ A
Sbjct: 3 LGQGTFTNIYKGVLR---------VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETAS 53
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
++S+L H ++V YGV + V E++ G L L ++ ++ +L +A
Sbjct: 54 LMSQLSHKHLVKLYGVCV-RDENIM--VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL 110
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR---PICKVGDFGLSKIKRNTLVTGGVRGT 752
A + YL K +VH ++ N+LV P K+ D G I L
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG---IPITVLSREERVER 167
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP------------YANMHYGAI 799
+PW+APE + + ++ D +SFG L EI + GEEP Y + H
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH---- 223
Query: 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
R P+P C L+ QCW DP RPSF I R L
Sbjct: 224 ---------RLPMPD-CAELANLIN-QCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 83/272 (30%), Positives = 130/272 (47%), Gaps = 25/272 (9%)
Query: 586 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LG G FG VY + G ++A+K+++ F S E + E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 699
+V +YG ++D TL+ E M GS++ L S E + R I+ G+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-----GV 119
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG----GVRGTLPW 755
YLHS IVH D+K N+ L+D + + K+GDFG SK + ++G V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANI---LRDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
M+PE+++G K D++S G + E+LT + P+A A I I P +P
Sbjct: 176 MSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847
R +++ + + +RPS E+ R V
Sbjct: 234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 96/309 (31%), Positives = 137/309 (44%), Gaps = 55/309 (17%)
Query: 566 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 625
LG + + + E L E G+ F + VA+K + R+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDG------QPVLVAVKML-------RADVTKT 59
Query: 626 LTLEFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERH-- 682
+F +E +I+S+L +PN++ GV V D P L +TE+M NG L L +E
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGDLNQFLSQREIEST 116
Query: 683 ---------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733
+ L +A+ A GM+YL S N VH DL N LV I K+ D
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTI----KIAD 172
Query: 734 FGLSKIKRNTLVTGGV-----RGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEI- 784
FG+S RN L +G R LP WMA E +L G + S DV++FG+ LWE+
Sbjct: 173 FGMS---RN-LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS---DVWAFGVTLWEMF 225
Query: 785 -LTGEEPYANMHYGAII---GGIVNNTLRP---PVPGFCDSEWRLLMEQCWAPDPVVRPS 837
L E+PY+ + +I G N R C S LM +CW+ D RP+
Sbjct: 226 TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
Query: 838 FTEIARRLR 846
F +I LR
Sbjct: 286 FNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 90/257 (35%), Positives = 118/257 (45%), Gaps = 59/257 (22%)
Query: 629 EFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
+F +E +ILS+L PN++ GV V + P L +TE+M NG L L S HLD ++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDP---LCMITEYMENGDLNQFLSS--HHLDDKE 119
Query: 688 R--------------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727
L +A+ A GM+YL S N VH DL N LV I
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTI-- 177
Query: 728 ICKVGDFGLSKIKRNTLVTGGV-----RGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGI 779
K+ DFG+S RN L G R LP WMA E +L G + S DV++FG+
Sbjct: 178 --KIADFGMS---RN-LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS---DVWAFGV 228
Query: 780 VLWEILT--GEEPYANMHYGAII---GGIVNNT------LRPPVPGFCDSEWRLLMEQCW 828
LWEIL E+PY + +I G + RPP C LM QCW
Sbjct: 229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP---CPQGLYELMLQCW 285
Query: 829 APDPVVRPSFTEIARRL 845
+ D RPSF++I L
Sbjct: 286 SRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 53/282 (18%)
Query: 585 LKELGSGTFGTVYHGKWRGTDV------AIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
++G GTFG VY ++ A+K I+ + E E ++L
Sbjct: 5 GNKIGGGTFGKVY----TAVNLDTGELMAVKEIRIQ------DNDPKTIKEIADEMKVLE 54
Query: 639 KLHHPNVVAFYGV-VQDG---------PGGTLATVTEFMVNGSLRHVLLSKERHLDR-RK 687
L HPN+V +YGV V GGTL + L H + E +
Sbjct: 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEEL--------LEHGRILDEHVIRVYTL 106
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVT 746
+L+ G+ YLHS IVH D+K N+ ++ I K+GDFG + +K NT
Sbjct: 107 QLLE------GLAYLHSHGIVHRDIKPANIFLDHNGVI----KLGDFGCAVKLKNNTTTM 156
Query: 747 G----GVRGTLPWMAPELLNGSSSKVSEK-VDVFSFGIVLWEILTGEEPYANMHYGAIIG 801
G + GT +MAPE++ G K + D++S G V+ E+ TG+ P++ + I
Sbjct: 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216
Query: 802 GIVNNTLRPPVPG--FCDSEWRLLMEQCWAPDPVVRPSFTEI 841
V +PP+P E + +++C DP RP+ +E+
Sbjct: 217 FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 88/295 (29%), Positives = 130/295 (44%), Gaps = 48/295 (16%)
Query: 586 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
K LG G FG V + G D VA+K +K S E+ + E E+
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-------SDATEKDLSDLISEMEM 76
Query: 637 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 679
+ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 77 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 680 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK- 738
E L + + A A GMEYL SK +H DL N+LV + + K+ DFGL++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN----VMKIADFGLARD 189
Query: 739 IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795
I G LP WMAPE L + + DV+SFG++LWEI T G PY +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL-RVMS 849
+ ++ R P C +E ++M CW P RP+F ++ L R+++
Sbjct: 248 VEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 5e-23
Identities = 84/268 (31%), Positives = 125/268 (46%), Gaps = 25/268 (9%)
Query: 586 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LG G FG VY + G ++A K+++ F S E + E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 699
+V +YG ++D TL E+M GS++ L + E + R I+ GM
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-----GM 119
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG-GVR---GTLPW 755
YLHS IVH D+K N+L + + K+GDFG SK + ++G G+R GT W
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNV----KLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
M+PE+++G K DV+S G + E+LT + P+A A I I P +P
Sbjct: 176 MSPEVISGEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSH 233
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
R + C + RPS E+ R
Sbjct: 234 ISEHARDFL-GCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 44/239 (18%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D + K +G G+F TV K + T+ AIK + K +E+ E E+L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVL 55
Query: 638 SKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KRLIIA--M 693
++L HP ++ Y QD L V E+ NG L + K LD + R A +
Sbjct: 56 TRLNGHPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQ-YIRKYGSLDEKCTRFYAAEIL 112
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR--- 750
A +EYLHSK I+H DLK +N+L++ I K+ DFG +K+ +
Sbjct: 113 LA---LEYLHSKGIIHRDLKPENILLDKDMHI----KITDFGTAKVLDPNSSPESNKGDA 165
Query: 751 ------------------GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
GT +++PELLN + + D+++ G +++++LTG+ P+
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA--GKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 77/272 (28%), Positives = 123/272 (45%), Gaps = 24/272 (8%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER--LTLEFWREAEILS 638
D E L+ +G G+FGTV + R +D I K+ + G +E+E+ L E IL
Sbjct: 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDY-GNMTEKEKQQLVSEV----NILR 54
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKER-HLDRRKRLIIAMDA 695
+L HPN+V +Y + D TL V E+ G L ++ KER +++ I
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 696 AFGMEYLH-----SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGV 749
+ H ++H DLK N+ ++ K+GDFGL+KI ++
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDAN----NNVKLGDFGLAKILGHDSSFAKTY 170
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809
GT +M+PE LN S EK D++S G +++E+ P+ + + I R
Sbjct: 171 VGTPYYMSPEQLNHMSY--DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR 228
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+P SE +++ DP RPS E+
Sbjct: 229 -RIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 79/268 (29%), Positives = 124/268 (46%), Gaps = 25/268 (9%)
Query: 586 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LG G FG VY + G ++A+K++ F S E + E ++L L H
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 699
+V +YG ++D L+ E+M GS++ L + E R R I+ G+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-----GV 119
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG----GVRGTLPW 755
YLHS IVH D+K N+L + + K+GDFG SK + ++G V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNV----KLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
M+PE+++G K DV+S + E+LT + P+A A I I +P +P
Sbjct: 176 MSPEVISGEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
R ++Q + + RP+ + R
Sbjct: 234 VSDACRDFLKQIFVEEK-RRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 71/272 (26%), Positives = 131/272 (48%), Gaps = 30/272 (11%)
Query: 583 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E +K++G G+FG +Y K IK I + + E + +E +L+K+
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKM 56
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-------RHVLLSKERHLDRRKRLIIAM 693
HPN+V F+ Q+ G L V E+ G L R VL S+++ L ++
Sbjct: 57 KHPNIVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI---- 110
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGT 752
+ G++++H + I+H D+K N+ ++ + K+GDFG+++ +++ + GT
Sbjct: 111 --SLGLKHIHDRKILHRDIKSQNIFLSKNG---MVAKLGDFGIARQLNDSMELAYTCVGT 165
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
+++PE+ + + K D++S G VL+E+ T + P+ + ++ I P
Sbjct: 166 PYYLSPEICQ--NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
P F + R L+ Q + P RPS T I +R
Sbjct: 224 PNF-SRDLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 39/220 (17%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+ +K+LG GTFG+VY + + G VAIK++KK F S +E + L RE + L KL
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK-FY---SWEECMNL---REVKSLRKL 54
Query: 641 -HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRK-RLIIAMDAAF 697
HPN+V V ++ L V E+M G+L ++ K + R II
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ- 110
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--- 754
G+ ++H H DLK +NLLV+ + + K+ DFGL++ +R P
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAR---------EIRSRPPYTD 157
Query: 755 -----WM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
W APE+L S+S S VD+++ G ++ E+ T
Sbjct: 158 YVSTRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 35/295 (11%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
++NEDLE + +LG+G G+V K T + KK G S + L RE +I
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA--KKVVHIGAKSSVRKQIL---RELQI 56
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+ + P +V+FYG + + EFM GSL + K + IA+
Sbjct: 57 MHECRSPYIVSFYGAFLNEN--NICMCMEFMDCGSLDRI-YKKGGPIPVEILGKIAVAVV 113
Query: 697 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 755
G+ YL++ + I+H D+K N+LVN + I K+ DFG+S N++ V GT +
Sbjct: 114 EGLTYLYNVHRIMHRDIKPSNILVNSRGQI----KLCDFGVSGELINSIADTFV-GTSTY 168
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA-----------NMHYGAIIGGIV 804
M+PE + G K + K DV+S GI + E+ G+ P+A M ++ IV
Sbjct: 169 MSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226
Query: 805 NNTLRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 855
P P S++ R ++ C DP RP+ ++ + A +
Sbjct: 227 QE----PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 81/286 (28%), Positives = 120/286 (41%), Gaps = 53/286 (18%)
Query: 584 ELKEL-GSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
EL E+ G GT+G VY + + T VAIK + E+E + E+ IL K
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-----IEDEEEEIKEEY----NILRKY 59
Query: 641 -HHPNVVAFYGV----VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR--LI--I 691
+HPN+ FYG G L V E GS+ L+ R +R + I I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYI 118
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK------IKRNTLV 745
+ G+ YLH ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV----KLVDFGVSAQLDSTLGRRNTFI 174
Query: 746 TGGVRGTLPWMAPELLNGSSS---KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 802
GT WMAPE++ + DV+S GI E+ G+ P +MH +
Sbjct: 175 -----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229
Query: 803 IVNN---TLRPPVPGFCDSEWRLL----MEQCWAPDPVVRPSFTEI 841
I N TL+ P W + +C + RP E+
Sbjct: 230 IPRNPPPTLKSP------ENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 75/231 (32%), Positives = 107/231 (46%), Gaps = 53/231 (22%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
++ E+L + GT+G VY + + T VA+K++K E+E + RE IL
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK------MEKEKEGFPITSLREINIL 58
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
KL HPN+V VV G L + +MV + H L K L+ M F
Sbjct: 59 LKLQHPNIVTVKEVVV---GSNLDKI--YMVMEYVEHDL----------KSLMETMKQPF 103
Query: 698 --------------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-----SK 738
G+ +LH I+H DLK NLL+N R I K+ DFGL S
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN----RGILKICDFGLAREYGSP 159
Query: 739 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+K T LV TL + APELL G + + S +D++S G + E+LT +
Sbjct: 160 LKPYTQLVV-----TLWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 81/296 (27%), Positives = 135/296 (45%), Gaps = 28/296 (9%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+LE + +GSG GTVY R T A+K I + ++ + + RE EIL
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-------YGNHEDTVRRQICREIEIL 126
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
++HPNVV + + G + + EFM GSL ++ E+ L R I++
Sbjct: 127 RDVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS----- 179
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLPW 755
G+ YLH ++IVH D+K NLL+N + K+ DFG+S+I T+ V GT+ +
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLINSAKNV----KIADFGVSRILAQTMDPCNSSV-GTIAY 234
Query: 756 MAPELLNGSSSKVSEK---VDVFSFGIVLWEILTGEEPYANMHYG--AIIGGIVNNTLRP 810
M+PE +N + + D++S G+ + E G P+ G A + + + P
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP 294
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQNQVP 866
P E+R + C +P R S ++ + ++ A G + +P
Sbjct: 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLP 350
|
Length = 353 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+ L +G G G V+ K R T VA+K++ R E + + RE + L
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKV-----ALRRLE-GGIPNQALREIKALQAC 56
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK-RLIIAMDAAFGM 699
HP VV V G G V E+M L VL +ER L + + + M G+
Sbjct: 57 QHPYVVKLLDVFPHGSG--FVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-GV 112
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRGTLPWM 756
Y+H+ I+H DLK NLL++ + K+ DFGL+++ + L + V T +
Sbjct: 113 AYMHANGIMHRDLKPANLLISADG----VLKIADFGLARLFSEEEPRLYSHQV-ATRWYR 167
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
APELL G + K VD+++ G + E+L G
Sbjct: 168 APELLYG-ARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D E +K LG+G+FG V + +G+ A+K + K+ +Q L E IL
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV--KLKQVEHVL---NEKRIL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL------II 691
+ HP +V YG QD L V E++ G L HL + R
Sbjct: 56 QSIRHPFLVNLYGSFQDD--SNLYLVMEYVPGGELFS-------HLRKSGRFPEPVARFY 106
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGG 748
A +EYLHS +IV+ DLK +NLL++ I K+ DFG +K + TL
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYI----KITDFGFAKRVKGRTYTLC--- 159
Query: 749 VRGTLPWMAPELLNGSSSKVSEK-VDVFSFGIVLWEILTGEEPYA----NMHYGAIIGGI 803
GT ++APE++ SK K VD ++ GI+++E+L G P+ Y I+ G
Sbjct: 160 --GTPEYLAPEII---LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
Query: 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 835
V P F + + L+ D R
Sbjct: 215 VR------FPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 44/221 (19%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E+ K+LG GT+ VY + + T VAIK+IK R ++ + RE ++L +L
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG---ERKEAKDGINFTALREIKLLQEL 59
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-------M 693
HPN++ V G + V EFM L V+ + K +++ M
Sbjct: 60 KHPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVI--------KDKSIVLTPADIKSYM 108
Query: 694 DAAF-GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRN---TLV 745
G+EYLHS I+H DLK +NLL+ + K+ DFGL++ R +V
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDG----VLKLADFGLARSFGSPNRKMTHQVV 164
Query: 746 TGGVRGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEIL 785
T W APELL G+ VD++S G + E+L
Sbjct: 165 T-------RWYRAPELLFGARH-YGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 76/276 (27%), Positives = 131/276 (47%), Gaps = 41/276 (14%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D + LK+LG G++G+VY K R +D A+K + G S++ER + E IL
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVD----LGSMSQKERE--DAVNEIRIL 53
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------- 690
+ ++HPN++++ DG L V E+ G L + ++++LI
Sbjct: 54 ASVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAI----SKRKKKRKLIPEQEIWR 107
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
I + G++ LH + I+H DLK N+L+ D + K+GD G+SK+ + +
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNM-AKTQI 162
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY-----ANMHYGAIIGGIVN 805
GT +MAPE+ G S K D++S G +L+E+ T P+ ++ Y + G
Sbjct: 163 GTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-KVQRGKY- 218
Query: 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
PP+P + + + P +RP+ +I
Sbjct: 219 ----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 38/276 (13%)
Query: 591 GTFGTVYHGKWRGTDVAIKR--IKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648
GTFG +++G + K+ S Q L L+ E+ +L L H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ---ESCLLYGLSHQNILPI 73
Query: 649 YGVVQDGPGGTLATVTEFMVNGSL-------RHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
V + + +M G+L R + + L ++ + +A+ A GM Y
Sbjct: 74 LHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGTLPWMA 757
LH + ++H D+ N +++ + + K+ D LS+ + + L R + WMA
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQV----KITDNALSRDLFPMDYHCLGDNENR-PVKWMA 187
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM------HYGAIIGGIVNNTLRP 810
E L + + S DV+SFG++LWE++T G+ PY + Y + + R
Sbjct: 188 LESL--VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY-------LKDGYRL 238
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
P C E +M CWA DP RPSF+++ + L
Sbjct: 239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 7e-21
Identities = 86/295 (29%), Positives = 129/295 (43%), Gaps = 48/295 (16%)
Query: 586 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
K LG G FG V + G D VA+K +K ++ + E E+
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-------DDATDKDLSDLVSEMEM 70
Query: 637 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 679
+ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 71 MKMIGKHKNIINLLGACTQDGP---LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 680 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739
E L + + A A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN----VMKIADFGLARD 183
Query: 740 KRNT-LVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795
N G LP WMAPE L + + DV+SFG++LWEI T G PY +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL-RVMS 849
+ ++ R P C E ++M +CW P RP+F ++ L RV++
Sbjct: 242 VEELF-KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 8e-21
Identities = 80/268 (29%), Positives = 129/268 (48%), Gaps = 31/268 (11%)
Query: 584 ELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
+L+ +G G+FG VY G T VAIK I E E + +E +LS+
Sbjct: 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 642 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
P + +YG G L + E++ GS +L K L+ I + G++Y
Sbjct: 61 SPYITRYYGSYLKG--TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDY 116
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTLPW 755
LHS+ +H D+K N+L++ + + K+ DFG+ ++IKRNT V GT W
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDV----KLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
MAPE++ S+ K D++S GI E+ GE P +++H ++ I N+ P + G
Sbjct: 168 MAPEVIKQSAYDF--KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQ 224
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
++ +E C DP RP+ E+ +
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-21
Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 48/297 (16%)
Query: 586 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
K LG G FG V + G D VA+K +K E+ + E E+
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEM 73
Query: 637 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 679
+ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 74 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 680 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739
+ + + + A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN----VMKIADFGLARD 186
Query: 740 KRNT-LVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795
N G LP WMAPE L + + DV+SFG+++WEI T G PY +
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL-RVMSAA 851
+ ++ R P C +E ++M CW P RP+F ++ L R+++
Sbjct: 245 VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 33/275 (12%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRI--KKSCFTGRSSEQERLTLEFWREAEIL 637
E + EL LG G G+V + + T I K+ T + + ++ L RE EI
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNT----GMIFALKTITTDPNPDLQKQIL---RELEIN 53
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV---LLSKERHLDRRKRLIIAMD 694
P +V +YG D ++ E+ GSL + + + + + IA
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAES 113
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
G+ YLHS+ I+H D+K N+L+ K + K+ DFG+S N+L G GT
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQV----KLCDFGVSGELVNSL-AGTFTGTSF 168
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY---ANMHYGAIIGGIVNNTLRPP 811
+MAPE + G ++ DV+S G+ L E+ P+ G I +++ + P
Sbjct: 169 YMAPERIQGKPYSITS--DVWSLGLTLLEVAQNRFPFPPEGEPPLGPI--ELLSYIVNMP 224
Query: 812 VPGFCDSE-----W----RLLMEQCWAPDPVVRPS 837
P D W + ++QC DP RP+
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 78/264 (29%), Positives = 130/264 (49%), Gaps = 18/264 (6%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
++ +G G++G V + R G IK++ +S +ER E +EA++LS+L H
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR----NASRRERKAAE--QEAQLLSQLKH 58
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAMDAAFGMEY 701
PN+VA Y +G G L V F G L H L K + L + + + A ++Y
Sbjct: 59 PNIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGTLPWMAPEL 760
LH K+I+H DLK N+ + + I KVGD G++++ N + + GT +M+PEL
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 820
S+ + K DV++ G ++E+ T + + +++ I+ L PP+P E
Sbjct: 174 F--SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPEL 230
Query: 821 RLLMEQCWAPDPVVRPSFTEIARR 844
L+ + P RPS I R+
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 82/288 (28%), Positives = 130/288 (45%), Gaps = 36/288 (12%)
Query: 570 DISTLQIIKNEDLEE----LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 625
D ++ +D E+ L+E+G G+FG VY + T+ + IKK ++G+ S
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSN--- 56
Query: 626 LTLEFW----REAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKE 680
E W +E L +L HPN + + G +++ T V E+ + GS +L +
Sbjct: 57 ---EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH---TAWLVMEYCL-GSASDILEVHK 109
Query: 681 RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740
+ L + I A G+ YLHS +H D+K N+L L +P K+ DFG + +
Sbjct: 110 KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL--LTEP--GTVKLADFGSASLV 165
Query: 741 R--NTLVTGGVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 797
N+ V GT WMAPE +L + KVDV+S GI E+ + P NM+
Sbjct: 166 SPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 798 AIIGGIVNNTLRPPV--PGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+ + I N P +R ++ C P RPS E+ +
Sbjct: 221 SALYHIAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 86/280 (30%), Positives = 128/280 (45%), Gaps = 41/280 (14%)
Query: 583 EELKELGSGTFGTVYH--GKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E ++ +G GT+G VY K G+ A+K + S E + E+ IL L
Sbjct: 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEY----NILQSL 75
Query: 641 -HHPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHV---LLSKERHLDRRKRLIIAM 693
+HPNVV FYG+ GG L V E GS+ + LL + LD I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTG 747
A G+++LH+ I+H D+K +N+L+ + + K+ DFG+S +++RNT V
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGV----KLVDFGVSAQLTSTRLRRNTSV-- 189
Query: 748 GVRGTLPWMAPELL---NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804
GT WMAPE++ + DV+S GI E+ G+ P +MH + I
Sbjct: 190 ---GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246
Query: 805 NN---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
N TL P +C + + QC D RPS T +
Sbjct: 247 RNPPPTLLHP-EKWCR-SFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 37/282 (13%)
Query: 586 KELGSGTFGTVYHGK-WRGTDVA---IKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
E+G+G FG V G+ RG A +K ++ S ++ E+L F +E + +L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-----ATPDEQLL--FLQEVQPYRELN 53
Query: 642 HPNVVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL----DRRKRLIIAMDAA 696
HPNV+ G ++ P V EF G L++ L S + + +A + A
Sbjct: 54 HPNVLQCLGQCIESIP---YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVA 110
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL--SKIKRNTLVTGGVRGT-L 753
G+ +LH + +H DL N + + K+GD+GL + + +T L
Sbjct: 111 SGLLWLHQADFIHSDLALRNCQLTADLSV----KIGDYGLALEQYPEDYYITKDCHAVPL 166
Query: 754 PWMAPELLNGSSS-----KVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV-NN 806
W+APEL+ ++K +++S G+ +WE+ T ++PY ++ ++ +V
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226
Query: 807 TLRPPVPGF---CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
++ P P W +M+ CW DP RP+ E+ L
Sbjct: 227 DIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 76/267 (28%), Positives = 128/267 (47%), Gaps = 24/267 (8%)
Query: 588 LGSGTFGTVYHG-KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 646
LG G +GTVY G +G +A+K+++ ++E+E L+ E ++L L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQ--EEVDLLKSLKHVNIV 65
Query: 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGMEYL 702
+ G D T++ EF+ GS+ +L E + + I+ G+ YL
Sbjct: 66 QYLGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPI---C--KVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
H+ +VH D+K +N+++ I+ I C ++ GL N L + + GT WMA
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPYWMA 176
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPGFC 816
PE++N S K D++S G ++E+ TG+ P A+M A + I + L P +P
Sbjct: 177 PEVIN--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF 234
Query: 817 DSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+ + C D RPS ++ R
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 39/226 (17%)
Query: 580 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKR--IKKSCFTGRSSEQERLTLEFWREAE 635
L+ ++G G+ G V K G VA+K+ ++K Q+R L F E
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---------QQRRELLF-NEVV 68
Query: 636 ILSKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
I+ HPN+V Y +V D L V EF+ G+L ++ + ++ + +A+
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAV 124
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG----LSK--IKRNTLVTG 747
A + +LH++ ++H D+K D++L+ + K+ DFG +SK +R +LV
Sbjct: 125 LKA--LSFLHAQGVIHRDIKSDSILLTSDGRV----KLSDFGFCAQVSKEVPRRKSLV-- 176
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
GT WMAPE++ S +VD++S GI++ E++ GE PY N
Sbjct: 177 ---GTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 74/255 (29%), Positives = 111/255 (43%), Gaps = 20/255 (7%)
Query: 585 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
LK + G FG+VY K R T AIK +KKS ++ + + E A ++ +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN-QVTNVKAE---RAIMMIQGES 56
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
P V Y Q L V E++ NG L+ L + G+E L
Sbjct: 57 PYVAKLYYSFQSK--DYLYLVMEYL-NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDL 113
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLN 762
H + I+H D+K +NLL++ + K+ DFGLS RN L GT ++APE +
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHL----KLTDFGLS---RNGLENKKFVGTPDYLAPETIL 166
Query: 763 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPGFCDSEW 820
G + D +S G V++E L G P+ A+ I++ + P V FC E
Sbjct: 167 GVGD--DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224
Query: 821 RLLMEQCWAPDPVVR 835
L+ + DP R
Sbjct: 225 VDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-20
Identities = 59/168 (35%), Positives = 85/168 (50%), Gaps = 12/168 (7%)
Query: 683 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 741
LD L + A GM +L SKN +H DL N+L+ I K+ DFGL++ R
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR----ITKICDFGLARDIRN 266
Query: 742 --NTLVTGGVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 797
N +V G R + WMAPE + N + S DV+S+GI+LWEI + G PY M
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFES---DVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
+ ++ R P SE +M+ CW DP+ RP+F +I + +
Sbjct: 324 SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-19
Identities = 87/267 (32%), Positives = 132/267 (49%), Gaps = 31/267 (11%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTLEFWRE 633
+K ED ++ LG+G+FG V ++ D VAIKR +KS + +Q+++ F E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS----KIIKQKQVDHVF-SE 81
Query: 634 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
+IL+ ++HP V YG +D L V EF++ G L + + A
Sbjct: 82 RKILNYINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEF-FTFLRRNKRFPNDVGCFYAA 138
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 753
EYL S NIV+ DLK +NLL++ KD K+ DFG +K+ T + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD-KD---GFIKMTDFGFAKVVDTRTYT--LCGTP 192
Query: 754 PWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YAN---MHYGAIIGGIVNNTL 808
++APE LLN K + D ++ GI ++EIL G P YAN + Y I+ GI+
Sbjct: 193 EYIAPEILLNVGHGKAA---DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--- 246
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVR 835
P F D+ + LM++ + D R
Sbjct: 247 ---FPKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 31/272 (11%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E +L+ +G G+FG V+ G T VAIK I E E + +E +L
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-------LEEAEDEIEDIQQEITVL 56
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
S+ P V +YG G L + E++ GS +L + D + + +
Sbjct: 57 SQCDSPYVTKYYGSYLKG--TKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILK 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRG 751
G++YLHS+ +H D+K N+L++ + + K+ DFG+ ++IKRNT V G
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEQGDV----KLADFGVAGQLTDTQIKRNTFV-----G 163
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
T WMAPE++ S+ K D++S GI E+ GE P ++MH ++ I N P
Sbjct: 164 TPFWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPT 220
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+ G ++ ++ C DP RP+ E+ +
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 19/223 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI- 636
+DLE ++ELG G +G V + GT +A+KRI+ + S EQ+RL ++ +I
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL----DIS 53
Query: 637 LSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
+ + P V FYG + ++G V + ++ + V K + IA+
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVY-DKGLTIPEDILGKIAVSI 112
Query: 696 AFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
+EYLHSK +++H D+K N+L+N ++ +C DFG+S +++ G P
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVK-LC---DFGISGYLVDSVAKTIDAGCKP 168
Query: 755 WMAPELLN--GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 795
+MAPE +N + K DV+S GI + E+ TG PY +
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 59/231 (25%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQER--LTLEFWREAEILS 638
E+L +G GT+G VY + + VA+K+++ + ER + + RE +L
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVR--------MDNERDGIPISSLREITLLL 61
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF- 697
L HPN+V VV G L ++ F+V L S L+ M F
Sbjct: 62 NLRHPNIVELKEVVV---GKHLDSI--FLVMEYCEQDLAS----------LLDNMPTPFS 106
Query: 698 -------------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744
G++YLH I+H DLK NLL+ K K+ DFGL++
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG----CLKIADFGLAR------ 156
Query: 745 VTGGVRG-------TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
G TL + APELL G + + +D+++ G +L E+L +
Sbjct: 157 TYGLPAKPMTPKVVTLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 83/272 (30%), Positives = 124/272 (45%), Gaps = 25/272 (9%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
NE E + ELG G FG VY K + T A K I+ T E E ++ E EI
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELE----DYMVEIEI 62
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
L+ +HP +V G G L + EF G++ ++L +R L + +I
Sbjct: 63 LATCNHPYIVKLLGAFYWD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT-GGVRGTLPW 755
++YLHS I+H DLK N+L+ L I K+ DFG+S TL GT W
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGDI----KLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 756 MAPELLNGSSSKVSE---KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
MAPE++ + K + K D++S GI L E+ E P+ ++ ++ I + PP
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT 234
Query: 813 ---PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P E+R ++ P RPS ++
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 68/271 (25%), Positives = 121/271 (44%), Gaps = 18/271 (6%)
Query: 585 LKELGSGTFGTVYHGKWR---GTDVAIKRI--KKSCFTGRSSEQERLTLEFWREAEILSK 639
L+ LGSG FG VY + + +A+K I F E+++ + E I+ +
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 640 -LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDA 695
L HPN+V +Y + L V + + L S K++ + I +
Sbjct: 65 QLRHPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 696 AFGMEYLH-SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
+ YLH K IVH DL +N+++ D + + DFGL+K K+ V GT+
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIMLGEDDKV----TITDFGLAKQKQPESKLTSVVGTIL 178
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814
+ PE++ + EK DV++FG +L+++ T + P+ + + ++ IV P G
Sbjct: 179 YSCPEIVK--NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236
Query: 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
+ ++ C PD RP +++ +
Sbjct: 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 82/284 (28%), Positives = 136/284 (47%), Gaps = 33/284 (11%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E +L+++G G+FG V+ G T VAIK I E E + +E +L
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-------LEEAEDEIEDIQQEITVL 56
Query: 638 SKLHHPNVVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
S+ P V +YG ++D L + E++ GS +L + LD + I +
Sbjct: 57 SQCDSPYVTKYYGSYLKDT---KLWIIMEYLGGGSALDLL--EPGPLDETQIATILREIL 111
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVR 750
G++YLHS+ +H D+K N+L++ + K+ DFG+ ++IKRNT V
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFV----- 162
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
GT WMAPE++ S+ K D++S GI E+ GE P++ +H ++ I N P
Sbjct: 163 GTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PP 219
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854
+ G + +E C +P RP+ E+ + ++ A +T
Sbjct: 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKT 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 566 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQ 623
LGNF I K++G G F VY G VA+K+++ + Q
Sbjct: 1 LGNFKI-------------EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ 47
Query: 624 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 683
+ L +E ++L +L HPNV+ + + L V E G L ++ +H
Sbjct: 48 DCL-----KEIDLLKQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMI----KHF 96
Query: 684 DRRKRLI-------IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736
++KRLI + +E++HSK I+H D+K N+ + + K+GD GL
Sbjct: 97 KKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG----VVKLGDLGL 152
Query: 737 SKI-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--AN 793
+ T + GT +M+PE ++ + K D++S G +L+E+ + P+
Sbjct: 153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDK 210
Query: 794 MHYGAIIGGIVNNTLRPPVPGFCDS-EWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850
M+ ++ I PP+P S E R L+ +C PDP RP + + + + M A
Sbjct: 211 MNLYSLCKKIEKCDY-PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 36/227 (15%)
Query: 586 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLT----LEF--WREAEIL 637
LG GT+G V G VAIK++K + ++ +L + F RE +I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 638 SKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+++ H N++ V V+ G + V + M L+ V+ K R + + + I+ +
Sbjct: 75 NEIKHENIMGLVDVYVE---GDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQIL 129
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----------------IK 740
G+ LH +H DL N+ +N K ICK+ DFGL++ ++
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 741 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
R +T V TL + APELL G + K VD++S G + E+LTG
Sbjct: 186 RREEMTSKVV-TLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 1e-18
Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 26/278 (9%)
Query: 584 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+L+E+G G+FG VY + T+ + IKK ++G+ S ++ + +E + L ++ HP
Sbjct: 29 DLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSNEK--WQDIIKEVKFLQRIKHP 85
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
N + + G L V E+ + GS +L ++ L + I A G+ YLH
Sbjct: 86 NSIEYKGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLPWMAPE-L 760
S N++H D+K N+L L +P + K+ DFG + I N+ V GT WMAPE +
Sbjct: 143 SHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 820
L + KVDV+S GI E+ + P NM+ + + I N P +EW
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPTLQSNEW 249
Query: 821 ----RLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854
R ++ C P RP+ E+ + + V+ +T
Sbjct: 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 41/280 (14%)
Query: 583 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E ++ +G GT+G V+ K G+ A+K + + E E IL L
Sbjct: 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---------HDIDEEIEAEYNILKAL 71
Query: 641 H-HPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM--- 693
HPNVV FYG+ G L V E GS+ ++ + +R + IIA
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTG 747
+A G+++LH +H D+K +N+L+ + + K+ DFG+S +++RNT V
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGV----KLVDFGVSAQLTSTRLRRNTSV-- 185
Query: 748 GVRGTLPWMAPELLNGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804
GT WMAPE++ S + DV+S GI E+ G+ P A++H + I
Sbjct: 186 ---GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242
Query: 805 NNTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
N PP P +E+ + +C D RP+ +++
Sbjct: 243 RNP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 88/333 (26%), Positives = 129/333 (38%), Gaps = 88/333 (26%)
Query: 586 KELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
K LG G FG V G + VA+K +K+ +SE + L E +IL
Sbjct: 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKALMTEL----KILI 65
Query: 639 KL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNG-------SLRHVLL------------- 677
+ HH NVV G PGG L + E+ G S R
Sbjct: 66 HIGHHLNVVNLLGACTK-PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMK 124
Query: 678 ---SKERHLDRR--------------KRLIIA-----------------------MDAAF 697
K++ LD K L A
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGGVRGTLP 754
GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R L
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 755 WMAPELLNGSSSKV-SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812
WMAPE + KV + + DV+SFG++LWEI + G PY + + R
Sbjct: 241 WMAPESI---FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA 297
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P + E +M CW +P RP+F+E+ L
Sbjct: 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-18
Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 52/241 (21%)
Query: 588 LGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
+G G G VY + VA+K+I++ SE L F REA+I + L HP +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIHPGI 64
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNG-SLRHVL--------LSKERHLDRRKRLIIAMDAA 696
V Y + DG T + G +L+ +L LSKE K + A +
Sbjct: 65 VPVYSICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFLSI 118
Query: 697 F-----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR---------- 741
F +EY+HSK ++H DLK DN+L+ L + + D+G + K+
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEV----VILDWGAAIFKKLEEEDLLDID 174
Query: 742 ---------NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 792
+ + G + GT +MAPE L G + SE D+++ G++L+++LT PY
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA--SESTDIYALGVILYQMLTLSFPYR 232
Query: 793 N 793
Sbjct: 233 R 233
|
Length = 932 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 74/254 (29%), Positives = 112/254 (44%), Gaps = 23/254 (9%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G FG V +++ T AIK +KK R E E L E R E + HP +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD-EVESLMCE-KRIFETANSERHPFL 64
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 704
V + Q + V E+ G L H+ + + R A G++YLH
Sbjct: 65 VNLFACFQTE--DHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAA-CVVLGLQYLHE 119
Query: 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---RNTLVTGGVRGTLPWMAPELL 761
IV+ DLK DNLL++ + + K+ DFGL K + T GT ++APE+L
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFV----KIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVL 173
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821
+S + VD + G++++E+L GE P+ + IVN+ P F E
Sbjct: 174 TETS--YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAI 229
Query: 822 LLMEQCWAPDPVVR 835
+M + +P R
Sbjct: 230 SIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 67/272 (24%), Positives = 131/272 (48%), Gaps = 31/272 (11%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
++K++G G+FG K + G IK I S + + E+ R +E +LS +
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVAVLSNM 56
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-------RHVLLSKERHLDRRKRLIIAM 693
HPN+V + ++ G L V ++ G L R VL +++ LD ++ +A
Sbjct: 57 KHPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA- 113
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGT 752
++++H + I+H D+K N+ + I K+GDFG++++ +T+ + GT
Sbjct: 114 -----LKHVHDRKILHRDIKSQNIFLTKDGTI----KLGDFGIARVLNSTVELARTCIGT 164
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
+++PE+ + + K D+++ G VL+E+ T + + + ++ I+ + PPV
Sbjct: 165 PYYLSPEIC--ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPV 221
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
+ R L+ Q + +P RPS I +
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 584 ELKELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
+L+E+G G+FG VY + R ++V IKK ++G+ S ++ + +E L KL H
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVA--IKKMSYSGKQSNEK--WQDIIKEVRFLQKLRH 74
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
PN + + G L V E+ + GS +L ++ L + + A G+ YL
Sbjct: 75 PNTIQYRGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTLPWMAPE- 759
HS N++H D+K N+L L +P + K+GDFG + I N V GT WMAPE
Sbjct: 132 HSHNMIHRDVKAGNIL--LSEP--GLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 819
+L + KVDV+S GI E+ + P NM+ + + I N P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPALQSGH 238
Query: 820 W----RLLMEQCWAPDPVVRPS 837
W R ++ C P RP+
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 4e-18
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 585 LKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
LK +GSG +G V K G VAIK+I + RE ++L L H
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 643 PNVVAFYGVVQDGPG---GTLATVTEFMVNGSLRHVLLSKERHL--DRRKRLIIAMDAAF 697
N++ +++ + VTE M + H ++ + L D + + +
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQYFLYQI--LR 114
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKI-----KRNTLVTGGV- 749
G++YLHS N++H DLK N+LVN + C K+ DFGL++ +T V
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 750 -RGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
R W APELL SSS+ ++ +D++S G + E+LT
Sbjct: 169 TR----WYRAPELL-LSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 66/215 (30%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
EEL E+G G +GTVY + G VA+K+++ +E + L RE +L +L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP------LSEEGIPLSTLREIALLKQL 55
Query: 641 ---HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV------LLSK--ERHLDRRKRL 689
HPN+V V T E + HV LSK + L
Sbjct: 56 ESFEHPNIVRLLDVCH-----GPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK 110
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 749
+ G+++LHS IVH DLK N+LV + K+ DFGL++I + V
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV----KIADFGLARIYSFEMALTSV 166
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI 784
TL + APE+L SS VD++S G + E+
Sbjct: 167 VVTLWYRAPEVLLQSSYATP--VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-18
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 578 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLE----FW 631
K D E + LG+G+FG V K +GT AIK +KK +E L ++
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---------REILKMKQVQHVA 66
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
+E IL +L HP +V QD + + EF+V G L L R + +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 751
A + EYLHSK+I++ DLK +NLL++ K + KV DFG + K+ T + G
Sbjct: 125 A-ELVLAFEYLHSKDIIYRDLKPENLLLDNKGHV----KVTDFGFA--KKVPDRTFTLCG 177
Query: 752 TLPWMAPELLNGSSSKVSEK-VDVFSFGIVLWEILTGEEPY 791
T ++APE++ SK K VD ++ G++L+E + G P+
Sbjct: 178 TPEYLAPEVIQ---SKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-18
Identities = 81/275 (29%), Positives = 128/275 (46%), Gaps = 30/275 (10%)
Query: 580 EDLEE----LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
+D EE L E+G G+FG VY T+ + +KK ++G+ + ++ + +E +
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVA-VKKMSYSGKQTNEK--WQDIIKEVK 73
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
L +L HPN + + G L V E+ + GS +L ++ L + I A
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGA 130
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTL 753
G+ YLHS N++H D+K N+L L +P + K+ DFG + N+ V GT
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSPANSFV-----GTP 181
Query: 754 PWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
WMAPE +L + KVDV+S GI E+ + P NM+ + + I N
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND----S 237
Query: 813 PGFCDSEW----RLLMEQCWAPDPVVRPSFTEIAR 843
P +EW R ++ C P RP+ E+ R
Sbjct: 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 586 KELGSGTFGTVYHGKWRGTDVAIKRIK--KSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ LG G+FGTVY K + A +R+K K G + E T++ +EA++LSKL HP
Sbjct: 6 QRLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNE--TVQANQEAQLLSKLDHP 62
Query: 644 NVVAFYG--VVQDGPGGTLATVTEFMVNGSLR---HVLLSKERHLDRRKRLIIAMDAAFG 698
+V F+ + +D +TE+ L L + L + + G
Sbjct: 63 AIVKFHASFLERD----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--LVTGGVRGTLPWM 756
+ Y+H + I+H DLK N+ + + K+GDFG+S++ + L T GT +M
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLK-----NNLLKIGDFGVSRLLMGSCDLAT-TFTGTPYYM 172
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
+PE L K D++S G +L+E+ + ++ +++ IV P +P
Sbjct: 173 SPEAL--KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETY 229
Query: 817 DSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+ +M+ DP +RPS EI R
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 37/221 (16%)
Query: 584 ELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
+++G G GTVY G +VAIK++ +Q + L E ++ +
Sbjct: 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-------QQPKKEL-IINEILVMRENK 74
Query: 642 HPNVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 698
HPN+V + Y V G L V E++ GSL V+ E +D + + +
Sbjct: 75 HPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 127
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGT 752
+E+LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GT 178
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
WMAPE++ + KVD++S GI+ E++ GE PY N
Sbjct: 179 PYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 83/272 (30%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 583 EELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E + ELG G FG VY + + T V A K I SE+E ++ E +IL+
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK------SEEE--LEDYMVEIDILASC 59
Query: 641 HHPNVV----AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
HPN+V AFY L + EF G++ V+L ER L + ++
Sbjct: 60 DHPNIVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPW 755
+ YLH I+H DLK N+L L I K+ DFG+S K R GT W
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDI----KLADFGVSAKNTRTIQRRDSFIGTPYW 169
Query: 756 MAPELLNGSSSK---VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
MAPE++ +SK K DV+S GI L E+ E P+ ++ ++ I + PP
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT 227
Query: 813 ---PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P SE++ +++C + R + T++
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 71/277 (25%), Positives = 129/277 (46%), Gaps = 36/277 (12%)
Query: 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K++G G F VY G VA+K+++ + + + +E ++L +L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-----KEIDLLKQLNHP 62
Query: 644 NVVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-------IAMDA 695
NV+ +Y ++D L V E G L ++ +H ++KRLI +
Sbjct: 63 NVIKYYASFIED---NELNIVLELADAGDLSRMI----KHFKKQKRLIPEKTVWKYFVQL 115
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP 754
+E++HS+ ++H D+K N+ + + K+GD GL + T + GT
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMHYGAIIGGIVNNTLRPPV 812
+M+PE ++ + K D++S G +L+E+ + P+ M+ ++ I PP+
Sbjct: 172 YMSPERIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPL 228
Query: 813 PG-FCDSEWRLLMEQCWAPDPVVRPSFT---EIARRL 845
P E R L+ C PDP RP T ++A+R+
Sbjct: 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 78/258 (30%), Positives = 123/258 (47%), Gaps = 28/258 (10%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LG G+FG V + +GT+ AIK +KK + E +E R L+ HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVE--RRVLALAW-EHP 56
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+ + Q L V E++ G L + S R + R R A + G+++LH
Sbjct: 57 FLTHLFCTFQTKE--HLFFVMEYLNGGDLMFHIQSSGRFDEARARFY-AAEIICGLQFLH 113
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVRGTLPWMA 757
K I++ DLK DN+L++ I K+ DFG+ K K +T GT ++A
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHI----KIADFGMCKENMNGEGKASTFC-----GTPDYIA 164
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817
PE+L G K +E VD +SFG++L+E+L G+ P+ + I+N+ RP P +
Sbjct: 165 PEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWIS 220
Query: 818 SEWRLLMEQCWAPDPVVR 835
E + + + + DP R
Sbjct: 221 KEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 71/274 (25%), Positives = 124/274 (45%), Gaps = 35/274 (12%)
Query: 588 LGSGTFGTVYHG---------KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
LG GTF ++ G + T+V +K + KS + F+ A ++S
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMS 54
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 698
+L H ++V YGV G + V E++ GSL L + ++ +L +A A+
Sbjct: 55 QLSHKHLVLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA 112
Query: 699 MEYLHSKNIVHFDLKCDNLLV----NLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGT 752
+ +L K + H ++ N+L+ + K P K+ D G+S + + L+
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-----R 167
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAIIGGIVNNTLRPP 811
+PW+ PE + + +S D +SFG LWEI +G ++P + + + + + P
Sbjct: 168 IPWVPPECIENPQN-LSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLP 225
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P + +E L+ QC +P RPSF I R L
Sbjct: 226 APKW--TELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 10/164 (6%)
Query: 683 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--- 739
LD L + A GM++L SKN +H D+ N+L+ + K+ DFGL++
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR----VAKICDFGLARDIMN 264
Query: 740 KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 798
N +V G R + WMAPE + V DV+S+GI+LWEI + G+ PY + +
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQS--DVWSYGILLWEIFSLGKSPYPGILVNS 322
Query: 799 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 842
+V + P F E +M+ CW +P RP+F++I+
Sbjct: 323 KFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 581 DLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTLEF 630
+ E L+ LG+G +G V+ G G A+K +KK+ T + ER LE
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
R L LH+ AF + L + +++ G L L +E + R+
Sbjct: 61 VRRCPFLVTLHY----AFQTDTK------LHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGG 748
IA + +++LH I++ D+K +N+L++ + + + DFGLSK
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILLDSEGHV----VLTDFGLSKEFLAEEEERAYS 165
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 792
GT+ +MAPE++ G S + VD +S G++ +E+LTG P+
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 40/219 (18%)
Query: 584 ELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
+L++LG GT+ TVY G+ R T VA+K I G S RE ++ +L
Sbjct: 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-------IREISLMKELK 56
Query: 642 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF---- 697
H N+V + V+ L V E+M +++ + H R A+D
Sbjct: 57 HENIVRLHDVIH--TENKLMLVFEYMDKDLKKYM----DTHGVRG-----ALDPNTVKSF 105
Query: 698 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGG 748
G+ + H ++H DLK NLL+N + + K+ DFGL++ I NT
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL----KLADFGLARAFGIPVNTFSNEV 161
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
V TL + AP++L GS + S +D++S G ++ E++TG
Sbjct: 162 V--TLWYRAPDVLLGSRT-YSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
D +++++G GT+G VY G+ + T VA+K+I+ SE+E + RE +L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR------LESEEEGVPSTAIREISLLK 54
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV-LLSKERHLDRRKRLIIAMDAAF 697
+L HPN+V V+ L + EF+ +++ L K +++D
Sbjct: 55 ELQHPNIVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------KIKRNTLVTGGVR 750
G+ + HS+ ++H DLK NLL++ K I K+ DFGL+ ++ + +V
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVI----KLADFGLARAFGIPVRVYTHEVV----- 163
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
TL + APE+L G S + S VD++S G + E+ T
Sbjct: 164 -TLWYRAPEVLLG-SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 78/316 (24%), Positives = 123/316 (38%), Gaps = 67/316 (21%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
+++K LG G G V+ + +GT A+K + K R+ + LT E EIL+
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-----EQEILA 56
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF- 697
L HP + Y Q L V ++ G L LL ++ K L A F
Sbjct: 57 TLDHPFLPTLYASFQTET--YLCLVMDYCPGGEL-FRLLQRQPG----KCLSEE-VARFY 108
Query: 698 ------GMEYLHSKNIVHFDLKCDNLLV---------------NLKDPIRPICKVGDFGL 736
+EYLH IV+ DLK +N+L+ P+ K G
Sbjct: 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 737 SKIKRNTLVT------GGVR-----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785
+ N++ + R GT ++APE+++G VD ++ GI+L+E+L
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH--GSAVDWWTLGILLYEML 226
Query: 786 TGEEPYA----NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
G P+ + + I+ V PPV R L+ + DP
Sbjct: 227 YGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVK----DP--------- 273
Query: 842 ARRLRVMSAACQTKSH 857
++RL A + K H
Sbjct: 274 SKRLGSKRGAAEIKQH 289
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 73/257 (28%), Positives = 124/257 (48%), Gaps = 23/257 (8%)
Query: 585 LKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
LK LG G+FG V+ G G A+K +KK+ R + ++ E +IL++
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM------ERDILAE 54
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
++HP +V + Q G L + +F+ G L LSKE + A +
Sbjct: 55 VNHPFIVKLHYAFQTE--GKLYLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLAELALAL 111
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAP 758
++LHS I++ DLK +N+L++ + I K+ DFGLSK + GT+ +MAP
Sbjct: 112 DHLHSLGIIYRDLKPENILLDEEGHI----KLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 818
E++N ++ D +SFG++++E+LTG P+ + I+ L +P F
Sbjct: 168 EVVNRRGH--TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSP 223
Query: 819 EWRLLMEQCWAPDPVVR 835
E + L+ + +P R
Sbjct: 224 EAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHH 642
K LG G+FG V+ + +GT+ AIK +KK + + E +LS H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLAWEH 55
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
P + Y Q L V E++ G L + S + D + A + G+++L
Sbjct: 56 PFLTHLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFL 112
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPE 759
HSK IV+ DLK DN+L++ I K+ DFG+ K N L T GT ++APE
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHI----KIADFGMC--KENMLGDAKTCTFCGTPDYIAPE 166
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+L G K + VD +SFG++L+E+L G+ P+
Sbjct: 167 ILLG--QKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 23/221 (10%)
Query: 580 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
EDL++L E+G G FGTV H GT +A+KRI+ T EQ+RL ++ + +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIRS---TVDEKEQKRLLMDL--DV-V 56
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL----RHVLLSKERHLDRRKRLIIA 692
+ P +V FYG + G E M + SL ++V + + IA
Sbjct: 57 MRSSDCPYIVKFYGALFRE--GDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 693 MDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 751
+ + YL + I+H D+K N+L++ I K+ DFG+S +++ G
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNGNI----KLCDFGISGQLVDSIAKTRDAG 169
Query: 752 TLPWMAPELLNGSSSKVSE-KVDVFSFGIVLWEILTGEEPY 791
P+MAPE ++ S+ + + DV+S GI L+E+ TG+ PY
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 589 GSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 644
G GT+G VY K G + AIK+ K G + ++ RE +L +L H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHEN 63
Query: 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLDRR--KRLIIAMD 694
VV+ V + ++ + ++ H L +K + K L+ +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI- 117
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----GGVR 750
G+ YLHS ++H DLK N+LV + P R + K+GD GL+++ L V
Sbjct: 118 -LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
T+ + APELL G + ++ +D+++ G + E+LT
Sbjct: 177 VTIWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 585 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
+ ++G GT+G VY + + T VA+K+++ +E+E + RE +IL +L+H
Sbjct: 12 IGQIGEGTYGQVYKARDKDTGELVALKKVR------LDNEKEGFPITAIREIKILRQLNH 65
Query: 643 PNVVAFYGVVQDGPG--------GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
N+V +V D G V E+M + L +L S H
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRG 751
G+ Y H KN +H D+KC N+L+N K I K+ DFGL+++ + + T V
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQI----KLADFGLARLYNSEESRPYTNKVI- 179
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
TL + PELL G + +DV+S G +L E+ T
Sbjct: 180 TLWYRPPELLLG-EERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGGVRGT 752
A GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
L WMAPE + + DV+SFG++LWEI + G PY + + R
Sbjct: 245 LKWMAPETIFDRVYTIQS--DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P + E M CW +P RP+F+E+ L
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 37/219 (16%)
Query: 586 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+++G G GTV+ G +VAIK+I + ++E + E ++ +L +P
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELII----NEILVMKELKNP 76
Query: 644 NVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
N+V F + V G L V E++ GSL V+ E +D + + + +E
Sbjct: 77 NIVNFLDSFLV-----GDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALE 129
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTLP 754
+LH+ ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GTPY 180
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
WMAPE++ + KVD++S GI+ E++ GE PY N
Sbjct: 181 WMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D E L +LG GTFG VY + G VA+K+I +E++ + RE +IL
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM------HNEKDGFPITALREIKIL 61
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEF-MVNGSLRHVL---LSKER-HLDRRKRLIIA 692
KL HPNVV + + P + MV + H L L L +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVT 746
+ G+ YLH +I+H D+K N+L++ + I K+ DFGL++
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQG----ILKIADFGLARPYDGPPPNPKGGGG 177
Query: 747 GGVRG------TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
GG R T + PELL G + + VD++ G V E+ T
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 75/251 (29%), Positives = 122/251 (48%), Gaps = 19/251 (7%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
+G G+FG V + R T A+K I+K+ RS L E +L++++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-----ERTVLAQVNCPFI 55
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 705
V Q L V F+ G L H L + R R R A + +E LH
Sbjct: 56 VPLKFSFQSP--EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKF 112
Query: 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGS 764
N+++ DLK +N+L++ + I +C DFGL K+ ++ T GT ++APELL G
Sbjct: 113 NVIYRDLKPENILLDYQGHI-ALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 765 SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM 824
++ VD ++ G++L+E+LTG P+ + + + I+ LR P GF D + + L+
Sbjct: 169 G--YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP-DGF-DRDAKDLL 224
Query: 825 EQCWAPDPVVR 835
+ DP R
Sbjct: 225 IGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEILSKL- 640
L ++G GTF V + R G AIK +KK +S EQ L RE + L +L
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQVNNL-----REIQALRRLS 55
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
HPN++ V+ D G LA V E M + +L ++ ++R L ++ ++
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP------ 754
++H I H D+K +N+L+ I K+ DFG + G+ P
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-----ILKLADFGSCR---------GIYSKPPYTEYIS 160
Query: 755 --WM-APE-LLNGSSSKVSEKVDVFSFGIVLWEILT 786
W APE LL + K+D+++ G V +EIL+
Sbjct: 161 TRWYRAPECLL--TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 71/261 (27%), Positives = 108/261 (41%), Gaps = 50/261 (19%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKR------IKKSCFTGRSSEQERLTLEFWRE 633
+D E+L ELG+G G V R + + + R IK + + RE
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-----------QIIRE 49
Query: 634 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--- 690
++L + + P +V FYG G ++ E M GSL VL ++ I
Sbjct: 50 LKVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL--------KKAGRIPEN 99
Query: 691 ----IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 745
I++ G+ YL K I+H D+K N+LVN R K+ DFG+S +++
Sbjct: 100 ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA 155
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP--------YANMHYG 797
V GT +M+PE L G+ V D++S G+ L E+ G P M
Sbjct: 156 NSFV-GTRSYMSPERLQGTHYTVQS--DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
Query: 798 AIIGGIVNNTLRPPVPGFCDS 818
+ G + RP DS
Sbjct: 213 PVSEGEAKESHRPVSGHPPDS 233
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 70/220 (31%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 580 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR----E 633
+D++ + LG G GTVY +A+K I +T+E + E
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-----------ITVELQKQIMSE 49
Query: 634 AEILSKLHHPNVVAFYGV--VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
EIL K P ++ FYG V++ ++ TEFM GSL E L R I
Sbjct: 50 LEILYKCDSPYIIGFYGAFFVEN----RISICTEFMDGGSLDVYRKIPEHVLGR-----I 100
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 751
A+ G+ YL S I+H D+K N+LVN + + K+ DFG+S N++ V G
Sbjct: 101 AVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQV----KLCDFGVSTQLVNSIAKTYV-G 155
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
T +MAPE ++G + DV+S GI E+ G PY
Sbjct: 156 TNAYMAPERISGEQYGIHS--DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
++++++G GT+G VY + + G VA+K+I+ +E E + RE +L +L
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKEL 55
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRR--KRLIIAMDAAF 697
+HPN+V VV L V EF ++ L+ + S LD K + +
Sbjct: 56 NHPNIVRLLDVVHSE--NKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ-- 110
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG------ 751
G+ Y HS ++H DLK NLL++ + + K+ DFGL++ VR
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLIDREGAL----KLADFGLARA-----FGVPVRTYTHEVV 161
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
TL + APE+L GS S VD++S G + E++
Sbjct: 162 TLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGGVRGT 752
A GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R
Sbjct: 184 ARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 753 LPWMAPELLNGSSSKV-SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810
L WMAPE + KV + + DV+SFG++LWEI + G PY + + + R
Sbjct: 240 LKWMAPESI---FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P E +M CW DP RP+F+ + L
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 68/293 (23%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
DLE L E+GSGT G VY +++ G +A+K++++ TG E +R+ + +++
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRR---TGNKEENKRIL----MDLDVV 67
Query: 638 SKLHH-PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------ 690
K H P +V YG F+ + + + LD+ + I
Sbjct: 68 LKSHDCPYIVKCYGY--------------FITDSDVFICMELMSTCLDKLLKRIQGPIPE 113
Query: 691 -----IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744
+ + + YL K ++H D+K N+L++ + K+ DFG+S L
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNV----KLCDFGIS----GRL 165
Query: 745 VTGGVR----GTLPWMAPELLNGSSSKVSEKV--DVFSFGIVLWEILTGEEPYAN--MHY 796
V + G +MAPE ++ + DV+S GI L E+ TG+ PY N +
Sbjct: 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225
Query: 797 GAIIGGIVNNTLRPPV--------PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
++ I+ PP P FC ++ C D RP + E+
Sbjct: 226 -EVLTKILQ--EEPPSLPPNEGFSPDFCS-----FVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G FG V + + T A K++ K R EQ L E +IL K+ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-----EKKILEKVSSRFI 55
Query: 646 V----AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGME 700
V AF L V M G L+ H+ E + + A G+E
Sbjct: 56 VSLAYAFETKDD------LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPE 759
+LH + IV+ DLK +N+L++ +R + D GL+ ++K + G GT +MAPE
Sbjct: 110 HLHQRRIVYRDLKPENVLLDDHGNVR----ISDLGLAVELKGGKKIKGRA-GTPGYMAPE 164
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+L G S VD F+ G L+E++ G P+
Sbjct: 165 VLQGEVYDFS--VDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 580 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E L+ ++G G+ G V K G VA+K++ +Q+R L F E I+
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-------KQQRRELLF-NEVVIM 73
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
HH NVV Y G L V EF+ G+L ++ ++ + + +
Sbjct: 74 RDYHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLR 129
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVTGGVRGTLPWM 756
+ YLH++ ++H D+K D++L+ I K+ DFG +++ + + GT WM
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLTSDGRI----KLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
APE++ S +VD++S GI++ E++ GE PY N
Sbjct: 186 APEVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 581 DLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTLEF 630
+ E LK LG+G +G V+ G G A+K +KK+ T + ER LE
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
R++ L LH+ AF + L + +++ G L L +ER ++ ++
Sbjct: 61 IRQSPFLVTLHY----AFQTDTK------LHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGG 748
+ +E+LH I++ D+K +N+L++ + + DFGLSK +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHV----VLTDFGLSKEFHEDEVERAYS 165
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
GT+ +MAP+++ G + VD +S G++++E+LTG P+
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+DLE +K +G+GTFG V+ + R A+K + EQ E +L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-----VHNEKRVL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
++ HP ++ + D L + E++ G L L + R L A +
Sbjct: 56 KEVSHPFIIRLFWTEHDQ--RFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVC 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
+EYLHSK IV+ DLK +N+L++ + I K+ DFG +K R+ T + GT ++A
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHI----KLTDFGFAKKLRDRTWT--LCGTPEYLA 166
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
PE++ S ++ VD ++ GI+++E+L G P+
Sbjct: 167 PEVI--QSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-15
Identities = 55/151 (36%), Positives = 77/151 (50%), Gaps = 12/151 (7%)
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR--NTLVTGGVRGT 752
A GME+L SKN VH DL N+L+ + + IC DFGL++ I R N + G
Sbjct: 249 ANGMEFLASKNCVHRDLAARNVLI-CEGKLVKIC---DFGLARDIMRDSNYISKGSTFLP 304
Query: 753 LPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810
L WMAPE + N + +S DV+SFGI+LWEI T G PY + + R
Sbjct: 305 LKWMAPESIFNNLYTTLS---DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P E +M++CW +RP F+++
Sbjct: 362 AKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEILSK 639
E L +G G +G V + + T VAIK+ K+S E ++ L RE ++L +
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTAL---REVKVLRQ 56
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAAF 697
L H N+V + G L V E+ V +L +L + L + I + A
Sbjct: 57 LRHENIVNLKEAFRRK--GRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--- 754
Y HS NI+H D+K +N+LV+ ++ +C DFG ++ + L
Sbjct: 114 A--YCHSHNIIHRDIKPENILVSESGVLK-LC---DFGFAR-----ALRARPASPLTDYV 162
Query: 755 ---WM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
W APELL G ++ + VDV++ G ++ E+L GE
Sbjct: 163 ATRWYRAPELLVGDTN-YGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 642
K LG G+FG V + +GTD A+K +KK + +T E +L+ H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMT-----EKRVLALAGKH 55
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEY 701
P + + Q L V E++ G L H+ + D + A + G+++
Sbjct: 56 PFLTQLHSCFQTKD--RLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQF 111
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWM 756
LH + I++ DLK DN+L++ + K+ DFG+ K + GGV GT ++
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCKEG----ILGGVTTSTFCGTPDYI 163
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
APE+L+ + VD ++ G++L+E+L G+ P+
Sbjct: 164 APEILSYQPYGPA--VDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 582 LEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
LE ++G G+ G V K G VA+K + +Q+R L F E I+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD-------LRKQQRRELLF-NEVVIMRD 74
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
H NVV Y G L + EF+ G+L ++ + L+ + + +
Sbjct: 75 YQHQNVVEMYKSYLVGE--ELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQAL 130
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVTGGVRGTLPWMAP 758
YLHS+ ++H D+K D++L+ L + K+ DFG ++I ++ + GT WMAP
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRV----KLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
E++ S + +VD++S GI++ E++ GE PY
Sbjct: 187 EVI--SRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 67/268 (25%), Positives = 125/268 (46%), Gaps = 20/268 (7%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
L+ +G G+FG + +D A+K I+ + + E R +EA +L+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSR------KEAVLLA 53
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMDAAF 697
K+ HPN+VAF + G L V E+ G L + + L + + L +
Sbjct: 54 KMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GTLPWM 756
G++++H K ++H D+K N+ + + K+GDFG +++ + GT ++
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKV----KLGDFGSARLLTSPGAYACTYVGTPYYV 167
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
PE+ + + K D++S G +L+E+ T + P+ + +I + + + P+P
Sbjct: 168 PPEIW--ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHY 224
Query: 817 DSEWRLLMEQCWAPDPVVRPSFTEIARR 844
E R L++Q + +P RPS T I R
Sbjct: 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 30/269 (11%)
Query: 581 DLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQE-----RLTLEF 630
+ E LK LG+G +G V+ G G A+K ++K+ ++ E R LE
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
R++ L LH+ AF + L + +++ G + L ++ + +
Sbjct: 61 VRQSPFLVTLHY----AFQTEAK------LHLILDYVSGGEMFTHLYQRD-NFSEDEVRF 109
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGG 748
+ + +E+LH IV+ D+K +N+L++ + + + DFGLSK + T
Sbjct: 110 YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHV----VLTDFGLSKEFLSEEKERTYS 165
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808
GT+ +MAPE++ G + VD +S GI+++E+LTG P+ + L
Sbjct: 166 FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
Query: 809 R--PPVPGFCDSEWRLLMEQCWAPDPVVR 835
+ PP P F E + L+ + DP R
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 68/278 (24%), Positives = 126/278 (45%), Gaps = 30/278 (10%)
Query: 586 KELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 644
+E+G+G FG V + + T VA +K+ S EQ EF ++ + L HPN
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN----EFLQQGDPYRILQHPN 56
Query: 645 VVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII---AMDAAFGME 700
++ G V+ P V E+ G L+ L ++ H + L++ A + A G+
Sbjct: 57 ILQCLGQCVEAIP---YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL--SKIKRNTLVT-GGVRGTLPWMA 757
++H N +H DL N + + KVGD+G+ S+ K + + T L W+A
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTV----KVGDYGIGPSRYKEDYIETEDDKCVPLRWLA 169
Query: 758 PELLNGSSSKV-----SEKVDVFSFGIVLWEIL-TGEEPYANMHYGAIIGGIVNNT---- 807
PEL+ + ++ +V++ G+ LWE+ +PY+++ ++ ++ +
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
+P + W +++ CW P R + E+ R L
Sbjct: 230 FKPQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-14
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 28/199 (14%)
Query: 603 GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 662
G +VAIK ++ + E+E F RE + ++L+HPN+VA + P G L
Sbjct: 3 GHEVAIKLLRTD-----APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFA 56
Query: 663 VTEFMVNGSLRHVL-----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 717
V E++ +LR VL L +++ A+ A H++ IVH DLK N+
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQGIVHRDLKPQNI 110
Query: 718 LVNLKDPIRPICKVGDFGLS-------KIKRNTLV-TGGVRGTLPWMAPELLNGSSSKVS 769
+V+ +RP KV DFG+ TL T V GT + APE L G V+
Sbjct: 111 MVSQTG-VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP--VT 167
Query: 770 EKVDVFSFGIVLWEILTGE 788
D++++G++ E LTG+
Sbjct: 168 PNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 35/277 (12%)
Query: 586 KELGSGTFGTVYHGK----WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
KE+G+G FG V G+ + V +K ++ S +S QE++ +F EA+ L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS-----ASVQEQM--KFLEEAQPYRSLQ 53
Query: 642 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH----LDRRKRLIIAMDAAF 697
H N++ G + L V EF G L+ L S + D +A + A
Sbjct: 54 HSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS--KIKRNTLVTGGVRGT-LP 754
G+ +LH N +H DL N L+ + K+GD+GLS K K + VT L
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTADLTV----KIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 755 WMAPELLNGSSSKV-----SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV-NNT 807
W+APEL++ + +++ +V+S G+ +WE+ G +PY ++ ++ V
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 808 LRPPVPGF---CDSEWRLLMEQCWAPDPVVRPSFTEI 841
L+ P P W +M+ CW P RPS E+
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPN 644
LG G+FG V + + + A+K +KK + +T E ILS HP
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT-----EKRILSLARNHPF 57
Query: 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 704
+ Y Q L V EF VNG + K R D + A + + +LH
Sbjct: 58 LTQLYCCFQTPD--RLFFVMEF-VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114
Query: 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNG 763
K I++ DLK DN+L++ + CK+ DFG+ K N T GT ++APE+L
Sbjct: 115 KGIIYRDLKLDNVLLDHEGH----CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 764 SSSKVSEKVDVFSFGIVLWEILTGEEPY 791
S VD ++ G++L+E+L G P+
Sbjct: 171 MLYGPS--VDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 585 LKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
+++G G GTVY G +VAIK++ + +Q+ E ++ + +
Sbjct: 24 FEKIGQGASGTVYTAIDIATGQEVAIKQM--------NLQQQPKKELIINEILVMRENKN 75
Query: 643 PNVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
PN+V + Y V G L V E++ GSL V+ E +D + + + +
Sbjct: 76 PNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQAL 128
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTL 753
++LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GTP 179
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
WMAPE++ + KVD++S GI+ E++ GE PY N
Sbjct: 180 YWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 30/219 (13%)
Query: 578 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
K E +L +LG GT+ TV+ G+ + T+ VA+K I R +E RE
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVS 55
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
+L L H N+V + ++ TL V E++ + L+ L + + I
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTL--VFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQL 112
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-------RNTLVTGG 748
G+ Y H + I+H DLK NLL+N K + K+ DFGL++ K N +V
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLINEKGEL----KLADFGLARAKSVPTKTYSNEVV--- 165
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
TL + P++L G S++ S +D++ G +L+E+ TG
Sbjct: 166 ---TLWYRPPDVLLG-STEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 68/233 (29%), Positives = 104/233 (44%), Gaps = 31/233 (13%)
Query: 626 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLD 684
+ L F+ A ++S++ H ++ +GV G + V EF+ +G L V L KE+ +
Sbjct: 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIM--VEEFVEHGPL-DVCLRKEKGRVP 115
Query: 685 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV---NLKDPIRPICKVGDFGLS--KI 739
++ +A A + YL KN+VH ++ N+L+ L + P K+ D G+S +
Sbjct: 116 VAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL 175
Query: 740 KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI-------LTGEEPYA 792
R V +PW+APE + G +S +S D +SFG L EI L P
Sbjct: 176 SREERVE-----RIPWIAPECVPGGNS-LSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
Query: 793 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
+ R P P C E L+ QC +P RPSF I R L
Sbjct: 230 KERF-------YEKKHRLPEPS-C-KELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 583 EELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+ ++ +GSG +G V G VAIK+I + + L RE +IL
Sbjct: 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKI------PHAFDVPTLAKRTLRELKILRHF 61
Query: 641 HHPNVVAFYGVVQ--DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF- 697
H N++A +++ + V + M L H++ S + + R F
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIR-------YFL 113
Query: 698 -----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSK------IKRNTL 744
G++Y+HS N++H DLK NLLVN +D C ++GDFG+++ +
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVN-ED-----CELRIGDFGMARGLSSSPTEHKYF 167
Query: 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785
+T V T + APELL S + + +D++S G + E+L
Sbjct: 168 MTEYV-ATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 70/231 (30%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED E +K + +G +G VY + + T A+K+I K R+ Q+ E +IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-----ERDIL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+ +P VV+ + + L V E++ G +L + R+ A +
Sbjct: 56 TFAENPFVVSMFCSFETKR--HLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVL 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGG------ 748
+EYLH+ IVH DLK DNLL+ I K+ DFGLSKI T + G
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHI----KLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 749 -------VRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
V GT ++APE +L K VD ++ GI+L+E L G P+
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 79/280 (28%), Positives = 122/280 (43%), Gaps = 40/280 (14%)
Query: 584 ELKEL-GSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-H 641
EL EL G+GT+G VY G+ T + IK TG E E +E +L K H
Sbjct: 9 ELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEE------EIKQEINMLKKYSH 61
Query: 642 HPNVVAFYGV-VQDGPGGT---LATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAMDAA 696
H N+ +YG ++ P G L V EF GS+ ++ +K L I +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVR 750
G+ +LH ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFI----- 172
Query: 751 GTLPWMAPELL---NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807
GT WMAPE++ + K D++S GI E+ G P +MH + I N
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN- 231
Query: 808 LRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTEIAR 843
P P +W + +E C + RP+ ++ +
Sbjct: 232 ---PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 584 ELKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
+L+ +G G FG V + G +VAIK+I K T +++ +RE ++L L
Sbjct: 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT------YRELKLLKHLR 67
Query: 642 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
H N+++ + P + VTE + G+ H LL R L+++ G++Y
Sbjct: 68 HENIISLSDIFIS-PLEDIYFVTELL--GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKY 123
Query: 702 LHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
+HS +VH DLK N+L+N LK IC DFGL++I+ + TG V T + A
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLK-----IC---DFGLARIQDPQM-TGYV-STRYYRA 173
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
PE++ + K +VD++S G + E+L G+
Sbjct: 174 PEIML-TWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 74/258 (28%), Positives = 119/258 (46%), Gaps = 28/258 (10%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHH 642
K LG G+FG V + +G A+K +KK + + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV-----EKRVLALAWEN 55
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
P + Y Q L V EF+ G L + K R D + A + G+++L
Sbjct: 56 PFLTHLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFL 112
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMA 757
HSK I++ DLK DN++++ I K+ DFG+ K V G R GT ++A
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHI----KIADFGMCKEN----VFGDNRASTFCGTPDYIA 164
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817
PE+L G K + VD +SFG++L+E+L G+ P+ + I +T P P +
Sbjct: 165 PEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYPRWIT 220
Query: 818 SEWRLLMEQCWAPDPVVR 835
E + ++E+ + DP R
Sbjct: 221 KESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 578 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
K E +L +LG GT+ TVY G+ + TD VA+K I R +E RE
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI-------RLEHEEGAPCTAIREVS 56
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
+L L H N+V + ++ +L V E++ + L+ L ++ +
Sbjct: 57 LLKDLKHANIVTLHDIIHTEK--SLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL 113
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGTLP 754
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ K T TL
Sbjct: 114 LRGLNYCHRRKVLHRDLKPQNLLINERGEL----KLADFGLARAKSIPTKTYSNEVVTLW 169
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
+ P++L G S+ S ++D++ G + +E+ TG
Sbjct: 170 YRPPDILLG-STDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 585 LKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
+++G G GTVY G +VAI+++ + +Q+ E ++ + +
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQM--------NLQQQPKKELIINEILVMRENKN 76
Query: 643 PNVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
PN+V + Y V G L V E++ GSL V+ E +D + + + +
Sbjct: 77 PNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQAL 129
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTL 753
E+LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GTP 180
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
WMAPE++ + KVD++S GI+ E++ GE PY N
Sbjct: 181 YWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 35/220 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ E+++++G GT+G VY + R T+ +A+K+I+ E E + RE +L
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR------LEQEDEGVPSTAIREISLL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD------RRKRLII 691
++ H N+V VV L V E++ L ++H+D + RLI
Sbjct: 56 KEMQHGNIVRLQDVVHSEK--RLYLVFEYLD--------LDLKKHMDSSPDFAKNPRLIK 105
Query: 692 AM--DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVT 746
G+ Y HS ++H DLK NLL+ D K+ DFGL++ I T
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPVRTFTH 162
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
V TL + APE+L GS S VD++S G + E++
Sbjct: 163 EVV--TLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G FG V + R T A K+++K R E L E +IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKQILEKVNSRFV 62
Query: 646 V--AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
V A+ +D L V M G L+ H+ D + + A + G+E L
Sbjct: 63 VSLAYAYETKDA----LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 761
H + IV+ DLK +N+L++ IR + D GL+ +I + G V GT+ +MAPE++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIR----ISDLGLAVEIPEGETIRGRV-GTVGYMAPEVV 173
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+ + + D + G +++E++ G+ P+
Sbjct: 174 K--NERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
D + L ++G G +G V+ K + T VA+KR+KKS + + LT E +IL+
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT-----ERDILT 56
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAA 696
+V QD LA E++ G R LL+ L + + M A
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAM--EYVPGGDFR-TLLNNLGVLSEDHARFYMAEMFEA 113
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGTL 753
++ LH +H DLK +N L++ I K+ DFGLSK N++V G+
Sbjct: 114 --VDALHELGYIHRDLKPENFLIDASGHI----KLTDFGLSKGIVTYANSVV-----GSP 162
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 792
+MAPE+L G VD +S G +L+E L G P++
Sbjct: 163 DYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 38/274 (13%)
Query: 582 LEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
L+ ++G G+ G V K G VA+K++ +Q+R L F E I+
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-------KQQRRELLF-NEVVIMRD 73
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
H NVV Y G L V EF+ G+L ++ + ++ + +A+ A +
Sbjct: 74 YQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVTGGVRGTLPWMAP 758
LH++ ++H D+K D++L+ + K+ DFG +++ + + GT WMAP
Sbjct: 132 --LHAQGVIHRDIKSDSILLTHDGRV----KLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------TLR 809
EL+ S +VD++S GI++ E++ GE PY N + I +N +
Sbjct: 186 ELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVS 243
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
P + GF D RLL+ DP R + E+ +
Sbjct: 244 PSLKGFLD---RLLVR-----DPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 53/248 (21%)
Query: 569 FDISTLQIIKNEDLEELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQER 625
FD+ + L +G G +G V H K G VAIK+I S F E +
Sbjct: 1 FDVG-------PRYQNLSYIGEGAYGMVCSATH-KPTGVKVAIKKI--SPF-----EHQT 45
Query: 626 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSK 679
RE +IL + H N++ +++ + + V E M L ++ ++
Sbjct: 46 FCQRTLREIKILRRFKHENIIGILDIIR---PPSFESFNDVYIVQELM-ETDLYKLIKTQ 101
Query: 680 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFG 735
D + + + G++Y+HS N++H DLK NLL+N LK IC DFG
Sbjct: 102 HLSNDHIQYFLYQI--LRGLKYIHSANVLHRDLKPSNLLLNTNCDLK-----IC---DFG 151
Query: 736 LSKIKRNTLVTGGVRGTLP------WM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
L+ R G L W APE++ +S ++ +D++S G +L E+L+
Sbjct: 152 LA---RIADPEHDHTGFLTEYVATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
Query: 789 EPYANMHY 796
+ Y
Sbjct: 208 PLFPGKDY 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 72/255 (28%), Positives = 111/255 (43%), Gaps = 23/255 (9%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LG GTFG V + + T A+K +KK + LT E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLQNTRHP 55
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+ A Q L V E+ NG LS+ER + + + YLH
Sbjct: 56 FLTALKYSFQTH--DRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH 112
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKR-NTLVTGGVRGTLPWMAPEL 760
S ++V+ DLK +NL+++ I K+ DFGL K I T+ T GT ++APE+
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHI----KITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 166
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 820
L + VD + G+V++E++ G P+ N + + I+ +R P E
Sbjct: 167 LE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEA 222
Query: 821 RLLMEQCWAPDPVVR 835
+ L+ DP R
Sbjct: 223 KSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-14
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 586 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LG GTFG V K G A+K ++K + +T E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-----ESRVLQNTRHP 55
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+ A Q L V E+ NG LS+ER + + +EYLH
Sbjct: 56 FLTALKYAFQTH--DRLCFVMEY-ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 112
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMAP 758
S+++V+ D+K +NL+++ I K+ DFGL K ++ G GT ++AP
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHI----KITDFGLCK----EGISDGATMKTFCGTPEYLAP 164
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
E+L + VD + G+V++E++ G P+ N + + I+ +R P
Sbjct: 165 EVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-14
Identities = 52/152 (34%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRGT 752
A GME+L SKN VH DL N+L+ I K+ DFGL++ N + G
Sbjct: 247 ARGMEFLASKNCVHRDLAARNVLLAQGK----IVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 753 LPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810
+ WMAPE + + + +S DV+S+GI+LWEI + G PY M + + + R
Sbjct: 303 VKWMAPESIFDNLYTTLS---DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 842
P E +M +CW +P RPSF ++
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 32/217 (14%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+ L +GSG +G V T VAIK++ + S+ + T +RE +L +
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---SAIHAKRT---YRELRLLKHM 71
Query: 641 HHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
H NV+ V P +L VT M L +++ ++ D + L+ +
Sbjct: 72 DHENVIGLLDVFT--PASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQI- 127
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGT 752
G++Y+HS I+H DLK N+ VN +D C K+ DFGL++ + +TG V T
Sbjct: 128 -LRGLKYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLAR-HTDDEMTGYV-AT 178
Query: 753 LPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ APE +LN ++ VD++S G ++ E+LTG+
Sbjct: 179 RWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G FG V + R T A K++ K R + + E IL+K+H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-----EKRILAKVHSRFI 55
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERH--LDRRKRLIIAMDAAFGMEYL 702
V+ Q L V M G LR H+ E + + G+E+L
Sbjct: 56 VSLAYAFQTKT--DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 761
H + I++ DLK +N+L++ +R + D GL+ ++K T G GT +MAPELL
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
G S VD F+ G+ L+E++ P+
Sbjct: 170 QGEEYDFS--VDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 46/227 (20%)
Query: 578 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
K E ++L +LG G++ TVY G+ + T VA+K I R +E REA
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAIREAS 55
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
+L L H N+V + ++ TL V E++ L + ++D ++M
Sbjct: 56 LLKDLKHANIVTLHDIIHTKK--TLTLVFEYL------DTDLKQ--YMDDCGG-GLSMHN 104
Query: 696 A--F------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK------- 740
F G+ Y H + ++H DLK NLL++ + + K+ DFGL++ K
Sbjct: 105 VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGEL----KLADFGLARAKSVPSKTY 160
Query: 741 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
N +V TL + P++L G S++ S +D++ G + +E+ TG
Sbjct: 161 SNEVV------TLWYRPPDVLLG-STEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 578 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
K E +L++LG GT+ TV+ G+ + T+ VA+K I R +E RE
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVS 56
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
+L L H N+V + +V TL V E++ + L+ + + I
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTL--VFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQI 113
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGTLP 754
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ K T TL
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLINERGEL----KLADFGLARAKSVPTKTYSNEVVTLW 169
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
+ P++L G SS+ S ++D++ G + +E+ +G
Sbjct: 170 YRPPDVLLG-SSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 67/233 (28%), Positives = 113/233 (48%), Gaps = 39/233 (16%)
Query: 584 ELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
+L+ LG G+ G V+ D VA+K+I T S + L RE +I+ +L
Sbjct: 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKI---VLTDPQSVKHAL-----REIKIIRRLD 60
Query: 642 HPNVVAFYGVVQDGPGGT-----LATVTEF--------MVNGSLRHVLLSKERHLDRRKR 688
H N+V Y V+ GP G+ + ++TE + L +L + + R
Sbjct: 61 HDNIVKVYEVL--GPSGSDLTEDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLSEEHAR 117
Query: 689 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRN 742
L G++Y+HS N++H DLK N+ +N +D + K+GDFGL++I +
Sbjct: 118 LF-MYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARIVDPHYSHKG 173
Query: 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 795
L G V T + +P LL S + ++ +D+++ G + E+LTG+ +A H
Sbjct: 174 YLSEGLV--TKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 37/222 (16%)
Query: 585 LKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
LK LG G +G V+ G G A+K +KK+ R+ + T E IL
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKD---TAHTKAERNILEA 56
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA--- 696
+ HP +V Q G G L + E++ G L HL+R I D A
Sbjct: 57 VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELF-------MHLEREG--IFMEDTACFY 105
Query: 697 -----FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGV 749
+E+LH + I++ DLK +N+L++ + + K+ DFGL K I T VT
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHV----KLTDFGLCKESIHEGT-VTHTF 160
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
GT+ +MAPE+L S + VD +S G +++++LTG P+
Sbjct: 161 CGTIEYMAPEIL--MRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+K++D E + ELG+G G V + + + + + R K + + + ++ RE ++
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
L + + P +V FYG G ++ E M GSL V L + + + +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQV-LKEAKRIPEEILGKVSIAVL 113
Query: 697 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 755
G+ YL K+ I+H D+K N+LVN + I K+ DFG+S +++ V GT +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
M+PE L G+ V D++S G+ L E+ G P
Sbjct: 169 MSPERLQGTHYSVQS--DIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 69/242 (28%), Positives = 109/242 (45%), Gaps = 19/242 (7%)
Query: 586 KELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K +G G+FG V K + A+K ++K + EQ+ + E +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK-EQKHIMAE---RNVLLKNVKHP 56
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+V + Q L V ++ VNG L +ER + A + A + YLH
Sbjct: 57 FLVGLHYSFQTAD--KLYFVLDY-VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPELL 761
S NI++ DLK +N+L++ + + + DFGL K I+ + T GT ++APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVV----LTDFGLCKEGIEHSK-TTSTFCGTPEYLAPEVL 168
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821
VD + G VL+E+L G P+ + + I+N LR P S
Sbjct: 169 R--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK-PNISVSARH 225
Query: 822 LL 823
LL
Sbjct: 226 LL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 66/257 (25%), Positives = 120/257 (46%), Gaps = 36/257 (14%)
Query: 570 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 627
I+ L++ K ED + +K +G G FG V + + + A+K + K RS +
Sbjct: 34 KITKLRM-KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD-----S 87
Query: 628 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
FW E +I++ + +V + QD L V E+M G L +++ + + +
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDK--YLYMVMEYMPGGDLVNLMSNYDIPEKWAR 145
Query: 688 ----RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743
+++A+DA +HS +H D+K DN+L++ + K+ DFG + +K +
Sbjct: 146 FYTAEVVLALDA------IHSMGFIHRDVKPDNMLLDKSGHL----KLADFG-TCMKMDA 194
Query: 744 LVTGGVR-----GTLPWMAPELL--NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 796
G VR GT +++PE+L G + D +S G+ L+E+L G+ P+
Sbjct: 195 --NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252
Query: 797 GAIIGGIVN--NTLRPP 811
I++ N+L P
Sbjct: 253 VGTYSKIMDHKNSLTFP 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 582 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E ++ +G+GT+G VY G+ G AIK + + E+E + LE +L K
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEI----NMLKK 68
Query: 640 L-HHPNVVAFYGV-VQDGPGG---TLATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAM 693
HH N+ +YG ++ P G L V EF GS+ ++ +K L I
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTG 747
+ G+ +LH+ ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFI-- 182
Query: 748 GVRGTLPWMAPELL---NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804
GT WMAPE++ + + D++S GI E+ G P +MH + I
Sbjct: 183 ---GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239
Query: 805 NNTLRPPVPGFCDSEWRL----LMEQCWAPDPVVRPS 837
N P P +W +E C + + RPS
Sbjct: 240 RN----PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPS 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHH 642
K LG G+FG V + +GTD AIK +KK +T E IL+ H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMT-----EKRILALAAKH 55
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
P + A + Q L V E+ VNG + + R D + A + + +L
Sbjct: 56 PFLTALHCCFQTKD--RLFFVMEY-VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELL 761
H +++ DLK DN+L++ + CK+ DFG+ K N + T GT ++APE+L
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGH----CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
S VD ++ G++++E++ G+ P+
Sbjct: 169 QELEYGPS--VDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
++++++G GT+G VY + + G VA+K+I+ +E E + RE +L +L
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLKEL 56
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF--- 697
+HPN+V V+ L V EF+ H L K + + + ++
Sbjct: 57 NHPNIVKLLDVIHT--ENKLYLVFEFL------HQDLKKFMDASPLSGIPLPLIKSYLFQ 108
Query: 698 ---GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRG 751
G+ + HS ++H DLK NLL+N + I K+ DFGL++ + T V
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAI----KLADFGLARAFGVPVRTYTHEVV-- 162
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
TL + APE+L G S VD++S G + E++T
Sbjct: 163 TLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 586 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K++G G F VY VA+K+++ + Q+ + +E ++L +L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-----KEIDLLKQLNHP 62
Query: 644 NVVAFY-GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-------IAMDA 695
NV+ + ++D L V E G L ++ ++ ++KRLI +
Sbjct: 63 NVIKYLDSFIEDN---ELNIVLELADAGDLSQMI----KYFKKQKRLIPERTVWKYFVQL 115
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP 754
+E++HS+ ++H D+K N+ + + K+GD GL + T + GT
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MHYGAIIGGIVNNTLRPPV 812
+M+PE ++ + K D++S G +L+E+ + P+ M+ ++ I PP+
Sbjct: 172 YMSPERIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPL 228
Query: 813 PGFCDSE-WRLLMEQCWAPDPVVRPSFT---EIARRLRV 847
P SE R L+ C PDP RP +IA+++ V
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 5e-13
Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 17/229 (7%)
Query: 586 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LG GTFG V K G A+K +KK + LT E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLKNTRHP 55
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+ + Q L V E+ VNG LS+ER + + ++YLH
Sbjct: 56 FLTSLKYSFQTK--DRLCFVMEY-VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH 112
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GTLPWMAPELLN 762
S IV+ DLK +NL+++ I K+ DFGL K T GT ++APE+L
Sbjct: 113 SGKIVYRDLKLENLMLDKDGHI----KITDFGLCKEGITDAATMKTFCGTPEYLAPEVL- 167
Query: 763 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
+ VD + G+V++E++ G P+ N + + I+ ++ P
Sbjct: 168 -EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E+L+++G GT+GTV+ K R T VA+KR++ + E + RE +L +L
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKEL 56
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
H N+V Y V+ TL V E+ + L+ S +D G+
Sbjct: 57 KHKNIVRLYDVLHSDKKLTL--VFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG------TLP 754
+ HS N++H DLK NLL+N + K+ DFGL+ R + VR TL
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGEL----KLADFGLA---RAFGIP--VRCYSAEVVTLW 164
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
+ P++L G+ S +D++S G + E+ P
Sbjct: 165 YRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E + E+G G +GTVY + G VA+K ++ + ++ L L RE +L +L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQ------TNEDGLPLSTVREVALLKRL 56
Query: 641 H---HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA- 696
HPN+V V T T E V HV +LD+ + +
Sbjct: 57 EAFDHPNIVRLMDVC-----ATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK 111
Query: 697 -------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 749
G+++LH+ IVH DLK +N+LV + K+ DFGL++I + V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQV----KLADFGLARIYSCQMALTPV 167
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785
TL + APE+L S + VD++S G + E+
Sbjct: 168 VVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 582 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
+ + LG G FG V + R T A KR++K R E L E +IL K
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-----EKQILEK 56
Query: 640 LHHPNVV--AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAA 696
++ VV A+ +D L V M G L+ H+ + + L A +
Sbjct: 57 VNSQFVVNLAYAYETKDA----LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEIL 112
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPW 755
G+E LH +N V+ DLK +N+L++ IR + D GL+ KI + G V GT+ +
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIR----ISDLGLAVKIPEGESIRGRV-GTVGY 167
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
MAPE+LN +S D + G +++E++ G+ P+
Sbjct: 168 MAPEVLNNQRYTLSP--DYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ----ERLTLEFWREA 634
D L LG G+FG V + +GTD AIK +KK + E+ L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 635 EILSKLHH--PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 692
L++LH + Y V++ GG L ++ V KE H + A
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMY--------QIQQVGRFKEPH-----AVFYA 107
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRG 751
+ A G+ +LHSK I++ DLK DN++++ + I K+ DFG+ K + + T G
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHI----KIADFGMCKENMWDGVTTKTFCG 163
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
T ++APE++ + + VD ++FG++L+E+L G+ P+
Sbjct: 164 TPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 29/276 (10%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+++E L ELG G +G+VY R T V A+K I R E + E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDIL 53
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMDA 695
K P +V FYG G + E+M GSL + + I
Sbjct: 54 HKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111
Query: 696 AFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
G+++L + NI+H D+K N+LVN ++ +C DFG+S +L + G
Sbjct: 112 VKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVK-LC---DFGVSGNLVASLAKTNI-GCQS 166
Query: 755 WMAPELLNGSSSK----VSEKVDVFSFGIVLWEILTGEEPYANMHYGAI---IGGIVNNT 807
+MAPE + + + DV+S G+ + E+ G PY Y I + IV+
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226
Query: 808 LRPP-VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 842
PP +P + + + +C P RP++ ++
Sbjct: 227 --PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 74/255 (29%), Positives = 111/255 (43%), Gaps = 22/255 (8%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LG GTFG V K + T A+K +KK + LT E +L HP
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVLQNSRHP 55
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+ A Q L V E+ NG LS+ER + + ++YLH
Sbjct: 56 FLTALKYSFQTH--DRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 112
Query: 704 S-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPEL 760
S KN+V+ DLK +NL+++ I K+ DFGL K IK + GT ++APE+
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHI----KITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 167
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 820
L + VD + G+V++E++ G P+ N + + I+ +R P E
Sbjct: 168 L--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEA 223
Query: 821 RLLMEQCWAPDPVVR 835
+ L+ DP R
Sbjct: 224 KSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 30/226 (13%)
Query: 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
K + E+L++LG G++ TVY GK + G VA+K I R E+E REA
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-------RLQEEEGTPFTAIREAS 55
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
+L L H N+V + ++ TL V E+ V+ L + L +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKE--TLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-------RNTLVTGG 748
G+ Y+H + I+H DLK NLL++ + K+ DFGL++ K N +V
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTGEL----KLADFGLARAKSVPSHTYSNEVV--- 165
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 794
TL + P++L G S++ S +D++ G + E++ G + M
Sbjct: 166 ---TLWYRPPDVLLG-STEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 29/223 (13%)
Query: 586 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
K + K T VA+K+I S +E L L +E +L HPN+
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLD-----SCSKEDLKLLQ-QEIITSRQLQHPNI 61
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM---DAAFGMEYL 702
+ + L V+ M GS L K + L IA D ++Y+
Sbjct: 62 LPYVTSFIVD--SELYVVSPLMAYGSCE--DLLKTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------KIKRNTLVTGGVRGT--- 752
HSK +H +K ++L + KV GL KR +V + +
Sbjct: 118 HSKGFIHRSVKASHIL------LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 795
LPW++PE+L + +EK D++S GI E+ G P+ +M
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 66/247 (26%), Positives = 106/247 (42%), Gaps = 48/247 (19%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D E +K +G G FG V+ + + T A+K ++KS R Q E +IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR--NQIAH---VRAERDIL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-MDAA 696
+ P +V Y QD L V E+M G L ++L+ K+ + R IA + A
Sbjct: 56 ADADSPWIVKLYYSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---------------IKR 741
++ +H +H D+K DN+L++ I K+ DFGL K
Sbjct: 114 --LDSVHKLGFIHRDIKPDNILIDADGHI----KLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 742 NTLVTGGVR---------------GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
VR GT ++APE+L G+ + D +S G++L+E+L
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVILYEMLY 225
Query: 787 GEEPYAN 793
G P+ +
Sbjct: 226 GFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ E+L+++G GT+G VY + + T VA+K+ T ++E + RE +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK------TRLEMDEEGIPPTALREISLL 54
Query: 638 SKLHH-PNVVAFYGVV---QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
L +V V + +L V E++ + L+ + S R R
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 694 DAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT- 743
+ G+ + H ++H DLK NLLV D + + K+ D GL + +K T
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 744 -LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+V TL + APE+L GS+ S VD++S G + E+ +
Sbjct: 171 EIV------TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 16/215 (7%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+K++D E++ ELG+G G V+ + + + + R K + + + ++ RE ++
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
L + + P +V FYG G ++ E M GSL V L K + + +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQV-LKKAGRIPEQILGKVSIAVI 113
Query: 697 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 755
G+ YL K+ I+H D+K N+LVN + I K+ DFG+S +++ V GT +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
M+PE L G+ V D++S G+ L E+ G P
Sbjct: 169 MSPERLQGTHYSVQS--DIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 59/230 (25%)
Query: 585 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
L++LG G +G V W+ D VA+K+I + F + Q +RE L
Sbjct: 12 LQKLGKGAYGIV----WKAIDRRTKEVVALKKIFDA-FRNATDAQRT-----FREIMFLQ 61
Query: 639 KL-HHPNVVAFYGVVQDGPGGTLATVTEFM---VNGSLRHVLLSKERHLDRRKRLII--- 691
+L HPN+V V++ + V E+M ++ +R +L ++ H KR I+
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL-EDVH----KRYIMYQL 116
Query: 692 --AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTG 747
A+ +Y+HS N++H DLK N+L+N C K+ DFGL++ +L
Sbjct: 117 LKAL------KYIHSGNVIHRDLKPSNILLNSD------CRVKLADFGLAR----SLSEL 160
Query: 748 GVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
P + APE+L G S++ ++ VD++S G +L E+L G
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
L++LG G++ TVY G R G VA+K I +E + REA +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKT-------EEGVPFTAIREASLLKGLKH 62
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
N+V + ++ TL V E+M + L ++ L + G+ Y+
Sbjct: 63 ANIVLLHDIIHTKE--TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR---NTLVTGGVRGTLPWMAPE 759
H ++I+H DLK NLL++ + K+ DFGL++ K T + V TL + P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGEL----KLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 792
+L G++ S +D++ G + E+L G+ +
Sbjct: 174 VLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 27/248 (10%)
Query: 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K +G G+FG V K + G A+K ++K R EQ+ + E +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAE---RNVLLKNVKHP 56
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+V + Q L V +F VNG L +ER + A + A + YLH
Sbjct: 57 FLVGLHYSFQTTE--KLYFVLDF-VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGTLPWMAPEL 760
S NIV+ DLK +N+L++ + + + DFGL K + +T T GT ++APE+
Sbjct: 114 SINIVYRDLKPENILLDSQGHV----VLTDFGLCKEGIAQSDTTTT--FCGTPEYLAPEV 167
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV---PGFCD 817
+ VD + G VL+E+L G P+ Y + + +N L P+ PG
Sbjct: 168 IR--KQPYDNTVDWWCLGAVLYEMLYGLPPF----YCRDVAEMYDNILHKPLVLRPGASL 221
Query: 818 SEWRLLME 825
+ W +L E
Sbjct: 222 TAWSILEE 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 633 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 692
EA +L ++HP+V+ + G T + + + L L + R L + LII
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAI-TCMVLPHY--SSDLYTYLTKRSRPLPIDQALIIE 163
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGT 752
G+ YLH++ I+H D+K +N+ +N D +C +GD G ++ G+ GT
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQFPVVAPAFLGLAGT 219
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL------------TGEEPYANMH 795
+ APE+L + K + K D++S GIVL+E+L T EE + H
Sbjct: 220 VETNAPEVL--ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH 272
|
Length = 357 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 586 KELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K +G G+FG V + + + A+K ++K + E+ ++ +L + HP
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS----ERNVLLKNVKHP 56
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+V + Q L V +++ G L + L + L+ R R A + A + YLH
Sbjct: 57 FLVGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLH 113
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPELL 761
S NIV+ DLK +N+L++ + I + DFGL K I+ N T GT ++APE+L
Sbjct: 114 SLNIVYRDLKPENILLDSQGHI----VLTDFGLCKENIEHNG-TTSTFCGTPEYLAPEVL 168
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809
+ VD + G VL+E+L G P+ + + + I+N L+
Sbjct: 169 H--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 214
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 31/220 (14%)
Query: 580 EDLEELKELGSGTFGTVYHG---KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ E + E+G G +G V+ K G VA+KR++ + +E + L RE +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVAV 54
Query: 637 LSKLH---HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR-------R 686
L L HPNVV + V T E + HV +LD+
Sbjct: 55 LRHLETFEHPNVVRLFDVCT-----VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 109
Query: 687 KRLIIAMDAAF-GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 745
+ + M G+++LHS +VH DLK N+LV I K+ DFGL++I +
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI----KLADFGLARIYSFQMA 165
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785
V TL + APE+L SS + VD++S G + E+
Sbjct: 166 LTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 24/212 (11%)
Query: 584 ELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
+LK++GSG +GTV R G VAIK++ R + E +RE +L +
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMK 72
Query: 642 HPNVVAFYGVVQDGPGGTLATVTEFMV----NGSLRHVLLSKER-HLDRRKRLIIAMDAA 696
H NV+ V P +L +F + G+ L+ E+ DR + L+ M
Sbjct: 73 HENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM--L 128
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
G++Y+H+ I+H DLK NL VN + K+ DFGL++ + ++ +TG V T +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCEL----KILDFGLAR-QTDSEMTGYVV-TRWYR 182
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
APE++ + ++ VD++S G ++ E+LTG+
Sbjct: 183 APEVIL-NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-12
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+K ED E +K +G G FG V + + T A+K + K RS + FW E
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEER 94
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
+I++ + P VV + QD L V E+M G L + L+S ++ R A +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTA-E 150
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVR-GT 752
++ +HS +H D+K DN+L++ + K+ DFG K+ + +V GT
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHL----KLADFGTCMKMNKEGMVRCDTAVGT 206
Query: 753 LPWMAPELL--NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+++PE+L G + D +S G+ L+E+L G+ P+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQE----RLTLEFWRE 633
E E+L ++G G++G V+ + R G VAIK+ F SE + ++ L RE
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK-----FV--ESEDDPVIKKIAL---RE 50
Query: 634 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
+L +L HPN+V V + L V E+ + ++ + L R + I
Sbjct: 51 IRMLKQLKHPNLVNLIEVFRRKR--KLHLVFEY-CDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR--- 750
+ + H N +H D+K +N+L+ + I K+ DFG ++I L G
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQI----KLCDFGFARI----LTGPGDDYTD 159
Query: 751 --GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T + APELL G ++ VDV++ G V E+LTG+
Sbjct: 160 YVATRWYRAPELLVG-DTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
D L LG G+FG V + +GTD AIK +KK + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMV-----EKRVLA 55
Query: 639 KLHHPN-VVAFYGVVQDGPGGTLATVTEFMVNGSL----RHVLLSKERHLDRRKRLIIAM 693
P + + Q L V E++ G L + V KE H + A
Sbjct: 56 LPGKPPFLTQLHSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGKFKEPH-----AVFYAA 108
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GT 752
+ A G+ +LHSK I++ DLK DN++++ + I K+ DFG+ K T GT
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI----KIADFGMCKENIFGGKTTRTFCGT 164
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
++APE++ + + VD ++FG++L+E+L G+ P+
Sbjct: 165 PDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 16/229 (6%)
Query: 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K +G G+FG V K + G+ A+K ++K + EQ + E +L L HP
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAE---RNVLLKNLKHP 56
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+V + Q L V ++ VNG L +ER + A + A + YLH
Sbjct: 57 FLVGLHYSFQTAE--KLYFVLDY-VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH 113
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLN 762
S NI++ DLK +N+L++ + + + DFGL K T GT ++APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHV----VLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR 169
Query: 763 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
VD + G VL+E+L G P+ + + I++ L+ P
Sbjct: 170 --KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E+L ++G GTFG V+ + + T VA+K++ +E+E + RE +IL L
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLL 68
Query: 641 HHPNVVAFYGVV------QDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRKRLII 691
H NVV + + G+ V EF + LLS + L K+++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTLSEIKKVMK 126
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLV 745
+ G+ Y+H I+H D+K N+L+ KD I K+ DFGL SK +
Sbjct: 127 MLLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSKPNRY 180
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
T V TL + PELL G +D++ G ++ E+ T
Sbjct: 181 TNRVV-TLWYRPPELLLGERD-YGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E E L +G G++G V K + T VAIK+ +S + + + RE +L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES------EDDKMVKKIAMREIRML 54
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH----LDRRKRLIIAM 693
+L H N+V V + L V EF+ H +L LD +
Sbjct: 55 KQLRHENLVNLIEVFRRKK--RLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG----- 748
G+E+ HS NI+H D+K +N+LV+ + K+ DFG ++ TL G
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFAR----TLAAPGEVYTD 159
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T + APELL G +K VD+++ G ++ E+LTGE
Sbjct: 160 YVATRWYRAPELLVG-DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 18/242 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED E LK +G G FG V K + D A+K + K R+ T F E ++L
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-----TACFREERDVL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+ + + QD L V ++ V G L +L E L +
Sbjct: 56 VNGDNQWITTLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI 113
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG--LSKIKRNTLVTGGVRGTLPW 755
++ +H + VH D+K DN+L+++ IR + DFG L ++ T+ + GT +
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQSSVAVGTPDY 169
Query: 756 MAPELLNG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
++PE+L K + D +S G+ ++E+L GE P+ G I+N+ R
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229
Query: 813 PG 814
P
Sbjct: 230 PA 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 74/282 (26%), Positives = 109/282 (38%), Gaps = 47/282 (16%)
Query: 586 KELGSGTFGTVYHGKWR----------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
+ LG GT +Y G + IK I K ++L F+ A
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVL----DPSHRDISLAFFETAS 56
Query: 636 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++ ++ H ++V YGV V+D V EF+ G L + K L + +A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVEN---IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQ 113
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLV---NLKDPIRPICKVGDFG--LSKIKRNTLVTGGV 749
A + YL K++VH ++ N+L+ + P K+ D G ++ + R V
Sbjct: 114 LASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE--- 170
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI-LTGEEPYANM-------HYGAIIG 801
+PW+APE + S +S D +SFG LWEI GE P + Y
Sbjct: 171 --RIPWIAPECVE-DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG--- 224
Query: 802 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
P C E LM C DP RP F I R
Sbjct: 225 -----QCMLVTPS-CK-ELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 40/224 (17%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
D+E + +G G FG V W TD VA+K++ F S + RE
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKMPN-VFQNLVSCKRVF-----REL 50
Query: 635 EILSKLHHPNVVAFYGVVQD---GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
++L H NV++ ++Q P + VTE M L +++S + ++ +
Sbjct: 51 KMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFL 109
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL--------SKIKRNT 743
G++YLHS I+H D+K NLLVN + + IC DFGL SK
Sbjct: 110 -YQILRGLKYLHSAGILHRDIKPGNLLVN-SNCVLKIC---DFGLARVEEPDESKHMTQE 164
Query: 744 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
+VT R APE+L GS S VD++S G + E+L
Sbjct: 165 VVTQYYR------APEILMGSRHYTS-AVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 585 LKELGSGTFGTV----YHGKWRGTDVAIKRI----KKSCFTGRSSEQERLTLEFWREAEI 636
+KELG G +G V VAIK+I K R+ + +L L +R
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKL-LRHFRG--- 60
Query: 637 LSKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
H N+ Y +V G L E M L ++ S + D + I
Sbjct: 61 -----HKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFI-YQ 113
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGG 748
G++Y+HS N++H DLK NLLVN ++ IC DFGL+ + +T
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELK-IC---DFGLARGFSENPGENAGFMTEY 169
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
V T + APE++ S ++ +DV+S G +L E+L
Sbjct: 170 V-ATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 26/231 (11%)
Query: 570 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 627
I LQ+ K ED + +K +G G FG V + + + A+K + K RS +
Sbjct: 34 KIRKLQM-KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD-----S 87
Query: 628 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
FW E +I++ + P VV + QD L V E+M G L + L+S ++
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDK--YLYMVMEYMPGGDLVN-LMSNYDVPEKWA 144
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747
+ A + ++ +HS ++H D+K DN+L++ + K+ DFG + +K + TG
Sbjct: 145 KFYTA-EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL----KLADFG-TCMKMDE--TG 196
Query: 748 GVR-----GTLPWMAPELL--NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
VR GT +++PE+L G + D +S G+ L+E+L G+ P+
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G FG V + R T A K+++K R E L E IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKRILEKVNSRFV 62
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 704
V+ + L V M G L+ H+ D ++ + A + G+E L
Sbjct: 63 VSLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELLNG 763
+ IV+ DLK +N+L++ + IR + D GL+ +I V G V GT+ +MAPE++N
Sbjct: 121 ERIVYRDLKPENILLDDRGHIR----ISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINN 175
Query: 764 SSSKVSEKVDVFSFGIVLWEILTGEEPY 791
S D + G +++E++ G+ P+
Sbjct: 176 EKYTFSP--DWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G FG V + R T A K+++K R E L E +IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-----EKQILEKVNSRFV 62
Query: 646 V--AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
V A+ +D L V M G L+ H+ E + + + A + G+E L
Sbjct: 63 VSLAYAYETKDA----LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 761
H + IV+ DLK +N+L++ IR + D GL+ + + G V GT+ +MAPE++
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIR----ISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVV 173
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
S D ++ G +L+E++ G+ P+
Sbjct: 174 KNERYTFSP--DWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 588 LGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG G FG V K G A K++ K +S E+ L E EIL K++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 704
V + L V M G L+ H+ ER L+ + + + G+ +LHS
Sbjct: 56 VNLAYAFESKT--HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 764
+IV+ D+K +N+L++ + C++ D GL+ ++ GT +MAPE+L
Sbjct: 114 MDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 765 SSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
VD F+ G ++E++ G P+ +
Sbjct: 170 PYSYP--VDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K +G G +G V K T+ VAIK+I + F R + L RE ++L L H
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTL-----REIKLLRHLDHE 64
Query: 644 NVVAFYGVVQDGPGGTLA-----TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 698
NV+A ++ P A V E M + L ++ S + D + + G
Sbjct: 65 NVIAIKDIMP--PPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFL-YQLLRG 120
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRG----T 752
++Y+HS N++H DLK NLL+N C K+ DFGL+ R T G T
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLA---RTTSEKGDFMTEYVVT 171
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ APELL + S+ + +DV+S G + E+L +
Sbjct: 172 RWYRAPELLL-NCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 580 EDLEELKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED E ++ +GSGT+G VY + G AIK IK + Q+ + + +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM--------M 60
Query: 638 SKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
H N+VA++G + +D L EF GSL+ + L + ++ +
Sbjct: 61 KDCKHSNIVAYFGSYLRRD----KLWICMEFCGGGSLQDI-YHVTGPLSESQIAYVSRET 115
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK------IKRNTLVTGGV 749
G+ YLHSK +H D+K N+L+ + K+ DFG+S KR + +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHV----KLADFGVSAQITATIAKRKSFI---- 167
Query: 750 RGTLPWMAPELLN-GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808
GT WMAPE+ ++ D+++ GI E+ + P ++H + + +
Sbjct: 168 -GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226
Query: 809 RPP 811
+PP
Sbjct: 227 QPP 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 9e-11
Identities = 41/118 (34%), Positives = 63/118 (53%), Gaps = 12/118 (10%)
Query: 676 LLSKERHLDRRK-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-LKDPIRPICKVGD 733
LL KE L + + II + LH NI+H D+K +N+L + KD I +C D
Sbjct: 99 LLKKEGKLSEAEVKKII-RQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY-LC---D 153
Query: 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+GL KI T GTL + +PE + G + VS D ++ G++ +E+LTG+ P+
Sbjct: 154 YGLCKI-IGT--PSCYDGTLDYFSPEKIKGHNYDVS--FDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL---SKLHH 642
+G GTFG VY + + T A+K + K + + E IL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG-----ERNILVRTLLDES 55
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
P +V Q L VT++M G L L + R + R + IA + +E+L
Sbjct: 56 PFIVGLKFSFQTD--SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPEL 760
H +IV+ DLK +N+L++ I +C DFGLSK + N T GT ++APE+
Sbjct: 113 HKYDIVYRDLKPENILLDATGHI-ALC---DFGLSKANLTDNKT-TNTFCGTTEYLAPEV 167
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILTGEEP---------YANMHYGAI 799
L ++ VD +S G++++E+ G P Y N+ +G +
Sbjct: 168 LL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV 214
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 18/241 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D E +K +G G FG V K + T+ A+K + K R+ T F E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE-----TACFREERNVL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+ + QD L V ++ V G L +L E L +
Sbjct: 56 VNGDCQWITTLHYAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL 113
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG--LSKIKRNTLVTGGVRGTLPW 755
+ +H + VH D+K DN+L+++ IR + DFG L + T+ + GT +
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 756 MAPELLNGSSS---KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
++PE+L K + D +S G+ ++E+L GE P+ G I+N+ R
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229
Query: 813 P 813
P
Sbjct: 230 P 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ----ERLTLEFWREA 634
D L LG G+FG V + +GTD AIK +KK + E+ L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
L++LH F V + L V E++ G L + + + + + A +
Sbjct: 61 PFLTQLHS----CFQTVDR------LYFVMEYVNGGDLMY-HIQQVGKFKEPQAVFYAAE 109
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGTL 753
+ G+ +LH + I++ DLK DN++++ + I K+ DFG+ K + + T GT
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI----KIADFGMCKEHMVDGVTTRTFCGTP 165
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
++APE++ + + VD +++G++L+E+L G+ P+
Sbjct: 166 DYIAPEII--AYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 45/146 (30%), Positives = 78/146 (53%), Gaps = 18/146 (12%)
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLP 754
+ ++HSK+++H D+K N+L+ + K+GDFG SK+ T V+ V GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNG----LVKLGDFGFSKMYAAT-VSDDVGRTFCGTPY 210
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR---PP 811
++APE+ S+K D+FS G++L+E+LT + P+ G + +++ TL P
Sbjct: 211 YVAPEIWR--RKPYSKKADMFSLGVLLYELLTLKRPFD----GENMEEVMHKTLAGRYDP 264
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPS 837
+P E + ++ + DP RPS
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 633 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 692
EA +L +L HP V+A V G G T + ++ L L ++ R L + +A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVG-GLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVA 266
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG---LSKIKRNTLVTGGV 749
++Y+H + I+H D+K +N+LVN + IC +GDFG ++ +T G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE---DIC-LGDFGAACFARGSWSTPFHYGI 322
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWE 783
GT+ APE+L G S VD++S G+V++E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPS--VDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 587 ELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
++G GT+G VY K + G D +K+ TG +++ RE +L +L HPNV
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNV 60
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLDRRKRLIIAMDAAF 697
+A V + + ++ L H++ K L R +
Sbjct: 61 IALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----GGVRGTL 753
G+ YLH+ ++H DLK N+LV + P R K+ D G +++ + L V T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ APELL G + ++ +D+++ G + E+LT E
Sbjct: 180 WYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE---ILSKLHH 642
+G G++ V + + T A+K IKK + E + W + E + +H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVN----DDEDID---WVQTEKHVFETASNH 55
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL------IIAMDAA 696
P +V + Q L V EF+ G L H+ R+++L + + +
Sbjct: 56 PFLVGLHSCFQTE--SRLFFVIEFVSGGDLMF-------HMQRQRKLPEEHARFYSAEIS 106
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPW 755
+ +LH + I++ DLK DN+L++ + I K+ D+G+ K R T GT +
Sbjct: 107 LALNFLHERGIIYRDLKLDNVLLDAEGHI----KLTDYGMCKEGIRPGDTTSTFCGTPNY 162
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+APE+L G S VD ++ G++++E++ G P+
Sbjct: 163 IAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 587 ELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
++G GT+G VY K + D A+K+I E +++ RE +L +L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----------EGTGISMSACREIALLRELKH 57
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLDRRKRLIIAMD 694
PNV++ V + + ++ L H++ K L R +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----GGVR 750
G+ YLH+ ++H DLK N+LV + P R K+ D G +++ + L V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T + APELL G + ++ +D+++ G + E+LT E
Sbjct: 177 VTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 585 LKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
LK++GSG +G+V K G VAIK++ R + E +RE +L + H
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQH 73
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLIIAMDAAFGME 700
NV+ V + +F + L K L K + G++
Sbjct: 74 ENVIGLLDVFTSAV--SGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPEL 760
Y+HS I+H DLK NL VN + K+ DFGL++ + +TG V T + APE+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCEL----KILDFGLAR-HADAEMTGYVV-TRWYRAPEV 185
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 796
+ + ++ VD++S G ++ E+LTG+ + Y
Sbjct: 186 IL-NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 588 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE---ILSKLHH 642
+G G++ V + + T+ A+K +KK ++ E + W + E +H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELV----NDDEDID---WVQTEKHVFEQASNH 55
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
P +V + Q L V E+ VNG + ++R L + + + + YL
Sbjct: 56 PFLVGLHSCFQTE--SRLFFVIEY-VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELL 761
H + I++ DLK DN+L++ + I K+ D+G+ K R T GT ++APE+L
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHI----KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 762 NGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
G S VD ++ G++++E++ G P+
Sbjct: 169 RGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVA-----------IKRIKKSCFTGRSSEQERLTL 628
+D E LK +G G FG V K + T +KR + +CF +ER L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACF-----REERDVL 55
Query: 629 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRR 686
+ ++ LH+ AF QD L V ++ V G L LLSK +R +
Sbjct: 56 VN-GDRRWITNLHY----AF----QD--ENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDM 103
Query: 687 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG--LSKIKRNTL 744
R +A + ++ +H VH D+K DN+L++ IR + DFG L + T+
Sbjct: 104 ARFYLA-EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR----LADFGSCLRLLADGTV 158
Query: 745 VTGGVRGTLPWMAPELLN---GSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+ GT +++PE+L + + D +S G+ ++E+L GE P+
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-09
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 16/151 (10%)
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP--ICKVGDFGLSKIKRNTL---VTGGVRG 751
++ +HS+ ++H DLK N+ + P I K+GDFG SK +++ V G
Sbjct: 180 LALDEVHSRKMMHRDLKSANIF------LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP- 810
T ++APEL + S+K D++S G++L+E+LT P+ I+ ++ P
Sbjct: 234 TPYYLAPELW--ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P P S + L++ + +P +RP+ ++
Sbjct: 292 PCP--VSSGMKALLDPLLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 572 STLQIIKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLE 629
ST ++K ++LK +GSG G V G +VA+K++ R + +
Sbjct: 15 STFTVLKR--YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------SRPFQNQTHAKR 66
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRK 687
+RE +L ++H N+++ V P +L + + L L + H LD +
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIHMELDHER 124
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747
+ G+++LHS I+H DLK N++V + K+ DFGL++ +
Sbjct: 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTACTNFMMT 180
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
T + APE++ G K E VD++S G ++ E++ G
Sbjct: 181 PYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-08
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 580 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E+ +K + G FG VY G K A+K +KK+ ++ + R+A L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQA---ERDALAL 60
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
SK P +V Y +Q L V E+++ G ++ LL + D + + A
Sbjct: 61 SK--SPFIVHLYYSLQSANNVYL--VMEYLIGGDVKS-LLHIYGYFDEEMAVKYISEVAL 115
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742
++YLH I+H DLK DN+L++ + I K+ DFGLSK+ N
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISNEGHI----KLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 580 EDLEELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
E + L +GSG +G+V Y + R VA+K++ + +S R T +RE +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLSRPF---QSLIHARRT---YRELRL 67
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEF-----MVNGSLRHVLLSKERHLDRRKRLII 691
L + H NV+ V P ++ E ++ L +++ ++ + + LI
Sbjct: 68 LKHMKHENVIGLLDVFT--PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY 125
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 751
+ G++Y+HS I+H DLK N+ VN +R + DFGL++ + + +TG V
Sbjct: 126 QL--LRGLKYIHSAGIIHRDLKPSNVAVNEDCELR----ILDFGLAR-QADDEMTGYV-A 177
Query: 752 TLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 796
T + APE +LN ++ VD++S G ++ E+L G+ + Y
Sbjct: 178 TRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 572 STLQIIKNEDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 629
ST ++K + LK +GSG G V + G +VAIK++ + F + +
Sbjct: 10 STFTVLKR--YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP-FQNVTHAKRA---- 62
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHL 683
+RE ++ ++H N++ V P +L V E M + +L V+ H
Sbjct: 63 -YRELVLMKLVNHKNIIGLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIQMDLDH- 117
Query: 684 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKR 741
+R L+ M G+++LHS I+H DLK N++V C K+ DFGL++
Sbjct: 118 ERMSYLLYQM--LCGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAG 169
Query: 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
+ + T + APE++ G K E VD++S G ++ E++ G
Sbjct: 170 TSFMMTPYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 62/249 (24%), Positives = 109/249 (43%), Gaps = 45/249 (18%)
Query: 580 EDLEELKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D E ++ +GSGT+G VY + G A+K IK S Q+ E ++
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ--------EIFMV 60
Query: 638 SKLHHPNVVAFYG----------VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
+ H N+VA++G ++ GG+L + + V G L + ++
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI--YHVTGPLSELQIA--------- 109
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVT 746
+ + G+ YLHSK +H D+K N+L+ + K+ DFG+ +KI
Sbjct: 110 --YVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDV----KLADFGVAAKITATIAKR 163
Query: 747 GGVRGTLPWMAPELL----NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 802
GT WMAPE+ NG +++ D+++ GI E+ + P ++H +
Sbjct: 164 KSFIGTPYWMAPEVAAVEKNGGYNQL---CDIWAVGITAIELAELQPPMFDLHPMRALFL 220
Query: 803 IVNNTLRPP 811
+ + +PP
Sbjct: 221 MSKSNFQPP 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 78/308 (25%), Positives = 128/308 (41%), Gaps = 63/308 (20%)
Query: 579 NEDLEELKE---LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWRE 633
N+ L LKE + G G Y GK + +K I +S +
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIPSSEIADM--- 737
Query: 634 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLII 691
KL HPN+V G+ + G L + E++ +L VL LS ER RRK I
Sbjct: 738 ----GKLQHPNIVKLIGLCRSEKGAYL--IHEYIEGKNLSEVLRNLSWER---RRK---I 785
Query: 692 AMDAAFGMEYLH---SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG 748
A+ A + +LH S +V +L + ++++ KD P ++ GL ++
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLRLSLPGLLCTDTKCFISSA 843
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--- 805
++APE + ++EK D++ FG++L E+LTG+ P A+ +G + G IV
Sbjct: 844 ------YVAPE--TRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFG-VHGSIVEWAR 893
Query: 806 ---------NTLRPPVPGFCDSEWRLLME------QCWAPDPVVRPSFTEIARRLRV--- 847
+ P + G ++E C A DP RP ++ + L
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
Query: 848 MSAACQTK 855
S++C T
Sbjct: 954 SSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 26/183 (14%)
Query: 628 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 686
L+ + +LS HPN++ + V G L ++ FM GS LL
Sbjct: 43 LKALQNEVVLSHFFRHPNIMTSWTVFT--TGSWLWVISPFMAYGSANS-LLKTYFPEGMS 99
Query: 687 KRLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744
+ LI I A G+ YLH +H ++K ++L++ D + V GLS + +L
Sbjct: 100 EALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS-GDGL-----VSLSGLSHL--YSL 151
Query: 745 VTGGVR------------GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 792
V G + LPW++PELL + K D++S GI E+ TG P+
Sbjct: 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211
Query: 793 NMH 795
+M
Sbjct: 212 DML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 588 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
+G G++G V G VAIK+I F S L RE ++L L HP++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRIL-----REIKLLRLLRHPDI 61
Query: 646 VAFYGVV--------QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
V ++ +D + V E M S H ++ L
Sbjct: 62 VEIKHIMLPPSRREFKD-----IYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-----TLVTGGVRGT 752
++Y+H+ N+ H DLK N+L N ++ IC DFGL+++ N T V T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLK-IC---DFGLARVAFNDTPTAIFWTDYV-AT 169
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ APEL SK + +D++S G + E+LTG+
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 572 STLQIIKNEDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 629
ST ++K + LK +GSG G V + +VAIK++ R + +
Sbjct: 11 STFTVLKR--YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKR 62
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRRK 687
+RE ++ ++H N+++ V P +L + + L L + + LD +
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747
+ G+++LHS I+H DLK N++V + K+ DFGL++ + +
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTAGTSFMMT 176
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785
T + APE++ G K E VD++S G ++ E++
Sbjct: 177 PYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 580 EDLEELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
E + L +GSG +G+V + K G VA+K++ + +S + T +RE +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPF---QSIIHAKRT---YRELRL 69
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLI 690
L + H NV+ V P +L VT M L +++ ++ D + LI
Sbjct: 70 LKHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 126
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
+ G++Y+HS +I+H DLK NL VN + K+ DFGL++ + + G
Sbjct: 127 YQI--LRGLKYIHSADIIHRDLKPSNLAVNEDCEL----KILDFGLARHTDDEMT--GYV 178
Query: 751 GTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILTG 787
T + APE +LN + VD++S G ++ E+LTG
Sbjct: 179 ATRWYRAPEIMLNWMHYNQT--VDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 633 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVN--GSLRHVLLSKERHLDRRKRLI 690
EA IL ++HP+++ G T T ++ + + L+ +R++ L
Sbjct: 133 EAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILA 186
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP--ICKVGDFGLS----KIKRNTL 744
I ++YLH I+H D+K +N+ +N P +C +GDFG + I N
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFIN-----HPGDVC-LGDFGAACFPVDINANKY 240
Query: 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE 789
G GT+ APELL + VD++S GIVL+E+ T +
Sbjct: 241 Y--GWAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 719
L V E+ VNG + ++R L A + + +LH + I++ DLK DN+L+
Sbjct: 71 LFLVIEY-VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL 129
Query: 720 NLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFG 778
+ I K+ D+G+ K T GT ++APE+L G S VD ++ G
Sbjct: 130 DADGHI----KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS--VDWWALG 183
Query: 779 IVLWEILTGEEPY 791
++++E++ G P+
Sbjct: 184 VLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 36/200 (18%)
Query: 637 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-- 692
+SKL +HPN+V + + D L VT FM GS + ++ + +D L IA
Sbjct: 52 VSKLFNHPNIVPYRATFIADN---ELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAYI 106
Query: 693 -MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-TLVTGGVR 750
++Y+H VH +K ++L+++ G LS ++ N +++ G R
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVD---------GKVYLSGLRSNLSMINHGQR 157
Query: 751 G------------TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 798
LPW++PE+L + K D++S GI E+ G P+ +M
Sbjct: 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217
Query: 799 IIGGIVNNTLRPPVPGFCDS 818
++ +N T VP D+
Sbjct: 218 MLLEKLNGT----VPCLLDT 233
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 580 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D E +K +G G FG V K G A+K+++KS + EQ E +IL
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK--EQ---VAHVRAERDIL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
++ +P VV Y QD L + E++ G + +L+ K+ + R IA +
Sbjct: 56 AEADNPWVVKLYYSFQDE--NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
++ +H +H D+K DNLL++ K I K+ DFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHI----KLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 588 LGSGTFGTVYHGKWRGT-DV-AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
+G G FG V + + T D+ A+K +KKS + F E +ILS + P +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKS-----VLLAQETVSFFEEERDILSISNSPWI 63
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 705
QD L V E+ G L +L E D + + +H
Sbjct: 64 PQLQYAFQDK--DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVR-GTLPWMAPELLNG 763
VH D+K +N+L++ I K+ DFG + ++ N +V + GT ++APE+L
Sbjct: 122 GYVHRDIKPENVLIDRTGHI----KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 764 --SSSKVSEKV--DVFSFGIVLWEILTGEEPYA 792
K + V D +S G++ +E++ G P+
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 572 STLQIIKNEDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 629
ST ++K + LK +GSG G V + +VAIK++ R + +
Sbjct: 18 STFTVLKR--YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------RPFQNQTHAKR 69
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRRK 687
+RE ++ ++H N++ V P +L + + L L + + LD +
Sbjct: 70 AYRELVLMKCVNHKNIIGLLNVFT--PQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747
+ G+++LHS I+H DLK N++V + K+ DFGL++ + +
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTAGTSFMMT 183
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
T + APE++ G K E VD++S G ++ E++ G
Sbjct: 184 PYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 39/129 (30%), Positives = 67/129 (51%), Gaps = 14/129 (10%)
Query: 667 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 726
++NG H LS+ ++ A + G+E++H++ +V+ DLK N+L++ +R
Sbjct: 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137
Query: 727 PICKVGDFGL----SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 782
+ D GL SK K + V GT +MAPE+L ++ S D FS G +L+
Sbjct: 138 ----ISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGTAYDSS-ADWFSLGCMLF 187
Query: 783 EILTGEEPY 791
++L G P+
Sbjct: 188 KLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 14/129 (10%)
Query: 667 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 726
++NG H LS+ + A + G+E++H++ +V+ DLK N+L++ +R
Sbjct: 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137
Query: 727 PICKVGDFGL----SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 782
+ D GL SK K + V GT +MAPE+L + S D FS G +L+
Sbjct: 138 ----ISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLF 187
Query: 783 EILTGEEPY 791
++L G P+
Sbjct: 188 KLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 3e-06
Identities = 59/238 (24%), Positives = 108/238 (45%), Gaps = 35/238 (14%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSE--QERLTLEFWREAEILS 638
+ E +K++G+G FG V+ K + T + C+ S +ER + E ++
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQ------EFFCWKAISYRGLKEREKSQLVIEVNVMR 67
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLR------HVLLSK-ERH--LDRRKRL 689
+L H N+V + + L + EF G L + + K E H +D ++L
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 690 IIAMDAAFGM-EYLHSKNIVHFDLKCDNLLV---------------NLKDPIRPICKVGD 733
+ A+ + + + + ++H DLK N+ + NL RPI K+GD
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG--RPIAKIGD 185
Query: 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
FGLSK + GT + +PELL + +K D+++ G +++E+ +G+ P+
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 54/253 (21%)
Query: 580 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED E LK +G G FG V K G A+K ++K+ E+E++ E +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML----EKEQVG-HIRAERDIL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+ VV + QD L + EF+ G + +L+ K+ + + IA +
Sbjct: 56 VEADSLWVVKMFYSFQDKL--NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVL 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------------------- 737
++ +H +H D+K DNLL++ K + K+ DFGL
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHV----KLSDFGLCTGLKKAHRTEFYRNLNHSLP 168
Query: 738 -----------------KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIV 780
K R L V GT ++APE+ + ++ D +S G++
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVF--MQTGYNKLCDWWSLGVI 225
Query: 781 LWEILTGEEPYAN 793
++E+L G P+ +
Sbjct: 226 MYEMLIGYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 54/253 (21%)
Query: 580 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D E LK +G G FG V K G A+K ++K+ E+E++ E +IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML----EKEQVA-HIRAERDIL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+ VV + QD L + EF+ G + +L+ K+ + + IA +
Sbjct: 56 VEADGAWVVKMFYSFQDKR--NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVL 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------------------- 737
++ +H +H D+K DNLL++ K + K+ DFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHV----KLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 738 -----------------KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIV 780
K R L V GT ++APE+ + ++ D +S G++
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVF--MQTGYNKLCDWWSLGVI 225
Query: 781 LWEILTGEEPYAN 793
++E+L G P+ +
Sbjct: 226 MYEMLIGYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 58/261 (22%), Positives = 102/261 (39%), Gaps = 72/261 (27%)
Query: 583 EELKELGSGTFGTVYHGKWRGTDV----AIKRIKKSCFTGRSS----EQERLTLEFWREA 634
++K +G G FG V R D A+K ++K+ R+ + ER
Sbjct: 4 VKIKTIGIGAFGEVCLV--RKVDTNALYAMKTLRKADVLMRNQAAHVKAER--------- 52
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
+IL++ + VV Y QD L V +++ G + +L+ + R IA +
Sbjct: 53 DILAEADNEWVVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-E 109
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------------------ 736
+E +H +H D+K DN+L++ I K+ DFGL
Sbjct: 110 LTCAIESVHKMGFIHRDIKPDNILIDRDGHI----KLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 737 ---------------SKIKRNTLVTGGVR-----------GTLPWMAPELLNGSSSKVSE 770
+ + L R GT ++APE+L + ++
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQ 223
Query: 771 KVDVFSFGIVLWEILTGEEPY 791
D +S G++L+E+L G+ P+
Sbjct: 224 LCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 582 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E L +G G +G V + + T VAIK+ K S E E + RE ++L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS------EENEEVKETTLRELKMLRT 56
Query: 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL-----DRRKRLIIAMD 694
L N+V + G L V E++ +++L E ++ + I +
Sbjct: 57 LKQENIVELKEAFRRR--GKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSYIYQLI 110
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
A + + H +IVH D+K +NLL++ D + K+ DFG ++ L G
Sbjct: 111 KA--IHWCHKNDIVHRDIKPENLLISHND----VLKLCDFGFAR----NLSEGSNANYTE 160
Query: 755 WMA------PELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
++A PELL G+ + VD++S G +L E+ G+
Sbjct: 161 YVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 580 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED +K +G G FG V K G A+K + KS ++++L E ++L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS----EMFKKDQLA-HVKAERDVL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
++ P VV+ Y QD L + EF+ G L +L+ + + R +A +
Sbjct: 56 AESDSPWVVSLYYSFQDA--QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVL 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737
+E +H +H D+K DN+L++ I K+ DFGLS
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHI----KLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 32/126 (25%), Positives = 49/126 (38%), Gaps = 18/126 (14%)
Query: 670 GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729
SL +L + R L+ + + + + LH + L + L+ L
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-------- 52
Query: 730 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE 789
G K T R +MAPE++ G S +EK D++S GI L+E L E
Sbjct: 53 ----DGSVAFK--TPEQS--RPDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYEL 102
Query: 790 PYANMH 795
PY
Sbjct: 103 PYNEER 108
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 14/94 (14%)
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG-----TL 753
+ Y+HSK I H DLK NLL+ DP K+ DFG +K N L G R +
Sbjct: 183 LAYIHSKFICHRDLKPQNLLI---DPNTHTLKLCDFGSAK---NLL--AGQRSVSYICSR 234
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
+ APEL+ G+++ + +D++S G ++ E++ G
Sbjct: 235 FYRAPELMLGATNYTTH-IDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 64/258 (24%)
Query: 584 ELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
++K LG G FG V T A+K ++K R+ E +IL++
Sbjct: 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-----VAHVKAERDILAEAD 59
Query: 642 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
+ VV Y QD L V +++ G + +L+ E + R IA + +E
Sbjct: 60 NEWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIES 116
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL----------------SKIKRNTL- 744
+H +H D+K DN+L++L I K+ DFGL S I+++++
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHI----KLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 745 -------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVD 773
+ + GT ++APE+L ++ D
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCD 230
Query: 774 VFSFGIVLWEILTGEEPY 791
+S G++L+E+L G+ P+
Sbjct: 231 WWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 41/172 (23%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 625 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLS 678
R ++ E L +L+H N++ +++ + T + FM + +
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW---- 260
Query: 679 KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
K+R L ++ R I+ +EY+H K ++H D+K +N+ +N I +GDFG +
Sbjct: 261 KDRPLLKQTRAIMKQLLC-AVEYIHDKKLIHRDIKLENIFLNCDGKI----VLGDFGTAM 315
Query: 739 IKRNTLVTG--GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
G GT+ +PE+L G E D++S G++L ++L+ +
Sbjct: 316 PFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 29/72 (40%), Positives = 35/72 (48%), Gaps = 13/72 (18%)
Query: 582 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 641
L KEL GT VY G+WRG +VA+K R + R LE +EA+IL L
Sbjct: 24 LRVEKELAKGTTSVVYLGEWRGGEVALKV--------RRRDSPRRNLE--KEAKILEILA 73
Query: 642 HPNV---VAFYG 650
V V FYG
Sbjct: 74 GEGVTPEVYFYG 85
|
Length = 201 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 40/213 (18%)
Query: 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 644
L L G+ G V+ G + K I K+ G++ RE +IL + H
Sbjct: 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG---------REIDILKTISHRA 147
Query: 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---------LSKERHLDRRKRLIIAMDA 695
++ + T MV + L L E+ + ++RL+ A+
Sbjct: 148 IINLIHAYRWKS-------TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEAL-- 198
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS---KIKRNTLVTGGVRGT 752
YLH + I+H D+K +N+ ++ +P + +GDFG + +T G GT
Sbjct: 199 ----AYLHGRGIIHRDVKTENIFLD--EPENAV--LGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785
L +PELL + K D++S G+VL+E+
Sbjct: 251 LETNSPELL--ALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 867 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.94 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.88 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.67 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.26 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.23 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.95 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.88 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.87 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.87 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.7 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.67 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.56 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.28 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.19 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.05 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.91 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.85 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.66 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.48 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.42 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.02 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.49 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.36 | |
| PLN02236 | 344 | choline kinase | 95.19 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.05 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.73 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.7 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.63 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.28 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.36 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.0 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.32 | |
| PTZ00296 | 442 | choline kinase; Provisional | 91.89 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.31 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 89.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.28 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 87.95 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 87.76 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 86.62 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 85.91 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 85.38 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=406.54 Aligned_cols=271 Identities=48% Similarity=0.808 Sum_probs=239.7
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECCce-EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G~~-VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
.+.+...++.+.+.||.|+||+||+|.|+|+. ||||++......+. . ...|.+|+.+|.+++|||||+++|+|
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~-----~-~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE-----S-RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChH-----H-HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 44666777778888999999999999999998 99999986543321 1 67899999999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCCcceEeccCCCCCCcEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~-~~~~Lse~~~l~Ia~QIa~ALayLHs~G-IIHrDLKPsNILLd~dg~~~~~vK 730 (867)
...+. .+++|||||++|+|.++++. ....+++..++.|+.+|++||.|||+++ ||||||||+|||++.++ .++|
T Consensus 109 ~~~~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~---~~~K 184 (362)
T KOG0192|consen 109 TSPPG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG---KTLK 184 (362)
T ss_pred cCCCC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC---CEEE
Confidence 98643 68999999999999999987 4788999999999999999999999999 99999999999999665 3679
Q ss_pred EeecCCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 731 VGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 731 L~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
|+|||+++..... .......||+.|||||++.+....++.|+||||||++||||+||+.||...........++....+
T Consensus 185 I~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 185 IADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR 264 (362)
T ss_pred ECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9999999866543 333346799999999999954456899999999999999999999999999988888888889999
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
++++..+++.+..+|..||..||..||+|.+++..|+.+......
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999999999999876554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=397.28 Aligned_cols=276 Identities=29% Similarity=0.349 Sum_probs=234.4
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
.+...++.|.+.+.||+|+||.|-+|.. +|+.||||++.+....+... .........+|+++|++|+|||||+++++
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 3344677899999999999999999987 58899999998876655433 11122345799999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
|...+ ..|+||||+.||.|.+.+.. .+.+.+.....+++||+.|+.|||++||+||||||+|||+..+. ....+||
T Consensus 245 f~~~d--s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-e~~llKI 320 (475)
T KOG0615|consen 245 FEVPD--SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-EDCLLKI 320 (475)
T ss_pred eecCC--ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC-cceEEEe
Confidence 99866 88999999999999999864 45688888899999999999999999999999999999998764 3467899
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCCh-hhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhhcCCC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSE-KVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLR 809 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~-kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~~~lr 809 (867)
+|||+|+..+......+.|||+.|.|||++.+.+..+.. ++|+|||||+||-+++|.+||....... ....+..+.+.
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 999999998887788889999999999999866555544 8999999999999999999998766555 66677777664
Q ss_pred --CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 810 --PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 810 --~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
++....++++..+||.+||..||++|||+.|+|.+.|...++|.+
T Consensus 401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 344566899999999999999999999999999999988766554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=396.56 Aligned_cols=295 Identities=36% Similarity=0.587 Sum_probs=247.6
Q ss_pred HHHhhhcccccccccCCCCCCCCC--CccccccCCCCC-ccccccccCCeeEEEEeeecCcEEEEEEEECCc-eEEEEEe
Q 002908 536 EVVNHRIQESDYEEGRLDLPTAGI--PLVDLALGNFDI-STLQIIKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRI 611 (867)
Q Consensus 536 elv~~~~~e~~~~~~~l~lP~ag~--pl~~~a~~~fd~-~~l~~I~~sdyqilk~LG~GafG~VYka~~~G~-~VAVKv~ 611 (867)
+++.++.........++..|..-. +.+ ...+. ...+.+..+.+++++.||+|-||.||+|.|++. +||+|.+
T Consensus 163 ~lv~~~~~~~~gl~~~l~~p~~~~~~~~p----~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~i 238 (468)
T KOG0197|consen 163 QLVNYYSKNADGLCTRLRDPCSKQGHTKP----QTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTI 238 (468)
T ss_pred HHHhhhhccCcchhhcccCchhccCCCCC----CCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEE
Confidence 345555555555555555554321 111 11111 456788899999999999999999999999876 8999999
Q ss_pred eccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhc-ccccCCHHHHHH
Q 002908 612 KKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLI 690 (867)
Q Consensus 612 k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~-~~~~Lse~~~l~ 690 (867)
+...++ ...|.+|+.+|++|+|+|||+++++|..+. .++||||||+.|+|.++|.. .+..+...+.+.
T Consensus 239 k~~~m~---------~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~ 307 (468)
T KOG0197|consen 239 KEGSMS---------PEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLD 307 (468)
T ss_pred eccccC---------hhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEecccCcHHHHhhhcCCCccchHHHHH
Confidence 875433 256889999999999999999999999854 79999999999999999986 557799999999
Q ss_pred HHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc--cccCCcCCCCCccCccccccCCCCC
Q 002908 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKV 768 (867)
Q Consensus 691 Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~--~~~s~~~GT~~Y~APEvl~g~~~~~ 768 (867)
|+.|||+||+||+++++|||||.+.||||+.+. .|||+|||+|+...+. ....+..-+..|.|||.+. ...+
T Consensus 308 ~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~----~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~--~~~F 381 (468)
T KOG0197|consen 308 FAAQIAEGMAYLESKNYIHRDLAARNILVDEDL----VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALN--YGKF 381 (468)
T ss_pred HHHHHHHHHHHHHhCCccchhhhhhheeeccCc----eEEEcccccccccCCCceeecCCCCCCceecCHHHHh--hCCc
Confidence 999999999999999999999999999999654 6799999999954332 2334445677899999999 7789
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 769 SEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 769 S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.+|||||||++||||+| |+.||.++...+.+.. +..+++++.|..||+.+.++|..||..+|++||||+.+...|++
T Consensus 382 S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 382 SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 999999999999999999 9999999999888765 67789999999999999999999999999999999999999999
Q ss_pred HHHHh
Q 002908 848 MSAAC 852 (867)
Q Consensus 848 l~~a~ 852 (867)
+....
T Consensus 461 ~~~~~ 465 (468)
T KOG0197|consen 461 FFTST 465 (468)
T ss_pred hhhcc
Confidence 87654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=380.60 Aligned_cols=258 Identities=33% Similarity=0.487 Sum_probs=222.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++++.++.||+|..|+||++.++ ++-+|+|++... .++...+++.+|+++++.++|||||.+||.|.
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-------IDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 356678899999999999999999995 777999999532 23455678999999999999999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.... .+.|+||||++|+|...+... +.+++..+..|+.+|++||.|||+ ++||||||||+|||++..|++ |||
T Consensus 148 ~~~~-~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeV----Kic 221 (364)
T KOG0581|consen 148 SNGE-EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEV----KIC 221 (364)
T ss_pred eCCc-eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCE----Eec
Confidence 8543 599999999999999988544 569999999999999999999996 999999999999999987765 999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC-----ChhHHHHhHhhcC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-----HYGAIIGGIVNNT 807 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~-----~~~e~l~~iv~~~ 807 (867)
|||.+....+. ...++.||..|||||.+.| ..|+.++||||||++++||++|+.||... ...+.+..++.+.
T Consensus 222 DFGVS~~lvnS-~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 222 DFGVSGILVNS-IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred cccccHHhhhh-hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 99999976655 5567889999999999995 46888999999999999999999999874 4556666776654
Q ss_pred CCCCCCC-CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 808 LRPPVPG-FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 808 lr~~ip~-~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
. +..|. .++++|++|+..||++||.+||++.+++.|.+....
T Consensus 299 p-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 299 P-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred C-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 3 44455 499999999999999999999999999998876643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=387.27 Aligned_cols=252 Identities=30% Similarity=0.444 Sum_probs=224.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|...+.||+|||+.||.+++ +|..||+|++.+...... .......+|+++.+.|+|||||+++++|++..
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-----~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~- 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-----KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN- 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-----chHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-
Confidence 6799999999999999999998 589999999987654432 23456778999999999999999999999966
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+|||.|+|..++|..++. ..+.++++++..++.||+.||.|||+++|||||||..|+||+.+- .+||+|||+|
T Consensus 92 -nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~----~VKIgDFGLA 165 (592)
T KOG0575|consen 92 -NVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM----NVKIGDFGLA 165 (592)
T ss_pred -ceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC----cEEeccccee
Confidence 9999999999999999886 667899999999999999999999999999999999999999554 5699999999
Q ss_pred ccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
...... ....+.||||.|+|||++. ....+..+||||+||+||-||.|++||......+.+..+....+.. |..+
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~--k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~--P~~l 241 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLN--KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM--PSHL 241 (592)
T ss_pred eeecCcccccceecCCCcccChhHhc--cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc--cccc
Confidence 976643 6667889999999999999 4456788999999999999999999999998888888888876654 5588
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.+.++||.++|+.+|.+|||+++|+.+-.-
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 9999999999999999999999999987544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=371.25 Aligned_cols=254 Identities=29% Similarity=0.468 Sum_probs=217.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|.+.+.||.|+||+||+|++ ++..||||.+..... ......-+..|+.+|+.++|||||++++++..++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 35788888999999999999998 478899999976432 2334455678999999999999999999999865
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCC--CcEEEeec
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR--PICKVGDF 734 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~--~~vKL~DF 734 (867)
.+|||||||.||+|.+++...+ .+++..+..++.||+.||++||+++||||||||+||||+...... ..+||+||
T Consensus 83 --~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 83 --FIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred --eEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999999999997654 699999999999999999999999999999999999999763333 68899999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-CCCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVP 813 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l-r~~ip 813 (867)
|+|+...+.......||++.|||||++. ..+|+.|+|+||+|++||+|++|+.||...+..+....+..+.. .+..+
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~--~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~ 237 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIM--SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP 237 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHH--hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence 9999998888888899999999999998 67799999999999999999999999999888887776554443 34445
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe 843 (867)
...+..+.+++...++.+|.+|-++.+...
T Consensus 238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 238 AELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred hhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 566777788888999999988887766543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=362.74 Aligned_cols=253 Identities=32% Similarity=0.475 Sum_probs=219.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|+++++||+|+||+||.++. +++-+|+|++++...... ........|..+|..++||.||.++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 56778999999999999999999987 477799999987654432 12345678999999999999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. .+|+|++|+.||.|...+. +++.+++..+..++.+|+.||.|||+.|||||||||+|||+|.+|+. +|+|
T Consensus 96 t~~--kLylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi----~LtD 168 (357)
T KOG0598|consen 96 TEE--KLYLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHI----KLTD 168 (357)
T ss_pred cCC--eEEEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcE----EEec
Confidence 965 9999999999999999985 45669999999999999999999999999999999999999988765 9999
Q ss_pred cCCccc-ccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 734 FGLSKI-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 734 FGLA~~-~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
||+++. ......+..++||+.|||||++. ...++.++|+||||+++|||++|.+||...+.......+..... ...
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~--~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-~~~ 245 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILL--GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-PLP 245 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHh--cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-CCC
Confidence 999994 44445666789999999999999 45789999999999999999999999999998888888887763 344
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCC----CHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRP----SFTEIAR 843 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRP----Sa~ELLe 843 (867)
+..++.+.+++++++|+.+|++|. ++.+|..
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 566899999999999999999995 4555433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=355.78 Aligned_cols=262 Identities=29% Similarity=0.490 Sum_probs=210.9
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCcee
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 646 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIV 646 (867)
+.+..++|++.++||.|+||.||+|.+. ++.||||+++... .......+.+|+.++..+ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv 74 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-------TASEHKALMSELKILIHIGNHLNVV 74 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-------chHHHHHHHHHHHHHHHhccCccee
Confidence 4577889999999999999999999752 3569999986431 111235688999999999 899999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhccc----------------------------------------------
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 680 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------------------------------------- 680 (867)
+++++|... ...+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 75 NLLGACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eEEeEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 999988754 346899999999999998885421
Q ss_pred ---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc--
Q 002908 681 ---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-- 743 (867)
Q Consensus 681 ---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~-- 743 (867)
..+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||+++.....
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~----~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPD 229 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC----cEEEeecccccccccCcc
Confidence 2477888999999999999999999999999999999998665 4699999999754221
Q ss_pred -cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHH
Q 002908 744 -LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821 (867)
Q Consensus 744 -~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~ 821 (867)
.......++..|+|||++. ...++.++|||||||+||+|++ |..||............+........+..+++.+.
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY 307 (338)
T ss_pred hhcccCCCCCccccCcHHhh--cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1222334667899999997 4457889999999999999997 99999876544444344444444555667889999
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 822 LLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 822 dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.45 Aligned_cols=265 Identities=26% Similarity=0.379 Sum_probs=220.9
Q ss_pred ccccccCCeeEE--EEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 574 LQIIKNEDLEEL--KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 574 l~~I~~sdyqil--k~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
++.+..++++.. ..||+|++|.||+|.++|+.||||+++... .........|.+|+.+|.+++||||++++++
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFH-----KGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccc-----cccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 344444454444 679999999999999999999999997532 1223345678899999999999999999999
Q ss_pred ccc--CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCc
Q 002908 652 VQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 652 ~~~--~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~ 728 (867)
+.+ .....+++||||+++|+|.+++.. ...+++...+.++.+++.||.|||+ .+++||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~---- 161 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK---- 161 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc----
Confidence 876 333478999999999999999864 4568999999999999999999998 49999999999999997654
Q ss_pred EEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 729 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
+||+|||++....... ....++..|+|||++.+....++.++|||||||++|+|++|+.||...........+.....
T Consensus 162 ~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 239 (283)
T PHA02988 162 LKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN 239 (283)
T ss_pred EEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence 5999999988544322 22457899999999975445789999999999999999999999998887777777666666
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+.+.+..+++.+.+++.+||+.||.+|||+.+++..|+.++.
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 667776789999999999999999999999999999998753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=355.58 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=217.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
..+..+|+++++||.|+||.||++.. +|..||.|.+.-..+ +.........|+.+|++|+|||||+++++-.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM------DAKARQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc------cHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 34557899999999999999999987 688899998873322 2334567889999999999999999999544
Q ss_pred cCCCCeEEEEEEeecCCchhhhhh---cccccCCHHHHHHHHHHHHHHHHHHHH--CC--eeccCCCCcceEeccCCCCC
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLL---SKERHLDRRKRLIIAMDAAFGMEYLHS--KN--IVHFDLKCDNLLVNLKDPIR 726 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~---~~~~~Lse~~~l~Ia~QIa~ALayLHs--~G--IIHrDLKPsNILLd~dg~~~ 726 (867)
..+...++||||||..|+|.+++. ...+.+++..+|+++.|++.||.++|. .. |+||||||.||+|+.+|.
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv-- 166 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV-- 166 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--
Confidence 333445899999999999999884 344679999999999999999999998 44 999999999999997764
Q ss_pred CcEEEeecCCcccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 727 PICKVGDFGLSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 727 ~~vKL~DFGLA~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
+||+|||+++.... ........|||.||+||.+. ...|+.+|||||+||++|||+.-.+||.+........++..
T Consensus 167 --vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~--~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q 242 (375)
T KOG0591|consen 167 --VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIH--ESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ 242 (375)
T ss_pred --eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHh--cCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc
Confidence 59999999997654 34556778999999999999 56689999999999999999999999999988888888877
Q ss_pred cCCCCCCC-CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 806 NTLRPPVP-GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 806 ~~lr~~ip-~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.+. ++| ..++..+..+|..|+..||+.||+.-.++..++.
T Consensus 243 gd~~-~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 GDYP-PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCC-CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 7554 345 7889999999999999999999986555555544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=355.35 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=215.3
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|...+.||+|+||.||++... |...|||.+.... ... ...+.+|+.+|.+++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPT----SESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chh----HHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 456778889999999999999984 7889999987541 111 456789999999999999999999754433
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEecc-CCCCCCcEEEeecC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPICKVGDFG 735 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~-dg~~~~~vKL~DFG 735 (867)
...+++.|||+++|+|.+++...+..+++..+..++.||++||+|||++|||||||||+|||++. ++ .+||+|||
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~----~~KlaDFG 163 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG----DVKLADFG 163 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC----eEEeccCc
Confidence 23689999999999999999766557999999999999999999999999999999999999997 34 45999999
Q ss_pred CcccccC----ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC-CChhHHHHhHhhcCCCC
Q 002908 736 LSKIKRN----TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 736 LA~~~~~----~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~-~~~~e~l~~iv~~~lr~ 810 (867)
++..... ........||+.|||||++.. ......++|||||||++.||+||+.||.. ......+..+......+
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP 242 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC
Confidence 9986553 122345779999999999984 22233589999999999999999999987 44455555555555667
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.+|..++...++|+.+|++.+|++|||+.++|.+......
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 8889999999999999999999999999999998876543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=356.78 Aligned_cols=262 Identities=29% Similarity=0.453 Sum_probs=222.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~ 652 (867)
......|.+.+.||+|+||.|++|.+ +++.||||++......... ......+.+|+.+++.++ ||||++++.++
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 34567899999999999999999987 5889999987765322111 112234558999999999 99999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccC-CCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK-DPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~d-g~~~~~vKL 731 (867)
.... .+++||||+.||.|.+++.. ..++.+..+..++.|++.|++|||++||+||||||+|||++.+ ++ +||
T Consensus 90 ~t~~--~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~----~Kl 162 (370)
T KOG0583|consen 90 ATPT--KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN----LKL 162 (370)
T ss_pred ecCC--eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC----EEE
Confidence 9866 79999999999999999987 6679999999999999999999999999999999999999977 54 599
Q ss_pred eecCCcccc-cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 732 GDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 732 ~DFGLA~~~-~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
+|||++... .........+||+.|+|||++.+....-+.++||||+|++||-|++|..||...........+....+
T Consensus 163 ~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-- 240 (370)
T KOG0583|consen 163 SDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-- 240 (370)
T ss_pred eccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--
Confidence 999999977 45556677899999999999996542336899999999999999999999999877777777665544
Q ss_pred CCCCCC-cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 811 PVPGFC-DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 811 ~ip~~~-s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.+|..+ ++++..|+++||..+|.+|+|+.+++.+-|-..
T Consensus 241 ~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 456666 999999999999999999999999997777654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=375.13 Aligned_cols=263 Identities=38% Similarity=0.655 Sum_probs=234.0
Q ss_pred ccccccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 572 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 572 ~~l~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
..+|+|..+....++-||.|+.|.||+|+..++.||||.++.. -..+++-|++|+||||+.+.|+
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------------kETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------------KETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------------hhhhHHHHHhccCcceeeEeee
Confidence 3567888888888899999999999999999999999987521 1246788999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
|...+ ++|||||||..|-|...|. .++.+.......|..+||.||.|||.+.|||||||.-||||..+.. +||
T Consensus 181 CtqsP--cyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~----VKI 253 (904)
T KOG4721|consen 181 CTQSP--CYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV----VKI 253 (904)
T ss_pred ecCCc--eeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce----EEe
Confidence 99987 9999999999999999985 4567888899999999999999999999999999999999997654 599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
+|||-++..........++||..|||||++. ....++|+|||||||+|||||||..||...+...++-.+-...+..+
T Consensus 254 sDFGTS~e~~~~STkMSFaGTVaWMAPEvIr--nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp 331 (904)
T KOG4721|consen 254 SDFGTSKELSDKSTKMSFAGTVAWMAPEVIR--NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP 331 (904)
T ss_pred ccccchHhhhhhhhhhhhhhhHhhhCHHHhh--cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc
Confidence 9999999877777777899999999999999 56689999999999999999999999998877777766666777889
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCCCCC
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHG 858 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~~~~ 858 (867)
.|..|++.|+-||++||+..|..||+|.+++.+|+.+......+..+
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee 378 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEE 378 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHH
Confidence 99999999999999999999999999999999999988776655443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=329.97 Aligned_cols=256 Identities=32% Similarity=0.560 Sum_probs=211.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
+...+|++.+.||+|+||.||+|.+. +..||+|.++.... ......|.+|+.++..++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-------DKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-------HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45678999999999999999999763 45799999875321 1223568899999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+.... ..++||||+++++|.+++......+++..++.++.||+.||+|||++|++||||||+|||++.++ .+++
T Consensus 75 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~----~~~l 148 (266)
T cd05064 75 ITRGN--TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL----VCKI 148 (266)
T ss_pred EecCC--CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC----cEEE
Confidence 98754 89999999999999999876566789999999999999999999999999999999999998655 4699
Q ss_pred eecCCcccccCccc--cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCC
Q 002908 732 GDFGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~~--~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~l 808 (867)
+|||.+........ .....++..|+|||.+. ...++.++|||||||++|+|++ |..||...........+. ...
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~ 225 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGF 225 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHh--hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCC
Confidence 99998764322211 11223567899999987 4567889999999999999876 999998877666555543 344
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+.+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 5566778899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.48 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=203.9
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|+..+.||+|+||.||++.+ +++.||||.+...... .......+.+|+.++..++|+||+++++++.+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-----hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 377889999999999999987 4788999998754321 1122345778999999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|..++... ...+++..+..++.|++.||+|||+.||+||||||+|||++.++. ++|+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~----~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH----IRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC----EEEeeCCCc
Confidence 899999999999998877543 346899999999999999999999999999999999999986654 599999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh--cCCCCCCCCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--NTLRPPVPGF 815 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~--~~lr~~ip~~ 815 (867)
.............||..|+|||++. ...++.++|||||||++|+|++|+.||...........+.. .......+..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVIN--NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhc--CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc
Confidence 8654433334456899999999998 45678899999999999999999999987543222111111 1222344556
Q ss_pred CcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLR 846 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq 846 (867)
++..+.+|+++||+.+|.+||+ +.+++++.+
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 7899999999999999999997 899988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.96 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=210.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||+|.+. ++.||||++..... ........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-----IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-----hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 46899999999999999999985 78899999975321 11223456788999999999999999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~----~kl~Dfg~~ 148 (291)
T cd05612 75 -FLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH----IKLTDFGFA 148 (291)
T ss_pred -eEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC----EEEEecCcc
Confidence 89999999999999998854 346899999999999999999999999999999999999987664 599999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
....... ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ...+..++
T Consensus 149 ~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~ 222 (291)
T cd05612 149 KKLRDRT--WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLD 222 (291)
T ss_pred hhccCCc--ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCC
Confidence 8654322 23468999999999984 457889999999999999999999998877766666665543 34455678
Q ss_pred HHHHHHHHHhhcCCCCCCCC-----HHHHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPS-----FTEIARRLRV 847 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq~ 847 (867)
..+.+||.+||+.||.+||+ +.+++++.+-
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 99999999999999999995 9999988665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=361.01 Aligned_cols=253 Identities=29% Similarity=0.415 Sum_probs=218.6
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 653 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~ 653 (867)
....+|..++.||.|+|++|++|+. .++.+|||++.+... ..+.....+.+|..+|.+| .||.|++||..|+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-----ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-----IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-----HhhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 4457899999999999999999988 478899999976432 2334456677899999999 7999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. .+|+|+||+++|.|.+++.+. +.|++..+..++.+|+.||+|||++|||||||||+|||||.++.. +|+|
T Consensus 145 D~~--sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhi----kITD 217 (604)
T KOG0592|consen 145 DEE--SLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHI----KITD 217 (604)
T ss_pred ccc--ceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcE----EEee
Confidence 965 899999999999999999655 569999999999999999999999999999999999999977755 9999
Q ss_pred cCCcccccCcccc--------------CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH
Q 002908 734 FGLSKIKRNTLVT--------------GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 799 (867)
Q Consensus 734 FGLA~~~~~~~~~--------------s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~ 799 (867)
||.|+.+...... ..+.||..|.+||++. ....+..+|+|+|||+||+|+.|.+||.....--.
T Consensus 218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~--~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN--DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc--CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 9999865432111 3477999999999999 55678899999999999999999999999888777
Q ss_pred HHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 800 l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.++++...+ +++...++.+.+||+++|..||.+|+|.++|.+|.
T Consensus 296 FqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 FQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 888876544 56778899999999999999999999999987764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.59 Aligned_cols=255 Identities=29% Similarity=0.378 Sum_probs=215.6
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 653 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~ 653 (867)
+..++|.++++||.|.||.||+|+. .+..||||.++....+ ..+. .-+||+..|++|+ |||||++.+++.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s----~ee~---~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS----WEEC---MNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc----HHHH---HHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 4457899999999999999999987 5788999999876533 3332 2358999999999 999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.+. .+++||||| ..+|++++..+.+.|++..+..|+.||++||+|+|.+|+.||||||+|||+.. ...+||+|
T Consensus 80 d~~~-~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~----~~~iKiaD 153 (538)
T KOG0661|consen 80 DNDR-ILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG----NDVIKIAD 153 (538)
T ss_pred ccCc-eEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc----cceeEecc
Confidence 8643 999999999 79999999988999999999999999999999999999999999999999984 34579999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC------
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT------ 807 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~------ 807 (867)
||+|+........+....|.+|+|||++.. ...|+.++|+||+||+++|+.+-++.|++...-+.+.+++.-.
T Consensus 154 FGLARev~SkpPYTeYVSTRWYRAPEvLLr-s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 154 FGLAREVRSKPPYTEYVSTRWYRAPEVLLR-SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD 232 (538)
T ss_pred cccccccccCCCcchhhhcccccchHHhhh-ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence 999997766666667779999999999985 4568999999999999999999999999987766655544311
Q ss_pred -------------CCCC---------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 808 -------------LRPP---------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 808 -------------lr~~---------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
++.+ +...++.++.++|.+||++||.+|||+.+++++.
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111 0123678899999999999999999999998864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=342.23 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=206.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
+.|+.+.++|+|++|+||+++. +|+-||||.|.. .++++...+-.+||+++|++|.|+|+|.++.+|...
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E------sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-- 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE------SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-- 73 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeecc------CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc--
Confidence 4578888999999999999998 488899999974 234455566678999999999999999999999884
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
+.++||+||| ..++.+.+.....-++...+..+++|++.|+.|||++++|||||||+||||+.+|. +||||||+|
T Consensus 74 rklhLVFE~~-dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv----vKLCDFGFA 148 (396)
T KOG0593|consen 74 RKLHLVFEYC-DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV----VKLCDFGFA 148 (396)
T ss_pred ceeEEEeeec-chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc----EEeccchhh
Confidence 4899999999 56666667666677899999999999999999999999999999999999997775 499999999
Q ss_pred cccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc----------
Q 002908 738 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 806 (867)
Q Consensus 738 ~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~---------- 806 (867)
+... +....+....|.+|+|||.+.| ...|+..+||||+||++.||++|.+.|++...-+.+..++..
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvG-DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVG-DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcc-cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 9765 4444555678999999999997 456899999999999999999999999987665544333321
Q ss_pred ---------CCCCCCCC----------CCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 807 ---------TLRPPVPG----------FCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 807 ---------~lr~~ip~----------~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+.+.|.+. ..+.-+.+|++.||..||.+|++-++++.+
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11222221 245568999999999999999999998754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=330.27 Aligned_cols=251 Identities=26% Similarity=0.336 Sum_probs=200.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.++||.|+||.||+|.. ++..||+|+++...... ....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKNLKHANIVTLHDIIHTER 76 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-------cchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 46799999999999999999988 47789999997542211 1234668999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+. ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~----~kl~DfG~ 149 (288)
T cd07871 77 --CLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE----LKLADFGL 149 (288)
T ss_pred --eEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC----EEECcCcc
Confidence 8999999996 5898888666667899999999999999999999999999999999999997664 59999999
Q ss_pred cccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC------
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------ 809 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr------ 809 (867)
+...... .......+++.|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLG-STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcC-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 8754322 12233457899999999874 345788999999999999999999999876655443332211000
Q ss_pred -------------C---------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 -------------P---------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 -------------~---------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
. .....++.++.+||.+||+.||.+|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0012357789999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=341.81 Aligned_cols=251 Identities=28% Similarity=0.392 Sum_probs=210.7
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||+|++. ++.||||+++..... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-----KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 4578999999999999999999984 778999999753211 122345678999999999999999999999885
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||
T Consensus 91 ~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~----~kl~Dfg 163 (329)
T PTZ00263 91 N--RVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH----VKVTDFG 163 (329)
T ss_pred C--EEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC----EEEeecc
Confidence 4 899999999999999988643 46889999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ...+..
T Consensus 164 ~~~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~~ 237 (329)
T PTZ00263 164 FAKKVPDRT--FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNW 237 (329)
T ss_pred CceEcCCCc--ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCCC
Confidence 998654332 23568999999999984 456889999999999999999999998877666666655543 445667
Q ss_pred CcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLR 846 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq 846 (867)
++..+.+||.+||+.||.+||+ +.+++.+.+
T Consensus 238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 8899999999999999999986 788887753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.35 Aligned_cols=255 Identities=33% Similarity=0.495 Sum_probs=201.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC------------------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHH
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR------------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~------------------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk 638 (867)
+...+|++.++||+|+||.||+|.+. +..||||++.... .......|.+|+.++.
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~ 74 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILS 74 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHh
Confidence 34678999999999999999999752 2359999986432 1223467889999999
Q ss_pred hCCCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhccc------------------ccCCHHHHHHHHHHHHHHHH
Q 002908 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------------------RHLDRRKRLIIAMDAAFGME 700 (867)
Q Consensus 639 ~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~------------------~~Lse~~~l~Ia~QIa~ALa 700 (867)
+++||||+++++++.+.. ..++||||+.+++|.+++.... ..+++..++.++.||+.||.
T Consensus 75 ~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 75 RLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred hcCCCCeeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999999999998754 7899999999999998874321 24678889999999999999
Q ss_pred HHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHH
Q 002908 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSF 777 (867)
Q Consensus 701 yLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSL 777 (867)
|||+.||+||||||+|||++.++ .+||+|||+++...... ......++..|+|||++. ...++.++|||||
T Consensus 153 ~lH~~~ivH~dlkp~Nill~~~~----~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~sl 226 (304)
T cd05096 153 YLSSLNFVHRDLATRNCLVGENL----TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL--MGKFTTASDVWAF 226 (304)
T ss_pred HHHHCCccccCcchhheEEcCCc----cEEECCCccceecccCceeEecCcCCCCccccCHHHHh--cCCCCchhhhHHH
Confidence 99999999999999999999765 45999999997543221 122334578899999987 4457899999999
Q ss_pred HHHHHHHHh--CCCCCCCCChhHHHHhHhh---c---CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 778 GIVLWEILT--GEEPYANMHYGAIIGGIVN---N---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 778 GvLLyELLT--Gk~PF~~~~~~e~l~~iv~---~---~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
||++|+|++ +..||.............. . ......+..++..+.+|+.+||+.+|.+|||+.+|.+.|+
T Consensus 227 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 227 GVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 999999987 5678877665544433211 1 1112234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.09 Aligned_cols=252 Identities=28% Similarity=0.424 Sum_probs=210.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||+|.+. ++.||||+++..... .......+.+|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-----KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 47899999999999999999985 888999999754321 1123456788999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~----~kL~Dfg~~ 148 (350)
T cd05573 75 -HLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH----IKLADFGLC 148 (350)
T ss_pred -eEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC----EEeecCCCC
Confidence 899999999999999998654 57899999999999999999999999999999999999997764 599999999
Q ss_pred ccccCcc------------------------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhC
Q 002908 738 KIKRNTL------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787 (867)
Q Consensus 738 ~~~~~~~------------------------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTG 787 (867)
....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccC
Confidence 7543322 2234568999999999984 4678999999999999999999
Q ss_pred CCCCCCCChhHHHHhHhh--cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCC-HHHHHHHHH
Q 002908 788 EEPYANMHYGAIIGGIVN--NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPS-FTEIARRLR 846 (867)
Q Consensus 788 k~PF~~~~~~e~l~~iv~--~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPS-a~ELLe~Lq 846 (867)
+.||...........+.. .....+....+++.+.+||.+||. +|.+||+ +.+++.+.+
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 999988877666666655 333344444479999999999997 9999999 999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=340.13 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=207.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|++.+.||+|+||.||+|.+. ++.||||+++..... .......+.+|+.++..++||||+++++++....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 36899999999999999999984 788999999754211 1223456788999999999999999999998855
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~----~kL~Dfg~a 148 (333)
T cd05600 75 -YLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH----IKLTDFGLS 148 (333)
T ss_pred -EEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC----EEEEeCcCC
Confidence 89999999999999998854 346899999999999999999999999999999999999997664 599999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC----
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP---- 813 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip---- 813 (867)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........+
T Consensus 149 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 224 (333)
T cd05600 149 KGIVT--YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224 (333)
T ss_pred ccccc--ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCc
Confidence 85543 2334568999999999984 467899999999999999999999998877665554443322111111
Q ss_pred --CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 814 --GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 814 --~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
..++.++.++|.+||..+|.+||++.+++.+.+
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 145889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=347.38 Aligned_cols=260 Identities=33% Similarity=0.507 Sum_probs=211.2
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCce
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 645 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNI 645 (867)
.+.+..++|++.+.||+|+||.||+|++. +..||||+++.... ......+.+|+.+|..+ +||||
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~il~~l~~HpnI 101 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHINI 101 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------cHHHHHHHHHHHHHHHhcCCcce
Confidence 34566778999999999999999999752 45799999864321 11235678899999999 89999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------------------------------------
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------------------------------------- 680 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~--------------------------------------------- 680 (867)
++++++|.... ..++||||+++|+|.+++....
T Consensus 102 v~l~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 179 (375)
T cd05104 102 VNLLGACTVGG--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV 179 (375)
T ss_pred eeeeeeeccCC--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence 99999998855 8899999999999998885321
Q ss_pred -----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 681 -----------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 681 -----------------------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
..+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~----~~kl 255 (375)
T cd05104 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR----ITKI 255 (375)
T ss_pred ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC----cEEE
Confidence 2478889999999999999999999999999999999998654 4699
Q ss_pred eecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 732 GDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 732 ~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
+|||++....... ......++..|+|||++. ...++.++|||||||++|+|++ |..||............+...
T Consensus 256 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~ 333 (375)
T cd05104 256 CDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG 333 (375)
T ss_pred ecCccceeccCcccccccCCCCCCcceeChhHhc--CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC
Confidence 9999997543221 112233567799999998 4457889999999999999998 899998776555555555555
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+...+...+.++.+|+.+||+.+|++||++.+|++.|+..
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 55556667789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=348.15 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=213.5
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCce
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 645 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNI 645 (867)
.+.+..++|++.+.||+|+||.||+|.+. +..||||+++.... ......+.+|+.+++.+ +||||
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~~h~nI 104 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------TDEREALMSELKILSHLGQHKNI 104 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------HHHHHHHHHHHHHHHhhccCCce
Confidence 34567789999999999999999999862 24699999975321 11235678899999999 89999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------------------------------------
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------------------------------------- 680 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~--------------------------------------------- 680 (867)
++++++|.... ..++||||+++++|.+++....
T Consensus 105 v~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 105 VNLLGACTHGG--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred eeEeeEecCCC--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 99999998854 8999999999999998875321
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 681 ------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 681 ------------------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~----~~kL~DfGl 258 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR----VAKICDFGL 258 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC----eEEEeecee
Confidence 2478889999999999999999999999999999999998654 469999999
Q ss_pred cccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 737 SKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 737 A~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
++...... ......++..|+|||++. ...++.++|||||||++|+|++ |+.||.....................
T Consensus 259 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 336 (374)
T cd05106 259 ARDIMNDSNYVVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR 336 (374)
T ss_pred eeeccCCcceeeccCCCCccceeCHHHhc--CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC
Confidence 97543221 112233566799999997 4557899999999999999997 99999877665555555666666666
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+..+++++.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 7778999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.48 Aligned_cols=244 Identities=27% Similarity=0.369 Sum_probs=203.1
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 586 k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
+.||+|+||.||++.+ .++.||||+++..... .......+.+|+.+++.++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEE
Confidence 3699999999999987 4788999999754221 1223456778999999999999999999998855 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-C
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~-~ 742 (867)
|||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||+++... .
T Consensus 74 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~----~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH----IKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC----EEEeeCCCCcccccC
Confidence 999999999888854 456899999999999999999999999999999999999997664 5999999987432 2
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
........||+.|+|||++. ...++.++|||||||++|+|++|..||...........+.... ...+..+++.+.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKS 224 (323)
T ss_pred CCcccceecCccccChhhhc--CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 22233456999999999998 4557889999999999999999999998877666665555443 3455678999999
Q ss_pred HHHHhhcCCCCCCC-----CHHHHHHHH
Q 002908 823 LMEQCWAPDPVVRP-----SFTEIARRL 845 (867)
Q Consensus 823 LI~kCLq~DPeeRP-----Sa~ELLe~L 845 (867)
||.+||+.||++|| ++.+++++-
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 99999999999999 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=361.16 Aligned_cols=265 Identities=35% Similarity=0.576 Sum_probs=222.2
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
..|.|..+++.+...||+|.||+||+|.|-| +||||++.....+ .+ ....|..|+.+|++-+|.||+-+.|+|
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt-----~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPT-----PE-QLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCC-----HH-HHHHHHHHHHHHhhcchhhheeeehhh
Confidence 5778899999999999999999999999976 6999999865322 22 567899999999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
..++ +.||+.||+|.+|+.+++..+..|.....+.|+.||++||.|||.++|||||||..||++..++ .|||+
T Consensus 458 ~~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~----kVkIg 530 (678)
T KOG0193|consen 458 MNPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL----KVKIG 530 (678)
T ss_pred cCCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC----cEEEe
Confidence 9865 4999999999999999998888899999999999999999999999999999999999999765 45999
Q ss_pred ecCCcccccCc---cccCCcCCCCCccCccccc-cCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 733 DFGLSKIKRNT---LVTGGVRGTLPWMAPELLN-GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 733 DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~-g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
|||++...... .......|...|||||+++ .....|++.+|||||||++|||+||..||.....+.++..+-.+.+
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l 610 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL 610 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc
Confidence 99999853321 1112234778899999986 3456789999999999999999999999996555555544333322
Q ss_pred CCC---CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 809 RPP---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 809 r~~---ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
.+. ....++.++++|+..||..++++||.|.+|+..|+.+...
T Consensus 611 ~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 222 2346788999999999999999999999999988887663
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.51 Aligned_cols=250 Identities=36% Similarity=0.633 Sum_probs=206.5
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..++|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---------HHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 3467899999999999999999985 457999987643211 245778999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++......+++..++.++.|++.||.|||++||+|+||+|+||+++.++ .++|+|||.
T Consensus 73 --~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~kl~d~g~ 146 (256)
T cd05114 73 --PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG----VVKVSDFGM 146 (256)
T ss_pred --CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC----eEEECCCCC
Confidence 88999999999999998865555689999999999999999999999999999999999998655 469999999
Q ss_pred cccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 737 SKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 737 A~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
+....... ......++..|+|||++. ...++.++||||||+++|+|++ |+.||...........+... .+...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~ 223 (256)
T cd05114 147 TRYVLDDEYTSSSGAKFPVKWSPPEVFN--FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-FRLYRP 223 (256)
T ss_pred ccccCCCceeccCCCCCchhhCChhhcc--cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCC
Confidence 87543221 112233566899999997 3457889999999999999999 89999887766666655443 234445
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 56788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=349.66 Aligned_cols=255 Identities=35% Similarity=0.569 Sum_probs=199.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+.|.....||+|+||.||+|... ++.||||.+...... . ..+|.+|+.+|.+++|||||+++|||.+...
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~------~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ------G--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc------c--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 55666678999999999999995 488999977643211 0 2569999999999999999999999998542
Q ss_pred eEEEEEEeecCCchhhhhhcccc-cCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 659 TLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMDAAFGMEYLHSKN---IVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~-~Lse~~~l~Ia~QIa~ALayLHs~G---IIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
..+||+|||++|+|.++++.... .++|..+++|+.++|+||+|||... ||||||||+|||+|.+.+ +||+||
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~----aKlsDF 221 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN----AKLSDF 221 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC----EEccCc
Confidence 58999999999999999987766 8999999999999999999999853 999999999999996654 599999
Q ss_pred CCcccccC-ccccCCc-CCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---h---hHHHHhHhhc
Q 002908 735 GLSKIKRN-TLVTGGV-RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---Y---GAIIGGIVNN 806 (867)
Q Consensus 735 GLA~~~~~-~~~~s~~-~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~---~---~e~l~~iv~~ 806 (867)
|+|+.... ....... .||.+|+|||++. ....+.++||||||++|+||+||+.+.+... . .......+..
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~--~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAS--TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhc--cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99976554 3222222 7999999999998 4678999999999999999999998876432 1 1111111111
Q ss_pred -----CCCCCCC-CCCc-----HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 807 -----TLRPPVP-GFCD-----SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 807 -----~lr~~ip-~~~s-----~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
-+.+.+. .... ..+..+..+|++.+|.+||+|.++++.|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1111111 2222 23556777999999999999999999995543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.27 Aligned_cols=255 Identities=36% Similarity=0.623 Sum_probs=211.5
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
..++|++.+.||+|+||.||+|.+. ...||||+++... .......|.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 4567899999999999999999984 2469999886432 122345688899999999999999999998
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.... ..++||||+++++|.+++......+++..++.++.|++.||.|||+++|+|+||||+|||++.++. ++|+
T Consensus 75 ~~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~----~~l~ 148 (266)
T cd05033 75 TKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV----CKVS 148 (266)
T ss_pred ecCC--ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC----EEEC
Confidence 8754 789999999999999998766667899999999999999999999999999999999999996654 5999
Q ss_pred ecCCcccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCC
Q 002908 733 DFGLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 733 DFGLA~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~l 808 (867)
|||++..... ........++..|+|||.+. ...++.++||||||+++|+|++ |..||...........+. ...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~ 225 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGY 225 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhc--cCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999986531 11112233567899999987 4557889999999999999998 999998877666555544 334
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+.+..++..+.+++.+||+.+|.+||++.+++++|..+
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 4555677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.97 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=197.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+ +++.||||+++...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-------TPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-------cchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 46799999999999999999998 47889999987532111 1234668999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+ .++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 77 --~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~----~kl~Dfg~ 149 (303)
T cd07869 77 --TLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE----LKLADFGL 149 (303)
T ss_pred --eEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEECCCCc
Confidence 899999999 56787777666667899999999999999999999999999999999999997664 59999999
Q ss_pred cccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhHhh---cCC---
Q 002908 737 SKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVN---NTL--- 808 (867)
Q Consensus 737 A~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~iv~---~~l--- 808 (867)
+..... ........+++.|+|||++.+ ...++.++|||||||++|+|++|..||...... ..+..+.. ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLG-STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 874332 122234558899999999874 235788999999999999999999999875432 22211111 000
Q ss_pred ---------------CCCCC---------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 809 ---------------RPPVP---------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 809 ---------------r~~ip---------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....+ ...+..+.+|+.+||+.||.+|||+.+++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 00000 113467889999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.73 Aligned_cols=259 Identities=31% Similarity=0.587 Sum_probs=212.8
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCc----eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~----~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+...+|++.+.||+|+||.||+|.+ .+. .||||+++... ......++.+|+.+++.++||||++++
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45677899999999999999999987 333 38999986321 122345688899999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
++|... ..++|++|+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +
T Consensus 76 g~~~~~---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~----~ 148 (316)
T cd05108 76 GICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH----V 148 (316)
T ss_pred EEEcCC---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc----E
Confidence 998764 467899999999999999776667899999999999999999999999999999999999986654 5
Q ss_pred EEeecCCcccccCccc---cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~---~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
+|+|||+++....... .....++..|+|||++. ...++.++|||||||++|+|++ |..||........ ..+..
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~ 225 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILE 225 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhc--cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHh
Confidence 9999999986543221 12223467899999997 4567899999999999999998 9999987665443 34444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
.....+.+..++..+.+++.+||+.+|.+||++.+++..|..+...
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 5555566677889999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=356.88 Aligned_cols=250 Identities=29% Similarity=0.460 Sum_probs=212.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
..|....+||+|+.|.||.+.. ++..||||.+....-.. ..-++.|+.+|+..+|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--------keLilnEi~Vm~~~~H~NiVnfl~Sylv~d- 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--------KELLLNEILVMRDLHHPNIVNFLDSYLVGD- 343 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--------hhhhHHHHHHHHhccchHHHHHHHHhcccc-
Confidence 4577778999999999999987 46779999997654321 133568999999999999999999888754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.++.|||||+||+|.+.+. ...+++.++..|+++++.||+|||.+||||||||.+|||++.+|.. ||+|||++
T Consensus 344 -eLWVVMEym~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~v----KltDFGFc 416 (550)
T KOG0578|consen 344 -ELWVVMEYMEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSV----KLTDFGFC 416 (550)
T ss_pred -eeEEEEeecCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcE----EEeeeeee
Confidence 8999999999999999884 3458999999999999999999999999999999999999988864 99999999
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc-CCCCCCCCC
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPGF 815 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~-~lr~~ip~~ 815 (867)
..+.... ......||++|||||++. ...|+.++||||||++++||+.|.+||-..+.-..+..+... ......+..
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvt--rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVT--RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEK 494 (550)
T ss_pred eccccccCccccccCCCCccchhhhh--hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccc
Confidence 8655443 556678999999999998 667899999999999999999999999876655555554443 334556778
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+++.|++|+.+||+.|+++|+++.|||++---
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 99999999999999999999999999987543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=318.41 Aligned_cols=254 Identities=33% Similarity=0.578 Sum_probs=210.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.|..++|++.++||+|+||.||+|.+. +..||+|.+..... ....+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDKLVRLYAVVTK 72 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---------hHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 467789999999999999999999874 56799998764211 13567889999999999999999999887
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+++||||+|+||+++.++ .++|+|
T Consensus 73 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~d 146 (261)
T cd05072 73 EE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL----MCKIAD 146 (261)
T ss_pred CC--CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC----cEEECC
Confidence 54 789999999999999988643 35688999999999999999999999999999999999999665 459999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||++....... ......++..|+|||++. ...++.++|||||||++|+|+| |..||...........+. .....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~ 223 (261)
T cd05072 147 FGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRM 223 (261)
T ss_pred CccceecCCCceeccCCCccceecCCHHHhc--cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99998654322 112233567899999987 3457889999999999999998 999998776655555443 33445
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+....++..+.+++.+||..+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 5556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=360.27 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=224.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.-|++++-||.|+.|.|-+|++ +|+.+|||++.+.... .+.....+.+|+.+|+-+.|||++++|+++.+..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-----s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~- 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-----SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ- 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc-----ccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-
Confidence 3477888999999999999988 6999999999875311 1222345778999999999999999999999865
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
++|+|.||+++|-|.+++..++ ++++.++.+++.||+.|+.|||..+||||||||+|+|||..++ +||+|||+|
T Consensus 86 -~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n----IKIADFGMA 159 (786)
T KOG0588|consen 86 -HLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN----IKIADFGMA 159 (786)
T ss_pred -eEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC----Eeeecccee
Confidence 9999999999999999997655 5889999999999999999999999999999999999997766 499999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
.+..+.....+.||++.|+|||++.|..++ +.++||||.||+||.||||+.||+..+....+.++..+.+. +|..++
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYd-G~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--MPs~Is 236 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYD-GRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--MPSNIS 236 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCC-CCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--CCCcCC
Confidence 987777777778999999999999986554 78999999999999999999999988888888888777665 458899
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+.++||++||..||+.|.|+++|++|.+-.
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 9999999999999999999999999998765
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.45 Aligned_cols=254 Identities=37% Similarity=0.621 Sum_probs=208.5
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
..++|++.+.||+|+||.||+|.+.+ ..||+|.++... .......|.+|+.++..++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------EPKVQQEFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------CHHHHHHHHHHHHHHHhcCCcccceEEE
Confidence 34678889999999999999998743 459999886431 1223456889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCc
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 715 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPs 715 (867)
++.... ..+++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+
T Consensus 76 ~~~~~~--~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05048 76 VCTKEQ--PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAAR 153 (283)
T ss_pred EEcCCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccc
Confidence 988744 7899999999999999885431 45788999999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCC
Q 002908 716 NLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 791 (867)
Q Consensus 716 NILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF 791 (867)
||+++.++. ++|+|||++...... .......+++.|+|||.+. ...++.++|||||||++|+|++ |..||
T Consensus 154 Nil~~~~~~----~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDv~slG~il~el~~~g~~p~ 227 (283)
T cd05048 154 NCLVGEGLT----VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEIFSYGLQPY 227 (283)
T ss_pred eEEEcCCCc----EEECCCcceeeccccccccccCCCcccccccCHHHhc--cCcCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 999996654 599999998743221 1122334678899999987 4457899999999999999998 99999
Q ss_pred CCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 792 ~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+.........+... ...+.+..++..+.+|+.+||+.+|.+||++.+|+++|+.
T Consensus 228 ~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 228 YGFSNQEVIEMIRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHHHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 887776665554433 3445667889999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=331.80 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=205.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+..++|++.+.||+|+||.||++++. +..+|+|++.... .......+.+|+++|+.++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 45678999999999999999999984 7779999987531 12334678899999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++. ++|+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~----~kl~D 147 (331)
T cd06649 75 DG--EISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE----IKLCD 147 (331)
T ss_pred CC--EEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc----EEEcc
Confidence 54 89999999999999998854 34689999999999999999999986 6999999999999997664 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHh---------
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV--------- 804 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv--------- 804 (867)
||++...... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus 148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred Cccccccccc-ccccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 9998754332 2234568999999999984 457889999999999999999999997654432211100
Q ss_pred ------------------------------------hcCCCCCC-CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 805 ------------------------------------NNTLRPPV-PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 805 ------------------------------------~~~lr~~i-p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.....+.. ...+++++.+||.+||+.||++|||+.+++++.+-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00001111 12467889999999999999999999999999875
Q ss_pred HH
Q 002908 848 MS 849 (867)
Q Consensus 848 l~ 849 (867)
..
T Consensus 305 ~~ 306 (331)
T cd06649 305 KR 306 (331)
T ss_pred hh
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=353.19 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=213.7
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..+.|+.+++||+|.||.||+|++ +|+-||+|.++..... +.+.....||+.+|++|+||||+++.+++.+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~------~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK------EGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC------CcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 446788899999999999999998 5788999999865432 22345567999999999999999999999987
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..+.+|+|+||| ..+|..++...+-.|++.++..++.|++.||+|||.+||+|||||.+|||||.+|.. ||+|||
T Consensus 189 ~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~L----KiaDFG 263 (560)
T KOG0600|consen 189 LSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVL----KIADFG 263 (560)
T ss_pred CCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCE----Eecccc
Confidence 667999999999 688999887777789999999999999999999999999999999999999977755 999999
Q ss_pred CcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC---
Q 002908 736 LSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--- 810 (867)
Q Consensus 736 LA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~--- 810 (867)
+|+++.... ..+...-|.+|+|||.+.|. ..|+.++|+||.||+|.||++|++.|.+.+.-+.+..|......+
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 999765443 23445579999999999984 578999999999999999999999999988877666554321110
Q ss_pred -----CCC-------------------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 811 -----PVP-------------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 811 -----~ip-------------------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+| ...+....+|+..||..||.+|.|+.++|..
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 011 2356778899999999999999999988653
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=341.39 Aligned_cols=254 Identities=29% Similarity=0.433 Sum_probs=211.8
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
..+..++|++.+.||+|+||.||+|.+. +..||||++...... .......+.+|+.+++.++||||++++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 4566788999999999999999999874 257999998753211 12234567889999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+.+.. .+++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|
T Consensus 100 ~~~~~--~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~----ikL 172 (340)
T PTZ00426 100 FKDES--YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF----IKM 172 (340)
T ss_pred EEeCC--EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC----EEE
Confidence 98854 89999999999999998854 346899999999999999999999999999999999999986654 599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... .
T Consensus 173 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--~ 246 (340)
T PTZ00426 173 TDFGFAKVVDTR--TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--Y 246 (340)
T ss_pred ecCCCCeecCCC--cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--C
Confidence 999999865432 234568999999999984 4568899999999999999999999998777666666655443 3
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
.+..+++.+.++|++||+.+|.+|+ ++++++++.+
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 4566789999999999999999995 8999988754
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=317.79 Aligned_cols=255 Identities=35% Similarity=0.612 Sum_probs=211.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+...+|++.+.||.|++|.||+|.+. ++.||+|++.... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---------hHHHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 456678999999999999999999884 7789999986421 11356788999999999999999999988
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
... ..++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++. ++|+
T Consensus 73 ~~~--~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~----~kl~ 146 (263)
T cd05052 73 REP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL----VKVA 146 (263)
T ss_pred CCC--CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc----EEeC
Confidence 754 889999999999999988643 346899999999999999999999999999999999999986654 5999
Q ss_pred ecCCcccccCcccc--CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCC
Q 002908 733 DFGLSKIKRNTLVT--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 733 DFGLA~~~~~~~~~--s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr 809 (867)
|||++......... ....++..|+|||.+. ...++.++|||||||++|+|++ |..||...........+ .....
T Consensus 147 df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~ 223 (263)
T cd05052 147 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKGYR 223 (263)
T ss_pred CCccccccccceeeccCCCCCccccCCHHHhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCC
Confidence 99999865433221 1223456799999987 4557889999999999999998 99999877665554443 34455
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+.+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 666778899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.31 Aligned_cols=247 Identities=38% Similarity=0.672 Sum_probs=201.2
Q ss_pred eEEEEeeecCcEEEEEEEEC------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 583 EELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 583 qilk~LG~GafG~VYka~~~------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.+.+.||.|+||.||+|.+. +..|+||+++... .......|.+|++.+++++||||++++|++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------ccccceeeeecccccccccccccccccccccccc
Confidence 46789999999999999997 5679999995421 1223567889999999999999999999999543
Q ss_pred CCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..++||||+++++|.+++... ...+++..++.|+.||+.||.|||+++++|++|++.|||++.++ .+||+|||
T Consensus 75 --~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~----~~Kl~~f~ 148 (259)
T PF07714_consen 75 --PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG----QVKLSDFG 148 (259)
T ss_dssp --SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT----EEEEESTT
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccc
Confidence 689999999999999999776 56799999999999999999999999999999999999999755 56999999
Q ss_pred CcccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 736 LSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 736 LA~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
++..... ............|+|||.+.+ ..++.++||||||+++|||++ |+.||...........+ ....+.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~ 225 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLP 225 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETT
T ss_pred ccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-cccccce
Confidence 9986521 112233446778999999983 447999999999999999999 78999888777766665 4445566
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.+..++..+.++|.+||..+|.+||++.++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 7778999999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.27 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=197.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC--
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 656 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~-- 656 (867)
+|++.+.||+|+||.||+|.+ ++..||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 588999999999999999987 4788999998643211 112346789999999999999999999875432
Q ss_pred -CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 -GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 -~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
...+++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 75 ~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~----~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK----LKICDFG 148 (338)
T ss_pred CCceEEEEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc----EEEccCc
Confidence 23589999999 5788887753 346899999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh------
Q 002908 736 LSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN------ 805 (867)
Q Consensus 736 LA~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~------ 805 (867)
+++..... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99743221 11233568999999999875445678899999999999999999999976543222111100
Q ss_pred --------------------cCCCCCC---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 806 --------------------NTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 806 --------------------~~lr~~i---p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.....+. ...+++.+.+++.+||+.+|++|||+.+++++-+-
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 0000000 11356788999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.54 Aligned_cols=254 Identities=35% Similarity=0.612 Sum_probs=210.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.+..++|++.+.||+|++|.||+|.+. +..||||.++.... ....+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---------DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 456788999999999999999999874 56799999864321 12457889999999999999999999887
Q ss_pred CCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++. ++|+|
T Consensus 73 ~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~~l~d 146 (261)
T cd05068 73 EE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI----CKVAD 146 (261)
T ss_pred CC--CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC----EEECC
Confidence 54 7899999999999999986543 56899999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCcccc--CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTLVT--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~~~--s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||++......... .....+..|+|||++. ...++.++||||||+++|+|++ |+.||...........+. .....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 223 (261)
T cd05068 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAAL--YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRM 223 (261)
T ss_pred cceEEEccCCcccccCCCcCceeccCccccc--cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 9999865432211 1222345799999987 4457889999999999999999 999998877666555443 34445
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 5666788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.96 Aligned_cols=250 Identities=24% Similarity=0.277 Sum_probs=197.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||+++++ ++.||||+++..... +.....+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN------EEVKETTLRELKMLRTLKQENIVELKEAFRRRG- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc------ccchhhHHHHHHHHHhCCCccccchhhhEecCC-
Confidence 36899999999999999999984 678999999754221 122356778999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||++++.+..+. .....+++..++.++.|++.||.|||+.||+||||||+|||++.++. ++|+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~----~kl~Dfg~~ 147 (287)
T cd07848 74 -KLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV----LKLCDFGFA 147 (287)
T ss_pred -EEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc----EEEeeccCc
Confidence 899999999887665443 34456899999999999999999999999999999999999987664 599999999
Q ss_pred ccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC--------
Q 002908 738 KIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 807 (867)
Q Consensus 738 ~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-------- 807 (867)
....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccccccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 8643221 2223468999999999984 457889999999999999999999998765433322211100
Q ss_pred -----------CCCC-----------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 808 -----------LRPP-----------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 808 -----------lr~~-----------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
...+ ....++..+.+||.+||+.+|++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 012357789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.31 Aligned_cols=244 Identities=26% Similarity=0.387 Sum_probs=202.4
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 586 k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
+.||+|+||.||++.. .|..||+|+++..... .+.....+.+|+.+++.++||||++++++|.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEE
Confidence 3699999999999987 4788999999754221 1223456778999999999999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-cC
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~-~~ 742 (867)
|||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++... ..
T Consensus 74 ~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~----~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH----IKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC----EEecccHHhccccCC
Confidence 999999999887754 356899999999999999999999999999999999999997664 599999998743 22
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+..... ..+..+++.+.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~ 224 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRTLSPEAKS 224 (323)
T ss_pred CCccccccCCcCcCCccccc--CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 22223456899999999998 45678899999999999999999999988776666665554433 345678999999
Q ss_pred HHHHhhcCCCCCCC-----CHHHHHHHH
Q 002908 823 LMEQCWAPDPVVRP-----SFTEIARRL 845 (867)
Q Consensus 823 LI~kCLq~DPeeRP-----Sa~ELLe~L 845 (867)
+|.+||+.+|.+|| ++.+++++-
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 99999999999998 899988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.08 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=205.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||+|++ +++.||||+++..... .......+.+|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 4789999999999999999998 4788999999753211 1223456778999999999999999999998855
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~----~kl~Dfg~~ 148 (364)
T cd05599 75 -YLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLC 148 (364)
T ss_pred -eEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC----EEEeecccc
Confidence 899999999999999988643 46899999999999999999999999999999999999997664 599999998
Q ss_pred ccccCcc---------------------------------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHH
Q 002908 738 KIKRNTL---------------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFG 778 (867)
Q Consensus 738 ~~~~~~~---------------------------------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLG 778 (867)
....... ......||+.|+|||++. ...++.++||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG 226 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--QTGYNKECDWWSLG 226 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc--CCCCCCeeeeecch
Confidence 6432110 001245899999999997 45678999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC--CCCCcHHHHHHHHHhhcCCCCCCCC---HHHHHHHHH
Q 002908 779 IVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PGFCDSEWRLLMEQCWAPDPVVRPS---FTEIARRLR 846 (867)
Q Consensus 779 vLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i--p~~~s~eL~dLI~kCLq~DPeeRPS---a~ELLe~Lq 846 (867)
|++|+|++|..||...........+......... ...+++.+.++|.+||. +|.+|++ +.+++.+.+
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 9999999999999887766666555543322222 23468999999999997 8999987 999988753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.83 Aligned_cols=252 Identities=27% Similarity=0.348 Sum_probs=197.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC---CCCceeeEecccc
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQ 653 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L---~HPNIVrL~g~~~ 653 (867)
.+|++.+.||+|+||.||+|++. ++.||||+++........ ...+.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc------hHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36899999999999999999872 577999998754322211 13345666666655 6999999999875
Q ss_pred c---CCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 654 D---GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 654 ~---~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
. .....+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~----~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----I 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC----E
Confidence 3 22347899999995 6888887543 345899999999999999999999999999999999999997664 5
Q ss_pred EEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 730 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
+|+|||++.............||+.|+|||++. ...++.++|||||||++|+|++|++||........+..+......
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 150 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred EEccccceEeccCCcccccccccccccChHHHh--CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 999999998655444444566899999999997 445788999999999999999999999887665555444332110
Q ss_pred C-------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 P-------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 ~-------------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+ .....++..+.+++.+||+.+|++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 0012356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.17 Aligned_cols=241 Identities=28% Similarity=0.455 Sum_probs=212.4
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
...++|+.++.||.|+||.|.+++. .|..+|+|++.+... .....+.....|..+|+.+.||.++++++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-----VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-----VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-----HHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 4557889999999999999999988 478899999976432 223344556789999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++||||++||.|..++++. ++|++..+..++.||+.||+|||+++|++|||||+|||+|.+|.. ||+||
T Consensus 116 ~~--~lymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~i----KitDF 188 (355)
T KOG0616|consen 116 NS--NLYMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHI----KITDF 188 (355)
T ss_pred CC--eEEEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcE----EEEec
Confidence 55 999999999999999999654 569999999999999999999999999999999999999988765 99999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
|+|+..... +...||||.|+|||++. ...+..++|+||||+++|||+.|.+||.......+..+++.+.+. .|.
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~--sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~ 262 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQ--SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPS 262 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhh--cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCc
Confidence 999966554 45688999999999999 566888999999999999999999999999888899999988765 567
Q ss_pred CCcHHHHHHHHHhhcCCCCCC
Q 002908 815 FCDSEWRLLMEQCWAPDPVVR 835 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeR 835 (867)
..+..+++|++.+|+.|-.+|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 889999999999999999999
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=336.28 Aligned_cols=262 Identities=30% Similarity=0.506 Sum_probs=210.9
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCcee
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 646 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIV 646 (867)
|.+..++|++.+.||.|+||.||+|.+. ++.||+|+++.... ......+.+|+.++.++ +|+||+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~E~~~~~~l~~h~niv 74 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-------ASEYKALMTELKILIHIGHHLNVV 74 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-------HHHHHHHHHHHHHHHhhccCcchh
Confidence 4567789999999999999999999753 36799999864321 11234577899999999 899999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhccc----------------------------------------------
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 680 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------------------------------------- 680 (867)
+++++|... +..++++|||+++++|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 75 NLLGACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred heeeeEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 999988653 347889999999999998875321
Q ss_pred --------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc---
Q 002908 681 --------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--- 743 (867)
Q Consensus 681 --------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~--- 743 (867)
..+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++......
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~----~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDY 229 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC----cEEEeccccchhcccCcch
Confidence 2578999999999999999999999999999999999999655 4699999999854221
Q ss_pred cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 744 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 744 ~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
.......++..|+|||++. ...++.++|||||||++|+|++ |..||.....................+..+++.+.+
T Consensus 230 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 230 VRKGDARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred hhccCCCCCccccCcHHhc--CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHH
Confidence 1122334567899999998 4568889999999999999998 999997755444444444444555556677899999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 823 LMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
++.+||+.+|++||++.+++++|..+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.17 Aligned_cols=242 Identities=26% Similarity=0.382 Sum_probs=200.6
Q ss_pred eeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 588 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 588 LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
||+|+||.||++.+. ++.||||+++..... .......+.+|+.++.+++||||+++++++.... ..++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEc
Confidence 699999999999984 678999999753211 1223456788999999999999999999998754 8999999
Q ss_pred eecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-Ccc
Q 002908 666 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTL 744 (867)
Q Consensus 666 y~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~-~~~ 744 (867)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.... ...
T Consensus 74 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~----~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH----IALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc----EEEEECcccccCccCCC
Confidence 9999999998864 346899999999999999999999999999999999999997664 5999999997532 222
Q ss_pred ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHH
Q 002908 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM 824 (867)
Q Consensus 745 ~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI 824 (867)
......||+.|+|||++. ...++.++|||||||++|+|++|..||...........+.... ...+..+++.+.++|
T Consensus 149 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 224 (312)
T cd05585 149 KTNTFCGTPEYLAPELLL--GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--LRFPDGFDRDAKDLL 224 (312)
T ss_pred ccccccCCcccCCHHHHc--CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHH
Confidence 334456999999999998 4567889999999999999999999998877766666655543 344567889999999
Q ss_pred HHhhcCCCCCCCC---HHHHHHHH
Q 002908 825 EQCWAPDPVVRPS---FTEIARRL 845 (867)
Q Consensus 825 ~kCLq~DPeeRPS---a~ELLe~L 845 (867)
.+||+.+|.+||+ +.+++.+.
T Consensus 225 ~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 225 IGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred HHHcCCCHHHcCCCCCHHHHHcCC
Confidence 9999999999974 67777653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=365.90 Aligned_cols=267 Identities=36% Similarity=0.602 Sum_probs=231.7
Q ss_pred ccccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc
Q 002908 572 STLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 644 (867)
Q Consensus 572 ~~l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN 644 (867)
.....++..+.+..+.||+|+||+||+|+.. ..-||||.++.. .+.....+|.+|+++|..++|||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-------a~~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-------AENQARQDFRREAELLAELQHPN 550 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-------ccHHHHHHHHHHHHHHHhccCCC
Confidence 3456788899999999999999999999873 234999999853 23335688999999999999999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------c----cCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------R----HLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 711 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------~----~Lse~~~l~Ia~QIa~ALayLHs~GIIHrD 711 (867)
||+++|+|.+++ .+++|+|||..|+|.++|.... . +++..+.+.|+.|||.||.||-++.+||||
T Consensus 551 IVrLlGVC~~~~--P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRD 628 (774)
T KOG1026|consen 551 IVRLLGVCREGD--PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRD 628 (774)
T ss_pred eEEEEEEEccCC--eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccc
Confidence 999999999966 8999999999999999995422 2 388999999999999999999999999999
Q ss_pred CCCcceEeccCCCCCCcEEEeecCCccc-ccCcccc--CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-C
Q 002908 712 LKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVT--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 787 (867)
Q Consensus 712 LKPsNILLd~dg~~~~~vKL~DFGLA~~-~~~~~~~--s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-G 787 (867)
|-..|+||.+ ...|||+|||+++. |...... +...-+.+|||||.+. ..+++.+||||||||+|||+++ |
T Consensus 629 LATRNCLVge----~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl--y~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 629 LATRNCLVGE----NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL--YGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred hhhhhceecc----ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh--cCcccchhhhhhhhhhhhhhhccc
Confidence 9999999984 45779999999983 3322211 1233568999999999 7889999999999999999999 9
Q ss_pred CCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 788 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 788 k~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
+.||.+..+.+.+.-+..+.. .+.|..||.+++.||..||+.+|.+||+|+||-..|+....+...
T Consensus 703 ~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 703 KQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred cCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 999999999999998888887 899999999999999999999999999999999999998766543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=331.00 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=201.5
Q ss_pred eeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHH---HhCCCCceeeEecccccCC
Q 002908 582 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL---SKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiL---k~L~HPNIVrL~g~~~~~~ 656 (867)
|++++.||+|+||.||+|.+. ++.||||+++...... ......+.+|+.++ +.++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-----RDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 678899999999999999884 7889999997542211 11233455565554 5678999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 76 --~~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~----~kL~Dfg~ 147 (324)
T cd05589 76 --HVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF----VKIADFGL 147 (324)
T ss_pred --EEEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc----EEeCcccC
Confidence 8999999999999988774 346899999999999999999999999999999999999997764 59999999
Q ss_pred ccccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 737 SKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 737 A~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
+.... .........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... ..+..
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--~~p~~ 223 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--RYPRF 223 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCC
Confidence 87432 2222334668999999999984 4578899999999999999999999998877776666655433 34566
Q ss_pred CcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRP-----SFTEIARRL 845 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~L 845 (867)
++..+.++|.+||+.+|.+|| ++.+++++.
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 899999999999999999999 678887764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=335.64 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=202.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||+||++.. +++.||||+++.... ........+.+|+.++..++||||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 4789999999999999999988 478899999975321 11223456778999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~----vkL~DFGla 148 (363)
T cd05628 75 -NLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH----VKLSDFGLC 148 (363)
T ss_pred -eEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC----EEEeeccCc
Confidence 899999999999999988643 56899999999999999999999999999999999999997664 599999998
Q ss_pred ccccCcc------------------------------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHH
Q 002908 738 KIKRNTL------------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVL 781 (867)
Q Consensus 738 ~~~~~~~------------------------------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLL 781 (867)
+...... .....+||+.|+|||++. ...++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~~DvwSlGvil 226 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM--QTGYNKLCDWWSLGVIM 226 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc--CCCCCCchhhhhhHHHH
Confidence 7432110 012346999999999998 44578899999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHhHhhcCCC--CCCCCCCcHHHHHHHHHhhcC--CCCCCCCHHHHHHH
Q 002908 782 WEILTGEEPYANMHYGAIIGGIVNNTLR--PPVPGFCDSEWRLLMEQCWAP--DPVVRPSFTEIARR 844 (867)
Q Consensus 782 yELLTGk~PF~~~~~~e~l~~iv~~~lr--~~ip~~~s~eL~dLI~kCLq~--DPeeRPSa~ELLe~ 844 (867)
|+|++|+.||...........+...... .+....+++.+.++|.+|+.. ++..||++.+|+++
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999999999887776666666543222 222234688999999986642 23346899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=318.81 Aligned_cols=255 Identities=33% Similarity=0.550 Sum_probs=206.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
.+..++|++.+.||+|+||.||+|.+. +..||||++.... ......++.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~iv~~ 74 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 456788999999999999999999864 3469999875321 11223568899999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEe
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 719 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILL 719 (867)
++++.... ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+|||+
T Consensus 75 ~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~ 152 (277)
T cd05062 75 LGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 152 (277)
T ss_pred EEEEcCCC--CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE
Confidence 99997754 8899999999999999885422 235788899999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEeecCCcccccCccc---cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002908 720 NLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795 (867)
Q Consensus 720 d~dg~~~~~vKL~DFGLA~~~~~~~~---~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~ 795 (867)
+.++. ++|+|||++........ .....+++.|+|||++. ...++.++|||||||++|+|++ |..||....
T Consensus 153 ~~~~~----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 153 AEDFT----VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred cCCCC----EEECCCCCccccCCcceeecCCCCccCHhhcChhHhh--cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 97654 59999999874332111 11223567899999998 4557889999999999999999 789998877
Q ss_pred hhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 796 ~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.......+.... ....+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 227 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 227 NEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 666555444433 34456678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=334.65 Aligned_cols=243 Identities=27% Similarity=0.382 Sum_probs=201.9
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEE
Q 002908 587 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 664 (867)
Q Consensus 587 ~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVm 664 (867)
.||+|+||.||++.. .++.||||++...... .......+.+|+.+++.++||||+++++++.... .+++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~ 74 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFVM 74 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEEE
Confidence 699999999999987 4788999999754221 1223456788999999999999999999998754 899999
Q ss_pred EeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-Cc
Q 002908 665 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NT 743 (867)
Q Consensus 665 Ey~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~-~~ 743 (867)
||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++.... ..
T Consensus 75 Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~----~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 75 EYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH----IKITDFGLCKEGITDA 149 (328)
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc----EEEecCcCCccCCCcc
Confidence 99999999888754 456899999999999999999999999999999999999997664 5999999987532 22
Q ss_pred cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHH
Q 002908 744 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLL 823 (867)
Q Consensus 744 ~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dL 823 (867)
.......||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.... ...+..++..+.+|
T Consensus 150 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l 225 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKSL 225 (328)
T ss_pred cccccccCCcCccChhhhc--CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHHH
Confidence 2233456999999999998 4457889999999999999999999998877666555544332 34566789999999
Q ss_pred HHHhhcCCCCCCC-----CHHHHHHHH
Q 002908 824 MEQCWAPDPVVRP-----SFTEIARRL 845 (867)
Q Consensus 824 I~kCLq~DPeeRP-----Sa~ELLe~L 845 (867)
|.+||+.+|.+|| ++.+++++.
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 9999999999997 899998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.31 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=206.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||+|++ +++.||||.++..... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-----DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN- 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-----CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-
Confidence 5789999999999999999987 5788999988653221 1233456788999999999999999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 658 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++++|+||+|+|||++.++. ++|+||
T Consensus 76 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~----~~l~d~ 150 (267)
T cd08228 76 -ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV----VKLGDL 150 (267)
T ss_pred -eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC----EEECcc
Confidence 88999999999999887742 2345889999999999999999999999999999999999987654 599999
Q ss_pred CCcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHHhHhhcCCCCC
Q 002908 735 GLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNNTLRPP 811 (867)
Q Consensus 735 GLA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~--~e~l~~iv~~~lr~~ 811 (867)
|++....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ......+........
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC
Confidence 9987544322 2223458889999999974 4578899999999999999999999865432 233333332233332
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
....++..+.++|.+||+.+|.+||++.++++.|+.++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 33457788999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.54 Aligned_cols=254 Identities=30% Similarity=0.466 Sum_probs=210.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
+.|++.+.||.|++|.||++.. .+..||||.+...... .........+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 4688889999999999999987 4788999998754321 112223456889999999999999999999998855
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++
T Consensus 78 -~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~----~~l~dfg~~ 151 (263)
T cd06625 78 -TLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN----VKLGDFGAS 151 (263)
T ss_pred -eEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC----EEEeecccc
Confidence 99999999999999988854 346889999999999999999999999999999999999997664 599999998
Q ss_pred ccccCcccc----CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 738 KIKRNTLVT----GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 738 ~~~~~~~~~----s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
......... ....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.....................+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred eeccccccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 754322111 23457789999999984 447889999999999999999999998766655555555555566677
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..++..+.++|.+||..+|.+|||+.+++.+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 78899999999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.69 Aligned_cols=251 Identities=36% Similarity=0.613 Sum_probs=206.6
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~G-~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..++|++.+.||+|+||.||++.+.+ ..+|||.++..... ...|.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---------HHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45679999999999999999998865 45999988643211 245788999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+.+++|.+++......+++..++.++.||+.||+|||+.|++|+||+|.|||++.++ .++|+|||.
T Consensus 73 --~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~----~~kl~d~g~ 146 (256)
T cd05113 73 --PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG----CVKVSDFGL 146 (256)
T ss_pred --CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC----CEEECCCcc
Confidence 78999999999999999876555789999999999999999999999999999999999998655 469999999
Q ss_pred cccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 737 SKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 737 A~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
+....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.. ..+...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 223 (256)
T cd05113 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRP 223 (256)
T ss_pred ceecCCCceeecCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCC
Confidence 87543221 1122335678999999973 457889999999999999999 9999987776655555443 3344455
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
...+..+.+++.+||+.+|.+||++.+|+..|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 667899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.24 Aligned_cols=252 Identities=36% Similarity=0.610 Sum_probs=208.8
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
.+...+|++.+.||+|+||.||++...+..||+|.++... ....+.+|+.++++++|+|++++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 3566789999999999999999999999999999985321 134678899999999999999999976442
Q ss_pred CCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++. ++|+||
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~----~kl~df 146 (256)
T cd05082 72 -KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV----AKVSDF 146 (256)
T ss_pred -CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc----EEecCC
Confidence 337899999999999999986543 35889999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
|++....... ....++..|+|||++. ...++.++|||||||++|+|++ |+.||...........+. .......+
T Consensus 147 g~~~~~~~~~--~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 221 (256)
T cd05082 147 GLTKEASSTQ--DTGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAP 221 (256)
T ss_pred ccceeccccC--CCCccceeecCHHHHc--cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCC
Confidence 9987543322 2233567899999987 4457889999999999999998 999998776655544433 33445556
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..+++.+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 6789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.25 Aligned_cols=258 Identities=31% Similarity=0.583 Sum_probs=210.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCc----eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~----~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+...+|++.+.||+|+||+||+|.+ ++. .||||+++... ......++.+|+.++..+.||||++++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-------SPKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-------CHHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 46678899999999999999999987 343 48999986432 122345688899999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++... ..+++|+|+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++. +
T Consensus 76 ~~~~~~---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~----~ 148 (279)
T cd05109 76 GICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH----V 148 (279)
T ss_pred EEEcCC---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc----E
Confidence 998753 467899999999999998765667999999999999999999999999999999999999986654 5
Q ss_pred EEeecCCcccccCccc---cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~---~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
+|+|||+++....... .....++..|+|||.+. ...++.++|||||||++|||++ |..||.......... ...
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~ 225 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESIL--HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLE 225 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHH
Confidence 9999999985532221 11223467899999997 4457889999999999999998 999998766544433 333
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.....+.+..++..+.+++.+||+.+|+.||++.+++..|..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 444455566788999999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=346.68 Aligned_cols=255 Identities=22% Similarity=0.241 Sum_probs=200.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.....+|++.+.||+|+||.||+|.+ .++.||||.+.... ....+|+.+++.++||||+++++++.
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~ 129 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYY 129 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEe
Confidence 34557899999999999999999988 47889999885321 12346899999999999999988764
Q ss_pred cC------CCCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC
Q 002908 654 DG------PGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 654 ~~------~~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~ 724 (867)
.. ....+++||||++ ++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 130 ~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 130 TECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred ecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC
Confidence 31 1235779999996 567666532 3467899999999999999999999999999999999999986542
Q ss_pred CCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHh
Q 002908 725 IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804 (867)
Q Consensus 725 ~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv 804 (867)
.+||+|||+++............||+.|+|||++.+ ...++.++|||||||+||+|++|.+||.+......+..+.
T Consensus 209 ---~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 209 ---TLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG-ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred ---ceeeeccccchhccCCCCcccCCCCcCccCHHHhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 369999999986544333344568999999999874 2357889999999999999999999998866544443332
Q ss_pred hcCC---------------------------CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 805 NNTL---------------------------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 805 ~~~l---------------------------r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.... ....+...++++.+||.+||+.+|.+|||+.+++.+.+-
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 2100 011233467889999999999999999999999987663
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=338.32 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=202.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
+.|++++.||+|+||+||+|.+ ++..||||++...... .......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~- 74 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-----NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-
Confidence 3688999999999999999988 4678999999753211 2233456889999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++... ..+++..+..++.||+.||.|||..||+||||||+|||++.++ .++|+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~----~~kL~DFGl~ 148 (381)
T cd05626 75 -NLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG----HIKLTDFGLC 148 (381)
T ss_pred -EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC----CEEEeeCcCC
Confidence 899999999999999988643 4588999999999999999999999999999999999998665 4699999997
Q ss_pred ccccCc------------------------------------------------cccCCcCCCCCccCccccccCCCCCC
Q 002908 738 KIKRNT------------------------------------------------LVTGGVRGTLPWMAPELLNGSSSKVS 769 (867)
Q Consensus 738 ~~~~~~------------------------------------------------~~~s~~~GT~~Y~APEvl~g~~~~~S 769 (867)
...... .......||+.|+|||++. ...++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~ 226 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL--RKGYT 226 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc--CCCCC
Confidence 532100 0012346999999999998 44578
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC--CCCCCCCCCcHHHHHHHHH--hhcCCCCCCCCHHHHHHHH
Q 002908 770 EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--LRPPVPGFCDSEWRLLMEQ--CWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 770 ~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~--lr~~ip~~~s~eL~dLI~k--CLq~DPeeRPSa~ELLe~L 845 (867)
.++|||||||++|+|++|..||...........+.... ...+....+++++.+||.+ |+..++..||++.+++.+.
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 89999999999999999999998876655555544322 2333334578999999998 4455666699999999875
Q ss_pred H
Q 002908 846 R 846 (867)
Q Consensus 846 q 846 (867)
+
T Consensus 307 ~ 307 (381)
T cd05626 307 F 307 (381)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=346.83 Aligned_cols=256 Identities=28% Similarity=0.388 Sum_probs=214.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|+++++||+|+||.||+|+- +|..+|+|++++..+-. ...+.-.+.|..+|....+|+||++|..|+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-----~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-----KNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-----hhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 45678999999999999999999987 58889999999865432 223455678999999999999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. ++||||||++||++..+|.. ...|++..+..++.+++.|+..||+.|+|||||||+|+|||..|++ ||+|
T Consensus 212 D~~--~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHi----KLSD 284 (550)
T KOG0605|consen 212 DKE--YLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHI----KLSD 284 (550)
T ss_pred CCC--eeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCE----eecc
Confidence 976 99999999999999998864 4569999999999999999999999999999999999999987765 9999
Q ss_pred cCCcccccC-----------------------ccc-----c--------------------CCcCCCCCccCccccccCC
Q 002908 734 FGLSKIKRN-----------------------TLV-----T--------------------GGVRGTLPWMAPELLNGSS 765 (867)
Q Consensus 734 FGLA~~~~~-----------------------~~~-----~--------------------s~~~GT~~Y~APEvl~g~~ 765 (867)
||++..... ... . ....|||.|||||++.+
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-- 362 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-- 362 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--
Confidence 999852100 000 0 01349999999999995
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC--CCCCCCCCCcHHHHHHHHHhhcCCCCCCC---CHHH
Q 002908 766 SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--LRPPVPGFCDSEWRLLMEQCWAPDPVVRP---SFTE 840 (867)
Q Consensus 766 ~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~--lr~~ip~~~s~eL~dLI~kCLq~DPeeRP---Sa~E 840 (867)
..|+..+|+|||||+|||||.|.+||...+..+.+.+++.-. +..|....++++..+||.+||. ||+.|. .++|
T Consensus 363 kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 363 KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 458889999999999999999999999999999888887655 4444455678999999999999 999995 6788
Q ss_pred HHHHHH
Q 002908 841 IARRLR 846 (867)
Q Consensus 841 LLe~Lq 846 (867)
|.+|..
T Consensus 442 IK~HPf 447 (550)
T KOG0605|consen 442 IKKHPF 447 (550)
T ss_pred HhcCCc
Confidence 766543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.41 Aligned_cols=250 Identities=36% Similarity=0.638 Sum_probs=205.8
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
...+|++.+.||+|+||.||++.+. +..+|||++...... ...+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3456888999999999999999885 457999998643211 235778999999999999999999987754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||+
T Consensus 73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~----~kl~dfg~ 146 (256)
T cd05059 73 --PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV----VKVSDFGL 146 (256)
T ss_pred --ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc----EEECCccc
Confidence 889999999999999998765567899999999999999999999999999999999999997654 59999999
Q ss_pred cccccCcccc--CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 737 SKIKRNTLVT--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 737 A~~~~~~~~~--s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
++........ ....++..|+|||.+. ...++.++||||||+++|+|++ |..||...........+. ...+...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 223 (256)
T cd05059 147 ARYVLDDQYTSSQGTKFPVKWAPPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRP 223 (256)
T ss_pred ceecccccccccCCCCCCccccCHHHhc--cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 8754332111 1222345799999998 3457889999999999999999 899998776655554433 34455566
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..++..+.+++.+||..+|.+|||+.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 67899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.47 Aligned_cols=258 Identities=35% Similarity=0.547 Sum_probs=208.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--Cc--eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 653 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~--~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~ 653 (867)
+++|++.+.||+|+||.||+|.+. +. .+++|.++... .......+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence 468999999999999999999874 32 47888876321 112235678899999999 7999999999988
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceE
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 718 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNIL 718 (867)
... ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil 151 (297)
T cd05089 74 NRG--YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVL 151 (297)
T ss_pred cCC--cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEE
Confidence 754 7899999999999999885422 35889999999999999999999999999999999999
Q ss_pred eccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChh
Q 002908 719 VNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 797 (867)
Q Consensus 719 Ld~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~ 797 (867)
++.++. ++|+|||++..............+..|+|||++. ...++.++|||||||++|+|++ |..||......
T Consensus 152 l~~~~~----~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~ 225 (297)
T cd05089 152 VGENLA----SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN--YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225 (297)
T ss_pred ECCCCe----EEECCcCCCccccceeccCCCCcCccccCchhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 987654 5999999987433222222222356799999987 4457889999999999999997 99999887766
Q ss_pred HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 798 e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
.....+. .....+.+..++..+.+|+.+||+.+|.+||++.++++.|..+...-
T Consensus 226 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 226 ELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 6555543 33455566678999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.67 Aligned_cols=255 Identities=34% Similarity=0.572 Sum_probs=206.7
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
+..++|++.+.||+|+||.||+|.+ .+..||+|.++... .......+.+|+.+++.++||||+++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEE
Confidence 3457889999999999999999985 24679999986431 1122356788999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcc----------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCC
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSK----------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC 714 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~----------------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKP 714 (867)
++.... ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||
T Consensus 75 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 152 (283)
T cd05090 75 VVTQEQ--PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAA 152 (283)
T ss_pred EEecCC--ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhcccc
Confidence 988754 789999999999999988532 13478899999999999999999999999999999
Q ss_pred cceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCC
Q 002908 715 DNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP 790 (867)
Q Consensus 715 sNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~P 790 (867)
+|||++.++ .++|+|||+++..... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 153 ~nili~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p 226 (283)
T cd05090 153 RNILIGEQL----HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQP 226 (283)
T ss_pred ceEEEcCCC----cEEeccccccccccCCcceecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 999999665 4599999999754221 12223345678999999973 457889999999999999998 9999
Q ss_pred CCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 791 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 791 F~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
|...........+ ......+.+..+++.+.+++.+||+.+|.+||++.+|+++|..
T Consensus 227 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 227 YYGFSNQEVIEMV-RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 9876655444443 3333455667789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=335.06 Aligned_cols=254 Identities=29% Similarity=0.457 Sum_probs=201.3
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|+.++.||+|+||.||+|.+. ++.||||++.... .+.....+.+|+.+++.++|+||+++++++...
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-------cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 3467888999999999999999984 7889999986431 223346788999999999999999999999874
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. .+++||||+.+++|.... ...+..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 145 ~--~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~----~kL~DfG 213 (353)
T PLN00034 145 G--EIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN----VKIADFG 213 (353)
T ss_pred C--eEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC----EEEcccc
Confidence 4 899999999999986532 3567788899999999999999999999999999999997654 5999999
Q ss_pred CcccccCcc-ccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHhHhhcCC
Q 002908 736 LSKIKRNTL-VTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNNTL 808 (867)
Q Consensus 736 LA~~~~~~~-~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---e~l~~iv~~~l 808 (867)
++....... ......||..|+|||++... ....+.++|||||||++|+|++|+.||...... ..... .....
T Consensus 214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-~~~~~ 292 (353)
T PLN00034 214 VSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA-ICMSQ 292 (353)
T ss_pred cceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-HhccC
Confidence 998644322 22345689999999998531 223456899999999999999999999743222 11212 11223
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
....+..++..+.+||.+||+.+|++||++.+++++-+-...
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 344556788999999999999999999999999998765543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=352.21 Aligned_cols=267 Identities=38% Similarity=0.625 Sum_probs=233.2
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC---C--ce-EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceee
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR---G--TD-VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~---G--~~-VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVr 647 (867)
.|++.-++..+.++||+|+||.||+|+++ + .. ||||..+... ...+....+|++|+++++.++|||||+
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-----~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-----ELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-----cccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 45677778888899999999999999983 2 13 8999987532 223556789999999999999999999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
+||++.... .++||||+|.||+|.++|......++..+.+.++.+.+.||+|||++++|||||-+.|+|++.++
T Consensus 226 ~yGVa~~~~--Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~---- 299 (474)
T KOG0194|consen 226 FYGVAVLEE--PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG---- 299 (474)
T ss_pred EEEEEcCCC--ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC----
Confidence 999998855 89999999999999999987777899999999999999999999999999999999999999654
Q ss_pred cEEEeecCCcccccCccccC-CcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 728 ICKVGDFGLSKIKRNTLVTG-GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~~~s-~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
.+||+|||+++......... ...-+..|+|||.+. ...++.++|||||||++||+++ |..||.++...+....+..
T Consensus 300 ~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~--~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLN--TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred eEEeCccccccCCcceeeccccccCcceecChhhhc--cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 36999999998654332222 223568899999998 5589999999999999999999 8899999999999999889
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
..++.+.+...+..+..++.+||..+|++||+|.++.+.|+.+.....
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 999999999999999999999999999999999999999999877655
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=352.13 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=213.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~ 652 (867)
.+..++|.++++||+|.||+|+++..+ +..+|||++++...-.+. .+.....|.+++...+ ||.|+.++..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d-----~Ve~~~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD-----EVESLMCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc-----cHHHHHHHHHHHHHhccCCeEeeccccc
Confidence 567789999999999999999999985 567999999987554322 2345667888888775 99999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
++.. ++|+||||+.||++..+ .....|++..+..++..|+.||.|||++||||||||.+|||+|.+|.. ||+
T Consensus 439 QT~~--~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~----kiA 510 (694)
T KOG0694|consen 439 QTKE--HLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHV----KIA 510 (694)
T ss_pred ccCC--eEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcE----Eec
Confidence 9966 99999999999994433 355679999999999999999999999999999999999999987754 999
Q ss_pred ecCCcccc-cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 733 DFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 733 DFGLA~~~-~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
|||+++.. .....++++|||+.|||||++. ...|+.++|+|||||+|||||.|..||.+.+.++....++.....
T Consensus 511 DFGlcKe~m~~g~~TsTfCGTpey~aPEil~--e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~-- 586 (694)
T KOG0694|consen 511 DFGLCKEGMGQGDRTSTFCGTPEFLAPEVLT--EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR-- 586 (694)
T ss_pred ccccccccCCCCCccccccCChhhcChhhhc--cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC--
Confidence 99999843 2445677899999999999999 567899999999999999999999999999999999998877654
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSF 838 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa 838 (867)
.|..++.+...+|+++|..+|++|..+
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCC
Confidence 466789999999999999999999644
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=322.89 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=205.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|++.+.||+|+||.||++.+ +++.||||++...... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-----hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 478899999999999999987 4788999998653221 1222345678999999999999999999998755
Q ss_pred eEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|..++... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~----~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH----IRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC----EEEeeCCCc
Confidence 899999999999999887543 346899999999999999999999999999999999999986654 599999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh--cCCCCCCCCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--NTLRPPVPGF 815 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~--~~lr~~ip~~ 815 (867)
.............|++.|+|||++. ...++.++|||||||++|+|++|..||...........+.. .......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVK--NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhc--CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc
Confidence 8654333333456899999999997 45578899999999999999999999987654332222211 1123334556
Q ss_pred CcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLRV 847 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq~ 847 (867)
++..+.+|+.+||+.||.+|| ++.+++.+.+-
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence 789999999999999999999 89999887443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.10 Aligned_cols=257 Identities=32% Similarity=0.574 Sum_probs=208.0
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
+..++|++.+.||+|++|.||+|.+.+ ..||+|.+.... .......|.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 456789999999999999999998843 568888875321 122235688899999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhccc------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCC
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 723 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg 723 (867)
+++.+.. ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|||++.++
T Consensus 76 ~~~~~~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 76 GVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153 (277)
T ss_pred EEEccCC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC
Confidence 9887754 7789999999999999885432 2589999999999999999999999999999999999998765
Q ss_pred CCCCcEEEeecCCcccccCccc---cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 002908 724 PIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 799 (867)
Q Consensus 724 ~~~~~vKL~DFGLA~~~~~~~~---~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~ 799 (867)
. ...++|+|||+++....... ......+..|+|||++. ...++.++|||||||++|+|++ |..||........
T Consensus 154 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 154 P-GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL--DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred C-CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHh--cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 3 34679999999985432211 11222356799999997 4558899999999999999997 9999988776655
Q ss_pred HHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 800 l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
... +........+..++..+.+++.+||+.+|.+||++.+++++|+
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 MEF-VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHH-HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 443 3333445556678899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=338.26 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=202.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||.||++.+ +++.||||++..... ........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~- 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ- 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 4789999999999999999988 478899999865321 12223456788999999999999999999998855
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~----~kl~DfGla 148 (377)
T cd05629 75 -YLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH----IKLSDFGLS 148 (377)
T ss_pred -eeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC----EEEeecccc
Confidence 89999999999999998864 356899999999999999999999999999999999999986654 599999998
Q ss_pred ccccCcc------------------------------------------------ccCCcCCCCCccCccccccCCCCCC
Q 002908 738 KIKRNTL------------------------------------------------VTGGVRGTLPWMAPELLNGSSSKVS 769 (867)
Q Consensus 738 ~~~~~~~------------------------------------------------~~s~~~GT~~Y~APEvl~g~~~~~S 769 (867)
+...... ......||+.|+|||++. ...++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~ 226 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL--QQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc--cCCCC
Confidence 6321100 001245899999999998 45578
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC--CCCcHHHHHHHHHhhcCCCCCC---CCHHHHHHH
Q 002908 770 EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--GFCDSEWRLLMEQCWAPDPVVR---PSFTEIARR 844 (867)
Q Consensus 770 ~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip--~~~s~eL~dLI~kCLq~DPeeR---PSa~ELLe~ 844 (867)
.++|||||||++|+|++|..||...........+.........+ ..++..+.+||.+||. +|.+| +++.+++.+
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999999999999998776655555554422222223 3578899999999997 66665 699999988
Q ss_pred HH
Q 002908 845 LR 846 (867)
Q Consensus 845 Lq 846 (867)
.+
T Consensus 306 p~ 307 (377)
T cd05629 306 PF 307 (377)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=316.25 Aligned_cols=254 Identities=34% Similarity=0.587 Sum_probs=211.9
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
....+|++.+.||.|+||.||+|.+. +..+|+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--------LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--------hhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 34567899999999999999999985 6779999986532 11234577899999999999999999999875
Q ss_pred CCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
. ..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+|+||+|+|||++.++. ++|+||
T Consensus 75 ~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~----~kl~d~ 148 (261)
T cd05148 75 E--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV----CKVADF 148 (261)
T ss_pred C--CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce----EEEccc
Confidence 5 889999999999999998653 356899999999999999999999999999999999999997654 599999
Q ss_pred CCcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 735 GLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 735 GLA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
|.+....... ......++..|+|||.+. ...++.++||||||+++|+|++ |+.||...........+. ...+.+.
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 225 (261)
T cd05148 149 GLARLIKEDVYLSSDKKIPYKWTAPEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPC 225 (261)
T ss_pred cchhhcCCccccccCCCCceEecCHHHHc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCC
Confidence 9997554322 122334567899999987 4457889999999999999998 899998877666655544 4455666
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+..+++.+.++|.+||+.+|.+|||+.+|++.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 77889999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.54 Aligned_cols=255 Identities=35% Similarity=0.587 Sum_probs=208.8
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
.+..++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~ 74 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeEE
Confidence 4567899999999999999999998742 569999975321 11223567889999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEe
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 719 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILL 719 (867)
++++.... ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+|||+
T Consensus 75 ~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill 152 (277)
T cd05032 75 LGVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV 152 (277)
T ss_pred EEEEcCCC--CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE
Confidence 99998754 8899999999999999885422 246888999999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002908 720 NLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795 (867)
Q Consensus 720 d~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~ 795 (867)
+.++. ++|+|||+++...... ......++..|+|||.+. ...++.++|||||||++|+|++ |..||....
T Consensus 153 ~~~~~----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 153 AEDLT----VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred cCCCC----EEECCcccchhhccCcccccCCCCCccccccCHHHHh--cCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 97664 5999999987433221 122334678899999987 4457889999999999999998 999998777
Q ss_pred hhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 796 ~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.......+. .......+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 227 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 227 NEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 666555544 44445566778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=338.47 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=211.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||++.+. +..||||++...... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 345678999999999999999999884 778999999753211 1112345678999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. .+++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|
T Consensus 114 ~~~--~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~----~kL~D 185 (370)
T cd05596 114 DDK--YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH----LKLAD 185 (370)
T ss_pred cCC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC----EEEEe
Confidence 754 89999999999999998843 35888999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~--~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
||++....... ......||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||...........+......
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc
Confidence 99997543321 223456999999999987432 34788999999999999999999999987776666666654433
Q ss_pred CCCCC--CCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHH
Q 002908 810 PPVPG--FCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLR 846 (867)
Q Consensus 810 ~~ip~--~~s~eL~dLI~kCLq~DPee--RPSa~ELLe~Lq 846 (867)
...+. .++..+.+||.+||+.+|.+ |+++.+++.+.+
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 33333 57899999999999999988 999999988864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=350.87 Aligned_cols=248 Identities=30% Similarity=0.499 Sum_probs=214.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|.+.+.||+|+||.||+|+.+ ...||+|.+.+... .+...+.+.+|+++++.++|||||.++++|....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr------~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~- 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR------NEKELKNLRQEVRILRSLKHPNIVEMLESFETSA- 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC------chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-
Confidence 56888889999999999999985 56799999976432 2233466889999999999999999999999855
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|+||+.| +|..++. ....++++.+..|+.++..||.|||+++|+|||+||.|||++..|. +||||||+|
T Consensus 75 -~~~vVte~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~----~KlcdFg~A 147 (808)
T KOG0597|consen 75 -HLWVVTEYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT----LKLCDFGLA 147 (808)
T ss_pred -eEEEEehhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc----eeechhhhh
Confidence 99999999966 9999885 4567999999999999999999999999999999999999996664 599999999
Q ss_pred cccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
+... +........|||.|||||.+. ...|+..+|+|||||++|||++|++||...........|......++ ...
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~--e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p--~~~ 223 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVE--EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP--STA 223 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHc--CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc--ccc
Confidence 9544 444556778999999999999 56788999999999999999999999988777777777777665544 478
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+..+..|+..+|.+||..|.+..+++.+-
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 89999999999999999999999998764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=330.43 Aligned_cols=246 Identities=28% Similarity=0.414 Sum_probs=202.3
Q ss_pred EEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeE
Q 002908 586 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 586 k~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l 660 (867)
+.||+|+||.||++.. .++.||||+++..... ........+.+|+.+|+.++||||+++++++.... ..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--KL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH----hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--eE
Confidence 5799999999999876 3677999999753211 11122345678999999999999999999998754 89
Q ss_pred EEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 661 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
++||||+.+++|.+++.. ...+.+..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~----~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH----VKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC----EEEeeCcCCeec
Confidence 999999999999988854 346788899999999999999999999999999999999997664 599999998742
Q ss_pred -cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHH
Q 002908 741 -RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 819 (867)
Q Consensus 741 -~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~e 819 (867)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ...+..+++.
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 226 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPPYLTPE 226 (323)
T ss_pred ccCCCcccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 22222334568999999999984 456789999999999999999999999887766666665543 3456678899
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 820 WRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 820 L~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
+.++|.+||+.+|.+|| ++.+++.+.+
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 99999999999999999 8999888643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.36 Aligned_cols=253 Identities=32% Similarity=0.529 Sum_probs=201.6
Q ss_pred eeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 582 LEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
|++.+.||+|+||+||++.+ .+..||+|+++.... ......|.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-------QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 38889999999999988754 356799999875321 12235678899999999999999999988765
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
....+++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR----LVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC----cEEEeecc
Confidence 55578999999999999998853 3589999999999999999999999999999999999998665 45999999
Q ss_pred CcccccCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--------------
Q 002908 736 LSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-------------- 797 (867)
Q Consensus 736 LA~~~~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-------------- 797 (867)
++........ .....++..|+|||.+. ...++.++|||||||++|+|+||+.||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLK--ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhc--ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch
Confidence 9985443211 11223566799999987 445788999999999999999999998543211
Q ss_pred HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 798 e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.............+.+..++..+.+++.+||+.+|.+|||+++++..|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111222233344556678899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=317.72 Aligned_cols=253 Identities=36% Similarity=0.595 Sum_probs=207.6
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
...+|.+.+.||+|+||.||+|.+. +..||||.++... .......+.+|+++|+.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-------CHHHHHHHHHHHHHHHhcCCCCchheee
Confidence 4567888899999999999999863 3579999986431 1123467889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhccc-------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcce
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE-------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 717 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNI 717 (867)
++.... ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~ni 153 (280)
T cd05049 76 VCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153 (280)
T ss_pred EEecCC--CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceE
Confidence 998854 8999999999999999985432 3478899999999999999999999999999999999
Q ss_pred EeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCC
Q 002908 718 LVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 793 (867)
Q Consensus 718 LLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~ 793 (867)
|++.++ .++|+|||++....... ......+++.|+|||++. ...++.++|||||||++|+|++ |..||..
T Consensus 154 li~~~~----~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 154 LVGYDL----VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EEcCCC----eEEECCcccceecccCcceecCCCCcccceecChhhhc--cCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999765 45999999987432211 122334577899999998 4557889999999999999998 9999988
Q ss_pred CChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 794 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 794 ~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.........+.... ....+..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus 228 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 228 LSNEEVIECITQGR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 77666665555333 33445678899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.32 Aligned_cols=251 Identities=37% Similarity=0.629 Sum_probs=210.7
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
+...+|++.+.||.|++|.||+|...++.||||.++.... ...++.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 4567899999999999999999999999999999975321 2467889999999999999999999988744
Q ss_pred CCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++|+|||
T Consensus 74 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~----~~l~d~g 147 (256)
T cd05039 74 --PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV----AKVSDFG 147 (256)
T ss_pred --CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC----EEEcccc
Confidence 8899999999999999986544 36899999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
.+........ ....+..|+|||++. ...++.++||||||+++|+|++ |..||...........+. .......+.
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~ape~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 222 (256)
T cd05039 148 LAKEASQGQD--SGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPE 222 (256)
T ss_pred cccccccccc--cCCCcccccCchhhc--CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCcc
Confidence 9986533222 233566799999987 4457889999999999999997 999998776655544333 333445566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+++.+.++|.+||..+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=332.08 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=208.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||++.+ .++.||||+++.... ........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-----LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 3689999999999999999988 478899999975422 12223456778999999999999999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~----~kL~Dfg~a 149 (330)
T cd05601 75 -NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH----IKLADFGSA 149 (330)
T ss_pred -eEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC----EEeccCCCC
Confidence 899999999999999999766567999999999999999999999999999999999999997664 599999999
Q ss_pred ccccCcc--ccCCcCCCCCccCccccccC----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC--C
Q 002908 738 KIKRNTL--VTGGVRGTLPWMAPELLNGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--R 809 (867)
Q Consensus 738 ~~~~~~~--~~s~~~GT~~Y~APEvl~g~----~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l--r 809 (867)
....... ......||+.|+|||++... ...++.++|||||||++|+|++|..||...........+..... .
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence 7543322 22234689999999998632 23467899999999999999999999988776666665554322 2
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+....++..+.+|+.+||. +|.+||++.+++.+.+
T Consensus 230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 22333578999999999998 9999999999987643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.62 Aligned_cols=260 Identities=30% Similarity=0.481 Sum_probs=211.6
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCcee
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVV 646 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIV 646 (867)
+.+..++|+++++||.|+||.||+|++.+ ..||||+++... .......+.+|+.+|+++. ||||+
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-------RSSEKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhcCCCCCee
Confidence 35667899999999999999999998732 359999986432 1122356889999999996 99999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhccc----------------------------------------------
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 680 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------------------------------------- 680 (867)
+++++|.... ..++|||||++|+|.+++....
T Consensus 105 ~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (400)
T cd05105 105 NLLGACTKSG--PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ 182 (400)
T ss_pred eEEEEEccCC--ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence 9999998754 8999999999999998875321
Q ss_pred -------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Q 002908 681 -------------------------------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 711 (867)
Q Consensus 681 -------------------------------------------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrD 711 (867)
..+++..++.++.||+.||.|||+.+|+|||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~d 262 (400)
T cd05105 183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRD 262 (400)
T ss_pred ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 2477888899999999999999999999999
Q ss_pred CCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-C
Q 002908 712 LKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 787 (867)
Q Consensus 712 LKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-G 787 (867)
|||+|||++.++ .++|+|||+++...... ......++..|+|||.+. ...++.++|||||||++|+|++ |
T Consensus 263 ikp~Nill~~~~----~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwSlGvil~ellt~g 336 (400)
T cd05105 263 LAARNVLLAQGK----IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLG 336 (400)
T ss_pred CChHhEEEeCCC----EEEEEeCCcceeccccccccccCCcCCCcceEChhhhc--CCCCCchhhHHHHHHHHHHHHHCC
Confidence 999999998654 46999999997543211 122334678899999997 3457889999999999999997 9
Q ss_pred CCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 788 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 788 k~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
..||............+....+.+.+..++..+.+++.+||+.+|.+||++.+|.+.|+.+.
T Consensus 337 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 337 GTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 99998765554444445555566667788999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.90 Aligned_cols=258 Identities=36% Similarity=0.583 Sum_probs=211.6
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
|.+.+|.+.+.||+|+||.||++... +..+|+|.+... .......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--------CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 46778999999999999999999752 345899988642 122345688999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhccc------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcce
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 717 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNI 717 (867)
+++.... ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEecCC--ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 9998754 8999999999999999885332 2489999999999999999999999999999999999
Q ss_pred EeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCC
Q 002908 718 LVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 793 (867)
Q Consensus 718 LLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~ 793 (867)
|++.++. ++|+|||++....... ......++..|+|||++. ...++.++|||||||++|+|++ |..||..
T Consensus 152 li~~~~~----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 152 LVGENLL----VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred EEccCCc----EEeccCCccccccCCceeecCCCCCccccccCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9997654 5999999997443211 112233567899999998 4567889999999999999998 9999988
Q ss_pred CChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 794 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 794 ~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
.........+..... ...+..++..+.+|+.+||+.+|.+|||+.++++.|+.+...
T Consensus 226 ~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 226 LSNNEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 776666666554432 334556789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.84 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=203.3
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC-ceeeEecccccCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP-NVVAFYGVVQDGPG 657 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP-NIVrL~g~~~~~~~ 657 (867)
+|++++.||+|+||.||+|.+. ++.||||+++..... .......+..|+.++..+.|+ +|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 5889999999999999999985 567999999754321 112235677899999999765 5888988888754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~----~kL~Dfg~~ 148 (324)
T cd05587 75 -RLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH----IKIADFGMC 148 (324)
T ss_pred -EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC----EEEeecCcc
Confidence 899999999999999888543 45899999999999999999999999999999999999997664 599999998
Q ss_pred cccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||...........+.... ...+..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 224 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Confidence 7421 2222334568999999999984 457889999999999999999999999887777766665543 3455678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSF-----TEIARR 844 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa-----~ELLe~ 844 (867)
+..+.+++.+||..+|.+|++. .+++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.89 Aligned_cols=244 Identities=35% Similarity=0.637 Sum_probs=199.5
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEE
Q 002908 587 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 664 (867)
Q Consensus 587 ~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVm 664 (867)
.||+|+||.||+|++ .++.||+|.+.... .......+.+|+++++.++||||+++++++.... ..++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 72 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVM 72 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEE
Confidence 589999999999988 57889999875321 1223456889999999999999999999998754 889999
Q ss_pred EeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc
Q 002908 665 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744 (867)
Q Consensus 665 Ey~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~ 744 (867)
||+++++|.+++......+++..++.++.|++.||.|||++||+||||||.|||++.++. ++|+|||++.......
T Consensus 73 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~----~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 73 ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV----LKISDFGMSREEEDGV 148 (252)
T ss_pred eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc----EEECccccCccccccc
Confidence 999999999998665567899999999999999999999999999999999999986654 5999999987543221
Q ss_pred cc---CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHH
Q 002908 745 VT---GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 820 (867)
Q Consensus 745 ~~---s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL 820 (867)
.. .....+..|+|||.+. ...++.++|||||||++|+|++ |..||........... .......+.+..++..+
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 225 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALN--YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQGVRLPCPELCPDAV 225 (252)
T ss_pred ccccCCCCCCceeecCchhhc--CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCCcccCCHHH
Confidence 11 1112345699999987 3457889999999999999998 8899977665444333 33344556667788999
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 821 RLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 821 ~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+++.+||+.+|.+|||+.++++.|+
T Consensus 226 ~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.57 Aligned_cols=249 Identities=31% Similarity=0.505 Sum_probs=207.8
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||+|++|.||++.+ ++..|++|.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN------RREREEAIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 478889999999999999988 4788999998653221 223467889999999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++... ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~----~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC----EEEcccccc
Confidence 899999999999999998654 467899999999999999999999999999999999999997654 599999998
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
....... ......+++.|+|||++. ...++.++|+|||||++|+|++|+.||...........+.... ..+.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCE--DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPPVSQMY 225 (256)
T ss_pred eeccCccchhhccccCccccCHHHhc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcccc
Confidence 8543322 223345788999999998 4457889999999999999999999998877655555544433 34455578
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+..+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=336.58 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=213.4
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++..+||.|..++||+|+. ++..||||++...... .....+.+|+..+..++||||++++..|.
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-------~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-------NDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-------hhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 45668999999999999999999998 5788999999754221 11467889999999999999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.+. .+++||.||.+|++.+.+.... ..+++..+..|++++++||.|||++|.||||||+.||||+.+|.+ +|+
T Consensus 95 v~~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~V----kLa 168 (516)
T KOG0582|consen 95 VDS--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTV----KLA 168 (516)
T ss_pred ecc--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcE----EEc
Confidence 865 9999999999999999986432 458999999999999999999999999999999999999988865 999
Q ss_pred ecCCcccc-cCcc---cc-CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC
Q 002908 733 DFGLSKIK-RNTL---VT-GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 733 DFGLA~~~-~~~~---~~-s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~ 807 (867)
|||.+... .... .. ..+.||+.|||||++......|+.|+||||||++..||.+|..||..+.....+...+.+.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 99987532 2211 11 4557999999999976667789999999999999999999999999888776665444433
Q ss_pred CCC--------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 808 LRP--------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 808 lr~--------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
... +.....+..+++++..||+.||.+|||+.+++++-
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 321 11123567899999999999999999999998763
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.30 Aligned_cols=260 Identities=34% Similarity=0.546 Sum_probs=208.1
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC--Cce--EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFY 649 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~--G~~--VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~ 649 (867)
+.+.+++|++.+.||+|+||.||+|.+. +.. +|+|.++... .......+.+|+.++.++ +||||++++
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~ 74 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLL 74 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-------CHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence 3567789999999999999999999874 443 5777765321 122345778899999999 899999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCC
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC 714 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKP 714 (867)
+++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 75 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp 152 (303)
T cd05088 75 GACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 152 (303)
T ss_pred EEECCCC--CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccch
Confidence 9998754 8999999999999999886432 2578999999999999999999999999999999
Q ss_pred cceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCC
Q 002908 715 DNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 793 (867)
Q Consensus 715 sNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~ 793 (867)
+|||++.++. ++|+|||++.............++..|+|||++.+ ..++.++|||||||++|+|+| |..||..
T Consensus 153 ~Nili~~~~~----~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 153 RNILVGENYV----AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred heEEecCCCc----EEeCccccCcccchhhhcccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 9999986654 59999999864322222222234667999999873 457889999999999999998 9999987
Q ss_pred CChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 794 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 794 ~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.........+ ........+..++..+.+++.+||+.+|.+||++.+++..|..+..
T Consensus 227 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 227 MTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred CChHHHHHHH-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 6665544433 3333444555678999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=328.96 Aligned_cols=252 Identities=26% Similarity=0.408 Sum_probs=201.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccccc
Q 002908 581 DLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 654 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~ 654 (867)
+|++.+.||+|+||.||+++. .++.||+|+++..... ........+..|+.++..++ ||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV----QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh----hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 488999999999999999876 3678999999754221 11223456778999999994 8999999999887
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 77 ~~--~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~----~kl~Df 149 (332)
T cd05614 77 EA--KLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH----VVLTDF 149 (332)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC----EEEeeC
Confidence 54 89999999999999998854 346899999999999999999999999999999999999997764 599999
Q ss_pred CCcccccC--ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhHhhcCC
Q 002908 735 GLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 808 (867)
Q Consensus 735 GLA~~~~~--~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~----~e~l~~iv~~~l 808 (867)
|+++.... ........||+.|+|||++.+ ...++.++|||||||++|+|++|..||..... ......+. ..
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~ 226 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KC 226 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcC-CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cC
Confidence 99975322 122234568999999999974 23467899999999999999999999964322 12222222 23
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
..+.+..++..+.+++.+||+.||.+|| ++++++++.+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 3455667899999999999999999999 7889987753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.15 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=199.0
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
...+|++.+.||+|+||.||++.+ .+..||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc------chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 347899999999999999999987 478899999875421 122235677899999999999999999988643
Q ss_pred C----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 656 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 656 ~----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
. ...+++||||+. ++|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|
T Consensus 93 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~----~kl 164 (359)
T cd07876 93 KSLEEFQDVYLVMELMD-ANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKI 164 (359)
T ss_pred CCccccceeEEEEeCCC-cCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC----EEE
Confidence 2 135799999995 45655553 34788999999999999999999999999999999999997664 599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh------
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN------ 805 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~------ 805 (867)
+|||+++............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 165 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 165 LDFGLARTACTNFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ecCCCccccccCccCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 99999986544333344568999999999984 5578899999999999999999999987654332221111
Q ss_pred ----------------cCCCC------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 806 ----------------NTLRP------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 806 ----------------~~lr~------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..... ......++.+.+||.+||+.||.+|||+.|++.+.+-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 00000 01112356789999999999999999999999987653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.38 Aligned_cols=255 Identities=35% Similarity=0.584 Sum_probs=208.7
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G-~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.+..++|++.++||+|+||.||+|.+.+ ..||||+++..... ...+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVSE 72 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---------HHHHHHHHHHHHhCCCCCcceEEEEECC
Confidence 3566789999999999999999998853 46999998753211 1457889999999999999999998754
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
. ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+++|+||||.||+++.++. ++|+|
T Consensus 73 ~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~----~~L~d 145 (262)
T cd05071 73 E---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV----CKVAD 145 (262)
T ss_pred C---CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc----EEecc
Confidence 2 578999999999999998643 345799999999999999999999999999999999999997654 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||.+....... ......++..|+|||++. ...++.++|||||||++|+|+| |..||...........+.. ....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~ 222 (262)
T cd05071 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRM 222 (262)
T ss_pred CCceeeccccccccccCCcccceecCHhHhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCC
Confidence 99997543322 112334667899999987 4557899999999999999999 8889988776665554433 3344
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+.+..++..+.+++.+||+.+|.+||++.++++.|+.++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 455678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=368.51 Aligned_cols=264 Identities=36% Similarity=0.640 Sum_probs=229.6
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC---Cc----eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCcee
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR---GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 646 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~---G~----~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIV 646 (867)
++.+.+...++.+.||+|+||.||.|+.. +. .||||.++... ++....+|++|..+|+.++|||||
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-------~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-------SEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCccee
Confidence 66788999999999999999999999883 33 38899887532 234467899999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhcc------cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEec
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 720 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd 720 (867)
+++|++.+ .+..+|++|||++|+|..++... ...++..+++.|+.+||+|+.||+++++|||||.+.|+||+
T Consensus 759 ~liGv~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~ 836 (1025)
T KOG1095|consen 759 SLIGVCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD 836 (1025)
T ss_pred eEEEeecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec
Confidence 99999988 34789999999999999999876 67799999999999999999999999999999999999999
Q ss_pred cCCCCCCcEEEeecCCcc-cccCcccc-CC-cCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002908 721 LKDPIRPICKVGDFGLSK-IKRNTLVT-GG-VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHY 796 (867)
Q Consensus 721 ~dg~~~~~vKL~DFGLA~-~~~~~~~~-s~-~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~ 796 (867)
.. ..+||+|||+|+ ++...... .. ..-+..|||||.+. .+.++.++|||||||+|||++| |..||...+.
T Consensus 837 ~~----r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~--d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 837 ER----RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK--DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred cc----CcEEEcccchhHhhhhchheeccCccccceecCCHHHHh--hcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 55 568999999999 44332222 12 23457899999998 6789999999999999999999 9999999999
Q ss_pred hHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 797 GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 797 ~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
.+.+.-++.+. +.+.|..|+..+.++|.+||+.+|++||+|..|++.+..+.....
T Consensus 911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 88887667666 999999999999999999999999999999999999888876544
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.76 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=202.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|++ .+..||||.++...... ....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-------cchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 46799999999999999999988 46779999987543211 1234668999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+. ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||+
T Consensus 78 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~----~kl~Dfg~ 150 (309)
T cd07872 78 --SLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE----LKLADFGL 150 (309)
T ss_pred --eEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEECcccc
Confidence 8999999996 5888887666667899999999999999999999999999999999999997654 59999999
Q ss_pred cccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC--------
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 807 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-------- 807 (867)
+...... .......+++.|+|||++.+ ...++.++|||||||++|+|+||+.||...........+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 151 ARAKSVPTKTYSNEVVTLWYRPPDVLLG-SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred ceecCCCccccccccccccccCCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 8754322 12223457899999999874 3457889999999999999999999998766544333222110
Q ss_pred -------------CCC-------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 808 -------------LRP-------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 808 -------------lr~-------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
... .....++.++.++|.+||+.||.+|||+.+++.+.+-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence 000 00123578899999999999999999999999876654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.52 Aligned_cols=253 Identities=36% Similarity=0.617 Sum_probs=208.7
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.+..++|++.++||+|++|.||+|.+. +..+|+|.++..... ...+.+|+.++++++|+|++++++++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVSE 72 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEECC
Confidence 466788999999999999999999874 567999998753221 1357889999999999999999998754
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
. ..++||||+++++|.+++... ...+++..++.++.+++.||.|||++||+||||+|+||+++.++ .++|+|
T Consensus 73 ~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~----~~~l~d 145 (260)
T cd05070 73 E---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL----VCKIAD 145 (260)
T ss_pred C---CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc----eEEeCC
Confidence 2 578999999999999988653 34589999999999999999999999999999999999999655 459999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||++....... ......++..|+|||.+. ...++.++|+||||+++|+|++ |..||...........+. .....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (260)
T cd05070 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRM 222 (260)
T ss_pred ceeeeeccCcccccccCCCCCccccChHHHh--cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99997543322 112233566799999987 4557889999999999999999 899998877666555443 34455
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.+...+..+.+|+.+||..+|.+|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6667788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=312.10 Aligned_cols=253 Identities=36% Similarity=0.611 Sum_probs=210.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.|..++|+++++||+|+||.||+|.. .++.||+|.+...... ...+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEANLMKQLQHPRLVRLYAVVTQ 72 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---------HHHHHHHHHHHHhcCCcCeeeEEEEEcc
Confidence 56778999999999999999999987 4678999998643221 2467889999999999999999998754
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
...++||||+.+++|.+++... ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~----~~l~d 145 (260)
T cd05067 73 ---EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC----CKIAD 145 (260)
T ss_pred ---CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC----EEEcc
Confidence 2689999999999999987543 356899999999999999999999999999999999999997654 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||++....... ......++..|+|||++. ...++.++||||||+++|+|++ |+.||...........+ ......
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~ 222 (260)
T cd05067 146 FGLARLIEDNEYTAREGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRM 222 (260)
T ss_pred CcceeecCCCCcccccCCcccccccCHHHhc--cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCCCC
Confidence 99997554221 122334567899999987 3457889999999999999999 99999887766555443 344455
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.+..++..+.+++.+||..+|.+||++++++..|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 6677788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.00 Aligned_cols=258 Identities=31% Similarity=0.552 Sum_probs=208.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCce----EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~----VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+...+|++.+.||.|+||+||+|.+ .+.. +++|.+... .......++..|+.+++++.||||++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~ 75 (279)
T cd05111 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLL 75 (279)
T ss_pred cCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 34567889999999999999999998 3443 666665321 1122335677888899999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++... ..+++|||+++++|.+++......+++..++.++.||+.||.|||++|++||||||+|||++.++ .+
T Consensus 76 ~~~~~~---~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~----~~ 148 (279)
T cd05111 76 GICPGA---SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS----IV 148 (279)
T ss_pred EEECCC---ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC----cE
Confidence 987542 56789999999999999977667899999999999999999999999999999999999998655 45
Q ss_pred EEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
+|+|||+++...... ......++..|+|||.+. ...++.++|||||||++|+|++ |..||........ ..++.
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~ 225 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL--FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLE 225 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhc--cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHH
Confidence 999999997543221 122344677899999997 3457899999999999999998 9999987765443 33344
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.....+.+..++..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 444555566788899999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.07 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=202.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
+.|++++.||+|+||.||+|.+ .++.||||++..... ........+.+|+.+++.++||||+++++.+.+..
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~- 74 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD- 74 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-
Confidence 3689999999999999999998 467899999875321 12233456788999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|||||++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~----~kL~DFGla 148 (382)
T cd05625 75 -NLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH----IKLTDFGLC 148 (382)
T ss_pred -EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC----EEEeECCCC
Confidence 899999999999999988543 46889999999999999999999999999999999999997664 599999997
Q ss_pred ccccCc------------------------------------------------cccCCcCCCCCccCccccccCCCCCC
Q 002908 738 KIKRNT------------------------------------------------LVTGGVRGTLPWMAPELLNGSSSKVS 769 (867)
Q Consensus 738 ~~~~~~------------------------------------------------~~~s~~~GT~~Y~APEvl~g~~~~~S 769 (867)
...... .......||+.|+|||++.+ ..++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~ 226 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYT 226 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCC
Confidence 522100 00123468999999999984 4578
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC--CCCCCCCCcHHHHHHHHHhhcCCCCCCCC---HHHHHHH
Q 002908 770 EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--RPPVPGFCDSEWRLLMEQCWAPDPVVRPS---FTEIARR 844 (867)
Q Consensus 770 ~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l--r~~ip~~~s~eL~dLI~kCLq~DPeeRPS---a~ELLe~ 844 (867)
.++|||||||+||+|++|+.||...........+..... ..+....+++.+.++|.+|+ .+|.+|++ +.+++.+
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 899999999999999999999988776655555544322 23333457899999999876 59999987 8888876
Q ss_pred H
Q 002908 845 L 845 (867)
Q Consensus 845 L 845 (867)
-
T Consensus 306 p 306 (382)
T cd05625 306 P 306 (382)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=336.64 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=202.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||.||+++. .++.||||++...... .......+.+|+.+|..++||||+++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-----MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 4799999999999999999987 4788999998643211 1122356778999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||+|
T Consensus 75 -~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~----ikL~DFG~a 148 (376)
T cd05598 75 -NLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH----IKLTDFGLC 148 (376)
T ss_pred -EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC----EEEEeCCCC
Confidence 999999999999999998543 46889999999999999999999999999999999999997664 599999997
Q ss_pred ccccCc--------------------------------------------cccCCcCCCCCccCccccccCCCCCChhhH
Q 002908 738 KIKRNT--------------------------------------------LVTGGVRGTLPWMAPELLNGSSSKVSEKVD 773 (867)
Q Consensus 738 ~~~~~~--------------------------------------------~~~s~~~GT~~Y~APEvl~g~~~~~S~kSD 773 (867)
...... .......||+.|+|||++. ...++.++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~D 226 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL--RTGYTQLCD 226 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc--CCCCCccee
Confidence 522100 0012346999999999998 455788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC--CCCCCCCCcHHHHHHHHHhhcCCCCCCC---CHHHHHHHHH
Q 002908 774 VFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--RPPVPGFCDSEWRLLMEQCWAPDPVVRP---SFTEIARRLR 846 (867)
Q Consensus 774 VWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l--r~~ip~~~s~eL~dLI~kCLq~DPeeRP---Sa~ELLe~Lq 846 (867)
||||||++|+|++|+.||...........+..... ..+....+++.+.++|.+|+ .+|.+|+ ++.+++.+.+
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 99999999999999999988776555544443222 22233457889999999977 5999999 9999998854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.19 Aligned_cols=253 Identities=27% Similarity=0.460 Sum_probs=226.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|++.+.||+|.||.|-+++. .|+.||||.+++.... ++.-...+.+|++++..|+||||+.+|.+|...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-----deqDlvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-----DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-----cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 45799999999999999999986 4899999999876433 3344567889999999999999999999999866
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+.|||||..+|.|++++... +.+++.++..+++||.+|+.|||.++++|||||.+|||+|.+++. ||+|||+
T Consensus 127 --KIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~Ni----KIADFGL 199 (668)
T KOG0611|consen 127 --KIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNI----KIADFGL 199 (668)
T ss_pred --eEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCe----eeeccch
Confidence 899999999999999999644 569999999999999999999999999999999999999998876 9999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
+..+........+||++.|.+||+++|..+ .++.+|.||||++||-|+.|..||++.+...++.++..+.++.+..
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY-~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~--- 275 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPY-KGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET--- 275 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCC-CCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC---
Confidence 999888888888999999999999998654 4678999999999999999999999999999999988888875543
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+....-||++||..+|++|.|+.+|..+.|-
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 5567889999999999999999999998875
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=319.78 Aligned_cols=262 Identities=31% Similarity=0.528 Sum_probs=212.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC---------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCce
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 645 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G---------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNI 645 (867)
.+..++|.+.+.||+|+||.||++.+.+ ..+|+|.++... .+....++.+|+.+++.+ +||||
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCCCE
Confidence 5566899999999999999999998632 359999986431 112235678899999999 79999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 710 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHr 710 (867)
+++++++.... ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||
T Consensus 87 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 87 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred eeEEEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999998754 8899999999999999986432 358899999999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-
Q 002908 711 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT- 786 (867)
Q Consensus 711 DLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT- 786 (867)
||||+|||++.++ .++|+|||.+....... ......+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 165 dlkp~Nill~~~~----~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 165 DLAARNVLVTEDN----VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred cccHHheEEcCCC----cEEECCCcccccccccchhhccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcC
Confidence 9999999999765 45999999987543211 1112224568999999973 457889999999999999998
Q ss_pred CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 787 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 787 Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
|..||........... +......+.+..++..+.+++.+||..+|.+||++.++++.|+.+...+.
T Consensus 239 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 239 GGSPYPGVPVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred CCCCCCcCCHHHHHHH-HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 8899977665444433 33444556667789999999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.23 Aligned_cols=255 Identities=35% Similarity=0.597 Sum_probs=208.9
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
...+|++.+.||+|+||.||+|.+. +..+|+|.++.... ......+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-------EKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3467899999999999999999873 23689998864321 12245788899999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.... ..++||||+++++|.+++......+++..++.++.|++.||.|||+++++||||||+|||++.++ .++|+
T Consensus 75 ~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~----~~~l~ 148 (267)
T cd05066 75 TKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL----VCKVS 148 (267)
T ss_pred ecCC--ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC----eEEeC
Confidence 8754 88999999999999999976666789999999999999999999999999999999999998655 46999
Q ss_pred ecCCcccccCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 733 DFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 733 DFGLA~~~~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
|||++........ .....++..|+|||.+. ...++.++|+|||||++|++++ |..||...........+.. .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~ 225 (267)
T cd05066 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-G 225 (267)
T ss_pred CCCcccccccccceeeecCCCccceeecCHhHhc--cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-C
Confidence 9999985433211 11122356799999998 4457889999999999999887 9999987766555554443 3
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+.+.+..+++.+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 45566667889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=307.11 Aligned_cols=245 Identities=39% Similarity=0.659 Sum_probs=207.1
Q ss_pred EEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeE
Q 002908 586 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 586 k~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l 660 (867)
+.||+|+||.||+|.+. +..|+||+++..... .....+.+|+.++..++|+||+++++++... ...
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-------EERKDFLKEARVMKKLGHPNVVRLLGVCTEE--EPL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch-------hHHHHHHHHHHHHhhcCCCChheeeeeecCC--Cce
Confidence 36899999999999985 677999998754221 1346788999999999999999999999884 489
Q ss_pred EEEEEeecCCchhhhhhcc--------cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 661 ATVTEFMVNGSLRHVLLSK--------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~--------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++. ++|+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~----~~l~ 147 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV----VKIS 147 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc----EEEc
Confidence 9999999999999998765 467999999999999999999999999999999999999997754 5999
Q ss_pred ecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCC
Q 002908 733 DFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 733 DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~l 808 (867)
|||.+...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.. ..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~ 224 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GY 224 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC
Confidence 99999865432 22334557889999999884 467899999999999999999 6999988876666655444 44
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....+..++..+.+++.+||..+|.+|||+.+++.+|+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 55667778999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.28 Aligned_cols=259 Identities=32% Similarity=0.541 Sum_probs=211.5
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCcee
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 646 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIV 646 (867)
..+..++|++.+.||+|+||.||++.+.+ ..+|+|.+.... ......++.+|+.++.++ +||||+
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-------CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 45677899999999999999999998742 468999886431 112235688999999999 799999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhc---------------ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS---------------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 711 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~---------------~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrD 711 (867)
++++++.... ..++||||+++++|..++.. ....+++..++.++.|++.||.|||+.+|+|||
T Consensus 80 ~~~~~~~~~~--~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d 157 (293)
T cd05053 80 NLLGVCTQEG--PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD 157 (293)
T ss_pred eEEEEEcCCC--CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 9999998754 89999999999999998853 235689999999999999999999999999999
Q ss_pred CCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-C
Q 002908 712 LKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 787 (867)
Q Consensus 712 LKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-G 787 (867)
|||+|||++.++ .++|+|||+++...... ......++..|+|||++. ...++.++|||||||++|+|++ |
T Consensus 158 lkp~Nil~~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g 231 (293)
T cd05053 158 LAARNVLVTEDH----VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLG 231 (293)
T ss_pred cceeeEEEcCCC----eEEeCccccccccccccceeccCCCCCCccccCHHHhc--cCCcCcccceeehhhHHHHHhcCC
Confidence 999999998665 45999999998543321 111223457799999987 4557889999999999999998 9
Q ss_pred CCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 788 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 788 k~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
..||...........+ ........+..++..+.+|+.+||..+|.+|||+.++++.|+.+.
T Consensus 232 ~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 232 GSPYPGIPVEELFKLL-KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 9999887665555443 334445566678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.84 Aligned_cols=245 Identities=33% Similarity=0.553 Sum_probs=200.8
Q ss_pred EeeecCcEEEEEEEE----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEE
Q 002908 587 ELGSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 587 ~LG~GafG~VYka~~----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
+||+|+||.||+|.+ .+..+|||+++... .......++.+|+.+++.+.||||+++++++... ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEAE---SWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CcEE
Confidence 589999999999976 35679999986432 1233456788999999999999999999988643 5789
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~ 742 (867)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||.|||++.++ .++|+|||++.....
T Consensus 73 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~----~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC----eEEECCCccccccCC
Confidence 9999999999998853 35689999999999999999999999999999999999999654 469999999975432
Q ss_pred ccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 743 TLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 743 ~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
... .....++..|+|||.+. ...++.++|+|||||++|+|++ |..||...........+. .....+.+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 224 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCP 224 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhc--cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCC
Confidence 211 11223457899999987 4457889999999999999998 999998776655554443 344566777889
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
+.+.++|.+||+.+|.+||++.+|...|+.+
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.71 Aligned_cols=243 Identities=28% Similarity=0.437 Sum_probs=200.0
Q ss_pred EeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCeEEEE
Q 002908 587 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 587 ~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
.||+|+||.||+|.++ ++.||||+++..... .+.....+..|..++..+ +||||+++++++.... .+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~iv 74 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFFV 74 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEEE
Confidence 6999999999999984 678999999754211 112235567788888876 6999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-cC
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~-~~ 742 (867)
|||+++++|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++. ++|+|||++... ..
T Consensus 75 ~Ey~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~----~kL~DfG~~~~~~~~ 149 (320)
T cd05590 75 MEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH----CKLADFGMCKEGIFN 149 (320)
T ss_pred EcCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc----EEEeeCCCCeecCcC
Confidence 999999999988754 356899999999999999999999999999999999999997664 599999998743 22
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.... ...+..++..+.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~ 225 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQ--EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAVD 225 (320)
T ss_pred CCcccccccCccccCHHHHc--CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHH
Confidence 22334456899999999998 4557889999999999999999999999887777766665443 3345678999999
Q ss_pred HHHHhhcCCCCCCCCH------HHHHHHH
Q 002908 823 LMEQCWAPDPVVRPSF------TEIARRL 845 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa------~ELLe~L 845 (867)
++.+||+.||.+||++ ++++.+.
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~ 254 (320)
T cd05590 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHP 254 (320)
T ss_pred HHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence 9999999999999998 6776653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=341.91 Aligned_cols=268 Identities=28% Similarity=0.395 Sum_probs=223.5
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChH------HHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSE------QERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~------~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
...++|++++.||+|.||.|-+|+. .++.||||++.+......... ...-.....+|+.+|++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4457899999999999999999998 478899999976443211110 11123467899999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhccccc-CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~-Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
+.+..++....+|||+|||..|.+...- ...+ +++.+++.++.+++.||.|||.+|||||||||+|+||+.+|.
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--- 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--- 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc---
Confidence 9999998888999999999988776432 3344 899999999999999999999999999999999999997764
Q ss_pred cEEEeecCCccccc------CccccCCcCCCCCccCccccccC--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH
Q 002908 728 ICKVGDFGLSKIKR------NTLVTGGVRGTLPWMAPELLNGS--SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 799 (867)
Q Consensus 728 ~vKL~DFGLA~~~~------~~~~~s~~~GT~~Y~APEvl~g~--~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~ 799 (867)
+||+|||.+.... .........|||.|+|||.+.+. ....+.+.||||+||+||.|+.|+.||......+.
T Consensus 249 -VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 249 -VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred -EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 5999999987542 11122235699999999999752 23357899999999999999999999999888889
Q ss_pred HHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 800 l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
..+|+...+..+......+.+++||.+||.+||+.|.+..+|..++|....
T Consensus 328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 999999888777776789999999999999999999999999999887543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.97 Aligned_cols=262 Identities=31% Similarity=0.523 Sum_probs=209.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceee
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVA 647 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVr 647 (867)
....++|++.+.||+|+||.||+|.+ .++.||||+++.... ......+.+|+.++.++ +||||++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-------hHHHHHHHHHHHHHHhccCCccHhh
Confidence 45678899999999999999999975 256799999864321 11235678899999999 6899999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhccc-----------------------------------------------
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------------------------------------------- 680 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~----------------------------------------------- 680 (867)
+++++... +...++||||+++++|.+++....
T Consensus 76 ~~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (343)
T cd05103 76 LLGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVE 154 (343)
T ss_pred hcceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccC
Confidence 99988653 347889999999999998875321
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 681 -------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 681 -------------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
..+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~~ 230 (343)
T cd05103 155 EKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIY 230 (343)
T ss_pred CCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC----cEEEEecccccccc
Confidence 2367888899999999999999999999999999999999665 46999999987532
Q ss_pred Cc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 742 NT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 742 ~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
.. .......++..|+|||++. ...++.++|||||||++|+|++ |..||............+........+..++
T Consensus 231 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (343)
T cd05103 231 KDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 308 (343)
T ss_pred cCcchhhcCCCCCCcceECcHHhc--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCC
Confidence 21 1122233567899999987 4457889999999999999997 9999987654444444444445555666778
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
+.+.+++..||+.+|.+|||+.+|+++|+.+..+
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 8999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=316.23 Aligned_cols=259 Identities=36% Similarity=0.570 Sum_probs=211.0
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
+...+|.+.+.||+|+||.||+|.+. +..+++|.++... ......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------LAARKDFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------HHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 34567899999999999999999853 2448888875321 12235678999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCC
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC 714 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKP 714 (867)
+++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 151 (291)
T cd05094 74 GVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLAT 151 (291)
T ss_pred EEEccCC--ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCc
Confidence 9998754 8899999999999999985432 3488999999999999999999999999999999
Q ss_pred cceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCC
Q 002908 715 DNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP 790 (867)
Q Consensus 715 sNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~P 790 (867)
+|||++.++ .++|+|||++....... ......++..|+|||++. ...++.++|||||||++|+|+| |..|
T Consensus 152 ~Nil~~~~~----~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p 225 (291)
T cd05094 152 RNCLVGANL----LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGKQP 225 (291)
T ss_pred ceEEEccCC----cEEECCCCcccccCCCceeecCCCCCcceeecChHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999665 46999999997543221 122344678899999988 4557889999999999999999 9999
Q ss_pred CCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 791 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 791 F~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
|...........+.. ......+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 226 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 226 WFQLSNTEVIECITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred CCCCCHHHHHHHHhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 988776665555443 3333445567899999999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.49 Aligned_cols=259 Identities=31% Similarity=0.511 Sum_probs=212.2
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCcee
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 646 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIV 646 (867)
+.+.+++|++.+.||+|+||.||++.+. +..||||+++.... ......+.+|+.+++++ +||||+
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-------SSEREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-------hHHHHHHHHHHHHHHhccCCCCcc
Confidence 3566788999999999999999999752 34699998864321 12235688999999999 799999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
++++++.... ..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++
T Consensus 103 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-- 178 (302)
T cd05055 103 NLLGACTIGG--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-- 178 (302)
T ss_pred eEEEEEecCC--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--
Confidence 9999998754 7899999999999999986433 3489999999999999999999999999999999999998554
Q ss_pred CCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 002908 726 RPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIG 801 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~ 801 (867)
.++|+|||++....... ......++..|+|||.+. ...++.++|||||||++|+|++ |..||..........
T Consensus 179 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~ 254 (302)
T cd05055 179 --IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY 254 (302)
T ss_pred --eEEECCCcccccccCCCceeecCCCCcccccCCHhhhc--cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH
Confidence 46999999997543221 122234567899999987 4457889999999999999998 999998776655555
Q ss_pred hHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 802 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 802 ~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
...........+...++.+.+++.+||..+|++|||+.++++.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 55555555555667789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=316.26 Aligned_cols=254 Identities=32% Similarity=0.520 Sum_probs=207.0
Q ss_pred CeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 581 DLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
+|++.+.||+|+||.||+|.+.. ..+++|.+..... ......+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-------SSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-------HHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47788899999999999998732 4588888864321 122356889999999999999999999988
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcc-----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSK-----------------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 710 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~-----------------------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHr 710 (867)
... ..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+|+||
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 QDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred cCC--CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 754 789999999999999887431 1357899999999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-
Q 002908 711 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT- 786 (867)
Q Consensus 711 DLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT- 786 (867)
||||+|||++.++ .++|+|||+++...... ......++..|+|||.+. ...++.++||||||+++|+|++
T Consensus 152 dikp~nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 152 DLAARNVLVAEGR----KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred hhhhheEEEcCCC----cEEeccccccccccCccchhcccCCCCCccccCHHHHc--cCCcchHhHHHHHHHHHHHHHhc
Confidence 9999999998665 45999999997432211 112234567899999987 4557899999999999999999
Q ss_pred CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 787 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 787 Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
|..||.+........ ........+.+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 226 g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 226 GGNPYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCCCCHHHHHH-HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 999998776555443 344455666677889999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=330.84 Aligned_cols=245 Identities=28% Similarity=0.378 Sum_probs=201.9
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 586 k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
+.||+|+||.||++.+ ++..||+|+++..... .......+..|+.++..++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEE
Confidence 3699999999999987 4788999999764321 1223456778999999999999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 741 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~- 741 (867)
|||+++++|..++.. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++. ++|+|||++....
T Consensus 74 ~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~----~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH----IKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC----EEEecCCCCeecCC
Confidence 999999999887753 4568999999999999999999997 79999999999999997664 5999999987432
Q ss_pred CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHH
Q 002908 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821 (867)
Q Consensus 742 ~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~ 821 (867)
.........||+.|+|||++. ...++.++|||||||++|+|++|..||...........+.... ...+..+++.+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~ 224 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAK 224 (325)
T ss_pred CCcccccccCCcccCCHHHHc--cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 222223456999999999998 4467889999999999999999999998877666655554433 334567899999
Q ss_pred HHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 822 LLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 822 dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
+++.+||+.||.+|+ ++.+++++.+
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 999999999999996 8999987743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=308.20 Aligned_cols=254 Identities=37% Similarity=0.617 Sum_probs=210.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.+..++|++.+.||.|++|.||++.+. +..||||.+...... ..++.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---------HHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 467789999999999999999999874 467999998743211 2457889999999999999999999877
Q ss_pred CCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. ..++||||+++++|.+++.... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++. ++|+|
T Consensus 73 ~~--~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~----~~l~d 146 (261)
T cd05034 73 EE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV----CKIAD 146 (261)
T ss_pred CC--ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC----EEECc
Confidence 44 7899999999999999986543 56899999999999999999999999999999999999997654 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||++....... ......++..|+|||.+. ...++.++|+|||||++|+|++ |+.||...........+. ..+..
T Consensus 147 ~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~ 223 (261)
T cd05034 147 FGLARLIEDDEYTAREGAKFPIKWTAPEAAN--YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRM 223 (261)
T ss_pred cccceeccchhhhhhhccCCCccccCHHHhc--cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99987543221 111223456899999998 4457889999999999999998 999998877666665544 33445
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 5566678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.90 Aligned_cols=244 Identities=25% Similarity=0.408 Sum_probs=201.5
Q ss_pred EeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCeEEEE
Q 002908 587 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 587 ~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
+||+|+||.||+|++. ++.||||+++..... .+.....+..|.+++..+ +||||+++++++.... .+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv 74 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFV 74 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEE
Confidence 6999999999999984 678999999754221 112234566788888866 7999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-C
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~-~ 742 (867)
|||+++++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.... .
T Consensus 75 ~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~----~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 75 MEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH----CKLADFGMCKEGILN 149 (321)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC----EEEeecccceecccC
Confidence 999999999888754 456899999999999999999999999999999999999997664 5999999987432 2
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+..... ..+..++.++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 225 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQ--ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--LYPVWLSKEAVS 225 (321)
T ss_pred CccccccccCccccCHHHHc--CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence 22233456899999999998 45578899999999999999999999998887777776665443 345567899999
Q ss_pred HHHHhhcCCCCCCC-------CHHHHHHHHH
Q 002908 823 LMEQCWAPDPVVRP-------SFTEIARRLR 846 (867)
Q Consensus 823 LI~kCLq~DPeeRP-------Sa~ELLe~Lq 846 (867)
++.+||+.+|.+|| ++.+++++.+
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 99999999999999 8899987753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=343.21 Aligned_cols=248 Identities=21% Similarity=0.357 Sum_probs=206.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..|.+.+.||+|+||.||+|... +..||+|.+... .......+.+|+.+|+.++|||||+++++|....
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 34999999999999999999873 566888876422 1222345678999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 657 GGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.+++||||+++++|.+++.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|
T Consensus 139 --~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~----~~kL~D 212 (478)
T PTZ00267 139 --KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGD 212 (478)
T ss_pred --EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC----cEEEEe
Confidence 89999999999999987753 234689999999999999999999999999999999999999765 459999
Q ss_pred cCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||++....... .....+||+.|+|||++. ...++.++|||||||++|+|++|+.||........+..+..... .
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~ 289 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWE--RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-D 289 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhC--CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C
Confidence 99998654321 233456999999999998 45678999999999999999999999988777666666655443 3
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+.+..++..+.++|.+||+.+|.+||++.+++.+
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 4556788999999999999999999999998754
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.71 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=203.3
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~ 657 (867)
+|++.+.||+|+||.||+|.+. +..||||+++..... .+.....+..|..++..+ .|++|+++++++....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 5888999999999999999884 568999999764221 122234566788888777 5889999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~----~kL~DfG~~ 148 (323)
T cd05616 75 -RLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH----IKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc----EEEccCCCc
Confidence 899999999999999888543 46899999999999999999999999999999999999997764 599999998
Q ss_pred cccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
.... .........||+.|+|||++. ...++.++|||||||++|+|+||+.||...........+..... ..+..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSM 224 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhc--CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCcC
Confidence 7432 222334466899999999998 45578999999999999999999999998877777766665443 345678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSF-----TEIARR 844 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa-----~ELLe~ 844 (867)
+..+.+++.+||+.+|.+|++. .+++.+
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 9999999999999999999974 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=311.44 Aligned_cols=254 Identities=35% Similarity=0.613 Sum_probs=207.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--C---ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G---~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
..+|++.+.||+|+||.||+|.+. + ..||||+++... .+....+|..|+.+++.+.||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 457899999999999999999874 3 359999986431 1233467889999999999999999999987
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+++++|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|
T Consensus 76 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~----~~kl~d 149 (269)
T cd05065 76 KSR--PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL----VCKVSD 149 (269)
T ss_pred CCC--ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC----cEEECC
Confidence 754 78999999999999999876666789999999999999999999999999999999999998654 469999
Q ss_pred cCCcccccCcccc----CCc--CCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhc
Q 002908 734 FGLSKIKRNTLVT----GGV--RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806 (867)
Q Consensus 734 FGLA~~~~~~~~~----s~~--~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~ 806 (867)
||++......... ... ..+..|+|||++. ...++.++|||||||++|||++ |..||...........+. .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~ 226 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-Q 226 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhc--cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-c
Confidence 9998754322111 111 1235799999997 4557889999999999999987 999998876665555543 3
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
....+.+..++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 445555667889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.79 Aligned_cols=257 Identities=24% Similarity=0.429 Sum_probs=207.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||.|++|.||++.+ .+..+|||.+..... ........+.+|+.+++.++||||+++++++....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-----MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN- 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-----hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-
Confidence 4678888999999999999997 578899998865321 12233467889999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 658 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+||
T Consensus 76 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~----~~l~df 150 (267)
T cd08229 76 -ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV----VKLGDL 150 (267)
T ss_pred -eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC----EEECcc
Confidence 89999999999999988753 2346899999999999999999999999999999999999986654 699999
Q ss_pred CCcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--HHHHhHhhcCCCCC
Q 002908 735 GLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AIIGGIVNNTLRPP 811 (867)
Q Consensus 735 GLA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~--e~l~~iv~~~lr~~ 811 (867)
|++....... ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...... .....+........
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC
Confidence 9987554322 2234468899999999973 45788999999999999999999999754332 22233332222222
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.+..++..+.+++.+||+.+|.+|||+.+|++.+.++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 33457889999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=311.25 Aligned_cols=246 Identities=34% Similarity=0.583 Sum_probs=201.2
Q ss_pred EeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEE
Q 002908 587 ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 587 ~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
.||+|+||.||+|.+. +..||||++.... .......+.+|+.++++++||||+++++++... ..++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~---~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE---ALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC---CeEE
Confidence 3899999999999873 3459999986431 123345688999999999999999999988542 6789
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~ 742 (867)
||||+++++|.+++......+++..++.++.|++.||.|||++|++||||||+|||++.++ .++|+|||++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH----YAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC----cEEeccCCccccccC
Confidence 9999999999999876566799999999999999999999999999999999999998655 469999999874432
Q ss_pred cc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 743 TL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 743 ~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
.. ......++..|+|||.+. ...++.++|||||||++|+|++ |..||........... +....+...+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 224 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF-IEQGKRLDCPAECP 224 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHc--cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HHCCCCCCCCCCCC
Confidence 21 111122357899999987 3457889999999999999996 9999988776665543 33444566677889
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+++.++|.+||..+|++||++.++.+.|+.++
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 99999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=312.55 Aligned_cols=256 Identities=36% Similarity=0.574 Sum_probs=203.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
..+|++.+.||+|+||.||++.+ .+..||||.+.... ......+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--------AEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 35788999999999999999875 36789999986431 22345788999999999999999999987
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.......+++||||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++.++ .++|+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~----~~~l~ 150 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN----RVKIG 150 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC----eEEEC
Confidence 65545578999999999999999866556689999999999999999999999999999999999998665 45999
Q ss_pred ecCCcccccCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-----------
Q 002908 733 DFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----------- 797 (867)
Q Consensus 733 DFGLA~~~~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~----------- 797 (867)
|||++........ .....++..|+|||++. ...++.++|||||||++|+|++|..++......
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhc--cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc
Confidence 9999985432211 11112345699999997 445788999999999999999987765432211
Q ss_pred ----HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 798 ----AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 798 ----e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+...+......+.+..++..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011223333444555667889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.68 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=206.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|++|.||+|.+. +..||+|.++.....+ ......+.+|+.++++++|+||+++++++....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-----AKARQDCLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 57899999999999999999984 8889999987543221 122356789999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 658 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
..++||||+++++|..++.. ....+++..++.++.+++.||.|||+.||+|+||+|+||+++.++. ++|+||
T Consensus 76 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~----~~l~d~ 150 (267)
T cd08224 76 -ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV----VKLGDL 150 (267)
T ss_pred -eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc----EEEecc
Confidence 88999999999999988753 2355899999999999999999999999999999999999997664 499999
Q ss_pred CCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHHhHhhcCCCCC
Q 002908 735 GLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNNTLRPP 811 (867)
Q Consensus 735 GLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~--~e~l~~iv~~~lr~~ 811 (867)
|++...... .......++..|+|||.+. ...++.++|||||||++|+|++|+.||..... ......+... ...+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~ 227 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPP 227 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhc--cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC-CCCC
Confidence 998754322 1222345888999999987 45578899999999999999999999965432 2222222222 2233
Q ss_pred CCC-CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 812 VPG-FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 812 ip~-~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.+. .++..+.++|.+||..+|.+|||+.+|++.|+.++
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 333 67889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.21 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=195.1
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 588 LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 588 LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
||+|+||+||++.+ +++.||||.+...... .......+..|+.+++.++||||+++++++.... ..++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-----KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-----hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEe
Confidence 69999999999987 4788999998753221 1122346778999999999999999999988754 8999999
Q ss_pred eecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 002908 666 FMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742 (867)
Q Consensus 666 y~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~ 742 (867)
|+++++|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~----~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN----VRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEEeeCccceecCC
Confidence 9999999877743 3356899999999999999999999999999999999999986654 59999999975433
Q ss_pred c-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC--CCCCCCCCCcHH
Q 002908 743 T-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--LRPPVPGFCDSE 819 (867)
Q Consensus 743 ~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~--lr~~ip~~~s~e 819 (867)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... .....+..++..
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPA 227 (280)
T ss_pred CCccccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHH
Confidence 2 22234568999999999984 457889999999999999999999997654322111111111 122345568899
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 820 WRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 820 L~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
+.+++.+||+.+|++|| ++++++++.+
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 99999999999999999 7788888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=309.09 Aligned_cols=256 Identities=36% Similarity=0.612 Sum_probs=209.0
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--Cc---eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GT---DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~---~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
|...+|+..+.||+|+||.||+|... +. .+|||.++... .......+..|+.+++.++||||++++++
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGV 74 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 44567889999999999999999873 32 58999886431 12224568899999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+.... ..++||||+++++|.+++......+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|
T Consensus 75 ~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~----~~kl 148 (268)
T cd05063 75 VTKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL----ECKV 148 (268)
T ss_pred EccCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC----cEEE
Confidence 98754 78999999999999999876666789999999999999999999999999999999999998655 4599
Q ss_pred eecCCcccccCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhc
Q 002908 732 GDFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806 (867)
Q Consensus 732 ~DFGLA~~~~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~ 806 (867)
+|||++........ ......+..|+|||++. ...++.++|||||||++|+|++ |..||...........+..
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~- 225 (268)
T cd05063 149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND- 225 (268)
T ss_pred CCCccceecccccccceeccCCCcCceecCHHHhh--cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-
Confidence 99999875432111 11122345799999987 4557899999999999999998 9999987766555555443
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
....+.+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 345555667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.35 Aligned_cols=253 Identities=34% Similarity=0.549 Sum_probs=205.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
..+|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.++..++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 456777889999999999999873 3569999987431 12234568889999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcc---------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcc
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 716 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~---------------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsN 716 (867)
+.... ..+++++|+.+++|..++... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 77 ~~~~~--~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N 154 (283)
T cd05091 77 VTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154 (283)
T ss_pred EcCCC--ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence 98755 789999999999999887421 1347888899999999999999999999999999999
Q ss_pred eEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCC
Q 002908 717 LLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 792 (867)
Q Consensus 717 ILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~ 792 (867)
||++.++. +||+|||+++...... ......+++.|+|||.+. ...++.++|||||||++|+|++ |..||.
T Consensus 155 il~~~~~~----~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 155 VLVFDKLN----VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred eEecCCCc----eEecccccccccccchheeeccCccCCccccCHHHHh--cCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 99986654 5999999987532211 122334577899999987 3457889999999999999998 888998
Q ss_pred CCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 793 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 793 ~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.........+.... ..+.+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 229 ~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 229 GYSNQDVIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 877666555544433 345567889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=336.76 Aligned_cols=259 Identities=29% Similarity=0.377 Sum_probs=227.1
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 654 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~ 654 (867)
....|++.+.||.|.||+||+++. +|+.+|+|++++....... ....+.+|+.+|+++. |||||.+++.|.+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 346789999999999999999998 4788999999876554321 2346778999999998 9999999999999
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+.........++++||
T Consensus 108 ~~--~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 108 PD--SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred CC--eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 66 999999999999999999766 39999999999999999999999999999999999999877554457899999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--CC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--PV 812 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~--~i 812 (867)
|++............+||+.|+|||++. ...++..+||||+|+++|.|++|.+||...........+....+.. +.
T Consensus 184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~--~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 184 GLAKFIKPGERLHTIVGTPEYVAPEVLG--GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP 261 (382)
T ss_pred CCceEccCCceEeeecCCccccCchhhc--CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC
Confidence 9999877766667889999999999998 4668999999999999999999999999998888887877776643 33
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
...++..++++|+.||..||.+|+|+.++|++.|.
T Consensus 262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 45679999999999999999999999999998774
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=307.89 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=205.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|+||.||++.+ .+..+|+|.++.... ......+.+|+.+++.++||||+++++.+.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 588999999999999999988 477899999864321 122356778999999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~-~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||.+
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~----~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK----VKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc----EEEcccCcc
Confidence 89999999999999988754 3456899999999999999999999999999999999999987664 599999998
Q ss_pred ccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
...... .......+++.|+|||++. ...++.++|+||||+++|+|++|..||...........+.... ..+.+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 224 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWE--NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS-YKPLPSHY 224 (255)
T ss_pred eeecccccccccccCCccccCHHHHc--cCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC-CCCCCccc
Confidence 754332 2223355888999999997 4457889999999999999999999998876665555544333 34456678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+..+.++|.+||+.+|.+||++.+++..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.65 Aligned_cols=242 Identities=29% Similarity=0.476 Sum_probs=196.0
Q ss_pred EeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh-CCCCceeeEecccccCCCCeEEEE
Q 002908 587 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 587 ~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~-L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
.||+|+||.||+|.+. +..||||+++..... .+.....+..|..++.. ++||||+++++++.... .+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv 74 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-----EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFFV 74 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEE
Confidence 6999999999999984 667999999864321 11122344566667765 48999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-C
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~-~ 742 (867)
|||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.... .
T Consensus 75 ~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~----~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 75 MEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH----IKIADFGMCKENMNG 149 (316)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC----EEEccCcCCeECCCC
Confidence 9999999999888543 46899999999999999999999999999999999999997664 5999999997432 2
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+... .+..+..++..+.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ 225 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAKD 225 (316)
T ss_pred CCccccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHH
Confidence 233345669999999999984 45788999999999999999999999988776666555433 34456678999999
Q ss_pred HHHHhhcCCCCCCCCHH-HHHHH
Q 002908 823 LMEQCWAPDPVVRPSFT-EIARR 844 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa~-ELLe~ 844 (867)
++.+||+.+|.+||++. +++.+
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcC
Confidence 99999999999999875 56553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=309.40 Aligned_cols=254 Identities=32% Similarity=0.496 Sum_probs=204.2
Q ss_pred eeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 582 LEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
|++.+.||+|+||.||+|.+. +..||||+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 467788999999999999873 25699999874321 1222456889999999999999999999876543
Q ss_pred C----CeEEEEEEeecCCchhhhhhcc-----cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 657 G----GTLATVTEFMVNGSLRHVLLSK-----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 657 ~----~~l~LVmEy~~ggSL~d~L~~~-----~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
. ...++||||+++++|..++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~---- 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM---- 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC----
Confidence 1 2478999999999998887432 24689999999999999999999999999999999999998665
Q ss_pred cEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhH
Q 002908 728 ICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 803 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~i 803 (867)
.++|+|||+++...... ......++..|+|||.+. ...++.++|||||||++|+|++ |..||...........+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 45999999998543221 111223567899999987 4557889999999999999999 89999887766655544
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 804 v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
... .....+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 229 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 433 34455677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=324.97 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=202.6
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+..++|++.+.||.|+||.||++.+. +..+|+|++.... .......+.+|+++++.++||||++++++|..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 45678999999999999999999984 6779999886532 12234568899999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. .+++||||+++++|.+++.. ...+++..+..++.+++.||.|||+. +|+|+||||+|||++.++. ++|+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~----~kL~D 147 (333)
T cd06650 75 DG--EISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCD 147 (333)
T ss_pred CC--EEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC----EEEee
Confidence 54 89999999999999998854 34588999999999999999999985 7999999999999987664 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH----------
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI---------- 803 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i---------- 803 (867)
||++...... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 9998754332 2234568999999999984 45788999999999999999999999754332211100
Q ss_pred ---------------------------------hhcCCCCCC-CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 804 ---------------------------------VNNTLRPPV-PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 804 ---------------------------------v~~~lr~~i-p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
+.....+.. ....+.++.+||.+||+.||++|||+.+++.+-+-.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 000011111 123567899999999999999999999998876653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=309.31 Aligned_cols=253 Identities=32% Similarity=0.466 Sum_probs=200.2
Q ss_pred eEEEEeeecCcEEEEEEEECC--c--eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC--
Q 002908 583 EELKELGSGTFGTVYHGKWRG--T--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 656 (867)
Q Consensus 583 qilk~LG~GafG~VYka~~~G--~--~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~-- 656 (867)
.+.+.||+|+||.||+|.+.. . .||||.++.... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 456789999999999999843 2 589998875321 1222467888999999999999999999764321
Q ss_pred --CCeEEEEEEeecCCchhhhhhc-----ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 657 --GGTLATVTEFMVNGSLRHVLLS-----KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 657 --~~~l~LVmEy~~ggSL~d~L~~-----~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
....++||||+++++|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM----NV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC----CE
Confidence 2256899999999999887742 224588999999999999999999999999999999999998665 45
Q ss_pred EEeecCCcccccCccc---cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~---~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
+|+|||++........ .....+++.|+|||.+. ...++.++|||||||++|+|++ |..||...........+..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA--DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHcc--CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999985432211 11223567899999998 4567899999999999999999 8899987666555444433
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
. ...+.+..++..+.++|.+||+.+|.+|||+.+|++.|+.+
T Consensus 230 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 G-NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3 33344556889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.99 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=209.5
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+..++|++.+.||+|+||.||++++. ++.||+|++...... .......+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 34578999999999999999999984 678999999753211 11123457789999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~----~kL~DF 186 (370)
T cd05621 115 DK--YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH----LKLADF 186 (370)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC----EEEEec
Confidence 54 89999999999999998843 35889999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCcc--ccCCcCCCCCccCccccccCC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 735 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 735 GLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~--~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
|++....... ......||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||...........++......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 9998653321 223456999999999997432 236789999999999999999999998887766666666544333
Q ss_pred CCC--CCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHHH
Q 002908 811 PVP--GFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLRV 847 (867)
Q Consensus 811 ~ip--~~~s~eL~dLI~kCLq~DPee--RPSa~ELLe~Lq~ 847 (867)
..+ ..++..+.+++..||..++.+ |+++.+++++.+-
T Consensus 267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 333 356889999999999865543 8999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=309.69 Aligned_cols=257 Identities=33% Similarity=0.598 Sum_probs=210.1
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~G-----~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
+...+|++.+.||+|+||.||+|.+.. ..||||.+.... .......+.+|+.+++.+.||||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 456779999999999999999998732 358999886432 12234578889999999999999999998
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+... ..++||||+++++|.+++......+++..++.++.+++.||.|||+.|++|+||||+|||++.++ .++|
T Consensus 76 ~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~----~~~l 148 (270)
T cd05056 76 ITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD----CVKL 148 (270)
T ss_pred EcCC---CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC----CeEE
Confidence 8753 46899999999999999976555689999999999999999999999999999999999999765 4599
Q ss_pred eecCCcccccCccc--cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCC
Q 002908 732 GDFGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~~--~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~l 808 (867)
+|||++........ .....++..|+|||.+. ...++.++|||||||++|+|++ |..||...........+. ...
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~ 225 (270)
T cd05056 149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGE 225 (270)
T ss_pred ccCceeeecccccceecCCCCccccccChhhhc--cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCC
Confidence 99999875433211 11223456799999987 4457889999999999999996 999998877665554433 333
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
..+.+..++..+.++|.+||..+|.+|||+.++++.|+.+..
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 445667789999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=357.80 Aligned_cols=260 Identities=35% Similarity=0.604 Sum_probs=232.1
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC--C---ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~--G---~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+|..+...+.++||.|.||.||+|+.+ | ..||||.+|... .+....+|+.|+.||.+..||||++|.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-------tekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-------cHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 3677788999999999999999999984 3 459999998643 345568999999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
|++.... ..+||+|||++|+|..+|...+..|++-++..|++.|+.||.||-++++|||||-+.|||++ ..+.|
T Consensus 697 GVVTks~--PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN----snLvC 770 (996)
T KOG0196|consen 697 GVVTKSK--PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN----SNLVC 770 (996)
T ss_pred EEEecCc--eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec----cceEE
Confidence 9998855 89999999999999999998888899999999999999999999999999999999999999 55789
Q ss_pred EEeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHh
Q 002908 730 KVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 804 (867)
Q Consensus 730 KL~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv 804 (867)
|++|||+++...+.. .+.+-.-+.+|.|||.+. .++++.+|||||||++|||.++ |.+||..+.+.+.+.. +
T Consensus 771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa--~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-I 847 (996)
T KOG0196|consen 771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-I 847 (996)
T ss_pred EeccccceeecccCCCccccccCCccceeecChhHhh--hcccCchhhccccceEEEEecccCCCcccccchHHHHHH-H
Confidence 999999999765433 112222357899999998 7889999999999999999998 9999999999998877 4
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 805 ~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+..++.|.|..|+..|.+||..||++|-.+||.|.+|+..|.++..
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 5678999999999999999999999999999999999999999865
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.27 Aligned_cols=253 Identities=36% Similarity=0.597 Sum_probs=206.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G-~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.+..++|++...||.|++|.||++.+.+ ..+|+|.+..... ....+.+|+.+++.++|||++++++++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3455789999999999999999998854 4799998764321 12457789999999999999999998754
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
...++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~----~~l~d 145 (260)
T cd05069 73 ---EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV----CKIAD 145 (260)
T ss_pred ---CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe----EEECC
Confidence 2578999999999999998653 345899999999999999999999999999999999999997654 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||++....... ......++..|+|||.+. ...++.++||||||+++|+|++ |..||...........+. .....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (260)
T cd05069 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRM 222 (260)
T ss_pred CccceEccCCcccccCCCccchhhCCHHHhc--cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99997543321 112234567899999987 4557889999999999999999 999998877666555443 33445
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 5566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=312.72 Aligned_cols=251 Identities=27% Similarity=0.339 Sum_probs=194.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC---CCCceeeEecccccC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQDG 655 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L---~HPNIVrL~g~~~~~ 655 (867)
+|++.+.||+|+||+||+|.+ +++.||+|.++........ ...+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 588999999999999999998 4778999998764322211 12334566666554 799999999987642
Q ss_pred ---CCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 656 ---PGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 656 ---~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.....++||||+. ++|..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~----~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ----VKL 149 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC----EEE
Confidence 2346899999996 58888775433 45899999999999999999999999999999999999997664 599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC---
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--- 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l--- 808 (867)
+|||++.............+|..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 99999986654433344568899999999973 4578899999999999999999999987665544433322100
Q ss_pred ---------------CC-------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 809 ---------------RP-------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 809 ---------------r~-------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.. .....++..+.+++.+||+.||.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0112456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=328.01 Aligned_cols=242 Identities=29% Similarity=0.421 Sum_probs=199.5
Q ss_pred EEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeE
Q 002908 586 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 586 k~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l 660 (867)
+.||+|+||.||++.. .++.||||+++..... ......+.+|+.+|++++||||+++++++.... .+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EE
Confidence 5799999999999875 3678999999754211 112345678999999999999999999998754 89
Q ss_pred EEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 661 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++...
T Consensus 74 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH----IKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc----EEEeeccCCccc
Confidence 999999999999998854 346899999999999999999999999999999999999997664 599999998754
Q ss_pred cCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHH
Q 002908 741 RNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSE 819 (867)
Q Consensus 741 ~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~e 819 (867)
... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ...+..+++.
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~ 224 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPE 224 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 332 22334568999999999984 456889999999999999999999998877766666555443 3455678899
Q ss_pred HHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 002908 820 WRLLMEQCWAPDPVVRPS-----FTEIARR 844 (867)
Q Consensus 820 L~dLI~kCLq~DPeeRPS-----a~ELLe~ 844 (867)
+.++|.+||+.+|.+||+ +.+++.+
T Consensus 225 ~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 225 AQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 999999999999999999 5556554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.29 Aligned_cols=250 Identities=34% Similarity=0.636 Sum_probs=206.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
..+|++.+.||.|+||.||++.+. +..+|+|.++..... ...|.+|+.++++++|||++++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTERS- 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEccCC-
Confidence 467899999999999999999885 778999988643221 235778999999999999999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++......+++..++.++.+++.+|+|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~----~~~l~d~g~~ 147 (256)
T cd05112 73 -PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ----VVKVSDFGMT 147 (256)
T ss_pred -ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC----eEEECCCcce
Confidence 78999999999999998876666789999999999999999999999999999999999998655 4599999998
Q ss_pred ccccCccc--cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 738 KIKRNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 738 ~~~~~~~~--~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.. ..+...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 224 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPR 224 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCCC
Confidence 75432211 122335678999999873 457889999999999999998 9999987766555554432 23444455
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
..+..+.+|+.+||+.+|.+||++.++++.|.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 67899999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.39 Aligned_cols=254 Identities=34% Similarity=0.538 Sum_probs=204.4
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEECC------------------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWRG------------------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~G------------------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~ 639 (867)
...+|++.+.||+|+||.||++.+.. ..||+|.+.... .......+.+|+.+++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-------SDNAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHh
Confidence 45688999999999999999987632 348999886432 11334678899999999
Q ss_pred CCCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhccc----------ccCCHHHHHHHHHHHHHHHHHHHHCCeec
Q 002908 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 709 (867)
Q Consensus 640 L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~----------~~Lse~~~l~Ia~QIa~ALayLHs~GIIH 709 (867)
++||||+++++++.... ..++||||+++++|..++.... ..+++..++.++.|++.||+|||+.||+|
T Consensus 76 l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 76 LSDPNIARLLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred cCCCCEeEEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 99999999999998754 8899999999999999886433 26899999999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 710 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 710 rDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
+||||+||+++.++ .++|+|||++...... .......+++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 154 ~dlkp~Nili~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 154 RDLATRNCLVGKNY----TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred cccchhceeecCCC----ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHh
Confidence 99999999999765 4599999998753222 12223446778999999873 457899999999999999998
Q ss_pred --CCCCCCCCChhHHHHhHhhc------CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 787 --GEEPYANMHYGAIIGGIVNN------TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 787 --Gk~PF~~~~~~e~l~~iv~~------~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+..||........+...... ....+.+..++.++.+++.+||+.+|.+|||+.+|++.|+
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 77888776665554443322 1122334456789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.93 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=199.0
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc------ChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 347899999999999999999987 478899999865321 122345677899999999999999999988643
Q ss_pred C----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 656 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 656 ~----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
. ....++||||+. ++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~----~kl 160 (355)
T cd07874 89 KSLEEFQDVYLVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKI 160 (355)
T ss_pred ccccccceeEEEhhhhc-ccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC----EEE
Confidence 2 235799999995 46666553 34788999999999999999999999999999999999997664 599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC---
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--- 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l--- 808 (867)
+|||+++............+|..|+|||++.+ ..++.++|||||||++|+|++|+.||........+..++....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred eeCcccccCCCccccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999986655444445678999999999984 4578899999999999999999999987654333222111000
Q ss_pred -------------------C------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 809 -------------------R------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 809 -------------------r------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
. .......+..+.+||.+||+.||++|||+.+++++.+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 0 00111235678999999999999999999999998544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.81 Aligned_cols=262 Identities=29% Similarity=0.516 Sum_probs=212.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCce
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 645 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNI 645 (867)
.+...+|++.+.||+|+||.||++++. +..||+|.++... .......+.+|+.+++.+ +||||
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------chHHHHHHHHHHHHHHhhccCCCc
Confidence 466788999999999999999999752 2358999886421 112235678899999999 89999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhcc---------------cccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 710 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~---------------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHr 710 (867)
+++++++.... ..++||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 84 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred hheeEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 99999998754 889999999999999998643 1357888999999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-
Q 002908 711 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT- 786 (867)
Q Consensus 711 DLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT- 786 (867)
||||+|||++.++ .++|+|||+++...... ......++..|+|||++. ...++.++||||||+++|+|++
T Consensus 162 dlkp~Nili~~~~----~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 162 DLAARNVLVTENN----VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred ccccceEEEcCCC----cEEECCCccceecccccccccccCCCCCceeeCchhhc--cCCCCchhhHHHHHHHHHHHHcC
Confidence 9999999998665 45999999998543321 122233567899999997 3457889999999999999998
Q ss_pred CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 787 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 787 Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
|..||...........+ ....+...+..++..+.+++.+||+.+|.+||++.++++.|+.+...+.
T Consensus 236 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 236 GGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred CCCCcccCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 88899887766655544 3334455566788999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.10 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=207.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|+||.||++.+ .+..||+|++...... ......+..|+.+++.++||||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 488899999999999999987 4678999998754221 22235677899999999999999999988765556
Q ss_pred eEEEEEEeecCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHH-----HCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 659 TLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLH-----SKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~---~~~Lse~~~l~Ia~QIa~ALayLH-----s~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
..+++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||+++.++. ++
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~----~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN----VK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC----EE
Confidence 789999999999999888543 467899999999999999999999 889999999999999997654 59
Q ss_pred EeecCCcccccCccc-cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 731 VGDFGLSKIKRNTLV-TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 731 L~DFGLA~~~~~~~~-~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
|+|||++........ .....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...........+. ....
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~ 227 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKF 227 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCC
Confidence 999999986544332 334568899999999984 457889999999999999999999998876554444433 3334
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
...+...+..+.+++.+||+.+|.+||++.+|+++
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 45666788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.85 Aligned_cols=255 Identities=27% Similarity=0.346 Sum_probs=212.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|..+++||+|.||+||+|++ +|+.||||.++.....++- ....+||+.+|+.++|+||+.++++|....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi------~~talREIK~Lqel~h~nIi~LiD~F~~~~- 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI------NRTALREIKLLQELKHPNIIELIDVFPHKS- 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc------cHHHHHHHHHHHHccCcchhhhhhhccCCC-
Confidence 4678889999999999999998 5889999999987655443 245679999999999999999999998865
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+.||+||| ..+|...+......++..++..++.++++||+|||.+.|+||||||.|+||+.+|.. ||+|||+|
T Consensus 75 -~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~l----KiADFGLA 148 (318)
T KOG0659|consen 75 -NLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQL----KIADFGLA 148 (318)
T ss_pred -ceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcE----Eeecccch
Confidence 899999999 688999998888899999999999999999999999999999999999999987754 99999999
Q ss_pred ccccCccc-cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC------
Q 002908 738 KIKRNTLV-TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP------ 810 (867)
Q Consensus 738 ~~~~~~~~-~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~------ 810 (867)
+.+..... .....-|.+|+|||.+.| ...|+..+|+||.||++.||+-|.+.|.+...-+.+..+......+
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfG-sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFG-SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhcc-chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 97654332 222357899999999998 4678999999999999999999999998877655544333211110
Q ss_pred ---------------C-----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 811 ---------------P-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 811 ---------------~-----ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
. .-..++.++.+|+.+||..||.+|.++.|++++-.-.
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 0 1123567789999999999999999999998875443
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=332.48 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=208.4
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||++.+. ++.||+|++...... .......+.+|+.+++.++||||+++++.+.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 445689999999999999999999984 678999998653211 1122345778999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... .+++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 114 ~~~--~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~----ikL~D 185 (371)
T cd05622 114 DDR--YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH----LKLAD 185 (371)
T ss_pred cCC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC----EEEEe
Confidence 754 89999999999999998843 35889999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~--~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
||++....... ......||+.|+|||++.+.. ..++.++|||||||++|+|++|..||...........++.....
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 99998553321 223456999999999997432 23788999999999999999999999887776666666554332
Q ss_pred --CCCCCCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHH
Q 002908 810 --PPVPGFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLR 846 (867)
Q Consensus 810 --~~ip~~~s~eL~dLI~kCLq~DPee--RPSa~ELLe~Lq 846 (867)
.+....++..+.++|.+||...+.+ |+++.+++++.+
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 3333467899999999999844433 789999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=342.09 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=210.5
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
...+|++.+.||+|+||+||++.+ +++.||||++...... +.....+.+|+.++..++|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 447999999999999999999987 5889999999754321 22345678899999999999999998876542
Q ss_pred CC------CeEEEEEEeecCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCC
Q 002908 656 PG------GTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 726 (867)
Q Consensus 656 ~~------~~l~LVmEy~~ggSL~d~L~~~---~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~ 726 (867)
.. ..+++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--- 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--- 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC---
Confidence 21 2478999999999999988543 35689999999999999999999999999999999999999765
Q ss_pred CcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH
Q 002908 727 PICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 803 (867)
Q Consensus 727 ~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i 803 (867)
.+||+|||+++..... .......||+.|+|||++. ...++.++|||||||+||+|++|+.||........+..+
T Consensus 181 -~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 181 -LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR--RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred -CEEEEecccCeeccccccccccccccCCcceeCHHHhC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 4699999999754322 1223456999999999998 455889999999999999999999999887776666665
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 804 v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..... .+.+..+++.+.+++.+||+.+|.+||++.+++.+.
T Consensus 258 ~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 258 LAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred hcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 54433 345667899999999999999999999999998763
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.91 Aligned_cols=244 Identities=25% Similarity=0.416 Sum_probs=200.5
Q ss_pred EEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCeEEE
Q 002908 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 586 k~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~l~L 662 (867)
+.||+|+||+||++.+. +..||||+++..... .......+.+|..++..+ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-----QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEE
Confidence 36999999999999984 678999999864321 112234567888898887 6999999999998754 8999
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-c
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-R 741 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~-~ 741 (867)
||||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++... .
T Consensus 74 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~----~kl~Dfg~~~~~~~ 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCKEGIL 148 (318)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc----EEecccCCCeecCc
Confidence 99999999999887543 46899999999999999999999999999999999999997664 599999998742 2
Q ss_pred CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHH
Q 002908 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821 (867)
Q Consensus 742 ~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~ 821 (867)
.........|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... ..+..++..+.
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--RYPRWLSKEAK 224 (318)
T ss_pred CCCcccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCHHHH
Confidence 2222334568999999999984 5578899999999999999999999988776666665554433 34566889999
Q ss_pred HHHHHhhcCCCCCCCCH-----HHHHHHH
Q 002908 822 LLMEQCWAPDPVVRPSF-----TEIARRL 845 (867)
Q Consensus 822 dLI~kCLq~DPeeRPSa-----~ELLe~L 845 (867)
+||.+||+.+|.+||++ .+++.+-
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 99999999999999999 8887763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=334.99 Aligned_cols=261 Identities=30% Similarity=0.477 Sum_probs=214.6
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCce
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNV 645 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNI 645 (867)
.+.+..++|.+.+.||+|+||.||+|++.+ ..||||+++.... ......+.+|+.+|.++. ||||
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-------SSEKQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-------hhHHHHHHHHHHHHHhcCCCCCe
Confidence 367888899999999999999999998743 4699999975321 112346789999999997 9999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------------------------------------
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------------------------------------- 680 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~--------------------------------------------- 680 (867)
++++++|.... ..++||||+.+|+|.+++....
T Consensus 104 v~~~~~~~~~~--~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (401)
T cd05107 104 VNLLGACTKGG--PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM 181 (401)
T ss_pred EEEEEEEccCC--CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence 99999998754 8999999999999999885421
Q ss_pred ----------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCee
Q 002908 681 ----------------------------------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 708 (867)
Q Consensus 681 ----------------------------------------------------~~Lse~~~l~Ia~QIa~ALayLHs~GII 708 (867)
..+++..++.++.||+.||.|||+.+|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 261 (401)
T cd05107 182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261 (401)
T ss_pred CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcC
Confidence 2367778899999999999999999999
Q ss_pred ccCCCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHH
Q 002908 709 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785 (867)
Q Consensus 709 HrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELL 785 (867)
||||||+|||++.++ .++|+|||+++..... .......++..|+|||.+.+ ..++.++|||||||++|||+
T Consensus 262 Hrdlkp~NiLl~~~~----~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l 335 (401)
T cd05107 262 HRDLAARNVLICEGK----LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIF 335 (401)
T ss_pred cccCCcceEEEeCCC----EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHH
Confidence 999999999998654 4699999999854321 11223346788999999973 45788999999999999999
Q ss_pred h-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 786 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 786 T-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+ |..||............+....+.+.+..++..+.+++.+||..+|.+||++.+|+..|+.+.
T Consensus 336 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 336 TLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 8 899998766555555555556666677778999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.21 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=210.3
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
+..++|++.+.||+|+||.||+|.+. +..|++|+++... .......+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------SEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 56788999999999999999999984 3669999876321 2223466788999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCC
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE-------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 723 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg 723 (867)
++... ....+++++|+++++|..++.... ..+++..++.++.|++.||+|||+++++|+||||+||+++.++
T Consensus 76 ~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~ 154 (280)
T cd05043 76 VCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL 154 (280)
T ss_pred EEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC
Confidence 87654 246789999999999999885432 4589999999999999999999999999999999999998664
Q ss_pred CCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 002908 724 PIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 799 (867)
Q Consensus 724 ~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~ 799 (867)
.++|+|||+++...... ......++..|+|||++. ...++.++|||||||++|++++ |+.||........
T Consensus 155 ----~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 228 (280)
T cd05043 155 ----QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV--NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228 (280)
T ss_pred ----cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHh--cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence 45999999997542211 112234567899999997 4457899999999999999999 9999987665444
Q ss_pred HHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 800 l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
... .........+..+++.+.+++.+||..+|++|||+.+++..|+.+..
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 229 AAY-LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHH-HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 433 33344445556678999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.41 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=202.1
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
....+|++.+.||+|+||.||+|.+ .++.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--------DDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--------chHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 4456899999999999999999997 477899999864311 112346789999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++. ++|+||
T Consensus 78 ~~--~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~----~~l~df 150 (267)
T cd06646 78 RE--KLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD----VKLADF 150 (267)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC----EEECcC
Confidence 54 89999999999999988854 346899999999999999999999999999999999999986664 599999
Q ss_pred CCcccccCcc-ccCCcCCCCCccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 735 GLSKIKRNTL-VTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 735 GLA~~~~~~~-~~s~~~GT~~Y~APEvl~g~-~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
|++....... ......++..|+|||.+.+. ...++.++|||||||++|+|++|..||...........+.......+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd06646 151 GVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK 230 (267)
T ss_pred ccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCC
Confidence 9998543221 22345688899999998532 344678999999999999999999998655433332222222222221
Q ss_pred ---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 813 ---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 813 ---p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
...++..+.++|.+||+.+|++||++++++++|
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 234678999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=326.70 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=199.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc------CchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 47899999999999999999987 478899999865321 1222356778999999999999999999876432
Q ss_pred ----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
....++||||+. ++|...+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++. ++|+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~----~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKIL 168 (364)
T ss_pred cccccCeEEEEEeCCC-CCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc----EEEE
Confidence 235799999995 56666653 34788999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC---
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 809 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr--- 809 (867)
|||+++............+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..++.....
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999986655444445568999999999984 56788999999999999999999999876654443333221000
Q ss_pred -----------------C--------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 810 -----------------P--------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 810 -----------------~--------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+ ......+..+.+||.+||+.||.+|||+.+++++.+-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 0 0011134578999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=315.34 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=191.0
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 588 LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 588 LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
||+|+||.||++.. .|+.||+|.+....... ......+..|+++++.++||||+++++++.... ..++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-----KSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-----chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEe
Confidence 69999999999987 47889999986432211 111234556999999999999999999998754 8999999
Q ss_pred eecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc
Q 002908 666 FMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744 (867)
Q Consensus 666 y~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~ 744 (867)
|+++++|..++.... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~----~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC----EEEeeceeeeecCCCc
Confidence 999999988875433 45899999999999999999999999999999999999997654 5999999988654433
Q ss_pred ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh----HHHHhHhhcCCCCCCCCCCcHHH
Q 002908 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----AIIGGIVNNTLRPPVPGFCDSEW 820 (867)
Q Consensus 745 ~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~----e~l~~iv~~~lr~~ip~~~s~eL 820 (867)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ............. ....++.++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (277)
T cd05607 150 TITQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEES 226 (277)
T ss_pred eeeccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHH
Confidence 3334568999999999984 44889999999999999999999999764332 2222222222211 123578899
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHH
Q 002908 821 RLLMEQCWAPDPVVRPSFTEIAR 843 (867)
Q Consensus 821 ~dLI~kCLq~DPeeRPSa~ELLe 843 (867)
.+++.+||+.+|.+||++.++++
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchh
Confidence 99999999999999999966543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.53 Aligned_cols=260 Identities=33% Similarity=0.540 Sum_probs=207.8
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceee
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVr 647 (867)
|.+..++|++.+.||+|+||.||+|.++ +..||||.+.... .......+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~ 73 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-------SLRERIEFLNEASVMKGFTCHHVVR 73 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-------CHHHHHHHHHHHHHHHhCCCCCeee
Confidence 3567789999999999999999998753 3469999875321 1112345788999999999999999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceE
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 718 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNIL 718 (867)
+++++.... ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 74 ~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nil 151 (288)
T cd05061 74 LLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 151 (288)
T ss_pred EEEEEcCCC--CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEE
Confidence 999988754 7899999999999999986421 23467788899999999999999999999999999999
Q ss_pred eccCCCCCCcEEEeecCCcccccCccc---cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCC
Q 002908 719 VNLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM 794 (867)
Q Consensus 719 Ld~dg~~~~~vKL~DFGLA~~~~~~~~---~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~ 794 (867)
++.++. ++|+|||+++....... .....++..|+|||.+. ...++.++|||||||++|+|++ |..||...
T Consensus 152 i~~~~~----~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 152 VAHDFT----VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred EcCCCc----EEECcCCccccccccccccccCCCcccccccCHHHhc--cCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 996654 59999999874322111 11223467899999987 4457889999999999999998 78899887
Q ss_pred ChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 795 HYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 795 ~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
........+.... ....+..+++.+.+++.+||+.+|.+|||+.++++.|+....
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 226 SNEQVLKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 7666555544432 234455678999999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.16 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=202.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|+..+.||.|+||+||++.+ +++.||+|.+...... .......+.+|+.+++.++|+||+++++.+...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-----KRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--
Confidence 377888999999999999998 4778999998653221 1122345678999999999999999999988754
Q ss_pred eEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|..++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~----~~kl~Dfg~~ 149 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG----HIRISDLGLA 149 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC----CEEEecCCcc
Confidence 8999999999999998876443 4699999999999999999999999999999999999998665 4699999998
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc--CCCCCCCCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPPVPGF 815 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~--~lr~~ip~~ 815 (867)
.............|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+... ......+..
T Consensus 150 ~~~~~~~~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 150 VKIPEGESIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227 (285)
T ss_pred eecCCCCcccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCcc
Confidence 75443333334568999999999973 45788999999999999999999999876554332222211 112234456
Q ss_pred CcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPS-----FTEIARRL 845 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~L 845 (867)
++..+.+|+.+||+.+|.+||+ +.+++.+-
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP 262 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcCh
Confidence 7889999999999999999999 77887763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=368.99 Aligned_cols=359 Identities=24% Similarity=0.321 Sum_probs=242.0
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCCCCCCCCCCccccccCCc------
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNE------ 531 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn~------ 531 (867)
++++.+|..|++++.|+.|++++|+|+ |. +|..+.+..+...++.+|..+|++......|...........
T Consensus 558 ~l~~~~p~~l~~l~~L~~l~ls~N~l~--~~-~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~ 634 (968)
T PLN00113 558 QLSGEIPKNLGNVESLVQVNISHNHLH--GS-LPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITC 634 (968)
T ss_pred cccccCChhHhcCcccCEEeccCCcce--ee-CCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhH
Confidence 678899999999999999999999999 95 999999999999999999999986533211111000000000
Q ss_pred chh----hHH---Hhhhcccccc-cccCCCCCCCCCCccccccCCCCCc-----cccccccCCeeEEEEeeecCcEEEEE
Q 002908 532 SLQ----SEV---VNHRIQESDY-EEGRLDLPTAGIPLVDLALGNFDIS-----TLQIIKNEDLEELKELGSGTFGTVYH 598 (867)
Q Consensus 532 sL~----sel---v~~~~~e~~~-~~~~l~lP~ag~pl~~~a~~~fd~~-----~l~~I~~sdyqilk~LG~GafG~VYk 598 (867)
.+. ..+ +..+...... ...+....... .....+... ....+ ...|...+.||+|+||.||+
T Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ig~G~~g~Vy~ 708 (968)
T PLN00113 635 TLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT-----WELQFFDSKVSKSITINDI-LSSLKEENVISRGKKGASYK 708 (968)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhccccccccccccc-----ccccccccccchhhhHHHH-HhhCCcccEEccCCCeeEEE
Confidence 000 000 0000000000 00000000000 000001100 01111 13466778899999999999
Q ss_pred EEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEEeecCCchhhhh
Q 002908 599 GKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 676 (867)
Q Consensus 599 a~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L 676 (867)
|.+ .+..||||.++.... ....|++++++++|||||+++++|.+.. ..++||||+++++|.+++
T Consensus 709 ~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~Ey~~~g~L~~~l 774 (968)
T PLN00113 709 GKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIHEYIEGKNLSEVL 774 (968)
T ss_pred EEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEEeCCCCCcHHHHH
Confidence 997 578899998864211 1123577899999999999999998754 789999999999999998
Q ss_pred hcccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCC
Q 002908 677 LSKERHLDRRKRLIIAMDAAFGMEYLH---SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 753 (867)
Q Consensus 677 ~~~~~~Lse~~~l~Ia~QIa~ALayLH---s~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~ 753 (867)
. .+++..+..|+.|++.||+||| +.+|+||||||+||+++.++.. ++. ||........ ....+++
T Consensus 775 ~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~----~~~-~~~~~~~~~~---~~~~~t~ 842 (968)
T PLN00113 775 R----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP----HLR-LSLPGLLCTD---TKCFISS 842 (968)
T ss_pred h----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCce----EEE-eccccccccC---CCccccc
Confidence 4 3899999999999999999999 6699999999999999976543 443 5554432211 1235789
Q ss_pred CccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--HHHH--h----------HhhcCCCC--CCCCCCc
Q 002908 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AIIG--G----------IVNNTLRP--PVPGFCD 817 (867)
Q Consensus 754 ~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~--e~l~--~----------iv~~~lr~--~ip~~~s 817 (867)
.|+|||++. ...++.++|||||||++|||+||+.||...... .... . .++..... +.+....
T Consensus 843 ~y~aPE~~~--~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (968)
T PLN00113 843 AYVAPETRE--TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI 920 (968)
T ss_pred cccCccccc--CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHH
Confidence 999999988 456889999999999999999999998542110 0100 0 00001100 0111122
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
..+.+++.+||+.+|.+|||+.++++.|+.+....+
T Consensus 921 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 921 VEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred HHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 356788999999999999999999999999866443
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.98 Aligned_cols=266 Identities=30% Similarity=0.514 Sum_probs=213.6
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 644 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPN 644 (867)
+.+..++|.+.+.||+|+||.||++++. ...+|+|+++.... ......+..|+.+++.+ +|||
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-------DKDLADLISEMELMKLIGKHKN 79 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhccCCCC
Confidence 4566789999999999999999999752 34589998864311 12245678899999999 6999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhcc---------------cccCCHHHHHHHHHHHHHHHHHHHHCCeec
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVH 709 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~---------------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIH 709 (867)
|+++++++.... ..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+|
T Consensus 80 iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H 157 (314)
T cd05099 80 IINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH 157 (314)
T ss_pred eeeEEEEEccCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 999999987744 789999999999999988542 235889999999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCccc---cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 710 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 710 rDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~---~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
|||||+|||++.++. ++|+|||+++....... .....++..|+|||++. ...++.++|||||||++|+|++
T Consensus 158 ~dlkp~Nill~~~~~----~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~ 231 (314)
T cd05099 158 RDLAARNVLVTEDNV----MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFT 231 (314)
T ss_pred ccccceeEEEcCCCc----EEEccccccccccccccccccccCCCCccccCHHHHc--cCCcCccchhhHHHHHHHHHHh
Confidence 999999999987654 59999999975432111 11122446799999987 3457889999999999999999
Q ss_pred -CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCCC
Q 002908 787 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKS 856 (867)
Q Consensus 787 -Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~~ 856 (867)
|..||...........+.. ......+..++..+.+++.+||..+|.+||++.++++.|+.+........
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 301 (314)
T cd05099 232 LGGSPYPGIPVEELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEY 301 (314)
T ss_pred CCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCc
Confidence 8999988766555554433 33445566788999999999999999999999999999999887665443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.33 Aligned_cols=253 Identities=37% Similarity=0.584 Sum_probs=206.3
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~-------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
+.+.+|++.++||+|+||.||++.. .+..+|+|.++... ......+.+|+++++.++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--------HHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 4567889999999999999999874 24568999876421 22345788999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhccc--------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCc
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 715 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~--------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPs 715 (867)
+++.... ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 151 (280)
T cd05092 74 GVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151 (280)
T ss_pred EEEecCC--ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence 9988754 7899999999999999886432 34789999999999999999999999999999999
Q ss_pred ceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCC
Q 002908 716 NLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 791 (867)
Q Consensus 716 NILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF 791 (867)
|||++.++ .++|+|||++....... ......+++.|+|||.+. ...++.++|||||||++|+|++ |.+||
T Consensus 152 nil~~~~~----~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~ 225 (280)
T cd05092 152 NCLVGQGL----VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDIWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred hEEEcCCC----CEEECCCCceeEcCCCceeecCCCccccccccCHHHhc--cCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99998654 46999999987443211 112233567899999988 4457899999999999999998 99999
Q ss_pred CCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 792 ~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
...........+... .....+..+++.+.+++.+||+.+|.+||++.+|++.|+
T Consensus 226 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 226 YQLSNTEAIECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ccCCHHHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 877666655554433 334456678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.46 Aligned_cols=244 Identities=23% Similarity=0.370 Sum_probs=195.6
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCeEEEE
Q 002908 587 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 587 ~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
.||+|+||.||++.+ .+..||||+++..... .......+.+|..++..+ +||||+++++++.... .+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~lv 74 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-----DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFFV 74 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEEE
Confidence 699999999999998 4778999999864321 122235577899999988 6999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-cC
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~-~~ 742 (867)
|||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++... ..
T Consensus 75 ~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~----~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 75 IEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH----IKLTDYGMCKEGIRP 149 (329)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC----EEECcCccccccccC
Confidence 999999999888753 356999999999999999999999999999999999999997654 599999998742 22
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--------h-hHHHHhHhhcCCCCCCC
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--------Y-GAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~--------~-~e~l~~iv~~~lr~~ip 813 (867)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... . ......+... ....+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p 225 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIP 225 (329)
T ss_pred CCccccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCC
Confidence 223334578999999999984 457889999999999999999999996321 1 1122223332 23456
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCC------HHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPS------FTEIARRLR 846 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPS------a~ELLe~Lq 846 (867)
..++..+.++|.+||+.+|.+||+ +.+++++-+
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 678899999999999999999987 678876633
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.42 Aligned_cols=250 Identities=38% Similarity=0.522 Sum_probs=199.5
Q ss_pred eeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
|++++.||+|+||+||++... +..+|+|++.... ..........+|+.+++.++||||+++++++.... .
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--Y 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--E
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhccccccccccccccccccccc--c
Confidence 789999999999999999995 5579999998642 22222334456999999999999999999998844 8
Q ss_pred EEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.++|||++.+++|.+++. ....+++..++.++.||++||.+||+.||+|+||||+|||++.++. ++|+|||.+..
T Consensus 73 ~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~----~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE----VKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE----EEESSGTTTEE
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccc
Confidence 999999999989999986 4567899999999999999999999999999999999999996654 49999999975
Q ss_pred c-cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHhHhhcCCCCCC--C
Q 002908 740 K-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNNTLRPPV--P 813 (867)
Q Consensus 740 ~-~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---e~l~~iv~~~lr~~i--p 813 (867)
. ..........++..|+|||++.. ...++.++||||||+++|+|++|..||...... ............... .
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 2 33334445668999999999872 345788999999999999999999999887322 222222221111111 1
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
......+.+++.+||+.+|.+||++.+++++.
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 12248999999999999999999999998753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=312.98 Aligned_cols=256 Identities=30% Similarity=0.529 Sum_probs=202.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 580 EDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
..|++++.||+|+||.||++.+ .+..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3478889999999999999875 25679999986431 1222456889999999999999999999987
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.......++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~----~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ----VKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC----EEECC
Confidence 75445789999999999999998655556899999999999999999999999999999999999986654 59999
Q ss_pred cCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--------------
Q 002908 734 FGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-------------- 795 (867)
Q Consensus 734 FGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~-------------- 795 (867)
||++....... ......++..|+|||++. ...++.++|||||||++|+|++++.|+....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI--QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhc--cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 99998543221 112344677899999987 3457889999999999999999876642210
Q ss_pred hhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 796 ~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
...............+.+..++..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00111122223334455667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.53 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=203.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||++.. .++.||||+++.... ........+.+|+.++..++||||+++++.+.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-----LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 4688999999999999999988 478899999975321 11223456778999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~----vkL~DfG~~ 148 (360)
T cd05627 75 -NLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH----VKLSDFGLC 148 (360)
T ss_pred -EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC----EEEeeccCC
Confidence 89999999999999998854 346899999999999999999999999999999999999987664 599999998
Q ss_pred ccccCcc------------------------------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHH
Q 002908 738 KIKRNTL------------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVL 781 (867)
Q Consensus 738 ~~~~~~~------------------------------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLL 781 (867)
....... ......||+.|+|||++. ...++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~~~~~DiwSlGvil 226 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM--QTGYNKLCDWWSLGVIM 226 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc--CCCCCCcceecccccee
Confidence 6432110 011346899999999998 45578899999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHhHhhcCCCCCC--CCCCcHHHHHHHHHhhcCCCCCCC---CHHHHHHHHH
Q 002908 782 WEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PGFCDSEWRLLMEQCWAPDPVVRP---SFTEIARRLR 846 (867)
Q Consensus 782 yELLTGk~PF~~~~~~e~l~~iv~~~lr~~i--p~~~s~eL~dLI~kCLq~DPeeRP---Sa~ELLe~Lq 846 (867)
|+|++|+.||...........+......... ...+++.+.++|.+|+. +|.+|+ ++.+++++-+
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 9999999999887776666665543222222 23468899999999774 999998 4788887743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.83 Aligned_cols=254 Identities=32% Similarity=0.563 Sum_probs=206.3
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
+...+|++.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEE
Confidence 45678999999999999999999863 4679999986432 122345688999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhccc---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCee
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 708 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------------~~Lse~~~l~Ia~QIa~ALayLHs~GII 708 (867)
+++..+. ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++++
T Consensus 75 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~ 152 (288)
T cd05050 75 GVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152 (288)
T ss_pred EEEcCCC--ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9998754 7899999999999999885321 2478889999999999999999999999
Q ss_pred ccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHH
Q 002908 709 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785 (867)
Q Consensus 709 HrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELL 785 (867)
||||||+|||++.++. ++|+|||++....... .......+..|+|||.+. ...++.++|||||||++|+|+
T Consensus 153 H~dl~p~nil~~~~~~----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 153 HRDLATRNCLVGENMV----VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIF 226 (288)
T ss_pred cccccHhheEecCCCc----eEECccccceecccCccccccCCCccChhhcCHHHHh--cCCCCchhHHHHHHHHHHHHH
Confidence 9999999999986654 5999999987432221 112223466799999987 445788999999999999999
Q ss_pred h-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 786 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 786 T-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+ |..||...........+..... .+.+..++..+.+|+.+||+.+|.+|||+.|+++.|+
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 227 SYGMQPYYGMAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 8 8889987776666555444332 3445677899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.48 Aligned_cols=243 Identities=28% Similarity=0.437 Sum_probs=196.3
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCeEEE
Q 002908 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 586 k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~l~L 662 (867)
+.||+|+||.||+|++ ++..||||+++...... +.....+..|..++..+ .||||+++++++.... .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-----DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEE
Confidence 3699999999999998 47789999997642211 11123456677777754 8999999999998754 8999
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 741 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~- 741 (867)
||||+.+++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++....
T Consensus 74 v~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~----~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH----IKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC----EEeCccCCCeeccc
Confidence 9999999999988854 356899999999999999999999999999999999999997664 5999999987421
Q ss_pred CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHH
Q 002908 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821 (867)
Q Consensus 742 ~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~ 821 (867)
.........||+.|+|||++. ...++.++|||||||++|+|++|..||...........+... .+..+..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQ--GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESK 224 (316)
T ss_pred CCCceeccCCCcCccCHHHHc--CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence 122233456899999999998 445788999999999999999999999887766666554433 2345567899999
Q ss_pred HHHHHhhcCCCCCCCCHH-HHHHH
Q 002908 822 LLMEQCWAPDPVVRPSFT-EIARR 844 (867)
Q Consensus 822 dLI~kCLq~DPeeRPSa~-ELLe~ 844 (867)
++|.+||+.||.+||++. +++.+
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcC
Confidence 999999999999999984 66644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.02 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=205.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCC-ChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGR-SSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~-~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
+|.+...||.|++|.||+|.+ .+..+|+|.+........ ..........+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 366778999999999999987 467899999876533222 1122334567889999999999999999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||.+
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~----~~l~dfg~~ 153 (267)
T cd06628 80 -HLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG----IKISDFGIS 153 (267)
T ss_pred -ccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC----EEecccCCC
Confidence 889999999999999988543 56889999999999999999999999999999999999986654 599999998
Q ss_pred ccccCcc-------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 738 KIKRNTL-------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 738 ~~~~~~~-------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
....... ......++..|+|||.+. ...++.++|+|||||++|+|++|+.||...........+.. ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~ 230 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVK--QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASP 230 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhc--cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCC
Confidence 7543211 111234788999999997 44578899999999999999999999987665444444333 3345
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..+..++..+.++|.+||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 231 EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 5666788999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.40 Aligned_cols=255 Identities=28% Similarity=0.478 Sum_probs=224.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|..++.+|+|+||.+++++++ +..+++|.+.....+++. .....+|+.+++++.|||||.+++.|....
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~------r~~A~~E~~lis~~~hP~iv~y~ds~~~~~- 76 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE------RRSAIQEMDLLSKLLHPNIVEYKDSFEEDG- 76 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh------hHHHHHHHHHHHhccCCCeeeeccchhcCC-
Confidence 57888999999999999988874 567999999876544332 235678999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++|||+||+||+|.+.+.... ..|++..++.++.||+.|+.|||++.|+|||||+.|||++.++.+ +|+|||+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~V----kLgDfGl 152 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKV----KLGDFGL 152 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCce----eecchhh
Confidence 23999999999999999987554 679999999999999999999999999999999999999977654 9999999
Q ss_pred cccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 737 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 737 A~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
|+...... ....+.||+.||+||++. ...|..|+|||||||++|||++-+++|...+....+.++.... -.+++..
T Consensus 153 aK~l~~~~~~a~tvvGTp~YmcPEil~--d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ 229 (426)
T KOG0589|consen 153 AKILNPEDSLASTVVGTPYYMCPEILS--DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSM 229 (426)
T ss_pred hhhcCCchhhhheecCCCcccCHHHhC--CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCcc
Confidence 99887765 667788999999999999 5678999999999999999999999999999988888888776 4677889
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
++.+++.+|+.||..+|+.||++.+||.+.-..
T Consensus 230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 230 YSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 999999999999999999999999999875444
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.06 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=208.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|+..+.||+|++|.||++.. .+..+|||.+...... ......+.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT------KDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--
Confidence 588999999999999999887 4778999998754322 122456889999999999999999999987744
Q ss_pred eEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++... ...+++..+..++.+++.+|.|||++|++|+||+|+||+++.++. .++|+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~---~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM---VVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEEccCCCc
Confidence 899999999999999998654 345899999999999999999999999999999999999985542 4699999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
.............++..|+|||.+. ...++.++||||||+++|+|++|..||...........+.... ..+.+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCE--GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-FAPISDRYS 226 (256)
T ss_pred eecCCCccccccccCCcccCchhcc--CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC-CCCCCCCcC
Confidence 8665444434456889999999998 4457889999999999999999999998876665555544433 334566688
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..+.+++.+||+.+|.+|||+.+++.+
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.96 Aligned_cols=243 Identities=29% Similarity=0.442 Sum_probs=196.5
Q ss_pred EEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh-CCCCceeeEecccccCCCCeEEE
Q 002908 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 586 k~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~-L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
+.||+|+||.||+|++. ++.||||+++...... +.....+..|..++.. ++||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEE
Confidence 36999999999999984 6779999997643211 1122345667778876 48999999999998854 8999
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 741 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~- 741 (867)
||||+++++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++....
T Consensus 74 v~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~----~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH----IKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC----EEEccCCcceECCC
Confidence 9999999999988854 346899999999999999999999999999999999999997664 5999999987421
Q ss_pred CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHH
Q 002908 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821 (867)
Q Consensus 742 ~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~ 821 (867)
.........||+.|+|||++. ...++.++|||||||++|+|++|..||...........+.... +..+..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILL--GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAK 224 (316)
T ss_pred CCCceeeecCCccccCHHHHc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHH
Confidence 122233456899999999998 4457899999999999999999999998877666655544332 334556889999
Q ss_pred HHHHHhhcCCCCCCCCHH-HHHHH
Q 002908 822 LLMEQCWAPDPVVRPSFT-EIARR 844 (867)
Q Consensus 822 dLI~kCLq~DPeeRPSa~-ELLe~ 844 (867)
+++.+||+.+|.+||++. +++.+
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHHcC
Confidence 999999999999999997 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.96 Aligned_cols=252 Identities=28% Similarity=0.417 Sum_probs=205.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||.|++|.||+|.+ .+..+++|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--------DDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--------hhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 46899999999999999999988 367899999975321 12356788999999999999999999988754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.++++|||+.+++|.+++......+++..+..++.|++.||.|||+++|+|+||+|+||+++.++. ++|+|||+
T Consensus 74 --~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~----~~l~d~g~ 147 (262)
T cd06613 74 --KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD----VKLADFGV 147 (262)
T ss_pred --EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC----EEECcccc
Confidence 899999999999999988665567999999999999999999999999999999999999997664 59999999
Q ss_pred cccccCcc-ccCCcCCCCCccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC---
Q 002908 737 SKIKRNTL-VTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--- 811 (867)
Q Consensus 737 A~~~~~~~-~~s~~~GT~~Y~APEvl~g~-~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~--- 811 (867)
+....... ......++..|+|||.+.+. ...++.++|+|||||++|+|++|..||................+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227 (262)
T ss_pred chhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence 87543322 22345678899999998742 12678899999999999999999999987665544443333322221
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+..++.++.+++.+||..+|.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 223456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.65 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=202.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~ 655 (867)
.+.|++.+.||+|+||.||+|.+ .++.||+|++..... ....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 35677888999999999999988 467899999864321 124567889999998 699999999998653
Q ss_pred C----CCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 656 P----GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 656 ~----~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
. ...+++||||+.+++|.+++... ...+++..+..++.|++.||+|||+++|+|+||+|+||+++.++. ++
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~----~~ 151 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE----VK 151 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC----EE
Confidence 2 24689999999999999988653 356899999999999999999999999999999999999997654 59
Q ss_pred EeecCCcccccCc-cccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc
Q 002908 731 VGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806 (867)
Q Consensus 731 L~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~ 806 (867)
|+|||++...... .......|+..|+|||++.+. ...++.++|||||||++|+|++|..||...............
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~ 231 (272)
T cd06637 152 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 231 (272)
T ss_pred EccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC
Confidence 9999998754322 223345688999999998632 235778999999999999999999999776554444433333
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..+......++..+.+|+.+||..+|.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 33333445678899999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=324.45 Aligned_cols=242 Identities=28% Similarity=0.394 Sum_probs=195.5
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHH-HHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 587 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 587 ~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEie-iLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
.||+|+||+||+|.+ +++.||||++...... .......+..|.. +++.++||||+++++++.... ..++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~lv 74 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-----KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYFV 74 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEEE
Confidence 699999999999998 4788999999753211 1112234455554 467899999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-cC
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~-~~ 742 (867)
|||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++... ..
T Consensus 75 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~----~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 75 LDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH----VVLTDFGLCKEGIEH 149 (323)
T ss_pred EcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc----EEEeccCCCcccccC
Confidence 999999999988854 456899999999999999999999999999999999999997664 599999998743 22
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
........||+.|+|||++. ...++.++|||||||++|+|++|..||...........+..... ..+..++..+.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~ 225 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLR--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSARH 225 (323)
T ss_pred CCccccccCChhhcChhhhc--CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence 22333456899999999998 44578899999999999999999999988777666666555433 234457899999
Q ss_pred HHHHhhcCCCCCCCCH----HHHHHH
Q 002908 823 LMEQCWAPDPVVRPSF----TEIARR 844 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa----~ELLe~ 844 (867)
+|.+||+.+|.+||++ .+++.+
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 226 LLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 9999999999999987 466554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.91 Aligned_cols=255 Identities=32% Similarity=0.513 Sum_probs=201.4
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEECC----------------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWRG----------------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~G----------------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L 640 (867)
+...+|++.+.||+|+||.||++++.+ ..||||.++.... ......|.+|+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~ei~~l~~l 74 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-------KTARNDFLKEIKIMSRL 74 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhC
Confidence 456789999999999999999987632 2389999864321 12245688999999999
Q ss_pred CCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhccc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCeec
Q 002908 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 709 (867)
Q Consensus 641 ~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-----------~~Lse~~~l~Ia~QIa~ALayLHs~GIIH 709 (867)
+||||+++++++.... ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|
T Consensus 75 ~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H 152 (295)
T cd05097 75 KNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVH 152 (295)
T ss_pred CCCCcCeEEEEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 9999999999998754 8899999999999999885432 24688899999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 710 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 710 rDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
+||||+|||++.++. ++|+|||++....... ......++..|+|||++. ...++.++|||||||++|+|++
T Consensus 153 ~dlkp~Nill~~~~~----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 153 RDLATRNCLVGNHYT----IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred cccChhhEEEcCCCc----EEecccccccccccCcceeccCcCcCceeecChhhhc--cCCcCchhhHHHHHHHHHHHHH
Confidence 999999999986653 6999999987532211 112233567899999987 4457899999999999999998
Q ss_pred --CCCCCCCCChhHHHHhHhh------cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 787 --GEEPYANMHYGAIIGGIVN------NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 787 --Gk~PF~~~~~~e~l~~iv~------~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+..||.............. .......+..+++.+.+|+.+||+.+|.+||++.++++.|+
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 227 LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6678877665554433221 11122334457899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=306.98 Aligned_cols=249 Identities=34% Similarity=0.623 Sum_probs=206.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
+...+|++.+.||+|+||.||++...++.||+|.++... ....+.+|+.+++.++|||++++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 344679999999999999999999999999999986421 124678899999999999999999998653
Q ss_pred CCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||
T Consensus 72 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~----~kl~Dfg 145 (254)
T cd05083 72 --GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV----AKVSDFG 145 (254)
T ss_pred --CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc----EEECCCc
Confidence 4689999999999999986543 35899999999999999999999999999999999999987654 5999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
++....... .....+..|+|||.+. ...++.++|+|||||++|+|++ |+.||...........+ ......+.+.
T Consensus 146 ~~~~~~~~~--~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~ 220 (254)
T cd05083 146 LARVGSMGV--DNSKLPVKWTAPEALK--HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPPE 220 (254)
T ss_pred cceeccccC--CCCCCCceecCHHHhc--cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-hCCCCCCCCC
Confidence 987543221 2233467899999987 4457889999999999999998 99999887766555443 3344555566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.++..+.+++.+||+.+|.+||++.+++..|+.
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.44 Aligned_cols=258 Identities=32% Similarity=0.573 Sum_probs=212.4
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--Cc----eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~----~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+...+|++.+.||+|+||.||+|.+. +. .+|+|.+..... .....++.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------PKANKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456788999999999999999999873 32 589998764321 23345688999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++.. ...++||||+++++|.+++......+++..++.++.||+.||+|||++||+|+||+|+|||++.++ .+
T Consensus 76 ~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~----~~ 148 (279)
T cd05057 76 GICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ----HV 148 (279)
T ss_pred EEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC----eE
Confidence 99876 378899999999999999977666799999999999999999999999999999999999998665 45
Q ss_pred EEeecCCcccccCccc---cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~---~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
+|+|||+++....... .....++..|+|||.+. ...++.++|+|||||++|+|++ |..||...........+.
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~- 225 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL--HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE- 225 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhh--cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-
Confidence 9999999985432221 11222356799999987 4567889999999999999999 999998877665554443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.....+.+..++..+.+++.+||..+|.+||++.++++.|..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 226 KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 334455566788999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.69 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=203.7
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|++.+.||+|+||.||++.+. ++.||||.+...... .......+.+|+.+++.++|++++.+++.+....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-----chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 3778889999999999999984 778999998754322 1122345678999999999999999999988754
Q ss_pred eEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++. ++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~----~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH----IRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC----EEEeeccce
Confidence 8999999999999998885433 46899999999999999999999999999999999999997654 599999998
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHhHhhcCCCCCCCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---e~l~~iv~~~lr~~ip~ 814 (867)
.............|+..|+|||++. ...++.++|||||||++|+|++|..||...... ........ ......+.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVK--NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSE 226 (285)
T ss_pred eecCCCccccCCCCCccccChHHHc--CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCc
Confidence 7544333333456899999999998 455788999999999999999999999864432 11222211 12223455
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLRVM 848 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq~l 848 (867)
.+++++.+|+.+||+.+|.+||| +.+++++.+-.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 67889999999999999999999 89999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.27 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=208.3
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|+.++.||.|+||.||.+.. ++..+++|.+...... ......+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS------EKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--
Confidence 588999999999999988876 4788999998654322 223456789999999999999999999998854
Q ss_pred eEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~----~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL----IKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC----EEECcCcce
Confidence 899999999999999998654 456899999999999999999999999999999999999997664 599999999
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...... +.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 225 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVY 225 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCcccc
Confidence 8543322 2234568899999999884 44678899999999999999999999887766666665544433 344667
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+..+.+++.+||..+|.+||++.++++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 89999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.51 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=204.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||++... ++.||||++..... ........+.+|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 47899999999999999999884 77899999974211 11222355778999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~----~kl~Dfg~~ 149 (331)
T cd05597 75 -NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH----IRLADFGSC 149 (331)
T ss_pred -eEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC----EEEEECCce
Confidence 899999999999999998765667999999999999999999999999999999999999987664 599999998
Q ss_pred ccccCcc--ccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 738 KIKRNTL--VTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 738 ~~~~~~~--~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
....... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...........+.........
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 7543221 12234589999999998632 234678999999999999999999999877666655555443322222
Q ss_pred ---CCCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHH
Q 002908 813 ---PGFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLR 846 (867)
Q Consensus 813 ---p~~~s~eL~dLI~kCLq~DPee--RPSa~ELLe~Lq 846 (867)
...++..+.++|.+||..++.+ ||++.+++.+.+
T Consensus 230 ~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 230 PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 2347899999999988664443 789999999854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=301.90 Aligned_cols=250 Identities=28% Similarity=0.449 Sum_probs=204.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|++.+.||.|++|.||++.+ .+..||||.+..... .......+.+|+.++++++|+|++++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CC
Confidence 488999999999999999987 467899999864321 122245677899999999999999999887543 34
Q ss_pred eEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++... ...+++.+++.++.+++.||+|||++|++|+||+|+||+++.++ .++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~----~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC----cEEEecccce
Confidence 689999999999999988653 35689999999999999999999999999999999999998655 4599999998
Q ss_pred ccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
...... .......+++.|+|||++. ...++.++|||||||++++|++|+.||...........+.... ....+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFS--NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKDY 226 (257)
T ss_pred EEecccCCccccccCCcCccChhHhc--CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCcccc
Confidence 754322 2223345789999999998 4557889999999999999999999998776655555444433 23455678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
++.+.+++.+||+.+|.+||++.+++.+
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.51 Aligned_cols=255 Identities=33% Similarity=0.574 Sum_probs=208.0
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
+..++|++.+.||.|+||.||+|++. ...|++|.+... ..+.....+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 74 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRRELDMFRKLSHKNVVRLL 74 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-------cchHHHHHHHHHHHHHHhcCCcceeeeE
Confidence 34578999999999999999999863 345899987532 1223446788999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhccc--------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEecc
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 721 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~--------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~ 721 (867)
+++.+.. ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.
T Consensus 75 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~ 152 (275)
T cd05046 75 GLCREAE--PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS 152 (275)
T ss_pred EEECCCC--cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC
Confidence 9998754 7899999999999999986433 15899999999999999999999999999999999999987
Q ss_pred CCCCCCcEEEeecCCcccccCc--cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhH
Q 002908 722 KDPIRPICKVGDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 798 (867)
Q Consensus 722 dg~~~~~vKL~DFGLA~~~~~~--~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e 798 (867)
++. ++++|||++...... .......++..|+|||.+. ...++.++||||||+++|+|++ |..||.......
T Consensus 153 ~~~----~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~ 226 (275)
T cd05046 153 QRE----VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ--EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226 (275)
T ss_pred CCc----EEEcccccccccCcccccccCCceeEEeecChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence 664 499999998643221 1122334567799999987 3456789999999999999999 888998766666
Q ss_pred HHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 799 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 799 ~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
............+.+..++..+.+++.+||+.+|.+||++.+++..|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 666555555555556678899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.67 Aligned_cols=244 Identities=34% Similarity=0.615 Sum_probs=200.5
Q ss_pred EeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 587 ELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 587 ~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
.||+|+||.||+|.. .+..+|+|+++... .......+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVME 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEE
Confidence 689999999999987 46779999886432 1222346889999999999999999999998754 7899999
Q ss_pred eecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccc
Q 002908 666 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 745 (867)
Q Consensus 666 y~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~ 745 (867)
|+++++|.+++......+++..++.++.+++.+|.|||++|++||||+|+||+++.++ .++|+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~----~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN----VLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC----eEEECCCccceecccccc
Confidence 9999999998876666789999999999999999999999999999999999998665 459999999875432221
Q ss_pred c--CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 746 T--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 746 ~--s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
. ....++..|+|||++. ...++.++||||||+++|+|++ |..||...........+. ...+...+..++..+.+
T Consensus 149 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALN--YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYK 225 (250)
T ss_pred ccCCCCCCcccccCHHHhc--cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence 1 1123456799999997 4557889999999999999998 999998876665554433 34455556678899999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 823 LMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
++.+||+.+|.+||++.++++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.79 Aligned_cols=248 Identities=26% Similarity=0.371 Sum_probs=188.1
Q ss_pred EEEeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeE
Q 002908 585 LKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l 660 (867)
.++||+|+||+||+|.+. ++.||||.+..... ...+.+|+.+|++++||||+++++++........
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 357999999999999863 46799999864321 1345689999999999999999999876656688
Q ss_pred EEEEEeecCCchhhhhhcc--------cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 661 ATVTEFMVNGSLRHVLLSK--------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~--------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
++||||+ +++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++..+.....+||+
T Consensus 76 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 9999998 56777766321 23589999999999999999999999999999999999997654455678999
Q ss_pred ecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---------HH
Q 002908 733 DFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---------AI 799 (867)
Q Consensus 733 DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---------e~ 799 (867)
|||+++...... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|++||...... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcC-CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 999998653321 2234568999999999975 245788999999999999999999999643211 11
Q ss_pred HHhHhhcC-----------------------C-CC------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 002908 800 IGGIVNNT-----------------------L-RP------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843 (867)
Q Consensus 800 l~~iv~~~-----------------------l-r~------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe 843 (867)
+..+.... + .. ......+..+.+||.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11110000 0 00 000112456889999999999999999999987
Q ss_pred H
Q 002908 844 R 844 (867)
Q Consensus 844 ~ 844 (867)
+
T Consensus 314 h 314 (317)
T cd07868 314 D 314 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.04 Aligned_cols=249 Identities=31% Similarity=0.573 Sum_probs=197.6
Q ss_pred EeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEE
Q 002908 587 ELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 587 ~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~ 661 (867)
.||+|+||.||+|.+. ...||||.+.... .......+.+|+.+++.++||||+++++++... ++..+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~ 73 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPL 73 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC-------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcE
Confidence 5899999999999863 2469999875321 112245678899999999999999999977543 33678
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
+||||+.+++|.+++......+++..+..++.|++.||.|||+.+++||||||+|||++.++ .++|+|||+++...
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~----~~kl~dfg~~~~~~ 149 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF----TVKVADFGLARDIY 149 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC----cEEECCcccccccc
Confidence 99999999999999876556678888899999999999999999999999999999999665 45999999987432
Q ss_pred Ccc-----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 742 NTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 742 ~~~-----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
... ......++..|+|||.+. ...++.++|||||||++|+|++ |.+||...........+. .......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEY 226 (262)
T ss_pred CCcceeecccccCcCCccccChhHhc--cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCc
Confidence 211 112334577899999987 4567899999999999999999 566777665544444333 3334445566
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 78999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.70 Aligned_cols=255 Identities=25% Similarity=0.346 Sum_probs=202.1
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||.|+||.||+|.+. +..||+|.++...... ....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-------chhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 3578999999999999999999884 6789999987543211 123456899999999999999999999875
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ..++||||+. ++|..++......+++..+..++.||+.||.|||++||+|+||||+|||++.++. ++|+|||
T Consensus 77 ~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~----~kl~dfg 149 (301)
T cd07873 77 K--SLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE----LKLADFG 149 (301)
T ss_pred C--eEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc----EEECcCc
Confidence 4 8999999995 6888888766667899999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC------
Q 002908 736 LSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL------ 808 (867)
Q Consensus 736 LA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l------ 808 (867)
++...... .......+++.|+|||++.+ ...++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 150 LARAKSIPTKTYSNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred chhccCCCCCcccccceeecccCcHHHhC-CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 98753322 12223457889999999874 33568899999999999999999999987665443322211000
Q ss_pred -------------CC---------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 809 -------------RP---------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 809 -------------r~---------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.. .....+++.+.+||.+||+.||.+|||+.+++.+.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00 0112467889999999999999999999999986554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.83 Aligned_cols=244 Identities=36% Similarity=0.606 Sum_probs=202.9
Q ss_pred EeeecCcEEEEEEEEC---Cc--eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEE
Q 002908 587 ELGSGTFGTVYHGKWR---GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 587 ~LG~GafG~VYka~~~---G~--~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~ 661 (867)
.||+|++|.||+|.+. ++ .||||.+...... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 71 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLM 71 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEE
Confidence 5899999999999873 22 5899998754321 345678899999999999999999999877 3889
Q ss_pred EEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 662 TVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~----~~kl~dfg~~~~~ 147 (257)
T cd05040 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRAL 147 (257)
T ss_pred EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC----EEEeccccccccc
Confidence 9999999999999986654 5789999999999999999999999999999999999999765 4599999999854
Q ss_pred cCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 741 RNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 741 ~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
.... ......++..|+|||++. ...++.++|||||||++|+|++ |..||...........+.........+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225 (257)
T ss_pred cccccceecccCCCCCceecCHHHhc--ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCcc
Confidence 3311 111234678899999987 4457889999999999999999 99999877766666555544444555667
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=359.16 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=212.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+...+|++++.||.|+||+||++.+. +..||+|++...... +.....|..|+.+|+.|+|||||+++++|.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK------EREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 445679999999999999999999984 667999998754321 223456889999999999999999999987
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHC-------CeeccCCCCcceEeccCC
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSK-------NIVHFDLKCDNLLVNLKD 723 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~---~~~Lse~~~l~Ia~QIa~ALayLHs~-------GIIHrDLKPsNILLd~dg 723 (867)
......++|||||+++++|.+++... ...+++..++.|+.||+.||.|||.. +||||||||+||||+.+.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 65556899999999999999988542 35699999999999999999999984 499999999999997532
Q ss_pred -------------CCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC
Q 002908 724 -------------PIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790 (867)
Q Consensus 724 -------------~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~P 790 (867)
.....++|+|||++.............||+.|+|||++.+....++.++|||||||+||+|+||..|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 1234589999999986554444445679999999999975556688999999999999999999999
Q ss_pred CCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 791 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 791 F~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
|........+...+......+. ...+..+.+||..||+.+|.+||++.+++.+-+
T Consensus 243 F~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 9766544444333333322222 346889999999999999999999999996544
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=323.10 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=226.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
...+.|++-++||+|+|+.||++.. +|+.+|+|++....++... ..++.+|+.+-+.|+||||++++..+.+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~------~e~l~rEarIC~~LqHP~IvrL~~ti~~ 81 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD------FQKLEREARICRKLQHPNIVRLHDSIQE 81 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcccc------HHHHHHHHHHHHhcCCCcEeehhhhhcc
Confidence 3456788888999999999998877 5888999998776655432 3467789999999999999999999887
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
. +..|+|+|+|.|+.|...+..+ ..+++..+...+.||+++|.|+|.+||||||+||+|+|+...... ..+||+||
T Consensus 82 ~--~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~-A~vKL~~F 157 (355)
T KOG0033|consen 82 E--SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKG-AAVKLADF 157 (355)
T ss_pred c--ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCC-Cceeeccc
Confidence 4 4999999999999998777554 457999999999999999999999999999999999999765533 34699999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC--
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV-- 812 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i-- 812 (867)
|+|...+......+..|||.|||||++. ...++..+|||+.|++||-|+.|++||.+.+...+.+.++.+.+..+.
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvr--kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhh--cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc
Confidence 9999888888888999999999999999 567899999999999999999999999998888888998888776544
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
...++++.++|+++||..||.+|.|+.|.|.+.|..
T Consensus 236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 456899999999999999999999999999887754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.71 Aligned_cols=250 Identities=29% Similarity=0.455 Sum_probs=211.9
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
....|+.+++||+|+||.||+|.+ .++.||+|++..... +.....+.+|+.+|..++++||.++|+.+..+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-------~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-------EDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhc-------chhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 345677788999999999999998 477899999976432 22245677899999999999999999999886
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. .++++||||.||++.+.+. .+..+++..+..|+++++.||.|||.++.+|||||+.|||+..+|. +||+|||
T Consensus 84 ~--~LwiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~----vkl~Dfg 156 (467)
T KOG0201|consen 84 T--KLWIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD----VKLADFG 156 (467)
T ss_pred c--cHHHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc----EEEEecc
Confidence 5 8999999999999999885 3445688889999999999999999999999999999999997765 4999999
Q ss_pred CcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 736 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 736 LA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
.+....... ....+.||+.|||||++. ...|+.++||||||++.+||++|.+||...+....+..+-. ...+.+..
T Consensus 157 Va~ql~~~~~rr~tfvGTPfwMAPEVI~--~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-~~PP~L~~ 233 (467)
T KOG0201|consen 157 VAGQLTNTVKRRKTFVGTPFWMAPEVIK--QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLDG 233 (467)
T ss_pred eeeeeechhhccccccccccccchhhhc--cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-CCCCcccc
Confidence 998665543 336788999999999999 56789999999999999999999999998887554443332 33444556
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+++.|++|+..||..+|+.||++.+++++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 789999999999999999999999999876
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=337.63 Aligned_cols=263 Identities=34% Similarity=0.601 Sum_probs=230.6
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.-|++.+.+..+.++||-|.||.||.|.|+ ...||||.++. +.+-+.+|+.|+.+|+.+.|||+|+++|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---------DtMeveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---------DTMEVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---------cchhHHHHHHHHHHHHhhcCccHHHHhh
Confidence 467888999999999999999999999996 45699999874 2344689999999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccc-cCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~-~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+|...+ ..|||+|||..|+|.++|....+ .++.-.++.|+.||..||.||..+.+|||||-+.|+|+..+. .+
T Consensus 331 VCT~Ep--PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh----iV 404 (1157)
T KOG4278|consen 331 VCTHEP--PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----IV 404 (1157)
T ss_pred hhccCC--CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc----eE
Confidence 999866 89999999999999999987664 467778889999999999999999999999999999998553 56
Q ss_pred EEeecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhc
Q 002908 730 KVGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806 (867)
Q Consensus 730 KL~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~ 806 (867)
|++|||++++....+ ...+...+..|.|||-+. ...++.|+|||+||++|||+.| |-.||.+.+.... ..++..
T Consensus 405 KvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA--yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEk 481 (1157)
T KOG4278|consen 405 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEK 481 (1157)
T ss_pred EeeccchhhhhcCCceecccCccCcccccCccccc--ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhc
Confidence 999999999765433 333455678899999998 6778999999999999999999 9999999876554 466788
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
.+++.-|..|++.+.+||+.||+++|.+||+|.|+-+.++.+....+
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999999999999999998876444
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.02 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=205.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 581 DLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
+|++.+.||.|+||.||+|.. .++.+|||.++..... ..........+.+|+.+++.++|+||+++++++.+. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--Ce
Confidence 477888999999999999987 5788999998754322 122234456688999999999999999999999875 48
Q ss_pred EEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++. ++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~----~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI----IKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe----EEeccchhhHh
Confidence 99999999999999988543 46889999999999999999999999999999999999996654 59999999874
Q ss_pred ccC-------ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc-CCCCC
Q 002908 740 KRN-------TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPP 811 (867)
Q Consensus 740 ~~~-------~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~-~lr~~ 811 (867)
... ........++..|+|||++. ...++.++|||||||++|+|++|..||...........+... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVIN--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhc--CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 321 11112345788999999998 345788999999999999999999999876654443333322 23345
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+..++..+.++|.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 566789999999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.89 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=206.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.++||+|+||.||++.++ ++.+|+|++..... ........+..|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 47899999999999999999984 56799999864211 11222345778999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~----~kL~DfG~a 149 (332)
T cd05623 75 -NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH----IRLADFGSC 149 (332)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC----EEEeecchh
Confidence 899999999999999999765667899999999999999999999999999999999999996654 599999998
Q ss_pred ccccC--ccccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 738 KIKRN--TLVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 738 ~~~~~--~~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
..... ........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...........+.....+...
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC
Confidence 74322 1222335699999999998631 235788999999999999999999999887776766666554433333
Q ss_pred C---CCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHH
Q 002908 813 P---GFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRL 845 (867)
Q Consensus 813 p---~~~s~eL~dLI~kCLq~DPee--RPSa~ELLe~L 845 (867)
+ ..++..+.+|+.+||..++.+ |+++.+++++.
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 2 356899999999999765544 68999999884
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.11 Aligned_cols=256 Identities=29% Similarity=0.419 Sum_probs=206.4
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
...+.|+++++||.|+||.||+|.+. +..+++|++... .......+.+|+.+++.++||||+++++.+..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 34567999999999999999999984 678999998642 12234567889999999999999999999877
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|..++......+++..++.++.|++.+|.|||++|++||||+|+||+++.++. ++|+||
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~----~kl~df 154 (292)
T cd06644 81 DG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADF 154 (292)
T ss_pred CC--eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC----EEEccC
Confidence 44 899999999999998887666667899999999999999999999999999999999999986654 599999
Q ss_pred CCcccccCc-cccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-C
Q 002908 735 GLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-R 809 (867)
Q Consensus 735 GLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l-r 809 (867)
|++...... .......+++.|+|||++.+. ...++.++|||||||++|+|++|..||...........+..... .
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (292)
T cd06644 155 GVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234 (292)
T ss_pred ccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc
Confidence 998743221 222334578899999998531 34467899999999999999999999977655444443332221 2
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
...+..++..+.++|.+||..+|++||++.+++++..
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 2334567889999999999999999999999987644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=322.81 Aligned_cols=237 Identities=27% Similarity=0.366 Sum_probs=192.2
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHH-HHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 587 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 587 ~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEie-iLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
.||+|+||.||+|++ .+..||||++...... .......+.+|.. +++.++||||+++++++.+.. ..++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv 74 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFV 74 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEE
Confidence 699999999999998 4778999999753211 1122334555554 578899999999999988754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-cC
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~-~~ 742 (867)
|||+++++|...+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++. +||+|||++... ..
T Consensus 75 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~----~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 75 LDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH----VVLTDFGLCKEGVEP 149 (321)
T ss_pred EcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC----EEEccCCCCccCCCC
Confidence 999999999887753 456889999999999999999999999999999999999997764 599999998743 22
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
........||+.|+|||++. ...++.++|||||||++|+|++|..||...+.......+.... ...+...+..+.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~ 225 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLR--KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQLPGGKTVAACD 225 (321)
T ss_pred CCccccccCCcccCCHHHhc--CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHH
Confidence 22334456899999999997 4457889999999999999999999998877666666655443 3445567889999
Q ss_pred HHHHhhcCCCCCCCCHH
Q 002908 823 LMEQCWAPDPVVRPSFT 839 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa~ 839 (867)
++.+||+.+|.+||++.
T Consensus 226 li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 226 LLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHccCCHhhcCCCC
Confidence 99999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=329.37 Aligned_cols=257 Identities=28% Similarity=0.413 Sum_probs=219.8
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECC--ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G--~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
..+..++|++++.||+|.-|+||+++.++ ..+|+|++.+..... .....+...|.+||+.+.||.++.||..|
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-----rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-----RKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-----hhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 34566788899999999999999999975 679999998765432 33346677899999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+... +.|||||||+||+|...++++ ++.|++..+..++.+++.||+|||..|||+|||||+||||.++|++ .|
T Consensus 147 et~~--~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHI----ML 220 (459)
T KOG0610|consen 147 ETDK--YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHI----ML 220 (459)
T ss_pred eccc--eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcE----Ee
Confidence 9865 999999999999999988754 4789999999999999999999999999999999999999988866 89
Q ss_pred eecCCcccc-------cC----------------------------c----------------------cccCCcCCCCC
Q 002908 732 GDFGLSKIK-------RN----------------------------T----------------------LVTGGVRGTLP 754 (867)
Q Consensus 732 ~DFGLA~~~-------~~----------------------------~----------------------~~~s~~~GT~~ 754 (867)
+||.++... .. . .....+.||..
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 999986421 00 0 01123458999
Q ss_pred ccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCC
Q 002908 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVV 834 (867)
Q Consensus 755 Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPee 834 (867)
|+|||++.|.+ -+.++|+|+||++||||+.|..||.+.+..+.+.+++......+....++..+++||+++|.+||.+
T Consensus 301 YlAPEvI~G~G--HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 301 YLAPEVIRGEG--HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred cccceeeecCC--CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999644 5678999999999999999999999999999999999988877776678899999999999999999
Q ss_pred CCC----HHHHHHH
Q 002908 835 RPS----FTEIARR 844 (867)
Q Consensus 835 RPS----a~ELLe~ 844 (867)
|.. +.||.+|
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 987 7887654
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.57 Aligned_cols=253 Identities=34% Similarity=0.564 Sum_probs=208.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.+..++|++.+.||+|+||.||++.+. +..+|+|.++... .....+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---------hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 567789999999999999999999874 5679999876421 123567889999999999999999999876
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
...+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~----~~~l~d 145 (260)
T cd05073 73 ---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIAD 145 (260)
T ss_pred ---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC----cEEECC
Confidence 3678999999999999998653 35678899999999999999999999999999999999998655 469999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||.+....... ......++..|+|||++. ...++.++|+|||||++|+|++ |..||...........+. .....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (260)
T cd05073 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRM 222 (260)
T ss_pred CcceeeccCCCcccccCCcccccccCHhHhc--cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCC
Confidence 99987543221 122233567799999997 4457889999999999999999 999998877665554433 33444
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 5556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.45 Aligned_cols=254 Identities=26% Similarity=0.330 Sum_probs=198.7
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC--
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 656 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~-- 656 (867)
+|++.+.||+|+||.||++.+ .++.||||.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 477889999999999999997 588899999864311 1122356789999999999999999999987643
Q ss_pred -CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 -GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 -~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
....++||||+. ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~----~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV----LKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC----EEecccc
Confidence 126899999995 677776643 456899999999999999999999999999999999999997654 5999999
Q ss_pred CcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh--------
Q 002908 736 LSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN-------- 805 (867)
Q Consensus 736 LA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~-------- 805 (867)
+++...... ......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 998543221 12234578899999999852 3468899999999999999999999987665443332211
Q ss_pred ---------------cCCCC-------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 806 ---------------NTLRP-------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 806 ---------------~~lr~-------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..... ......++.+.+||.+||+.||.+|||+.+++.+.+-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 291 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence 11111 1223457889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.80 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=201.5
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPG 657 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~ 657 (867)
+|+..+.||+|+||.||+|.++ ++.||||+++..... .......+..|..++..+. |++|+++++++....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 4778899999999999999884 778999999753211 1122345677888888886 577888998888754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~----ikL~Dfg~~ 148 (323)
T cd05615 75 -RLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH----IKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC----EEEeccccc
Confidence 899999999999999888543 46899999999999999999999999999999999999997764 599999998
Q ss_pred cccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... ..+..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--SYPKSL 224 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccC
Confidence 7432 2222334568999999999984 4578899999999999999999999998877777766665443 345667
Q ss_pred cHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSF-----TEIARR 844 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa-----~ELLe~ 844 (867)
+..+.+++.+||+.+|.+|++. .+++++
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 8999999999999999999974 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.49 Aligned_cols=253 Identities=30% Similarity=0.440 Sum_probs=205.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||+|+||.||++.+ ++..||+|++...... .........+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC---chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC
Confidence 578888999999999999987 4788999998754322 12233445688999999999999999999998765456
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.++++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+|+||||+|+||+++.++. ++|+|||++.
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~----~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN----VKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC----EEEccCCCcc
Confidence 889999999999999988543 45899999999999999999999999999999999999986654 5999999987
Q ss_pred cccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 739 IKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 739 ~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
..... .......++..|+|||.+. ...++.++|||||||++|+|++|+.||..................+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVIS--GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhC--CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCch
Confidence 43321 1112345788999999998 45578899999999999999999999987765555555444444555566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+++.+.+++ +||..+|.+||++++++.+
T Consensus 233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 233 HISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 7788899999 6777899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=322.74 Aligned_cols=238 Identities=27% Similarity=0.378 Sum_probs=191.8
Q ss_pred EeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHH-HHHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 587 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREA-EILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 587 ~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEi-eiLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
.||+|+||+||+|.+. +..||+|++...... .......+..|. .+++.++||||+++++++.... .+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~lv 74 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL-----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFV 74 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH-----hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEEE
Confidence 6999999999999984 667999999753211 111123344444 3567889999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-cC
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~-~~ 742 (867)
|||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++... ..
T Consensus 75 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~----~kl~DfG~a~~~~~~ 149 (325)
T cd05602 75 LDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH----IVLTDFGLCKENIEH 149 (325)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC----EEEccCCCCcccccC
Confidence 999999999988854 445888899999999999999999999999999999999997664 599999998743 22
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
........||+.|+|||++. ...++.++|||||||++|+|++|..||...........+..... ..+..++..+.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~ 225 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLH--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSARH 225 (325)
T ss_pred CCCcccccCCccccCHHHHc--CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHHH
Confidence 22334456999999999998 45578899999999999999999999988777666666554433 334467899999
Q ss_pred HHHHhhcCCCCCCCCHHH
Q 002908 823 LMEQCWAPDPVVRPSFTE 840 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa~E 840 (867)
++.+||+.+|.+||++.+
T Consensus 226 li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHcccCHHHCCCCCC
Confidence 999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=303.17 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=205.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|++.+.||+|+||.||++.+ +++.||||.+...... .........+.+|+.+++++.||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC---cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 5789999999999999999987 4788999988643211 1112234677889999999999999999999877555
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..+++||||+++++|.+++... ..+++..++.++.|++.||.|||+++|+|+||+|+|||++.++. ++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~----~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN----VKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC----EEECcCccc
Confidence 5788999999999999988543 45789999999999999999999999999999999999996654 599999998
Q ss_pred ccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 738 KIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 738 ~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
...... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..................+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc
Confidence 753321 11223457889999999974 457889999999999999999999998766555555544444445556
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
...+..+.+++.+||. +|.+||++.+++++.
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 6677889999999995 899999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.54 Aligned_cols=246 Identities=35% Similarity=0.583 Sum_probs=200.4
Q ss_pred EEeeecCcEEEEEEEEC--C---ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeE
Q 002908 586 KELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 586 k~LG~GafG~VYka~~~--G---~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l 660 (867)
++||+|+||.||+|.+. + ..+|+|.+...... ....++.+|+.+++.+.||||+++++++... ..
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------AGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---ce
Confidence 36999999999999873 2 56999998754221 2345788999999999999999999987642 57
Q ss_pred EEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 661 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
++||||+++++|.+++.... .+++..++.++.|++.||.|||..+++|+||||+|||++.++. ++|+|||+++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~----~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ----AKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc----EEecccccccee
Confidence 89999999999999986543 6899999999999999999999999999999999999997664 599999999854
Q ss_pred cCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 741 RNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 741 ~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
..... .....++..|+|||.+. ...++.++|||||||++|+|++ |..||...........+. .....+.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 222 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECIN--YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEE 222 (257)
T ss_pred ecCCcccccccCccccccccCHHHhc--CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCC
Confidence 32211 11122346799999997 4557889999999999999998 999998877655544433 3334556677
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
++..+.++|.+||..+|.+||++.++++.|+.+.
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 8899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.21 Aligned_cols=264 Identities=30% Similarity=0.503 Sum_probs=213.3
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 644 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPN 644 (867)
+.+...+|++.+.||+|+||.||++++. +..||+|+++... .......+.+|+.+++++ +|||
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------TDKDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------CHHHHHHHHHHHHHHHhhcCCCC
Confidence 4566678999999999999999999762 1258999886421 122345788999999999 7999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhcc---------------cccCCHHHHHHHHHHHHHHHHHHHHCCeec
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVH 709 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~---------------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIH 709 (867)
|++++++|.... ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+|
T Consensus 80 iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 80 IINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred eeeeeEEEccCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 999999998754 889999999999999988542 235788899999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 710 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 710 rDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
|||||+|||++.++. ++|+|||+++...... ......++..|+|||++. ...++.++|||||||++|+|++
T Consensus 158 ~dlkp~Nill~~~~~----~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 158 RDLAARNVLVTEDNV----MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred cccccceEEEcCCCc----EEECCcccceecccccccccccCCCcCceEcCHHHhc--cCCcCchhhhHHHHHHHHHHHh
Confidence 999999999987654 5999999997543321 111223456799999997 4557889999999999999998
Q ss_pred -CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 787 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 787 -Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
|..||...........+. .....+.+..++..+.+++.+||+.+|.+||++.+++..|+.+...+..
T Consensus 232 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 232 LGGSPYPGIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred cCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 889998877666555443 3344555667889999999999999999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.29 Aligned_cols=247 Identities=29% Similarity=0.408 Sum_probs=197.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||+|.+ .+..||||++..... .....++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-------VELQKQIMSELEILYKCDSPYIIGFYGAFFVEN- 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-
Confidence 3678889999999999999987 477899999864321 122356889999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++. ++|+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~----~~l~dfg~~ 142 (279)
T cd06619 73 -RISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ----VKLCDFGVS 142 (279)
T ss_pred -EEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC----EEEeeCCcc
Confidence 889999999999886542 4688899999999999999999999999999999999997664 599999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-------HHHHhHhhcCCCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-------AIIGGIVNNTLRP 810 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-------e~l~~iv~~~lr~ 810 (867)
....... .....++..|+|||++. ...++.++|||||||++|+|++|..||...... .....+.......
T Consensus 143 ~~~~~~~-~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (279)
T cd06619 143 TQLVNSI-AKTYVGTNAYMAPERIS--GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219 (279)
T ss_pred eeccccc-ccCCCCChhhcCceeec--CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC
Confidence 7543322 23456899999999998 345788999999999999999999999653221 1112222111111
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
......++.+.+++.+||+.+|.+||++.+++++.+-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 1223467889999999999999999999999988654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.51 Aligned_cols=255 Identities=30% Similarity=0.456 Sum_probs=208.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||.|++|.||++.+. +..+|+|+++.. .......|.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 356888999999999999999984 778999998643 1222356888999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||+
T Consensus 76 --~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~----~~l~d~g~ 149 (280)
T cd06611 76 --KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD----VKLADFGV 149 (280)
T ss_pred --eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC----EEEccCcc
Confidence 899999999999999998766677999999999999999999999999999999999999987654 59999999
Q ss_pred cccccCc-cccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-CCC
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPP 811 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l-r~~ 811 (867)
+...... .......+++.|+|||.+... ...++.++|+|||||++|+|++|..||...........+..... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 150 SAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229 (280)
T ss_pred chhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC
Confidence 8744322 122334588999999998532 23467799999999999999999999988766555544443322 223
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+..++..+.++|.+||+.+|.+||++.+++++-+-
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 345678899999999999999999999999887553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.85 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=205.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||++.+. ++.||||++..... ........+..|..++..+.|+||+++++++.+..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-----LKRAETACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 47999999999999999999884 67799999864211 11222345778999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 75 -~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~----~kl~DfG~a 149 (331)
T cd05624 75 -YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH----IRLADFGSC 149 (331)
T ss_pred -EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC----EEEEeccce
Confidence 899999999999999999765667899999999999999999999999999999999999997664 599999998
Q ss_pred ccccCcc--ccCCcCCCCCccCccccccCC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 738 KIKRNTL--VTGGVRGTLPWMAPELLNGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 738 ~~~~~~~--~~s~~~GT~~Y~APEvl~g~~---~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
....... ......||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||...........+.....+.+.
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC
Confidence 7543322 122356999999999987421 34678999999999999999999999887766666666554433333
Q ss_pred C---CCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHH
Q 002908 813 P---GFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRL 845 (867)
Q Consensus 813 p---~~~s~eL~dLI~kCLq~DPee--RPSa~ELLe~L 845 (867)
+ ..++..+.+++.+||...+.+ |+++++++++.
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 3 346889999999999876544 46899988774
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=300.05 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=206.9
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|+..+.||+|++|.||+|.+ .+..|++|.+....... ..+.....+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc---cchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--
Confidence 466778899999999999998 47889999986543211 12333567889999999999999999999988754
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~----~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV----VKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEEccCccce
Confidence 899999999999999988543 45899999999999999999999999999999999999997654 5999999987
Q ss_pred cccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcH
Q 002908 739 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 818 (867)
Q Consensus 739 ~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~ 818 (867)
............++..|+|||.+.... .++.++|+|||||++|+|++|..||...........+.........+..+++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 654433334456889999999987422 3788999999999999999999999876654444444433334455667889
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 819 EWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 819 eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 99999999999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.60 Aligned_cols=257 Identities=32% Similarity=0.548 Sum_probs=207.3
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
..+|++.+.||+|+||.||++.+. +..+|||+++..... .....|.+|+.+++.+.||||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------QHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------HHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 356788899999999999999874 567999998754211 2346788999999999999999999998
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
........++||||+++++|.+++......+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~----~~~l~ 151 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED----LVKIS 151 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC----CEEEc
Confidence 77545588999999999999999976665699999999999999999999999999999999999999764 45999
Q ss_pred ecCCcccccCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-----------
Q 002908 733 DFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----------- 797 (867)
Q Consensus 733 DFGLA~~~~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~----------- 797 (867)
|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 9999986542211 112234567999999873 45788999999999999999999997653221
Q ss_pred ---HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 798 ---AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 798 ---e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
......+....+.+.+..++..+.+++.+||+.+|.+|||+.+|+++|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112233334445555667789999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.55 Aligned_cols=247 Identities=36% Similarity=0.579 Sum_probs=197.7
Q ss_pred EeeecCcEEEEEEEEC--Cc--eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCeEE
Q 002908 587 ELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 587 ~LG~GafG~VYka~~~--G~--~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~l~ 661 (867)
.||+|+||.||+|.+. +. .+++|.++... .......+.+|+.++.++ .||||+++++++.... ..+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--Cce
Confidence 5899999999999984 33 46888876421 112235678899999999 7999999999998754 789
Q ss_pred EEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCC
Q 002908 662 TVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 726 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~ 726 (867)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+|||++.++
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--- 149 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--- 149 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC---
Confidence 9999999999999885422 2478999999999999999999999999999999999999665
Q ss_pred CcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 727 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 727 ~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
.++|+|||++..............+..|+|||++. ...++.++|||||||++|+|++ |..||...........+.
T Consensus 150 -~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~- 225 (270)
T cd05047 150 -VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 225 (270)
T ss_pred -eEEECCCCCccccchhhhccCCCCccccCChHHHc--cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-
Confidence 46999999986332221112223456799999987 4557889999999999999997 999998776655554443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.....+.+..++..+.+++.+||..+|.+|||+.+++..|..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 33444556667899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.79 Aligned_cols=247 Identities=24% Similarity=0.296 Sum_probs=193.1
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+...+|++++.||+|+||.||++.+ +++.||||.... ..+.+|+.+|+.++||||++++++|..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 5567899999999999999999998 478899996431 245689999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++|||++ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 155 ~~--~~~lv~e~~-~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~----vkL~DF 226 (391)
T PHA03212 155 NK--FTCLILPRY-KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD----VCLGDF 226 (391)
T ss_pred CC--eeEEEEecC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC----EEEEeC
Confidence 54 889999998 5788877754 346899999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCc--cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-------hhHHHHhHhh
Q 002908 735 GLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-------YGAIIGGIVN 805 (867)
Q Consensus 735 GLA~~~~~~--~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~-------~~e~l~~iv~ 805 (867)
|+|...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+..+..
T Consensus 227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 227 GAACFPVDINANKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred CcccccccccccccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 999753221 12234569999999999984 457899999999999999999998764321 0111111110
Q ss_pred --------------------------cCCCCC--CC-----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 806 --------------------------NTLRPP--VP-----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 806 --------------------------~~lr~~--ip-----~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.....+ .+ ..++.++.+||.+||+.||.+|||+.|++++-+-
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 000000 00 1245678999999999999999999999987653
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=310.77 Aligned_cols=254 Identities=31% Similarity=0.517 Sum_probs=200.4
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC------------------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR------------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~------------------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~ 639 (867)
..++|++.+.||+|+||.||++.+. +..||||++.... .......|.+|+.+++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------NKNARNDFLKEIKIMSR 75 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHh
Confidence 4567999999999999999998643 2358999886431 12334578899999999
Q ss_pred CCCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhccc----------ccCCHHHHHHHHHHHHHHHHHHHHCCeec
Q 002908 640 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 709 (867)
Q Consensus 640 L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~----------~~Lse~~~l~Ia~QIa~ALayLHs~GIIH 709 (867)
++|+||+++++++.... ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|
T Consensus 76 l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 153 (296)
T cd05095 76 LKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153 (296)
T ss_pred CCCCCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99999999999998754 7899999999999999885432 24778899999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 710 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 710 rDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
+||||+|||++.++ .++|+|||++....... ......++..|++||... ...++.++|||||||++|+|++
T Consensus 154 ~dlkp~Nili~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 154 RDLATRNCLVGKNY----TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL--LGKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred ccCChheEEEcCCC----CEEeccCcccccccCCcceeccCcCcCccccCCHHHHh--cCCccchhhhhHHHHHHHHHHH
Confidence 99999999998655 45999999987543221 112233467899999877 3457899999999999999998
Q ss_pred --CCCCCCCCChhHHHHhHhh------cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 787 --GEEPYANMHYGAIIGGIVN------NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 787 --Gk~PF~~~~~~e~l~~iv~------~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
|..||.............. .....+.+..++..+.+|+.+||+.+|.+||++.+|++.|+
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7788876655443332211 11123345567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.28 Aligned_cols=244 Identities=22% Similarity=0.364 Sum_probs=194.0
Q ss_pred EEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCeEEE
Q 002908 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 586 k~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~l~L 662 (867)
+.||+|+||.||++.+. ++.||+|+++...... ......+.+|+.++..+ +||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-----hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEE
Confidence 36999999999999884 6789999998653221 12234567888888876 7999999999998854 8999
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 741 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~- 741 (867)
||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||+++...
T Consensus 74 v~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~----~kL~DfG~~~~~~~ 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH----IKLTDYGMCKEGLR 148 (329)
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC----EEEeeCCccccccC
Confidence 9999999999887753 356899999999999999999999999999999999999997764 5999999987432
Q ss_pred CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---------hhHHHHhHhhcCCCCCC
Q 002908 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---------YGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 742 ~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~---------~~e~l~~iv~~~lr~~i 812 (867)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||.... .......+... ....
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 224 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHc--CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCC
Confidence 222233456899999999998 4457889999999999999999999995311 11122222222 3345
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCC------HHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPS------FTEIARRL 845 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPS------a~ELLe~L 845 (867)
+..++..+.++|.+||+.+|.+||+ +.+++.+.
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 6678899999999999999999998 56777663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.29 Aligned_cols=259 Identities=33% Similarity=0.618 Sum_probs=209.4
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCc----eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~----~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+..++|+..+.||+|+||.||+|.+ .+. .||+|++.... ......++.+|+.+++.+.||||++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~ 75 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-------GPKANVEFMDEALIMASMDHPHLVRLL 75 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 46678899999999999999999987 343 46888775321 122234688899999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++... ..+++++|+++++|.+++......+++..++.++.|++.||.|||++||+|+||||+|||++.++. +
T Consensus 76 ~~~~~~---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~----~ 148 (303)
T cd05110 76 GVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH----V 148 (303)
T ss_pred EEEcCC---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc----e
Confidence 998753 457899999999999998766667899999999999999999999999999999999999986654 5
Q ss_pred EEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
||+|||+++...... ......++..|+|||.+. ...++.++|||||||++|+|++ |..||......... .+..
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~ 225 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH--YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLE 225 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhc--cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH
Confidence 999999998543221 112233567899999987 4557899999999999999998 99999876544433 3344
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
.....+.+..++..+.+++.+||..+|++||++.++++.|+.+...
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 4445555667789999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.95 Aligned_cols=248 Identities=30% Similarity=0.493 Sum_probs=204.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||.|++|.||+|.+. +..+++|.+.... . ...+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------D---LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------H---HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 467888999999999999999985 6789999986421 1 457889999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..+++|||+.+++|.+++......+++..+..++.|++.||.|||+.+++|+||+|.||+++.++. ++|+|||+
T Consensus 72 --~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~----~~l~dfg~ 145 (256)
T cd06612 72 --DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ----AKLADFGV 145 (256)
T ss_pred --cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc----EEEccccc
Confidence 899999999999999998766678999999999999999999999999999999999999997664 59999999
Q ss_pred cccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-CCCCCCC
Q 002908 737 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPG 814 (867)
Q Consensus 737 A~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-lr~~ip~ 814 (867)
+....... ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.... .....+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd06612 146 SGQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE 223 (256)
T ss_pred chhcccCccccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchh
Confidence 88654332 2233457889999999874 467889999999999999999999998765544333322211 1122334
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.++..+.++|.+||+.+|.+|||+.+++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 567889999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=308.46 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=204.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
+-|++.+.||.|+||.||++.+. +..+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~- 75 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--------EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN- 75 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-
Confidence 34678889999999999999984 5678999885321 122456788999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|..++......+++..+..++.|++.||.|||+.|++||||+|+|||++.++. ++|+|||++
T Consensus 76 -~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~----~kl~dfg~~ 150 (282)
T cd06643 76 -NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVS 150 (282)
T ss_pred -EEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC----EEEcccccc
Confidence 899999999999998887665667999999999999999999999999999999999999987654 599999998
Q ss_pred ccccCc-cccCCcCCCCCccCcccccc---CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-CCCCC
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPV 812 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g---~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-lr~~i 812 (867)
...... .......++..|+|||++.. ....++.++|||||||++|+|++|..||...........+.... .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd06643 151 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQ 230 (282)
T ss_pred ccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCC
Confidence 743321 22234568899999999842 23446789999999999999999999998766555444443322 22334
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+..++..+.++|.+||+.+|.+||++.+++++.+
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 5567899999999999999999999999987765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.82 Aligned_cols=258 Identities=26% Similarity=0.461 Sum_probs=208.6
Q ss_pred CeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCC--hHHHHHHHHHHHHHHHHHh-CCCCceeeEeccccc
Q 002908 581 DLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRS--SEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQD 654 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~--~~~e~~~~eflrEieiLk~-L~HPNIVrL~g~~~~ 654 (867)
.|++.+.||+|+||.||+|.+. +..+|||.+......... ........++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3677889999999999999984 467999998654322211 1223334567789988875 799999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEE
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
.. ..++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+ .+++|+||+|+|||++.++. ++
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~----~~ 154 (269)
T cd08528 81 ND--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK----VT 154 (269)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc----EE
Confidence 54 89999999999999887742 34568999999999999999999996 78999999999999987654 59
Q ss_pred EeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
|+|||++.............++..|+|||++. ...++.++||||||+++|+|++|+.||...........+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVK--NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhc--CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 99999998655443334556889999999998 3457899999999999999999999998776666555555554444
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.....+++.+.++|.+||+.+|.+||++.++..++.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 344467899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.54 Aligned_cols=250 Identities=28% Similarity=0.349 Sum_probs=195.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|++|.||+|+. ++..||||.++..... +.....+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE------EGVPSTAIREISLLKELQHPNIVCLQDVLMQES-- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc------CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--
Confidence 588899999999999999988 4788999998653211 112345678999999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 659 TLATVTEFMVNGSLRHVLLSK--ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~--~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+|+||+|+|||++.++. ++|+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~----~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV----IKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc----EEECcccc
Confidence 8999999996 6787777533 256899999999999999999999999999999999999997664 59999999
Q ss_pred cccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC--------
Q 002908 737 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 807 (867)
Q Consensus 737 A~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-------- 807 (867)
+....... ......+++.|+|||++.+. ..++.++|||||||++|+|+||+.||...........+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 87543221 12233468899999998742 346789999999999999999999997654432222111100
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 808 -------------------LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 808 -------------------lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
........+++++.++|.+||+.||.+|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0001123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.13 Aligned_cols=250 Identities=30% Similarity=0.456 Sum_probs=205.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||.|++|.||+|.+ .+..||+|++..... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence 3678888999999999999998 478899999864321 122356778999999999999999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~----~~l~d~g~~ 145 (274)
T cd06609 73 -KLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD----VKLADFGVS 145 (274)
T ss_pred -eEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC----EEEcccccc
Confidence 899999999999999988643 7899999999999999999999999999999999999997665 599999999
Q ss_pred ccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC-
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF- 815 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~- 815 (867)
...... .......++..|+|||++.+ ..++.++|||||||++|+|+||..||...........+... ..+..+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNK 222 (274)
T ss_pred eeecccccccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccc
Confidence 865433 22234457889999999984 44889999999999999999999999876654444333332 23333333
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
++..+.+++.+||..+|++|||+++++++-+-
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 78899999999999999999999999886543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=346.80 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=216.3
Q ss_pred ccccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeE
Q 002908 572 STLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAF 648 (867)
Q Consensus 572 ~~l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL 648 (867)
...-.|...++++.+.|.+|||+.||+|+.. |..+|+|++... ++.....+.+|+.+|+.|. |+|||.+
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence 3444677788999999999999999999984 378999988532 4556678889999999996 9999999
Q ss_pred ecc-ccc--CC--CCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCCcceEec
Q 002908 649 YGV-VQD--GP--GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVN 720 (867)
Q Consensus 649 ~g~-~~~--~~--~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~G--IIHrDLKPsNILLd 720 (867)
++. ... .. .-.++|+||||.||.|-+++..+. ..|++.++++|++++++|+++||..+ |||||||-+||||+
T Consensus 101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS 180 (738)
T ss_pred eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc
Confidence 993 221 11 235789999999999999997543 45999999999999999999999987 99999999999999
Q ss_pred cCCCCCCcEEEeecCCcccccCcc-ccC---------CcCCCCCccCccccc-cCCCCCChhhHHHHHHHHHHHHHhCCC
Q 002908 721 LKDPIRPICKVGDFGLSKIKRNTL-VTG---------GVRGTLPWMAPELLN-GSSSKVSEKVDVFSFGIVLWEILTGEE 789 (867)
Q Consensus 721 ~dg~~~~~vKL~DFGLA~~~~~~~-~~s---------~~~GT~~Y~APEvl~-g~~~~~S~kSDVWSLGvLLyELLTGk~ 789 (867)
.+|+ +||||||.|+..-... ... ....|+.|+|||++. -.+...++|+|||||||+||-||....
T Consensus 181 ~~g~----~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~ 256 (738)
T KOG1989|consen 181 ADGN----YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT 256 (738)
T ss_pred CCCC----EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence 8775 4999999998432211 111 123689999999985 224568999999999999999999999
Q ss_pred CCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 790 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 790 PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
||+.... .+|+...+..|....++..+.+||+.||+.+|.+||++-+++..+..+..
T Consensus 257 PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 257 PFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred CcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 9987532 35667778777777899999999999999999999999999999988764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=321.74 Aligned_cols=237 Identities=27% Similarity=0.363 Sum_probs=192.1
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHH-HHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 587 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 587 ~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEie-iLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
.||+|+||.||++.+ +|+.||||++...... .......+..|.. +++.++||||+++++++.... .+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~lv 74 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-----NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYFV 74 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEEE
Confidence 699999999999988 4788999999754221 1122344555554 467799999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-C
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~-~ 742 (867)
|||+++++|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.... .
T Consensus 75 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~----~kL~DfG~~~~~~~~ 149 (325)
T cd05604 75 LDFVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH----VVLTDFGLCKEGIAQ 149 (325)
T ss_pred EcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC----EEEeecCCcccCCCC
Confidence 99999999988775 3456899999999999999999999999999999999999997764 5999999987432 2
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
........||+.|+|||++. ...++.++|||||||++|+|++|..||...........+..... ..+...+..+.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 225 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIR--KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAWS 225 (325)
T ss_pred CCCcccccCChhhCCHHHHc--CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHHH
Confidence 22233456899999999998 45578899999999999999999999988776666666554432 233457889999
Q ss_pred HHHHhhcCCCCCCCCHH
Q 002908 823 LMEQCWAPDPVVRPSFT 839 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa~ 839 (867)
++.+||+.+|.+||++.
T Consensus 226 ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 226 ILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHhccCHHhcCCCC
Confidence 99999999999999775
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.82 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=223.1
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
-..++|++.+.||+|-||.||.|+.+ +--||+|++.+... ........+.+|+++...|+||||+++|++|.+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-----~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-----LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-----HHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 44578899999999999999999985 45699999987542 223345678899999999999999999999998
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. ..||++||...|+|...|... ...+++.....++.|+|.||.|+|..+||||||||+|+|++..|.. |++|
T Consensus 94 ~~--riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~l----kiAd 167 (281)
T KOG0580|consen 94 SK--RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGEL----KIAD 167 (281)
T ss_pred cc--eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCe----eccC
Confidence 65 999999999999999999633 3569999999999999999999999999999999999999988766 9999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
||-+.... .......|||..|++||+.. +...+..+|+|++|++.||++.|.+||......+....+..-.+. .|
T Consensus 168 fGwsV~~p-~~kR~tlcgt~dyl~pEmv~--~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~--~p 242 (281)
T KOG0580|consen 168 FGWSVHAP-SNKRKTLCGTLDYLPPEMVE--GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK--FP 242 (281)
T ss_pred CCceeecC-CCCceeeecccccCCHhhcC--CCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc--CC
Confidence 99987654 44556788999999999999 456788999999999999999999999998888888887765544 45
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..++.+..++|.+|+..+|.+|....+++.+.+..
T Consensus 243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 243 STISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred cccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 78999999999999999999999999999998864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=323.94 Aligned_cols=256 Identities=26% Similarity=0.354 Sum_probs=207.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc---
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD--- 654 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~--- 654 (867)
..|..++.||.|++|.|+.+.+ +|..||||.+... ......+++.+||+.+|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh------hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 4555678999999999999988 4888999988632 2345567788999999999999999999999876
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.....+|+|+|+| +.+|...+. .++.++...+..+++|+++||.|+|+.+|+||||||.|+|++.+... |||||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~l----KI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDL----KICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCE----Eeccc
Confidence 3456789999999 677877774 45569999999999999999999999999999999999999988765 99999
Q ss_pred CCcccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc-----
Q 002908 735 GLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----- 806 (867)
Q Consensus 735 GLA~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~----- 806 (867)
|+|+.... ....+....|.+|.|||++.. ...|+.++||||.||+|.||++|++.|.+.+.-..+..++.-
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 99997643 233345568999999999964 567999999999999999999999999887654433322211
Q ss_pred -------------------CCCCCCC-----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 807 -------------------TLRPPVP-----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 807 -------------------~lr~~ip-----~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
...+..+ ...++...+|+++||..||.+|+|++|+|++.=-.
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 1111111 25678899999999999999999999999876443
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=305.35 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=202.2
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 653 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~ 653 (867)
...++|++.+.||+|+||.||++.+ .++.+|+|++..... ....+.+|+.++..+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---------IDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---------hHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3567899999999999999999988 477899998754211 113566788999999 6999999999874
Q ss_pred c---CCCCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 654 D---GPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 654 ~---~~~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
. ..+...++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--- 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--- 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC---
Confidence 2 223578999999999999987742 2356889999999999999999999999999999999999997664
Q ss_pred cEEEeecCCcccccCc-cccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH
Q 002908 728 ICKVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 803 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i 803 (867)
++|+|||++...... .......|++.|+|||++... ...++.++|||||||++|+|++|..||............
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 163 -VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred -EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 599999998754322 222344588999999998632 234688999999999999999999999876544433332
Q ss_pred hhcC-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 804 VNNT-LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 804 v~~~-lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.... .....+..++..+.++|.+||+.+|.+|||+.++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 2211 122234456788999999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.06 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=199.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||.|+||.||+|.+ .+..||||++.... ........+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF------QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh------hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 36799999999999999999987 46789999986431 11223355778999999999999999999886432
Q ss_pred ----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
....+++|+++ +++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~----~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE----LRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC----EEEc
Confidence 13578999988 888887763 346899999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC---
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 809 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr--- 809 (867)
|||++...... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|..||........+..+......
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcC-CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865432 234568999999999874 245788999999999999999999999876544333322211000
Q ss_pred --------------------CC------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 810 --------------------PP------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 810 --------------------~~------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+ .....++.+.+|+.+||..||.+|||+.+++.+-+-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 00 0123456788999999999999999999999886554
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.47 Aligned_cols=243 Identities=22% Similarity=0.370 Sum_probs=194.5
Q ss_pred EeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCeEEEE
Q 002908 587 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 587 ~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
.||+|+||.||++... ++.||||+++..... .+.....+.+|+.++.++ .||||+++++++.... .+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv 74 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFLV 74 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEEE
Confidence 6999999999999884 678999999864221 222345677899999888 6999999999998754 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-cC
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~-~~ 742 (867)
|||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++... ..
T Consensus 75 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~----~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 75 IEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH----IKLTDYGMCKEGLGP 149 (327)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC----EEEeccccceeccCC
Confidence 999999999887753 356999999999999999999999999999999999999997664 599999998742 22
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC------hh-HHHHhHhhcCCCCCCCCC
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH------YG-AIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~------~~-e~l~~iv~~~lr~~ip~~ 815 (867)
........||+.|+|||++. ...++.++|||||||+||+|++|..||.... .. .....+... ....+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~ 225 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILR--GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRF 225 (327)
T ss_pred CCceecccCCcccCCHHHHC--CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCC
Confidence 22334466999999999998 4567889999999999999999999995321 11 222222222 3345667
Q ss_pred CcHHHHHHHHHhhcCCCCCCCC------HHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPS------FTEIARRL 845 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPS------a~ELLe~L 845 (867)
++..+.+++.+||+.||.+|++ +.+++.+-
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 8899999999999999999997 46776653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.63 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=187.5
Q ss_pred EEEeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeE
Q 002908 585 LKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l 660 (867)
..+||+|+||.||+|.+. +..||+|.+..... ...+.+|+.+++.++||||+++++++........
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKV 75 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence 357999999999999873 36799998864321 1346689999999999999999999876556688
Q ss_pred EEEEEeecCCchhhhhhc--------ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 661 ATVTEFMVNGSLRHVLLS--------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~--------~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+|||+..++.....++|+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 76 WLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 99999985 577666532 123588999999999999999999999999999999999997655455678999
Q ss_pred ecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---------HH
Q 002908 733 DFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---------AI 799 (867)
Q Consensus 733 DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---------e~ 799 (867)
|||+++...... ......+|+.|+|||++.+ ...++.++|||||||++|+|+||.+||...... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcC-CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 999998654321 1233457899999999874 245788999999999999999999999643211 00
Q ss_pred HHhHhhc-----------------------CC-C------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 002908 800 IGGIVNN-----------------------TL-R------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843 (867)
Q Consensus 800 l~~iv~~-----------------------~l-r------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe 843 (867)
...+... .. . .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 00 0 0001123456889999999999999999999987
Q ss_pred HH
Q 002908 844 RL 845 (867)
Q Consensus 844 ~L 845 (867)
+.
T Consensus 314 hp 315 (317)
T cd07867 314 DP 315 (317)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=310.03 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=209.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|++.+.||+|++|.||+|... +..||||.+...... .......+..|+++++.++||||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKVKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-----hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 36899999999999999999984 688999999754221 1223456888999999999999999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 658 GTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+.+++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||+
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~----~~l~dfg~ 149 (316)
T cd05574 75 -YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH----IMLSDFDL 149 (316)
T ss_pred -EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC----EEEeecch
Confidence 899999999999999988643 356899999999999999999999999999999999999997664 59999999
Q ss_pred cccccCcc------------------------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 737 SKIKRNTL------------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 737 A~~~~~~~------------------------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
+....... ......|+..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhh
Confidence 86432111 1112357889999999984 457889999999999999999
Q ss_pred CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCC----HHHHHHHHH
Q 002908 787 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPS----FTEIARRLR 846 (867)
Q Consensus 787 Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPS----a~ELLe~Lq 846 (867)
|..||...........+.......+.....+..+.+++.+||+.+|++||+ +.+++.+-+
T Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 228 GTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred CCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 999998887776666666555444444447899999999999999999999 888887643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=322.24 Aligned_cols=245 Identities=25% Similarity=0.362 Sum_probs=196.6
Q ss_pred eeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC---CCCceeeEecccccCCCCeEEE
Q 002908 588 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 588 LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L---~HPNIVrL~g~~~~~~~~~l~L 662 (867)
||+|+||+||+|.+. ++.||||++...... .+.....+..|..++..+ .||||+++++++.... ..++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-----hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEE
Confidence 699999999999884 788999999653211 122234455677777665 6999999999998855 8999
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-c
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-R 741 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~-~ 741 (867)
||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++... .
T Consensus 74 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~----~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH----IALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC----EEEecCCcCcCCCC
Confidence 9999999999988754 456899999999999999999999999999999999999997664 599999998743 2
Q ss_pred CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHH
Q 002908 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821 (867)
Q Consensus 742 ~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~ 821 (867)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...........+.......+ ...+++.+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~ 226 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLD-EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-KNVLSDEGR 226 (330)
T ss_pred CCCCccCccCCccccCHHHHcC-CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-CccCCHHHH
Confidence 2223345669999999999874 23468899999999999999999999988777666666555444333 234688999
Q ss_pred HHHHHhhcCCCCCCC----CHHHHHHHHH
Q 002908 822 LLMEQCWAPDPVVRP----SFTEIARRLR 846 (867)
Q Consensus 822 dLI~kCLq~DPeeRP----Sa~ELLe~Lq 846 (867)
+++.+||+.+|.+|| ++.+++++.+
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 999999999999998 6788877644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=307.01 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=208.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|++|.||++.+ .++.||+|++...... .......+.+|+++++++.||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 4689999999999999999998 4788999998753211 1223456788999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|.|||++.++. ++|+|||++
T Consensus 75 -~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~----~kl~dfg~~ 148 (290)
T cd05580 75 -NLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFA 148 (290)
T ss_pred -eEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC----EEEeeCCCc
Confidence 899999999999999988644 56899999999999999999999999999999999999997664 599999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
...... .....+++.|+|||.+.+ ...+.++||||||+++|+|++|..||...........+... ..+.+...+
T Consensus 149 ~~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 222 (290)
T cd05580 149 KRVKGR--TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVRFPSFFS 222 (290)
T ss_pred cccCCC--CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CccCCccCC
Confidence 865443 334568899999999873 45788999999999999999999999877755555555433 334556678
Q ss_pred HHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
..+.+++.+||+.+|.+|+ ++++++.+.+
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 9999999999999999998 8888887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=309.48 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=202.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|++.+.||+|++|.||+|.+ .+..||+|.+...... ....+.+|+.+++.+.||||+++++.+....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~- 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-
Confidence 5899999999999999999987 4788999998653211 1245778999999999999999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++ .++|+|||++
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~----~~kl~dfg~~ 163 (296)
T cd06654 91 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFC 163 (296)
T ss_pred -EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC----CEEECccccc
Confidence 89999999999999998843 4589999999999999999999999999999999999998665 4599999998
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-CCCCCCCC
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPGF 815 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-lr~~ip~~ 815 (867)
....... ......+++.|+|||.+. ...++.++|||||||++|+|++|+.||................ .....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred hhccccccccCcccCCccccCHHHHc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 7543221 122345889999999998 4456889999999999999999999997765433332222221 12233456
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
++..+.+++.+||..+|.+||++.+++.+-+-
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence 78899999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=301.95 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=203.4
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 654 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~ 654 (867)
.+++|++.+.||.|++|.||+|.+. +..+++|++..... ....+.+|+.+++++ .|+||+++++++..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---------EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 3578999999999999999999984 67899999864321 124678899999999 69999999999865
Q ss_pred CC----CCeEEEEEEeecCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 655 GP----GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 655 ~~----~~~l~LVmEy~~ggSL~d~L~~~---~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
.. ...+++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--- 151 (275)
T cd06608 75 KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--- 151 (275)
T ss_pred cCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe---
Confidence 33 34689999999999999887543 357899999999999999999999999999999999999997654
Q ss_pred cEEEeecCCcccccCc-cccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH
Q 002908 728 ICKVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 803 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i 803 (867)
++|+|||++...... .......++..|+|||++.+. ...++.++|||||||+||+|++|..||...........+
T Consensus 152 -~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 230 (275)
T cd06608 152 -VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230 (275)
T ss_pred -EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence 599999998754322 222345588899999998532 234678999999999999999999999876555544444
Q ss_pred hhcCC-CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 804 VNNTL-RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 804 v~~~l-r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..... ....+..++..+.++|.+||..||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 33322 122223467889999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=331.68 Aligned_cols=256 Identities=19% Similarity=0.241 Sum_probs=193.5
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC------CCceeeE
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH------HPNVVAF 648 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~------HPNIVrL 648 (867)
+...+|+++++||+|+||+||+|.+ .+..||||+++... .....+..|+.+++.++ |.+++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 3457899999999999999999988 46789999996421 11223445666666554 4568899
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCC--
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPI-- 725 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~-- 725 (867)
+++|... ...+++||+++ +++|.+++... ..+++..+..|+.||+.||.|||+ .|||||||||+|||++.++..
T Consensus 197 ~~~~~~~-~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 197 QRYFQNE-TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEEEEcC-CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccc
Confidence 9988754 34789999988 78888887543 568999999999999999999998 599999999999999876531
Q ss_pred ----------CCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 002908 726 ----------RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 795 (867)
Q Consensus 726 ----------~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~ 795 (867)
...+||+|||.+...... .....||+.|+|||++. ...++.++|||||||+||||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVL--GLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhh--cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 224799999988643322 23457999999999998 4568899999999999999999999998766
Q ss_pred hhHHHHhHhhcCCCC-------------------------C--------------C-CCCCcHHHHHHHHHhhcCCCCCC
Q 002908 796 YGAIIGGIVNNTLRP-------------------------P--------------V-PGFCDSEWRLLMEQCWAPDPVVR 835 (867)
Q Consensus 796 ~~e~l~~iv~~~lr~-------------------------~--------------i-p~~~s~eL~dLI~kCLq~DPeeR 835 (867)
....+..+....... . . .....+.+.+||.+||+.||.+|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 543332221110000 0 0 00123567899999999999999
Q ss_pred CCHHHHHHHHHHH
Q 002908 836 PSFTEIARRLRVM 848 (867)
Q Consensus 836 PSa~ELLe~Lq~l 848 (867)
||+.|+++|.+-.
T Consensus 430 ~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 430 LNARQMTTHPYVL 442 (467)
T ss_pred CCHHHHhcCcccc
Confidence 9999999976653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=305.75 Aligned_cols=251 Identities=27% Similarity=0.340 Sum_probs=195.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|+||.||+|.+ .|..||+|.++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~------~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLYDVLHSDK-- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc------cCccchhHHHHHHHhcCCCCeeeHHHHhccCC--
Confidence 488899999999999999998 47889999987542211 12245667999999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+. ++|..++......+++..++.++.||+.||.|||++||+||||||+||+++.++. ++|+|||++.
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~----~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE----LKLADFGLAR 147 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc----EEECccchhh
Confidence 8999999995 6788777655567999999999999999999999999999999999999997654 5999999987
Q ss_pred cccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCC-CCChhHHHHhHhhcC---------
Q 002908 739 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA-NMHYGAIIGGIVNNT--------- 807 (867)
Q Consensus 739 ~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~-~~~~~e~l~~iv~~~--------- 807 (867)
..... .......++..|+|||++.+ ...++.++|||||||++|+|+||..||. .......+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhC-CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 54322 11223457889999999874 2346889999999999999999888853 333222222211100
Q ss_pred ---------CCC---------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 808 ---------LRP---------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 808 ---------lr~---------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
... .....+++.+.++|.+||+.+|.+|||+.+++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 000 01123578899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=298.13 Aligned_cols=244 Identities=40% Similarity=0.666 Sum_probs=200.9
Q ss_pred EeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 587 ELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 587 ~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
+||+|++|.||++.+. ++.||+|+++..... .....+.+|+.+++++.||||+++++++.... ..++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e 72 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVME 72 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEE
Confidence 6899999999999885 788999988654211 23456889999999999999999999988754 8899999
Q ss_pred eecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccc
Q 002908 666 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 745 (867)
Q Consensus 666 y~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~ 745 (867)
|+.+++|.+++......+++..++.++.+++.+|.|||+++++||||+|+|||++.++. ++|+|||++........
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~----~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV----LKISDFGMSREEEGGIY 148 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc----EEEeeccccccccCCcc
Confidence 99999999998766667899999999999999999999999999999999999987664 59999999975432111
Q ss_pred c---CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHH
Q 002908 746 T---GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821 (867)
Q Consensus 746 ~---s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~ 821 (867)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|+| |..||...........+ ......+.+..++..+.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 225 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIY 225 (251)
T ss_pred eeccccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHHH
Confidence 1 11223567999999873 457889999999999999999 88999877654444433 33345556677889999
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 822 LLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 822 dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+++.+||..+|.+||++.++++.|+
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=303.02 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=202.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|++|.||+|.+ .+..||||++....... .....+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG------GIPNQALREIKALQACQHPYVVKLLDVFPHGS-- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc------hhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 588999999999999999998 47889999997643221 22356788999999999999999999998854
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+ +++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~----~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV----LKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc----EEEeeeeecc
Confidence 899999999 99999998766677999999999999999999999999999999999999997554 5999999988
Q ss_pred cccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC------
Q 002908 739 IKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP------ 810 (867)
Q Consensus 739 ~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~------ 810 (867)
...... ......++..|+|||++.+ ...++.++|||||||++|+|++|.+||...........+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYG-ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCCCccccccCcccccCceeeec-cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 654332 1234458899999999864 3346889999999999999999988887665444333322211000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 811 ----------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 811 ----------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
......+..+.+++.+||..+|.+||++++++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00123468899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=306.45 Aligned_cols=242 Identities=29% Similarity=0.451 Sum_probs=191.7
Q ss_pred EeeecCcEEEEEEEEC--------------------------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC
Q 002908 587 ELGSGTFGTVYHGKWR--------------------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640 (867)
Q Consensus 587 ~LG~GafG~VYka~~~--------------------------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L 640 (867)
.||+|+||.||+|.+. ...||+|++... ......+|.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 5899999999998751 134888887532 122345688899999999
Q ss_pred CCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEec
Q 002908 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 720 (867)
Q Consensus 641 ~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd 720 (867)
+||||+++++++.... ..++||||+++++|..++......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 9999999999998754 88999999999999998876566789999999999999999999999999999999999998
Q ss_pred cCCC---CCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCh
Q 002908 721 LKDP---IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL-TGEEPYANMHY 796 (867)
Q Consensus 721 ~dg~---~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELL-TGk~PF~~~~~ 796 (867)
..+. ....++++|||++...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||.....
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 6542 2235799999987643221 123467889999998742 55789999999999999985 69999977654
Q ss_pred hHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 797 GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 797 ~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..... ...... ..+....+.+.++|.+||+.+|.+|||+.++++.|
T Consensus 228 ~~~~~-~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKER-FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH-HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 43322 222222 22334567899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=311.11 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=202.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||++.+. +..+|+|.+.... .......+.+|++++.+++||||++++++|....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 36899999999999999999884 6778999886431 1223456888999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+|||++.++. ++|+|||+
T Consensus 73 -~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~----~~l~dfg~ 146 (308)
T cd06615 73 -EISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGV 146 (308)
T ss_pred -EEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc----EEEccCCC
Confidence 899999999999999998644 568999999999999999999997 69999999999999987654 59999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh-----------
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN----------- 805 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~----------- 805 (867)
+...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 147 SGQLIDS-MANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred ccccccc-ccccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 8754332 2234568899999999874 4478899999999999999999999865432221111000
Q ss_pred ------------------------cCCCCCCC-CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 806 ------------------------NTLRPPVP-GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 806 ------------------------~~lr~~ip-~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
....+..+ ..++.++.+|+.+||..+|.+||++.+++.+.+-......
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 00011111 1357789999999999999999999999999887654443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.70 Aligned_cols=258 Identities=29% Similarity=0.482 Sum_probs=204.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCC--hHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRS--SEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~--~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
+|.+.+.||.|+||.||+|.. .+..||||.++........ .........+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999987 4788999998653222111 112234456788999999999999999999988754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||+
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~----~~~l~d~~~ 154 (272)
T cd06629 82 --YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG----ICKISDFGI 154 (272)
T ss_pred --ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC----eEEEeeccc
Confidence 899999999999999988654 5689999999999999999999999999999999999999665 469999999
Q ss_pred cccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 737 SKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 737 A~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
+....... ......++..|+|||.+.+....++.++|+||||+++|+|++|..||...........+.........+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC
Confidence 87543211 122345788999999987544457889999999999999999999997665544443333332222222
Q ss_pred ----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 814 ----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 814 ----~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..++..+.+++.+||..+|.+||++.+++++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 24588999999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.07 Aligned_cols=248 Identities=29% Similarity=0.436 Sum_probs=197.5
Q ss_pred EEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEE
Q 002908 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
...||+|+||.||+|.+. +..||+|.+.... ......+.+|+.+++.++|+||+++++++.... ..++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 82 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--FFKI 82 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--EEEE
Confidence 347999999999999874 5679999886432 112356789999999999999999999998854 8999
Q ss_pred EEEeecCCchhhhhhcccccC--CHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 663 VTEFMVNGSLRHVLLSKERHL--DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~L--se~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
||||+++++|.+++......+ ++..+..++.||+.||.|||++||+||||||+||+++.+. ..++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~---~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC---CeEEEecchhheec
Confidence 999999999999987554455 8888999999999999999999999999999999997532 24699999998754
Q ss_pred cCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhhcCCCCCCCCCCcH
Q 002908 741 RNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRPPVPGFCDS 818 (867)
Q Consensus 741 ~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~~~lr~~ip~~~s~ 818 (867)
... .......++..|+|||++.+....++.++||||||+++|+|++|..||....... ...........+..+..+++
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 321 1222345788999999987544557889999999999999999999997644322 11111112233445667889
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 819 EWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 819 eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.+.+++.+||+.+|.+|||+.+++.+-
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 999999999999999999999998763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=302.78 Aligned_cols=246 Identities=28% Similarity=0.482 Sum_probs=189.9
Q ss_pred EeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEE
Q 002908 587 ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 587 ~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
.||+|+||.||+|.+. +..+|+|.++.... ......+.+|+.++++++||||+++++++.+.. ..++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 72 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLL 72 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEE
Confidence 5899999999999874 34589998764321 112346888999999999999999999998754 7899
Q ss_pred EEEeecCCchhhhhhccc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 663 VTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~----~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
||||+++++|.+++.... ...++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~----~~kL~dfg~~~ 148 (269)
T cd05087 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL----TVKIGDYGLSH 148 (269)
T ss_pred EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC----cEEECCccccc
Confidence 999999999999886422 2456778889999999999999999999999999999998654 46999999987
Q ss_pred cccCcc---ccCCcCCCCCccCccccccCC-----CCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhc-CC
Q 002908 739 IKRNTL---VTGGVRGTLPWMAPELLNGSS-----SKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN-TL 808 (867)
Q Consensus 739 ~~~~~~---~~s~~~GT~~Y~APEvl~g~~-----~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~-~l 808 (867)
...... ......++..|+|||++.+.. ..++.++|+|||||++|+|++ |..||............+.. ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL 228 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC
Confidence 533221 122344678899999986422 135789999999999999996 99999876655443332221 12
Q ss_pred C---CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 809 R---PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 809 r---~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
. +......++.+.+++.+|| .+|++|||+.+|+..|.
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 2222346788999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=325.07 Aligned_cols=254 Identities=26% Similarity=0.329 Sum_probs=205.2
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|+..+++|.|+||.||+|... +..||||...... +.--+|+.+|+.+.|||||++.-+|....+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------------RYKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 5788899999999999999884 6789999875421 1122689999999999999999888654333
Q ss_pred ---eEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 659 ---TLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 659 ---~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
++.+||||| ..+|.+.+.. ....++...+.-+.+||++||+|||..|||||||||.|+|+|.+ ++.+|||
T Consensus 93 d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~---tg~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD---TGVLKIC 168 (364)
T ss_pred chhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC---CCeEEec
Confidence 677899999 6888888753 25678888889999999999999999999999999999999965 3568999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC---
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 809 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr--- 809 (867)
|||.|+.............|..|+|||.+.| ...|+.+.||||.||++.||+-|++.|.+......+..+++-...
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifg-a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcC-ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999998776666667778999999999997 567899999999999999999999999987665554443321100
Q ss_pred ------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHHHHH
Q 002908 810 ------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR--LRVMSAA 851 (867)
Q Consensus 810 ------------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~--Lq~l~~a 851 (867)
.-.....++++.+|+.++|+.+|.+|.++.+++.+ .+.++..
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 00223468899999999999999999999999765 3444443
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=306.10 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=205.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||.||++.+. +..||+|.++... .+.....+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG- 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-
Confidence 46888999999999999999984 7889999886431 1222356889999999999999999999988744
Q ss_pred CeEEEEEEeecCCchhhhhhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 658 GTLATVTEFMVNGSLRHVLLSK--ERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~--~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
..++||||+++++|..++... ...+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++. ++|+||
T Consensus 73 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~----~~l~df 147 (286)
T cd06622 73 -AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ----VKLCDF 147 (286)
T ss_pred -eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC----EEEeec
Confidence 899999999999998887543 2368999999999999999999997 59999999999999997554 599999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCC----CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH--hhcCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSS----SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI--VNNTL 808 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~----~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i--v~~~l 808 (867)
|++....... .....+++.|+|||.+.+.. ..++.++|+|||||++|+|++|+.||...........+ .....
T Consensus 148 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd06622 148 GVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226 (286)
T ss_pred CCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence 9987543322 22345788999999986422 24578999999999999999999999765443332221 11222
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
....+..++..+.++|.+||+.+|.+||++.+++.+.+-....
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 3445556889999999999999999999999999987654443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=303.39 Aligned_cols=251 Identities=27% Similarity=0.339 Sum_probs=198.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|++|.||+|.+. +..||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP------VIKKIALREIRMLKQLKHPNLVNLIEVFRRKR- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc------cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-
Confidence 46899999999999999999984 7889999987532111 11235678999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|..+.. ....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus 74 -~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~ 147 (286)
T cd07847 74 -KLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFA 147 (286)
T ss_pred -EEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC----cEEECccccc
Confidence 8999999998887777653 344689999999999999999999999999999999999999765 4699999999
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC---------
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--------- 807 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~--------- 807 (867)
....... ......++..|+|||++.+. ..++.++|||||||++|+|++|..||.+....+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8654332 22234578899999998742 346789999999999999999999998766544332221100
Q ss_pred ----------CCCCC----------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 808 ----------LRPPV----------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 808 ----------lr~~i----------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
...+. ....+..+.+|+.+||+.+|++||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 12357789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=319.73 Aligned_cols=257 Identities=26% Similarity=0.329 Sum_probs=213.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|+.+..|++|+||.||+|+++ ++-||+|.++...-..+ +--..+||+.+|.+++|||||.+-.++....
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G------FPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG------FPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC------CcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 467999999999999999999984 66799999987542222 2245679999999999999999999998877
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
-+.+|+||||| ..+|...+....++|...++..+..|+++|++|||.+.|+|||||++|+|++..|.. ||+|||+
T Consensus 149 ~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~l----KiaDFGL 223 (419)
T KOG0663|consen 149 MDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGIL----KIADFGL 223 (419)
T ss_pred cceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcE----Eecccch
Confidence 77899999999 688888888888899999999999999999999999999999999999999977754 9999999
Q ss_pred cccccCccc-cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-------
Q 002908 737 SKIKRNTLV-TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL------- 808 (867)
Q Consensus 737 A~~~~~~~~-~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l------- 808 (867)
|+.++.... .+...-|.+|+|||.+.| ...|+.++|+||+||++.||+++++.|.+......+..+.....
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG-~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLG-AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcC-CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 998876532 234457899999999998 46789999999999999999999999988776555544432110
Q ss_pred ----------------------CCCCCCC-CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 809 ----------------------RPPVPGF-CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 809 ----------------------r~~ip~~-~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+..++.. +++.-.+|+..+|..||.+|.|+.+.|++=+-
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F 364 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF 364 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence 0111111 45778999999999999999999999877443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.23 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=205.1
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|+||.||++.+. +..||+|++...... .......+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-----chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 4889999999999999999984 788999999754221 1233567889999999999999999999998755
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.+++||||+.+++|..++... ..+++..+..++.|++.||.|||+++++|+||+|.||+++.++. ++|+|||.+.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~----~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH----VHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC----EEEeeccccc
Confidence 899999999999999988544 57899999999999999999999999999999999999997664 5999999998
Q ss_pred cccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHHhHhhcCCCCCCCCCC
Q 002908 739 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 739 ~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~--~e~l~~iv~~~lr~~ip~~~ 816 (867)
............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .......... .....+..+
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATW 225 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccC
Confidence 6554433445668889999999984 4478899999999999999999999987663 2222222221 344556678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCH--HHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSF--TEIAR 843 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa--~ELLe 843 (867)
+..+.++|.+||+.+|.+||++ ++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 8999999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.89 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=201.9
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||+|+||.||+|.+ .+..|++|.++..... +.....+..|+.+++.++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 588899999999999999987 4788999998754211 334567889999999999999999999987754
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++|+||+++++|.+++... ..+++..+..++.+++.||.|||+.||+|+||+|+||+++.++. ++|+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~----~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV----IKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEEccccccc
Confidence 899999999999999988643 45889999999999999999999999999999999999997654 5999999988
Q ss_pred cccCccc-----cCCcCCCCCccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 739 IKRNTLV-----TGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 739 ~~~~~~~-----~s~~~GT~~Y~APEvl~g~~-~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
....... .....++..|+|||++.+.. ...+.++||||||+++|+|++|..||..................+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 5433221 11245788999999997433 34788999999999999999999999765433322222222223333
Q ss_pred CC--CCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 813 PG--FCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 813 p~--~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+. .++..+.+++.+||+.+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 33 348899999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=297.07 Aligned_cols=247 Identities=41% Similarity=0.672 Sum_probs=203.4
Q ss_pred eEEEEeeecCcEEEEEEEECC------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 583 EELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 583 qilk~LG~GafG~VYka~~~G------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
++.+.||.|+||.||++.+.. ..||+|+++.... ......+..|+.++..++|+||+++++++....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-------EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE 74 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-------hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 466789999999999999853 7799999864321 113457888999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhccccc-CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~-Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..+++|||+++++|.+++...... +++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||
T Consensus 75 --~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~----~~~l~dfg 148 (258)
T smart00219 75 --PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFG 148 (258)
T ss_pred --eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC----eEEEcccC
Confidence 899999999999999998654444 89999999999999999999999999999999999999766 45999999
Q ss_pred CcccccCccccC--CcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 736 LSKIKRNTLVTG--GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 736 LA~~~~~~~~~s--~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
++.......... ...+++.|+|||.+. ...++.++|||||||++|+|++ |..||...........+... ...+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~ 225 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLK--DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-YRLPK 225 (258)
T ss_pred CceecccccccccccCCCcccccChHHhc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCC
Confidence 998554321111 233678999999986 4567889999999999999998 88999876666655554433 34455
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+..++..+.+++.+||..+|.+|||+.++++.|
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 666899999999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.10 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=206.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||+|+||.||++.. .++.||+|.+...... .....++.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS------PKEREESRKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 588999999999999999987 4788999998753221 122356788999999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||+|+|||++.++. ++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~----~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT----IKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC----EEEeeccce
Confidence 899999999999999988643 345789999999999999999999999999999999999986654 599999999
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
....... ......+++.|+|||++.+ ..++.++|+|||||++++|++|..||...........+.... ..+.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-YPPVSSHY 225 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-CCCCcccC
Confidence 7543322 1123457888999999873 457889999999999999999999998777666665554433 33455677
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+..+.++|.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.34 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=201.2
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 654 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~ 654 (867)
..+.|++.+.||.|+||.||+|.+ .+..+|+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---------DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 346788899999999999999998 46789999985421 1124567889999998 69999999999853
Q ss_pred C----CCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 655 G----PGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 655 ~----~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
. .....+++|||+.+++|.+++... ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++. +
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~----~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE----V 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----E
Confidence 2 245789999999999999888643 345888889999999999999999999999999999999997664 5
Q ss_pred EEeecCCcccccCc-cccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
+|+|||++...... .......+++.|+|||++... ...++.++|||||||++|+|++|..||...........+..
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 240 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence 99999998754321 122345588999999998531 34567899999999999999999999977654444433333
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..........++..+.+||.+||+.+|.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 322223344578999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=321.32 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=192.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+....|++++.||+|+||.||+|.+. +..||+|+.... ....|+.+++.++||||+++++++.
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~ 127 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLV 127 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEE
Confidence 345567999999999999999999985 567999975422 1245888999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||+++ .++|..++......+++..++.|+.||+.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 128 ~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~----~kl~D 200 (357)
T PHA03209 128 SGA--ITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ----VCIGD 200 (357)
T ss_pred eCC--eeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEEec
Confidence 854 889999999 57888888766778999999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC-CCCCChh---------HHHHhH
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYG---------AIIGGI 803 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~P-F~~~~~~---------e~l~~i 803 (867)
||++.............||+.|+|||++.+ ..++.++|||||||++|+|+++..+ |...... ..+..+
T Consensus 201 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~ 278 (357)
T PHA03209 201 LGAAQFPVVAPAFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278 (357)
T ss_pred CccccccccCcccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence 999975443333344568999999999984 4578999999999999999985544 3321110 011111
Q ss_pred hhc-CC-CC-----------------------CC-------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 804 VNN-TL-RP-----------------------PV-------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 804 v~~-~l-r~-----------------------~i-------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+.. .. .. +. ...++..+.+||.+||+.||.+|||+.|++.+-+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 110 00 00 00 0134566778999999999999999999998743
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=298.23 Aligned_cols=241 Identities=30% Similarity=0.472 Sum_probs=190.5
Q ss_pred EeeecCcEEEEEEEECCc------------eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 587 ELGSGTFGTVYHGKWRGT------------DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 587 ~LG~GafG~VYka~~~G~------------~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.||+|+||.||+|.+... .+++|++.... .. ...|.+|+.+++.++||||+++++++..
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH--------RD-SLAFFETASLMSQLSHKHLVKLYGVCVR 72 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch--------hh-HHHHHHHHHHHHcCCCcchhheeeEEec
Confidence 589999999999998532 37777765321 11 4678889999999999999999999877
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC---CCCcEEE
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP---IRPICKV 731 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~---~~~~vKL 731 (867)
. ..++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++. ....++|
T Consensus 73 -~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 73 -D--ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred -C--CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence 3 578999999999999998765557899999999999999999999999999999999999987651 2235799
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
+|||++..... .....++..|+|||++.+....++.++|||||||++|+|++ |..||............. .....
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~ 225 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRL 225 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCC
Confidence 99999985433 22334677899999998543467899999999999999999 578886664333222222 21112
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+......+.+++.+||..+|.+|||+.++++.|
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 226 --PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 222237899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.85 Aligned_cols=242 Identities=27% Similarity=0.434 Sum_probs=190.3
Q ss_pred EeeecCcEEEEEEEEC--------------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 587 ELGSGTFGTVYHGKWR--------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 587 ~LG~GafG~VYka~~~--------------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
.||+|+||.||+|.+. ...|++|++... .......|..|+.++..++||||+++++++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~ 73 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGVC 73 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 5899999999999853 124888876532 223345678899999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC---CCCcE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP---IRPIC 729 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~---~~~~v 729 (867)
.... ..++||||+++++|..++......+++..++.++.||+.||+|||+++|+||||||+|||++.++. ....+
T Consensus 74 ~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 74 VRDV--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred ecCC--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence 8754 778999999999998888766667999999999999999999999999999999999999986553 22347
Q ss_pred EEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHH-hCCCCCCCCChhHHHHhHhhcCC
Q 002908 730 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL-TGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELL-TGk~PF~~~~~~e~l~~iv~~~l 808 (867)
+++|||++...... ....++..|+|||.+.+ ...++.++|||||||++|+|+ +|..||......... .......
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~ 226 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVED-SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQC 226 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCc
Confidence 99999998754322 23457888999998863 345788999999999999998 588888765433322 2222222
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
. .....+.++.+||.+||+.+|.+||++.+|+..|
T Consensus 227 ~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 2223467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=303.74 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=199.5
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+ .++.||+|+++.... .....+.+|+.+++.++||||+++++.+....
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--------EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--------hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 45788888999999999999988 478899999875321 11235678999999999999999999988754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||+
T Consensus 80 --~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~----~~l~dfg~ 152 (267)
T cd06645 80 --KLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH----VKLADFGV 152 (267)
T ss_pred --EEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEECccee
Confidence 89999999999999998754 346899999999999999999999999999999999999986654 59999999
Q ss_pred cccccCc-cccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC--
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV-- 812 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i-- 812 (867)
+...... .......|+..|+|||++.. ....++.++|+|||||++|+|++|..||..................++.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232 (267)
T ss_pred eeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence 8744322 12234568999999999742 1334788999999999999999999998765543333333322222221
Q ss_pred -CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 813 -PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 813 -p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
...++..+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 12467889999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.73 Aligned_cols=243 Identities=29% Similarity=0.494 Sum_probs=193.5
Q ss_pred EeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 587 ELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 587 ~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.||.|+||.||+|.+. ...+|+|.+... .......+..|+.+++.+.||||+++++++..+.
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 72 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD- 72 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-
Confidence 5899999999999873 223788877432 1233456788999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC----CCcEEEee
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI----RPICKVGD 733 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~----~~~vKL~D 733 (867)
..++||||+.+++|..++......+++..++.++.||+.||+|||+.||+||||||+|||++.++.. ...++++|
T Consensus 73 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 73 -ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred -CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 7899999999999999997666678999999999999999999999999999999999999876532 24579999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCC-CCCCCCChhHHHHhHhhcCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE-EPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk-~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
||++...... ....++..|+|||++.+ ...++.++|||||||++|+|++|. .||.......... .... +...
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~~~~ 224 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIEN-PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--RHQL 224 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccC-CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--cccC
Confidence 9998754332 23457889999999974 234688999999999999999984 6665544433222 2222 2334
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+...+..+.+++.+||+.+|.+|||++++++.|+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 5556788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=290.55 Aligned_cols=252 Identities=32% Similarity=0.489 Sum_probs=208.4
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||+|++|.||+|.+. +..|++|++...... ......+.+|+.++++++||||+++++.+......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4778899999999999999985 788999998754321 23346788999999999999999999999875335
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+.+++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~----~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV----VKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC----EEEcccccEE
Confidence 8999999999999999886544 7899999999999999999999999999999999999997654 5999999998
Q ss_pred cccCccc---cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhHhhcCCCCCCCC
Q 002908 739 IKRNTLV---TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 739 ~~~~~~~---~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~-~~e~l~~iv~~~lr~~ip~ 814 (867)
....... .....++..|+|||.+.+ ...+.++||||||+++|+|++|..||.... .......+.........+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc
Confidence 6554432 344568899999999974 447889999999999999999999998765 2223333333234455666
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..+..+.+++.+||+.+|.+||++.+++.+-
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 7799999999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.60 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=205.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
+.+|++.+.||.|++|.||+|.+ .++.||||.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--------KKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--------hHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 35799999999999999999987 5788999998643211 1245678999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|..++.. ..+++.++..++.+++.||+|||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 90 --~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~----~kl~dfg~ 161 (296)
T cd06655 90 --ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS----VKLTDFGF 161 (296)
T ss_pred --eEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEEccCcc
Confidence 89999999999999998743 45899999999999999999999999999999999999987654 59999999
Q ss_pred cccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-CCCCCCC
Q 002908 737 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPG 814 (867)
Q Consensus 737 A~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-lr~~ip~ 814 (867)
+....... ......++..|+|||.+. ...++.++|||||||++|+|++|+.||...........+.... .....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06655 162 CAQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (296)
T ss_pred chhcccccccCCCcCCCccccCcchhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcc
Confidence 87543322 223345888999999987 4557889999999999999999999998766544443333222 1223455
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+++.+.++|.+||..+|.+||++.+++.+-+-.
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 6788999999999999999999999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=300.93 Aligned_cols=248 Identities=35% Similarity=0.583 Sum_probs=198.6
Q ss_pred EeeecCcEEEEEEEECC--------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 587 ELGSGTFGTVYHGKWRG--------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 587 ~LG~GafG~VYka~~~G--------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.||+|+||.||+|++.. ..+|||.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-- 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--
Confidence 58999999999998742 4689998754311 122356888999999999999999999988754
Q ss_pred eEEEEEEeecCCchhhhhhcc------cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCC-CCCCcEEE
Q 002908 659 TLATVTEFMVNGSLRHVLLSK------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PIRPICKV 731 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg-~~~~~vKL 731 (867)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++ .....++|
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 789999999999999988642 23478899999999999999999999999999999999998765 22336799
Q ss_pred eecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 732 GDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 732 ~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
+|||++....... ......++..|+|||++. ...++.++|||||||++|+|++ |..||...........+ ...
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~ 229 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL--DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAG 229 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHc--cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcC
Confidence 9999987432221 112234567899999997 4557899999999999999998 99999876655544433 333
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.....+..++..+.++|.+||+.+|.+||++.++++.|+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 344555677899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.70 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=204.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|+..+.||+|++|.||++.. ++..||+|++...... ....+.....+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT--SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC--chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--
Confidence 467788999999999999987 5788999998753321 1223345678889999999999999999999998755
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++. .++|+|||.+.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~---~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ---RLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEEccccccc
Confidence 89999999999999998854 346899999999999999999999999999999999999986543 46999999987
Q ss_pred cccCcc-----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHhHhhcCCCC
Q 002908 739 IKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVNNTLRP 810 (867)
Q Consensus 739 ~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---e~l~~iv~~~lr~ 810 (867)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... .............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC
Confidence 543321 1123457889999999873 45788999999999999999999999654322 2222323333445
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..+..+++.+.+++.+||..+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 5666788999999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.87 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=193.2
Q ss_pred EEEEeeec--CcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 584 ELKELGSG--TFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 584 ilk~LG~G--afG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
++++||+| +|++||++.+ +|..||||++...... ......+.+|+.+++.++||||++++++|.... .
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT------NEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--E 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc------HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--E
Confidence 45679999 7899999987 4788999998654211 122345667999999999999999999998855 8
Q ss_pred EEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 660 LATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++. ++++||+.+.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~----~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK----VYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc----EEEcccchhh
Confidence 99999999999999988543 345899999999999999999999999999999999999997664 4899998654
Q ss_pred cccCcc--------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC-
Q 002908 739 IKRNTL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR- 809 (867)
Q Consensus 739 ~~~~~~--------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr- 809 (867)
...... ......++..|+|||++.+....++.++|||||||++|+|++|+.||..................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 221100 01122456779999999754456789999999999999999999999765443322221111000
Q ss_pred -------------------------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 -------------------------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 -------------------------------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+....+++.+.+|+.+||+.||++|||+.+++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0011234678999999999999999999999998654
Q ss_pred H
Q 002908 847 V 847 (867)
Q Consensus 847 ~ 847 (867)
-
T Consensus 310 f 310 (327)
T cd08227 310 F 310 (327)
T ss_pred h
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.37 Aligned_cols=246 Identities=27% Similarity=0.507 Sum_probs=190.3
Q ss_pred EeeecCcEEEEEEEE-C---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEE
Q 002908 587 ELGSGTFGTVYHGKW-R---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 587 ~LG~GafG~VYka~~-~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
.||+|+||.||+|.. . ...+|+|.+.... .......|.+|+.+++.++||||+++++.+.... ..++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~l 72 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLL 72 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEE
Confidence 589999999999975 2 2357777764321 1222456888999999999999999999998754 8999
Q ss_pred EEEeecCCchhhhhhccc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 663 VTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~----~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. ++|+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~----~kl~dfg~~~ 148 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS----VKIGDYGLAL 148 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc----EEEecccccc
Confidence 999999999999986532 23467888899999999999999999999999999999997664 5999999987
Q ss_pred cccCc---cccCCcCCCCCccCccccccC-----CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCC-
Q 002908 739 IKRNT---LVTGGVRGTLPWMAPELLNGS-----SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL- 808 (867)
Q Consensus 739 ~~~~~---~~~s~~~GT~~Y~APEvl~g~-----~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~l- 808 (867)
..... .......++..|+|||++... ...++.++|||||||++|+|++ |..||.................
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc
Confidence 43221 111223456789999997531 2356889999999999999999 7889987766555444433221
Q ss_pred ---CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 809 ---RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 809 ---r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+..+..++..+.+++..|| .+|++|||+++|++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 12233467888999999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.96 Aligned_cols=254 Identities=29% Similarity=0.413 Sum_probs=208.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|++.+.||+|+||.||+|.+ ++..||+|.+...... .........+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS---QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc---chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 5789999999999999999987 4788999987543211 1122334678899999999999999999999877655
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~----~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN----VKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC----EEECccccc
Confidence 6789999999999999988543 34889999999999999999999999999999999999986654 599999999
Q ss_pred ccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 738 KIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 738 ~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
...... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+......+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC
Confidence 754321 11123458889999999984 457889999999999999999999998776666555555555556677
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..+++.+.+++.+||+ +|..||++.+++.+
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 7889999999999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.77 Aligned_cols=264 Identities=24% Similarity=0.304 Sum_probs=206.7
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||.|+||.||+|.+ ++..||+|+++....... ....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG------IPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC------CcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 356899999999999999999998 478899999975432211 112455799999999999999999998765
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
....+++||||+. ++|.+++......+++..++.++.||+.||.|||+.|++||||+|+||+++.++. ++|+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~----~kL~dfg 153 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC----LKIADFG 153 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC----EEECccc
Confidence 5557899999995 5788887655567899999999999999999999999999999999999997654 5999999
Q ss_pred CcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC------
Q 002908 736 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL------ 808 (867)
Q Consensus 736 LA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l------ 808 (867)
++....... ......++..|+|||++.+ ...++.++|||||||++|+|++|..||........+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 154 LARTYGLPAKPMTPKVVTLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred eeeecCCccCCCCcccccccccChhhhcC-CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 998654321 1122335778999999874 24468899999999999999999999987766555444332110
Q ss_pred -------------CCC-C--------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 809 -------------RPP-V--------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 809 -------------r~~-i--------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
... . ....++.+.++|.+||+.||++|||+.+++.+.+-...++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 000 0 01247888999999999999999999999988776544443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.23 Aligned_cols=249 Identities=26% Similarity=0.297 Sum_probs=195.6
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCCC
Q 002908 582 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~~ 658 (867)
|++.+.||+|+||.||+|.. ++..||+|.++...... . .....+|+.++.++. |+||+++++++.+...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~----~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL----E---QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc----h---hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 67889999999999999987 47889999987542211 1 123447888899885 99999999999876446
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.+++||||+. ++|.+.+......+++..++.++.|++.||.|||+.|++||||+|+||+++. + .++|+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~----~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D----ILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C----CeEEEeccccc
Confidence 8999999995 5888877655567899999999999999999999999999999999999996 4 46999999998
Q ss_pred cccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-----------
Q 002908 739 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----------- 807 (867)
Q Consensus 739 ~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~----------- 807 (867)
............++..|+|||++.. ...++.++|||||||++|+|++|..||...+.......+....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLT-DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhc-CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 6543333334457889999998753 2346789999999999999999999998765544332222100
Q ss_pred -----CCCCC-----------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 808 -----LRPPV-----------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 808 -----lr~~i-----------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..... ...++..+.++|.+||+.+|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 12457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.79 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=196.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHH-HHhCCCCceeeEecccccCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI-LSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEiei-Lk~L~HPNIVrL~g~~~~~~ 656 (867)
++|++.+.||+|+||.||++.+ +|..||||+++...... ....+..|+.+ ++.+.||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-------EQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-------HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 3689999999999999999998 47889999987542211 12344455554 66678999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 GGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
..++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||++.++. ++|+
T Consensus 74 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~----~kl~ 146 (283)
T cd06617 74 --DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ----VKLC 146 (283)
T ss_pred --cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC----EEEe
Confidence 7999999995 677766643 235689999999999999999999997 9999999999999997654 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccC--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhHhhcCCC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS--SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAIIGGIVNNTLR 809 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~--~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~-~e~l~~iv~~~lr 809 (867)
|||++.............++..|+|||.+.+. ...++.++|+|||||++|+|++|+.||..... ...+...... ..
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~ 225 (283)
T cd06617 147 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-PS 225 (283)
T ss_pred ecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-CC
Confidence 99999865443333334588899999998642 13467899999999999999999999975332 2233333322 22
Q ss_pred CCC-CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 810 PPV-PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 810 ~~i-p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
... ...++..+.++|.+||..+|.+||++.+++.+-+-..
T Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 222 2357889999999999999999999999988655443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.78 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=203.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||.|++|+||+|.+ .+..+|+|++...... . ....+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ------T-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc------h-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence 4689999999999999999987 4678999998643221 1 3456789999999999999999999988754
Q ss_pred CeEEEEEEeecCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~--~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..++|||++++++|.+++.... ..+++..+..++.|++.||+|||++||+|+||+|+||+++.++. ++|+|||
T Consensus 73 -~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~----~~l~df~ 147 (267)
T cd06610 73 -ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS----VKIADFG 147 (267)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC----EEEcccc
Confidence 8999999999999999986532 46899999999999999999999999999999999999997654 5999999
Q ss_pred CcccccCcc-----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC-
Q 002908 736 LSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR- 809 (867)
Q Consensus 736 LA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr- 809 (867)
++....... ......++..|+|||++... ..++.++|+|||||++|+|++|+.||..................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS 226 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCC
Confidence 987543321 11334588899999998743 35788999999999999999999999877665544444433211
Q ss_pred CCC---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 PPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 ~~i---p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
... ...+++.+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111 12567889999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=304.98 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=202.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||++.+. ++.|+||.+..... ........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 36889999999999999999884 67899999865321 12223456778999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|.||+++.++. ++|+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~----~~l~dfg~~ 148 (305)
T cd05609 75 -HLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH----IKLTDFGLS 148 (305)
T ss_pred -EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC----EEEeeCCCc
Confidence 899999999999999998544 46899999999999999999999999999999999999986654 599999998
Q ss_pred ccccCcc----------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 002908 738 KIKRNTL----------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 801 (867)
Q Consensus 738 ~~~~~~~----------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~ 801 (867)
+...... ......++..|+|||.+. ...++.++|+|||||++|+|++|..||.+........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL--RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhcc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 6321100 011234678899999987 4557899999999999999999999998877666666
Q ss_pred hHhhcCCCCCC-CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 802 GIVNNTLRPPV-PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 802 ~iv~~~lr~~i-p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.........+. ...++..+.++|.+||+.+|++||++.++.+.|+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 65554433222 23578999999999999999999985444444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.85 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=205.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
..|+..+.||.|+||.||+|.+ .+..||||+++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT- 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 3567788899999999999987 477899999874321 223467889999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~----~~l~dfg~~ 148 (277)
T cd06640 76 -KLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD----VKLADFGVA 148 (277)
T ss_pred -EEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC----EEEcccccc
Confidence 89999999999999998853 46889999999999999999999999999999999999997654 599999999
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
....... ......++..|+|||++. ...++.++|+|||||++|+|++|..||...........+ .....+..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQ--QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEF 225 (277)
T ss_pred eeccCCccccccccCcccccCHhHhc--cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhh
Confidence 7543222 222345788999999987 445788999999999999999999999876655444332 223334445567
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
+..+.+++.+||+.+|.+||++.+++.+..-.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence 88999999999999999999999998886544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=306.97 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=204.4
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+..++|++++.||+|+||+||++.+. +..||+|++.... .+.....+.+|+++++.++||||+++++++..
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 34578889999999999999999985 7889999886431 12234678899999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. .+++||||+++++|.+++.. ...+++..+..++.+++.+|.|||+ .+++||||+|+||+++.++. ++|+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~----~~l~d 147 (284)
T cd06620 75 EN--NICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ----IKLCD 147 (284)
T ss_pred CC--EEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc----EEEcc
Confidence 64 89999999999999888754 3568999999999999999999997 69999999999999986654 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-----------HHHHh
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-----------AIIGG 802 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-----------e~l~~ 802 (867)
||++....... .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...... .....
T Consensus 148 ~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 148 FGVSGELINSI-ADTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred CCcccchhhhc-cCccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 99986442221 223468999999999873 46788999999999999999999999764432 12222
Q ss_pred HhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 803 iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+............++..+.+|+.+||+.+|.+|||+.++++++.-+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 225 IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 22222111112236788999999999999999999999998865544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=289.06 Aligned_cols=248 Identities=32% Similarity=0.525 Sum_probs=203.9
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||+|++|.||++.+. +..+++|++..... .....+.+|+.+++.++|+|++++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 4788899999999999999985 78899999975421 23467888999999999999999999988754
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..+++|||+++++|.+++......+++..+..++.|++.||.|||..|++||||+|.||+++.++. ++|+|||.+.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~----~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE----VKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe----EEEeeccccc
Confidence 889999999999999988765567999999999999999999999999999999999999997654 5999999998
Q ss_pred cccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-CCCCCCCCc
Q 002908 739 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVPGFCD 817 (867)
Q Consensus 739 ~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l-r~~ip~~~s 817 (867)
............++..|+|||.+.+ ..++.++||||||+++|+|++|..||................. ..+....++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWS 224 (253)
T ss_pred cccccccccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccC
Confidence 6544332334568899999999984 3478899999999999999999999987654444333332211 111222348
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..+.+++.+||+.+|.+|||+.+++++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 899999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.62 Aligned_cols=267 Identities=24% Similarity=0.313 Sum_probs=227.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~ 657 (867)
.|.-.+.||.|..++|-++.. +|..+|+|++.........+...+...+-.+|+.+|+++ .||+|+.+.+++....
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s- 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA- 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence 455566799999999988876 478899999987666554555566677788999999998 6999999999999865
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|+|.|+.|.|.+++... -.+++.....|++|+++|+.|||.+.|+||||||+|||++++-++ +|+|||+|
T Consensus 97 -F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i----~isDFGFa 170 (411)
T KOG0599|consen 97 -FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNI----KISDFGFA 170 (411)
T ss_pred -hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccce----EEecccee
Confidence 899999999999999999543 469999999999999999999999999999999999999976654 99999999
Q ss_pred ccccCccccCCcCCCCCccCcccccc----CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--C
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNG----SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--P 811 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g----~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~--~ 811 (867)
+...........||||+|+|||.+.. ....|+..+|+||+|++||-|+.|++||.....--++.-++.+.+.. +
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 98888877788999999999999853 35678999999999999999999999997655555566677777644 4
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
....++...++||.+||+.||.+|.|++|.|.+..-..-..+.
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~ 293 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ 293 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence 4456788999999999999999999999999998876655443
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.23 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=204.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
...|+..+.||+|+||.||+|.+ .+..||+|++...... .......+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 35688899999999999999987 4788999998643211 1222356788999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+. +++.+.+......+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||+
T Consensus 89 --~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~----~kL~dfg~ 161 (307)
T cd06607 89 --TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT----VKLADFGS 161 (307)
T ss_pred --eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC----EEEeecCc
Confidence 7899999995 6777766555567899999999999999999999999999999999999997664 59999999
Q ss_pred cccccCccccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
+...... ....++..|+|||++.+ ....++.++||||||+++|+|+||..||...........+.........+..
T Consensus 162 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (307)
T cd06607 162 ASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND 238 (307)
T ss_pred ceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchh
Confidence 8754332 23457889999999853 1345788999999999999999999999877665544443333222222345
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
++..+.++|.+||+.+|.+||++.+++.+.+-.
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 678899999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=304.22 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=202.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|+..+.||+|+||.||+|.+ .+..||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--
Confidence 466667899999999999987 46789999986431 1223457889999999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+++++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~----~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD----VKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC----EEEccccccc
Confidence 8999999999999998874 346899999999999999999999999999999999999987654 5999999987
Q ss_pred cccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 739 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 739 ~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+ ...........++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 226 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PKNSPPTLEGQYS 226 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-hcCCCCCCCcccC
Confidence 543322 2223457889999999984 45788999999999999999999999765544433322 2222334445678
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+.+++.+||+.+|.+||++.+++.+.+-.
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 8999999999999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.12 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=203.7
Q ss_pred eeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 588 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 588 LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
||.|++|.||++.+. +..||+|++...... .......+.+|+.+++.++||||+++++++.++. ..++|||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-----ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-----hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEe
Confidence 689999999999996 788999999754322 1223456889999999999999999999988754 8999999
Q ss_pred eecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccc
Q 002908 666 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 745 (867)
Q Consensus 666 y~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~ 745 (867)
|+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|.||+++.++. ++|+|||++........
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~----~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC----EEEeeCCcccccCcccc
Confidence 99999999988643 45899999999999999999999999999999999999997654 59999999986544333
Q ss_pred cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--hhHHHHhHhhcCCCCCCCCCCcHHHHHH
Q 002908 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH--YGAIIGGIVNNTLRPPVPGFCDSEWRLL 823 (867)
Q Consensus 746 ~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~--~~e~l~~iv~~~lr~~ip~~~s~eL~dL 823 (867)
.....++..|++||.+. ...++.++|+||||+++|+|++|..||.... .......+.........+...++.+.++
T Consensus 149 ~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 149 TWTFCGTPEYVAPEIIL--NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred cccccCCcCccChhHhc--CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 33446788999999987 3457889999999999999999999998766 4455555554444556666678999999
Q ss_pred HHHhhcCCCCCCCC-----HHHHHHHHH
Q 002908 824 MEQCWAPDPVVRPS-----FTEIARRLR 846 (867)
Q Consensus 824 I~kCLq~DPeeRPS-----a~ELLe~Lq 846 (867)
|.+||+.+|.+||+ +.+++++-+
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcChh
Confidence 99999999999999 888887654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=293.32 Aligned_cols=250 Identities=32% Similarity=0.507 Sum_probs=206.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||.|++|.||++.+. +..|+||++...... .....+.+|+.++..++|+||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEG- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence 36888999999999999999984 788999998754211 23467889999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||.
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~----~~l~df~~ 146 (264)
T cd06623 73 -EISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE----VKIADFGI 146 (264)
T ss_pred -eEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC----EEEccCcc
Confidence 899999999999999998644 668999999999999999999999 99999999999999997664 59999999
Q ss_pred cccccCcccc-CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---hhHHHHhHhhcCCCCCC
Q 002908 737 SKIKRNTLVT-GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 737 A~~~~~~~~~-s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~---~~e~l~~iv~~~lr~~i 812 (867)
+......... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... .......+. .......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 223 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSL 223 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCC
Confidence 8855432222 23457889999999884 467889999999999999999999997763 333333333 3333444
Q ss_pred CCC-CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 813 PGF-CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 813 p~~-~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+.. ++..+.++|.+||..+|.+||++.+++++-+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 445 7899999999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.15 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=202.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|++++.||+|++|.||++.. .+..||||.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD- 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 6799999999999999999987 4788999998643211 1245678999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++. ++|+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~----~~l~Dfg~~ 162 (297)
T cd06656 90 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFC 162 (297)
T ss_pred -EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEECcCccc
Confidence 89999999999999998843 45789999999999999999999999999999999999987654 599999998
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc-CCCCCCCCC
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPGF 815 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~-~lr~~ip~~ 815 (867)
....... ......+++.|+|||.+. ...++.++|+|||||++|+|++|..||...........+... ......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 7543221 222345788999999998 455788999999999999999999999765443332222221 112223456
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
++..+.+++.+||..+|.+||++.+++++-+-
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 78889999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.92 Aligned_cols=251 Identities=29% Similarity=0.360 Sum_probs=196.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||+|.+. ++.||+|++...... ......+.+|+++++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD------KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc------chhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-
Confidence 46899999999999999999984 788999998653221 122345778999999999999999999998744
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|..+... ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~----~~l~dfg~~ 147 (286)
T cd07846 74 -RLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV----VKLCDFGFA 147 (286)
T ss_pred -eEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc----EEEEeeeee
Confidence 89999999998888776543 345899999999999999999999999999999999999987664 599999998
Q ss_pred ccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc----------
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 806 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~---------- 806 (867)
...... .......++..|+|||++.+. ..++.++||||||+++|+|++|++||...........+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 754322 222234578899999998742 34678999999999999999999999765433322221110
Q ss_pred ---------CCCCC----------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 807 ---------TLRPP----------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 807 ---------~lr~~----------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
....+ ....++..+.+|+.+||+.+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 112457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=291.07 Aligned_cols=249 Identities=30% Similarity=0.526 Sum_probs=208.8
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|++|.||++.+. +..|++|++...... ......+.+|+++++.++|||++++++.+... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS------EKEREDALNEVKILKKLNHPNIIKYYESFEEK--G 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC------hHHHHHHHHHHHHHHhcCCCChhheEEEEecC--C
Confidence 5888999999999999999985 788999998754221 23345678899999999999999999998875 4
Q ss_pred eEEEEEEeecCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 659 TLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~---~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..++||||+++++|.+++... ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~----~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL----VKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc----EEECCcc
Confidence 899999999999999988654 367999999999999999999999999999999999999997654 5999999
Q ss_pred CcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 736 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 736 LA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
++....... ......+++.|+|||.+. ...++.++|+||||+++++|++|..||................ ..+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 225 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQ--NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPS 225 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhc--cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCC
Confidence 998654432 223345788999999987 4457889999999999999999999998877666555544433 445566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.++..+.+++.+||..+|.+|||+.+++.+
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.38 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=195.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
.+...+|++++.||.|+||.||++... +..||||.+... ..+.+|+.+|+.++||||++++++
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~ 154 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHA 154 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeee
Confidence 445678999999999999999999763 466899987542 123479999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+.... ..++||+++ +++|..++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|
T Consensus 155 ~~~~~--~~~lv~e~~-~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~----~~l 226 (392)
T PHA03207 155 YRWKS--TVCMVMPKY-KCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN----AVL 226 (392)
T ss_pred EeeCC--EEEEEehhc-CCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC----EEE
Confidence 88754 899999998 57888877 34467999999999999999999999999999999999999997664 599
Q ss_pred eecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHhHhh
Q 002908 732 GDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIVN 805 (867)
Q Consensus 732 ~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---e~l~~iv~ 805 (867)
+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.... ..+..+..
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA--LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhc--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 9999997543321 122456899999999998 445788999999999999999999999664321 11111111
Q ss_pred -------------------------cCCCCC--CC-----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 806 -------------------------NTLRPP--VP-----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 806 -------------------------~~lr~~--ip-----~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
...+.+ .+ ..++.++.++|.+||..+|.+|||+.+++.+-+-
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 000110 11 2346678999999999999999999999988654
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.31 Aligned_cols=249 Identities=34% Similarity=0.524 Sum_probs=202.2
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|+..+.||.|++|.||++.+. +..+|+|.+..... .....++.+|+.+++.+.||||+++++++... .
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-------EAIQKQILRELDILHKCNSPYIVGFYGAFYNN--G 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-------hHHHHHHHHHHHHHHHCCCCchhhhheeeecC--C
Confidence 5777888999999999999985 78899999875421 12345678999999999999999999999875 4
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+.+++|.+++......+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++. ++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~----~~l~d~g~~ 148 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ----IKLCDFGVS 148 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC----EEEeecccc
Confidence 8999999999999999887655778999999999999999999999 99999999999999997654 599999998
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHhHhhcCCCCCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-----YGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~-----~~e~l~~iv~~~lr~~i 812 (867)
......... ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||.... .......+... ..+..
T Consensus 149 ~~~~~~~~~-~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 224 (265)
T cd06605 149 GQLVNSLAK-TFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPRL 224 (265)
T ss_pred hhhHHHHhh-cccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCCC
Confidence 754332221 2568889999999984 467889999999999999999999997642 12222222222 22233
Q ss_pred CCC-CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 813 PGF-CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 813 p~~-~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+.. ++..+.++|.+||..+|.+|||+.+++.+-+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 333 7889999999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=299.41 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=192.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|++.+.||+|+||.||+|.. ++..||||++....... ....+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~- 76 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-------VPFTAIREASLLKGLKHANIVLLHDIIHTKE- 76 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-------CcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-
Confidence 6799999999999999999987 47889999986543211 1234568999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+. ++|..++......+++..+..++.|++.||.|||+.||+|+||||+|||++.++. ++|+|||++
T Consensus 77 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~----~~l~Dfg~~ 150 (291)
T cd07870 77 -TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE----LKLADFGLA 150 (291)
T ss_pred -eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc----EEEeccccc
Confidence 8999999995 6777776555556788899999999999999999999999999999999987654 599999998
Q ss_pred ccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhHhhc---------
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNN--------- 806 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~iv~~--------- 806 (867)
+..... .......+++.|+|||++.+ ...++.++|||||||++|+|++|..||...... +.+..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 151 RAKSIPSQTYSSEVVTLWYRPPDVLLG-ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred cccCCCCCCCCCccccccccCCceeec-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 753221 12233457889999999874 234678899999999999999999999765432 111111100
Q ss_pred -------C-----CCCCCC---------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 807 -------T-----LRPPVP---------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 807 -------~-----lr~~ip---------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
. .....+ ...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 000000 1125678999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=293.33 Aligned_cols=251 Identities=25% Similarity=0.454 Sum_probs=204.7
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|+||.||++.++ +..+|+|.+....... .....+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------KEKEASKKEVILLAKMKHPNIVTFFASFQENG-- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------hhhHHHHHHHHHHHhCCCCChhhhhheeccCC--
Confidence 4788999999999999999984 6789999986532211 11345678999999999999999999988754
Q ss_pred eEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. .++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM---VAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC---eEEecccccc
Confidence 8999999999999999886533 35799999999999999999999999999999999999986643 3699999998
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
....... ......|++.|+|||++. ...++.++|+||||+++|+|++|..||................ ..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQ--NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-FAPISPNF 226 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-CCCCCCCC
Confidence 7554322 222345888999999987 4457889999999999999999999998766655555444333 23344567
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+..+.+++.+||..+|++|||+.+++++.
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 227 SRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 88999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.98 Aligned_cols=250 Identities=27% Similarity=0.469 Sum_probs=200.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---CCceeeEecccccC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDG 655 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~---HPNIVrL~g~~~~~ 655 (867)
.|++.+.||.|+||.||+|.+ .+..||||+++.... .....++.+|+.+++.+. |||++++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 367778899999999999998 478899999864321 112345778999999986 99999999998875
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||
T Consensus 75 ~--~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~----~~~l~dfg 146 (277)
T cd06917 75 P--RLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG----NVKLCDFG 146 (277)
T ss_pred C--EEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC----CEEEccCC
Confidence 4 89999999999999988754 3689999999999999999999999999999999999999755 45999999
Q ss_pred CcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 736 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 736 LA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
++....... ......|+..|+|||.+.+ ...++.++|+|||||++|+|++|..||...........+... ..+..+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLED 224 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhcc-CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCc
Confidence 987543322 2233468889999999864 344688999999999999999999999876554433322222 1222222
Q ss_pred -CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 815 -FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 815 -~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..+..+.+++.+||+.+|.+||++.+++.+-+-
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 378899999999999999999999999887554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.18 Aligned_cols=253 Identities=27% Similarity=0.374 Sum_probs=200.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||.|++|.||+|.+. ++.+|||.++..... +.....+.+|+.++..++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 46888899999999999999984 778999999754322 1223456789999999999999999999887644
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
...++||||+. ++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+|||++.++. ++|+|||++
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~----~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI----LKICDFGLA 153 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc----EEEeecCce
Confidence 68999999996 5888888665567999999999999999999999999999999999999997654 599999998
Q ss_pred ccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC---------
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--------- 807 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~--------- 807 (867)
...... .......+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eeccCCccccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 854432 222334578899999998742 336789999999999999999999998765443333221100
Q ss_pred --------------------CCCCCCCC-CcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 808 --------------------LRPPVPGF-CDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 808 --------------------lr~~ip~~-~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.....+.. +++.+.++|.+||+.+|++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 01112222 57889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.29 Aligned_cols=255 Identities=27% Similarity=0.336 Sum_probs=200.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|++|.||+|.+ .++.||||.++....... .......+..|+.+++.++|+||+++++++.+. .
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA---KDGINFTALREIKLLQELKHPNIIGLLDVFGHK--S 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc---cchhhHHHHHHHHHHhhcCCCCChhhhheeecC--C
Confidence 478889999999999999998 478899999976543211 122334567899999999999999999999884 4
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+ +++|.+++......+++..++.++.||++||.|||++||+|+||+|+|||++.++. ++|+|||++.
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~----~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV----LKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC----EEEccceeee
Confidence 899999999 99999998655447999999999999999999999999999999999999997654 5999999998
Q ss_pred cccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC--------
Q 002908 739 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 809 (867)
Q Consensus 739 ~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr-------- 809 (867)
...... ......++..|+|||.+.+ ...++.++|||||||++|+|++|.+||...........+......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFG-ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhC-CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 654322 2223346788999999864 345688999999999999999998888765543333222211000
Q ss_pred -------------CC-----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 -------------PP-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 -------------~~-----ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+ .....+..+.++|.+||+++|.+|||+.+++.+-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~ 284 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence 00 11234678999999999999999999999988633
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.68 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=223.7
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
-|.+.+.||+|.|.+|-++++ +|..||||++.+..+. +.....+.+|++||+.++|||||++|.++....
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD------~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-- 90 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-- 90 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc------hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc--
Confidence 366777899999999999886 8999999999765432 233455778999999999999999999998855
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.+|||+|+-.+|+|.+++.+.+..+.+..+.+++.||+.|+.|||+..+|||||||+||.+-+.- +.+||+|||++.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl---GlVKLTDFGFSN 167 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL---GLVKLTDFGFSN 167 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec---CceEeeeccccc
Confidence 89999999999999999998888899999999999999999999999999999999999886432 457999999999
Q ss_pred cccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcH
Q 002908 739 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 818 (867)
Q Consensus 739 ~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~ 818 (867)
.+.+.......||+..|-|||++.|..+. .+++||||||++||.|++|++||...+..+.+..+++..+ ..|..++.
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYD-APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~ 244 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYD-APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSK 244 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccC-CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhH
Confidence 88887777888999999999999986554 5789999999999999999999999888888888887765 46788999
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 819 EWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 819 eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+.++||..||..||.+|.+.++|...-|-
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 99999999999999999999999876654
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=299.41 Aligned_cols=253 Identities=29% Similarity=0.429 Sum_probs=200.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|+..+.||.|++|.||++.+ .++.+|+|.+..... .....++.+|+++++.++||||++++++|.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-------PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 4688999999999999999998 467899999875321 1234568889999999999999999999876655
Q ss_pred CeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 658 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
..+++||||+++++|.+++.. ....+++..+..++.||+.||+|||+.|++|+||+|.||+++.++. ++|+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~----~~l~df 149 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ----VKLCDF 149 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe----EEEeec
Confidence 688999999999999887642 3456899999999999999999999999999999999999986654 699999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-----hHHHHhHhhcCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-----GAIIGGIVNNTLR 809 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~-----~e~l~~iv~~~lr 809 (867)
|++........ ....++..|+|||.+. ...++.++|||||||++|+|++|+.||..... ......+.. ...
T Consensus 150 g~~~~~~~~~~-~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~ 225 (287)
T cd06621 150 GVSGELVNSLA-GTFTGTSFYMAPERIQ--GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPN 225 (287)
T ss_pred ccccccccccc-ccccCCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCc
Confidence 99874432221 2345788999999987 44578899999999999999999999976521 222222221 111
Q ss_pred CCCC------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 810 PPVP------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 810 ~~ip------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
...+ ...++.+.+++.+||..+|.+|||+.+++++.+-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 1111 2346789999999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=298.85 Aligned_cols=253 Identities=30% Similarity=0.436 Sum_probs=201.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~ 655 (867)
.++|++.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 57899999999999999999988 47889999986421 1123456788899988 799999999998653
Q ss_pred C---CCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 656 P---GGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 656 ~---~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+ .+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~----~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG----V 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC----E
Confidence 2 2468999999999999988753 3456899999999999999999999999999999999999987664 5
Q ss_pred EEeecCCcccccCcc-ccCCcCCCCCccCccccccCC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNTL-VTGGVRGTLPWMAPELLNGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~---~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
+|+|||++....... ......++..|+|||++.... ..++.++|||||||++|+|++|+.||...........+..
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 999999987543222 223345788999999986322 2367899999999999999999999988766555444332
Q ss_pred cCC-CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 806 NTL-RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 806 ~~l-r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
... ....+...+..+.++|.+||+.+|++||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 221 122234567789999999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=299.29 Aligned_cols=251 Identities=26% Similarity=0.382 Sum_probs=194.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||.|++|.||+|.. .++.||||.+........ ...+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-------PFTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-------chhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 36799999999999999999988 478899999875432111 124567999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+. ++|.+++......+++..+..++.|++.||.|||+++|+||||+|+|||++.++. ++|+|||+
T Consensus 77 --~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~----~kl~dfg~ 149 (291)
T cd07844 77 --TLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE----LKLADFGL 149 (291)
T ss_pred --eEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC----EEECcccc
Confidence 8999999996 5898888766667899999999999999999999999999999999999997664 59999999
Q ss_pred cccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhHhhc---C----
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNN---T---- 807 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~-~~e~l~~iv~~---~---- 807 (867)
++..... .......++..|+|||++.+ ...++.++|||||||++|+|++|+.||.... .......+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLG-STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhc-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 8743221 11122346788999999874 2346889999999999999999999997654 22221111100 0
Q ss_pred ------------CCC----C-----CCCCCc--HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 808 ------------LRP----P-----VPGFCD--SEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 808 ------------lr~----~-----ip~~~s--~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
... + ...... ..+.+++.+||+.+|.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0 001123 778899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.39 Aligned_cols=257 Identities=26% Similarity=0.338 Sum_probs=196.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
+|++.+.||+|++|.||+|.+ .+..||||.+...... .+.....+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-----YTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-----ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 478899999999999999998 3578999999763211 1112245668999999999999999999998874
Q ss_pred CCeEEEEEEeecCCchhhhhhcc----cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSK----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~----~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
...+++||||+. ++|.+.+... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.....+||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 468999999995 4666555321 23689999999999999999999999999999999999999866566778999
Q ss_pred ecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH---------H
Q 002908 733 DFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA---------I 799 (867)
Q Consensus 733 DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e---------~ 799 (867)
|||++....... ......++..|+|||++.+ ...++.++|||||||++|+|++|..||....... .
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999988543221 1233457889999998874 2346889999999999999999999997544321 0
Q ss_pred HHhHhh------------------------cCCCCCCC-----------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 800 IGGIVN------------------------NTLRPPVP-----------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 800 l~~iv~------------------------~~lr~~ip-----------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+..++. .......+ ...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111000 00001111 1456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=305.40 Aligned_cols=256 Identities=28% Similarity=0.441 Sum_probs=208.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
...|...+.||+|+||.||++.+ .+..||||.+...... .......+.+|+.+++.++|||++++++++....
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-----chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 34477888999999999999987 4778999998643211 2233456888999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+. ++|.+.+......+++..+..++.+++.||.|||++||+||||+|+||+++.++. ++|+|||+
T Consensus 99 --~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~----~kl~dfg~ 171 (317)
T cd06635 99 --TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ----VKLADFGS 171 (317)
T ss_pred --eEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC----EEEecCCC
Confidence 7899999995 5777777655667899999999999999999999999999999999999987654 59999999
Q ss_pred cccccCccccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
+...... ....++..|+|||++.. ....++.++|||||||++|+|++|..||...........+............
T Consensus 172 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T cd06635 172 ASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248 (317)
T ss_pred ccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCcc
Confidence 8754332 23458889999999742 2345788999999999999999999999877665555555554444444456
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+++.+.+++.+||+.+|.+||++.+++.++..+.
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 7889999999999999999999999999876643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=297.03 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=204.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
-|++.+.||.|+||.||+|.+ .+..||||++.... .......+.+|+.++..++||||+++++++....
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-- 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--
Confidence 467788999999999999987 46789999875431 1223457888999999999999999999998855
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+++++|..++.. ..+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~----~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE----VKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC----EEEeecccce
Confidence 89999999999999988743 46899999999999999999999999999999999999986654 5999999987
Q ss_pred cccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 739 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 739 ~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
...... ......++..|+|||.+. ...++.++|+|||||++|+|++|..||...........+ .....+..+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 226 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIK--QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYS 226 (277)
T ss_pred ecccchhhhccccCCccccChhhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hcCCCCCCCcccC
Confidence 543321 222345788999999987 445788999999999999999999999876654444433 2233344556678
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+.+++.+||+.+|.+||++.+++.+..-.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~ 257 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 9999999999999999999999999975443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=295.04 Aligned_cols=254 Identities=33% Similarity=0.528 Sum_probs=199.2
Q ss_pred eeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 582 LEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
|.+.+.||+|+||.||+|.+. +..||||+++..... .....++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS------SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC------hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 556778999999999999863 577999999754221 222456788999999999999999999876432
Q ss_pred C----CeEEEEEEeecCCchhhhhhcc-----cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 657 G----GTLATVTEFMVNGSLRHVLLSK-----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 657 ~----~~l~LVmEy~~ggSL~d~L~~~-----~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
. ...+++++|+.+++|..++... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~---- 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM---- 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC----
Confidence 1 2347899999999998776422 23578899999999999999999999999999999999998655
Q ss_pred cEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhH
Q 002908 728 ICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 803 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~i 803 (867)
.++|+|||+++...... ......+++.|++||.+. ...++.++|||||||++|+|++ |.+||...........+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLA--DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHh--cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 46999999988543211 112233567899999987 4457889999999999999999 89999877655544443
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 804 v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
... .....+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 229 ~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 332 23334456788999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=297.49 Aligned_cols=251 Identities=26% Similarity=0.333 Sum_probs=197.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|++|.||+|.+. +..||||+++.... .......+.+|+++++.++|+||+++++++....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc------cccchhHHHHHHHHHHhcCCCCeeehhheEEECC-
Confidence 36899999999999999999884 67899999875322 1223356788999999999999999999998744
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||++++.+..+. .....+++..++.++.||+.||.|||+++++|+||+|+||+++.++. ++|+|||++
T Consensus 74 -~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~----~kl~d~g~~ 147 (288)
T cd07833 74 -RLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV----LKLCDFGFA 147 (288)
T ss_pred -EEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC----EEEEeeecc
Confidence 899999999876665544 34456899999999999999999999999999999999999997554 599999998
Q ss_pred ccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc---------
Q 002908 738 KIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--------- 806 (867)
Q Consensus 738 ~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~--------- 806 (867)
....... ......++..|+|||++.+. ..++.++||||||+++|+|++|..||...........+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 8654332 22335578899999999843 26788999999999999999999999765443322211110
Q ss_pred -------CC---C-----------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 807 -------TL---R-----------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 807 -------~l---r-----------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+ . ...+..++..+.+||.+||..+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0 01122357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=330.41 Aligned_cols=254 Identities=26% Similarity=0.300 Sum_probs=206.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CC-----ceeeEecc
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HP-----NVVAFYGV 651 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HP-----NIVrL~g~ 651 (867)
.+|.+.+.||+|+||.|.+|.+ +++.||||+++.. ..+..+...|+.+|..|+ |. |+|+++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 3899999999999999999998 4788999999864 234456667999999997 43 89999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
|.... ++|||+|.+ ..+|.+++... ...++...+..|+.||+.||.+||..||||+||||+||||...+.. .+|
T Consensus 257 F~fr~--HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~--~vK 331 (586)
T KOG0667|consen 257 FYFRN--HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS--RIK 331 (586)
T ss_pred ccccc--ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC--cee
Confidence 99855 999999998 89999999644 3669999999999999999999999999999999999999876544 789
Q ss_pred EeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc----
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---- 806 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~---- 806 (867)
|+|||.|+....... ....+..|+|||++. +..|+.+.|||||||++.||++|.+.|.+....+.+..++.-
T Consensus 332 VIDFGSSc~~~q~vy--tYiQSRfYRAPEVIL--GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 332 VIDFGSSCFESQRVY--TYIQSRFYRAPEVIL--GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred EEecccccccCCcce--eeeeccccccchhhc--cCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 999999997655443 456788999999999 566899999999999999999999999887665443322210
Q ss_pred ------------------------------------------------CCCCC-C--------CCCCcHHHHHHHHHhhc
Q 002908 807 ------------------------------------------------TLRPP-V--------PGFCDSEWRLLMEQCWA 829 (867)
Q Consensus 807 ------------------------------------------------~lr~~-i--------p~~~s~eL~dLI~kCLq 829 (867)
..+.+ . +..-...|.+|+.+||.
T Consensus 408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 00000 0 00123458999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHH
Q 002908 830 PDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 830 ~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
+||.+|+|..+++.|-+--...
T Consensus 488 ~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 488 WDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred cCchhcCCHHHHhcCccccccc
Confidence 9999999999999988766443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=329.77 Aligned_cols=258 Identities=33% Similarity=0.594 Sum_probs=222.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC----Cc--eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR----GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~----G~--~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+.++...+.+.||.|.||.||+|.+. |. .||||+.+..+..+. ...|+.|+.+++.++|||||+++
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-------tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-------TEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-------HHHHHHHHHHHHhCCCcchhhee
Confidence 355666777889999999999999984 32 399999987654432 36799999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
|+|.+.+ .+||||+++-|.|..++......++...+..++.||+.||+|||+...|||||-+.|||+.... .+
T Consensus 458 Gv~~e~P---~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~----CV 530 (974)
T KOG4257|consen 458 GVCVEQP---MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ----CV 530 (974)
T ss_pred eeeeccc---eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc----ee
Confidence 9999864 8999999999999999988888899999999999999999999999999999999999998543 56
Q ss_pred EEeecCCcccccCcccc--CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhc
Q 002908 730 KVGDFGLSKIKRNTLVT--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~~--s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~ 806 (867)
||+|||+++........ +...-+..|||||.++ ...++.++|||.||++|||++. |..||.+..+.+.+.. +..
T Consensus 531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-iEn 607 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-IEN 607 (974)
T ss_pred eecccchhhhccccchhhccccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-ecC
Confidence 99999999966543322 2233467799999998 7889999999999999999988 9999999877766654 455
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+-++|+|..|++.|..|+.+||+.+|.+||+|.+|...|..+..
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 67899999999999999999999999999999999988887755
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=290.04 Aligned_cols=248 Identities=26% Similarity=0.470 Sum_probs=205.9
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|++|.||++.+ .+..+|+|.+...... .....++.+|+.+++.++|+||+++++++... .
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS------QKEREDAVNEIRILASVNHPNIISYKEAFLDG--N 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc------HHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--C
Confidence 488899999999999999987 4678999998754322 12235677899999999999999999999875 4
Q ss_pred eEEEEEEeecCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 659 TLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~---~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..++||||+++++|..++... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~----~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC----cEEEeecc
Confidence 899999999999999887542 35689999999999999999999999999999999999999755 35999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
++...... ......++..|+|||.+. ...++.++|+||||+++|+|++|+.||...........+.. ....+.+..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~--~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 224 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWK--GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPI 224 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCchh
Confidence 99865544 223345788999999997 45577899999999999999999999988776555444433 333445557
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
++.++.+++.+||+.+|.+||++.+++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 88999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=296.32 Aligned_cols=250 Identities=27% Similarity=0.351 Sum_probs=195.9
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|++|.||+|.+ .+..||||.++...... .....+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNIVKLLDVIHTEN-- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc------ccchHHHHHHHHHHhcCCCCCcchhhhcccCC--
Confidence 478899999999999999988 47889999886543221 12246778999999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+. ++|..++... ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~----~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA----IKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEEeeccch
Confidence 8999999995 6788877543 356899999999999999999999999999999999999997764 599999998
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC------
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP------ 810 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~------ 810 (867)
....... ......++..|+|||++.+. ..++.++|||||||++|+|+||+.||...........+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hhcccCccccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 7543221 22233467889999998742 335788999999999999999999997765443333222111000
Q ss_pred ---------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 811 ---------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 811 ---------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.....++..+.++|.+||+.||.+|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0112357788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=310.23 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=199.3
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
...+|++.+.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 357899999999999999999987 578899999864321 112234567899999999999999999987643
Q ss_pred C----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 656 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 656 ~----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
. ....++||||+. ++|.+.+.. .++...+..++.|++.||+|||++||+||||||+|||++.++. ++|
T Consensus 88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~----~kL 159 (353)
T cd07850 88 KSLEEFQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKI 159 (353)
T ss_pred CCccccCcEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC----EEE
Confidence 2 235799999994 578777643 2889999999999999999999999999999999999997664 599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC-
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP- 810 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~- 810 (867)
+|||++.............++..|+|||++. ...++.++|||||||++|+|++|+.||...+.......+......+
T Consensus 160 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 160 LDFGLARTAGTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ccCccceeCCCCCCCCCCcccccccCHHHHh--CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999998665444334456889999999998 4567889999999999999999999997665433322221100000
Q ss_pred ----------------------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 811 ----------------------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 811 ----------------------------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+...+..+.++|.+||+.||.+|||+.+++.+-+-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 00113456789999999999999999999999886543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=291.87 Aligned_cols=242 Identities=31% Similarity=0.443 Sum_probs=197.4
Q ss_pred eeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 588 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 588 LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
||.|+||.||++.+. +..+++|++..... ........+.+|+.++++++||||+++++.+.... ..++|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--NLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc--EEEEEEe
Confidence 689999999999984 88899999865422 12334567888999999999999999999988744 8999999
Q ss_pred eecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc-
Q 002908 666 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL- 744 (867)
Q Consensus 666 y~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~- 744 (867)
|+++++|.+++.... .+++..++.++.||+.||+|||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~----~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH----LKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC----EEEEecccchhcccCcc
Confidence 999999999886544 6899999999999999999999999999999999999997764 5999999987533221
Q ss_pred --------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 745 --------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 745 --------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
......++..|+|||.+.+ ...+.++||||||+++|+|++|..||...........+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226 (265)
T ss_pred cccccccccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccC
Confidence 2233457889999999874 447889999999999999999999998877766666655544433333334
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIAR 843 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe 843 (867)
+..+.+++.+||+.+|.+|||+..+.+
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 899999999999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.09 Aligned_cols=252 Identities=28% Similarity=0.384 Sum_probs=199.5
Q ss_pred eeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
|++.+.||.|++|.||+|.+. +..+|||++..... .......+.+|+.+++.++|||++++++++.....+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE------KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc------cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678899999999999999984 68899999986531 1122356778999999999999999999998753358
Q ss_pred EEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.++||||++ ++|..++......+++..++.++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~----~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV----LKLADFGLARP 149 (287)
T ss_pred EEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC----EEEccccceee
Confidence 999999996 5888888665567999999999999999999999999999999999999997664 59999999985
Q ss_pred ccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC-------
Q 002908 740 KRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP------- 810 (867)
Q Consensus 740 ~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~------- 810 (867)
..... ......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||...........+......+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLG-ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred ccCCCcccccccccccccCCceeeEc-cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 54332 1223446788999998864 2346889999999999999999999998766544433332210000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 811 ----------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 811 ----------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.....++..+.+++.+||..+|.+||++.+++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 00112378899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.76 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=202.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~ 652 (867)
.+..++|++.+.||+|++|.||+|.+. +..||||+++..... ....++.+|+.++.++. ||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-------EENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-------HHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 556788999999999999999999996 888999999754211 12345666777666664 99999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.... ..++||||+ +++|...+......+++..+..++.|++.||+|||+ .||+||||+|+||+++.++ .++|
T Consensus 84 ~~~~--~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~----~~kL 156 (296)
T cd06618 84 ITDS--DVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG----NVKL 156 (296)
T ss_pred ecCC--eEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC----CEEE
Confidence 8854 899999998 556776665545678999999999999999999997 5999999999999998655 4699
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhHhhcCC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS--SKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTL 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~--~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~iv~~~l 808 (867)
+|||++.............++..|+|||.+.+.. ..++.++||||||+++|+|++|+.||...... ..+..+.....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (296)
T cd06618 157 CDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236 (296)
T ss_pred CccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC
Confidence 9999987554333333345778999999987432 34788999999999999999999999764332 23333333321
Q ss_pred -CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 809 -RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 809 -r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+....++..+.+|+.+||..+|.+||++.+++.+.+-.
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 1222234688999999999999999999999999887644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=341.49 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=204.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.++||+|+||.||+|.+ .++.||||++..... ..+....+|.+|+.+++.++||||+++++++.+..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-----~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~- 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD- 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-----cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-
Confidence 5799999999999999999998 478899999875321 22344567899999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcc----------cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 658 GTLATVTEFMVNGSLRHVLLSK----------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~----------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
..++||||++|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 76 -~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--- 151 (932)
T PRK13184 76 -PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--- 151 (932)
T ss_pred -EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC---
Confidence 899999999999999887531 133567788899999999999999999999999999999997765
Q ss_pred cEEEeecCCcccccCc-------------------cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCC
Q 002908 728 ICKVGDFGLSKIKRNT-------------------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~-------------------~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk 788 (867)
++|+|||++...... .......||+.|+|||++. ...++.++|||||||++|+|+||.
T Consensus 152 -vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~--g~~~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 152 -VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL--GVPASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred -EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc--CCCCCcHhHHHHHHHHHHHHHHCC
Confidence 599999999754110 0112245899999999998 445789999999999999999999
Q ss_pred CCCCCCChhHHHHh-HhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHHHH
Q 002908 789 EPYANMHYGAIIGG-IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLRVMSAA 851 (867)
Q Consensus 789 ~PF~~~~~~e~l~~-iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRP-Sa~ELLe~Lq~l~~a 851 (867)
.||........... .............+++.+.+++.+||+.+|.+|| +++++++.|+.+...
T Consensus 229 ~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 229 FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 99977544332221 1111111111235788999999999999999995 678888888877553
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.39 Aligned_cols=246 Identities=24% Similarity=0.472 Sum_probs=188.8
Q ss_pred EeeecCcEEEEEEEE-CCc---eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEE
Q 002908 587 ELGSGTFGTVYHGKW-RGT---DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 587 ~LG~GafG~VYka~~-~G~---~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
.||+|+||.||++.+ .+. .+++|.++... .......|.+|+.+++.++||||+++++.|.... ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEE
Confidence 589999999999976 333 34556554321 1122467889999999999999999999998754 8899
Q ss_pred EEEeecCCchhhhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 663 VTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~---~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+++||||||+|||++.++. ++|+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~----~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT----VKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc----EEecccccccc
Confidence 999999999999886432 34677778899999999999999999999999999999986654 69999999863
Q ss_pred ccC-c--cccCCcCCCCCccCccccccC-----CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC---
Q 002908 740 KRN-T--LVTGGVRGTLPWMAPELLNGS-----SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT--- 807 (867)
Q Consensus 740 ~~~-~--~~~s~~~GT~~Y~APEvl~g~-----~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~--- 807 (867)
... . .......++..|+|||++... ...++.++|||||||++|+|++ |..||...........+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc
Confidence 211 1 112234578899999998531 2245778999999999999997 577887766655554443332
Q ss_pred -CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 808 -LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 808 -lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.++..+..+++.+.+++..|| .+|.+||++.++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 223344457888999999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.22 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=196.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||.|++|.||+|++ ++..||||+++...... ....+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-------TPSTAIREISLMKELKHENIVRLHDVIHTEN-- 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-------chHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--
Confidence 488999999999999999998 47889999997543211 1245667999999999999999999998854
Q ss_pred eEEEEEEeecCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 659 TLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~--~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||+
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~----~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE----LKLADFGL 146 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc----EEEeecch
Confidence 8899999997 47888775443 46899999999999999999999999999999999999997664 59999999
Q ss_pred cccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC--------
Q 002908 737 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-------- 807 (867)
Q Consensus 737 A~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-------- 807 (867)
+....... ......++..|++||++.+. ..++.++|||||||++|+|++|..||...........+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 97443221 12234468889999998642 346889999999999999999999998766544433322110
Q ss_pred --------CCCC-----------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 808 --------LRPP-----------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 808 --------lr~~-----------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+... ....++..+.+++.+||+.+|.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 012346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.86 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=195.7
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 588 LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 588 LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
||+|+||+||++.+ +++.||+|++...... .......+..|+.+++.++||||+++++++.... ..++|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-----KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-----hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEe
Confidence 68999999999987 4788999998753221 1112345678999999999999999999988754 8999999
Q ss_pred eecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc
Q 002908 666 FMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744 (867)
Q Consensus 666 y~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~ 744 (867)
|+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~----~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN----VRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC----EEEccCcchhhhccCC
Confidence 999999999886543 36899999999999999999999999999999999999997664 5999999987554333
Q ss_pred ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc--CCCCCCCCCCcHHHHH
Q 002908 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN--TLRPPVPGFCDSEWRL 822 (867)
Q Consensus 745 ~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~--~lr~~ip~~~s~eL~d 822 (867)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ......+...++.+.+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227 (277)
T ss_pred ccccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHH
Confidence 3334557889999999874 34788999999999999999999999765432111111111 1233445567899999
Q ss_pred HHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 002908 823 LMEQCWAPDPVVRP-----SFTEIARRLRV 847 (867)
Q Consensus 823 LI~kCLq~DPeeRP-----Sa~ELLe~Lq~ 847 (867)
+|.+||+.+|.+|| ++.+++.+.+-
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 99999999999999 77778776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.11 Aligned_cols=254 Identities=24% Similarity=0.264 Sum_probs=194.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~ 656 (867)
++|++.+.||+|+||.||+|.+ +++.||||.++...... .....+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE------GIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc------CCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 3688999999999999999998 47889999986542211 12245778999999995 699999999887543
Q ss_pred ---CCeEEEEEEeecCCchhhhhhcc----cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 657 ---GGTLATVTEFMVNGSLRHVLLSK----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 657 ---~~~l~LVmEy~~ggSL~d~L~~~----~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
....++||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||+|+||+++.++ ..+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~---~~~ 150 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK---GLL 150 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCC---CeE
Confidence 1237999999975 788777543 24589999999999999999999999999999999999998622 346
Q ss_pred EEeecCCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 730 KVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 730 KL~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
+|+|||++...... .......+++.|+|||++.+ ...++.++||||||+++|+|++|..||...........+.....
T Consensus 151 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG-STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EEeecccceecCCCccccCCcccccCCCChHHhhC-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998754322 11122346788999999864 34468899999999999999999999987655444333222100
Q ss_pred CC--------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 809 RP--------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 809 r~--------------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+ .....++..+.+||.+||..+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0012367889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=296.18 Aligned_cols=253 Identities=25% Similarity=0.310 Sum_probs=196.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||.|++|.||+|.+. ++.||||.+...... +.....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED------EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK- 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc------ccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-
Confidence 57999999999999999999984 778999998654221 112345778999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 658 GTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+. ++|...+... ...+++..++.++.||+.||.|||+++++|+||+|+||+++.++. .+||+|||+
T Consensus 75 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~---~~kl~dfg~ 149 (294)
T PLN00009 75 -RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGL 149 (294)
T ss_pred -eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC---EEEEccccc
Confidence 8999999995 5777766433 234688889999999999999999999999999999999985442 469999999
Q ss_pred cccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC------
Q 002908 737 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------ 809 (867)
Q Consensus 737 A~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr------ 809 (867)
+....... ......+++.|+|||++.+ ...++.++|||||||++|+|+||+.||...........+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEILLG-SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred ccccCCCccccccCceeecccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 97543221 1123346789999999874 345788999999999999999999999876554443332211000
Q ss_pred -----------------CC----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 810 -----------------PP----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 810 -----------------~~----ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.. .....++.+.+++.+||+.+|++||++.+++.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~ 285 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00 0123577899999999999999999999998764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.86 Aligned_cols=258 Identities=28% Similarity=0.352 Sum_probs=205.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc-eeeEecccccC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN-IVrL~g~~~~~ 655 (867)
...|..+++||+|+||+||+|+. +|..||+|.++......+ .-....+|+.+|+.|+|+| ||++++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG------~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG------VPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC------CCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 34567777899999999999998 588899999986543222 2234568999999999999 99999999874
Q ss_pred C----CCeEEEEEEeecCCchhhhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCc
Q 002908 656 P----GGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 656 ~----~~~l~LVmEy~~ggSL~d~L~~~~---~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~ 728 (867)
. .+.+++|+||+ ..+|..++.... ..++...+..++.||+.||+|||+++|+||||||+||||+.+|.
T Consensus 84 ~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~---- 158 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV---- 158 (323)
T ss_pred ccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc----
Confidence 3 24789999999 788888886655 35777899999999999999999999999999999999998665
Q ss_pred EEEeecCCccccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC
Q 002908 729 CKVGDFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 729 vKL~DFGLA~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~ 807 (867)
+||+|||+|+... +........+|..|+|||++.|. ..|+..+||||+||++.||++++..|.+......+..+....
T Consensus 159 lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred EeeeccchHHHhcCCcccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 4999999999655 33334556689999999999985 458999999999999999999999999887765554443211
Q ss_pred CCC----------------CCC------------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHH
Q 002908 808 LRP----------------PVP------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR--LRVM 848 (867)
Q Consensus 808 lr~----------------~ip------------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~--Lq~l 848 (867)
..+ ..+ ....+...+++.+||+.+|.+|.|++.++.+ +..+
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 110 000 1122478899999999999999999999987 4444
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.25 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=193.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+ ++..||||.+....... .....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC------CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 35799999999999999999998 47889999986542211 11234567999999999999999999876532
Q ss_pred ------CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 657 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 657 ------~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
....++||||+. ++|.+.+......+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~----~~k 159 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG----ILK 159 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC----cEE
Confidence 235699999994 588887766555789999999999999999999999999999999999998665 459
Q ss_pred EeecCCcccccCccc-----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNTLV-----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~~~-----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||++........ .....++..|+|||.+.+ ...++.++||||||+++|+|++|+.||...........+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC-CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999975432211 123346788999999874 23467899999999999999999999976554322211111
Q ss_pred --cCCCC---------------CC-------------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 806 --NTLRP---------------PV-------------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 806 --~~lr~---------------~i-------------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+.... .. ....+..+.+||.+||..+|.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 00 11235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=330.16 Aligned_cols=259 Identities=34% Similarity=0.585 Sum_probs=220.2
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC---Cc--eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR---GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~---G~--~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
--.|..++..+.++||+|.||+|++|.|+ |+ .||||+++...... ....|++|+.+|.+|+|||+++|
T Consensus 104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-------~mddflrEas~M~~L~H~hliRL 176 (1039)
T KOG0199|consen 104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-------IMDDFLREASHMLKLQHPHLIRL 176 (1039)
T ss_pred ceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------hHHHHHHHHHHHHhccCcceeEE
Confidence 34677888889999999999999999995 43 49999997543221 34789999999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~-~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
||++.+. .+.+|||+++.|+|.+.|++ ....|-...+..++.||+.||.||..++.|||||-+.|+|+-. ..
T Consensus 177 yGvVl~q---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas----pr 249 (1039)
T KOG0199|consen 177 YGVVLDQ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS----PR 249 (1039)
T ss_pred eeeeccc---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc----cc
Confidence 9999874 57889999999999999987 4456888888999999999999999999999999999999984 34
Q ss_pred cEEEeecCCcccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHh
Q 002908 728 ICKVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 802 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~ 802 (867)
++||||||+++.+... .......-...|+|||.++ ...++.++|||+|||+||||+| |..||.+.....+++.
T Consensus 250 tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr--h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~ 327 (1039)
T KOG0199|consen 250 TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR--HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN 327 (1039)
T ss_pred eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc--cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh
Confidence 6799999999955432 2223334566799999999 7889999999999999999999 8999999888777776
Q ss_pred HhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 803 iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+- ..-+.+.+..|++.+++++..||+.+|++||||..|.+.+-...
T Consensus 328 iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 328 ID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred cc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 54 77788999999999999999999999999999999975544433
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=284.03 Aligned_cols=248 Identities=30% Similarity=0.525 Sum_probs=204.8
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|++.+.||+|++|.||++.+ .+..|+||.+...... +.....+.+|++++.+++|||++++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--
Confidence 478899999999999999987 4678999999764321 223467889999999999999999999988754
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+++++|.+++... ..+++..++.++.|++.+|.|||+.||+|+||+|+||+++.++ .++|+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG----VVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC----CEEEeccccce
Confidence 899999999999999988544 5689999999999999999999999999999999999999755 45999999998
Q ss_pred cccCccc-cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 739 IKRNTLV-TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 739 ~~~~~~~-~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
....... .....++..|+|||.+.+ ..++.++|||+||+++|+|++|..||.............. ......+..++
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 224 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGIS 224 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCC
Confidence 5543222 233457889999999874 3378899999999999999999999977655444444332 33345566788
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..+.+++.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 999999999999999999999999754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=297.64 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=194.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~ 656 (867)
++|+..+.||+|+||.||++.+ .+..||||.+...... .....+.+|+.++.++. ||||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 4566677899999999999988 4788999998643211 22356788999999996 999999999987744
Q ss_pred CCeEEEEEEeecCCchhhh---hhc-ccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCCCCCcEEE
Q 002908 657 GGTLATVTEFMVNGSLRHV---LLS-KERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~---L~~-~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
..+++|||+. +++.++ +.. ....+++..+..++.+++.||+|||+. +|+||||||+|||++.++ .++|
T Consensus 77 --~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~----~~kl 149 (288)
T cd06616 77 --DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG----NIKL 149 (288)
T ss_pred --cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC----cEEE
Confidence 7889999984 455443 222 235689999999999999999999975 999999999999999665 4599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhHhhcCC-
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTL- 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~-~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~iv~~~l- 808 (867)
+|||++.............++..|+|||++.+.. ..++.++|||||||++|+|++|+.||...... ...........
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC
Confidence 9999997544333333445888999999987431 35788999999999999999999999765421 12222221111
Q ss_pred --CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 809 --RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 809 --r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
....+..++..+.+||.+||+.+|.+|||+.+++.+-+-
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 111223478899999999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.77 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=194.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC-
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP- 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~- 656 (867)
++|++.+.||+|+||.||+|.+ ++..||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 6899999999999999999987 47889999986321 1122356778999999999999999999876432
Q ss_pred --CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 657 --GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 657 --~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
....++||||+. ++|.+.+. ...+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~----~kl~df 150 (336)
T cd07849 78 ESFNDVYIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD----LKICDF 150 (336)
T ss_pred cccceEEEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC----EEECcc
Confidence 235799999995 57777663 356899999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC---
Q 002908 735 GLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--- 807 (867)
Q Consensus 735 GLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~--- 807 (867)
|++....... ......++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...+.......+....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~ 229 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9987543221 1123457889999998763 3457889999999999999999999997655433222111100
Q ss_pred ---------------------CCCC-----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 808 ---------------------LRPP-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 808 ---------------------lr~~-----ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.... .....+..+.++|.+||+.+|.+|||+.+++.+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0000 0123467799999999999999999999999983
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.69 Aligned_cols=255 Identities=27% Similarity=0.367 Sum_probs=197.7
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||+|.+ .++.||||+++....... ....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC------chHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 456789999999999999999998 478899999975432211 123566799999999999999999988764
Q ss_pred C--------CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 656 P--------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 656 ~--------~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
. .+.+++||||+++ ++...+......+++..++.++.|++.||+|||+.||+|+||+|+||+++.++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--- 154 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--- 154 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc---
Confidence 3 3478999999965 777777655557899999999999999999999999999999999999996654
Q ss_pred cEEEeecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 728 ICKVGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
++|+|||++....... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 155 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 155 -IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred -EEeCcccccccccCCcccccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 5999999998543322 11223457789999988642 3467899999999999999999999976554333322221
Q ss_pred cCCCC----------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 806 NTLRP----------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 806 ~~lr~----------------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
....+ .....++..+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10000 0112357899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=321.91 Aligned_cols=246 Identities=27% Similarity=0.349 Sum_probs=191.4
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
....|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|+.+|++++|+|||++++++...
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 3457999999999999999999984 67799996421 2345799999999999999999998874
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ..++||+++ .++|..++......+++..++.|+.||+.||.|||++||+||||||+||||+.++. ++|+|||
T Consensus 233 ~--~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~----vkL~DFG 305 (461)
T PHA03211 233 G--LTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED----ICLGDFG 305 (461)
T ss_pred C--EEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC----EEEcccC
Confidence 4 889999999 57888888665667999999999999999999999999999999999999986654 5999999
Q ss_pred CcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-------hhHHHHhHhh
Q 002908 736 LSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-------YGAIIGGIVN 805 (867)
Q Consensus 736 LA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~-------~~e~l~~iv~ 805 (867)
+++...... ......||..|+|||++.+ ..++.++|||||||+||||++|..++.... ....+..++.
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 998543221 1224569999999999984 457899999999999999999876542211 0111111111
Q ss_pred c-CC-------------------------CCCC--C-----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 806 N-TL-------------------------RPPV--P-----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 806 ~-~l-------------------------r~~i--p-----~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
. .. +... + ...+..+.+||.+||+.||.+|||+.|+|++-+
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 1 00 0000 0 123457899999999999999999999998743
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=292.37 Aligned_cols=249 Identities=27% Similarity=0.340 Sum_probs=195.2
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
|++.+.||.|++|.||+|.+ .|..||||++....... .....+.+|+.+++.++|||++++++++.+.. .
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE------GVPSTAIREISLLKELNHPNIVRLLDVVHSEN--K 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc------cchhHHHHHHHHHHhcCCCCccCHhheeccCC--e
Confidence 56788999999999999987 48889999987543221 12245678999999999999999999998754 8
Q ss_pred EEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 660 LATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.++||||+ +++|..++.... ..+++..++.++.|++.||.|||+++++||||+|+||+++.++ .++|+|||++.
T Consensus 73 ~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~----~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG----ALKLADFGLAR 147 (283)
T ss_pred EEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC----cEEEeeccccc
Confidence 99999999 578988875443 4689999999999999999999999999999999999999755 45999999987
Q ss_pred cccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC--------
Q 002908 739 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 809 (867)
Q Consensus 739 ~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr-------- 809 (867)
...... ......++..|+|||++.+ ...++.++||||||+++|+|++|+.||...........+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred ccCCCccccCccccccCCCCCceeec-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 543221 1122346788999998864 234678999999999999999999999776543333222211000
Q ss_pred -------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 -------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 -------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
......++..+.++|.+||+.+|.+|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01123456889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.88 Aligned_cols=254 Identities=29% Similarity=0.466 Sum_probs=206.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
...|+..+.||+|++|.||++.+. +..|++|++..... ....+.+|+++++.++|+|++++++++....
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 88 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLVGD 88 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence 345777889999999999999985 78899999975321 2356778999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++......+++..++.++.+++.||.|||+.||+|+||+|+||+++.++. ++|+|||+
T Consensus 89 --~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~----~~l~d~~~ 162 (286)
T cd06614 89 --ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGF 162 (286)
T ss_pred --EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC----EEECccch
Confidence 899999999999999999765447999999999999999999999999999999999999997664 59999998
Q ss_pred cccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC-CCCCC
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-PPVPG 814 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr-~~ip~ 814 (867)
+...... .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...........+...... ...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd06614 163 AAQLTKEKSKRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPE 240 (286)
T ss_pred hhhhccchhhhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchh
Confidence 8744322 12223457889999999873 45788999999999999999999999876655444443333222 12223
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.++..+.++|.+||+.+|.+||++.+++.+..-..
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 37889999999999999999999999988665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=294.95 Aligned_cols=254 Identities=28% Similarity=0.359 Sum_probs=195.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||.|++|.||+|.+. +..+|||++......... ...+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF------PITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc------chhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 478999999999999999999984 788999998754332211 124567999999999999999999876533
Q ss_pred ------CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 657 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 657 ------~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
...+++||+|+. ++|...+......+++..+..++.|+++||.|||++||+|+||||+|||++.++. ++
T Consensus 81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~----~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI----LK 155 (311)
T ss_pred ccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC----EE
Confidence 236799999995 5677766655567999999999999999999999999999999999999997664 59
Q ss_pred EeecCCcccccCccc------------cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH
Q 002908 731 VGDFGLSKIKRNTLV------------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 798 (867)
Q Consensus 731 L~DFGLA~~~~~~~~------------~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e 798 (867)
|+|||++........ .....+++.|+|||.+.+ ...++.++|||||||++|+|++|++||.......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC-CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999975432211 112346788999999864 2346889999999999999999999998765543
Q ss_pred HHHhHhhcCCC---------------------CCCC-------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 799 IIGGIVNNTLR---------------------PPVP-------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 799 ~l~~iv~~~lr---------------------~~ip-------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
....+...... ...+ ....+.+.+++.+||+.+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 33322211000 0000 1234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=324.42 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=207.1
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~ 652 (867)
-.|....|++++.||+||++.||++... .+-+|+|.+... ..+...+.-|+.|+..|.+|+ |.+||++|+|-
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~------~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL------EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh------hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 3577788999999999999999999875 455777766532 234556788999999999995 89999999998
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.. ++++|+||||= ..+|..+|......++...+..++.||+.|+.++|.+||||.||||.|+|+- .+.+||+
T Consensus 430 v~--d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG~LKLI 501 (677)
T KOG0596|consen 430 VT--DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KGRLKLI 501 (677)
T ss_pred cc--CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----eeeEEee
Confidence 77 45999999975 7899999987776666558889999999999999999999999999999994 4567999
Q ss_pred ecCCcccccCcc---ccCCcCCCCCccCccccccCCC---------CCChhhHHHHHHHHHHHHHhCCCCCCCCCh-hHH
Q 002908 733 DFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSS---------KVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAI 799 (867)
Q Consensus 733 DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~---------~~S~kSDVWSLGvLLyELLTGk~PF~~~~~-~e~ 799 (867)
|||.|......+ .....+||+.||+||.+..... ..++++|||||||+||+|+.|+.||..... -..
T Consensus 502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK 581 (677)
T KOG0596|consen 502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK 581 (677)
T ss_pred eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH
Confidence 999998655433 2245679999999999853222 267899999999999999999999976543 234
Q ss_pred HHhHhhcCCCCCCCCCCcHH-HHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 800 IGGIVNNTLRPPVPGFCDSE-WRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 800 l~~iv~~~lr~~ip~~~s~e-L~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+..+.+.....+++..-+.. +.++|+.||++||.+||+..+||++-
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 45555554555555544433 99999999999999999999998763
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=290.67 Aligned_cols=249 Identities=29% Similarity=0.432 Sum_probs=204.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~ 656 (867)
++|++.+.||+|++|.||++.+ .+..||+|++...... .+.....+.+|+.++.++. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-----chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 4789999999999999999998 4788999998753221 1222356778999999998 999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 76 --~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~----~~l~df~~ 148 (280)
T cd05581 76 --NLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH----IKITDFGT 148 (280)
T ss_pred --eEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC----EEecCCcc
Confidence 899999999999999988644 46999999999999999999999999999999999999997664 59999999
Q ss_pred cccccCcc---------------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 002908 737 SKIKRNTL---------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 795 (867)
Q Consensus 737 A~~~~~~~---------------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~ 795 (867)
+....... ......++..|+|||++.+ ..++.++|+||||+++++|++|..||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 87543321 1123457889999999873 457889999999999999999999998776
Q ss_pred hhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCH----HHHHHH
Q 002908 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSF----TEIARR 844 (867)
Q Consensus 796 ~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa----~ELLe~ 844 (867)
.......+.. .....+..+++.+.+++.+||+.+|.+||++ .+++.+
T Consensus 227 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 EYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 5554444442 2334556678999999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=330.37 Aligned_cols=247 Identities=31% Similarity=0.484 Sum_probs=209.1
Q ss_pred EEeeecCcEEEEEEEECC--ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 586 KELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 586 k~LG~GafG~VYka~~~G--~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
-+||+|.+|+||.|++.. ..+|||-+.... .+...-+..|+.+-++|+|.|||+++|.|.+ ++++-|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIF 650 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--------SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIF 650 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--------chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEE
Confidence 379999999999999854 457999875432 2223445678999999999999999999877 5699999
Q ss_pred EEeecCCchhhhhhcccccC--CHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc-
Q 002908 664 TEFMVNGSLRHVLLSKERHL--DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK- 740 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~L--se~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~- 740 (867)
||-++||+|..++..+-+++ .+...-.+.+||++||.|||++.|||||||.+||||+.- .+++||+|||-++..
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy---SGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY---SGVLKISDFGTSKRLA 727 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec---cceEEecccccchhhc
Confidence 99999999999998877777 888888999999999999999999999999999999843 356899999998854
Q ss_pred cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhhcCCCCCCCCCCcHH
Q 002908 741 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRPPVPGFCDSE 819 (867)
Q Consensus 741 ~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~~~lr~~ip~~~s~e 819 (867)
+-...+..+.||..|||||++......|+.++|||||||++.||.||++||-.+..+. .+.++-.-...+++|..++.+
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsae 807 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAE 807 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHH
Confidence 3344556678999999999998778889999999999999999999999998776554 344444445578899999999
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 820 WRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 820 L~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.+.||.+|+.++|.+||++.++|...
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhccCc
Confidence 99999999999999999999998643
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.98 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=190.3
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHH---HHHhCCCCceeeEecccccCCCCeEE
Q 002908 587 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE---ILSKLHHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 587 ~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEie---iLk~L~HPNIVrL~g~~~~~~~~~l~ 661 (867)
.||+|+||.||++.+ +++.+|||.+......... .+ ..+.+|.. ++....||||+.+++++.... ..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GE---TLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch--HH---HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEE
Confidence 389999999999988 4788999998754322111 11 12233433 344457999999999988754 889
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
+||||+++++|..++... ..+++..+..++.|++.||.|||+.+|+|+||||+|||++.++. ++|+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~----~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH----VRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC----EEEccCCcceecc
Confidence 999999999999887543 46899999999999999999999999999999999999997654 5999999987543
Q ss_pred CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--HHHHhHhhcCCCCCCCCCCcHH
Q 002908 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AIIGGIVNNTLRPPVPGFCDSE 819 (867)
Q Consensus 742 ~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~--e~l~~iv~~~lr~~ip~~~s~e 819 (867)
... .....|+..|+|||.+.+ ...++.++|||||||++|+|++|..||...... ..... .........+..++..
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 225 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTVNVELPDSFSPE 225 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcC-CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-HhhcCCcCCccccCHH
Confidence 322 223458999999999863 234688999999999999999999999754321 11211 1222344556678899
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHHHHHH
Q 002908 820 WRLLMEQCWAPDPVVRP-----SFTEIARRLRVM 848 (867)
Q Consensus 820 L~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq~l 848 (867)
+.++|.+||..+|.+|| ++++++++..-.
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~ 259 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence 99999999999999999 699999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.81 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=198.7
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
|.....||+|+||.||++.. ++..||||.+.... ......+.+|+.+++.++||||+++++.+.... .
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~ 93 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD--E 93 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--e
Confidence 44456799999999999987 47889999885421 122355788999999999999999999988754 8
Q ss_pred EEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++|+||||+|+||+++.++. ++|+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~----~kL~dfg~~~~ 167 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR----IKLSDFGFCAQ 167 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC----EEEccCcchhh
Confidence 9999999999999988743 45899999999999999999999999999999999999987654 59999999874
Q ss_pred ccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--CCCCCC
Q 002908 740 KRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--PVPGFC 816 (867)
Q Consensus 740 ~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~--~ip~~~ 816 (867)
..... ......++..|+|||.+. ...++.++||||||+++|+|++|+.||...........+.. .... .....+
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVIS--RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHKV 244 (292)
T ss_pred cccccccCceeecCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCcccccccc
Confidence 33221 222345888999999987 44578899999999999999999999987665444433322 1222 222346
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
+..+.+++.+||..+|.+|||+.+++++-+-.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~ 276 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence 78899999999999999999999999875544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.95 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=201.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|.+.+.||+|+||.||++.. .+..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--------QPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--------chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 46899999999999999999986 46789999985321 111345778999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 90 --~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~----~kL~dfg~ 161 (293)
T cd06647 90 --ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGF 161 (293)
T ss_pred --cEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC----EEEccCcc
Confidence 88999999999999998853 35789999999999999999999999999999999999987654 59999998
Q ss_pred cccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc-CCCCCCCC
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPG 814 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~-~lr~~ip~ 814 (867)
+...... .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+... ......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd06647 162 CAQITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (293)
T ss_pred eecccccccccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcc
Confidence 8644322 22233458889999999873 45788999999999999999999999775543332222211 11222334
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.++..+.++|.+||+.+|.+||++.+++.+-.-
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 567889999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.84 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=197.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~ 655 (867)
.++|++.+.||+|+||.||+|.+ .+..+|||.+...... ......+.+|+.++.++ +||||++++++|...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN------ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc------chhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 46788889999999999999988 4788999988542111 11124566899999999 999999999998765
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
.....++||||+. ++|..++... .+++..++.++.||+.||+|||+.||+|+||+|+||+++.++. ++|+|||
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~----~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR----VKLADFG 152 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc----EEEeecc
Confidence 5557899999996 5888877543 6889999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCcc------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-
Q 002908 736 LSKIKRNTL------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL- 808 (867)
Q Consensus 736 LA~~~~~~~------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l- 808 (867)
++....... ......++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeec-cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 997543221 1223457889999998864 24567899999999999999999999976554333222111100
Q ss_pred -------------------------C---CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 809 -------------------------R---PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 809 -------------------------r---~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
. ......++..+.++|.+||+.+|.+|||+.+++.+-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 0 0011226788999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=293.88 Aligned_cols=247 Identities=24% Similarity=0.421 Sum_probs=198.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|...+.||.|++|.||++.+ .++.+++|++.... ......+.+|+.+++.+.||||+++++++....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--------hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 355567899999999999987 46789999885321 111245778999999999999999999988754
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++|+||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++. ++|+|||++.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR----VKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc----EEEcccccch
Confidence 88999999999999998855 56899999999999999999999999999999999999997654 5999999887
Q ss_pred cccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-CCCCCCCC
Q 002908 739 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVPGFC 816 (867)
Q Consensus 739 ~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l-r~~ip~~~ 816 (867)
..... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..... ....+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKV 241 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccC
Confidence 43322 12233458899999999874 4578899999999999999999999977665554444443321 11112336
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+..+.+++.+||+.+|.+||++.+++++-
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 78999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=296.80 Aligned_cols=248 Identities=28% Similarity=0.435 Sum_probs=200.4
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
|...+.||+|+||.||+|.+ .+..|++|++...... .......+.+|+.+++.++|||++++++++.+.. .
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--T 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-----chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--E
Confidence 66677899999999999987 4788999998654211 1223356788999999999999999999998855 8
Q ss_pred EEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.++||||+. +++.+.+......+++..++.++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||++..
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~----~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ----VKLADFGSASK 170 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC----EEEeecCCCcc
Confidence 899999994 6777777665667899999999999999999999999999999999999987654 59999999864
Q ss_pred ccCccccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcH
Q 002908 740 KRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 818 (867)
Q Consensus 740 ~~~~~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~ 818 (867)
... .....++..|+|||++.. ....++.++|||||||++|+|++|..||...........+............++.
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD 247 (313)
T ss_pred cCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence 322 223458889999999853 1345788999999999999999999999877655555444433332223345678
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 819 EWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 819 eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+.+|+.+||+.+|.+||++.+++.+
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=299.32 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=204.5
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
...|+..+.||+|++|.||+|.+ .+..+|||.+...... .......+.+|+.+++.++|+|++++++++....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 34577788899999999999998 4678999988642111 1222456778999999999999999999988754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+. +++.+.+......+++..+..++.|++.||.|||+.+++||||+|+|||++.++ .++|+|||+
T Consensus 89 --~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~ 161 (308)
T cd06634 89 --TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGS 161 (308)
T ss_pred --eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC----cEEECCccc
Confidence 8899999995 678777755556789999999999999999999999999999999999998665 469999999
Q ss_pred cccccCccccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
+...... ....++..|+|||.+.+ ....++.++|||||||++|+|++|..||...........+............
T Consensus 162 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06634 162 ASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238 (308)
T ss_pred ceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCccc
Confidence 8754432 23457889999999753 1334678999999999999999999999776655444444433333333446
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
++..+.++|.+||+.+|.+||++.+++.+.+...
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 7888999999999999999999999998876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.45 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=197.9
Q ss_pred EEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEE
Q 002908 584 ELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~ 661 (867)
....||.|+||.||++.. .++.||||++..... .....+.+|+.++..+.||||+++++++.... ..+
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~ 94 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--ELW 94 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--------chHHHHHHHHHHHHhCCCCchhhhhhheeeCC--eEE
Confidence 344699999999999987 478899999864321 11245778999999999999999999998754 899
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
+||||+++++|..++. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 95 iv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~----~kL~dfg~~~~~~ 168 (297)
T cd06659 95 VLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQIS 168 (297)
T ss_pred EEEecCCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc----EEEeechhHhhcc
Confidence 9999999999988763 346899999999999999999999999999999999999997664 5999999987443
Q ss_pred Cc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-CCCCCCCCcHH
Q 002908 742 NT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVPGFCDSE 819 (867)
Q Consensus 742 ~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l-r~~ip~~~s~e 819 (867)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... ........+..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPV 246 (297)
T ss_pred cccccccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHH
Confidence 22 12233568899999999974 4578899999999999999999999987665544443332211 11223356788
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 820 WRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 820 L~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
+.++|.+||+.+|.+||++.+++++..-.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 99999999999999999999999975543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=285.86 Aligned_cols=243 Identities=28% Similarity=0.393 Sum_probs=191.3
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHH-HhCCCCceeeEecccccCCCCeEEE
Q 002908 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL-SKLHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 586 k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiL-k~L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
+.||.|++|.||+|.+ .++.||||+++..... .......+..|..++ ..+.|+|++++++++.... ..++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-----AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-----HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEE
Confidence 4689999999999988 4788999998643211 111123344554444 4558999999999998754 8999
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~ 742 (867)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|.||+++.++. ++|+|||++.....
T Consensus 75 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~----~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH----LKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc----EEEeecccceeccc
Confidence 99999999999988543 46899999999999999999999999999999999999997654 59999999875433
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC--CCCCCCCcHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--PPVPGFCDSEW 820 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr--~~ip~~~s~eL 820 (867)
.....++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+...... ......+++.+
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224 (260)
T ss_pred ---cccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHH
Confidence 2234588899999999853 3788999999999999999999999887766655554443322 22334578999
Q ss_pred HHHHHHhhcCCCCCCCCH---HHHHHHH
Q 002908 821 RLLMEQCWAPDPVVRPSF---TEIARRL 845 (867)
Q Consensus 821 ~dLI~kCLq~DPeeRPSa---~ELLe~L 845 (867)
.+++.+||+.+|.+||++ .+++.+.
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 999999999999999966 5655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=286.29 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=200.7
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+|.+.+.||+|+||.||++.+. +..+++|+++.......... ....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN---ETVQANQEAQLLSKLDHPAIVKFHASFLERD-- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcc---hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--
Confidence 5888999999999999999885 44577777765433211111 1234667899999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 659 TLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~-----~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-----LLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC-----CEeecccC
Confidence 78999999999999988753 34568999999999999999999999999999999999999742 36999999
Q ss_pred CcccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 736 LSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 736 LA~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
++..... ........+++.|+|||.+. ...++.++|+||||+++|+|++|..||...........+.. ...+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 227 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALK--HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPE 227 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcc
Confidence 9875432 22233455788999999987 44567889999999999999999999977665554444433 33344556
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.++..+.++|.+||..+|.+||++.+++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 778999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=289.31 Aligned_cols=249 Identities=27% Similarity=0.343 Sum_probs=198.4
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
|++.+.||.|++|.||++.. .+..+++|.++...... .....+.+|+.+++.++|+||+++++++.... .
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE------GIPKTALREIKLLKELNHPNIIKLLDVFRHKG--D 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc------hhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--C
Confidence 56678899999999999988 47889999987543221 22356778999999999999999999998754 8
Q ss_pred EEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.++||||++ ++|.+.+......+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++. ++|+|||.+..
T Consensus 73 ~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~----~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV----LKLADFGLARS 147 (283)
T ss_pred EEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc----EEEeeeeeeEe
Confidence 999999996 5888888665668999999999999999999999999999999999999996654 59999999976
Q ss_pred ccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC---------
Q 002908 740 KRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--------- 809 (867)
Q Consensus 740 ~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr--------- 809 (867)
..... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 54432 22234578889999998742 35788999999999999999999999776654433222211000
Q ss_pred -------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 -------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 -------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
......++..+.++|.+||+++|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00112357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=292.36 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=198.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccccc
Q 002908 581 DLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 654 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~ 654 (867)
.|++.+.||.|+||.||++.. +|..||+|+++..... ........+.+|+.++..+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh----hcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478899999999999999986 4778999999753211 1112235567899999999 58999999999887
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+|||++.++ .++|+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~----~~kl~df 149 (290)
T cd05613 77 DT--KLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDF 149 (290)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC----CEEEeeC
Confidence 44 889999999999999988643 4688999999999999999999999999999999999999765 4599999
Q ss_pred CCcccccCc--cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhHhhcCC
Q 002908 735 GLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 808 (867)
Q Consensus 735 GLA~~~~~~--~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~----~e~l~~iv~~~l 808 (867)
|++...... .......++..|+|||.+.+....++.++||||||+++|+|++|..||..... ......+.. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~ 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--c
Confidence 998754332 12223458889999999875444567889999999999999999999964322 122222221 2
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARR 844 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~ 844 (867)
..+.+..+++.+.+++.+||+.+|.+|| ++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 2345566889999999999999999997 78888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=299.84 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=195.2
Q ss_pred Eeeec--CcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEE
Q 002908 587 ELGSG--TFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 587 ~LG~G--afG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
.||.| +||+||++.+ .++.||||++...... ......+.+|+.+++.++||||++++++|..+. ..++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~ 76 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWV 76 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEE
Confidence 46666 9999999988 5889999998653211 122357788999999999999999999998854 8899
Q ss_pred EEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 663 VTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
||||+.+++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++. ++++||+.+....
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~----~~~~~~~~~~~~~ 152 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL----VSLSGLSHLYSLV 152 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc----EEEechHHHhhhh
Confidence 99999999999888643 245899999999999999999999999999999999999997654 5999998653221
Q ss_pred Cccc--------cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC------
Q 002908 742 NTLV--------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT------ 807 (867)
Q Consensus 742 ~~~~--------~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~------ 807 (867)
.... .....++..|+|||++.+....++.++|||||||++|+|++|..||................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 1000 01122456799999998654567899999999999999999999998765444332222111
Q ss_pred ---------------------------------------CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 808 ---------------------------------------LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 808 ---------------------------------------lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
...+.+..++..+.+|+++||+.+|++|||+.+++++.+-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 01111233567799999999999999999999999887765
Q ss_pred HHHhc
Q 002908 849 SAACQ 853 (867)
Q Consensus 849 ~~a~s 853 (867)
....+
T Consensus 313 ~~~~~ 317 (328)
T cd08226 313 QVKEQ 317 (328)
T ss_pred HHHHh
Confidence 54443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=326.34 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=213.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEECCce--EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~G~~--VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.+.|.++..||.|+||.||++..+... .|-|++... .+.....|+-|++||..+.||+||++++.|...
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--------seEELEDylVEIeILa~CdHP~ivkLl~ayy~e- 101 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFE- 101 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-
Confidence 345677789999999999999876433 577777532 223346788899999999999999999988774
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
+.++++.|||.||-....+..-++.+.+.++..+++|++.||.|||++.|||||||+.|||++.+|.+ +|+|||.
T Consensus 102 -nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdi----rLADFGV 176 (1187)
T KOG0579|consen 102 -NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDI----RLADFGV 176 (1187)
T ss_pred -CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcE----eeecccc
Confidence 48999999999999999988889999999999999999999999999999999999999999988876 9999998
Q ss_pred cccc-cCccccCCcCCCCCccCcccccc---CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-CCCC
Q 002908 737 SKIK-RNTLVTGGVRGTLPWMAPELLNG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPP 811 (867)
Q Consensus 737 A~~~-~~~~~~s~~~GT~~Y~APEvl~g---~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-lr~~ 811 (867)
+... ........+.|||+|||||++.. ....|+.++||||||++|.+|..+.+|.........+.++.... ...-
T Consensus 177 SAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 177 SAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL 256 (1187)
T ss_pred cccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc
Confidence 7633 23334456889999999999853 24568899999999999999999999988877777666665443 3344
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.|..++..|.+|+.+||..+|..||++.+|+++.+
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 56788999999999999999999999999988754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=301.72 Aligned_cols=258 Identities=25% Similarity=0.345 Sum_probs=200.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC--
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG-- 655 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~-- 655 (867)
++|++.+.||.|++|.||+|.. ++..||+|++...... ......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV------PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc------ccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 6789999999999999999987 4788999998753211 11234567899999999999999999987643
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
....+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||
T Consensus 79 ~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~----~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLM-ESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE----LRIGDFG 152 (334)
T ss_pred CCceEEEEEehh-hhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc----EEecccc
Confidence 234789999999 46888887543 45899999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCcc-----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc----
Q 002908 736 LSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---- 806 (867)
Q Consensus 736 LA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~---- 806 (867)
++....... ......++..|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLS-LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcC-CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 987543221 1123458889999999864 234788999999999999999999999776543322211110
Q ss_pred --------------------CCCCCC-----CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 807 --------------------TLRPPV-----PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 807 --------------------~lr~~i-----p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
...... ....+..+.++|.+||+.+|.+||++.+++.+.+-...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 000011 12357889999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=287.93 Aligned_cols=248 Identities=28% Similarity=0.373 Sum_probs=194.6
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCCC
Q 002908 582 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~~ 658 (867)
|++.+.||.|++|.||+|.+ .++.|+||.+...... .. .....+|+..+.+++ ||||+++++++... .
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WE---ECMNLREVKSLRKLNEHPNIVKLKEVFREN--D 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hh---HHHHHHHHHHHHhccCCCCchhHHHHhhcC--C
Confidence 57788999999999999998 4678999998754321 11 123456889999999 99999999999884 4
Q ss_pred eEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+ +++|.+.+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++. ++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~----~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV----VKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC----EEEeecccc
Confidence 899999999 889988886544 56899999999999999999999999999999999999997654 599999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc-----------
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN----------- 806 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~----------- 806 (867)
.............++..|+|||++.+ ...++.++|+||||+++++|++|+.||...........+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLR-STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeec-CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 86554333334557889999999864 344688999999999999999999999765543332221110
Q ss_pred ------CCCC-----------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 807 ------TLRP-----------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 807 ------~lr~-----------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.... ......+..+.+++++||+.+|.+|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 0011235789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=294.10 Aligned_cols=261 Identities=25% Similarity=0.328 Sum_probs=210.7
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.|..++|++.+.||+|||+.||+++. ++.-+|+|.+.-.. .+.....++|++..++++|||+++++++..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 67889999999999999999999885 57789999987542 112356779999999999999999999865
Q ss_pred cCC---CCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCCcceEeccCCCC
Q 002908 654 DGP---GGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 654 ~~~---~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~G--IIHrDLKPsNILLd~dg~~ 725 (867)
.+. ....||+++|...|+|.+.+.. ++..+++.+++.|+.+|++||.+||+.. ++||||||.|||+..++.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~- 167 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL- 167 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc-
Confidence 321 2368999999999999988753 3457999999999999999999999988 999999999999997554
Q ss_pred CCcEEEeecCCcccccCc----------cccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 002908 726 RPICKVGDFGLSKIKRNT----------LVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANM 794 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~~----------~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~ 794 (867)
++|.|||.++...-. ........|..|+|||.+.- .....++++|||||||+||.|+.|..||+..
T Consensus 168 ---~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 168 ---PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred ---eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 499999998743211 11123457899999999862 3456789999999999999999999999652
Q ss_pred Ch--hHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 795 HY--GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 795 ~~--~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.. .....++....+..+....+++.+.++|+.||+.||.+||++.+++..++.+
T Consensus 245 ~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 245 YQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred hhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 21 1122234444555566667899999999999999999999999999999875
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=296.86 Aligned_cols=255 Identities=28% Similarity=0.332 Sum_probs=202.3
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC--
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 656 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~-- 656 (867)
+|++.+.||.|++|.||+|.+. +..||||.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 5889999999999999999984 68899999875321 1222356788999999999999999999987642
Q ss_pred -CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 -GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 -~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
...+++||+|+. ++|.+++... ..+++..++.++.+|+.||+|||++||+||||||.|||++.++. ++|+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~----~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD----LKICDFG 148 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC----EEEcccC
Confidence 246899999996 5888877543 37999999999999999999999999999999999999997654 5999999
Q ss_pred CcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 736 LSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 736 LA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
++....... ......++..|+|||++.+.. .++.++|+|||||++|+|++|..||...........+......++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 998654432 223345788999999998532 678899999999999999999999987765544433332111000
Q ss_pred -----------------------------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 812 -----------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 812 -----------------------------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.....+..+.++|.+||+.+|.+||++.+++.+.+-.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 293 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence 0123578899999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=287.73 Aligned_cols=250 Identities=28% Similarity=0.340 Sum_probs=193.6
Q ss_pred eeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC---CCCceeeEecccccCC
Q 002908 582 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQDGP 656 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L---~HPNIVrL~g~~~~~~ 656 (867)
|++.+.||.|+||.||+|.++ +..||||+++..... ......+.+|+.+++++ +||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE------EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc------chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678899999999999999984 788999999754321 11123455677777665 5999999999987654
Q ss_pred C---CeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 G---GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ~---~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
. ...+++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++ .++|+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~----~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIA 149 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC----CEEEe
Confidence 1 23899999995 57888775433 3689999999999999999999999999999999999999765 45999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC---
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 809 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr--- 809 (867)
|||++.............++..|+|||++.+ ..++.++|+|||||++|+|++|.+||......+....+......
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 9999986544333334457889999999984 45788999999999999999999999876655544443321100
Q ss_pred ------------------CC----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 ------------------PP----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 ------------------~~----ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.. .....+..+.++|.+||+.+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 001235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=293.95 Aligned_cols=256 Identities=16% Similarity=0.178 Sum_probs=184.8
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECCc-----eEEEEEeeccccCCCChHHHHH------HHHHHHHHHHHHhCCCCc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRGT-----DVAIKRIKKSCFTGRSSEQERL------TLEFWREAEILSKLHHPN 644 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G~-----~VAVKv~k~~~~sd~~~~~e~~------~~eflrEieiLk~L~HPN 644 (867)
.+...+|++.+.||+|+||.||+|.+.+. .+|+|+..... .....+.. ......+...+..+.|+|
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~---~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN---ETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC---CchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 45567899999999999999999998533 56777543221 11111111 112234445566778999
Q ss_pred eeeEecccccCCC--CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccC
Q 002908 645 VVAFYGVVQDGPG--GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 722 (867)
Q Consensus 645 IVrL~g~~~~~~~--~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~d 722 (867)
++++++++..... ...+++|+++ ..++.+.+.. ....++..+..++.|++.||+|||+.+|+||||||+|||++.+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 9999987654321 2446777776 3455555432 3346788899999999999999999999999999999999865
Q ss_pred CCCCCcEEEeecCCcccccCc--------cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 002908 723 DPIRPICKVGDFGLSKIKRNT--------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 794 (867)
Q Consensus 723 g~~~~~vKL~DFGLA~~~~~~--------~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~ 794 (867)
+. ++|+|||+|+..... .......||+.|+|||++. ...++.++|||||||+||+|++|..||...
T Consensus 163 ~~----~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~--~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 163 NR----GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN--GACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred Cc----EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 54 599999999754211 1112346999999999998 455789999999999999999999999876
Q ss_pred Ch-hHHH--------HhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 795 HY-GAII--------GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 795 ~~-~e~l--------~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.. .... ..+..... ....++..+.+++..||..+|++||++.+|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 32 2211 11111111 1235688999999999999999999999998876
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=290.33 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=200.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccccc
Q 002908 581 DLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 654 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~ 654 (867)
+|++.+.||+|++|.||++.+ +++.||||+++..... ........+..|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 478899999999999999876 3567999998753211 1122345677899999999 59999999999877
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|.+++... ..+++..+..++.|++.+|.|||+.|++||||+|.||+++.++. ++|+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~----~~l~df 149 (288)
T cd05583 77 DT--KLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH----VVLTDF 149 (288)
T ss_pred CC--EEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC----EEEEEC
Confidence 54 889999999999999988543 46889999999999999999999999999999999999987654 599999
Q ss_pred CCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhHhhcCC
Q 002908 735 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 808 (867)
Q Consensus 735 GLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~----~e~l~~iv~~~l 808 (867)
|++....... ......++..|+|||.+.+.....+.++||||||+++|+|++|..||..... ......+...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence 9987533221 1223457899999999875443467899999999999999999999964321 2222222222
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+.+..++..+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 2345566788999999999999999999987776665553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.96 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=190.9
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEE
Q 002908 587 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 664 (867)
Q Consensus 587 ~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVm 664 (867)
.||+|+||.||++.+ .++.||+|++......... .+.........+.+++...||+|+.+++++...+ ..++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch--hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEE
Confidence 389999999999987 4788999998764332111 1111111122334555568999999999998755 899999
Q ss_pred EeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc
Q 002908 665 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744 (867)
Q Consensus 665 Ey~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~ 744 (867)
||+.+++|..++.. ...+++..+..++.|++.||.|||+.+|+||||+|+||+++.++. ++|+|||++.......
T Consensus 77 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~----~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 77 DLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH----VRISDLGLACDFSKKK 151 (278)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC----EEEccCcCccccCccC
Confidence 99999999988754 456899999999999999999999999999999999999996654 6999999987543222
Q ss_pred ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--HHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 745 ~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~--e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
.....|+..|+|||++.+ ...++.++|||||||++|+|++|..||...... ..... .........+..++..+.+
T Consensus 152 -~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~ 228 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVELPDSFSPELRS 228 (278)
T ss_pred -CcCcCCCcCCcCcHHhcC-CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-HhhccCCCCCCcCCHHHHH
Confidence 223468999999999873 224678999999999999999999999765321 11111 1122234556667899999
Q ss_pred HHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 002908 823 LMEQCWAPDPVVRP-----SFTEIARRLRV 847 (867)
Q Consensus 823 LI~kCLq~DPeeRP-----Sa~ELLe~Lq~ 847 (867)
++.+||..+|.+|| ++.+++++.+-
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 99999999999999 99999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.47 Aligned_cols=250 Identities=29% Similarity=0.447 Sum_probs=210.0
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
|+-++.||.|+||.||-+++ +...||||.+.-. +. ........++.|+..|.+++|||+|.+-|+|-... .
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS---GK--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS---GK--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--T 100 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeecccc---cc--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--h
Confidence 56677899999999999988 4667999987532 22 22334678999999999999999999999987754 7
Q ss_pred EEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.+|||||| -|+-.+.+.-..+++-+..+..|+.+.+.||+|||+.+.||||||+.|||+++.|- |||+|||.|.+
T Consensus 101 aWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~----VKLaDFGSAsi 175 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL----VKLADFGSASI 175 (948)
T ss_pred HHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe----eeeccccchhh
Confidence 89999999 56777777666678999999999999999999999999999999999999997664 59999999987
Q ss_pred ccCccccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcH
Q 002908 740 KRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 818 (867)
Q Consensus 740 ~~~~~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~ 818 (867)
..+. +.+.|||.|||||++.. ..+.|+-++||||||++..||...++|+.+|+....+..|....-+.-....++.
T Consensus 176 ~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~ 252 (948)
T KOG0577|consen 176 MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD 252 (948)
T ss_pred cCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHH
Confidence 6543 45789999999999863 2456888999999999999999999999999888777776655443333456789
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 819 EWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 819 eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.|..|+..||++-|.+|||..+++.+--
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 9999999999999999999999987643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=318.81 Aligned_cols=262 Identities=31% Similarity=0.493 Sum_probs=219.5
Q ss_pred ccccccccCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 572 STLQIIKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 572 ~~l~~I~~sdyqilk~LG~GafG~VYka~~~G-~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
..++++.++.+.+.++||+|-||.|.+++..+ ..||||.++... ......+|.+|+++|.+|+|||||+++|
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-------~~~~r~~F~kEIkiLsqLkhPNIveLvG 602 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-------TKNARNDFLKEIKILSRLKHPNIVELLG 602 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-------chhHHHHHHHHHHHHhccCCCCeeEEEe
Confidence 45778889999999999999999999999876 889999997542 3344588999999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccC-CHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL-DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~L-se~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+|..++ .+++|||||++|+|.+++...+.+. .-.....|+.||+.||+||.+..+|||||.+.|+|++.+. ++
T Consensus 603 VC~~De--PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~----~i 676 (807)
T KOG1094|consen 603 VCVQDD--PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF----TI 676 (807)
T ss_pred eeecCC--chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc----cE
Confidence 998855 8999999999999999997765433 5566778999999999999999999999999999999554 56
Q ss_pred EEeecCCcccc-cC--ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCChhHHHHhHh
Q 002908 730 KVGDFGLSKIK-RN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT--GEEPYANMHYGAIIGGIV 804 (867)
Q Consensus 730 KL~DFGLA~~~-~~--~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT--Gk~PF~~~~~~e~l~~iv 804 (867)
||+|||+++.+ .. ....+...-+.+|||||.+. ..+++.++|||+||++|||+++ ...||..++.+......-
T Consensus 677 KiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsil--lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 677 KIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred EecCcccccccccCCceeeecceeeeeeehhHHHHH--hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 99999999832 22 12223344678999999998 6679999999999999999887 778999988877665432
Q ss_pred h---cC---CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 805 N---NT---LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 805 ~---~~---lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
. .. .-+..|..|+..+.++|.+||..+-++||+|+++..+|++.
T Consensus 755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 11 12455778999999999999999999999999999999874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=300.22 Aligned_cols=254 Identities=26% Similarity=0.314 Sum_probs=196.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC-
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP- 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~- 656 (867)
.+|.+.+.||.|+||+||++.+ ++..||||.++..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN------RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc------cchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 4799999999999999999987 4788999998753211 111345668999999999999999999886532
Q ss_pred --CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 657 --GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 657 --~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
....++||||+ +++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++. ++|+||
T Consensus 79 ~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~----~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELM-DTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDF 152 (337)
T ss_pred cccCcEEEEEeCC-CCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC----EEECcC
Confidence 13589999999 4788887754 356999999999999999999999999999999999999997654 599999
Q ss_pred CCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHh---------
Q 002908 735 GLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV--------- 804 (867)
Q Consensus 735 GLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv--------- 804 (867)
|++...... .......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+.
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 999855332 222234578899999998642 347889999999999999999999997654322111110
Q ss_pred --------------hcCC---CC---CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 805 --------------NNTL---RP---PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 805 --------------~~~l---r~---~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.... .. .....+++.+.++|.+||+.+|++|||+.+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 0000 00 012346788999999999999999999999999844
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=294.84 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=193.7
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 584 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
+.+.+|.|+++.||++..+++.||||++..... .......+.+|+.+++.++||||+++++++.... ..+++
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~ 77 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVV 77 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEecccc------chhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEE
Confidence 444566667777777777889999999975321 1123456889999999999999999999998754 88999
Q ss_pred EEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 002908 664 TEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~ 742 (867)
|||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++. ++|+|||.+.....
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~----~kl~d~~~~~~~~~ 153 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK----VVLSGLRYSVSMIK 153 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc----eEEecCccceeecc
Confidence 9999999999988643 346889999999999999999999999999999999999997664 59999998864321
Q ss_pred cc--------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC------
Q 002908 743 TL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL------ 808 (867)
Q Consensus 743 ~~--------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l------ 808 (867)
.. ......++..|+|||++.+....++.++|+|||||++|+|++|..||.................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 11 1122346778999999975445578899999999999999999999987554333222111110
Q ss_pred --------------------------CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 809 --------------------------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 809 --------------------------r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
........+..+.+|+.+||+.+|++|||+.+++++..-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 0001112346788999999999999999999999987743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=279.92 Aligned_cols=241 Identities=30% Similarity=0.423 Sum_probs=199.1
Q ss_pred eeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 588 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 588 LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
||.|++|.||++.+. +..+|+|++...... .......+..|+.+++.++||||+++++.+.... ..++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-----KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--KLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-----chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--eeEEEEe
Confidence 689999999999984 788999998765322 1223456788999999999999999999988754 8999999
Q ss_pred eecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc-c
Q 002908 666 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-L 744 (867)
Q Consensus 666 y~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~-~ 744 (867)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~----~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH----IKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc----EEEeecCcceecccCCC
Confidence 99999999988543 46899999999999999999999999999999999999997664 599999999854432 2
Q ss_pred ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHH
Q 002908 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM 824 (867)
Q Consensus 745 ~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI 824 (867)
......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+.. ...+.+...+..+.+++
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i 224 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLI 224 (250)
T ss_pred cccCCcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHH
Confidence 2334567889999999973 4478899999999999999999999987766555555444 34556667799999999
Q ss_pred HHhhcCCCCCCCCH---HHHHHH
Q 002908 825 EQCWAPDPVVRPSF---TEIARR 844 (867)
Q Consensus 825 ~kCLq~DPeeRPSa---~ELLe~ 844 (867)
.+||..+|.+||++ .+++.+
T Consensus 225 ~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 225 SGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred HHHhcCCHhhCCCcccHHHHHhC
Confidence 99999999999999 666543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=295.39 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=198.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||.||++.+ .+..||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 46799999999999999999987 478899999864321 1223456778999999999999999999887543
Q ss_pred C----CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 G----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ~----~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
. ...++||+|+ +++|..++. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~----~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE----LKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC----EEEe
Confidence 1 2468999998 788887774 346899999999999999999999999999999999999996654 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-- 810 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~-- 810 (867)
|||++...... .....+++.|+|||++.+. ..++.++|+|||||++|+|++|..||...........+.......
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ecccccccccC--ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999855432 2234578899999998742 347889999999999999999999998765443333222111000
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 ---------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ---------------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.....+++.+.++|.+||+.+|.+|||+.+++.+-+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~ 301 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence 0113467789999999999999999999999966543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=294.66 Aligned_cols=260 Identities=26% Similarity=0.340 Sum_probs=197.4
Q ss_pred CCee-EEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHH------HHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 580 EDLE-ELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQE------RLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 580 sdyq-ilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e------~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
++|. +.+.||.|+||+||+|.+ .++.||||+++............ .....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 456799999999999987 47889999987543221110000 01235678999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.... ..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++
T Consensus 88 ~~~~~~--~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~----~~k 159 (335)
T PTZ00024 88 VYVEGD--FINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG----ICK 159 (335)
T ss_pred EEecCC--cEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC----CEE
Confidence 998754 8999999995 688888753 34589999999999999999999999999999999999999765 459
Q ss_pred EeecCCcccccC---------------ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 002908 731 VGDFGLSKIKRN---------------TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 795 (867)
Q Consensus 731 L~DFGLA~~~~~---------------~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~ 795 (867)
|+|||++..... ........++..|+|||.+.+. ..++.++|||||||++|+|++|..||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999875431 1111223467889999998752 346889999999999999999999998766
Q ss_pred hhHHHHhHhhcCCCC--------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 796 YGAIIGGIVNNTLRP--------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 796 ~~e~l~~iv~~~lr~--------------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
....+..+......+ ......+..+.++|.+||+.+|.+||++.+++.+.+-.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 554443332211000 00123467899999999999999999999999876653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=295.77 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=195.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|++.+.||.|+||.||+|.+ ++..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 6899999999999999999988 477899999865421 123457789999999999999999987765321
Q ss_pred ------------CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 658 ------------GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 658 ------------~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
...++||||+. ++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-- 151 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-- 151 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--
Confidence 25789999995 68887774 34689999999999999999999999999999999999998544
Q ss_pred CCcEEEeecCCcccccCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 002908 726 RPICKVGDFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 801 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~ 801 (867)
..++|+|||++........ .....++..|+|||++.+ ...++.++|||||||++|+|++|+.||..........
T Consensus 152 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 152 -LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred -ceEEECCcccceecCCccccccccccccccccccCHHHHhC-ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2469999999975432211 122346888999998753 3457889999999999999999999997765444333
Q ss_pred hHhhcC-----------------------CCC-----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 802 GIVNNT-----------------------LRP-----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 802 ~iv~~~-----------------------lr~-----~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+.... ... .....++..+.+||.+||+.+|.+|||+.+++.+-+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 222110 000 0112467789999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=321.21 Aligned_cols=248 Identities=32% Similarity=0.483 Sum_probs=205.4
Q ss_pred EEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEE
Q 002908 584 ELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~ 661 (867)
...+||+|+|-+||+|.+. |-.||--.++...+.. .+....+|..|+.+|+.|+|||||++|.+|.+....++-
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q----~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ----SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhc----ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 3457999999999999884 6666654444332221 233346788999999999999999999999987777899
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~--GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
+|+|+|..|+|..|+. +.+.++...+..|++||++||.|||++ .|||||||.+||+|+.. .+.|||+|+|+|..
T Consensus 120 ~iTEL~TSGtLr~Y~k-k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~---~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREYRK-KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN---LGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHHHH-HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC---cCceeecchhHHHH
Confidence 9999999999999985 445689999999999999999999987 59999999999999843 35689999999998
Q ss_pred ccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHH-hHhhcCCCCCCCCCCcH
Q 002908 740 KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG-GIVNNTLRPPVPGFCDS 818 (867)
Q Consensus 740 ~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~-~iv~~~lr~~ip~~~s~ 818 (867)
........ +.|||.|||||++. ..|.+.+||||||.+|+||+|+..||.....+..+. ++..+..+..+...-.+
T Consensus 196 ~r~s~aks-vIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 196 LRKSHAKS-VIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred hhccccce-eccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 88777665 78999999999997 458999999999999999999999998876665544 44444433334445578
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 819 EWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 819 eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
++++||.+||.. ..+|||+.|||.+
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 999999999999 9999999999865
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=295.30 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=199.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||.|++|.||+|.+. +..||||++..... .......+.+|+.+++.+.||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ------SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc------hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 467999999999999999999984 67899998864321 1222355778999999999999999999876543
Q ss_pred C----CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 G----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ~----~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
. ...++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++. ++|+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~----~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE----LKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC----EEEc
Confidence 1 3489999998 7799888753 46899999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-- 810 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~-- 810 (867)
|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|++|+.||........+..+......+
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhC-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 99999855432 233457889999999864 2356889999999999999999999998765544433322211000
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 ---------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 ---------------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
......++.+.++|.+||+.+|.+|||+.+|+.+-+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~ 301 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence 0012357889999999999999999999999886543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.05 Aligned_cols=253 Identities=24% Similarity=0.435 Sum_probs=204.4
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 653 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~ 653 (867)
...++++.+..||.|+.|+||+++.+ |.-.|||.+.... +....+++++.+.++.... +|+||+.+|+|.
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-------Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-------NKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-------CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 34566777888999999999999985 5779999987542 2223467778888877665 899999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
... ..++.||.| ...+..++....+++++..+-++...+..||.||-+ +||||||+||+|||+|..|++ |||
T Consensus 162 ~n~--dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gni----KlC 234 (391)
T KOG0983|consen 162 TNT--DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNI----KLC 234 (391)
T ss_pred eCc--hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCE----Eee
Confidence 865 677889998 444555555556789999999999999999999996 589999999999999988876 999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhHhhcCCCC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTLRP 810 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~-~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~iv~~~lr~ 810 (867)
|||.+....+....+...|.+.|||||.+.-. ...|+.++||||||++|+||.||..||.+...+ +.+..+... ..+
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-ePP 313 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-EPP 313 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-CCC
Confidence 99999877666655666799999999999743 557899999999999999999999999985544 344444442 222
Q ss_pred CCC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 811 PVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 811 ~ip--~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
-++ ...++.|.+|+..||++|+.+||.+.+++++
T Consensus 314 ~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222 3479999999999999999999999999876
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=294.41 Aligned_cols=252 Identities=27% Similarity=0.371 Sum_probs=194.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|.+.+.||+|+||.||+|.+ ++..||||+++..... +.....+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS------EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc------ccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 5799999999999999999987 4788999998753211 1223457789999999999999999998865321
Q ss_pred ----CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 658 ----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 658 ----~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
...++||+|+. .+|...+ ...+++..+..++.|++.||+|||+.||+||||||+|||++.++. ++|+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~----~kL~d 160 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE----LKILD 160 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEEee
Confidence 35689999985 4666554 235899999999999999999999999999999999999997654 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC------
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT------ 807 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~------ 807 (867)
||++...... .....++..|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+....
T Consensus 161 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 161 FGLARHADAE--MTGYVVTRWYRAPEVILN-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCCCcCCCCC--CCCceeeecccChhhhcC-ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998754322 223457889999999874 2347889999999999999999999998765443333222110
Q ss_pred ----------------CC----CC---CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHH
Q 002908 808 ----------------LR----PP---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR--LRVM 848 (867)
Q Consensus 808 ----------------lr----~~---ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~--Lq~l 848 (867)
.. .. .....+..+.+||.+||+.+|.+||++.+++.+ ++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00 00 011356778999999999999999999999976 5444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=293.27 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=197.0
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||++.+ ++..||||+++.... .......+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 347899999999999999999986 478899999865321 112234577899999999999999999987542
Q ss_pred C----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 656 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 656 ~----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
. ....+++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++. ++|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~----~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC----EEE
Confidence 1 23578888887 8889877743 35899999999999999999999999999999999999997664 599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC---
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--- 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l--- 808 (867)
+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|++|+.||...........+.....
T Consensus 162 ~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 162 LDFGLARHTDDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred eccccccccccc--ccccccCCCccCHHHHhC-ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999998754332 233457889999999864 24578899999999999999999999976554333222211100
Q ss_pred ---------------------CC-----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 809 ---------------------RP-----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 809 ---------------------r~-----~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+ ......++.+.++|.+||+.+|.+||++.+++.+-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 00 001135778999999999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=314.31 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=221.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
...|.+.+.||+|.|+.|.++++ +++.||||++.+... +......+.+|+++++.|+|||||+++.+.....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l------n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL------NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc------ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 45688999999999999999988 689999999976542 2223345789999999999999999999998855
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+|+||||+.+|.+.+++...++ +.+..+..++.|+.+|++|||++.|||||||++||||+.+-+ +||+|||+
T Consensus 129 --~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn----ikIaDfgf 201 (596)
T KOG0586|consen 129 --TLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN----IKIADFGF 201 (596)
T ss_pred --eeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc----eeeecccc
Confidence 89999999999999999976665 445888899999999999999999999999999999996554 59999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
+..+.........+|++.|.|||++.|.. ..++.+|+|++|++||-|+.|..||++..........+...++.+. .+
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~--~m 278 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF--YM 278 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc--ee
Confidence 99888877888899999999999999865 4578999999999999999999999998877776666666666544 46
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+.+..++|+++|..+|.+|++.+++.++-|...
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 778999999999999999999999988877643
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=286.71 Aligned_cols=244 Identities=24% Similarity=0.395 Sum_probs=195.7
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 586 k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
.+||+|+||.||++.. ++..||||.+.... ......+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 95 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVV 95 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--------hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEEEE
Confidence 5699999999999988 47889999875321 112355788999999999999999999998855 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~ 743 (867)
|||+++++|.+++. ...+++..+..++.|++.+|+|||+.|++|+||+|.||+++.++. ++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~----~~l~dfg~~~~~~~~ 169 (292)
T cd06657 96 MEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR----VKLSDFGFCAQVSKE 169 (292)
T ss_pred EecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC----EEEcccccceecccc
Confidence 99999999998774 345899999999999999999999999999999999999997654 599999998744322
Q ss_pred c-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-CCCCCCCCCcHHHH
Q 002908 744 L-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPGFCDSEWR 821 (867)
Q Consensus 744 ~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-lr~~ip~~~s~eL~ 821 (867)
. ......+++.|+|||.+. ...++.++|+||||+++|+|++|..||...........+.... ........++..+.
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~--~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK 247 (292)
T ss_pred cccccccccCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHH
Confidence 1 223345888999999987 4457889999999999999999999998765544433322211 11122345688999
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 822 LLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 822 dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+++.+||+.+|.+||++.+++.+-+-
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~~~~~ 273 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLKHPFL 273 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhcChHH
Confidence 99999999999999999999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=281.48 Aligned_cols=250 Identities=30% Similarity=0.379 Sum_probs=196.8
Q ss_pred eeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
|+..+.||.|++|.||+|... +..||+|++..... .+.....+..|+.+++.++|+||+++++++.... .
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHTER--K 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--c
Confidence 566788999999999999984 78899999976431 1222345678999999999999999999998754 8
Q ss_pred EEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.++||||+. ++|.+++......+++..+..++.+++.||.|||++||+||||+|+||+++.++. ++|+|||.+..
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~----~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV----LKLADFGLARA 147 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC----EEEecCCcccc
Confidence 999999996 6899988765457999999999999999999999999999999999999997554 59999999875
Q ss_pred ccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-----------
Q 002908 740 KRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----------- 807 (867)
Q Consensus 740 ~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~----------- 807 (867)
..... ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||........+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 43322 22233457789999998742 367889999999999999999999998766544333222100
Q ss_pred -----CCC-----------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 808 -----LRP-----------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 808 -----lr~-----------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
... ......+..+.++|.+||..+|.+||++.+++.+-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 000 00112367899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=314.74 Aligned_cols=259 Identities=19% Similarity=0.286 Sum_probs=184.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeecccc---------CCCChHHHHHHHHHHHHHHHHHhCCCCcee
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCF---------TGRSSEQERLTLEFWREAEILSKLHHPNVV 646 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~---------sd~~~~~e~~~~eflrEieiLk~L~HPNIV 646 (867)
..+|++++.||+|+||+||++.++ +..+++|.+..... .............+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998763 22223221110000 000001122345678999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhccc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccC
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 722 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~----~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~d 722 (867)
++++++.... ..++||+++ +++|..++.... .......+..|+.||+.||.|||++|||||||||+|||++.+
T Consensus 227 ~l~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEA--NTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECC--eeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999998855 789999998 567777664321 223456778899999999999999999999999999999976
Q ss_pred CCCCCcEEEeecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCC-CCCCCC--hh
Q 002908 723 DPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE-PYANMH--YG 797 (867)
Q Consensus 723 g~~~~~vKL~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~-PF~~~~--~~ 797 (867)
+. +||+|||++....... ......||..|+|||++.+ ..++.++|||||||+||+|++|.. ||.... ..
T Consensus 304 ~~----vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 304 GK----IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CC----EEEEeCCCceecCcccccccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 64 5999999998654322 2234569999999999984 457899999999999999999875 443321 11
Q ss_pred HHHHhHhhcC------CC-------------------CC-----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 798 AIIGGIVNNT------LR-------------------PP-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 798 e~l~~iv~~~------lr-------------------~~-----ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
..+..++... +. .. .....+..+.++|.+||+.||.+|||+.|++.+.+
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 1111111100 00 00 01124567888899999999999999999998755
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=343.36 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=210.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
+++....||.|.||.||.|.. +|.-.|||-++..... ......+.+|+.+|..|+|||+|++||+-.+..
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeecHH--
Confidence 577788999999999999887 5778999988765322 233455678999999999999999999977755
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..+|.||||.+|+|.+.+. .++..++.....+..|++.|++|||++|||||||||.||+++.+|- +|++|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~----iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL----IKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc----EEeeccccee
Confidence 7889999999999999874 4556777777888999999999999999999999999999998773 5999999998
Q ss_pred cccCcc-----ccCCcCCCCCccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 739 IKRNTL-----VTGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 739 ~~~~~~-----~~s~~~GT~~Y~APEvl~g~~-~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
...... ......||+-|||||++.|.. ..-..+.|||||||++.||+||+.||..++....+.=-+...-.+.+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 544332 223567999999999998654 34567899999999999999999999998877655544555667788
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
|..++++-.+||..||+.||.+|.++.||+++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 88899999999999999999999998887654
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=282.38 Aligned_cols=240 Identities=22% Similarity=0.321 Sum_probs=185.7
Q ss_pred CeeEEEE--eeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh-CCCCceeeEecccccC
Q 002908 581 DLEELKE--LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDG 655 (867)
Q Consensus 581 dyqilk~--LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~-L~HPNIVrL~g~~~~~ 655 (867)
.|.+.+. ||.|+||.||++.. .+..+|+|++....... .|+..... .+||||+++++.+...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444444 59999999999987 47789999987542211 01212221 2699999999999885
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|.||+++.++. .++|+|||
T Consensus 82 ~--~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~~l~dfg 155 (267)
T PHA03390 82 K--GHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD---RIYLCDYG 155 (267)
T ss_pred C--eeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC---eEEEecCc
Confidence 4 899999999999999988654 37999999999999999999999999999999999999997651 46999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH-HhHhh-cCCCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVN-NTLRPPVP 813 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l-~~iv~-~~lr~~ip 813 (867)
++...... ....++..|+|||++.+ ..++.++||||||+++|+|++|..||......... ..... .....+.+
T Consensus 156 ~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T PHA03390 156 LCKIIGTP---SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230 (267)
T ss_pred cceecCCC---ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc
Confidence 98754332 22458899999999984 45788999999999999999999999754432211 11111 12223344
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCC-HHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPS-FTEIARR 844 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPS-a~ELLe~ 844 (867)
..+++.+.++|.+||+.+|.+||+ +++++++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 568899999999999999999995 6999865
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-31 Score=287.84 Aligned_cols=254 Identities=26% Similarity=0.325 Sum_probs=193.8
Q ss_pred CeeEEEEeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 655 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~ 655 (867)
+|++.+.||+|+||.||++.+. +..||||.+..... .......+.+|+.+++++ .||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS------KKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc------cchhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4788999999999999999985 55799999864321 111234577899999999 599999999875432
Q ss_pred --CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 656 --PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 656 --~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
....++++|+|+ +++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|
T Consensus 75 ~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~----~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE----LKICD 148 (332)
T ss_pred cccCCcEEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC----EEeCc
Confidence 223578899988 5788887743 456899999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCcc-----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-
Q 002908 734 FGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT- 807 (867)
Q Consensus 734 FGLA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~- 807 (867)
||++....... ......|+..|+|||++.+ ...++.++|||||||++|+|++|..||...........++...
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99997543211 1123468899999998864 2457889999999999999999999997655433222211100
Q ss_pred ------------------------C-CC---CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 808 ------------------------L-RP---PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 808 ------------------------l-r~---~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
. .. ......+..+.+++.+||+.+|.+|||+.+++.+-+-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 0 00 0112347789999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=287.09 Aligned_cols=252 Identities=28% Similarity=0.368 Sum_probs=194.5
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||.|+||.||++.+ ++..||||++....... .....+.+|+.+++.++||||++++++|...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP------VLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc------chhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 456799999999999999999987 47789999886532211 1234567899999999999999999988653
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
....++||||+ +++|..++. ...+++..+..++.|++.||.|||+.+|+|+||+|.|||++.++ .++|+|||
T Consensus 82 -~~~~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~----~~~l~dfg 153 (328)
T cd07856 82 -LEDIYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC----DLKICDFG 153 (328)
T ss_pred -CCcEEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC----CEEeCccc
Confidence 23688999998 678887774 34578888999999999999999999999999999999998665 45999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh----------
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN---------- 805 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~---------- 805 (867)
++....... ....++..|+|||.+.+ ...++.++|||||||++|+|++|..||...........+..
T Consensus 154 ~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 154 LARIQDPQM--TGYVSTRYYRAPEIMLT-WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccccCCCc--CCCcccccccCceeeec-cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987543321 23457888999998863 24578899999999999999999999976553221111000
Q ss_pred --------------cCCCCCC-----CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 806 --------------NTLRPPV-----PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 806 --------------~~lr~~i-----p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.....+. ...++..+.++|.+||+.+|++||++.+++.+-+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~ 290 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCc
Confidence 0000011 1235788999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=316.14 Aligned_cols=262 Identities=29% Similarity=0.402 Sum_probs=207.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC--
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 656 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~-- 656 (867)
-|..-+.||+||||.||+|+. .|+.||||.++... ..+......+|+++|++++|||||+++++-.+..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-------ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 455567899999999999997 58999999998643 2223466789999999999999999999866544
Q ss_pred --CCeEEEEEEeecCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 --GGTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 --~~~l~LVmEy~~ggSL~d~L~~~~--~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.....+|||||.+|+|...+...+ .-+++.+.+.++..+..||.|||++|||||||||.||++-.........||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 456689999999999999997654 4599999999999999999999999999999999999997766566788999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-----HHHhHhhc-
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-----IIGGIVNN- 806 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-----~l~~iv~~- 806 (867)
|||+|+...+......+.||+.|++||++.. +..|+..+|.|||||++|+++||..||.....+. ++..+...
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 9999998877777778889999999999984 4668888999999999999999999996644332 22211111
Q ss_pred -----------------CCCCCCCCCCcHHH----HHHHHHhhcCCCCCCC--CHHHHHHHHHHHHH
Q 002908 807 -----------------TLRPPVPGFCDSEW----RLLMEQCWAPDPVVRP--SFTEIARRLRVMSA 850 (867)
Q Consensus 807 -----------------~lr~~ip~~~s~eL----~dLI~kCLq~DPeeRP--Sa~ELLe~Lq~l~~ 850 (867)
....|.+...++.+ ..++..+|..+|.+|- .+.+....+.++..
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 01123343444443 4456678899999998 77666666666543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=295.04 Aligned_cols=247 Identities=30% Similarity=0.418 Sum_probs=213.2
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
...+..++|..+++||+|.||.|-+++- .++.+|+|++++....... .+..-+.|-++|+..+||.+..+--.
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd-----EVAHTlTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD-----EVAHTLTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH-----HhhhhhhHHHHHHhccCcHHHHhhhh
Confidence 3456778999999999999999999887 4788999999987655322 12345678999999999999999888
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
|+..+ .+|+||||..||.|.-.+. ..+.+++.....+-..|+.||.|||+++||+||||.+|+|+|.+|++ ||
T Consensus 237 FQt~d--rlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHI----Ki 309 (516)
T KOG0690|consen 237 FQTQD--RLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHI----KI 309 (516)
T ss_pred hccCc--eEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCce----Ee
Confidence 88855 9999999999999998884 46679999999999999999999999999999999999999988866 99
Q ss_pred eecCCcccc-cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 732 GDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 732 ~DFGLA~~~-~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
+|||+++.. ........+||||.|+|||++. ...|+.++|+|.+|++||||++|+.||-..+......-++...++
T Consensus 310 tDFGLCKE~I~~g~t~kTFCGTPEYLAPEVle--DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k- 386 (516)
T KOG0690|consen 310 TDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE--DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK- 386 (516)
T ss_pred eecccchhcccccceeccccCChhhcCchhhc--cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc-
Confidence 999999842 3334556789999999999999 677999999999999999999999999998887777777666544
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCC
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRP 836 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRP 836 (867)
.|..++++.+.|+..+|.+||.+|.
T Consensus 387 -FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 -FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -CCccCCHHHHHHHHHHhhcChHhhc
Confidence 5677899999999999999999994
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-34 Score=301.33 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=209.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
+-|.++.+||+|++|.||++.+ .|..+|||.+.... -..++..|+.+++++..|++|++||.+....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s- 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS- 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----------hHHHHHHHHHHHHHcCCchhhhhhhhhccCC-
Confidence 3466778899999999999987 48889999886431 1467889999999999999999999877644
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|||||-.|++.+.+..+.+++++.++..++...+.||.|||...-||||||+.|||++.+|.. ||+|||.|
T Consensus 102 -DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~A----KLADFGVA 176 (502)
T KOG0574|consen 102 -DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIA----KLADFGVA 176 (502)
T ss_pred -ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchh----hhhhcccc
Confidence 7999999999999999999899999999999999999999999999999999999999999977755 99999999
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-CCCCCCCC
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPGF 815 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-lr~~ip~~ 815 (867)
..+.+.. ..+.+.||+-|||||++. .-.|..++||||||++..||..|++||...+....+.-+-... .....|..
T Consensus 177 GQLTDTMAKRNTVIGTPFWMAPEVI~--EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 177 GQLTDTMAKRNTVIGTPFWMAPEVIE--EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEE 254 (502)
T ss_pred chhhhhHHhhCccccCcccccHHHHH--HhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHh
Confidence 8665443 345678999999999998 4568899999999999999999999998876544433222111 12223566
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
++.++.+|+++||.+.|++|.|+.+++++-
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 788999999999999999999999988764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=314.09 Aligned_cols=148 Identities=28% Similarity=0.469 Sum_probs=128.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|+++++||+|+||.||+|.+. ++.||||+++..... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-----NKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 367999999999999999999985 788999999754321 2333466788999999999999999999888754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++||||+.+++|..++.. ...+++..++.|+.||+.||.|||.++||||||||+||||+.++ .++|+|||+
T Consensus 78 --~~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g----~vkL~DFGl 150 (669)
T cd05610 78 --NVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG----HIKLTDFGL 150 (669)
T ss_pred --EEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC----CEEEEeCCC
Confidence 89999999999999998854 34688999999999999999999999999999999999998665 469999998
Q ss_pred cc
Q 002908 737 SK 738 (867)
Q Consensus 737 A~ 738 (867)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=314.34 Aligned_cols=261 Identities=33% Similarity=0.509 Sum_probs=219.8
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCC
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 643 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HP 643 (867)
.+++..+.+.+.+.||.|+||.|++|... ...||||.++..... .....+..|+.+++.+ .|+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-------~~~~~~~~El~~m~~~g~H~ 362 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-------SEKKDLMSELNVLKELGKHP 362 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-------HHHHHHHHHHHHHHHhcCCc
Confidence 67888888888899999999999998752 345999999864321 2346788999999998 599
Q ss_pred ceeeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCee
Q 002908 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 708 (867)
Q Consensus 644 NIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GII 708 (867)
||+.++|+|.. .+.+++|+||+..|+|..++.... ..++..+++.++.||+.||+||++.++|
T Consensus 363 niv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 363 NIVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred chhhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 99999999998 458999999999999999997655 3489999999999999999999999999
Q ss_pred ccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc--ccCCcC--CCCCccCccccccCCCCCChhhHHHHHHHHHHHH
Q 002908 709 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVR--GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI 784 (867)
Q Consensus 709 HrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~--~~s~~~--GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyEL 784 (867)
||||-+.|||+..+ ..+||+|||+|+...... ...... -+..|||||.+. ...++.++||||||++|||+
T Consensus 441 HRDLAaRNVLi~~~----~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~--~~~ft~kSDVWSfGI~L~Ei 514 (609)
T KOG0200|consen 441 HRDLAARNVLITKN----KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF--DRVFTSKSDVWSFGILLWEI 514 (609)
T ss_pred chhhhhhhEEecCC----CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc--cCcccccchhhHHHHHHHHH
Confidence 99999999999955 467999999998432221 111111 345699999998 57799999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 785 LT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 785 LT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+| |..||.+......+...+..+.+.+.|..|++++.++|+.||+.+|++||+|.++.+.+....
T Consensus 515 fsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 515 FTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred hhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 99 999999876333335578888999999999999999999999999999999999999999853
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=326.06 Aligned_cols=258 Identities=27% Similarity=0.352 Sum_probs=214.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|.++++||+|+||.|..++.+ ++.+|+|++.+-.+..+. ...-|+.|..+|...+.+.|+.++-.|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~-----~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA-----ETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch-----hHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 356789999999999999999999985 566999999764332111 1245888999999999999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. ++|+||+||+||+|..++...+ .+++..+..++..|..||+-||+.|+|||||||+|||||..|++ ||+|
T Consensus 146 D~~--~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHi----kLAD 218 (1317)
T KOG0612|consen 146 DER--YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHI----KLAD 218 (1317)
T ss_pred Ccc--ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcE----eecc
Confidence 955 9999999999999999997777 89999999999999999999999999999999999999977755 9999
Q ss_pred cCCccccc-C-ccccCCcCCCCCccCcccccc--CC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 734 FGLSKIKR-N-TLVTGGVRGTLPWMAPELLNG--SS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 734 FGLA~~~~-~-~~~~s~~~GT~~Y~APEvl~g--~~-~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
||.+-... + ........|||.|++||++.. .. ..|+.-+|+||+||++|||+.|..||-....-..+.+|+...-
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE 298 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence 99886443 2 334455679999999999862 23 5689999999999999999999999988777777778877644
Q ss_pred CCCCC--CCCcHHHHHHHHHhhcCCCCCCCC---HHHHHHHHH
Q 002908 809 RPPVP--GFCDSEWRLLMEQCWAPDPVVRPS---FTEIARRLR 846 (867)
Q Consensus 809 r~~ip--~~~s~eL~dLI~kCLq~DPeeRPS---a~ELLe~Lq 846 (867)
...+| ..++++.++||.+.+. +|+.|.. ++++..|..
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 44444 5689999999999886 5777776 888877653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=287.76 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=208.7
Q ss_pred CCeeE-EEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccC
Q 002908 580 EDLEE-LKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 655 (867)
Q Consensus 580 sdyqi-lk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~ 655 (867)
++|++ -++||-|-.|.|..+.. ++..+|+|++... ....+|++.--.. .|||||.++++|...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 34444 25799999999998887 4788999998632 2334566654443 599999999998753
Q ss_pred --CCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 656 --PGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 656 --~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
...++.+|||.|+||.|...+..++ ..|++.++..|..||+.|+.|||+..|.||||||+|+|....+ .+-.+||+
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKLt 206 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKLT 206 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEec
Confidence 2357889999999999999887654 5799999999999999999999999999999999999998665 34578999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhHhhcCC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 808 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~----~e~l~~iv~~~l 808 (867)
|||+|+...........+.|+.|.|||++. ...|+...|+||+|++||-|++|.+||-..+. +.+...+..+.+
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg--~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhC--chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 999999766555556677899999999998 55688899999999999999999999976554 234556666666
Q ss_pred CCCCCC--CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 809 RPPVPG--FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 809 r~~ip~--~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
..+-++ .+++..+++|+.+|..+|.+|.|+.+++.+.|....
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 655554 478999999999999999999999999998887543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=293.42 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=209.8
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECCce--EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEec
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYG 650 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G~~--VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g 650 (867)
...|...+|..+.+||+|+||.|.++..+|+. +|||++++.......... --+.|.++|... +-|.+++++.
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDve-----ctm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVE-----CTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCccc-----ceehhhhheecCCCCchHHHHHH
Confidence 34677889999999999999999999997655 999999887654322211 122466677665 5689999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
+|+.-+ .+|+||||+.||+|...+.+- ..+.++.+..++.+|+-||-|||++|||+||||.+|||++.+|.+ |
T Consensus 418 cFQTmD--RLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHi----K 490 (683)
T KOG0696|consen 418 CFQTMD--RLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHI----K 490 (683)
T ss_pred Hhhhhh--heeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCce----E
Confidence 999865 999999999999998887544 458899999999999999999999999999999999999988765 9
Q ss_pred EeecCCccc-ccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 731 VGDFGLSKI-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 731 L~DFGLA~~-~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
|+|||+++. .-....+..++||+.|+|||++. ...|+..+|+||||++||||+.|++||++.+..+....+++....
T Consensus 491 i~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~--YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs 568 (683)
T KOG0696|consen 491 IADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS 568 (683)
T ss_pred eeecccccccccCCcceeeecCCCcccccceEE--ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc
Confidence 999999983 23344556789999999999998 677899999999999999999999999999999999999887664
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCC
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRP 836 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRP 836 (867)
.|..++.+...+.+..|...|.+|.
T Consensus 569 --yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 --YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --CcccccHHHHHHHHHHhhcCCcccc
Confidence 4567899999999999999999994
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=319.51 Aligned_cols=250 Identities=31% Similarity=0.511 Sum_probs=191.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc---
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD--- 654 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~--- 654 (867)
.+|+.++.||+||||.||+++. +|+.+|||.+.... .......+.+|+.+|.+|+|||||++|..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 5678889999999999999997 59999999997532 44556788999999999999999998753221
Q ss_pred ----------------------------------------------------C---------------------------
Q 002908 655 ----------------------------------------------------G--------------------------- 655 (867)
Q Consensus 655 ----------------------------------------------------~--------------------------- 655 (867)
.
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred ---------------------------CC--------CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHH
Q 002908 656 ---------------------------PG--------GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700 (867)
Q Consensus 656 ---------------------------~~--------~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALa 700 (867)
.. ..+||-||||+..++.+++......-.....|+++++|++||+
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 00 3568999999877777766433222257788999999999999
Q ss_pred HHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc-------------------CccccCCcCCCCCccCcccc
Q 002908 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-------------------NTLVTGGVRGTLPWMAPELL 761 (867)
Q Consensus 701 yLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~-------------------~~~~~s~~~GT~~Y~APEvl 761 (867)
|+|++|||||||||.||+++.++++ ||+|||+|+... +....+...||.-|+|||++
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~V----KIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNSV----KIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCCe----eecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999999999999999999977665 999999998511 11123356699999999999
Q ss_pred ccCCC-CCChhhHHHHHHHHHHHHHhCCCCCCC-CChhHHHHhHhhcCCCCC--CCCCCcHHHHHHHHHhhcCCCCCCCC
Q 002908 762 NGSSS-KVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGGIVNNTLRPP--VPGFCDSEWRLLMEQCWAPDPVVRPS 837 (867)
Q Consensus 762 ~g~~~-~~S~kSDVWSLGvLLyELLTGk~PF~~-~~~~e~l~~iv~~~lr~~--ip~~~s~eL~dLI~kCLq~DPeeRPS 837 (867)
.+... .|+.|+|+||||++|+||+. ||.. |.....+..+....++.+ +....-+.-..+|++||+.||.+|||
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence 86432 68999999999999999985 5654 444455555554444333 01122344578999999999999999
Q ss_pred HHHHHH
Q 002908 838 FTEIAR 843 (867)
Q Consensus 838 a~ELLe 843 (867)
+.|+|.
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=258.76 Aligned_cols=237 Identities=32% Similarity=0.460 Sum_probs=191.9
Q ss_pred CcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEEeecC
Q 002908 592 TFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVN 669 (867)
Q Consensus 592 afG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~g 669 (867)
+||.||+|.+. +..+|+|++........ ...+.+|+..++.++|+||+++++++.... ..+++|||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-------RERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-------HHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCC
Confidence 58999999985 58899999875432110 467889999999999999999999998754 89999999998
Q ss_pred CchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCc
Q 002908 670 GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 749 (867)
Q Consensus 670 gSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~ 749 (867)
++|..++..... +++..++.++.+++.+|.|||+.+++|+||+|.||+++.++ .++|+|||.+............
T Consensus 72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG----HVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC----cEEEccccceeeeccccccccc
Confidence 899998854333 89999999999999999999999999999999999999765 4599999999866554334455
Q ss_pred CCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC--CcHHHHHHHHHh
Q 002908 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF--CDSEWRLLMEQC 827 (867)
Q Consensus 750 ~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~--~s~eL~dLI~kC 827 (867)
.++..|++||.+. ...++.++|||+||+++++|++|..||........................ ++..+.+++.+|
T Consensus 147 ~~~~~~~~pE~~~--~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 147 VGTPEYMAPEVLL--GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred cCCcCCCCHHHHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 6888999999997 445678999999999999999999999873333333333333222222222 788999999999
Q ss_pred hcCCCCCCCCHHHHHHH
Q 002908 828 WAPDPVVRPSFTEIARR 844 (867)
Q Consensus 828 Lq~DPeeRPSa~ELLe~ 844 (867)
|..+|.+||++.+++++
T Consensus 225 l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 225 LVKDPEKRLTAEEALQH 241 (244)
T ss_pred ccCCchhccCHHHHhhC
Confidence 99999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.84 Aligned_cols=218 Identities=22% Similarity=0.250 Sum_probs=174.6
Q ss_pred cCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEEeec
Q 002908 591 GTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMV 668 (867)
Q Consensus 591 GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ 668 (867)
|.+|.||++.+ +++.+|+|.++... .+.+|...+....||||+++++++.... ..++||||++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCC
Confidence 89999999998 47889999987532 1223444555667999999999998754 8999999999
Q ss_pred CCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCC
Q 002908 669 NGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG 748 (867)
Q Consensus 669 ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~ 748 (867)
+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. ++++|||.+....... ..
T Consensus 69 ~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----~~l~df~~~~~~~~~~--~~ 141 (237)
T cd05576 69 GGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH----IQLTYFSRWSEVEDSC--DG 141 (237)
T ss_pred CCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC----EEEecccchhcccccc--cc
Confidence 99999988543 45899999999999999999999999999999999999997664 5999999876543321 22
Q ss_pred cCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhh
Q 002908 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCW 828 (867)
Q Consensus 749 ~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCL 828 (867)
..++..|+|||.+. ...++.++|+|||||++|+|++|..||...... .........+..+++.+.++|.+||
T Consensus 142 ~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 142 EAVENMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CCcCccccCCcccC--CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHc
Confidence 34677899999987 345678999999999999999999887543211 1111223455678899999999999
Q ss_pred cCCCCCCCCH
Q 002908 829 APDPVVRPSF 838 (867)
Q Consensus 829 q~DPeeRPSa 838 (867)
+.||.+||++
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=296.15 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=206.4
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
.+.+....|+..++||+|+||.||-++. +|+-+|.|.+.+.....+. -..-.+.|..+|.+++.+.||.+--.
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~-----ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRK-----GETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhh-----hhHHhhHHHHHHHHhccCcEEEEeee
Confidence 4567788899999999999999998776 5888999988654322211 12335679999999999999999888
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
|.+.+ .+|+||..|.||+|.-+++..+ ..|++..++.++.+|+.||.+||..+||+|||||+|||+|+.|++ .
T Consensus 254 feTkd--~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Ghv----R 327 (591)
T KOG0986|consen 254 FETKD--ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHV----R 327 (591)
T ss_pred ecCCC--ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCe----E
Confidence 88865 9999999999999998887655 469999999999999999999999999999999999999988765 9
Q ss_pred EeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh--cCC
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--NTL 808 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~--~~l 808 (867)
|+|+|+|..........+..||.+|||||++.+ ..|+...|+|+|||+||+|+.|+.||...........+-. ...
T Consensus 328 ISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~ 405 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED 405 (591)
T ss_pred eeccceEEecCCCCccccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc
Confidence 999999997766666666689999999999994 4488889999999999999999999976543322211111 122
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSF 838 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa 838 (867)
....+...++++++|.+.+|+.||.+|...
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 344567789999999999999999999643
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=300.16 Aligned_cols=249 Identities=30% Similarity=0.423 Sum_probs=209.0
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 586 k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
+.||.|.||+||-|.+ +|+.||||++.+..+..... ..+..|+.+|+.+.||.||.+...|...+ .++.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe------sqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE------SQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH------HHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEE
Confidence 5799999999999887 59999999999887764332 45568999999999999999999999876 89999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~ 743 (867)
||-+.|.-|...+......+++.....++.||+.||.|||.++|+|+||||+|||+.... ....+||||||+|++.+..
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCCceeeccccceeecchh
Confidence 999965555555655667899999999999999999999999999999999999998774 4578899999999998888
Q ss_pred cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC--CCCCCCCCcHHHH
Q 002908 744 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--RPPVPGFCDSEWR 821 (867)
Q Consensus 744 ~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l--r~~ip~~~s~eL~ 821 (867)
.....+.||+.|+|||++. ...|...-|+||.|+++|--++|..||.... ++..++....+ .+.....+++...
T Consensus 721 sFRrsVVGTPAYLaPEVLr--nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLR--NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhcCCccccCHHHHh--hccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHH
Confidence 8888889999999999999 5668888999999999999999999996532 22223333222 3334566899999
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 822 LLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 822 dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+||..+|+..-.+|-+...-+.+.|.
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhh
Confidence 99999999999999999887766553
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=305.06 Aligned_cols=261 Identities=33% Similarity=0.578 Sum_probs=220.4
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEE--CC----ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCcee
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKW--RG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 646 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~--~G----~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIV 646 (867)
.+.+.+..++...++||+|+||+||+|.| +| -+||||++..... .....+++.|+-+|.+|.||||+
T Consensus 689 ~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-------~~~s~e~LdeAl~masldHpnl~ 761 (1177)
T KOG1025|consen 689 LLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-------PKASIELLDEALRMASLDHPNLL 761 (1177)
T ss_pred heeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-------chhhHHHHHHHHHHhcCCCchHH
Confidence 34455566778889999999999999999 33 4699999864321 12246788999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCC
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 726 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~ 726 (867)
+++++|... .+.||++||+.|+|.++++.....+.....+.|..||++||.|||.++++||||-+.|||+..-.
T Consensus 762 RLLgvc~~s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~--- 835 (1177)
T KOG1025|consen 762 RLLGVCMLS---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN--- 835 (1177)
T ss_pred HHhhhcccc---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC---
Confidence 999999875 37899999999999999988777899999999999999999999999999999999999998443
Q ss_pred CcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHh
Q 002908 727 PICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 802 (867)
Q Consensus 727 ~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~ 802 (867)
++|+.|||+|+...... ....-.-.+.|||-|.+. ...++.++|||||||++||++| |..||.+....++- .
T Consensus 836 -hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~--~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-d 911 (1177)
T KOG1025|consen 836 -HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR--IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-D 911 (1177)
T ss_pred -eEEEEecchhhccCcccccccccccccCcHHHHHHHhh--ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-H
Confidence 56999999999754432 222333467799999998 6789999999999999999999 99999998876654 4
Q ss_pred HhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 803 iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+++.+.+.+.|..++-++..++.+||..|+..||+|+++...+..+..
T Consensus 912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 556666788999999999999999999999999999999988887654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=297.72 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=223.2
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEECCce--EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~G~~--VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+..++++++..||-|+||.|=++..++.. +|+|++++....+. .. ...+..|..+|..++.|.||++|-.|.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-kQ----qeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT-KQ----QEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch-hH----HHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 44566777778999999999998886555 89999987654432 11 2345678999999999999999999998
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ++|++||-|-||.|+..+..+ ..|+......++.-+++|++|||++|||+|||||+|.|++.+| .+||.||
T Consensus 492 ~k--yvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G----y~KLVDF 564 (732)
T KOG0614|consen 492 SK--YVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG----YLKLVDF 564 (732)
T ss_pred ch--hhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC----ceEEeeh
Confidence 55 999999999999999999654 4688899999999999999999999999999999999999666 4599999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
|+|+.......+.++|||+.|.|||++. ...-+.++|.||||+++|||++|.+||.+.+.......++.+--...+|.
T Consensus 565 GFAKki~~g~KTwTFcGTpEYVAPEIIL--nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr 642 (732)
T KOG0614|consen 565 GFAKKIGSGRKTWTFCGTPEYVAPEIIL--NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR 642 (732)
T ss_pred hhHHHhccCCceeeecCCcccccchhhh--ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc
Confidence 9999988888888999999999999998 44567899999999999999999999999998888888888877788889
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLRVM 848 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq~l 848 (867)
.+.....+||+++...+|.+|.. +.+|.+|-|-.
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 99999999999999999999964 67887776643
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=277.07 Aligned_cols=260 Identities=26% Similarity=0.353 Sum_probs=203.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
..|+.+..||+|.+|.||+|..+ ...+|||.|+......+- ....++|+.+++.++||||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi------S~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI------SMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc------CHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 46888999999999999999652 236899999876432221 245678999999999999999999988
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhc----ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~----~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
.. +..+++++||. ..+|+..++- ..+.++...+..|+.||+.|+.|||++=|+||||||.|||+..+|..++.+
T Consensus 98 ~~-d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 98 SH-DKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cc-CceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 75 56899999998 6788877742 336789999999999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh---------
Q 002908 730 KVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--------- 796 (867)
Q Consensus 730 KL~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~--------- 796 (867)
||+|||+++.+.+.. ....+.-|..|+|||.+.| ...|+.++||||+||++.||+|..+.|.+...
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcc-cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 999999999776543 2234557899999999998 56899999999999999999999888854211
Q ss_pred hHHHHhHhh---cC------------------------CCCCC--------CCCCcHHHHHHHHHhhcCCCCCCCCHHHH
Q 002908 797 GAIIGGIVN---NT------------------------LRPPV--------PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841 (867)
Q Consensus 797 ~e~l~~iv~---~~------------------------lr~~i--------p~~~s~eL~dLI~kCLq~DPeeRPSa~EL 841 (867)
...+..+.. .. +.... -..-++...+|+.+||..||-+|.|++++
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 011111111 00 00000 01124457889999999999999999999
Q ss_pred HHHHHHH
Q 002908 842 ARRLRVM 848 (867)
Q Consensus 842 Le~Lq~l 848 (867)
+++.--.
T Consensus 335 leh~yF~ 341 (438)
T KOG0666|consen 335 LEHPYFT 341 (438)
T ss_pred hcccccc
Confidence 8775433
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=276.77 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=202.8
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCCCeEEE
Q 002908 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 586 k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~~~l~L 662 (867)
+.||+|+++.|-.+.. +|..+|||++.+.. -....+..+|++++.+++ |+||++++++|.+.. ..||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEE
Confidence 4699999999987765 68999999997642 123467889999999995 999999999999965 8999
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~ 742 (867)
|||-|.||+|...+.+ .+.|++.++.+++++|+.||.|||.+||.||||||+|||-..-..+ ..+|||||.+.....-
T Consensus 154 VfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~v-sPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKV-SPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCc-Cceeeecccccccccc
Confidence 9999999999998854 4679999999999999999999999999999999999999765544 3469999999863211
Q ss_pred --c------cccCCcCCCCCccCccccc---cCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh---------------
Q 002908 743 --T------LVTGGVRGTLPWMAPELLN---GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--------------- 796 (867)
Q Consensus 743 --~------~~~s~~~GT~~Y~APEvl~---g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~--------------- 796 (867)
. ......+|+..|||||+.. +....|+.+.|.||||++||-|++|.+||.++-.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 1 1112345888899999863 4556689999999999999999999999976422
Q ss_pred hHHHHhHhhcCCCCCCC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 797 GAIIGGIVNNTLRPPVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 797 ~e~l~~iv~~~lr~~ip--~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
......|.++.+..|.. ..++.+.+++|..+|..++..|.++.+++.+.+--
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~ 365 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ 365 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence 12344555666655443 35789999999999999999999999998866543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=295.60 Aligned_cols=244 Identities=27% Similarity=0.352 Sum_probs=196.6
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh-CCCCceeeEeccccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQD 654 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~-L~HPNIVrL~g~~~~ 654 (867)
..+.|.+...+|.|+|+.|-.+.+ ++...+||++.... . .-.+|+.++.. -+||||+++++.+.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-~-----------~~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-D-----------DNQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-c-----------ccccccchhhhhcCCCcceeecceecC
Confidence 356788888899999999998887 46779999997651 1 11134444444 479999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEec-cCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-LKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd-~dg~~~~~vKL~D 733 (867)
.. ..++|||++.|+-|.+.+..... +. ..+..|+.+|+.|+.|||++|||||||||+|||++ ..+ +++|+|
T Consensus 388 ~~--~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g----~lrlty 459 (612)
T KOG0603|consen 388 GK--EIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG----HLRLTY 459 (612)
T ss_pred Cc--eeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC----cEEEEE
Confidence 55 89999999999988887754332 33 77778999999999999999999999999999995 444 459999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
||.++..... ....+-|..|.|||++. ...+++++||||||++||+|++|+.||........+ ...-..++..
T Consensus 460 FG~a~~~~~~--~~tp~~t~~y~APEvl~--~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei---~~~i~~~~~s 532 (612)
T KOG0603|consen 460 FGFWSELERS--CDTPALTLQYVAPEVLA--IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI---HTRIQMPKFS 532 (612)
T ss_pred echhhhCchh--hcccchhhcccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH---HHhhcCCccc
Confidence 9999976655 23345688999999999 677999999999999999999999999876665222 2222233444
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..++...++|+.+||+.||.+||++.+++.+-+..
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence 78899999999999999999999999999998873
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-31 Score=277.26 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=202.2
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFY 649 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~ 649 (867)
.+.....++++-+..||.|+||+|++-.++ |+..|||.++... .+....+++.|.+...+- ++||||++|
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-------~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-------IEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-------chHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 344455666777788999999999998874 7889999997542 233346777888776554 699999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhh---hc-ccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCC
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVL---LS-KERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L---~~-~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~ 724 (867)
|.+.. ++..++.||+| ..||..+- +. +...+++..+-.|..-...||.||-. ..|||||+||+|||++..|.
T Consensus 130 Ga~F~--EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFS--EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhc--CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC
Confidence 98766 34789999999 45554322 21 23568888888888889999999996 58999999999999998776
Q ss_pred CCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhH
Q 002908 725 IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGI 803 (867)
Q Consensus 725 ~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~i 803 (867)
+ ||||||.+..+.+....+...|...|||||.+......|+.+|||||||++|||+.||+.||.....- +.+..+
T Consensus 207 v----KLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V 282 (361)
T KOG1006|consen 207 V----KLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV 282 (361)
T ss_pred E----eeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH
Confidence 5 99999999877776666677799999999999876667999999999999999999999999875542 223333
Q ss_pred hhcCCC-CCCC---CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 804 VNNTLR-PPVP---GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 804 v~~~lr-~~ip---~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+.+... ...+ ..++..+..+|..||.+|-..||.+.+++++-
T Consensus 283 v~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 283 VIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred HcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 333221 1111 23688899999999999999999999997753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=285.44 Aligned_cols=263 Identities=26% Similarity=0.369 Sum_probs=208.4
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
-.++|-++..||+|+|+.||++.+ ..+.||||+-....... ....+.+.+-..+|..+-+.|.||.||++|++|.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr-dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR-DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh-hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 457888899999999999999987 47789999875432221 222344556678999999999999999999999764
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~--GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
. ...|.|+|||+|.+|.-+|. ..+.+++.++..|+.||+.||.||... .|||-||||.|||+- +|...+.+||+|
T Consensus 540 t-dsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv-~GtacGeIKITD 616 (775)
T KOG1151|consen 540 T-DSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLV-NGTACGEIKITD 616 (775)
T ss_pred c-ccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEe-cCcccceeEeee
Confidence 3 37889999999999988884 556799999999999999999999975 699999999999996 444567889999
Q ss_pred cCCcccccCcc--------ccCCcCCCCCccCcccccc--CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH-HHh
Q 002908 734 FGLSKIKRNTL--------VTGGVRGTLPWMAPELLNG--SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGG 802 (867)
Q Consensus 734 FGLA~~~~~~~--------~~s~~~GT~~Y~APEvl~g--~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~-l~~ 802 (867)
||++++..... .++...||.+|++||.+.- +....+.++||||+||++|.++.|+.||........ +..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 99998654322 2344569999999999852 356789999999999999999999999976543322 211
Q ss_pred --Hh-hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 803 --IV-NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 803 --iv-~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
++ ......|....++.+.++||++||+..-++|....+|..+
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 11 1222344445688999999999999999999999888654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=294.16 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=209.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccccc-
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD- 654 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~- 654 (867)
.+.|++.+.||.|.+|.||+++. .++.+|||+....... ..++..|.++|+.+ .|||++.+||+|.-
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---------deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---------EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---------cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 35688899999999999998876 5888999998654221 13445678888887 59999999998752
Q ss_pred --CCCCeEEEEEEeecCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 655 --GPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 655 --~~~~~l~LVmEy~~ggSL~d~L~~-~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
..++.++||||||.+||..+++.. .+..+.|..+..|++.++.||.|||.+.+||||||-.|||++.++.+ ||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~V----KL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEV----KL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcE----EE
Confidence 335699999999999999999853 36789999999999999999999999999999999999999988765 99
Q ss_pred eecCCcccccCc-cccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC
Q 002908 732 GDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 732 ~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~ 807 (867)
+|||++.....+ ...+...||+.|||||++... ...|+.++|+||||++..||..|.+|+..++....+..+-..+
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP 244 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 244 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence 999999865443 344567799999999999642 3457789999999999999999999999999877776654433
Q ss_pred C-CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 808 L-RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 808 l-r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
. ....+...+..|.+||..||.+|.+.||+..+++++-
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 2 2223566789999999999999999999999988753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=276.51 Aligned_cols=256 Identities=30% Similarity=0.545 Sum_probs=202.1
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh--CCCCceeeEeccccc-
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK--LHHPNVVAFYGVVQD- 654 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~--L~HPNIVrL~g~~~~- 654 (867)
-..+.++.+.||+|.||.||+|.|+|..||||+|... + ...+.+|.++++. |+|+||+.+++.-..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr--------d---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR--------D---ERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred hhheeEEEEEecCccccceeeccccCCceEEEEeccc--------c---hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 3457899999999999999999999999999999632 1 2567788888875 599999999876433
Q ss_pred -CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCCcceEeccCCCC
Q 002908 655 -GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 655 -~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~--------GIIHrDLKPsNILLd~dg~~ 725 (867)
+.-..++||++|.+.|||.++|.. ..++....++++..++.||+|||.. .|.|||||..|||+..++
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-- 353 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-- 353 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC--
Confidence 334579999999999999999954 6789999999999999999999952 499999999999999665
Q ss_pred CCcEEEeecCCcccccCcc-----ccCCcCCCCCccCccccccCCC----CCChhhHHHHHHHHHHHHHhC---------
Q 002908 726 RPICKVGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTG--------- 787 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~----~~S~kSDVWSLGvLLyELLTG--------- 787 (867)
.|-|+|+|+|....... ..+...||.+|||||++...-. .--..+||||||.++||++..
T Consensus 354 --~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 354 --TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred --cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 57999999998654432 2345679999999999864211 112469999999999999762
Q ss_pred -CCCCCCC-----ChhHHHHhHhhcCCCCCCCCCCc-----HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 788 -EEPYANM-----HYGAIIGGIVNNTLRPPVPGFCD-----SEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 788 -k~PF~~~-----~~~e~l~~iv~~~lr~~ip~~~s-----~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
..||... ..+++..-+....+++.+|.... ..+..+|+.||..+|..|.|+--+.+.|.++..
T Consensus 432 y~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred hcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 4566442 22344444556677777775532 346678999999999999999999998888763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=278.84 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=204.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh--CCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK--LHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~--L~HPNIVrL~g~~~ 653 (867)
.+....+++.++||+|.||.||+|...++.||||+|... ....|..|.++++. +.|+||+++++.-.
T Consensus 206 l~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 206 LLELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----------EKQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred cccCCchhhHHHhhcCccceeehhhccCceeEEEecCHH-----------HHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 334556777889999999999999999999999999632 23567778777765 57999999998755
Q ss_pred cCC--CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---------CeeccCCCCcceEeccC
Q 002908 654 DGP--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK---------NIVHFDLKCDNLLVNLK 722 (867)
Q Consensus 654 ~~~--~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~---------GIIHrDLKPsNILLd~d 722 (867)
..+ .-.++||++|.+.|+|.++|. ...++|....+|+..|++||+|||+. +|+|||||..|||+..|
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 432 347899999999999999994 45689999999999999999999962 59999999999999965
Q ss_pred CCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCC----CCCChhhHHHHHHHHHHHHHhCCCCCC-C-
Q 002908 723 DPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS----SKVSEKVDVFSFGIVLWEILTGEEPYA-N- 793 (867)
Q Consensus 723 g~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~----~~~S~kSDVWSLGvLLyELLTGk~PF~-~- 793 (867)
+ ++.|+|||+|..+.... ...+..||.+|||||++.|.- ...-.+.||||+|.+||||++.+.-+. +
T Consensus 353 l----TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~ 428 (534)
T KOG3653|consen 353 L----TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP 428 (534)
T ss_pred C----cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC
Confidence 4 56999999998665332 223466999999999997631 223357999999999999999665432 1
Q ss_pred ---------------CChhHHHHhHhhcCCCCCCCCCC-----cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 794 ---------------MHYGAIIGGIVNNTLRPPVPGFC-----DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 794 ---------------~~~~e~l~~iv~~~lr~~ip~~~-----s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
...+++..-++....|+.++... ...+.+.++.||..|++.|.|+.=+.++++.+....
T Consensus 429 vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 429 VPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11233444556666677666532 456889999999999999999999999888887654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=279.50 Aligned_cols=256 Identities=24% Similarity=0.265 Sum_probs=199.2
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC--C----ce
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--P----NV 645 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H--P----NI 645 (867)
+..+...+|.++..||+|.||.|-.+.+. +..||||+++.. ..+....+-|+++|.++.+ | -+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---------~kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---------DKYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---------HHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 33455789999999999999999998874 677999999742 2334455679999999942 3 27
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~-~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~ 724 (867)
|.+.+||.- .++.|||+|.+ |.|+.+++.. ...+++...+..|++|++++++|||+.+++|.||||+|||+-....
T Consensus 154 v~m~~wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 154 VQMRDWFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEY 230 (415)
T ss_pred Eeeehhhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccce
Confidence 888888887 45999999998 7899999975 3468999999999999999999999999999999999999953211
Q ss_pred ----------------CCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCC
Q 002908 725 ----------------IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788 (867)
Q Consensus 725 ----------------~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk 788 (867)
....++++|||.|+...... .....|..|+|||++. +-.++.++||||+||+|+||+||.
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViL--gLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVIL--GLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchhee--ccCcCCccCceeeeeEEEEeeccc
Confidence 12358999999998765443 3456899999999999 456999999999999999999999
Q ss_pred CCCCCCChhHHH---HhHhhcCC----------------CCC-----------------CC--------CCCcHHHHHHH
Q 002908 789 EPYANMHYGAII---GGIVNNTL----------------RPP-----------------VP--------GFCDSEWRLLM 824 (867)
Q Consensus 789 ~PF~~~~~~e~l---~~iv~~~l----------------r~~-----------------ip--------~~~s~eL~dLI 824 (867)
..|......+.+ +.++.... +.. .| ......|.+||
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 999887654422 21111000 000 00 01123589999
Q ss_pred HHhhcCCCCCCCCHHHHHHHH
Q 002908 825 EQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 825 ~kCLq~DPeeRPSa~ELLe~L 845 (867)
++||..||.+|+|+.|++.+.
T Consensus 387 ~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HHHHccCccccccHHHHhcCH
Confidence 999999999999999998764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=286.78 Aligned_cols=254 Identities=18% Similarity=0.176 Sum_probs=167.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
...++|++.+.||+|+||.||+|++. +..||||.+.... ..+. +..+ .+....+.+++.++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~----~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEI----WMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHH----HHHH--HHHhhchhhHHHHHH
Confidence 45678999999999999999999984 5689999875321 1111 1111 112222222322222
Q ss_pred ccc----cCCCCeEEEEEEeecCCchhhhhhccccc-------------------CCHHHHHHHHHHHHHHHHHHHHCCe
Q 002908 651 VVQ----DGPGGTLATVTEFMVNGSLRHVLLSKERH-------------------LDRRKRLIIAMDAAFGMEYLHSKNI 707 (867)
Q Consensus 651 ~~~----~~~~~~l~LVmEy~~ggSL~d~L~~~~~~-------------------Lse~~~l~Ia~QIa~ALayLHs~GI 707 (867)
.+. ......+++||||+.+++|.+++...... .....+..++.||+.||.|||+++|
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 211 12245789999999999999888543211 1233456799999999999999999
Q ss_pred eccCCCCcceEeccCCCCCCcEEEeecCCcccccC--ccccCCcCCCCCccCccccccCCC-------------------
Q 002908 708 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSS------------------- 766 (867)
Q Consensus 708 IHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~--~~~~s~~~GT~~Y~APEvl~g~~~------------------- 766 (867)
+||||||+|||++.+. ..+||+|||+|+.... ........+++.|+|||.+.....
T Consensus 277 iHRDLKP~NILl~~~~---~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 277 VHRDVKPQNIIFSEGS---GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred EeCcCCHHHEEEeCCC---CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 9999999999998532 2469999999975432 122334568999999997642211
Q ss_pred -CCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh--------------cCCCCC------CCCCCcHHHHHHHH
Q 002908 767 -KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN--------------NTLRPP------VPGFCDSEWRLLME 825 (867)
Q Consensus 767 -~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~--------------~~lr~~------ip~~~s~eL~dLI~ 825 (867)
.+..++|||||||+||+|+++..++.... ......+. ...... ..........+||.
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCchHH--HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 23456799999999999999776654321 11111110 000000 01112334568999
Q ss_pred HhhcCCCCCCCCHHHHHHHHHH
Q 002908 826 QCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 826 kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+||+.||.+|||+.+++++.+-
T Consensus 432 ~mL~~dP~kR~ta~e~L~Hpff 453 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAHPYF 453 (566)
T ss_pred HHccCCcccCCCHHHHhCCcCc
Confidence 9999999999999999998654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=278.59 Aligned_cols=266 Identities=19% Similarity=0.155 Sum_probs=185.3
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE------------------CCceEEEEEeeccccCCCChHH------HHHHHHHHH
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW------------------RGTDVAIKRIKKSCFTGRSSEQ------ERLTLEFWR 632 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~------------------~G~~VAVKv~k~~~~sd~~~~~------e~~~~eflr 632 (867)
...++|.+.++||+|+||+||+|.+ .++.||||.++........... ......+..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4678999999999999999999964 2457999998642110000000 001123445
Q ss_pred HHHHHHhCCCCce-----eeEecccccC------CCCeEEEEEEeecCCchhhhhhccc---------------------
Q 002908 633 EAEILSKLHHPNV-----VAFYGVVQDG------PGGTLATVTEFMVNGSLRHVLLSKE--------------------- 680 (867)
Q Consensus 633 EieiLk~L~HPNI-----VrL~g~~~~~------~~~~l~LVmEy~~ggSL~d~L~~~~--------------------- 680 (867)
|+.++.+++|.++ ++++++|... ..+..+|||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777888876654 6777777532 1246899999999999998885321
Q ss_pred --ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCC--cCCCCCcc
Q 002908 681 --RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG--VRGTLPWM 756 (867)
Q Consensus 681 --~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~--~~GT~~Y~ 756 (867)
..+++..++.++.|++.+|.|||+.+|+||||||+|||++.++ .++|+|||++........... ..+++.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG----QVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC----cEEEEeCcCccccccCCccCccccCCCccee
Confidence 1245677889999999999999999999999999999999765 459999999975433222122 22478999
Q ss_pred CccccccCC--------------------CCCChhhHHHHHHHHHHHHHhCCC-CCCCCChh-----------HHHHhHh
Q 002908 757 APELLNGSS--------------------SKVSEKVDVFSFGIVLWEILTGEE-PYANMHYG-----------AIIGGIV 804 (867)
Q Consensus 757 APEvl~g~~--------------------~~~S~kSDVWSLGvLLyELLTGk~-PF~~~~~~-----------e~l~~iv 804 (867)
|||.+.... +....+.||||+||++|+|+++.. ||...... ..+....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 999985321 111234799999999999999875 66532111 0111112
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhcCCC---CCCCCHHHHHHHHH
Q 002908 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDP---VVRPSFTEIARRLR 846 (867)
Q Consensus 805 ~~~lr~~ip~~~s~eL~dLI~kCLq~DP---eeRPSa~ELLe~Lq 846 (867)
...+..+.....++...+|+.+||..+| .+|+|+.|+|+|.+
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 2233344445678899999999999866 68999999998765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=266.27 Aligned_cols=263 Identities=26% Similarity=0.419 Sum_probs=217.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
.+.+.+++....+-+|.||.||.|.|+. +.|.||.++.. ..+.....++.|...|..+.|||+..+
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-------AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-------ASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-------ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 3455677888889999999999998842 34778877643 234556778999999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhc-------ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEecc
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLS-------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 721 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~-------~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~ 721 (867)
.+++.+. ....+.++.++.-|+|..++.. ..+.++..+...++.|++.|++|||.+||||.||-+.|.+|++
T Consensus 353 ~~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 353 LGVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD 431 (563)
T ss_pred eEEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh
Confidence 9988764 2366788999988999999862 2256788889999999999999999999999999999999995
Q ss_pred CCCCCCcEEEeecCCcccccC-c-c-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChh
Q 002908 722 KDPIRPICKVGDFGLSKIKRN-T-L-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 797 (867)
Q Consensus 722 dg~~~~~vKL~DFGLA~~~~~-~-~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~ 797 (867)
. ..+||+|=.+++..-+ . . .-.....+..||+||.+. ...|+.++||||||++||||+| |+.||...+..
T Consensus 432 ~----LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~--n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 432 Q----LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ--NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred h----eeEEeccchhccccCcccccccCCCCCCcccccCHHHHh--hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 5 5679999999884321 1 1 111223467899999998 5679999999999999999999 99999888765
Q ss_pred HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 798 e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+ +...+..+++...|-.||+++..+|..||+..|++||++++++.-|.++..+..
T Consensus 506 E-m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 506 E-MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred H-HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 5 445677889999999999999999999999999999999999999999987654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=244.97 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=200.6
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|...++||+|.+|+||+++.. ++-||+|.++.....++- -...++|+.+|+.+.|.|||++++......
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv------pssalreicllkelkhknivrl~dvlhsdk-- 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV------PSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC------cHHHHHHHHHHHHhhhcceeehhhhhccCc--
Confidence 3455678999999999999874 667999999865433332 345678999999999999999999987744
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.+.+|+||| ...|..+.......++...+..++.|+++||.|+|++.+.||||||.|.||+.+|.. ||+|||+++
T Consensus 75 kltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngel----kladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGEL----KLADFGLAR 149 (292)
T ss_pred eeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcE----Eecccchhh
Confidence 899999999 677887777777889999999999999999999999999999999999999988765 999999999
Q ss_pred cccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCC-----
Q 002908 739 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP----- 811 (867)
Q Consensus 739 ~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~----- 811 (867)
..+-.. ..+...-|..|.+|.++.| ..-|+...|+||-||++.|+.. |++.|++.+....+..+......+.
T Consensus 150 afgipvrcysaevvtlwyrppdvlfg-akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeee-eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 665433 2334457899999999987 4568889999999999999997 8888999888777665543211100
Q ss_pred ----CC------------------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 812 ----VP------------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 812 ----ip------------------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.+ ..+...-++++.++|.-+|..|.++++.+++
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 00 0122335788999999999999999998765
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=261.04 Aligned_cols=246 Identities=23% Similarity=0.380 Sum_probs=199.4
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGV 651 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~ 651 (867)
+.+...+|.++++||+|++..|.++++. .+-+|+|++++..+.++... .-...|..+..+. +||.+|-++.+
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedi-----dwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDI-----DWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccc-----hhHHhhHHHHHhccCCCeEEehhhh
Confidence 4566788999999999999999999884 55699999998877654322 2233466666665 79999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
|+... .+++|.||++||+|.-.+. +.+.++++.+..+...|+.||.|||++|||+||||.+|||+|..|.. ||
T Consensus 320 fqtes--rlffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghi----kl 392 (593)
T KOG0695|consen 320 FQTES--RLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHI----KL 392 (593)
T ss_pred hcccc--eEEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCce----ee
Confidence 99866 9999999999999987764 44679999999999999999999999999999999999999987765 99
Q ss_pred eecCCccc-ccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC--CC-----h-hHHHHh
Q 002908 732 GDFGLSKI-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN--MH-----Y-GAIIGG 802 (867)
Q Consensus 732 ~DFGLA~~-~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~--~~-----~-~e~l~~ 802 (867)
+|+|+.+. ..+...++.++|||.|+|||++.|. .|+..+|+|+||++|+||+.|+.||+- ++ . ....+-
T Consensus 393 tdygmcke~l~~gd~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv 470 (593)
T KOG0695|consen 393 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV 470 (593)
T ss_pred cccchhhcCCCCCcccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence 99999984 4455567789999999999999964 567779999999999999999999953 21 2 223344
Q ss_pred HhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCC
Q 002908 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRP 836 (867)
Q Consensus 803 iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRP 836 (867)
++....+. |..++-....+++.-|.+||.+|.
T Consensus 471 ilekqiri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 ILEKQIRI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred Hhhhcccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 44444443 445566677899999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=229.14 Aligned_cols=211 Identities=43% Similarity=0.651 Sum_probs=178.5
Q ss_pred eeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 588 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 588 LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
||.|++|.||++... +..++||++....... ....+.+|+.+++.+.|++++++++++.... ..+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDEN--HLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCC--eEEEEEe
Confidence 689999999999996 8899999997543211 3456889999999999999999999998754 8899999
Q ss_pred eecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEecc-CCCCCCcEEEeecCCcccccCcc
Q 002908 666 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPICKVGDFGLSKIKRNTL 744 (867)
Q Consensus 666 y~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~-dg~~~~~vKL~DFGLA~~~~~~~ 744 (867)
|+.+++|.+++......+++..++.++.+++.+|.+||+.|++|+||+|.||+++. ++ .++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~----~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG----KVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC----cEEEecCCceEEccCCc
Confidence 99889999988654356899999999999999999999999999999999999997 44 45999999998654432
Q ss_pred -ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHH
Q 002908 745 -VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLL 823 (867)
Q Consensus 745 -~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dL 823 (867)
......+...|++||.+... ...+.+.|+|+||+++++| ..+.++
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~ 193 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL---------------------------------PELKDL 193 (215)
T ss_pred chhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------HHHHHH
Confidence 12234578889999998742 2678899999999999998 568899
Q ss_pred HHHhhcCCCCCCCCHHHHHHHH
Q 002908 824 MEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 824 I~kCLq~DPeeRPSa~ELLe~L 845 (867)
+..|++.+|.+||++.+++++|
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=266.10 Aligned_cols=275 Identities=21% Similarity=0.235 Sum_probs=208.5
Q ss_pred cccccCCCCCcccccccc-CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHH
Q 002908 562 VDLALGNFDISTLQIIKN-EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638 (867)
Q Consensus 562 ~~~a~~~fd~~~l~~I~~-sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk 638 (867)
.++..++|.+..++.+.. .+|.+.++||+|-|++||++.++ .+.||+|+.+.. +.+....+.|+.+|+
T Consensus 59 ~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---------qhYtEaAlDEIklL~ 129 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---------QHYTEAALDEIKLLQ 129 (590)
T ss_pred hhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------hHHHHHHHHHHHHHH
Confidence 457788899889998888 99999999999999999999884 677999999742 344566778999999
Q ss_pred hCC-----C---CceeeEeccccc--CCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHH-CC
Q 002908 639 KLH-----H---PNVVAFYGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHS-KN 706 (867)
Q Consensus 639 ~L~-----H---PNIVrL~g~~~~--~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs-~G 706 (867)
+++ | .+||+|++.|.. ..+.++|+|+|++ |.+|..++.... +-++...+..|++||+.||.|||. .|
T Consensus 130 ~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 130 QVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred HHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 884 3 369999999863 3456899999998 889988886543 679999999999999999999997 59
Q ss_pred eeccCCCCcceEeccC-----------C----------------------------------------------------
Q 002908 707 IVHFDLKCDNLLVNLK-----------D---------------------------------------------------- 723 (867)
Q Consensus 707 IIHrDLKPsNILLd~d-----------g---------------------------------------------------- 723 (867)
|||.||||+|||+... +
T Consensus 209 IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l 288 (590)
T KOG1290|consen 209 IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASL 288 (590)
T ss_pred ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhh
Confidence 9999999999998211 0
Q ss_pred -----------------------C--------------------------------------------------------
Q 002908 724 -----------------------P-------------------------------------------------------- 724 (867)
Q Consensus 724 -----------------------~-------------------------------------------------------- 724 (867)
.
T Consensus 289 ~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~ 368 (590)
T KOG1290|consen 289 AGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSP 368 (590)
T ss_pred cccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCc
Confidence 0
Q ss_pred --------------------CCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHH
Q 002908 725 --------------------IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI 784 (867)
Q Consensus 725 --------------------~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyEL 784 (867)
....|||+|||-|++.....+ ....|..|+|||++.| ..|+..+||||++|++|||
T Consensus 369 ~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT--~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FEL 444 (590)
T KOG1290|consen 369 SSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFT--EDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFEL 444 (590)
T ss_pred CCccccccccccCCCCCCCccceeEEEeeccchhhhhhhhc--hhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHh
Confidence 001357777777765443222 2346889999999995 4578899999999999999
Q ss_pred HhCCCCCCCCCh------hHHHHhHhhcCCC---------------------------C-------------CCCCCCcH
Q 002908 785 LTGEEPYANMHY------GAIIGGIVNNTLR---------------------------P-------------PVPGFCDS 818 (867)
Q Consensus 785 LTGk~PF~~~~~------~e~l~~iv~~~lr---------------------------~-------------~ip~~~s~ 818 (867)
+||...|....- +..+..++..... . ..+..-..
T Consensus 445 aTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~ 524 (590)
T KOG1290|consen 445 ATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQ 524 (590)
T ss_pred hcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHH
Confidence 999998865321 1222211110000 0 01111234
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 819 EWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 819 eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
++.+|+.-||+.+|++|||+.+.+++.|....
T Consensus 525 ~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 525 QFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPV 556 (590)
T ss_pred HHHHHHHHHHhcCccccccHHHHhcCccccCC
Confidence 58889999999999999999999998887533
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=289.26 Aligned_cols=245 Identities=31% Similarity=0.451 Sum_probs=185.9
Q ss_pred eeEEEEeeecCcEE-EEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGT-VYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~-VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~ 659 (867)
|.-.+.+|.|+.|+ ||+|...|+.||||.+-... .....+|+.+|..- .|||||++|+.-.+ ..+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----------~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~qF 577 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----------FDFAQREIQLLQESDEHPNVIRYYCSEQD--RQF 577 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----------HHHHHHHHHHHHhccCCCceEEEEeeccC--Cce
Confidence 33345789999976 79999999999999885432 23456899999887 59999999876655 559
Q ss_pred EEEEEEeecCCchhhhhhcc--ccc-CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEecc-CCCCCCcEEEeecC
Q 002908 660 LATVTEFMVNGSLRHVLLSK--ERH-LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPICKVGDFG 735 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~--~~~-Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~-dg~~~~~vKL~DFG 735 (867)
+||..|+| ..+|.+++... +.. ......+.++.|+++||+|||+.+||||||||+||||+. ++.....++|+|||
T Consensus 578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence 99999999 79999999763 111 111445678899999999999999999999999999986 23345689999999
Q ss_pred CcccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 736 LSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 736 LA~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
+++..... ....+..||.+|+|||++... ..+.++|||||||++|+.++ |.+||......+ ..++.+.+..
T Consensus 657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L 732 (903)
T KOG1027|consen 657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTL 732 (903)
T ss_pred cccccCCCcchhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccce
Confidence 99854332 224566799999999999843 34668999999999999999 589997643322 2334443322
Q ss_pred CCC-CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 811 PVP-GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 811 ~ip-~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
... ..-..+..+||.+|+.++|..||++.+++.|
T Consensus 733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 733 VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111 1111278999999999999999999998754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=271.07 Aligned_cols=245 Identities=23% Similarity=0.348 Sum_probs=193.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..+-|..++.||-|+||.|.++.. +..-+|+|.+++... .....+.-...|..||.....+.||+||-.|+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-----l~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-----LMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-----HhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 45667799999999999999999876 344589999876532 22233445678999999999999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.+ .+|+||+|++||++..+|.+.+ .|.+..+..++.++..|+++.|..|+|||||||+|||||.+|.+ ||+|
T Consensus 700 Dkd--nLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHI----KLTD 772 (1034)
T KOG0608|consen 700 DKD--NLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHI----KLTD 772 (1034)
T ss_pred cCC--ceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCce----eeee
Confidence 966 9999999999999999987654 58899999999999999999999999999999999999988865 9999
Q ss_pred cCCcccc---------cCc----------------------------------cccCCcCCCCCccCccccccCCCCCCh
Q 002908 734 FGLSKIK---------RNT----------------------------------LVTGGVRGTLPWMAPELLNGSSSKVSE 770 (867)
Q Consensus 734 FGLA~~~---------~~~----------------------------------~~~s~~~GT~~Y~APEvl~g~~~~~S~ 770 (867)
||+++-+ +.. .......||+.|+|||++. ...++.
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~--r~g~~q 850 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA--RTGYTQ 850 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc--ccCccc
Confidence 9998521 100 0011234999999999998 556888
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH--hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCC
Q 002908 771 KVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI--VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 835 (867)
Q Consensus 771 kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i--v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeR 835 (867)
.+|+|+.|++||||+.|+.||-..+..+...++ ....+..+....++.+..++|.++.. +++.|
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~R 916 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSR 916 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhh
Confidence 999999999999999999999765554332222 23344455667789999999887443 35555
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=250.36 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=201.0
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 654 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~ 654 (867)
..++|++.+++|+|-++.||.|.. +...++||+++... .+.+.+|+.+|..|. ||||+++++++.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 456899999999999999999985 57889999997531 357889999999997 9999999999999
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
+......||+||+.+.+..... ..++...+..++.+++.||.|||++||+|||+||+|++||.... .++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r---kLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR---KLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc---eeeeeec
Confidence 8878889999999776655433 45788889999999999999999999999999999999996543 4699999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC-CChhHHHHh-----------
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGG----------- 802 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~-~~~~e~l~~----------- 802 (867)
|+|.++......+....+..|--||.+.. ...++..-|+|||||+|..|+..+.||.. .+....+-+
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 99998887766666667788999999874 34567789999999999999998888743 332222111
Q ss_pred ----------------HhhcC--------CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 803 ----------------IVNNT--------LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 803 ----------------iv~~~--------lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
++... ........++++..+|+.++|..|..+|+|++|.+.+..-
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 11111 1111223357899999999999999999999999887543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=258.41 Aligned_cols=259 Identities=24% Similarity=0.317 Sum_probs=199.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC-
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG- 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~- 655 (867)
.+.|....+||+|.||.||+|+. .|+.||+|.+....-..+ +-...++|+.+|..|.|+|++.++.+|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG------fpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC------CcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 35677778899999999999987 467789887644221122 223456899999999999999999988642
Q ss_pred -----CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 656 -----PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 656 -----~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
....+|+||.+| ..+|...+......++...+.++..++..||.|+|++.|+|||+||+|+||+.+|- ++
T Consensus 90 Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi----lk 164 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI----LK 164 (376)
T ss_pred CCcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce----EE
Confidence 234589999999 67888888777678999999999999999999999999999999999999997664 59
Q ss_pred EeecCCcccccCcc-----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||+++.+.... ......-|..|++||.+.| ...++.+.|||.-||+|.+|+|+.+-+.+.+....+..+..
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG-~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhc-ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 99999997543211 1122335899999999997 56789999999999999999999999887766554432221
Q ss_pred c--CCC------------------CCCC-------------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 806 N--TLR------------------PPVP-------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 806 ~--~lr------------------~~ip-------------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
- ... .|.+ -.-.++..+|+.++|..||.+|+++.+++.+-.-..
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 0 000 0111 112456889999999999999999999987755443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=270.84 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=206.8
Q ss_pred CCCCCccccccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC--
Q 002908 567 GNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-- 642 (867)
Q Consensus 567 ~~fd~~~l~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H-- 642 (867)
.+|+...+.++--.+|.+....|+|-|++|..|.+ .|..||||++... +.+.+.=++|+++|++|+.
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---------E~M~KtGl~EleiLkKL~~AD 489 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---------EVMHKTGLKELEILKKLNDAD 489 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---------hHHhhhhhHHHHHHHHhhccC
Confidence 44566678888889999999999999999999988 4778999999753 3444666789999999962
Q ss_pred ----CceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccc--cCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcc
Q 002908 643 ----PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 716 (867)
Q Consensus 643 ----PNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~--~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsN 716 (867)
-|+++++..|.... ++|||+|.+ ..+|.+.|...++ .|....+..++.|++.||.+|-..||+|+||||+|
T Consensus 490 ~Edk~Hclrl~r~F~hkn--HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDN 566 (752)
T KOG0670|consen 490 PEDKFHCLRLFRHFKHKN--HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDN 566 (752)
T ss_pred chhhhHHHHHHHHhhhcc--eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccc
Confidence 37899999998855 999999988 7899999976554 47778899999999999999999999999999999
Q ss_pred eEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh
Q 002908 717 LLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 796 (867)
Q Consensus 717 ILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~ 796 (867)
||++..-+ .+||||||.|........+ .+.-+.-|.|||++.|. .|+...|+||.||+||||.||+..|++.+.
T Consensus 567 iLVNE~k~---iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 567 ILVNESKN---ILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred eEeccCcc---eeeeccCcccccccccccc-HHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCc
Confidence 99997654 4799999999866554332 23345669999999954 567789999999999999999999998776
Q ss_pred hHHHHhHhhcCCCCC-------------------------------------------------------CCC---CCcH
Q 002908 797 GAIIGGIVNNTLRPP-------------------------------------------------------VPG---FCDS 818 (867)
Q Consensus 797 ~e~l~~iv~~~lr~~-------------------------------------------------------ip~---~~s~ 818 (867)
-.++.-.+......+ .+. ....
T Consensus 641 N~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~ 720 (752)
T KOG0670|consen 641 NQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQ 720 (752)
T ss_pred HHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHH
Confidence 544332221100000 000 0124
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 819 EWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 819 eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.|.+|+.+||..||++|.|..++|.+.
T Consensus 721 ~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 721 QLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred HHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 588999999999999999999998763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=224.99 Aligned_cols=207 Identities=37% Similarity=0.595 Sum_probs=169.7
Q ss_pred eeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCe
Q 002908 582 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~ 659 (867)
|.+.+.||.|++|.||++... +..+|+|.+...... .....+.+|+..+..++|+|++++++++.... .
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDPE--P 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecCC--c
Confidence 466788999999999999985 588999999754321 23467888999999999999999999988754 8
Q ss_pred EEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 660 l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.++++|++++++|.+++......+++..+..++.+++.++.+||+.+++|+||+|.||+++.++ .++|+|||.+..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~----~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG----LVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEeeCceeeE
Confidence 8999999999899998865433389999999999999999999999999999999999999764 459999999986
Q ss_pred ccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC-CChhHHHHh
Q 002908 740 KRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGG 802 (867)
Q Consensus 740 ~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~-~~~~e~l~~ 802 (867)
..... ......++..|++||.+. ....++.++|+|+||+++++|++|+.||.. ......+.+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 54432 223445788899999984 355677799999999999999999999977 444433333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=239.81 Aligned_cols=217 Identities=29% Similarity=0.456 Sum_probs=174.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~ 652 (867)
.+..+++.-+..||+|++|.|-+.++ .|.-.|+|.++.... .....+.++|+.+..+. .+|.+|.+||.+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 45556677788999999999877666 688899999975432 12235677888887765 699999999977
Q ss_pred ccCCCCeEEEEEEeecCCchhhh---hhcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCCCCCc
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHV---LLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~---L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~~~~~ 728 (867)
.. .+..++.||.| ..||..+ ....+...++..+-+|+..+..||.|||++ .+||||+||+||||+.+|++
T Consensus 115 ~r--egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqV--- 188 (282)
T KOG0984|consen 115 FR--EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQV--- 188 (282)
T ss_pred hc--cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcE---
Confidence 65 44799999999 4565443 345678899999999999999999999985 89999999999999988865
Q ss_pred EEEeecCCcccccCccccCCcCCCCCccCccccccC--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhHhh
Q 002908 729 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS--SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVN 805 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~--~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~iv~ 805 (867)
|+||||.+..+.+....+...|...|||||.+..+ +..|+-++||||||+++.||.+++.||+....+ +.+.+++.
T Consensus 189 -KiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 189 -KICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred -EEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 99999999887776666656788999999998632 346899999999999999999999999886554 44555554
Q ss_pred c
Q 002908 806 N 806 (867)
Q Consensus 806 ~ 806 (867)
.
T Consensus 268 e 268 (282)
T KOG0984|consen 268 E 268 (282)
T ss_pred C
Confidence 3
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=247.72 Aligned_cols=250 Identities=26% Similarity=0.328 Sum_probs=193.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|.-++.+|.|+- .|..+-+ .+++||+|..... +. +....++..+|..++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~-----n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQ-----NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cc-----cCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 457788888999998 6666655 5899999987654 22 1233466778999999999999999999987532
Q ss_pred ----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
....|+|||+| ..+|...+. ..++-..+..|+.|++.|+.|||+.||+||||||+||++..++. +||+
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~----lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT----LKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh----eeec
Confidence 23568999999 678877765 34677788899999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC---
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 809 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr--- 809 (867)
|||+|+..+.....+....|..|.|||++.|.+ +.+.+||||+||++.||++|+..|.+.+.-..+.++......
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 999999776665555667889999999999644 889999999999999999999999876553333222211000
Q ss_pred -----------------------------------CCC--CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 810 -----------------------------------PPV--PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 810 -----------------------------------~~i--p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
... +..-...+++++.+||..+|++|.+++++|.|.
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 000 001124478999999999999999999998874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-27 Score=248.17 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=188.0
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC---CeE
Q 002908 586 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG---GTL 660 (867)
Q Consensus 586 k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~---~~l 660 (867)
+.||.|+||+||.+++ .|+.||+|.+... ...-...+++.+|+.+|...+|.|++..+++.+...- ..+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnv------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNV------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchH------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3699999999999988 5899999988642 2223345778899999999999999999888765421 235
Q ss_pred EEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 661 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
|.|+|+| ..+|...+. ..+.++...+.-+++||++||.|||+.+|.||||||.|+|++.+. .+||||||+|+..
T Consensus 133 YV~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC----vLKICDFGLARve 206 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC----ILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc----eEEeccccccccc
Confidence 6777877 456655543 456799999999999999999999999999999999999999665 4699999999965
Q ss_pred cCcccc--CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH---------------
Q 002908 741 RNTLVT--GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI--------------- 803 (867)
Q Consensus 741 ~~~~~~--s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i--------------- 803 (867)
...... ....-|..|+|||++.| ...|+.++||||.||++.||+..+..|.....-+.+.-+
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMG-aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMG-ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhc-chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 433221 11235788999999998 567899999999999999999999888765443322211
Q ss_pred --------hhcCCCCC-C--------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 804 --------VNNTLRPP-V--------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 804 --------v~~~lr~~-i--------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+....+.+ . +.....+...++.+++.++|.+|.+..+.+.++..
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 11111111 1 11223456778889999999999999998877654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-26 Score=261.14 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=207.4
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|+++.++|.|.+|.||++++ .+...|||+++.....+ ..-+.+|+-+++.++|||||.++|.+...
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--------~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--------FSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--------ccccccceeeeecCCCcChHHHHhhhhhh
Confidence 457899999999999999999998 47889999998754322 13345688899999999999999988775
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
+ .+++.||||.+|+|.+.-+ -..++++.++..+++..+.+|+|||+.|=+|||||..|||+++.|.+ |+.|||
T Consensus 85 d--klwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDv----klaDfg 157 (829)
T KOG0576|consen 85 D--KLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDV----KLADFG 157 (829)
T ss_pred c--CcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCce----eecccC
Confidence 5 8899999999999987553 45679999999999999999999999999999999999999988876 999999
Q ss_pred CcccccCcc-ccCCcCCCCCccCccccc-cCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC-
Q 002908 736 LSKIKRNTL-VTGGVRGTLPWMAPELLN-GSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV- 812 (867)
Q Consensus 736 LA~~~~~~~-~~s~~~GT~~Y~APEvl~-g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i- 812 (867)
.+..+.... ....+.||+.|||||+.. +....|.+.+|||++|++..|+-.-++|-...+....+.-+.+..+.++.
T Consensus 158 vsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 158 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL 237 (829)
T ss_pred chhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc
Confidence 987554332 334678999999999863 34566889999999999999999888887666666666555555554332
Q ss_pred --CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 002908 813 --PGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843 (867)
Q Consensus 813 --p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe 843 (867)
+...++.|.+|++.||..+|.+||+++.++.
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 4457889999999999999999999987765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=252.42 Aligned_cols=205 Identities=26% Similarity=0.386 Sum_probs=163.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---CCceeeEecccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQ 653 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~---HPNIVrL~g~~~ 653 (867)
..+|..++.||.|+||.|++|.++ ...|+||.+.++..-.+.=-.++..-..-.|+.+|..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 357999999999999999999985 456999998765321110000111122446999999997 999999999999
Q ss_pred cCCCCeEEEEEEee-cCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFM-VNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~-~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
+.+ ++||+||.- ++.+|.+++.. ...+++.++..|++|++.|+++||+.||||||||-+||.++.+| .+||+
T Consensus 640 ddd--~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g----~~kli 712 (772)
T KOG1152|consen 640 DDD--YYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG----FVKLI 712 (772)
T ss_pred cCC--eeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC----eEEEe
Confidence 855 999999975 34488888853 45699999999999999999999999999999999999999766 45999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 792 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~ 792 (867)
|||.|....... ...+.||..|.|||++.|+.+ .+..-|||+||++||-++...-||-
T Consensus 713 dfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~y-~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEKY-LGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCC-cceeeeeccccchhhhCCCcc-CCCcchhhhhhheeeEEEeccCCCc
Confidence 999987544332 235679999999999998654 4677899999999999988888874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=266.17 Aligned_cols=204 Identities=19% Similarity=0.221 Sum_probs=148.6
Q ss_pred HhCCC-CceeeEecccccC-----CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Q 002908 638 SKLHH-PNVVAFYGVVQDG-----PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 711 (867)
Q Consensus 638 k~L~H-PNIVrL~g~~~~~-----~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrD 711 (867)
+.++| +||++++++|..+ ....++++|||+ +++|.+++......+++..++.++.||++||+|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 44566 6888888887321 123567788987 7799999976667799999999999999999999999999999
Q ss_pred CCCcceEeccCCC---------------CCCcEEEeecCCcccccCc-----------------cccCCcCCCCCccCcc
Q 002908 712 LKCDNLLVNLKDP---------------IRPICKVGDFGLSKIKRNT-----------------LVTGGVRGTLPWMAPE 759 (867)
Q Consensus 712 LKPsNILLd~dg~---------------~~~~vKL~DFGLA~~~~~~-----------------~~~s~~~GT~~Y~APE 759 (867)
|||+||||+..+. ....+|++|||+++..... .......||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999964321 2235688888888642110 0011235788999999
Q ss_pred ccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHH
Q 002908 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFT 839 (867)
Q Consensus 760 vl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ 839 (867)
++.+ ..++.++|||||||+||||++|..|+.... .....+..... ++......+....++.+||+++|.+||++.
T Consensus 186 ~~~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 186 EDNG--SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred hhcc--CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence 9984 457899999999999999999988875422 11222221111 111112245577899999999999999999
Q ss_pred HHHHHHHH
Q 002908 840 EIARRLRV 847 (867)
Q Consensus 840 ELLe~Lq~ 847 (867)
+++++.+-
T Consensus 261 eil~h~~~ 268 (793)
T PLN00181 261 ELLQSEFI 268 (793)
T ss_pred HHhhchhh
Confidence 99987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=209.12 Aligned_cols=165 Identities=24% Similarity=0.321 Sum_probs=128.2
Q ss_pred CchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCc
Q 002908 670 GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 749 (867)
Q Consensus 670 gSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~ 749 (867)
|+|.+++...+..+++..++.|+.||+.||.|||+++ ||+|||++.++.. ++ ||++....... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~----~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLL----KL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccce----ee--ccceEeecccc----C
Confidence 6788888766677999999999999999999999998 9999999976643 66 99988654432 2
Q ss_pred CCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhHhhcCCCC-----CCCCCCcH--HHH
Q 002908 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIVNNTLRP-----PVPGFCDS--EWR 821 (867)
Q Consensus 750 ~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~iv~~~lr~-----~ip~~~s~--eL~ 821 (867)
.||+.|+|||++.+ ..++.++|||||||++|+|+||..||...... .....+....... ..+...+. .+.
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 58899999999984 55788999999999999999999999764432 2222222211111 11112233 699
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 822 LLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 822 dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
+++.+||..+|.+||++.++++++.......
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 9999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-23 Score=222.90 Aligned_cols=260 Identities=21% Similarity=0.235 Sum_probs=200.6
Q ss_pred CeeEEEEeeecCcEEEEEEEECC---ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC----CceeeEecccc
Q 002908 581 DLEELKELGSGTFGTVYHGKWRG---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH----PNVVAFYGVVQ 653 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~G---~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H----PNIVrL~g~~~ 653 (867)
+|.+.+.||+|+||.||++.... ..+|+|+......... ..+..|+.++..+.. +++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 89999999999999999999854 3589998875432211 134567778887762 57888888774
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCC-CCCCcEEE
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PIRPICKV 731 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg-~~~~~vKL 731 (867)
....+.++||+.+ |.+|.++..... +.++...++.|+.|++.+|.+||+.|++||||||.|+++.... .....+.|
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 2244889999988 999999875444 7899999999999999999999999999999999999998765 22346799
Q ss_pred eecCCcc--cccCcc--------c-cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 002908 732 GDFGLSK--IKRNTL--------V-TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII 800 (867)
Q Consensus 732 ~DFGLA~--~~~~~~--------~-~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l 800 (867)
.|||+++ .+.... . ...+.||..|+++.+.. ....+.+.|+||+++++.+|+.|..||.........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~--~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL--GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhC--CCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 9999998 321110 1 23456999999999998 456789999999999999999999999775543222
Q ss_pred HhHh---hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 801 GGIV---NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 801 ~~iv---~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
..+. ............+..+..+...+-..+...+|.+..+...|+......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 2221 111111123445678889999898899999999999999999988776
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=225.76 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=184.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEECC--ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecc-cccC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGV-VQDG 655 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~G--~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~-~~~~ 655 (867)
+.|.+.+.||+|.||.+-++++++ +.+++|.+....+. ..+|.+|...--.| .|.||+.-|+. |+..
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---------QADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---------HHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 568889999999999999999964 56999998765432 46788887665556 48999988875 4553
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
+ .++++|||++.|+|..-+.. ..+.+.....++.|+++||.|+|+..+||||||.+||||-..+. ..+||||||
T Consensus 95 d--~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df--~rvKlcDFG 168 (378)
T KOG1345|consen 95 D--AYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF--YRVKLCDFG 168 (378)
T ss_pred c--eEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc--cEEEeeecc
Confidence 3 88899999999999988754 44788888999999999999999999999999999999965432 268999999
Q ss_pred CcccccCccccCCcCCCCCccCccccc---cCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC---ChhHHHHhHhhcCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLN---GSSSKVSEKVDVFSFGIVLWEILTGEEPYANM---HYGAIIGGIVNNTLR 809 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~---g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~---~~~e~l~~iv~~~lr 809 (867)
+.+..+.... ...-+..|.+||.+. ++.....+.+|+|+||+++|.++||++||... +....-.........
T Consensus 169 ~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 169 LTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 9875543322 233567799999864 23344677899999999999999999999742 111111111222222
Q ss_pred CCCC---CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 PPVP---GFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 ~~ip---~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+..| ...++.+..+.++-|..++++|--..++.+.
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 2333 2457788889999999999999444444333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-22 Score=198.30 Aligned_cols=252 Identities=33% Similarity=0.470 Sum_probs=197.0
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC-ceeeEecccccCCCCeE
Q 002908 582 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP-NVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP-NIVrL~g~~~~~~~~~l 660 (867)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +++++++.+.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EE
Confidence 678889999999999999988 7789999876533211 2356788999999999988 7999999995533 57
Q ss_pred EEEEEeecCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 661 ATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~~--~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
+++++++.++++.+++.... ..+.......++.|++.++.|+|..+++|||+||+||+++..+. .++++|||.+.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~---~~~l~dfg~~~ 150 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR---VVKLIDFGLAK 150 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC---eEEEeccCcce
Confidence 99999999999996664433 26899999999999999999999999999999999999996653 35999999998
Q ss_pred cccCcc-------ccCCcCCCCCccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhHhhc
Q 002908 739 IKRNTL-------VTGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNN 806 (867)
Q Consensus 739 ~~~~~~-------~~s~~~GT~~Y~APEvl~g~~-~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~----~e~l~~iv~~ 806 (867)
...... ......++..|++||.+.+.. .......|+|++|++++++++|..||..... ......+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 230 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence 543322 235567999999999998532 4678899999999999999999999877653 2333332222
Q ss_pred CCC---CCCCCCC----cHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 807 TLR---PPVPGFC----DSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 807 ~lr---~~ip~~~----s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
... ....... ...+.+++..|+..+|..|.+..+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 221 1111111 2578999999999999999988887665
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=232.24 Aligned_cols=245 Identities=22% Similarity=0.338 Sum_probs=185.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccc
Q 002908 580 EDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 653 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~ 653 (867)
..|..+++||.|.|++||++.+ +.+.||+|.+...... .++..|+++|..+. +.||+++.+++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----------~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----------SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----------hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 4678889999999999999876 2466999998764432 35778999999984 899999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
..+ ..++||||++.....++. ..++...+..+++.++.||.++|.+|||||||||.|+|++...+ .-.|+|
T Consensus 106 nnd--~v~ivlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~---rg~LvD 176 (418)
T KOG1167|consen 106 NND--QVAIVLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ---RGVLVD 176 (418)
T ss_pred cCC--eeEEEecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC---CceEEe
Confidence 855 899999999887777766 34778999999999999999999999999999999999986543 248999
Q ss_pred cCCcccccC---------------cc------------------------------ccCCcCCCCCccCccccccCCCCC
Q 002908 734 FGLSKIKRN---------------TL------------------------------VTGGVRGTLPWMAPELLNGSSSKV 768 (867)
Q Consensus 734 FGLA~~~~~---------------~~------------------------------~~s~~~GT~~Y~APEvl~g~~~~~ 768 (867)
||+|..+.. .. ......||++|.|||++... ..-
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~Q 255 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQ 255 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCc
Confidence 999862100 00 00113499999999999853 345
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhH--------------hhcC--------------------------
Q 002908 769 SEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGI--------------VNNT-------------------------- 807 (867)
Q Consensus 769 S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~i--------------v~~~-------------------------- 807 (867)
+.++||||.|++++.++++..||.....+ ..+..+ ..+.
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 78999999999999999999998432211 000000 0000
Q ss_pred -C--------CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 808 -L--------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 808 -l--------r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
. .....+..+..+.+|+.+||..+|.+|.|++++|++
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 000112235578999999999999999999999876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=209.50 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=208.0
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 653 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~ 653 (867)
+-.-.|.++++||+|.||+++.|.. ++.+||||.-....- +..+.-|.+.++.|. .++|..+|-+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----------APQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----------APQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC----------cchHHHHHHHHHHHcCCCCCCceeeecc
Confidence 3345799999999999999999986 799999998654321 133445666777775 689999988777
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC-CCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI-RPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~-~~~vKL~ 732 (867)
++- +-.||||++ |.||.++..-+++.|+...++.+|.||+.-+.|+|++.+|+|||||+|+||..-+.. ...+.++
T Consensus 95 eG~--~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 EGK--YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred ccc--hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 754 678899998 999999988889999999999999999999999999999999999999999865533 2457899
Q ss_pred ecCCcccccCcccc--------CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH---HH
Q 002908 733 DFGLSKIKRNTLVT--------GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI---IG 801 (867)
Q Consensus 733 DFGLA~~~~~~~~~--------s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~---l~ 801 (867)
|||+|+.+.+..+. ....||.+||+-....| ..-+.+.|+-|||.++++.|-|..||.+...+.. .+
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 99999976554322 34569999999998884 4568999999999999999999999998665433 33
Q ss_pred hHhhcCCCCC---CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 802 GIVNNTLRPP---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 802 ~iv~~~lr~~---ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+|-+..-..+ +....|.++..-++..-..+-.+-|.++-+...+..+....-
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 3322221122 124568889999998888899999999999888888776544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=202.40 Aligned_cols=259 Identities=21% Similarity=0.310 Sum_probs=205.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC-CceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H-PNIVrL~g~~ 652 (867)
.|-...|.++++||.|+||.+|.|.. .|..||||+-..... . ..+..|..++..|++ ..|..+..+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---h-------pqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---H-------PQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---C-------cchhHHHHHHHHhccCCCCchhhhhc
Confidence 46678899999999999999999987 689999998764321 1 245568889999975 5677777777
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.+.. +-.+||+++ |.+|.++..-..+.++...++.++-|++.-++|+|.+++|||||||+|+|..-+-.. ..+.|+
T Consensus 81 ~e~~--ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~-~kl~LI 156 (341)
T KOG1163|consen 81 TEKD--YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHC-NKLYLI 156 (341)
T ss_pred cccc--cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccccc-ceEEEE
Confidence 7754 778999998 999999998888999999999999999999999999999999999999999765433 456899
Q ss_pred ecCCcccccCcc--------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH---HH
Q 002908 733 DFGLSKIKRNTL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI---IG 801 (867)
Q Consensus 733 DFGLA~~~~~~~--------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~---l~ 801 (867)
|||+|+.+.+.. ......||.+|.+-....| ..-+.+.|+-|+|++|.++.-|..||.+...... ..
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 999998654322 1223458999999877763 3457889999999999999999999998765432 33
Q ss_pred hHhhcCCCCCC---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 802 GIVNNTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 802 ~iv~~~lr~~i---p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.+.+.....++ ....|.++.-.+..|-..--++-|++.-+.+....+..
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 34443333332 24568899999999999999999999888777766543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=202.63 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=208.2
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
..-|.-+++.++.+|....+|..|+|+|.|..+++|++.....+. +..+.|..|.-.|+-..||||+.+++.|.
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~------risrdfneefp~lrifshpnilpvlgacn 257 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTA------RISRDFNEEFPALRIFSHPNILPVLGACN 257 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcch------hhcchhhhhCcceeeecCCchhhhhhhcc
Confidence 345566677778889999999999999999999999997654432 23456777888888889999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC-ee-ccCCCCcceEeccCCCCCCcEE
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKN-IV-HFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~G-II-HrDLKPsNILLd~dg~~~~~vK 730 (867)
.++ .+.++..||+.++|+..++... -..+..++.+++.+|++|++|||+.. ++ ---|....|+||++-.. .+-
T Consensus 258 spp--nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta--ris 333 (448)
T KOG0195|consen 258 SPP--NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA--RIS 333 (448)
T ss_pred CCC--CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh--hee
Confidence 987 8899999999999999997654 34677899999999999999999863 33 34688899999966432 222
Q ss_pred EeecCCcccccCccccCCcCCCCCccCccccccCCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK-VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~-~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
.+|--++.. ..+..-.+.||+||.+...+.. .-.++|+|||.+++|||.|...||......+.-.++.-++++
T Consensus 334 mad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr 407 (448)
T KOG0195|consen 334 MADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR 407 (448)
T ss_pred cccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc
Confidence 333222211 1122346789999999743332 245799999999999999999999988877776777778899
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
..+|...+..+..||.-|+..||.+||.|..++-.|+++.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999999999999999999999888753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=206.63 Aligned_cols=166 Identities=22% Similarity=0.143 Sum_probs=123.5
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE---CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceee-Eeccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW---RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA-FYGVV 652 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~---~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVr-L~g~~ 652 (867)
.....|++.+.||+|+||+||+|.+ .++.||||++....... ........|.+|+++|+.++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWW---SKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccc---ccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 3456799999999999999999987 35668999875321100 01223456889999999999999985 4432
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCC-CCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL-KCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDL-KPsNILLd~dg~~~~~vKL 731 (867)
+..++||||++|++|.. +.. .. ...++.+++++|.|||++||+|||| ||+|||++.++ .++|
T Consensus 91 -----~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~----~ikL 153 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG----EAAV 153 (365)
T ss_pred -----CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC----CEEE
Confidence 25699999999999863 211 11 1457889999999999999999999 99999998655 3699
Q ss_pred eecCCcccccCccc---------cCCcCCCCCccCcccccc
Q 002908 732 GDFGLSKIKRNTLV---------TGGVRGTLPWMAPELLNG 763 (867)
Q Consensus 732 ~DFGLA~~~~~~~~---------~s~~~GT~~Y~APEvl~g 763 (867)
+|||+|+....... .....+++.|+|||++..
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999985433211 123457888999999863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-20 Score=217.42 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=189.7
Q ss_pred EEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEE
Q 002908 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~L 662 (867)
...+|.|++|.|+..... ...++.|.+... .. ...........+..|..+-..+.|||++..+..+.+.. ...-
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~ 398 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GILQ 398 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cchh
Confidence 457999999977766552 333455544321 10 11122222333667877888899999998888877654 3344
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~ 742 (867)
+||||++ +|..++... ..+....+..++.|++.|+.|||..||.|||||++|+++...| .+||+|||.+.....
T Consensus 399 ~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g----~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG----ILKIIDFGAASVFRY 472 (601)
T ss_pred hhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC----ceEEeecCcceeecc
Confidence 5999988 999888543 4688899999999999999999999999999999999999777 459999999986433
Q ss_pred c-----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHH-hHh-hcCC-----CC
Q 002908 743 T-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG-GIV-NNTL-----RP 810 (867)
Q Consensus 743 ~-----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~-~iv-~~~l-----r~ 810 (867)
. ....+.+|+..|+|||++.+..+. ....||||.|+++..|.+|+.||.......... ... .... ..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~yd-pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYD-PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccC-cchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 2 344677899999999999864433 457999999999999999999996544332211 000 0000 01
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCC
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 855 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~ 855 (867)
.+...++..-+.+|.+||+++|.+|.|+++|++.-|.....|+..
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v 596 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV 596 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence 112345677888999999999999999999999988877766643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=196.14 Aligned_cols=264 Identities=25% Similarity=0.285 Sum_probs=183.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC---------c----------------------------eEEEEEeeccccCC
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG---------T----------------------------DVAIKRIKKSCFTG 618 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G---------~----------------------------~VAVKv~k~~~~sd 618 (867)
....++|++...||+|....||.++... . +.|||.+..-...
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~- 231 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD- 231 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC-
Confidence 3456889999999999999999765410 0 2466655432221
Q ss_pred CChHHHHHHHHHHHHHH------HH--------Hh--------CCCCceeeEeccccc----------------------
Q 002908 619 RSSEQERLTLEFWREAE------IL--------SK--------LHHPNVVAFYGVVQD---------------------- 654 (867)
Q Consensus 619 ~~~~~e~~~~eflrEie------iL--------k~--------L~HPNIVrL~g~~~~---------------------- 654 (867)
..+....+..-+|+. .+ +. -+|||||+++++|.+
T Consensus 232 --s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 232 --SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred --CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 122222233323311 11 11 149999999988764
Q ss_pred ---CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 655 ---GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 655 ---~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+....+|+||..+ ..+|..++.. +..+......|+.|+++|+.|||.+||.|||||.+|||+..++..-.++.+
T Consensus 310 ~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred cccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 2234679999987 6899999854 345777788899999999999999999999999999999877767778899
Q ss_pred eecCCcccccCc-----c--ccCCcCCCCCccCccccccCCCCC----ChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 002908 732 GDFGLSKIKRNT-----L--VTGGVRGTLPWMAPELLNGSSSKV----SEKVDVFSFGIVLWEILTGEEPYANMHYGAII 800 (867)
Q Consensus 732 ~DFGLA~~~~~~-----~--~~s~~~GT~~Y~APEvl~g~~~~~----S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l 800 (867)
+|||.+-..... . .....-|....||||+.....+.. -.++|.|+.|.+.||+++..-||-.......-
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~ 466 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD 466 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec
Confidence 999987532210 0 001122567789999986433221 24899999999999999999998663321111
Q ss_pred HhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 801 GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 801 ~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.....+.--++++..+++.+++++..+|+.||.+|++..=....|
T Consensus 467 ~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 467 TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 111223334677889999999999999999999998775444433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-19 Score=187.57 Aligned_cols=180 Identities=11% Similarity=0.058 Sum_probs=135.4
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHH------HHHHHHHHHhCCCCceee
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE------FWREAEILSKLHHPNVVA 647 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~e------flrEieiLk~L~HPNIVr 647 (867)
...+-..+|++.+.||.|+||.||+...++..+|||++...... .+..... +.+|+..+.++.||+|..
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 34556789999999999999999998777888999999765321 2222223 678999999999999999
Q ss_pred EecccccCC------CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEecc
Q 002908 648 FYGVVQDGP------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 721 (867)
Q Consensus 648 L~g~~~~~~------~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~ 721 (867)
+..++.... .+..+|||||++|.+|.++. .+++ ....+++.+|..||+.|++|||++|.||+++.
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 988755321 23578999999999998763 1232 24568999999999999999999999999987
Q ss_pred CCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHH
Q 002908 722 KDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785 (867)
Q Consensus 722 dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELL 785 (867)
+| ++|+|||............ .++. ...+..++|+|+||+++..+.
T Consensus 171 ~g-----i~liDfg~~~~~~e~~a~d-----------~~vl--er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-----LRIIDLSGKRCTAQRKAKD-----------RIDL--ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-----EEEEECCCcccccchhhHH-----------HHHH--HhHhcccccccceeEeehHHH
Confidence 65 5999999887543221110 0222 233557899999999987553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-18 Score=174.91 Aligned_cols=145 Identities=21% Similarity=0.173 Sum_probs=106.7
Q ss_pred EEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCCh------------------HHHHHHHHHHHHHHHHHhCCCCcee
Q 002908 586 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSS------------------EQERLTLEFWREAEILSKLHHPNVV 646 (867)
Q Consensus 586 k~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~------------------~~e~~~~eflrEieiLk~L~HPNIV 646 (867)
..||+|+||.||+|.. +|+.||||+++......... ..........+|+.++.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4699999999999988 58999999998653221110 0001112234599999999877764
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHH-HHCCeeccCCCCcceEeccCCCC
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL-HSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayL-Hs~GIIHrDLKPsNILLd~dg~~ 725 (867)
....+... ..+|||||++++++..... ....+++..+..++.|++.+|.|| |+.||+||||||+|||++. +
T Consensus 83 ~p~~~~~~----~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~-- 154 (190)
T cd05147 83 CPEPILLK----SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G-- 154 (190)
T ss_pred CCcEEEec----CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--
Confidence 33322211 2379999998877665432 235689999999999999999999 6899999999999999983 3
Q ss_pred CCcEEEeecCCcccc
Q 002908 726 RPICKVGDFGLSKIK 740 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~ 740 (867)
.++|+|||+|...
T Consensus 155 --~v~LiDFG~a~~~ 167 (190)
T cd05147 155 --KLYIIDVSQSVEH 167 (190)
T ss_pred --cEEEEEccccccC
Confidence 3699999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=186.00 Aligned_cols=237 Identities=18% Similarity=0.207 Sum_probs=149.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC----------CceeeE
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH----------PNVVAF 648 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H----------PNIVrL 648 (867)
.+.....||.|+++.||.+++ ++.++|||++...... .......+.+|.-....+.+ -.++-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~-----~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADA-----SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTT-----HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccccc-----chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 467788999999999999999 4689999999765421 11223455555544444322 122222
Q ss_pred ecccc---------cCCC-C-----eEEEEEEeecCCchhhhhhc---cc---ccCCHHHHHHHHHHHHHHHHHHHHCCe
Q 002908 649 YGVVQ---------DGPG-G-----TLATVTEFMVNGSLRHVLLS---KE---RHLDRRKRLIIAMDAAFGMEYLHSKNI 707 (867)
Q Consensus 649 ~g~~~---------~~~~-~-----~l~LVmEy~~ggSL~d~L~~---~~---~~Lse~~~l~Ia~QIa~ALayLHs~GI 707 (867)
++... ...+ . ..+++|+-+ .++|..++.. .. ..+....++.+..|+++.+++||..|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 22211 1111 1 236677776 6777766532 11 123344556677899999999999999
Q ss_pred eccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccC------CCCCChhhHHHHHHHHH
Q 002908 708 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS------SSKVSEKVDVFSFGIVL 781 (867)
Q Consensus 708 IHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~------~~~~S~kSDVWSLGvLL 781 (867)
+|+||+|+|+|++.+|.. +|+||+.....+..... ...+..|.+||..... .-.++.+.|.|+||+++
T Consensus 167 VHgdi~~~nfll~~~G~v----~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGV----FLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEST-SGGGEEE-TTS-E----EE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCE----EEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999988755 99999988765544332 2345779999987421 23478899999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCC
Q 002908 782 WEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 835 (867)
Q Consensus 782 yELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeR 835 (867)
|.|+++..||............ -..+. .+++.++.||..+|+.+|.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~~-----f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEWD-----FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGGG-----GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCcccccccc-----chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999875433221111 11233 678999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=169.38 Aligned_cols=147 Identities=19% Similarity=0.141 Sum_probs=108.8
Q ss_pred EEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCC------------------hHHHHHHHHHHHHHHHHHhCCCCce
Q 002908 585 LKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS------------------SEQERLTLEFWREAEILSKLHHPNV 645 (867)
Q Consensus 585 lk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~------------------~~~e~~~~eflrEieiLk~L~HPNI 645 (867)
...||+|++|.||+|.+ +|+.||||+++........ .........+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999988 4999999999875321000 0111112234578999999999987
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCC
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~ 724 (867)
.....+... ..++||||++|+++..... ....++...+..++.|++.+|.+||+ .||+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~- 154 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG- 154 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC-
Confidence 544333322 2379999998876544322 23457888999999999999999999 9999999999999998 44
Q ss_pred CCCcEEEeecCCccccc
Q 002908 725 IRPICKVGDFGLSKIKR 741 (867)
Q Consensus 725 ~~~~vKL~DFGLA~~~~ 741 (867)
.++|+|||++....
T Consensus 155 ---~~~liDFG~a~~~~ 168 (190)
T cd05145 155 ---KPYIIDVSQAVELD 168 (190)
T ss_pred ---CEEEEEcccceecC
Confidence 35999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-19 Score=211.88 Aligned_cols=249 Identities=20% Similarity=0.201 Sum_probs=173.7
Q ss_pred CeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeE
Q 002908 581 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l 660 (867)
++...+.||.+.|=+|.+|+++.-.|+||+|.+....- .-+.+. +-+.|++ ...++|||.+++.-+.... ...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~---sL~~~~-qrL~~ik-~~l~~~pn~lPfqk~~~t~--kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTI---SLRPFK-QRLEEIK-FALMKAPNCLPFQKVLVTD--KAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCC---CchHHH-HHHHHHH-HHhhcCCcccchHHHHHhh--HHH
Confidence 67778899999999999999865559999997653221 112222 2233444 5667899999987765553 366
Q ss_pred EEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc-
Q 002908 661 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI- 739 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~- 739 (867)
|+|-+|. ..+|++.+..+ ..+...+...|+.|++.||..+|..||+|||||.+||||+. ..++.|+||..-+-
T Consensus 97 ylvRqyv-khnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS----WNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS----WNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee----echhhhhcccccCCc
Confidence 7777877 78899888543 34777888899999999999999999999999999999983 34678999987652
Q ss_pred c---cCccccCCcCCC----CCccCccccccCC---------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHh
Q 002908 740 K---RNTLVTGGVRGT----LPWMAPELLNGSS---------SKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGG 802 (867)
Q Consensus 740 ~---~~~~~~s~~~GT----~~Y~APEvl~g~~---------~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~ 802 (867)
+ .+.....-+..| ..|+|||.+.... ...+++-||||+||+++||++ |.+||.-.. +.+
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~a 246 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLA 246 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHh
Confidence 1 111111112222 3599999985311 115778999999999999998 788885311 111
Q ss_pred HhhcC-C--CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 803 IVNNT-L--RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 803 iv~~~-l--r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
..... . ..-+...-...++.+|..|++.||.+|.++++.|+..+
T Consensus 247 Yr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11110 0 00001112346899999999999999999999988733
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4e-19 Score=204.15 Aligned_cols=225 Identities=29% Similarity=0.415 Sum_probs=180.6
Q ss_pred eeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCCCeEE
Q 002908 588 LGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 588 LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~~~l~ 661 (867)
+|+|++|.|++++- .+.-+|+|+.++.....+... ....|..++..++ ||.+|+++..++... .++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~ 73 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLY 73 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeeecccc--chh
Confidence 79999999997542 466689998876544322211 3345777888887 999999999998854 899
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
+++++..++.|...+... ..+.+.....+...++-+++++|..+|+|||+|++||+++.+|.. ++.|||+++..-
T Consensus 74 l~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi----~~tdfglske~v 148 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHI----KLTDFGLSKEAV 148 (612)
T ss_pred HhhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCcc----ccCCchhhhHhH
Confidence 999999999998887544 446777777788899999999999999999999999999988765 999999998654
Q ss_pred CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHH
Q 002908 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWR 821 (867)
Q Consensus 742 ~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~ 821 (867)
..... |||..|||||+++| ...++|+||||+++++|+||..||.. +....+... ....|......+.
T Consensus 149 ~~~~~---cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~ 215 (612)
T KOG0603|consen 149 KEKIA---CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEAR 215 (612)
T ss_pred hhhhc---ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHH
Confidence 33332 79999999999983 36689999999999999999999987 444444433 3456777888999
Q ss_pred HHHHHhhcCCCCCCCCH
Q 002908 822 LLMEQCWAPDPVVRPSF 838 (867)
Q Consensus 822 dLI~kCLq~DPeeRPSa 838 (867)
+++.+++..+|..|...
T Consensus 216 ~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 216 SLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHhhCHHHHhcc
Confidence 99999999999999644
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=171.45 Aligned_cols=188 Identities=16% Similarity=0.043 Sum_probs=138.3
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCCCeEEE
Q 002908 584 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~~~l~L 662 (867)
+...|+.|+||+||.+...+.+++.+.+....... .......+.+|+++|++|. |+++++++++ . ..++
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~----~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~----~~~l 75 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWL----RGVAWWLARREALALRQLDGLPRTPRLLHW--D----GRHL 75 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhh----hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--c----CEEE
Confidence 34579999999999888888888888776543210 1112235788999999995 4789999886 1 4689
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCC-CCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL-KCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDL-KPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
+|+|+.|.+|...... ....++.|++.+|.+||++||+|||| ||.|||++.++. ++|+|||+|....
T Consensus 76 vmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~----i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS----PAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC----EEEEECCCceecC
Confidence 9999999988654311 11357789999999999999999999 799999987664 5999999998544
Q ss_pred Cccc--------------cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q 002908 742 NTLV--------------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 793 (867)
Q Consensus 742 ~~~~--------------~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~ 793 (867)
.... ..-...++.|+.|+...-....--.+.++++.|+-+|.++|+..++..
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 3221 011225778888876542222223678999999999999999888644
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-17 Score=163.85 Aligned_cols=142 Identities=22% Similarity=0.278 Sum_probs=112.4
Q ss_pred EEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 586 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 586 k~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
+.||+|++|.||+|.+.+..|+||+...................+.+|+.++..+.|++++....++.... ..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEEEE
Confidence 46899999999999999999999987654332222222233456788999999999998876666555433 6789999
Q ss_pred eecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 666 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 666 y~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
|++|++|.+++... .. .+..++.+++.+|.+||+.|++|+|++|.|||++ ++ .++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~----~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG----KIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC----CEEEEECCcccC
Confidence 99999999887432 12 7788999999999999999999999999999998 33 358999998764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.6e-17 Score=166.78 Aligned_cols=140 Identities=20% Similarity=0.204 Sum_probs=104.2
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-----CCCceeeEecccccCCC-C
Q 002908 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-----HHPNVVAFYGVVQDGPG-G 658 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-----~HPNIVrL~g~~~~~~~-~ 658 (867)
.+.||+|+||.||.....+. .+||++...... ....+.+|+.+++.+ .||||+++++++.+..+ +
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~--------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG--------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEeccccc--------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 45799999999996222233 468887643111 124678999999999 57999999999987532 3
Q ss_pred eEE-EEEEe--ecCCchhhhhhcccccCCHHHHHHHHHHHHHHH-HHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 659 TLA-TVTEF--MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM-EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 659 ~l~-LVmEy--~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~AL-ayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.++ +|||| +.+++|.+++... .+++. ..++.+++.++ +|||+++|+||||||+|||++..+.....++|+||
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 434 78999 5578999999542 35555 35577888777 99999999999999999999876544557899995
Q ss_pred CCc
Q 002908 735 GLS 737 (867)
Q Consensus 735 GLA 737 (867)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=160.91 Aligned_cols=138 Identities=22% Similarity=0.269 Sum_probs=105.6
Q ss_pred eeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEEee
Q 002908 588 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFM 667 (867)
Q Consensus 588 LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~ 667 (867)
||+|++|.||+|.+.+..|++|+..................++.+|+.++..+.|+++.....++.... ..++||||+
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEEEE
Confidence 799999999999999999999997654332222222333466788999999998876544333333322 568999999
Q ss_pred cCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 668 VNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 668 ~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
+|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++ .++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~----~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD----KLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC----cEEEEECCCCcCC
Confidence 99999887643211 7889999999999999999999999999998 33 3599999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.6e-16 Score=189.82 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=181.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---CCceeeEecc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGV 651 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~---HPNIVrL~g~ 651 (867)
.+..+.|.+.+.||+|++|.||+|.. +|+.||||+-+.....+-+. -.+++.+|+ -+.|..+...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----------~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----------CLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----------hHHHHHhhchhhhcchHHHHHH
Confidence 56778899999999999999999987 58889999988765443221 223445555 1234444443
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccC---CCCCCc
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK---DPIRPI 728 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~d---g~~~~~ 728 (867)
+.-.+ ..+||++|.+.|+|.+++. ..+.+++..+..+..||+..+.+||..+|||+||||+|+||... ......
T Consensus 763 ~~~~~--~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 763 HVFQN--ASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred HccCC--cceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 33322 5578999999999999986 55678999999999999999999999999999999999999531 112346
Q ss_pred EEEeecCCcc---cccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 729 CKVGDFGLSK---IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 729 vKL~DFGLA~---~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
++|+|||.+. ...+...-...++|-.+-++|+.. +..|+..+|.|.|+.+++-||.|+.. + ...
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~--grpWtYq~DyfGlAa~~h~mLFG~y~----------q-~~~ 906 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE--GRPWTYQIDYFGLAATVHVMLFGKYM----------E-VKN 906 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc--CCCCchhhhhHHHHHHHHHHHHHHHH----------H-hcC
Confidence 8999999986 344444555677899999999999 56799999999999999999988532 1 111
Q ss_pred cCCCCC---CCCCC-cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 806 NTLRPP---VPGFC-DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 806 ~~lr~~---ip~~~-s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
+..... ++... -+-+..|...+|..+=..=|...+|...++......
T Consensus 907 g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 907 GSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred CcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 111111 11111 234677888888844334478888877777765443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.5e-17 Score=192.61 Aligned_cols=206 Identities=31% Similarity=0.459 Sum_probs=152.5
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
-..++|..++.|-.|++|.||.++++ .+++|+|+-+... ||+ ||.. |.+
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------------------ilR-----nilt----~a~ 130 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------------------ILR-----NILT----FAG 130 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccccch--------------------hhh-----cccc----ccC
Confidence 34578999999999999999999885 6678886543210 222 1211 222
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.+ +.| |++...+... ++++. +++.+++|||+-||+|||+||+|.+|+.-|. +|++||
T Consensus 131 np----fvv------gDc~tllk~~-g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGh----iKlTDf 187 (1205)
T KOG0606|consen 131 NP----FVV------GDCATLLKNI-GPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGH----IKLTDF 187 (1205)
T ss_pred Cc----cee------chhhhhcccC-CCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeeccc----ccccch
Confidence 11 112 5555555322 23332 2377899999999999999999999996655 499999
Q ss_pred CCcccccCc----------------cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH
Q 002908 735 GLSKIKRNT----------------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 798 (867)
Q Consensus 735 GLA~~~~~~----------------~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e 798 (867)
|++.+.... .....++||+.|+|||++. .+.|+..+|+|++|+++|+.+-|+.||.+.+.++
T Consensus 188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil--rqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL--RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh--hhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 998742211 1112467999999999998 5678899999999999999999999999999888
Q ss_pred HHHhHhhcCCCCC-CCCCCcHHHHHHHHHhhcCCCCCCC
Q 002908 799 IIGGIVNNTLRPP-VPGFCDSEWRLLMEQCWAPDPVVRP 836 (867)
Q Consensus 799 ~l~~iv~~~lr~~-ip~~~s~eL~dLI~kCLq~DPeeRP 836 (867)
.+..++......+ -...++++++++|.++|+.+|..|-
T Consensus 266 lfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 266 LFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 8877776555433 3455789999999999999999994
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.1e-16 Score=179.37 Aligned_cols=142 Identities=24% Similarity=0.232 Sum_probs=111.6
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEE
Q 002908 582 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~ 661 (867)
|...+.||+|+||+||+|.+.+..+++|+..................++.+|+.++..++|++++..+.++.... ..+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCE
Confidence 455788999999999999998888777765433222111122233456889999999999999888776665533 568
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
+||||+++++|.+++. ....++.+++.+|.+||+.|++||||||+|||++ ++ .++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~----~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD----RLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC----cEEEEeCccccc
Confidence 9999999999998774 3567899999999999999999999999999994 33 359999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.7e-16 Score=178.11 Aligned_cols=209 Identities=34% Similarity=0.553 Sum_probs=163.7
Q ss_pred HHhCCCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCe-eccCCCCc
Q 002908 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI-VHFDLKCD 715 (867)
Q Consensus 637 Lk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GI-IHrDLKPs 715 (867)
|+.+.|.|+.+++|.+.+++ ..++|.+||..|+|.+.+......+++.-...++++|+.||.|||...| .|+.|++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--EMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCC--ceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 35688999999999999875 8899999999999999998878889999999999999999999998766 99999999
Q ss_pred ceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccC--CC---CCChhhHHHHHHHHHHHHHhC
Q 002908 716 NLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGS--SS---KVSEKVDVFSFGIVLWEILTG 787 (867)
Q Consensus 716 NILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~--~~---~~S~kSDVWSLGvLLyELLTG 787 (867)
|.+++ ..+.+||+|||+....... .......-..-|.|||.+.+. .. ..+.+.|+||||++++|+++.
T Consensus 79 nClvd----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 79 NCLVD----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred cceee----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999 5567899999998866431 111112234569999999753 11 157789999999999999999
Q ss_pred CCCCCCCCh----hHHHHhHhhcC---CCCCCCC--CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 788 EEPYANMHY----GAIIGGIVNNT---LRPPVPG--FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 788 k~PF~~~~~----~e~l~~iv~~~---lr~~ip~--~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
..||..... .+.+..+.... .++.... ..++.+..++..||..+|.+||++..+-..+..+...
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999976322 23444433312 2333321 3456799999999999999999999998888776553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=160.48 Aligned_cols=149 Identities=19% Similarity=0.137 Sum_probs=110.0
Q ss_pred CeeEEEEeeecCcEEEEEEE-E--CCceEEEEEeeccccCCCC----------------hHHHHHHHHHHHHHHHHHhCC
Q 002908 581 DLEELKELGSGTFGTVYHGK-W--RGTDVAIKRIKKSCFTGRS----------------SEQERLTLEFWREAEILSKLH 641 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~-~--~G~~VAVKv~k~~~~sd~~----------------~~~e~~~~eflrEieiLk~L~ 641 (867)
-|.+.+.||+|++|.||+|. . +|+.||||+++........ .........+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788899999999999998 3 6899999999864321100 011112234668999999997
Q ss_pred CC--ceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCCcceE
Q 002908 642 HP--NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN-IVHFDLKCDNLL 718 (867)
Q Consensus 642 HP--NIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~G-IIHrDLKPsNIL 718 (867)
+. .+.+++++ . ..++||||+.+.+|...... ...+....+..++.|++.+|.+||..| |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe---c---CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 53 34444442 1 34799999998888765422 234566677889999999999999999 999999999999
Q ss_pred eccCCCCCCcEEEeecCCccccc
Q 002908 719 VNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 719 Ld~dg~~~~~vKL~DFGLA~~~~ 741 (867)
++ ++ .++|+|||.+....
T Consensus 182 i~-~~----~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DG----KVVIIDVSQSVELD 199 (237)
T ss_pred EE-CC----CEEEEEChhhhccC
Confidence 98 43 35999999987443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.7e-15 Score=151.22 Aligned_cols=142 Identities=19% Similarity=0.064 Sum_probs=104.8
Q ss_pred eeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCCh-H-------------HHHHHHHHHHHHHHHHhCCCCc--
Q 002908 582 LEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSS-E-------------QERLTLEFWREAEILSKLHHPN-- 644 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~-~-------------~e~~~~eflrEieiLk~L~HPN-- 644 (867)
|.+.+.||.|+||.||++.+ +|+.||||++.......... . .......+.+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66778899999999999988 58999999987532110000 0 0011223667888999988774
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~ 724 (867)
++.+++. ...++||||++|++|...... .....++.+++.++.++|+.||+||||+|+||+++.++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~- 162 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE- 162 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-
Confidence 4444432 145899999999988765421 34567888999999999999999999999999998654
Q ss_pred CCCcEEEeecCCcccc
Q 002908 725 IRPICKVGDFGLSKIK 740 (867)
Q Consensus 725 ~~~~vKL~DFGLA~~~ 740 (867)
.++|+|||++...
T Consensus 163 ---~~~liDfg~~~~~ 175 (198)
T cd05144 163 ---KIYIIDWPQMVST 175 (198)
T ss_pred ---cEEEEECCccccC
Confidence 4599999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.2e-16 Score=174.42 Aligned_cols=171 Identities=27% Similarity=0.377 Sum_probs=127.1
Q ss_pred CeEEEEEEeecCCchhhhhhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 658 GTLATVTEFMVNGSLRHVLLSK--ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~--~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
.+++|.|++|...+|.+|+... ....++...+.++.|++.++.| +|.+|+|+||.||++..++.. ||+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~----kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQL----KIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhh----hhhhhh
Confidence 3689999999999999999533 3457888889999999999999 999999999999999877654 999999
Q ss_pred CcccccCcc-------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH-HHhHhhcC
Q 002908 736 LSKIKRNTL-------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGGIVNNT 807 (867)
Q Consensus 736 LA~~~~~~~-------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~-l~~iv~~~ 807 (867)
+........ ......||..||+||.+. +..|+.++||||||++|+||+. +|........ ...+.++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~--g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ 476 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR--GQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGI 476 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHh--hhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCC
Confidence 987543332 233456999999999999 5568999999999999999997 2222111111 12222222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~EL 841 (867)
+.+..... .+.-..|+.++|.+.|.+||++.+.
T Consensus 477 ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 477 IPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred CChHHhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence 22122222 2345689999999999999955443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=8e-14 Score=147.25 Aligned_cols=144 Identities=15% Similarity=0.145 Sum_probs=105.3
Q ss_pred EEee-ecCcEEEEEEEECCceEEEEEeecccc-----CCCChHHHHHHHHHHHHHHHHHhCCCCce--eeEecccccCCC
Q 002908 586 KELG-SGTFGTVYHGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTLEFWREAEILSKLHHPNV--VAFYGVVQDGPG 657 (867)
Q Consensus 586 k~LG-~GafG~VYka~~~G~~VAVKv~k~~~~-----sd~~~~~e~~~~eflrEieiLk~L~HPNI--VrL~g~~~~~~~ 657 (867)
..|| .|+.|+||.+...+..++||.+..... .+..........++.+|+.++..|.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 3577 889999999988899999999965321 11111111223567889999999998875 667766443221
Q ss_pred --CeEEEEEEeecC-CchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 658 --GTLATVTEFMVN-GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 658 --~~l~LVmEy~~g-gSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
...++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+.||+|+||||.|||++.++ .++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~----~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG----KFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC----CEEEEEC
Confidence 123599999987 588877643 334543 356899999999999999999999999998765 4699999
Q ss_pred CCccc
Q 002908 735 GLSKI 739 (867)
Q Consensus 735 GLA~~ 739 (867)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=8e-14 Score=138.80 Aligned_cols=143 Identities=20% Similarity=0.090 Sum_probs=94.7
Q ss_pred EEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHH----------------HHHHHHHHHHHHHHhCCCCc--e
Q 002908 585 LKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQE----------------RLTLEFWREAEILSKLHHPN--V 645 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e----------------~~~~eflrEieiLk~L~HPN--I 645 (867)
.+.||+|+||+||+|.+. ++.||||+++............ ........|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999885 8899999987643221110000 00001124555666654432 4
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCC
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~ 724 (867)
.+++++. ..++||||++++.+......... .. ..+..++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 82 ~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~- 151 (187)
T cd05119 82 PKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG- 151 (187)
T ss_pred CceEecC------CCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-
Confidence 4444321 35899999988543321111100 11 5678899999999999999 9999999999999999 44
Q ss_pred CCCcEEEeecCCcccc
Q 002908 725 IRPICKVGDFGLSKIK 740 (867)
Q Consensus 725 ~~~~vKL~DFGLA~~~ 740 (867)
.++|+|||.+...
T Consensus 152 ---~~~liDfg~a~~~ 164 (187)
T cd05119 152 ---KVYIIDVPQAVEI 164 (187)
T ss_pred ---cEEEEECcccccc
Confidence 3599999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-13 Score=128.56 Aligned_cols=132 Identities=23% Similarity=0.166 Sum_probs=107.2
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC--CceeeEecccccCCCCeEE
Q 002908 584 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--PNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H--PNIVrL~g~~~~~~~~~l~ 661 (867)
+++.||.|.++.||++...+..++||.+..... ...+.+|+.++..+.| .++++++.++... +..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESD--GWSY 69 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccE
Confidence 356799999999999999888899999864321 2457788899999976 5888888887764 4789
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK---NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~---GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
++|||+.+..+..+ +......++.+++.+|++||.. +++|+||+|.|||++..+ .++++|||.+.
T Consensus 70 ~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~----~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK----ILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc----EEEEEeccccc
Confidence 99999988777653 4556677889999999999984 799999999999998633 46999999876
Q ss_pred c
Q 002908 739 I 739 (867)
Q Consensus 739 ~ 739 (867)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 3
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.2e-14 Score=169.67 Aligned_cols=259 Identities=24% Similarity=0.260 Sum_probs=191.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 654 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~ 654 (867)
...|.+.+.||+|+|+.|-..... ...+|+|.+.... ...........|..+-+.+. |+|++.+++....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC------CccchhhhcCccccccccccccccccccCCccCC
Confidence 455777778999999999876552 2336666654432 11122233445677777776 9999999999888
Q ss_pred CCCCeEEEEEEeecCCchhhhh-hcccccCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 655 GPGGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L-~~~~~~Lse~~~l~Ia~QIa~ALayLH-s~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.. ..+++++|..++++.... .......+......++.|+..++.|+| ..++.|+|+||+|.+++..+. ..++.
T Consensus 93 ~~--~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~---~l~~~ 167 (601)
T KOG0590|consen 93 PR--SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS---ALKIA 167 (601)
T ss_pred Cc--ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC---cccCC
Confidence 65 888999999999999888 433335677778889999999999999 999999999999999998872 34999
Q ss_pred ecCCcccccC----ccccCCcCC-CCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH-HhHhhc
Q 002908 733 DFGLSKIKRN----TLVTGGVRG-TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVNN 806 (867)
Q Consensus 733 DFGLA~~~~~----~~~~s~~~G-T~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l-~~iv~~ 806 (867)
|||+|..+.. .......+| ++.|+|||...+. .......|+||.|+++.-+++|..||......... ......
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~ 246 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN 246 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccccceeeccc
Confidence 9999986544 223334568 9999999999853 33467899999999999999999999765433221 111111
Q ss_pred C--CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 807 T--LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 807 ~--lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
. ..............+++.+++..+|..|.+.+++...-+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1 123344567788999999999999999999998866554433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-11 Score=143.15 Aligned_cols=251 Identities=24% Similarity=0.202 Sum_probs=182.8
Q ss_pred ccCCeeEEEEeee--cCcEEEEEEEE----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEec
Q 002908 578 KNEDLEELKELGS--GTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYG 650 (867)
Q Consensus 578 ~~sdyqilk~LG~--GafG~VYka~~----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g 650 (867)
....+.+.+.+|. |.+|.||.+.. .+..+|+|.-+......... ..-++|+...+.+ .|+|.++.+.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~------~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS------KRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc------ccccchhhcccccCccccccccCc
Confidence 3445667788999 99999998776 36678998744322211111 1223455555555 4899999888
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHH----HHHHHHHCCeeccCCCCcceEeccCCCCC
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIR 726 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~----ALayLHs~GIIHrDLKPsNILLd~dg~~~ 726 (867)
.+.... .+++-+|++ +.+|..+.+.....++...++..+.++.. ||.++|...++|-|+||.||+...++
T Consensus 186 ~~e~~~--~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--- 259 (524)
T KOG0601|consen 186 AWEGSG--ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--- 259 (524)
T ss_pred ccccCC--cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc---
Confidence 888754 889899988 78998888877777899999999999999 99999999999999999999999774
Q ss_pred CcEEEeecCCcccccCccccCC------cCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 002908 727 PICKVGDFGLSKIKRNTLVTGG------VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII 800 (867)
Q Consensus 727 ~~vKL~DFGLA~~~~~~~~~s~------~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l 800 (867)
..++++|||+............ ..|...|++||...+ -++...|+|+||.++.+..++..++....... +
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W 335 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSS-W 335 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCC-c
Confidence 3469999999986554432221 147788999999984 36788999999999999998876654331111 1
Q ss_pred HhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 801 GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 801 ~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
..+.......+.....+..+...+.+|++.+|..|++++.++.+
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11111112233334456667779999999999999999887543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.6e-11 Score=136.23 Aligned_cols=148 Identities=22% Similarity=0.204 Sum_probs=97.0
Q ss_pred EEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCC--------------------------hHHHHH------HHHHHH
Q 002908 586 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS--------------------------SEQERL------TLEFWR 632 (867)
Q Consensus 586 k~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~--------------------------~~~e~~------~~eflr 632 (867)
+.||.|++|.||+|+. +|+.||||+.+......-. ...+.+ ...|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4699999999999998 6899999998754211000 000000 113556
Q ss_pred HHHHHHhCC----CCceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHH-HHHHHHHCCe
Q 002908 633 EAEILSKLH----HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF-GMEYLHSKNI 707 (867)
Q Consensus 633 EieiLk~L~----HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~-ALayLHs~GI 707 (867)
|+..+.++. |.+-+.+-.++.+- ....+|||||++|.+|.+.......... ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666653 32223332222221 1246899999999999887643222222 3446666665 5788999999
Q ss_pred eccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 708 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 708 IHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
+|+|++|.||+++.++. ++|+|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~----i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK----IIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCc----EEEEeCCCeeECC
Confidence 99999999999987664 5999999997554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.3e-11 Score=115.18 Aligned_cols=127 Identities=17% Similarity=0.106 Sum_probs=92.7
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce-eeEecccccCCCCeEEEE
Q 002908 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI-VrL~g~~~~~~~~~l~LV 663 (867)
++.|+.|.++.||+++..+..++||+....... ...+..|+.+++.+.+.++ .+++.+... ..++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---------~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---------LINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc---------ccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEE
Confidence 456899999999999999999999997543210 1234568888888765443 345544332 34789
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCe-----eccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI-----VHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GI-----IHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
|||++|.++.... . ....++.+++.+|+.||..++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 70 ~e~i~G~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~----~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG----RLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC----eEEEEeccccc
Confidence 9999998876431 1 112356789999999999885 9999999999998 33 35899999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.2e-10 Score=114.32 Aligned_cols=153 Identities=21% Similarity=0.202 Sum_probs=110.7
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEE
Q 002908 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 664 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVm 664 (867)
+..|-+|+-+.|+++.+.|+...||.-....+....-+......+..+|++.|.++.--.|.-..=++.+.. .-.|+|
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~i~M 89 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQIYM 89 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCeEEE
Confidence 456889999999999999999888866555454444445556677889999999886333322222233322 336799
Q ss_pred EeecC-CchhhhhhcccccCCHHH-HHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 665 EFMVN-GSLRHVLLSKERHLDRRK-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 665 Ey~~g-gSL~d~L~~~~~~Lse~~-~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
||++| .++.+++......-..+. ...++..|-+.+.-||.++|||+||..+||++..+++. ..+.|+|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~-~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQ-ITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCc-CceEEEeecchhcc
Confidence 99977 366677654433333333 36788999999999999999999999999999988754 45689999998654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=2e-10 Score=134.40 Aligned_cols=151 Identities=20% Similarity=0.236 Sum_probs=92.8
Q ss_pred eeEEEEeeecCcEEEEEEEE-C-CceEEEEEeeccccC---------------------CC--C---hHHHHHH------
Q 002908 582 LEELKELGSGTFGTVYHGKW-R-GTDVAIKRIKKSCFT---------------------GR--S---SEQERLT------ 627 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~-~-G~~VAVKv~k~~~~s---------------------d~--~---~~~e~~~------ 627 (867)
|.. +.||.|++|.||+|+. . |+.||||+.++.... .. . ..-+.+.
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 444 5799999999999998 3 899999999754210 00 0 0001111
Q ss_pred HHHHHHHHHHHhCC----CCceeeEecccccCCCCeEEEEEEeecCCchhhhh--hcccc---cCCHHHHHHHHHHHHHH
Q 002908 628 LEFWREAEILSKLH----HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKER---HLDRRKRLIIAMDAAFG 698 (867)
Q Consensus 628 ~eflrEieiLk~L~----HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L--~~~~~---~Lse~~~l~Ia~QIa~A 698 (867)
..|.+|+..+.++. +.+.+.+-.++.+- ....+|||||+.|+.+.+.. ...+. .+....+..++.
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~----- 274 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT----- 274 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH-----
Confidence 22445555555442 33323322222211 12568999999999997642 21111 122222333333
Q ss_pred HHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 699 LayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
.+...|++|+|+||.||+++.+|...+.++++|||++....
T Consensus 275 --Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 --QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34568999999999999999887556678999999987543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.7e-10 Score=113.61 Aligned_cols=139 Identities=21% Similarity=0.199 Sum_probs=103.1
Q ss_pred EeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEEe
Q 002908 587 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 666 (867)
Q Consensus 587 ~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmEy 666 (867)
.+++|+-+.||.+.|.|.++.+|.-.........-+......+-.+|+.+|.++.--.|...+=+..+.+ ...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~--~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--NGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCEEEEEE
Confidence 4789999999999998888888876655555443333444556778999999886433322222233333 55789999
Q ss_pred ecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 667 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 667 ~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
++|..|.+.+... ...++..+-.-+.-||..||||+||.++||++..++ +.++|||++...
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-----i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-----IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-----EEEEECCccccc
Confidence 9988888888543 245677888889999999999999999999998554 489999998743
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.9e-09 Score=110.29 Aligned_cols=144 Identities=19% Similarity=0.128 Sum_probs=97.3
Q ss_pred EEeeecCcEEEEEEEEC--------CceEEEEEeeccccC--CC------C----------hHHHHHHHHHHHHHHHHHh
Q 002908 586 KELGSGTFGTVYHGKWR--------GTDVAIKRIKKSCFT--GR------S----------SEQERLTLEFWREAEILSK 639 (867)
Q Consensus 586 k~LG~GafG~VYka~~~--------G~~VAVKv~k~~~~s--d~------~----------~~~e~~~~eflrEieiLk~ 639 (867)
..||.|--+.||.|... +..+|||+++..... .. . ........-..+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 36899999999999754 368999999854321 00 0 0011111223379999998
Q ss_pred CCC--CceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHH-HHCCeeccCCCCcc
Q 002908 640 LHH--PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL-HSKNIVHFDLKCDN 716 (867)
Q Consensus 640 L~H--PNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayL-Hs~GIIHrDLKPsN 716 (867)
+.. -++..++++ . ..+|||||+.+..+..... ....++......+..+++.+|..| |..||||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~L-kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKL-KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhh-hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 853 355566654 2 3478999996543322111 122345566677889999999999 89999999999999
Q ss_pred eEeccCCCCCCcEEEeecCCccccc
Q 002908 717 LLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 717 ILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
||+.. + .+.|+|||.+....
T Consensus 156 IL~~~-~----~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD-G----KVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC-C----cEEEEECCCceeCC
Confidence 99973 2 35899999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.6e-08 Score=118.54 Aligned_cols=162 Identities=23% Similarity=0.295 Sum_probs=118.2
Q ss_pred CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccc
Q 002908 602 RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER 681 (867)
Q Consensus 602 ~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~ 681 (867)
.+.+|.|..++...- .......+-++-|+.++||||++++..+.... .+|||+|.+ ..|..++..
T Consensus 36 ~~~~vsVF~~~~~~~--------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV--~Pl~~~lk~--- 100 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERV--RPLETVLKE--- 100 (690)
T ss_pred cCCceEEEEEeCCCc--------hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeecc--ccHHHHHHH---
Confidence 477888888875421 11223445677899999999999999998854 999999988 455555533
Q ss_pred cCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccc-cCCcCCCCCccCcc
Q 002908 682 HLDRRKRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV-TGGVRGTLPWMAPE 759 (867)
Q Consensus 682 ~Lse~~~l~Ia~QIa~ALayLH-s~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~-~s~~~GT~~Y~APE 759 (867)
+....+...+.||+.||.||| +.+++|++|.-..|+++..|.. ||++|.++........ .....--..|..|+
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeW----kLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEW----KLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcE----EEeeeEEEeccccCCcccccchhhhcccChh
Confidence 335666777889999999998 5679999999999999988876 9999998764332211 11111223467777
Q ss_pred ccccCCCCCChhhHHHHHHHHHHHHHhC
Q 002908 760 LLNGSSSKVSEKVDVFSFGIVLWEILTG 787 (867)
Q Consensus 760 vl~g~~~~~S~kSDVWSLGvLLyELLTG 787 (867)
.+.. .. ...|.|.|||++++++.|
T Consensus 176 ~~~~--s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDP--SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCc--cc--cchhhhhHHHHHHHHhCc
Confidence 6652 11 457999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.8e-10 Score=128.43 Aligned_cols=258 Identities=21% Similarity=0.176 Sum_probs=177.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGV 651 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~ 651 (867)
.....+|.++..||.|.|+.|+....+ +..+++|.......... ++ ..-+.|+.+...+ .|.+++..+..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~---~d---i~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA---SD---IFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH---hh---hcchhhhhHhhHhhcccccCCCCCC
Confidence 344568899999999999999987653 55688887765433211 11 1223556566655 48888887776
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
|..-. ..++--|||+++++.... .....+++..++++..|++.++.++|+..++|+|+||.||++..+| +..++
T Consensus 335 W~~~r--~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~---~~~~~ 408 (524)
T KOG0601|consen 335 WSQLR--QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG---FFSKL 408 (524)
T ss_pred ccccc--cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch---hhhhc
Confidence 66533 566889999999887665 2335578888899999999999999999999999999999998765 45699
Q ss_pred eecCCcccccCccccCCcCCCCCcc-CccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~-APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
+|||.+....- .......+-++. .+|++.. .+.+..+.|+++||..+.+.+++...-..... +..+..+ . .
T Consensus 409 ~~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e-~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~-~-~ 480 (524)
T KOG0601|consen 409 GDFGCWTRLAF--SSGVFHHIDRLYPIAEILLE-DYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSG-D-T 480 (524)
T ss_pred cccccccccce--ecccccccccccccchhhcc-ccccccccccccccccccccccCcccCccccc---ceeeecc-c-c
Confidence 99999863111 111122334444 2444442 56678899999999999999998754222111 1111111 1 1
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+........+..+.+.++.+++..||.+.++..+..-....|.
T Consensus 481 p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~~~ 523 (524)
T KOG0601|consen 481 PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDSRP 523 (524)
T ss_pred cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhccC
Confidence 2222233778888999999999999999999888777666553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.7e-08 Score=102.05 Aligned_cols=143 Identities=24% Similarity=0.268 Sum_probs=102.6
Q ss_pred EEeeecCcEEEEEEEECC-ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC--ceeeEecccccCC-CCeEE
Q 002908 586 KELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQDGP-GGTLA 661 (867)
Q Consensus 586 k~LG~GafG~VYka~~~G-~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP--NIVrL~g~~~~~~-~~~l~ 661 (867)
+.|+.|.++.||+++..+ ..++||+....... .....+.+|..+++.+.+. ++.+++.+..... .+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 568999999999998865 88999987543211 0123567888999998753 4566776665422 13568
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS------------------------------------- 704 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs------------------------------------- 704 (867)
+||||++|.++...+.. ..++......++.+++.+|.+||+
T Consensus 77 ~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 77 YVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 99999999888775521 346677777778888888888873
Q ss_pred -------------------CCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 705 -------------------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 705 -------------------~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
..+||+|+.+.||+++.++ ...+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~--~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE--PRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC--CcEEEEEecccccc
Confidence 2369999999999998641 12358999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.1e-09 Score=119.30 Aligned_cols=199 Identities=21% Similarity=0.260 Sum_probs=133.3
Q ss_pred HHHhCCCCceeeEecccccCC---CCeEEEEEEeecCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHC--Ce
Q 002908 636 ILSKLHHPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSK--NI 707 (867)
Q Consensus 636 iLk~L~HPNIVrL~g~~~~~~---~~~l~LVmEy~~ggSL~d~L~~~---~~~Lse~~~l~Ia~QIa~ALayLHs~--GI 707 (867)
-|-++-|-|||+++.|+.+.. .....++.|||..|++..+|... ...+......+|+-||+.||.|||+. .|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 345567999999999987532 23577899999999999999643 35677888889999999999999986 59
Q ss_pred eccCCCCcceEeccCCCCCCcEEEeecCCcccc------cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHH
Q 002908 708 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK------RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVL 781 (867)
Q Consensus 708 IHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~------~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLL 781 (867)
+|+++...-|++..+|- +|++ .+.-... .....+....+-++|.+||.-. ....+-++|||+||...
T Consensus 200 ihgnlTc~tifiq~ngL----Ikig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGL----IKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT--TTNTTGASDIYKFGMCA 272 (458)
T ss_pred ccCCcchhheeecCCce----EEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCc--ccccccchhhhhhhHHH
Confidence 99999999999996552 2432 1111110 0111112233668899999754 33456689999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 782 WEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 782 yELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
++|..+..--.............. .........--+.++.+|++..|..||++++++-+.
T Consensus 273 lemailEiq~tnseS~~~~ee~ia----~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEENIA----NVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHHHheeccCCCcceeehhhhhh----hheeeccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 999887654222111111100000 000011112234588999999999999999987764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.3e-09 Score=132.00 Aligned_cols=248 Identities=23% Similarity=0.252 Sum_probs=170.4
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..+.+.+.+-+-.|+++.++.+.-. |.-.++|+......-... . .....++-.++-...+|-++...--+...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-~----~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-D----YESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccc-c----ccccCCccCccccCCCCceecccCCCCCC
Confidence 4456667777889999998876543 323444443322111000 0 01112222233333456666555443333
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
+ ..+|||+|..+++|...++..+ ..+.......+..+..++.|||...+.|+|++|.|+|+..++.. ++.|||
T Consensus 877 s--P~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~----~l~~~~ 949 (1205)
T KOG0606|consen 877 S--PLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHR----PLTDFG 949 (1205)
T ss_pred C--CcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCc----ccCccc
Confidence 3 6899999999999998887555 45555556666788889999999999999999999999988876 888987
Q ss_pred Cccccc-------C-------------------------ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHH
Q 002908 736 LSKIKR-------N-------------------------TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWE 783 (867)
Q Consensus 736 LA~~~~-------~-------------------------~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyE 783 (867)
...... . ........+|+.|.+||...+ ......+|+|++|+++++
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhh
Confidence 432100 0 011223458999999999984 445678999999999999
Q ss_pred HHhCCCCCCCCChhHHHHhHhhcCCCCC-CCCCCcHHHHHHHHHhhcCCCCCCCCHH
Q 002908 784 ILTGEEPYANMHYGAIIGGIVNNTLRPP-VPGFCDSEWRLLMEQCWAPDPVVRPSFT 839 (867)
Q Consensus 784 LLTGk~PF~~~~~~e~l~~iv~~~lr~~-ip~~~s~eL~dLI~kCLq~DPeeRPSa~ 839 (867)
.++|..||...........+.......+ -+...+....+++...+..+|.+|-.+.
T Consensus 1028 ~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999998888777777665554333 3456788899999999999999997664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-07 Score=102.43 Aligned_cols=145 Identities=17% Similarity=0.086 Sum_probs=96.0
Q ss_pred EEEEEEEECCceEEEEEeeccccCCC-ChH--HHHHHHHHHHHHHHHHhCCCCce--eeEecccccCC---CCeEEEEEE
Q 002908 594 GTVYHGKWRGTDVAIKRIKKSCFTGR-SSE--QERLTLEFWREAEILSKLHHPNV--VAFYGVVQDGP---GGTLATVTE 665 (867)
Q Consensus 594 G~VYka~~~G~~VAVKv~k~~~~sd~-~~~--~e~~~~eflrEieiLk~L~HPNI--VrL~g~~~~~~---~~~l~LVmE 665 (867)
..|+++.+.|+.+.||.+........ ... ...-...+.+|...+.+|...+| +.++++..... ....+||||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 34667888889999998754321100 000 00001136688888887743332 23333433211 235689999
Q ss_pred eecCC-chhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccC---CCCCCcEEEeecCCcc
Q 002908 666 FMVNG-SLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK---DPIRPICKVGDFGLSK 738 (867)
Q Consensus 666 y~~gg-SL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~d---g~~~~~vKL~DFGLA~ 738 (867)
++++. +|.+++... ....+......++.+++..+..||..||+|+||++.|||++.+ +.....+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99876 788876422 2345667778899999999999999999999999999999852 2234568999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.3e-07 Score=97.45 Aligned_cols=132 Identities=24% Similarity=0.163 Sum_probs=81.0
Q ss_pred EEEEEE-CCceEEEEEeeccccCC-----------C-------ChHHHHHHHHHHHHHHHHHhCCCC--ceeeEeccccc
Q 002908 596 VYHGKW-RGTDVAIKRIKKSCFTG-----------R-------SSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQD 654 (867)
Q Consensus 596 VYka~~-~G~~VAVKv~k~~~~sd-----------~-------~~~~e~~~~eflrEieiLk~L~HP--NIVrL~g~~~~ 654 (867)
||.|.. .|..+|||+++.....- + ............+|.+.|.++..- ++.+++.+-
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 888887 68899999998632210 0 111222334566899999999765 456666542
Q ss_pred CCCCeEEEEEEeec--CCchhhhhhcccccCCHHHHHHHHHHHHHHHHH-HHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 655 GPGGTLATVTEFMV--NGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY-LHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 655 ~~~~~l~LVmEy~~--ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALay-LHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
..+|||||+. |..+..+... . ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-----~~~i 147 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-----KVYI 147 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-----CEEE
T ss_pred ----CCEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-----eEEE
Confidence 2378999998 5555443321 1 1133455677788875555 579999999999999999865 3589
Q ss_pred eecCCccccc
Q 002908 732 GDFGLSKIKR 741 (867)
Q Consensus 732 ~DFGLA~~~~ 741 (867)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.7e-07 Score=101.29 Aligned_cols=252 Identities=18% Similarity=0.206 Sum_probs=158.0
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceee----EecccccCCCC-
Q 002908 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVA----FYGVVQDGPGG- 658 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVr----L~g~~~~~~~~- 658 (867)
.+.||+|+.+.+|-.--- ...+-|++..... .... +-+..|... .||-+-. -......+..+
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~VAKIYh~Ppp-----a~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQVAKIYHAPPP-----AAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CccccCCccceeeecchh-hchhheeecCCCc-----hHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 446999999999953221 2234577754321 1111 112233333 4653322 22222233332
Q ss_pred eEEEEEEeecCCchhhhhhc------ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 659 TLATVTEFMVNGSLRHVLLS------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~------~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
...++|..+.+.---..++. ......|.-+++.++.++.+.+-||..|.+-+|+.++|+|+++++.+ .|.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V----~LV 159 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKV----VLV 159 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceE----EEE
Confidence 37889988877632222221 12457899999999999999999999999999999999999987754 677
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccc-cC--CCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCh--------h-HH
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLN-GS--SSKVSEKVDVFSFGIVLWEILTG-EEPYANMHY--------G-AI 799 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~-g~--~~~~S~kSDVWSLGvLLyELLTG-k~PF~~~~~--------~-e~ 799 (867)
|-..--+..+........|...|++||.-. +. +...+...|.|.||+++++++.| ++||.+... + .+
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 654333333333333455889999999864 11 22345679999999999999885 999976321 1 11
Q ss_pred HH------hHhhcCCCCC----CCCCCcHHHHHHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHh
Q 002908 800 IG------GIVNNTLRPP----VPGFCDSEWRLLMEQCWAPD--PVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 800 l~------~iv~~~lr~~----ip~~~s~eL~dLI~kCLq~D--PeeRPSa~ELLe~Lq~l~~a~ 852 (867)
.. ......+.++ ....+++.+..+..+|+... +.-|||++.++..|..+....
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00 0011111111 11346888999999999764 457999999999888876543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.3e-06 Score=100.58 Aligned_cols=217 Identities=17% Similarity=0.142 Sum_probs=150.1
Q ss_pred CcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC--CCCeEEEEEEee
Q 002908 592 TFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG--PGGTLATVTEFM 667 (867)
Q Consensus 592 afG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~--~~~~l~LVmEy~ 667 (867)
-..+.|++.. +|..+++|++.+.... .. .....-+++++++.|+|+|++..+|... .+..+++|++|+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--ST------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--Cc------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 3456788876 5888999999432211 11 0111235689999999999999988732 234789999999
Q ss_pred cCC-chhhhhhc--------------ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 668 VNG-SLRHVLLS--------------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 668 ~gg-SL~d~L~~--------------~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
++. +|.+..+. .+...++..+|.++.|+..||.++|+.|+..+-|.+.+||++.+ ..++|+
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~----~RIriS 435 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK----MRIRIS 435 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc----ceEEEe
Confidence 864 66555432 12346789999999999999999999999999999999999833 356888
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC-CCCCChhHHHHhHhhcCCCCC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~P-F~~~~~~e~l~~iv~~~lr~~ 811 (867)
..|...+...... +-+.+ -.+-|.-.||.+++.|.||..- +............
T Consensus 436 ~C~i~Dvl~~d~~-------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------- 489 (655)
T KOG3741|consen 436 GCGIMDVLQEDPT-------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------- 489 (655)
T ss_pred cccceeeecCCCC-------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------
Confidence 8887765443320 11221 2357999999999999998643 2221111111111
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+...++.++++++......++++ -++.+++.++-.
T Consensus 490 I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~ 524 (655)
T KOG3741|consen 490 ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS 524 (655)
T ss_pred hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence 23456888999999999998887 778887766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.4e-07 Score=93.87 Aligned_cols=110 Identities=24% Similarity=0.163 Sum_probs=81.1
Q ss_pred HHHHHHHHHHHhCCCCc--eeeEecccccCC--CCeEEEEEEeecCC-chhhhhhcccccCCHHHHHHHHHHHHHHHHHH
Q 002908 628 LEFWREAEILSKLHHPN--VVAFYGVVQDGP--GGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702 (867)
Q Consensus 628 ~eflrEieiLk~L~HPN--IVrL~g~~~~~~--~~~l~LVmEy~~gg-SL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayL 702 (867)
.+..+|...+..|.... +...+++..... ....+||+|++++. +|.+++..... ++......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 35667777777764322 344444444321 23458999999875 78887754222 66677888999999999999
Q ss_pred HHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 703 Hs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
|..||+|+|+++.|||++.++ ....+.|+||+.+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCC-CceeEEEEcchhcee
Confidence 999999999999999999876 345679999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=4e-06 Score=88.11 Aligned_cols=144 Identities=17% Similarity=0.102 Sum_probs=101.1
Q ss_pred eecCcEEEEEEEECCceEEEEEeeccccCC-CChHHHHHHHHHHHHHHHHHhCCCCc--eeeEecccc---cCCCCeEEE
Q 002908 589 GSGTFGTVYHGKWRGTDVAIKRIKKSCFTG-RSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQ---DGPGGTLAT 662 (867)
Q Consensus 589 G~GafG~VYka~~~G~~VAVKv~k~~~~sd-~~~~~e~~~~eflrEieiLk~L~HPN--IVrL~g~~~---~~~~~~l~L 662 (867)
|.||-+-|+.....|..+-||.-....... ..+. -...|.+|...|.+|..-+ +.++. ++. .+.....+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~---g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPF---GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCC---CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 568888889888888878888765222111 0011 1357889999998885322 33433 222 222335678
Q ss_pred EEEeecC-Cchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 663 VTEFMVN-GSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 663 VmEy~~g-gSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
|+|-+.+ .+|.+++.... .+.+......++.+++.+++-||+.|+.|+|+++.|||++.+|. ..+.|+||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~--~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGK--AEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCC--eeEEEEEhhccc
Confidence 9997754 47877774432 34577777899999999999999999999999999999986663 468999998765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.2e-06 Score=92.71 Aligned_cols=142 Identities=25% Similarity=0.114 Sum_probs=100.3
Q ss_pred eeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCC--------------ChHHHHHHHHHHHHHHHHHhCCCC--c
Q 002908 582 LEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGR--------------SSEQERLTLEFWREAEILSKLHHP--N 644 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~--------------~~~~e~~~~eflrEieiLk~L~HP--N 644 (867)
..+...||-|--+.||.|.. .|.++|||.-+...++-. .+..........+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35567899999999999998 599999997665432211 111122234456889999998654 5
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~ 724 (867)
+.+.+++ +..++|||+++|..|...-. +....-.++..|++-+..+-..||||+|+.+-||+++.+|.
T Consensus 173 VP~P~~~------nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW------NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc------ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 6666654 25689999998877765431 23333445555666666666899999999999999998876
Q ss_pred CCCcEEEeecCCccc
Q 002908 725 IRPICKVGDFGLSKI 739 (867)
Q Consensus 725 ~~~~vKL~DFGLA~~ 739 (867)
. .++||-.+..
T Consensus 241 ~----~vIDwPQ~v~ 251 (304)
T COG0478 241 I----VVIDWPQAVP 251 (304)
T ss_pred E----EEEeCccccc
Confidence 5 9999987753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.7e-05 Score=82.84 Aligned_cols=135 Identities=24% Similarity=0.231 Sum_probs=96.6
Q ss_pred CCeeEEEEeeecCc-EEEEEEEECCceEEEEEeeccccCCCCh------HH-------HHHHHHHHHHHHHHHhCC---C
Q 002908 580 EDLEELKELGSGTF-GTVYHGKWRGTDVAIKRIKKSCFTGRSS------EQ-------ERLTLEFWREAEILSKLH---H 642 (867)
Q Consensus 580 sdyqilk~LG~Gaf-G~VYka~~~G~~VAVKv~k~~~~sd~~~------~~-------e~~~~eflrEieiLk~L~---H 642 (867)
.+++.++.||.|.- |.||+++..|..+|||+++.-....... .. .....-|..|++...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78899999999999 9999999999999999954322111100 00 123446888999988885 4
Q ss_pred Cce--eeEecccccC----------------CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH
Q 002908 643 PNV--VAFYGVVQDG----------------PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 704 (867)
Q Consensus 643 PNI--VrL~g~~~~~----------------~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs 704 (867)
.++ |+++||+.-. ......||.||.+... .+.. .-+.+|.+-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHHH
Confidence 466 9999987311 1224578888875443 1222 234577778889999
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.||+-+|+++.|..= . +|+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~~-----G----~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYRG-----G----KLVDFSSS 206 (207)
T ss_pred CCeeeccCccccccC-----C----EEEecccC
Confidence 999999999999972 2 89999964
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=5.8e-07 Score=106.14 Aligned_cols=143 Identities=22% Similarity=0.289 Sum_probs=99.8
Q ss_pred HHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcccc----------CCcCCCCCccCccccc
Q 002908 694 DAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----------GGVRGTLPWMAPELLN 762 (867)
Q Consensus 694 QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~----------s~~~GT~~Y~APEvl~ 762 (867)
+++.||.|+|. .++||+.|.|++|.++..+.. ||+.|+++......... ........|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~w----kl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDW----KLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcce----eeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 45589999996 589999999999999977765 99999987643331110 0112345799999998
Q ss_pred cCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHH--HHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHH
Q 002908 763 GSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI--IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFT 839 (867)
Q Consensus 763 g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~--l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ 839 (867)
+ ...+.++|+|||||++|.+.. |+.-+........ ......+.........+++++++=+.+++..++..||++.
T Consensus 183 ~--~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 183 G--TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred c--ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence 4 556789999999999999884 5555543322111 1111111112233467889999999999999999999776
Q ss_pred HHH
Q 002908 840 EIA 842 (867)
Q Consensus 840 ELL 842 (867)
+++
T Consensus 261 ~l~ 263 (700)
T KOG2137|consen 261 LLL 263 (700)
T ss_pred hhh
Confidence 654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.5e-05 Score=90.52 Aligned_cols=146 Identities=19% Similarity=0.232 Sum_probs=92.3
Q ss_pred EEeeecCcEEEEEEEEC-CceEEEEEeeccccC--------------------CC---ChH---HHH------HHHHHHH
Q 002908 586 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFT--------------------GR---SSE---QER------LTLEFWR 632 (867)
Q Consensus 586 k~LG~GafG~VYka~~~-G~~VAVKv~k~~~~s--------------------d~---~~~---~e~------~~~eflr 632 (867)
..|+.++-|.||+|++. |+.||||+.+..... .. ... -+. ....+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 36899999999999996 999999998753211 00 000 011 1223445
Q ss_pred HHHHHHhCC-----CCc--eeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC
Q 002908 633 EAEILSKLH-----HPN--VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 705 (867)
Q Consensus 633 EieiLk~L~-----HPN--IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~ 705 (867)
|+.-+.+++ .++ |.++|.-+.. ...|+|||++|-.+.+........++...+.....++ .+..+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccC----CcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhc
Confidence 665555553 333 2333322222 4589999999999888754333445544433332222 23344458
Q ss_pred CeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 706 GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
|++|+|.+|.||+++.+|.. .+.|||+.....
T Consensus 285 gffHaDpHpGNi~v~~~g~i----~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRI----VLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEEecCCcE----EEEcCcceecCC
Confidence 99999999999999988654 899999986443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.1e-05 Score=94.78 Aligned_cols=149 Identities=16% Similarity=0.154 Sum_probs=96.8
Q ss_pred EEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChH------------------------HHH------HHHHHHHHH
Q 002908 586 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSE------------------------QER------LTLEFWREA 634 (867)
Q Consensus 586 k~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~------------------------~e~------~~~eflrEi 634 (867)
+.||..+.|.||+|+. .|..||||+-+...... -.. .++ ....|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~-~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKL-IMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHH-HHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 3589999999999998 58889999876532110 000 001 122344554
Q ss_pred HHHHhC----CCCc------eeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH
Q 002908 635 EILSKL----HHPN------VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 704 (867)
Q Consensus 635 eiLk~L----~HPN------IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs 704 (867)
+-..+. .|-+ |.++|..+.. ...|+||||+|..+.+.-.-....++...+..-+.++..-+ |=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHh
Confidence 443333 3544 4555554443 57899999999988776544445566665554444433222 224
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
.|++|+|-+|.||+++.+++....+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 6899999999999999776566678999999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00014 Score=77.02 Aligned_cols=146 Identities=16% Similarity=0.120 Sum_probs=96.6
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHH------HHHHHHHHhCC---CCc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEF------WREAEILSKLH---HPN 644 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~ef------lrEieiLk~L~---HPN 644 (867)
...+...+|.+.+++-......|.+-...|..+.+|..+... ...++....| .+++..+..+. ...
T Consensus 25 ~~~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~-----~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~ 99 (229)
T PF06176_consen 25 GEKILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREEN-----RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE 99 (229)
T ss_pred HHHHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhh-----hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence 345667889999999999999999888899999999886532 1222222222 22333333332 222
Q ss_pred eeeEecccccC---CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEecc
Q 002908 645 VVAFYGVVQDG---PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 721 (867)
Q Consensus 645 IVrL~g~~~~~---~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~ 721 (867)
+..++.+..-. -....++||||++|..|.+... +++ .++..+.+++.-||..|+.|+|..|.|++++.
T Consensus 100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN 170 (229)
T ss_pred cccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC
Confidence 22322221110 0124568999999988876531 222 24456778899999999999999999999985
Q ss_pred CCCCCCcEEEeecCCcc
Q 002908 722 KDPIRPICKVGDFGLSK 738 (867)
Q Consensus 722 dg~~~~~vKL~DFGLA~ 738 (867)
++ ++++||+..+
T Consensus 171 ~~-----i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-----IRIIDTQGKR 182 (229)
T ss_pred Cc-----EEEEECcccc
Confidence 54 4899998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00012 Score=77.26 Aligned_cols=72 Identities=19% Similarity=0.260 Sum_probs=48.6
Q ss_pred EEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc--eeeEecccccCCCCeEEEE
Q 002908 586 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 586 k~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN--IVrL~g~~~~~~~~~l~LV 663 (867)
..||+|..+.||+. .+..+++|+..... . .....+|.++++.+..-. +.+++++..... ..++|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-----~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-----D-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLI 72 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-----C-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeee
Confidence 46899999999983 36678889876421 0 123467888888775333 355666655533 57889
Q ss_pred EEeecCCc
Q 002908 664 TEFMVNGS 671 (867)
Q Consensus 664 mEy~~ggS 671 (867)
|++++|.+
T Consensus 73 ~e~i~G~~ 80 (226)
T TIGR02172 73 YELIVGKR 80 (226)
T ss_pred eeecCCcc
Confidence 99998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00018 Score=77.33 Aligned_cols=145 Identities=21% Similarity=0.162 Sum_probs=89.8
Q ss_pred EEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCC---------------hHHHHHHHH-HHHHHHHHHhCC--CCce
Q 002908 585 LKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS---------------SEQERLTLE-FWREAEILSKLH--HPNV 645 (867)
Q Consensus 585 lk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~---------------~~~e~~~~e-flrEieiLk~L~--HPNI 645 (867)
...|..|--+.||+|.. .+..+|||+++........ ......... ..+|..-|.++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34677888888999876 5889999999864321110 001111111 124666666653 3334
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchh-hhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCC
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKD 723 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~-d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg 723 (867)
.+.+++.. -.|||||+.....- -.| ..-.+.......+..++++.+.-|-. .++||+||..=|||+. ++
T Consensus 133 P~Pi~~~~------nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFRN------NVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeecC------CeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence 44444432 26899999433110 111 11223333566777888888888776 8999999999999998 33
Q ss_pred CCCCcEEEeecCCcccccC
Q 002908 724 PIRPICKVGDFGLSKIKRN 742 (867)
Q Consensus 724 ~~~~~vKL~DFGLA~~~~~ 742 (867)
. +.|+|||.|....+
T Consensus 204 ~----p~iID~~QaV~~~h 218 (268)
T COG1718 204 E----PYIIDVSQAVTIDH 218 (268)
T ss_pred e----EEEEECccccccCC
Confidence 3 48999999875543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0002 Score=72.51 Aligned_cols=80 Identities=18% Similarity=0.192 Sum_probs=54.9
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC--ceeeEecccccC-CCCeEE
Q 002908 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQDG-PGGTLA 661 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP--NIVrL~g~~~~~-~~~~l~ 661 (867)
++.|+.|..+.||+....+..+++|+.... .....+.+|..++..+... .+.+++.+.... .....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 467999999999999998789999997531 2234556778888777432 345666543222 233578
Q ss_pred EEEEeecCCchhh
Q 002908 662 TVTEFMVNGSLRH 674 (867)
Q Consensus 662 LVmEy~~ggSL~d 674 (867)
++|++++|..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999998887766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00012 Score=75.22 Aligned_cols=131 Identities=29% Similarity=0.359 Sum_probs=91.6
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCcee-eEecccccCCCCeE
Q 002908 582 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV-AFYGVVQDGPGGTL 660 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIV-rL~g~~~~~~~~~l 660 (867)
.+..+.||+|.+|.||+|.|+|..+|+|+-+.... ...+..|+++|..+.-.++. ++|.|-.+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----------r~~l~kEakiLeil~g~~~~p~vy~yg~~------ 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----------RRNLEKEAKILEILAGEGVTPEVYFYGED------ 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----------hhhHHHHHHHHHHhhhcCCCceEEEechh------
Confidence 45567899999999999999999999998765321 24577899999988765543 44444322
Q ss_pred EEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCC--cceEeccCCCCCCcEEEeecCCcc
Q 002908 661 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC--DNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKP--sNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
++.|||+.|..|....... +..+ +..+++..--|-..||-|+.|.- +||++... .+.|+||..|+
T Consensus 88 ~i~me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-----~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-----DVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCC-----cEEEEEccchh
Confidence 4569999888887665321 2222 33555665557778999999873 56666532 24899999988
Q ss_pred ccc
Q 002908 739 IKR 741 (867)
Q Consensus 739 ~~~ 741 (867)
+..
T Consensus 155 ~k~ 157 (201)
T COG2112 155 FKK 157 (201)
T ss_pred hcc
Confidence 543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00051 Score=71.67 Aligned_cols=139 Identities=20% Similarity=0.212 Sum_probs=93.8
Q ss_pred EEeeecCcEEEEEEEECCceEEEEEeeccccCCCChH--------HHHHHHHHHHHHHHHHhCC------CCceeeEecc
Q 002908 586 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSE--------QERLTLEFWREAEILSKLH------HPNVVAFYGV 651 (867)
Q Consensus 586 k~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~--------~e~~~~eflrEieiLk~L~------HPNIVrL~g~ 651 (867)
..||+|+.-.||.-- .....+||+............ ......++.+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 369999999999521 244578999876541100000 0011345566666666665 7889999999
Q ss_pred cccCCCCeEEEEEEeecCC------chhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 652 VQDGPGGTLATVTEFMVNG------SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~gg------SL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
..+.- -..+|+|.+.+. +|.+++.. ..++. . +...+-+-..||-+.+|+.+||+|+||++...+..
T Consensus 86 veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNL--GLGLVVELIRDADGNISPTLEDYLKE--GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCC--ceEEEEEEEECCCCCcCccHHHHHHc--CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 98854 678999987543 77777732 33554 3 33344455678889999999999999999887766
Q ss_pred CCcEEEee
Q 002908 726 RPICKVGD 733 (867)
Q Consensus 726 ~~~vKL~D 733 (867)
...+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 55667777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00049 Score=85.34 Aligned_cols=81 Identities=16% Similarity=0.237 Sum_probs=55.0
Q ss_pred EEEeeecCcEEEEEEEECC----ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCce--eeEecccccCC-
Q 002908 585 LKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNV--VAFYGVVQDGP- 656 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G----~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNI--VrL~g~~~~~~- 656 (867)
++.|+.|.+..+|+..+.+ ..+++|+........ ....+.+|..+|+.+. |+++ .+++.+|.+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-------SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 4568999999999987753 357777654321110 0235668999999985 6654 77788776532
Q ss_pred CCeEEEEEEeecCCch
Q 002908 657 GGTLATVTEFMVNGSL 672 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL 672 (867)
.+..|+||||++|..+
T Consensus 116 ~G~~flVME~v~G~~~ 131 (822)
T PLN02876 116 IGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCCceEEEEecCCccc
Confidence 2467899999987643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00048 Score=72.23 Aligned_cols=74 Identities=23% Similarity=0.135 Sum_probs=49.1
Q ss_pred eeecCc-EEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCCCeEEEEEE
Q 002908 588 LGSGTF-GTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 588 LG~Gaf-G~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
|-.|.+ ..||+....+..+.||+..... ...+.+|+++++.+. +--+.+++++.... +..++||+
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e 72 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTS 72 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEE
Confidence 445555 7889987777788888875431 123456777877773 33355667666543 35788999
Q ss_pred eecCCchhh
Q 002908 666 FMVNGSLRH 674 (867)
Q Consensus 666 y~~ggSL~d 674 (867)
+++|.++..
T Consensus 73 ~i~G~~l~~ 81 (244)
T cd05150 73 AVPGVPAAA 81 (244)
T ss_pred eeCCccHhH
Confidence 999877654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=1.5e-05 Score=93.75 Aligned_cols=231 Identities=18% Similarity=0.168 Sum_probs=146.7
Q ss_pred EEEEeeecCcEEEEEEEECCce-EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc-eeeEecccccCCCCeEE
Q 002908 584 ELKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~~G~~-VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN-IVrL~g~~~~~~~~~l~ 661 (867)
..+-+++|+.+.++|.+...+. ...+.+... ....-++++|.+++||| .+..++-+.. +...+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~--E~~~~ 310 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDG--EDYLW 310 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCc--ccccc
Confidence 3445789999999986653222 223333211 22334678999999999 5555554444 44889
Q ss_pred EEEEeecCC-chhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 662 TVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 662 LVmEy~~gg-SL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
++|+++.++ +-...+...+-.+...+...+.+.-++++++||+.--+|+| ||+..... .+.+||+....+
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~-----~~~~~~~v~~~L 381 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE-----VKLLDFAVPPQL 381 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc-----cccccccCCccc
Confidence 999999777 33322223334455666667777888999999988778998 88876532 389999998877
Q ss_pred cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC--CCCcH
Q 002908 741 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--GFCDS 818 (867)
Q Consensus 741 ~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip--~~~s~ 818 (867)
..........+++.++|||+.. ...+....|+|++|.-..+|.-|-+|-.... .....+-.....+.+. .....
T Consensus 382 ~~~~~~~t~~~~~~~~~pev~~--~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~ 457 (829)
T KOG0576|consen 382 TRTMKPRTAIGTPEPLAPEVIQ--ENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSP 457 (829)
T ss_pred CcccccccCCCCCCCCCchhhc--ccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCc
Confidence 6665566778999999999887 4456778999999987666777766643310 0000000000000000 01111
Q ss_pred HHH-HHHHHhhcCCCCCCCCHHHHH
Q 002908 819 EWR-LLMEQCWAPDPVVRPSFTEIA 842 (867)
Q Consensus 819 eL~-dLI~kCLq~DPeeRPSa~ELL 842 (867)
.+. ++...|+...|..|+....++
T Consensus 458 ~~~~~~~~~~~~g~P~~pkv~mgac 482 (829)
T KOG0576|consen 458 VFHRDFPAPCLNGLPPTPKVHMGAC 482 (829)
T ss_pred ccccCCcccccCCCCCCCcchhhHH
Confidence 122 366778888888888776653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00096 Score=83.42 Aligned_cols=204 Identities=22% Similarity=0.196 Sum_probs=133.9
Q ss_pred HHHHHHHHHHHhCCCCceeeEecccccCCC-C-eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC
Q 002908 628 LEFWREAEILSKLHHPNVVAFYGVVQDGPG-G-TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 705 (867)
Q Consensus 628 ~eflrEieiLk~L~HPNIVrL~g~~~~~~~-~-~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~ 705 (867)
....-|+.++..+.|+|++.++.|-..... + ...+..+++...++...+.. -...+...++.+..++.+||+|+|+.
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344458888999999999999887654321 1 12234466777777777643 34578888888999999999999998
Q ss_pred CeeccCCCCc---ceEeccCCCCCCcEEEe--ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHH
Q 002908 706 NIVHFDLKCD---NLLVNLKDPIRPICKVG--DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIV 780 (867)
Q Consensus 706 GIIHrDLKPs---NILLd~dg~~~~~vKL~--DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvL 780 (867)
...|.-|..+ +...+.. ..+.++ ||+................+..|.+||.............|+|++|.+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e----~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGE----GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ccceeEEecccccccccCcc----ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 5544444333 2222211 223444 888877655544444444567788888887545555666899999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 781 LWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 781 LyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+..+..|..+-.... ....+ .+........++..+|+..++++|+++.+++.+.-.
T Consensus 382 ~~~~~~~~~i~~~~~---~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA---VPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred HhhhhhcCccccccc---chhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 999888755422111 01110 111122267888999999999999999999877644
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0018 Score=67.86 Aligned_cols=75 Identities=16% Similarity=0.188 Sum_probs=43.5
Q ss_pred EEeeecCcE-EEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC---ceeeEecccccCCC-CeE
Q 002908 586 KELGSGTFG-TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP---NVVAFYGVVQDGPG-GTL 660 (867)
Q Consensus 586 k~LG~GafG-~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP---NIVrL~g~~~~~~~-~~l 660 (867)
+.|+.|+.. .||+. +..+.+|+.+... ....+.+|.++|..+... -+.++++....... +..
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----------~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----------YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----------hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 356766665 58865 3457778654211 123566788888877531 23444443332211 245
Q ss_pred EEEEEeecCCchh
Q 002908 661 ATVTEFMVNGSLR 673 (867)
Q Consensus 661 ~LVmEy~~ggSL~ 673 (867)
++||++++|.++.
T Consensus 70 ~~l~~~i~G~~l~ 82 (235)
T cd05155 70 WSVYRWLEGETAT 82 (235)
T ss_pred eEEEEeecCCCCC
Confidence 7899999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00017 Score=91.45 Aligned_cols=233 Identities=15% Similarity=0.108 Sum_probs=144.8
Q ss_pred EEEEEEECC---ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEEeecCCc
Q 002908 595 TVYHGKWRG---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGS 671 (867)
Q Consensus 595 ~VYka~~~G---~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggS 671 (867)
.-+++.|-+ .-+.+|+.+...+. ...+...+..+.|..-++...|+++...+.-.........+.+++|+.+|.
T Consensus 1241 ~~~R~k~Lr~kid~Fk~~I~ke~d~e---~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~ 1317 (2724)
T KOG1826|consen 1241 FHFRNKWLRSKIDWFKFSIYKEYDFE---NLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGK 1317 (2724)
T ss_pred eeeccchHhhhhceeEEEeehhhhHH---HHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhH
Confidence 335666632 23577777644321 122333344455666666778999988887776665667788999999999
Q ss_pred hhhhhhcccc---cCCHHHHHHHHHHHHHHHHHHHHC-----CeeccCCCCcceEeccCCCCCCcEEEeecCCcccccC-
Q 002908 672 LRHVLLSKER---HLDRRKRLIIAMDAAFGMEYLHSK-----NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN- 742 (867)
Q Consensus 672 L~d~L~~~~~---~Lse~~~l~Ia~QIa~ALayLHs~-----GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~- 742 (867)
+...+.+.-. .+...-+...-.+...+..-+|.. -.+|++||+.|.+|..+.+. +++++|+.++..+
T Consensus 1318 ~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v----~~gk~gLdKIknp~ 1393 (2724)
T KOG1826|consen 1318 LFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNV----KLGKGGLDKIKNPV 1393 (2724)
T ss_pred HHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcc----cccccccccccCch
Confidence 9998864332 233333333333335555555543 27899999999999966655 9999999994443
Q ss_pred ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHH
Q 002908 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRL 822 (867)
Q Consensus 743 ~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~d 822 (867)
....+...+++.|+.|++.+ .-.++.++|+|..|+.+|.+..|..+|.... ...+..++.......++...+.+...
T Consensus 1394 ~sf~Gl~l~sp~~v~qli~N--~ik~t~rsdilr~s~~ly~rs~~n~~fi~fl-q~~Lkgiidn~tf~sIe~l~pgdaNv 1470 (2724)
T KOG1826|consen 1394 LSFFGLELCSPIYVLQLIKN--EIKFTKRSDILRRSLSLYLRSDGNAYFIFFL-QPALKGIIDNHTFFSIEKLKPGDANV 1470 (2724)
T ss_pred HhhhhhhhCCHHHHHHHHHH--HHhhhhHHHHHHHHHHHHHHhcccHHHHHHH-HHHHcCcccccccccccccCCCcccH
Confidence 33445566888999999987 5567888999999999999888888764322 22233333333333333333333333
Q ss_pred HHHHhhcCCCCCCCC
Q 002908 823 LMEQCWAPDPVVRPS 837 (867)
Q Consensus 823 LI~kCLq~DPeeRPS 837 (867)
....+|-+.-..||.
T Consensus 1471 e~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1471 EALHRLLWKYMERPG 1485 (2724)
T ss_pred HHHHHHHHHhhhcch
Confidence 333333333444443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0066 Score=63.11 Aligned_cols=73 Identities=16% Similarity=0.205 Sum_probs=45.1
Q ss_pred EEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc-eeeEecccccCCCCeE
Q 002908 585 LKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDGPGGTL 660 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN-IVrL~g~~~~~~~~~l 660 (867)
++.|..|-...+|+.... +..+++|++.... .. . ....+|+.+++.+...+ .+++++.+..
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~-~-------~d~~~E~~~~~~l~~~gl~P~v~~~~~~------ 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-EL-I-------IDRERELRIHKLLSKHGLAPKLYATFQN------ 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cc-e-------ecHHHHHHHHHHHHhCCCCCeEEEEeCC------
Confidence 456788889999998765 4678899775321 10 0 11125777777774333 3444443321
Q ss_pred EEEEEeecCCch
Q 002908 661 ATVTEFMVNGSL 672 (867)
Q Consensus 661 ~LVmEy~~ggSL 672 (867)
.+||||++|.++
T Consensus 68 ~~l~e~i~G~~l 79 (235)
T cd05157 68 GLIYEFIPGRTL 79 (235)
T ss_pred cEEEEeeCCCcC
Confidence 379999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0038 Score=64.44 Aligned_cols=99 Identities=22% Similarity=0.142 Sum_probs=76.5
Q ss_pred HHHHHHHhCCC-CceeeEecccccCCCCeEEEEEEeecCCchhhhhh--cccccCCHHHHHHHHHHHHHHHHHHHH---C
Q 002908 632 REAEILSKLHH-PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--SKERHLDRRKRLIIAMDAAFGMEYLHS---K 705 (867)
Q Consensus 632 rEieiLk~L~H-PNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~--~~~~~Lse~~~l~Ia~QIa~ALayLHs---~ 705 (867)
.|.-+++.+++ +++++++|+|-. ++|+||...+++...-. ..-...+|..+.+|+.++++.+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 36668888876 699999999943 56999997665542110 011246899999999999999999997 3
Q ss_pred CeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 706 GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
.+.-+|++++|+-++.++. +|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~----lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGR----LKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCc----EEEEechhcchh
Confidence 4788999999999997765 599999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.00074 Score=75.16 Aligned_cols=140 Identities=19% Similarity=0.073 Sum_probs=95.6
Q ss_pred eeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCCh--------------HHHHHHHHHHHHHHHHHhCCC-C-c
Q 002908 582 LEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSS--------------EQERLTLEFWREAEILSKLHH-P-N 644 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~--------------~~e~~~~eflrEieiLk~L~H-P-N 644 (867)
+.+++.||-|--+-||.+.+. |++.++|+-+...++-+.- +.........+|...|+.|.- - -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 677889999999999999884 9999999665433321111 111223345568888888753 2 2
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~ 724 (867)
+.+.+++. ..++|||++.+..|....+- .+.+. +...+..-+.-|-.+|+||||..-=||+++.++.
T Consensus 174 VPkpiD~~------RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 174 VPKPIDHN------RHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCccccc------ceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 44444432 56889999998888765421 22232 3445555667788899999999999999997665
Q ss_pred CCCcEEEeecCCcc
Q 002908 725 IRPICKVGDFGLSK 738 (867)
Q Consensus 725 ~~~~vKL~DFGLA~ 738 (867)
. +++||-...
T Consensus 241 i----~vIDFPQmv 250 (465)
T KOG2268|consen 241 I----VVIDFPQMV 250 (465)
T ss_pred E----EEeechHhh
Confidence 4 899998654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0085 Score=63.60 Aligned_cols=134 Identities=16% Similarity=0.105 Sum_probs=74.2
Q ss_pred eeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce-eeEecccccCCCCeEEEEEEe
Q 002908 588 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAFYGVVQDGPGGTLATVTEF 666 (867)
Q Consensus 588 LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI-VrL~g~~~~~~~~~l~LVmEy 666 (867)
+..|-.+.+|+....+..+++|+.......-. ....+|..+++.+....+ .+++.... -++||+|
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~--------~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALG--------VDRQREYQILQALSALGLAPKPILVNE------HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccccc--------CcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEe
Confidence 45688889998887788888987643211100 112457777777753322 33333322 2589999
Q ss_pred ecCCchhhh-----------------hhcc---cccCCHHH-HHHHHHHH---------HHHHHHHHH--------CCee
Q 002908 667 MVNGSLRHV-----------------LLSK---ERHLDRRK-RLIIAMDA---------AFGMEYLHS--------KNIV 708 (867)
Q Consensus 667 ~~ggSL~d~-----------------L~~~---~~~Lse~~-~l~Ia~QI---------a~ALayLHs--------~GII 708 (867)
++|..+... ++.. ...++... +..+..++ ...+..+-. ..+|
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 988765421 1111 11122111 11111111 112222222 2489
Q ss_pred ccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 709 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 709 HrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
|+|+.|.||+++.++ +.|+||..|...
T Consensus 150 H~Dl~~~Nil~~~~~-----~~lIDwE~a~~g 176 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-----LKLIDWEYASDG 176 (256)
T ss_pred cCCCCcCcEEEeCCC-----CEEEeccccCcC
Confidence 999999999998655 379999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.017 Score=62.20 Aligned_cols=139 Identities=19% Similarity=0.141 Sum_probs=78.8
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc--eeeEeccccc----CCCC
Q 002908 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQD----GPGG 658 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN--IVrL~g~~~~----~~~~ 658 (867)
.+.|..|....+|+....+..+++|++... . ......|+.++..+.+.+ +.+++..... ...+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-----~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-----S------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC-----C------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 456778888899998777778999987531 1 123345666666664322 4444432111 1123
Q ss_pred eEEEEEEeecCCchhh----hh----------hcccc----------cCCHHHHH----------HHHHHHHHHHHHHHH
Q 002908 659 TLATVTEFMVNGSLRH----VL----------LSKER----------HLDRRKRL----------IIAMDAAFGMEYLHS 704 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d----~L----------~~~~~----------~Lse~~~l----------~Ia~QIa~ALayLHs 704 (867)
..++||+|++|..+.. .. +.... ...+.... .....+..++.++..
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 5688999998875432 00 10000 00111110 011123344455543
Q ss_pred -------CCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 705 -------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 705 -------~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.++||+|+.|.|||++.++ .+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~----~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDE----LSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCc----eEEEeehhhhc
Confidence 4799999999999998643 23799999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.038 Score=63.67 Aligned_cols=81 Identities=20% Similarity=0.085 Sum_probs=51.7
Q ss_pred EEEeeecCcEEEEEEEECC--ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---CCceeeEecccccCCCCe
Q 002908 585 LKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G--~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~---HPNIVrL~g~~~~~~~~~ 659 (867)
.+.||.|.+..||++...+ +.|.||.-.......+... .....++..|.+.|..+. ..++++++.+-.+ .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~w-pl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~----~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESW-PLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEE----L 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccc-cccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCC----C
Confidence 4579999999999998853 4799998543221111110 011234556777777763 3457777776443 4
Q ss_pred EEEEEEeecCC
Q 002908 660 LATVTEFMVNG 670 (867)
Q Consensus 660 l~LVmEy~~gg 670 (867)
.++||||+++.
T Consensus 106 ~~lVME~L~~~ 116 (401)
T PRK09550 106 AVTVMEDLSDH 116 (401)
T ss_pred CEEEEecCCCc
Confidence 68999999764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.019 Score=62.31 Aligned_cols=73 Identities=19% Similarity=0.325 Sum_probs=43.8
Q ss_pred EEeeecCcEEEEEEEEC--------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc-eeeEecccccCC
Q 002908 586 KELGSGTFGTVYHGKWR--------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDGP 656 (867)
Q Consensus 586 k~LG~GafG~VYka~~~--------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN-IVrL~g~~~~~~ 656 (867)
+.|..|-...+|+.... +..+++|++...... .....+|..++..+.... ..++++++..
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~-- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---------LIDRERELVVFARLSERNLGPKLYGIFPN-- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---------eechHHHHHHHHHHHhCCCCCceEEEeCC--
Confidence 45667888899988764 367899997543211 012335666777664322 2345555432
Q ss_pred CCeEEEEEEeecCCchh
Q 002908 657 GGTLATVTEFMVNGSLR 673 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~ 673 (867)
.+||+|++|.++.
T Consensus 73 ----~~v~e~i~G~~l~ 85 (302)
T cd05156 73 ----GRIEEFIPSRTLT 85 (302)
T ss_pred ----CchhheeCCCcCC
Confidence 2489999887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.031 Score=61.07 Aligned_cols=30 Identities=27% Similarity=0.365 Sum_probs=24.2
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.++||+|+.|.|||++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~----~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR----LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc----eEEEEeccccc
Confidence 3799999999999998432 23699999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.025 Score=61.88 Aligned_cols=140 Identities=19% Similarity=0.158 Sum_probs=76.7
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc--eeeEecccc----cCCCC
Q 002908 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQ----DGPGG 658 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN--IVrL~g~~~----~~~~~ 658 (867)
++.++.|....+|+....+..+++|++.... .. .....|.+++..|.... +.+++.... ....+
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~~------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV----KA------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC----CH------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 4557778778899887666678889875321 11 12234555666663222 334433211 11134
Q ss_pred eEEEEEEeecCCchhh-----------h---hhcccccC-----------CHHHHH------------HHHHHHHHHHHH
Q 002908 659 TLATVTEFMVNGSLRH-----------V---LLSKERHL-----------DRRKRL------------IIAMDAAFGMEY 701 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d-----------~---L~~~~~~L-----------se~~~l------------~Ia~QIa~ALay 701 (867)
..+++|+|++|..+.. . ++.....+ .|.... .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 6789999998854321 0 11100000 011000 001123345555
Q ss_pred HHH-------CCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 702 LHS-------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 702 LHs-------~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
+.. .++||+|+.+.||+++.++ .+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~----~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDS----VKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCc----eEEEeeccccc
Confidence 542 5799999999999998654 24799999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.048 Score=62.12 Aligned_cols=147 Identities=22% Similarity=0.218 Sum_probs=92.6
Q ss_pred EEeeecCcEEEEEEEE-CCceEEEEEeeccccC--CCC--------------hHHHHHHHHHH--HHHHHHHhCCCCcee
Q 002908 586 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFT--GRS--------------SEQERLTLEFW--REAEILSKLHHPNVV 646 (867)
Q Consensus 586 k~LG~GafG~VYka~~-~G~~VAVKv~k~~~~s--d~~--------------~~~e~~~~efl--rEieiLk~L~HPNIV 646 (867)
..|..|--+-||.+.- .|..+|||+++.+.+. ++. ..+.+-.-..| .|++-|++|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4678888899999887 5888999999865432 110 00111112233 466677777654432
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCCcceEeccCCCC
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLH-s~GIIHrDLKPsNILLd~dg~~ 725 (867)
-.--+... ...|||+|+ |.+=+-.-.-+...++...+..+-.+++.-|.-|- ..++||.||.--|+|+-.
T Consensus 230 ~PePIlLk----~hVLVM~Fl-Grdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd---- 300 (520)
T KOG2270|consen 230 CPEPILLK----NHVLVMEFL-GRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD---- 300 (520)
T ss_pred CCCceeee----cceEeeeec-cCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC----
Confidence 21111111 347899999 43222111123345777777777788888777765 468999999999999963
Q ss_pred CCcEEEeecCCcccccC
Q 002908 726 RPICKVGDFGLSKIKRN 742 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~ 742 (867)
+.+.++|-+.+.....
T Consensus 301 -G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEHDH 316 (520)
T ss_pred -CEEEEEEccccccCCC
Confidence 3468999998765443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.1 Score=57.48 Aligned_cols=107 Identities=13% Similarity=0.030 Sum_probs=72.9
Q ss_pred eEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC---CceeeEecccccC-CCC
Q 002908 583 EELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH---PNVVAFYGVVQDG-PGG 658 (867)
Q Consensus 583 qilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H---PNIVrL~g~~~~~-~~~ 658 (867)
.-.+.||.|..+.||.....+..+.+|..+... . ...+.+|...|+.|.- -.+.++++++... ..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g 86 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSFS-T---------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG 86 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecccc-c---------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence 345679999999999987655567888864310 1 1356788889988853 3577888776543 234
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 705 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~ 705 (867)
..+||||++++.++.+. ..+......+..+++++|+-||+.
T Consensus 87 ~~~LVmE~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 87 PDVLLLERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred CeEEEEeccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 68999999998887651 123333445666777888888863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.13 Score=55.72 Aligned_cols=29 Identities=24% Similarity=0.362 Sum_probs=23.9
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.++||+|+.+.||+++. +. +.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~----i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE----VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc----EEEEECcccc
Confidence 47999999999999985 32 4799999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.12 Score=58.22 Aligned_cols=31 Identities=16% Similarity=0.352 Sum_probs=24.9
Q ss_pred CeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 706 GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.+||+|+++.|||++.++ ..+.|+||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~---~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEET---RAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCC---CcEEEEeehhccc
Confidence 589999999999998532 2359999998763
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.052 Score=63.93 Aligned_cols=154 Identities=19% Similarity=0.324 Sum_probs=91.8
Q ss_pred HHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCee
Q 002908 629 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIV 708 (867)
Q Consensus 629 eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GII 708 (867)
.++.-..+++.+.|+|+...+++...... ...+|||++ +.+|.+.+.... +-... +. .+++.
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~-r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~~-------~~~~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHE-RVIVVMEHY-TMSLEDILKTGN--LKDES-------LL-------AHGVL 89 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccc-eEEEEehhh-ccchHHHHHhcc--cchhh-------hc-------ccccc
Confidence 45556678999999999999988776654 477899998 889998874332 21111 10 11221
Q ss_pred ccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCC
Q 002908 709 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788 (867)
Q Consensus 709 HrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk 788 (867)
| -|++ +.+| -++..+ | ....+|+|||++|.++.++.-|.
T Consensus 90 ~-----~~~~-----------~~td-~~~t~~-----------------~-------~~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 90 H-----LNII-----------YITD-HFLTKY-----------------P-------SPIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred e-----ehhh-----------hccc-cccccC-----------------C-------CCCCcchhhhhHHHHHHHHHHhh
Confidence 1 1222 2233 111100 0 00124899999999999999998
Q ss_pred CCCCCCChhHHHHhHhhcCCCC----------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHH
Q 002908 789 EPYANMHYGAIIGGIVNNTLRP----------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841 (867)
Q Consensus 789 ~PF~~~~~~e~l~~iv~~~lr~----------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~EL 841 (867)
..|......+....+..-.... .+...++..+.++..+|+-..|..||...++
T Consensus 129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 129 SLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 8876655444433332211110 0112345567778889999999988865444
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.22 Score=54.41 Aligned_cols=32 Identities=22% Similarity=0.318 Sum_probs=24.9
Q ss_pred CeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 706 GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
.+||+|++|.|||++.++. ..-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~---~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR---VTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC---EEEEECcHhcccC
Confidence 4899999999999985432 2368999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.21 Score=55.71 Aligned_cols=30 Identities=27% Similarity=0.295 Sum_probs=24.3
Q ss_pred eeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 707 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 707 IIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.||+||.+.|||++.++. .++|+||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~---~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEG---KLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCC---cEEEEcccccCC
Confidence 799999999999975432 359999998763
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.37 Score=54.11 Aligned_cols=149 Identities=17% Similarity=0.170 Sum_probs=81.8
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC--CceeeEecccccCCCCeEE
Q 002908 584 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--PNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H--PNIVrL~g~~~~~~~~~l~ 661 (867)
+++.+-.|..-.+|....+++.++|. ....... . .......+|..+++.+.- --+...+++|.++.-+..+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~--~----~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDP--V----ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCcccc--c----hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 34444455555566665567777777 2211100 0 112334467777777642 2345667777765445778
Q ss_pred EEEEeecCCchhhhhhccc-----------------------------c--cCCHHHHHHHHH--------------HHH
Q 002908 662 TVTEFMVNGSLRHVLLSKE-----------------------------R--HLDRRKRLIIAM--------------DAA 696 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~-----------------------------~--~Lse~~~l~Ia~--------------QIa 696 (867)
.||+|++|..+...+.... + .....++..+.. .+.
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 9999998842221110000 0 000011111111 223
Q ss_pred HHHHHHHHC--------CeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc
Q 002908 697 FGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743 (867)
Q Consensus 697 ~ALayLHs~--------GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~ 743 (867)
....+|+.+ .++|+|+.+.||+++.++. +=+.||+++....+.
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~----~gVlDwe~~~lGDP~ 232 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP----TGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe----eEEEeccccccCCcH
Confidence 345555543 4899999999999997765 378999999865543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.25 Score=54.27 Aligned_cols=30 Identities=17% Similarity=0.109 Sum_probs=25.3
Q ss_pred CeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 706 GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
++||+|+.++|||++.++.. .++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~----~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGG----YFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCE----EEEEhhhccc
Confidence 79999999999999876543 7899998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.31 Score=55.63 Aligned_cols=79 Identities=18% Similarity=0.088 Sum_probs=46.5
Q ss_pred EeeecCcEEEEEEEECC--ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC--CC-ceeeEecccccCCCCeEE
Q 002908 587 ELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--HP-NVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 587 ~LG~GafG~VYka~~~G--~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~--HP-NIVrL~g~~~~~~~~~l~ 661 (867)
.||.|....||++...+ +.|+||.-.......+... .....+..-|..+|+... .| .++++|.+-.+ ...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~w-pl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e----~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESW-PLTLDRARIESSALIRQGEHVPHLVPRIFHFDTE----MAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCC-CCCccHHHHHHHHHHHhhccCccccCeEEEEccc----cce
Confidence 57999999999998753 5799997653322111000 011123335667776653 34 45556654333 456
Q ss_pred EEEEeecCC
Q 002908 662 TVTEFMVNG 670 (867)
Q Consensus 662 LVmEy~~gg 670 (867)
+|||+++..
T Consensus 77 ~vMEdL~~~ 85 (370)
T TIGR01767 77 TVMEDLSHH 85 (370)
T ss_pred ehHhhCccc
Confidence 899998654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.00 E-value=1.1 Score=51.43 Aligned_cols=78 Identities=19% Similarity=0.194 Sum_probs=44.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEECC---ce-----EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc-eeeEec
Q 002908 580 EDLEELKELGSGTFGTVYHGKWRG---TD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYG 650 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~G---~~-----VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN-IVrL~g 650 (867)
+++++. .|..|-...+|++...+ .. |.++++-. .. +... .-.+|..+++.+...+ -.++++
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~-------~l~I-dR~~E~~i~~~Ls~~glgP~l~~ 120 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YN-------SLVI-DNDLQYNIAKLLGDNNFGPKIIG 120 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccC-CC-------ceEe-ccHHHHHHHHHHHhCCCCCeEEE
Confidence 334444 45458889999987642 12 44443211 10 0011 1135788888886544 456666
Q ss_pred ccccCCCCeEEEEEEeecCCchh
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLR 673 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~ 673 (867)
.+.. ++|+||++|.+|.
T Consensus 121 ~f~~------g~l~efIeGr~l~ 137 (383)
T PTZ00384 121 RFGD------FTIQEWVEGNTMG 137 (383)
T ss_pred ecCC------EEEEEEeccccCC
Confidence 6643 5799999988664
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.76 E-value=0.66 Score=52.33 Aligned_cols=138 Identities=19% Similarity=0.191 Sum_probs=77.1
Q ss_pred EeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---CCc---eeeEecccccCCCC--
Q 002908 587 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPN---VVAFYGVVQDGPGG-- 658 (867)
Q Consensus 587 ~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~---HPN---IVrL~g~~~~~~~~-- 658 (867)
.|.+ .-..||+....+..+++|++... .+ ..++..|+..|..|. .+- +..+-|-....-.+
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~---------~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~ 101 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRYILKIYRPG-WT---------RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGP 101 (331)
T ss_pred cccc-ccCceEEEEecCCCeEEEEecCC-CC---------HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCc
Confidence 3454 55668888886666699998764 22 123334555666553 111 22222211111122
Q ss_pred eEEEEEEeecCCchhh-hh--------------hc--cc---------ccCCHHH----H---------HHHHHHHHHHH
Q 002908 659 TLATVTEFMVNGSLRH-VL--------------LS--KE---------RHLDRRK----R---------LIIAMDAAFGM 699 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d-~L--------------~~--~~---------~~Lse~~----~---------l~Ia~QIa~AL 699 (867)
..+-|++|++|..+.. .. +. .+ ....|.. . .....++...+
T Consensus 102 r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~ 181 (331)
T COG2334 102 RPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAAL 181 (331)
T ss_pred eeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHH
Confidence 7788999998887662 10 10 00 0122220 0 11233455556
Q ss_pred HHHHHC-------C---eeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 700 EYLHSK-------N---IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 700 ayLHs~-------G---IIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..+.+. + +||+|+.|.||+++.+.. .+-++||+-+.
T Consensus 182 ~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~---~~g~iDFdDa~ 227 (331)
T COG2334 182 DRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTD---VSGFIDFDDAG 227 (331)
T ss_pred HHHHhhchhhCCcccceeeecCCCccceeEcCCCC---eeeEEEccccc
Confidence 665542 3 999999999999997764 34799999875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.32 E-value=0.49 Score=54.76 Aligned_cols=80 Identities=19% Similarity=0.136 Sum_probs=49.0
Q ss_pred EEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC--CC-ceeeEecccccCCCCe
Q 002908 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--HP-NVVAFYGVVQDGPGGT 659 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~--HP-NIVrL~g~~~~~~~~~ 659 (867)
.+.||.|....||++.+. ++.|+||.-......... . .....+..-|.++|+... .| .++++|.+-.+ .
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~s-w-pL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e----~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDE-F-KLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV----M 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCC-C-CCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH----H
Confidence 567899999999999974 567999976443321111 0 111233445677777653 34 45566654333 4
Q ss_pred EEEEEEeecCC
Q 002908 660 LATVTEFMVNG 670 (867)
Q Consensus 660 l~LVmEy~~gg 670 (867)
..+|||+++..
T Consensus 108 ~~~vMEdL~~~ 118 (409)
T PRK12396 108 NCCVMEDLSDH 118 (409)
T ss_pred hhHHHHhCccc
Confidence 56789888643
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.89 E-value=0.93 Score=53.05 Aligned_cols=77 Identities=13% Similarity=0.252 Sum_probs=44.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC----------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce-eeE
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR----------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAF 648 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~----------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI-VrL 648 (867)
++. .++.|..|-.-.+|++... ++.|.++++-... +.+. .-..|..+++.+...+| .++
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--------e~lI-dR~~E~~v~~~ls~~gi~P~l 175 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--------DELY-NPISEFEVYKTMSKYRIAPQL 175 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--------ccee-CHHHHHHHHHHHHHCCCCCce
Confidence 445 4566767888888988754 3568888874321 1111 11245666666643333 245
Q ss_pred ecccccCCCCeEEEEEEeecCCch
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSL 672 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL 672 (867)
++.+.. +.|.+|++|.+|
T Consensus 176 ~~~f~g------g~I~efi~g~~l 193 (442)
T PTZ00296 176 LNTFSG------GRIEEWLYGDPL 193 (442)
T ss_pred EEEeCC------CEEEEeeCCccC
Confidence 555533 347899987744
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.31 E-value=0.69 Score=51.16 Aligned_cols=75 Identities=20% Similarity=0.134 Sum_probs=45.4
Q ss_pred eEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---CCceeeEecccccCCCCe
Q 002908 583 EELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 583 qilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~---HPNIVrL~g~~~~~~~~~ 659 (867)
+..+.++.|....+|+....+..+.||+-.... ...|..|.+-|+.|. .-.+.+++++..... .
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~ 86 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--D 86 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--C
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhh-----------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--C
Confidence 445678989999999988778889999876321 134667888888873 335677777766543 4
Q ss_pred EEEEEEeecCC
Q 002908 660 LATVTEFMVNG 670 (867)
Q Consensus 660 l~LVmEy~~gg 670 (867)
.+|||||++.+
T Consensus 87 ~fLlle~l~~~ 97 (288)
T PF03881_consen 87 AFLLLEFLEMG 97 (288)
T ss_dssp CEEEEE-----
T ss_pred ceEEEEeecCC
Confidence 58999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.83 E-value=0.21 Score=60.53 Aligned_cols=26 Identities=19% Similarity=0.224 Sum_probs=12.9
Q ss_pred ccCCCCcccccCCCccccCCCCCCCC
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLK 484 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls 484 (867)
|+|.||+.++.|+.|+.|+|++|+|+
T Consensus 454 l~g~iP~~~~~l~~L~~LdLs~N~ls 479 (623)
T PLN03150 454 IRGNIPPSLGSITSLEVLDLSYNSFN 479 (623)
T ss_pred ccCcCChHHhCCCCCCEEECCCCCCC
Confidence 34445544555555555555555554
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.28 E-value=5.3 Score=44.55 Aligned_cols=28 Identities=18% Similarity=0.076 Sum_probs=22.9
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.++||+|+.+.|||++ ++ . .|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d~-~----~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-DG-P----HFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-CC-c----EEEeCCCCC
Confidence 3689999999999995 32 2 689999875
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.95 E-value=0.35 Score=58.69 Aligned_cols=70 Identities=14% Similarity=0.152 Sum_probs=55.9
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCc-cCCCCCCCCCCCccccccCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSI-VGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l-~gPs~~~~~P~l~k~~Lagn 530 (867)
+|+|.+|+.+++|++|+.|+|++|+|. |. +|. .+.+.++..+.+..|... ..|......+.++...+.+|
T Consensus 429 ~L~g~ip~~i~~L~~L~~L~Ls~N~l~--g~-iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 429 GLRGFIPNDISKLRHLQSINLSGNSIR--GN-IPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500 (623)
T ss_pred CccccCCHHHhCCCCCCEEECCCCccc--Cc-CChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence 578999999999999999999999999 85 774 556678888888888765 44666667777777666666
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.76 E-value=8 Score=49.94 Aligned_cols=33 Identities=30% Similarity=0.372 Sum_probs=25.8
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.++||+|+.+.|||++.++.. ...=|+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~-~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGE-RISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCc-ceEEEEECcccc
Confidence 479999999999999976532 122499999875
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=86.62 E-value=1.9 Score=46.99 Aligned_cols=75 Identities=19% Similarity=0.116 Sum_probs=48.3
Q ss_pred EeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEEEE
Q 002908 587 ELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665 (867)
Q Consensus 587 ~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LVmE 665 (867)
.+..|..+.|+.++. .|+++++|+.....- ...| . .....|+..+-...|++++.-.. .-.+++|
T Consensus 9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~----~~~E-----~-~g~~~L~~w~G~GaVrll~~d~~----~~AlLLE 74 (253)
T PF04655_consen 9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAE----AEHE-----A-RGEAALRWWNGRGAVRLLAADPE----RGALLLE 74 (253)
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEecCCccc----chhh-----h-hHHhHhheeCCCCceeeeccccc----cchhhhh
Confidence 356799999999976 689999999864311 0111 1 11245676777778999886533 3467888
Q ss_pred eec-CCchhhh
Q 002908 666 FMV-NGSLRHV 675 (867)
Q Consensus 666 y~~-ggSL~d~ 675 (867)
.+. +.+|.+.
T Consensus 75 rl~~g~~L~~~ 85 (253)
T PF04655_consen 75 RLDPGRSLASL 85 (253)
T ss_pred hccCCCchhhc
Confidence 884 4455443
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=85.91 E-value=1.8 Score=49.88 Aligned_cols=72 Identities=18% Similarity=0.195 Sum_probs=56.3
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..+.|++|++- |+++... ..-.+.+++.|+.+++..++-|... ..-||||.-.||||+ .|++ .|+||-
T Consensus 298 ~~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gnv----tLIDfk 366 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNV----TLIDFK 366 (488)
T ss_pred ceEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCce----EEEEee
Confidence 34677888875 5555432 2346788899999999888888764 689999999999999 7766 899999
Q ss_pred Cccc
Q 002908 736 LSKI 739 (867)
Q Consensus 736 LA~~ 739 (867)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=85.38 E-value=0.26 Score=58.58 Aligned_cols=61 Identities=13% Similarity=0.121 Sum_probs=54.5
Q ss_pred CCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCCCCCCCCCCccc
Q 002908 461 LGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRS 525 (867)
Q Consensus 461 ~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~ 525 (867)
-.||+.+++++.|++||||.|+|+ ..|...+++-+..++..+|...++|...+..+.+..+
T Consensus 111 r~ip~~i~~L~~lt~l~ls~NqlS----~lp~~lC~lpLkvli~sNNkl~~lp~~ig~~~tl~~l 171 (722)
T KOG0532|consen 111 RTIPEAICNLEALTFLDLSSNQLS----HLPDGLCDLPLKVLIVSNNKLTSLPEEIGLLPTLAHL 171 (722)
T ss_pred eecchhhhhhhHHHHhhhccchhh----cCChhhhcCcceeEEEecCccccCCcccccchhHHHh
Confidence 468999999999999999999999 8999999999999999999999999998855544433
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 867 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-45 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-45 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-41 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-40 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-40 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-35 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-32 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-32 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-32 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-32 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-32 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-32 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-32 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-32 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-32 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-31 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-31 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-31 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-31 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-31 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-31 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-31 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-31 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-31 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-31 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-31 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-31 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-30 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-30 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-30 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-30 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-30 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-30 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-30 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-30 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-30 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-30 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-30 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-30 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-30 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-30 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-30 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-30 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-30 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-30 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-29 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-29 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-29 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-29 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-29 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-29 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-29 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-29 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-29 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-29 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-29 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-29 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-29 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-29 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-29 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-29 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-29 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-29 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-29 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-29 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-29 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-29 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-29 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-29 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-29 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-29 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-29 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-29 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-29 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-29 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-29 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-29 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-29 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-29 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-29 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-29 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-29 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-29 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-28 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-28 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-28 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-28 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-28 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-28 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-28 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-28 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-28 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-28 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-28 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-28 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-28 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-28 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-28 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-28 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-28 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-28 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-28 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-28 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-28 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-28 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-28 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-28 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-28 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-28 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-28 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-28 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-27 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-27 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-27 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-27 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-27 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-27 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-27 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-27 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-27 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-27 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-27 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-27 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-27 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-27 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-27 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-27 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-27 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-27 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-27 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-27 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-27 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-27 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-27 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-27 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-27 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-27 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-27 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-27 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-27 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-27 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-27 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-27 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-27 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-27 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-27 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-27 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-27 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-27 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-26 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-26 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-26 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-26 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-26 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-26 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-26 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-26 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-26 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-26 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-26 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-26 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-26 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-26 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-26 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-26 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-26 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-26 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-26 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-26 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-26 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-26 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-26 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-26 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-26 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-26 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-26 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-26 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-26 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-25 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-25 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-25 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-25 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-25 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-25 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-25 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-25 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-25 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-25 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-25 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-25 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-25 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-25 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-25 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-25 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-25 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-25 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-25 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-25 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-25 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-24 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-24 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-24 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-24 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-24 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-24 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-24 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-23 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-23 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-23 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-23 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-23 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-23 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-23 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-23 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-23 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-23 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-23 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-23 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-23 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-23 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-23 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-23 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-23 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-23 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-23 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-23 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-23 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-23 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-23 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-23 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-23 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-23 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-23 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-23 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-23 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-22 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-22 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-22 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-22 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-22 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-22 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-22 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-22 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-22 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-22 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-22 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-22 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-22 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-22 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-22 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-22 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-22 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-21 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-21 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-21 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-21 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-21 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-21 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-21 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-21 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-21 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-21 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-21 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-21 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-21 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-21 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-21 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-20 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-20 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-20 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-20 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-20 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-20 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-20 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-20 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-20 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-20 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-20 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-19 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-19 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-17 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-17 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-16 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-16 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-14 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-14 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-130
Identities = 102/288 (35%), Positives = 151/288 (52%), Gaps = 14/288 (4%)
Query: 568 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQER 625
F S L + + ++E K++G G FG V+ G+ + VAIK + G + E+
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 626 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR 685
EF RE I+S L+HPN+V YG++ + P V EF+ G L H LL K +
Sbjct: 67 FQ-EFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 686 RKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPIC-KVGDFGLSKIKRN 742
+L + +D A G+EY+ ++N IVH DL+ N+ + D P+C KV DFGLS+ +
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181
Query: 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG--AII 800
+ G+ G WMAPE + +EK D +SF ++L+ ILTGE P+ YG I
Sbjct: 182 S--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 801 GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
I LRP +P C R ++E CW+ DP RP F+ I + L +
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-127
Identities = 105/286 (36%), Positives = 158/286 (55%), Gaps = 19/286 (6%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
I DL +++G+G+FGTV+ +W G+DVA+K + + F EF RE I
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN------EFLREVAI 87
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLIIAMD 694
+ +L HPN+V F G V P L+ VTE++ GSL +L LD R+RL +A D
Sbjct: 88 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 695 AAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG-GVRG 751
A GM YLH++N IVH +LK NLLV+ + KV DFGLS++K +T ++ G
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
T WMAPE+L S +EK DV+SFG++LWE+ T ++P+ N++ ++ + R
Sbjct: 202 TPEWMAPEVLRDEPS--NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSH 857
+P + + ++E CW +P RPSF I LR + + +
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 382 bits (984), Expect = e-127
Identities = 95/279 (34%), Positives = 136/279 (48%), Gaps = 18/279 (6%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
I +L + +G G FG VY W G +VA+K + + + +EA++
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH----DPDEDISQTIENVRQEAKL 59
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+ L HPN++A GV P L V EF G L VL + + + A+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIA 115
Query: 697 FGMEYLHSKN---IVHFDLKCDNLLVN----LKDPIRPICKVGDFGLSKIKRNTLVTGGV 749
GM YLH + I+H DLK N+L+ D I K+ DFGL++ T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809
G WMAPE++ S S+ DV+S+G++LWE+LTGE P+ + A+ G+ N L
Sbjct: 176 -GAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
P+P C + LME CW PDP RPSFT I +L +
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 380 bits (978), Expect = e-126
Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 18/277 (6%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
I + L L +L G ++ G+W+G D+ +K +K ++ R S +F E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSR------DFNEECPR 60
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDA 695
L HPNV+ G Q P +T +M GSL +VL +D+ + + A+D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 696 AFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 753
A GM +LH+ I L +++++ ++ + ++ G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMT----ARISMADVKFSFQSP----GRMYAP 172
Query: 754 PWMAPELLNGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
W+APE L D++SF ++LWE++T E P+A++ I + LRP +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
P LM+ C DP RP F I L M
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-119
Identities = 93/281 (33%), Positives = 146/281 (51%), Gaps = 22/281 (7%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
I + + + +GSG+FGTVY GKW G DVA+K + + T + + F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ------AFKNEVGV 73
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
L K H N++ F G LA VT++ SL H L + E + +K + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTL 753
GM+YLH+K+I+H DLK +N+ ++ + K+GDFGL+ K + G++
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDN----TVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 754 PWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRP- 810
WMAPE++ S+ S + DV++FGIVL+E++TG+ PY+N+ + II + +L P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 811 --PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
V C + LM +C RPSF I + ++
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-117
Identities = 93/282 (32%), Positives = 140/282 (49%), Gaps = 27/282 (9%)
Query: 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
+L +I +++E + +G G FG V KWR DVAIK+I+ E F
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE----------SESERKAFIV 50
Query: 633 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLI 690
E LS+++HPN+V YG + + V E+ GSL +VL E + +
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 691 IAMDAAFGMEYLHS---KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747
+ + G+ YLHS K ++H DLK NLL+ + K+ DFG + + +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV---LKICDFGTACDIQTHMTNN 163
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGGIVNN 806
+G+ WMAPE+ GS SEK DVFS+GI+LWE++T +P+ + A I V+N
Sbjct: 164 --KGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
RPP+ LM +CW+ DP RPS EI + + +
Sbjct: 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-117
Identities = 84/294 (28%), Positives = 119/294 (40%), Gaps = 27/294 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
I E LE + +G G FG VYHG+W G +VAI+ I + E F RE
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIE------RDNEDQLKAFKREVMA 82
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+ H NVV F G P LA +T +L V+ + LD K IA +
Sbjct: 83 YRQTRHENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG------GVR 750
GM YLH+K I+H DLK N+ + + DFGL I
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNGK-----VVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 751 GTLPWMAPELLNGSSSKV-------SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 803
G L +APE++ S S+ DVF+ G + +E+ E P+ AII +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255
Query: 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSH 857
E ++ CWA + RP+FT++ L + + SH
Sbjct: 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = 8e-99
Identities = 83/323 (25%), Positives = 135/323 (41%), Gaps = 58/323 (17%)
Query: 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWRE 633
+Q + ++ +K++G G +G V+ GKWRG VA+K + ++RE
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-----------SWFRE 79
Query: 634 AEI--LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
EI + H N++ F G G L +T++ NGSL L K LD + L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSML 137
Query: 690 IIAMDAAFGMEYLHSKN--------IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741
+A + G+ +LH++ I H DLK N+LV C + D GL+
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN----GTCCIADLGLAVKFI 193
Query: 742 NT-----LVTGGVRGTLPWMAPELLNGSSSKVS----EKVDVFSFGIVLWEILTGEE--- 789
+ + GT +M PE+L+ S ++ D++SFG++LWE+
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
Query: 790 -------PYANM-----HYGAIIGGIVNNTLRPPVPGF-----CDSEWRLLMEQCWAPDP 832
PY ++ Y + + LRP P C + LM +CWA +P
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 833 VVRPSFTEIARRLRVMSAACQTK 855
R + + + L MS + K
Sbjct: 314 ASRLTALRVKKTLAKMSESQDIK 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 3e-97
Identities = 90/291 (30%), Positives = 127/291 (43%), Gaps = 34/291 (11%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWRE 633
I + DL + LG G FG R T + +K + + E +R F +E
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQR---TFLKE 57
Query: 634 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
+++ L HPNV+ F GV+ L +TE++ G+LR ++ S + +R+ A
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---------- 743
D A GM YLHS NI+H DL N LV V DFGL+++ +
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENK----NVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 744 -----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YG 797
V G WMAPE++NG S EKVDVFSFGIVL EI+ +
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSY--DEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
G V L P C + + +C DP RPSF ++ L +
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 3e-87
Identities = 80/322 (24%), Positives = 127/322 (39%), Gaps = 58/322 (18%)
Query: 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
Q + + +G G FG V+ GKWRG +VA+K S +ER ++REA
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS--------SREER---SWFREA 85
Query: 635 EI--LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
EI L H N++ F G L V+++ +GSL L + +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIK 143
Query: 691 IAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742
+A+ A G+ +LH + I H DLK N+LV C + D GL+ +
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDS 199
Query: 743 TLVTG-----GVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTG------ 787
T GT +MAPE+L+ S + + ++ D+++ G+V WEI
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 788 EEPYANMHYG---------AIIGGIVNNTLRPPVPGF-----CDSEWRLLMEQCWAPDPV 833
E Y +Y + + LRP +P +M +CW +
Sbjct: 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319
Query: 834 VRPSFTEIARRLRVMSAACQTK 855
R + I + L +S K
Sbjct: 320 ARLTALRIKKTLSQLSQQEGIK 341
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 6e-85
Identities = 76/317 (23%), Positives = 131/317 (41%), Gaps = 58/317 (18%)
Query: 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
++Q D+ L+ +G G +G V+ G W+G +VA+K SS E+ ++R
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIF--------SSRDEK---SWFR 49
Query: 633 EAEI--LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKR 688
E E+ L H N++ F + L +T + GSL L + LD
Sbjct: 50 ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSC 107
Query: 689 LIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740
L I + A G+ +LH + I H DLK N+LV C + D GL+ +
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG----QCCIADLGLAVMH 163
Query: 741 RNTLVTG-----GVRGTLPWMAPELLNGS----SSKVSEKVDVFSFGIVLWEILTGEE-- 789
+ GT +MAPE+L+ + ++VD+++FG+VLWE+
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
Query: 790 --------PYANMH-----YGAIIGGIVNNTLRPPVP-----GFCDSEWRLLMEQCWAPD 831
P+ ++ + + + + RP +P + LM++CW +
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283
Query: 832 PVVRPSFTEIARRLRVM 848
P R + I + L +
Sbjct: 284 PSARLTALRIKKTLTKI 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 7e-75
Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 27/289 (9%)
Query: 570 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQ 623
+ + L+I+K + +++K LGSG FGTVY G W VAIK ++++ +S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPK 59
Query: 624 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 683
E EA +++ + +P+V G+ + +T+ M G L + + ++
Sbjct: 60 ANK--EILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNI 114
Query: 684 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN 742
+ L + A GM YL + +VH DL N+LV K+ DFGL+K +
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAE 170
Query: 743 TLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 799
G +P WMA E + + + DV+S+G+ +WE++T G +PY + I
Sbjct: 171 EKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
Query: 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
I+ R P P C + ++M +CW D RP F E+ M
Sbjct: 229 S-SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 6e-74
Identities = 95/279 (34%), Positives = 136/279 (48%), Gaps = 24/279 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+ +EDL +++G G FG V+ G+ R T VA+K +++ + +F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-----LPPDLKA--KFLQEA 163
Query: 635 EILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
IL + HPN+V GV Q P + V E + G L ++ L + L +
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGT 752
DAA GMEYL SK +H DL N LV K+ + K+ DFG+S+ G
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQ 276
Query: 753 LP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 809
+P W APE LN + S + DV+SFGI+LWE + G PY N+ + R
Sbjct: 277 VPVKWTAPEALN--YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GR 333
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
P P C LMEQCWA +P RPSF+ I + L+ +
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-72
Identities = 84/280 (30%), Positives = 129/280 (46%), Gaps = 25/280 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
I ED+ + LG G FG VY G + +VA+K KK + + +F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-----CTLDNKE--KFM 61
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
EA I+ L HP++V G++++ P + E G L H L + L ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 751
++ M YL S N VH D+ N+LV + K+GDFGLS+ +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYKASVT 174
Query: 752 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808
LP WM+PE +N + + DV+ F + +WEIL+ G++P+ + +I G++
Sbjct: 175 RLPIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-GVLEKGD 231
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
R P P C LM +CW DP RP FTE+ L +
Sbjct: 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-72
Identities = 90/280 (32%), Positives = 138/280 (49%), Gaps = 25/280 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
I+ E +E + +G G FG V+ G + VAIK K +S+ R +F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-----TSDSVRE--KFL 64
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
+EA + + HP++V GV+ + P + + E G LR L ++ LD ++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 751
A + + YL SK VH D+ N+LV+ D K+GDFGLS+ ++ +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 752 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808
LP WMAPE +N + + DV+ FG+ +WEIL G +P+ + +I G + N
Sbjct: 178 KLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-GRIENGE 234
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
R P+P C LM +CWA DP RP FTE+ +L +
Sbjct: 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-72
Identities = 89/284 (31%), Positives = 128/284 (45%), Gaps = 24/284 (8%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEF 630
+I +DL L++LG G+FG V G+W VA+K +K + + + F
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD-----F 68
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
RE + L H N++ YGVV P + VTE GSL L + H
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGG 748
A+ A GM YL SK +H DL NLL+ +D + K+GDFGL + + +
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQ 181
Query: 749 VRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805
+P W APE L + S D + FG+ LWE+ T G+EP+ ++ I+ I
Sbjct: 182 EHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
R P P C + +M QCWA P RP+F + L
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 9e-72
Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 54/312 (17%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
++ L+ L+ G FG V+ + VA+K Q++ + + E
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF---------PIQDKQSWQNEYEVYS 71
Query: 637 LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
L + H N++ F G + G L +T F GSL L K + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129
Query: 695 AAFGMEYLHSK----------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---R 741
A G+ YLH I H D+K N+L+ K+ + + DFGL+ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--KNNLT--ACIADFGLALKFEAGK 185
Query: 742 NTLVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMH--- 795
+ T G GT +MAPE+L G+ ++D+++ G+VLWE+ +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 796 ---YGAIIGG----------IVNNTLRPPVPGFCDSEWRL-----LMEQCWAPDPVVRPS 837
+ IG +V+ RP + + + +E+CW D R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 838 FTEIARRLRVMS 849
+ R+ M
Sbjct: 306 AGCVGERITQMQ 317
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 5e-71
Identities = 92/277 (33%), Positives = 140/277 (50%), Gaps = 24/277 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
+K E++ LKELGSG FG V GKW+G DVA+K IK+ S ++ EF++EA+
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-----SMSED----EFFQEAQ 55
Query: 636 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
+ KL HP +V FYGV ++ P + VTE++ NG L + L S + L+ + L + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
GM +L S +H DL N LV+ KV DFG+++ + V P
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDL----CVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W APE+ + K S K DV++FGI++WE+ + G+ PY ++ V+ R
Sbjct: 169 VKWSAPEVFH--YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LKVSQGHRLY 225
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
P +M CW P RP+F ++ + +
Sbjct: 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 7e-71
Identities = 92/298 (30%), Positives = 133/298 (44%), Gaps = 27/298 (9%)
Query: 577 IKNEDLEELK-ELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
+K ++L ELG G FG+V G +R DVAIK +K+ G E
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTE---EMM 58
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
REA+I+ +L +P +V GV Q L V E G L L+ K + +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 749
+ GM+YL KN VH DL N+L+ + K+ DFGLSK ++ T
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAKISDFGLSKALGADDSYYTARS 171
Query: 750 RGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806
G P W APE +N K S + DV+S+G+ +WE L+ G++PY M ++ +
Sbjct: 172 AGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQ 228
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQNQ 864
R P C E LM CW RP F + +R+R + +K GH +
Sbjct: 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHHH 286
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-70
Identities = 95/274 (34%), Positives = 132/274 (48%), Gaps = 24/274 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I +DL LKELG+G FG V +GKWRG DVAIK IK+ S ++ EF EA+
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSED----EFIEEAK 71
Query: 636 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++ L H +V YGV + P + +TE+M NG L + L ++ L + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRP---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
MEYL SK +H DL N LVN + + KV DFGLS+ + T V P
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFP 184
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W PE+L SK S K D+++FG+++WEI + G+ PY I LR
Sbjct: 185 VRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLY 241
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P + +M CW RP+F + +
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-70
Identities = 85/280 (30%), Positives = 136/280 (48%), Gaps = 24/280 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I +L ++E+GSG FG V+ G W VAIK I++ + +E +F EAE
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEE----DFIEEAE 55
Query: 636 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++ KL HP +V YGV + P + VTEFM +G L L ++ L + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAP---ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
GM YL ++H DL N LV + KV DFG+++ + T P
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQ----VIKVSDFGMTRFVLDDQYTSSTGTKFP 168
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W +PE+ + S+ S K DV+SFG+++WE+ + G+ PY N ++ ++ R
Sbjct: 169 VKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLY 225
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851
P + +M CW P RP+F+ + R+L ++ +
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 5e-70
Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 27/289 (9%)
Query: 570 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQ 623
+ + L+I+K + +++K LGSG FGTVY G W VAIK ++++ +S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPK 59
Query: 624 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 683
E EA +++ + +P+V G+ + +T+ M G L + + ++
Sbjct: 60 ANK--EILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNI 114
Query: 684 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN 742
+ L + A GM YL + +VH DL N+LV K+ DFGL+K +
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAE 170
Query: 743 TLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAI 799
G +P WMA E + + + DV+S+G+ +WE++T G +PY + I
Sbjct: 171 EKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
Query: 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
I+ R P P C + ++M +CW D RP F E+ M
Sbjct: 229 S-SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 6e-70
Identities = 90/299 (30%), Positives = 140/299 (46%), Gaps = 42/299 (14%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 629
I + L+ + +LG G FG+V ++ VA+K+++ S +Q+R +
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQR---D 70
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
F RE +IL LH +V + GV +L V E++ +G LR L LD + L
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT---LV 745
+ + GMEYL S+ VH DL N+LV + K+ DFGL+K + + +V
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEA----HVKIADFGLAKLLPLDKDYYVV 186
Query: 746 TGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH-----YG 797
G P W APE L+ + S + DV+SFG+VL+E+ T ++ + G
Sbjct: 187 REP--GQSPIFWYAPESLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242
Query: 798 AIIGGIVNNTL--------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+ L R P P C +E LM+ CWAP P RPSF+ + +L ++
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 2e-69
Identities = 87/296 (29%), Positives = 126/296 (42%), Gaps = 27/296 (9%)
Query: 577 IKNEDLE-ELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
+ + L E KELGSG FGTV G ++ VA+K +K + + E
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN----EANDPALKD--ELL 66
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
EA ++ +L +P +V G+ + V E G L L + RH+ + + +
Sbjct: 67 AEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNK-YLQQNRHVKDKNIIEL 122
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 749
+ GM+YL N VH DL N+L+ + K+ DFGLSK
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQT 178
Query: 750 RGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806
G P W APE +N K S K DV+SFG+++WE + G++PY M + ++
Sbjct: 179 HGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEK 235
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQ 862
R P C E LM CW D RP F + RLR + H H
Sbjct: 236 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 2e-69
Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 34/287 (11%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
+ + + +G G FG VYHG A+K + + E +F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEVS--QFL 74
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
E I+ HPNV++ G+ G+ V +M +G LR+ + ++ + + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGG 748
+ A GM+YL SK VH DL N +++ K KV DFGL++ + V
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKF----TVKVADFGLARDMYDKEYYSVHNK 189
Query: 749 VRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIG 801
LP WMA E L + K + K DV+SFG++LWE++T G PY +++ ++
Sbjct: 190 TGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
Query: 802 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
G R P +C +M +CW P +RPSF+E+ R+ +
Sbjct: 248 GR-----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-69
Identities = 82/281 (29%), Positives = 126/281 (44%), Gaps = 34/281 (12%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+ +G G FG VYHG++ AIK + + Q+ F RE
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----EMQQVE--AFLREG 73
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++ L+HPNV+A G++ G + +M +G L + S +R+ + + +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN--TLVTGGVRG 751
A GMEYL + VH DL N +++ KV DFGL++ I V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESF----TVKVADFGLARDILDREYYSVQQHRHA 188
Query: 752 TLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIV 804
LP W A E L + + + K DV+SFG++LWE+LT G PY ++ + G
Sbjct: 189 RLPVKWTALESLQ--TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR- 245
Query: 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
R P P +C +M+QCW DP VRP+F + +
Sbjct: 246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-69
Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 33/290 (11%)
Query: 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQE 624
I+NEDL + LG GTF ++ G R T+V +K + K+
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYS 56
Query: 625 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 684
F+ A ++SKL H ++V YGV G V EF+ GSL L + ++
Sbjct: 57 E---SFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCIN 111
Query: 685 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR----PICKVGDFGLSKIK 740
+L +A A M +L ++H ++ N+L+ ++ + P K+ D G+S
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--- 168
Query: 741 RNTLVTGGVRGTLPWMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 798
L ++ +PW+ PE + N ++ D +SFG LWEI + G++P + +
Sbjct: 169 ITVLPKDILQERIPWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
Query: 799 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+ + + P P +E L+ C +P RPSF I R L +
Sbjct: 227 KLQFYEDR-HQLPAP--KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-69
Identities = 91/276 (32%), Positives = 130/276 (47%), Gaps = 26/276 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
++ D+ +LG G +G VY G W+ VA+K +K+ + E E EF +EA
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEA 60
Query: 635 EILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IA 692
++ ++ HPN+V GV ++ P +TEFM G+L L R L+ +A
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGT 752
+ MEYL KN +H DL N LV + KV DFGLS++ T
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 753 LP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 809
P W APE L +K S K DV++FG++LWEI T G PY + + + + R
Sbjct: 174 FPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR 230
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C + LM CW +P RPSF EI +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-69
Identities = 89/295 (30%), Positives = 130/295 (44%), Gaps = 40/295 (13%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
+ +++ ++ LG G FG VY G+ G VA+K + + C SEQ+ L +
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDEL--D 79
Query: 630 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLS------KERH 682
F EA I+SK +H N+V GV Q P + E M G L+ L +
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 683 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR 741
L L +A D A G +YL + +H D+ N L+ P R + K+GDFG+++ I R
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR 195
Query: 742 NTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH--- 795
+ G LP WM PE + K D +SFG++LWEI + G PY +
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
Query: 796 -YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
+ G R P C +M QCW P RP+F I R+ +
Sbjct: 254 VLEFVTSGG-----RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 6e-69
Identities = 89/298 (29%), Positives = 126/298 (42%), Gaps = 38/298 (12%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
I L K LG G FG+V G + VA+K +K SS++E EF
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL----DNSSQREIE--EFL 84
Query: 632 REAEILSKLHHPNVVAFYGVV-QDGPGGTLAT--VTEFMVNGSLRHVLLS-----KERHL 683
EA + HPNV+ GV + G + FM G L LL +H+
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 684 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN 742
+ L +D A GMEYL ++N +H DL N ++ V DFGLSK I
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM----TVCVADFGLSKKIYSG 200
Query: 743 TLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH---- 795
G +P W+A E L + K DV++FG+ +WEI T G PY +
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853
Y ++ G R P C E +M CW DP+ RP+F+ + +L + +
Sbjct: 259 YDYLLHGH-----RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 6e-69
Identities = 92/274 (33%), Positives = 136/274 (49%), Gaps = 28/274 (10%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ ++L+ L+ +G G FG V G +RG VA+K IK ++ Q F EA +
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQ-----AFLAEASV 67
Query: 637 LSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 694
+++L H N+V GV+ ++ L VTE+M GSL L S+ R + L+ ++D
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKG--GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
MEYL N VH DL N+LV+ + + KV DFGL+ + + G LP
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT---KE-ASSTQDTGKLP 177
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W APE L K S K DV+SFGI+LWEI + G PY + ++ V +
Sbjct: 178 VKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMD 234
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C +M+ CW D +RPSF ++ +L
Sbjct: 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-68
Identities = 93/282 (32%), Positives = 128/282 (45%), Gaps = 26/282 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
I+ + K +GSG G V +G+ R VAIK +K +E++R +F
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-----TERQRR--DFL 98
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
EA I+ + HPN++ GVV G VTE+M NGSL L + + + + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 749
GM YL VH DL N+LV+ +CKV DFGLS++
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL----VCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 750 RGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806
G +P W APE + S DV+SFG+V+WE+L GE PY NM +I V
Sbjct: 213 GGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-SSVEE 269
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
R P P C LM CW D RP F++I L +
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-68
Identities = 91/291 (31%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
I + + LG G FG+V + + VA+K +K + + EF
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA----DIIASSDIE--EFL 73
Query: 632 REAEILSKLHHPNVVAFYGVV-QDGPGGTLAT---VTEFMVNGSLRHVLLS-----KERH 682
REA + + HP+V GV + G L + FM +G L LL+ +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 683 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKR 741
L + + +D A GMEYL S+N +H DL N ++ V DFGLS KI
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM----TVCVADFGLSRKIYS 189
Query: 742 NTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH--- 795
G LP W+A E L + + DV++FG+ +WEI+T G+ PYA +
Sbjct: 190 GDYYRQGCASKLPVKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 796 -YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
Y +IGG R P C E LM QCW+ DP RPSFT + L
Sbjct: 248 IYNYLIGGN-----RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-68
Identities = 88/274 (32%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
+ E L+ ++ LG+G FG V+ G + G T VA+K +K+ S + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-----SMSPD----AFLAEAN 60
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 694
++ +L H +V Y VV P + +TE+M NGSL L + +L+ +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+++ + T P
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTL----SCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W APE +N + K DV+SFGI+L EI+T G PY M +I + R
Sbjct: 174 IKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMV 230
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C E LM CW P RP+F + L
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-68
Identities = 91/299 (30%), Positives = 135/299 (45%), Gaps = 41/299 (13%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 629
+ L+ L++LG G FG+V ++ VA+K+++ S +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLR----D 57
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
F RE EIL L H N+V + GV L + E++ GSLR L + +D K L
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 747
GMEYL +K +H DL N+LV ++ K+GDFGL+K + ++
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEFFKV 173
Query: 748 GVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT----------------GEE 789
G P W APE L SK S DV+SFG+VL+E+ T G +
Sbjct: 174 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 790 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
M +I + NN R P P C E ++M +CW + RPSF ++A R+ +
Sbjct: 232 KQGQMIVFHLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-68
Identities = 96/316 (30%), Positives = 141/316 (44%), Gaps = 47/316 (14%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
+ E + +ELG G+FG VY G +G T VAIK + ++ S +ER+ E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----SMRERI--E 74
Query: 630 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-- 686
F EA ++ + + +VV GVV Q P + E M G L+ L S +
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQP---TLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 687 ------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-K 738
++I +A + A GM YL++ VH DL N +V K+GDFG++
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF----TVKIGDFGMTRD 187
Query: 739 IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795
I G +G LP WM+PE L + DV+SFG+VLWEI T E+PY +
Sbjct: 188 IYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 796 ----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL-RVMSA 850
++ G P C LM CW +P +RPSF EI + M
Sbjct: 246 NEQVLRFVMEGG-----LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 851 ACQTKSHGHQVQNQVP 866
+ S + +N++P
Sbjct: 301 GFREVSFYYSEENKLP 316
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-68
Identities = 78/283 (27%), Positives = 122/283 (43%), Gaps = 27/283 (9%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 629
I K +L +LK LGSG FGTV+ G W V IK I+ S Q
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-----SGRQSFQ--A 61
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
+ L H ++V G+ L VT+++ GSL + L + L
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLL 118
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGG 748
+ A GM YL +VH +L N+L+ +V DFG++ + +
Sbjct: 119 NWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS----QVQVADFGVADLLPPDDKQLLY 174
Query: 749 VRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805
P WMA E ++ K + + DV+S+G+ +WE++T G EPYA + + ++
Sbjct: 175 SEAKTPIKWMALESIH--FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLE 231
Query: 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
R P C + ++M +CW D +RP+F E+A M
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 5e-68
Identities = 87/297 (29%), Positives = 134/297 (45%), Gaps = 37/297 (12%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLE 629
+ L+ +++LG G FG V ++ G VA+K +K S +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-----SGGNHIA--D 69
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
+E EIL L+H N+V + G+ + G + + EF+ +GSL+ L + ++ +++L
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 747
A+ GM+YL S+ VH DL N+LV + K+GDFGL+K I+ + T
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKAIETDKEYYTV 185
Query: 748 GVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH--------- 795
P W APE L SK DV+SFG+ L E+LT + + M
Sbjct: 186 KDDRDSPVFWYAPECLM--QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
Query: 796 YGAIIGGIVNNTL----RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+G + + NTL R P P C E LM +CW P R SF + +
Sbjct: 244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 5e-68
Identities = 88/373 (23%), Positives = 152/373 (40%), Gaps = 40/373 (10%)
Query: 491 PQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEG 550
P + ++ I+ P E L + + E+ Y +G
Sbjct: 6 PMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIE-----ELSTSLYKKAGSENLYFQG 60
Query: 551 RLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG-----TD 605
+ + ++ L + + + + +G G FG VYHG
Sbjct: 61 A-NTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 606 VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 665
A+K + + E +F E I+ HPNV++ G+ G+ V
Sbjct: 120 CAVKSLNRIT-----DIGEVS--QFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLP 171
Query: 666 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725
+M +G LR+ + ++ + + + + A GM++L SK VH DL N +++ K
Sbjct: 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-- 229
Query: 726 RPICKVGDFGLSK-IKRN--TLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIV 780
KV DFGL++ + V LP WMA E L + K + K DV+SFG++
Sbjct: 230 --TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVL 285
Query: 781 LWEILT-GEEPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 835
LWE++T G PY +++ ++ G R P +C +M +CW P +R
Sbjct: 286 LWELMTRGAPPYPDVNTFDITVYLLQGR-----RLLQPEYCPDPLYEVMLKCWHPKAEMR 340
Query: 836 PSFTEIARRLRVM 848
PSF+E+ R+ +
Sbjct: 341 PSFSELVSRISAI 353
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 6e-68
Identities = 91/283 (32%), Positives = 137/283 (48%), Gaps = 27/283 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEF 630
I + K +G+G FG VY G + VAIK +K +E++R+ +F
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----TEKQRV--DF 93
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
EA I+ + H N++ GV+ + +TE+M NG+L L K+ + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
+ A GM+YL + N VH DL N+LVN +CKV DFGLS++ +
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLEDDPEATYTT 207
Query: 751 --GTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805
G +P W APE ++ K + DV+SFGIV+WE++T GE PY + ++ +N
Sbjct: 208 SGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KAIN 264
Query: 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+ R P P C S LM QCW + RP F +I L +
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 8e-68
Identities = 97/334 (29%), Positives = 142/334 (42%), Gaps = 43/334 (12%)
Query: 541 RIQESDYEEGRLDLP---TAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVY 597
+Q +Y+ +L T P A IS L+ + +++ ++ LG G FG VY
Sbjct: 29 ELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVY 88
Query: 598 HGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650
G+ G VA+K + + C SEQ+ L +F EA I+SK +H N+V G
Sbjct: 89 EGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDEL--DFLMEALIISKFNHQNIVRCIG 141
Query: 651 VV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------IAMDAAFGMEYLH 703
V Q P + E M G L+ L + L +A D A G +YL
Sbjct: 142 VSLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP--WMAPEL 760
+ +H D+ N L+ P R + K+GDFG+++ I R G LP WM PE
Sbjct: 199 ENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 257
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH----YGAIIGGIVNNTLRPPVPGF 815
+ K D +SFG++LWEI + G PY + + G R P
Sbjct: 258 FM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-----RMDPPKN 310
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
C +M QCW P RP+F I R+ +
Sbjct: 311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 8e-68
Identities = 93/299 (31%), Positives = 138/299 (46%), Gaps = 41/299 (13%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 629
+ L+ L++LG G FG+V ++ VA+K+++ S + E R +
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLR---D 88
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
F RE EIL L H N+V + GV L + E++ GSLR L + +D K L
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 747
GMEYL +K +H DL N+LV ++ K+GDFGL+K + ++
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEYYKV 204
Query: 748 GVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT----------------GEE 789
G P W APE L SK S DV+SFG+VL+E+ T G +
Sbjct: 205 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
Query: 790 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
M +I + NN R P P C E ++M +CW + RPSF ++A R+ +
Sbjct: 263 KQGQMIVFHLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 8e-68
Identities = 70/325 (21%), Positives = 110/325 (33%), Gaps = 69/325 (21%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ ++L+ L+ +G G +G VY G VA+K S + F E I
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF--------SFANRQ---NFINEKNI 58
Query: 637 --LSKLHHPNVVAFYGVVQDGPGGT---LATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
+ + H N+ F + V E+ NGSL L D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116
Query: 692 AMDAAFGMEYLHS---------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742
A G+ YLH+ I H DL N+LV C + DFGLS
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG----TCVISDFGLSMRLTG 172
Query: 743 T---------LVTGGVRGTLPWMAPELLNGSSS-----KVSEKVDVFSFGIVLWEIL--- 785
GT+ +MAPE+L G+ + ++VD+++ G++ WEI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 786 TGEEPYANMH-----YGAIIGG----------IVNNTLRPPVPGFCDSEWRL------LM 824
T P ++ + +G + RP P +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 825 EQCWAPDPVVRPSFTEIARRLRVMS 849
E CW D R + R+ +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELM 317
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 2e-67
Identities = 103/355 (29%), Positives = 158/355 (44%), Gaps = 36/355 (10%)
Query: 503 SQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESD-YEEGRLDLPTAGIPL 561
+ S I+ P S +L NE + E+D Y E + T +P
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381
Query: 562 VDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCF 616
I+ E +E + +G G FG V+ G + VAIK K
Sbjct: 382 TRD----------YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-- 429
Query: 617 TGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 676
+S+ R +F +EA + + HP++V GV+ + P + + E G LR L
Sbjct: 430 ---TSDSVRE--KFLQEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFL 481
Query: 677 LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736
++ LD ++ A + + YL SK VH D+ N+LV+ D K+GDFGL
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGL 537
Query: 737 SKIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 793
S+ ++ +G LP WMAPE +N + + DV+ FG+ +WEIL G +P+
Sbjct: 538 SRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQG 595
Query: 794 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+ +I G + N R P+P C LM +CWA DP RP FTE+ +L +
Sbjct: 596 VKNNDVI-GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 5e-67
Identities = 99/323 (30%), Positives = 154/323 (47%), Gaps = 31/323 (9%)
Query: 531 ESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGS 590
E+L ++V H ++D RL P V + + + ++L+ L+ +G
Sbjct: 147 ENLM-QLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYR--SGWALNMKELKLLQTIGK 203
Query: 591 GTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650
G FG V G +RG VA+K IK +++ F EA ++++L H N+V G
Sbjct: 204 GEFGDVMLGDYRGNKVAVKCIK----NDATAQ------AFLAEASVMTQLRHSNLVQLLG 253
Query: 651 VV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDAAFGMEYLHSKNIV 708
V+ ++ L VTE+M GSL L S+ R + L+ ++D MEYL N V
Sbjct: 254 VIVEEKG--GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 709 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLNGSSS 766
H DL N+LV+ + + KV DFGL+K + ++ G LP W APE L
Sbjct: 312 HRDLAARNVLVSEDN----VAKVSDFGLTK-EASSTQDT---GKLPVKWTAPEALR--EK 361
Query: 767 KVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLME 825
K S K DV+SFGI+LWEI + G PY + ++ + + P C +M+
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYDVMK 420
Query: 826 QCWAPDPVVRPSFTEIARRLRVM 848
CW D RP+F ++ +L +
Sbjct: 421 NCWHLDAATRPTFLQLREQLEHI 443
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 7e-67
Identities = 92/304 (30%), Positives = 126/304 (41%), Gaps = 54/304 (17%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
I + ++ELG FG VY G G VAIK +K R E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-----EGPLRE--E 58
Query: 630 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 688
F EA + ++L HPNVV GVV +D P L+ + + +G L L+ + H D
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 689 ---------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733
+ + A GMEYL S ++VH DL N+LV K K+ D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL----NVKISD 171
Query: 734 FGLS-KIKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GE 788
GL ++ LP WMAPE ++ G K S D++S+G+VLWE+ + G
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFSYGL 228
Query: 789 EPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
+PY I P P C + LM +CW P RP F +I R
Sbjct: 229 QPYCGYSNQDVVEMIRNRQ-----VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
Query: 845 LRVM 848
LR
Sbjct: 284 LRAW 287
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-66
Identities = 88/282 (31%), Positives = 130/282 (46%), Gaps = 26/282 (9%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 631
+ ++ K +G+G FG V G+ + VAIK +K +E++R +F
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-----TEKQRR--DFL 94
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
EA I+ + HPN++ GVV + VTE+M NGSL L + + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 749
A GM+YL VH DL N+L+N +CKV DFGL ++
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNL----VCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 750 RGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806
G +P W +PE + K + DV+S+GIVLWE+++ GE PY M +I V+
Sbjct: 209 GGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDE 265
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
R P P C + LM CW D RP F +I L +
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-66
Identities = 102/344 (29%), Positives = 154/344 (44%), Gaps = 31/344 (9%)
Query: 531 ESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGS 590
+L E+V+H +D L P + + + ++ + D+ +LG
Sbjct: 173 NTLA-ELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEM-ERTDITMKHKLGG 230
Query: 591 GTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648
G +G VY G W+ VA+K +K+ + E E EF +EA ++ ++ HPN+V
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEAAVMKEIKHPNLVQL 281
Query: 649 YGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDAAFGMEYLHSKN 706
GV ++ P +TEFM G+L L R L+ +A + MEYL KN
Sbjct: 282 LGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 707 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLNGS 764
+H +L N LV + KV DFGLS++ T P W APE L
Sbjct: 339 FIHRNLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA-- 392
Query: 765 SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLL 823
+K S K DV++FG++LWEI T G PY + + + + R P C + L
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVYEL 451
Query: 824 MEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQNQVPK 867
M CW +P RPSF EI + M Q S +V+ ++ K
Sbjct: 452 MRACWQWNPSDRPSFAEIHQAFETM---FQESSISDEVEKELGK 492
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-66
Identities = 93/307 (30%), Positives = 132/307 (42%), Gaps = 55/307 (17%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
IK D+ +ELG G FG V+ + VA+K +K + R +
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAARK--D 63
Query: 630 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVL------------ 676
F REAE+L+ L H ++V FYGV P L V E+M +G L L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 677 ---LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733
+ L + L IA A GM YL S++ VH DL N LV + K+GD
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL----LVKIGD 176
Query: 734 FGLSK-IKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GE 788
FG+S+ + G LP WM PE ++ K + + DV+SFG++LWEI T G+
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGK 233
Query: 789 EPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
+P+ + I G P C E +M CW +P R + EI +
Sbjct: 234 QPWFQLSNTEVIECITQGR-----VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 845 LRVMSAA 851
L + A
Sbjct: 289 LHALGKA 295
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-66
Identities = 94/274 (34%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E L +LG G FG V+ G W G T VAIK +K + E F +EA+
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 231
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 694
++ KL H +V Y VV + P + VTE+M GSL L + R +L+ +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ + T P
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W APE + + K DV+SFGI+L E+ T G PY M ++ + R P
Sbjct: 345 IKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C LM QCW +P RP+F + L
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-65
Identities = 78/305 (25%), Positives = 131/305 (42%), Gaps = 39/305 (12%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 629
+ L+++++LG G FG V + VA+K +K +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSG 79
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
+ +E +IL L+H +++ + G +D +L V E++ GSLR L + + L
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLL 137
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 747
+ A GM YLH+++ +H DL N+L++ + K+GDFGL+K +
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAVPEGHEYYRV 193
Query: 748 GVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAII---- 800
G P W APE L K DV+SFG+ L+E+LT + + +
Sbjct: 194 REDGDSPVFWYAPECLK--EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
Query: 801 -GGIVNNTL--------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851
G + L R P P C +E LM+ CW + RP+F + L+ +
Sbjct: 252 QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
Query: 852 CQTKS 856
Q ++
Sbjct: 312 YQGQA 316
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 8e-65
Identities = 95/304 (31%), Positives = 134/304 (44%), Gaps = 51/304 (16%)
Query: 570 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQER 625
D + ++ D++ +G G FG V + + D AIKR+K+ +S+ +
Sbjct: 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH 69
Query: 626 LTLEFWREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVL------- 676
+F E E+L KL HHPN++ G G L E+ +G+L L
Sbjct: 70 R--DFAGELEVLCKLGHHPNIINLLGACEHRGY---LYLAIEYAPHGNLLDFLRKSRVLE 124
Query: 677 --------LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 728
S L ++ L A D A GM+YL K +H DL N+LV +
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY----V 180
Query: 729 CKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
K+ DFGLS+ + + G LP WMA E LN S + DV+S+G++LWEI++
Sbjct: 181 AKIADFGLSRGQEVYVKKTM--GRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVS 236
Query: 787 -GEEPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
G PY M Y + G R P CD E LM QCW P RPSF +I
Sbjct: 237 LGGTPYCGMTCAELYEKLPQGY-----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 291
Query: 842 ARRL 845
L
Sbjct: 292 LVSL 295
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-64
Identities = 95/303 (31%), Positives = 134/303 (44%), Gaps = 54/303 (17%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
IK D+ ELG G FG V+ + VA+K +K++ SE R +
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 89
Query: 630 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-- 686
F REAE+L+ L H ++V F+GV + P L V E+M +G L L S
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRP---LLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 687 -----------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734
+L+ +A A GM YL + VH DL N LV + K+GDF
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL----VVKIGDF 202
Query: 735 GLSK-IKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEE 789
G+S+ I G R LP WM PE +L K + + DV+SFG+VLWEI T G++
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGKQ 259
Query: 790 PYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P+ + I G P C E +M CW +P R S ++ RL
Sbjct: 260 PWYQLSNTEAIDCITQGR-----ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314
Query: 846 RVM 848
+ +
Sbjct: 315 QAL 317
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-64
Identities = 91/274 (33%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E L+ K+LG+G FG V+ + T VA+K +K S E F EA
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVE----AFLAEAN 235
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 694
++ L H +V + VV P + +TEFM GSL L S E +LI +
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
A GM ++ +N +H DL+ N+LV+ +CK+ DFGL+++ + T P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W APE +N + K DV+SFGI+L EI+T G PY M +I + R P
Sbjct: 349 IKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C E +M +CW P RP+F I L
Sbjct: 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-64
Identities = 98/357 (27%), Positives = 148/357 (41%), Gaps = 28/357 (7%)
Query: 503 SQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP--TAGIP 560
S ++S T+ HP + ++L S+ + +P T+
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316
Query: 561 LVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCF 616
L + ++ L ELG G FG+V G +R DVAIK +K+
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT- 375
Query: 617 TGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 676
++ T E REA+I+ +L +P +V GV Q L V E G L L
Sbjct: 376 ------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFL 426
Query: 677 LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736
+ K + + + GM+YL KN VH +L N+L+ + K+ DFGL
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----YAKISDFGL 482
Query: 737 SKI--KRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 791
SK ++ T G P W APE +N K S + DV+S+G+ +WE L+ G++PY
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
M G + + R P C E LM CW RP F + +R+R
Sbjct: 541 KKMK-GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 6e-64
Identities = 94/274 (34%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E L +LG G FG V+ G W G T VAIK +K + E F +EA+
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 314
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 694
++ KL H +V Y VV + P + VTE+M GSL L + R +L+ +A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ + T P
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 755 --WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811
W APE + + K DV+SFGI+L E+ T G PY M ++ + R P
Sbjct: 428 IKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C LM QCW +P RP+F + L
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-64
Identities = 85/312 (27%), Positives = 125/312 (40%), Gaps = 62/312 (19%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
++E ++++G G FG V+ + G T VA+K +K+ S + +
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----SADMQA--D 96
Query: 630 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-- 686
F REA ++++ +PN+V GV P + + E+M G L L S H
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKP---MCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 687 --------------------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725
+ IA A GM YL + VH DL N LV
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-- 211
Query: 726 RPICKVGDFGLS-KIKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVL 781
+ K+ DFGLS I +P WM PE + + + + DV+++G+VL
Sbjct: 212 --VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVL 266
Query: 782 WEILT-GEEPYANMH----YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRP 836
WEI + G +PY M + G P C E LM CW+ P RP
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYVRDGN-----ILACPENCPLELYNLMRLCWSKLPADRP 321
Query: 837 SFTEIARRLRVM 848
SF I R L+ M
Sbjct: 322 SFCSIHRILQRM 333
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-63
Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 47/296 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEF 630
+ L K LG G FG V + G VA+K +K +E++ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDLS--DL 87
Query: 631 WREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK--------- 679
E E++ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 680 ------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733
E + + + A GMEYL S+ +H DL N+LV + + K+ D
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN----VMKIAD 200
Query: 734 FGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEE 789
FGL+ I G LP WMAPE L + + DV+SFG+++WEI T G
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 790 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
PY + + + R P C +E ++M CW P RP+F ++ L
Sbjct: 259 PYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-63
Identities = 89/301 (29%), Positives = 126/301 (41%), Gaps = 52/301 (17%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
++L K LG G FG V T VA+K +K++ S E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSELR--DLLS 75
Query: 633 EAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK------------ 679
E +L +++HP+V+ YG QDGP L + E+ GSLR L
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 680 -----------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 728
ER L + A + GM+YL +VH DL N+LV
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR----K 188
Query: 729 CKVGDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785
K+ DFGLS + +G +P WMA E L + + DV+SFG++LWEI+
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIV 246
Query: 786 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
T G PY + + + R P C E LM QCW +P RP F +I++
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
Query: 845 L 845
L
Sbjct: 306 L 306
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 6e-63
Identities = 87/296 (29%), Positives = 126/296 (42%), Gaps = 46/296 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
L K LG+G FG V G VA+K +K S + ER
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTERE--ALMS 75
Query: 633 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK----------- 679
E ++LS L +H N+V G GP +TE+ G L + L K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP---TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 680 ------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733
E LD L + A GM +L SKN +H DL N+L+ I K+ D
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR----ITKICD 188
Query: 734 FGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEE 789
FGL+ IK ++ LP WMAPE + + + + DV+S+GI LWE+ + G
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 790 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
PY M + ++ R P +E +M+ CW DP+ RP+F +I + +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 7e-63
Identities = 83/298 (27%), Positives = 122/298 (40%), Gaps = 45/298 (15%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 629
+ L+ K LG G FG V G VA+K +K+ + E
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THSEHR--A 76
Query: 630 FWREAEILSKL-HHPNVVAFYGVV--QDGPGGTLATVTEFMVNGSLRHVLLSK------- 679
E +IL + HH NVV G GP L + EF G+L L SK
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 680 --------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731
+ L + + A GME+L S+ +H DL N+L++ K+ + K+
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKI 189
Query: 732 GDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 787
DFGL+ I ++ LP WMAPE + + + DV+SFG++LWEI + G
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 788 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
PY + + R P + E M CW +P RP+F+E+ L
Sbjct: 248 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 4e-62
Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 47/296 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEF 630
+ L K LG G FG V + G VA+K +K +E++ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDLS--DL 133
Query: 631 WREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK--------- 679
E E++ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 680 ------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733
E + + + A GMEYL S+ +H DL N+LV + + K+ D
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN----VMKIAD 246
Query: 734 FGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEE 789
FGL+ I G LP WMAPE L + + DV+SFG+++WEI T G
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGS 304
Query: 790 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
PY + + + R P C +E ++M CW P RP+F ++ L
Sbjct: 305 PYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-62
Identities = 87/300 (29%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLT 627
+ + L K LG G FG V + G T VA+K +K ++E++
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLS- 119
Query: 628 LEFWREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK------ 679
+ E E++ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 120 -DLISEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLQARRPPGLE 175
Query: 680 ---------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730
E L + + A A GMEYL SK +H DL N+LV + + K
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN----VMK 231
Query: 731 VGDFGLS-KIKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT 786
+ DFGL+ I G LP WMAPE L + + + DV+SFG++LWEI T
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVLLWEIFT 288
Query: 787 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
G PY + + + R P C +E ++M CW P RP+F ++ L
Sbjct: 289 LGGSPYPGVPVEELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 4e-61
Identities = 83/293 (28%), Positives = 129/293 (44%), Gaps = 44/293 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
+L+ K LG+G FG V G VA+K +K + E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADEKE--ALMS 98
Query: 633 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR---- 686
E +I+S L H N+V G GP + +TE+ G L + L K R L+
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP---VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 687 --------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737
+ L+ + A GM +L SKN +H D+ N+L+ + K+GDFGL+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH----VAKIGDFGLA 211
Query: 738 -KIKRNTLVTGGVRGTLP--WMAPE-LLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 792
I ++ LP WMAPE + + + + DV+S+GI+LWEI + G PY
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFSLGLNPYP 268
Query: 793 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
+ + +V + + P F +M+ CWA +P RP+F +I L
Sbjct: 269 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-60
Identities = 89/301 (29%), Positives = 126/301 (41%), Gaps = 51/301 (16%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
E+LE K LGSG FG V + G VA+K +K+ ER
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-----DSSERE--ALMS 97
Query: 633 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK----------- 679
E +++++L H N+V G GP + + E+ G L + L SK
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGP---IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 680 -----------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 728
L L A A GME+L K+ VH DL N+LV +
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK----V 210
Query: 729 CKVGDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785
K+ DFGL+ I ++ LP WMAPE L + K DV+S+GI+LWEI
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIF 268
Query: 786 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
+ G PY + A ++ N + P + E ++M+ CWA D RPSF +
Sbjct: 269 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
Query: 845 L 845
L
Sbjct: 329 L 329
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-59
Identities = 77/262 (29%), Positives = 125/262 (47%), Gaps = 21/262 (8%)
Query: 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
E+G G+F TVY G +VA ++ + ++ ER + EAE+L L HP
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDR----KLTKSERQRFK--EEAEMLKGLQHP 85
Query: 644 NVVAFYGVVQDGPGG--TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
N+V FY + G + VTE M +G+L+ L + + + + G+++
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQF 144
Query: 702 LHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 759
LH++ I+H DLKCDN+ + K+GD GL+ +KR + V GT +MAPE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASFAKA-VIGTPEFMAPE 200
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV-PGFCDS 818
+ K E VDV++FG+ + E+ T E PY+ A I V + ++P
Sbjct: 201 MYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 819 EWRLLMEQCWAPDPVVRPSFTE 840
E + ++E C + R S +
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKD 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-53
Identities = 67/265 (25%), Positives = 101/265 (38%), Gaps = 22/265 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ + L LG G++G V+ + + A+KR R + L E
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP---FRGPKDRARKL---AEVGSH 110
Query: 638 SKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
K+ HP V ++G G L TE SL+ + L + D
Sbjct: 111 EKVGQHPCCVRLEQAWEEG--GILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
+ +LHS+ +VH D+K N+ + + CK+GDFGL G +M
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRG----RCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
APELL GS DVFS G+ + E+ E H G + L P
Sbjct: 224 APELLQGSYGT---AADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPEFTAGL 277
Query: 817 DSEWRLLMEQCWAPDPVVRPSFTEI 841
SE R ++ PDP +R + +
Sbjct: 278 SSELRSVLVMMLEPDPKLRATAEAL 302
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-51
Identities = 72/256 (28%), Positives = 114/256 (44%), Gaps = 19/256 (7%)
Query: 588 LGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645
LG GT+G VY G +AIK I + + L E + L H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPER------DSRYSQPLH--EEIALHKHLKHKNI 81
Query: 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGMEYLH 703
V + G + G + E + GSL +L SK L ++ I G++YLH
Sbjct: 82 VQYLGSFSEN--GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLN 762
IVH D+K DN+L+N + K+ DFG SK + T GTL +MAPE+++
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGV---LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 763 GSSSKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPPVPGFCDSEWR 821
+ D++S G + E+ TG+ P+ + A + + + P +P +E +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 822 LLMEQCWAPDPVVRPS 837
+ +C+ PDP R
Sbjct: 257 AFILKCFEPDPDKRAC 272
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-50
Identities = 68/279 (24%), Positives = 121/279 (43%), Gaps = 41/279 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D +E++ +GSG FG V+ K R G IKR+K + +E+ RE + L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAE------REVKAL 58
Query: 638 SKLHHPNVVAFYGVVQDG--------------PGGTLATVTEFMVNGSLRHVL-LSKERH 682
+KL H N+V + G L EF G+L + +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 683 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742
LD+ L + G++Y+HSK +++ DLK N+ + + K+GDFGL +N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV----KIGDFGLVTSLKN 174
Query: 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 802
+GTL +M+PE ++ ++VD+++ G++L E+L +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFETS------K 226
Query: 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ + D + + L+++ + P RP+ +EI
Sbjct: 227 FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-49
Identities = 66/285 (23%), Positives = 111/285 (38%), Gaps = 39/285 (13%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ EL+++GSG FG+V+ R G AIKR KK G EQ L RE
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP-LAGSVDEQNAL-----REVYA 63
Query: 637 LSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRKRLIIA 692
+ L H +VV ++ + + E+ GSL + R + + +
Sbjct: 64 HAVLGQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP---------------ICKVGDFGLS 737
+ G+ Y+HS ++VH D+K N+ ++ + K+GD G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-Y 796
+ V G ++A E+L + + K D+F+ + + E N +
Sbjct: 182 TRISSPQV---EEGDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 797 GAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
I G + P +P E+ L++ PDP RPS +
Sbjct: 238 HEIRQGRL-----PRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-48
Identities = 66/284 (23%), Positives = 124/284 (43%), Gaps = 24/284 (8%)
Query: 562 VDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGR 619
VDL N ++ E L+++G G+FG K IK I S R
Sbjct: 11 VDLGTENLYFQSM-----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS----R 61
Query: 620 SSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-LS 678
S +ER RE +L+ + HPN+V + ++ G+L V ++ G L +
Sbjct: 62 MSSKEREESR--REVAVLANMKHPNIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQ 117
Query: 679 KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
K + L + ++++H + I+H D+K N+ + + ++GDFG+++
Sbjct: 118 KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTV----QLGDFGIAR 173
Query: 739 I-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 797
+ + GT +++PE+ + K D+++ G VL+E+ T + +
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKP--YNNKSDIWALGCVLYELCTLKHAFEAGSMK 231
Query: 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
++ I++ + PPV + R L+ Q + +P RPS I
Sbjct: 232 NLVLKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-48
Identities = 85/299 (28%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 582 LEELKE----------LGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQ-ERLTLE 629
L +L+E +G G FG VY G R G VA+KR S Q E
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT------PESSQGIE---E 81
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRR 686
F E E LS HP++V+ G + + + ++M NG+L+ L + +
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 687 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNT 743
+RL I + AA G+ YLH++ I+H D+K N+L L + P K+ DFG+SK T
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINIL--LDENFVP--KITDFGISKKGTELDQT 195
Query: 744 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN---------- 793
++ V+GTL ++ PE +++EK DV+SFG+VL+E+L
Sbjct: 196 HLSTVVKGTLGYIDPEYF--IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 794 -----MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLM--EQCWAPDPVVRPSFTEIARRL 845
H + IV+ L + +S + +C A RPS ++ +L
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 61/292 (20%), Positives = 112/292 (38%), Gaps = 46/292 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D EE+ LG G FG V + AIK+I+ + + + E +L
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTIL----SEVMLL 56
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLAT-----------VTEFMVNGSLRHVLLSKERHLDRR 686
+ L+H VV +Y + E+ NG+L ++ S+ + R
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 687 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 746
+ + + Y+HS+ I+H DLK N+ ++ + K+GDFGL+K +L
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV----KIGDFGLAKNVHRSLDI 172
Query: 747 GGVR---------------GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+ GT ++A E+L+G+ +EK+D++S GI+ +E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 792 ANMH--YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ + P + ++ DP RP +
Sbjct: 232 MERVNILKKLRSVSIE--FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 74/229 (32%), Positives = 116/229 (50%), Gaps = 27/229 (11%)
Query: 565 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQ- 623
NFD + + N+ +G G FG VY G T VA+K++ ++E+
Sbjct: 23 VTNNFDERPISVGGNK-------MGEGGFGVVYKGYVNNTTVAVKKLAAM--VDITTEEL 73
Query: 624 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-- 681
++ +F +E ++++K H N+V G DG L V +M NGSL L +
Sbjct: 74 KQ---QFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 682 HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-- 739
L R IA AA G+ +LH + +H D+K N+L L + K+ DFGL++
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL--LDEAFTA--KISDFGLARASE 184
Query: 740 -KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
T++T + GT +MAPE L G +++ K D++SFG+VL EI+TG
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITG 230
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 45/290 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D E ++ LG G FG V+ K + D AIKRI+ + E R + RE + L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-----NRELARE--KVMREVKAL 57
Query: 638 SKLHHPNVVAFYGVVQDGP----------GGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
+KL HP +V ++ + L + +L+ + + +R +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 688 RLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-- 743
+ I + A +E+LHSK ++H DLK N+ + D + KVGDFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV----KVGDFGLVTAMDQDEE 173
Query: 744 ------------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
TG V GT +M+PE ++G+S S KVD+FS G++L+E+L
Sbjct: 174 EQTVLTPMPAYARHTGQV-GTKLYMSPEQIHGNSY--SHKVDIFSLGLILFELLYP--FS 228
Query: 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
M + + N PP+ ++++ +P P+ RP I
Sbjct: 229 TQMERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-47
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 24/276 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED E L +G+G++G + + + K + +E E+ L E +L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG----SMTEAEKQMLV--SEVNLL 59
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---LSKERHLDRRKRLIIAMD 694
+L HPN+V +Y + D TL V E+ G L V+ + ++LD L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 695 AAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGG 748
++ H ++ ++H DLK N+ ++ K + K+GDFGL++I +T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV----KLGDFGLARILNHDTSFAKT 175
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808
GT +M+PE +N +EK D++S G +L+E+ P+ + G I
Sbjct: 176 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
+P E ++ + RPS EI
Sbjct: 234 -RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 67/290 (23%), Positives = 124/290 (42%), Gaps = 23/290 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ K++G G F VY VA+K+++ + R +E ++L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ---IFDLMDAKARADCI--KEIDLL 86
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---LSKERHLDRRKRLIIAMD 694
+L+HPNV+ +Y + L V E G L ++ ++R + R +
Sbjct: 87 KQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGTL 753
+E++HS+ ++H D+K N+ + + K+GD GL + + + GT
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVV----KLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA--NMHYGAIIGGIVNNTLRPP 811
+M+PE ++ + + K D++S G +L+E+ + P+ M+ ++ I PP
Sbjct: 201 YYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-PP 257
Query: 812 VP-GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQ 860
+P E R L+ C PDP RP T + + M A + H
Sbjct: 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-46
Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 30/261 (11%)
Query: 586 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+G G+FG V+ K G A+K+++ E E + L P
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVE--------ELVACAGLSSP 110
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+V YG V++GP + E + GSL L+ + L + L A G+EYLH
Sbjct: 111 RIVPLYGAVREGP--WVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH 167
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK------IKRNTLVTGGVRGTLPWMA 757
++ I+H D+K DN+L++ + DFG + + ++ L + GT MA
Sbjct: 168 TRRILHGDVKADNVLLSSDG---SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LRPPVPGFC 816
PE++ G KVD++S ++ +L G P+ G + I + +P C
Sbjct: 225 PEVVMGKPC--DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282
Query: 817 DSEWRLLMEQCWAPDPVVRPS 837
+++ +PV R S
Sbjct: 283 APLTAQAIQEGLRKEPVHRAS 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-46
Identities = 70/306 (22%), Positives = 115/306 (37%), Gaps = 31/306 (10%)
Query: 567 GNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQE 624
+ + II N+ +++LG G F V + G A+KRI +Q+
Sbjct: 16 NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH------EQQD 69
Query: 625 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVL---LSK 679
R + REA++ +HPN++ G + F G+L + + K
Sbjct: 70 REEAQ--READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127
Query: 680 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739
L + L + + G+E +H+K H DLK N+L+ + + D G
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP----VLMDLGSMNQ 183
Query: 740 KRNTLVT----------GGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGE 788
+ R T+ + APEL + S + E+ DV+S G VL+ ++ GE
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 789 EPY-ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847
PY G + V N L P S L+ DP RP + +L
Sbjct: 244 GPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
Query: 848 MSAACQ 853
+
Sbjct: 304 LQPPAP 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-45
Identities = 74/282 (26%), Positives = 124/282 (43%), Gaps = 24/282 (8%)
Query: 570 DISTLQIIKNEDLEELKELGSGTFGTVYH-GKWRGTDVAIKRIKKSCFTGRSSEQERLTL 628
+ +++ I+ LG G GT+ + G + DVA+KRI CF+
Sbjct: 14 EETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD-------- 65
Query: 629 EFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
RE ++L + HPNV+ ++ +D E +L+ + K+ +
Sbjct: 66 ---REVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIEL-CAATLQEYVEQKDFAHLGLE 119
Query: 688 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC-KVGDFGLSKI----KRN 742
+ + G+ +LHS NIVH DLK N+L+++ + I + DFGL K + +
Sbjct: 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 743 TLVTGGVRGTLPWMAPELLNGSSSK-VSEKVDVFSFGIVLWEILT-GEEPYANMHYGAII 800
GV GT W+APE+L+ + + VD+FS G V + +++ G P+
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239
Query: 801 GGIVNNTLRPPVP-GFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ +L P D R L+E+ A DP RPS +
Sbjct: 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-44
Identities = 80/213 (37%), Positives = 113/213 (53%), Gaps = 24/213 (11%)
Query: 588 LGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 646
LG G FG VY G+ GT VA+KR+K+ G E +F E E++S H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG----EL---QFQTEVEMISMAVHRNLL 90
Query: 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH---LDRRKRLIIAMDAAFGMEYLH 703
G L V +M NGS+ L + LD KR IA+ +A G+ YLH
Sbjct: 91 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 704 SK---NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTLPWMAP 758
I+H D+K N+L L + VGDFGL+K+ ++T VT VRGT+ +AP
Sbjct: 149 DHCDPKIIHRDVKAANIL--LDEEFEA--VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 204
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
E L S+ K SEK DVF +G++L E++TG+ +
Sbjct: 205 EYL--STGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 5e-44
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 17/233 (7%)
Query: 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
Q N LG G V+ G+ + G AIK F + R
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQM----R 56
Query: 633 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLI 690
E E+L KL+H N+V + + ++ + EF GSL VL L + LI
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
+ D GM +L IVH ++K N++ + + + + K+ DFG ++ + +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 751 GTLPWMAPELLNGSSSKV------SEKVDVFSFGIVLWEILTGEEPYANMHYG 797
GT ++ P++ + + VD++S G+ + TG P+
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 62/286 (21%), Positives = 114/286 (39%), Gaps = 41/286 (14%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
+K LK++GSG V+ AIK + ++ + + E
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------YRNEIA 78
Query: 636 ILSKLHHPN--VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
L+KL + ++ Y + V E N L L K+ +D +R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWK 134
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--------IKRNTLV 745
+ + +H IVH DLK N L+ + K+ DFG++ + +++ V
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 746 TGGVRGTLPWMAPELLNGSS---------SKVSEKVDVFSFGIVLWEILTGEEPYANM-H 795
GT+ +M PE + S SK+S K DV+S G +L+ + G+ P+ + +
Sbjct: 190 -----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ + I++ P + + + +++ C DP R S E+
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-43
Identities = 62/286 (21%), Positives = 114/286 (39%), Gaps = 41/286 (14%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
+K LK++GSG V+ AIK + ++ + + E
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------YRNEIA 59
Query: 636 ILSKLHHPN--VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
L+KL + ++ Y + V E N L L K+ +D +R
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWK 115
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--------IKRNTLV 745
+ + +H IVH DLK N L+ + K+ DFG++ + +++ V
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 746 TGGVRGTLPWMAPELLNGSS---------SKVSEKVDVFSFGIVLWEILTGEEPYANM-H 795
GT+ +M PE + S SK+S K DV+S G +L+ + G+ P+ + +
Sbjct: 171 -----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ + I++ P + + + +++ C DP R S E+
Sbjct: 226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 64/320 (20%), Positives = 122/320 (38%), Gaps = 41/320 (12%)
Query: 543 QESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR 602
+ + + R + + + D + + +K LK++GSG V+
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE 78
Query: 603 -GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQDGPGGT 659
AIK + + Q + E L+KL + ++ Y
Sbjct: 79 KKQIYAIKYVNLE----EADNQTLDSYR--NEIAYLNKLQQHSDKIIRLYDYEITD--QY 130
Query: 660 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 719
+ V E N L L K+ +D +R + + +H IVH DLK N L+
Sbjct: 131 IYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 188
Query: 720 NLKDPIRPICKVGDFGLSK--------IKRNTLVTGGVRGTLPWMAPELLNGSS------ 765
+ K+ DFG++ + +++ V G + +M PE + S
Sbjct: 189 V-----DGMLKLIDFGIANQMQPDTTSVVKDSQV-----GAVNYMPPEAIKDMSSSRENG 238
Query: 766 ---SKVSEKVDVFSFGIVLWEILTGEEPYANM-HYGAIIGGIVNNTLRPPVPGFCDSEWR 821
SK+S K DV+S G +L+ + G+ P+ + + + + I++ P + + +
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 298
Query: 822 LLMEQCWAPDPVVRPSFTEI 841
+++ C DP R S E+
Sbjct: 299 DVLKCCLKRDPKQRISIPEL 318
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-42
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 17/226 (7%)
Query: 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
Q N LG G V+ G+ + G AIK F + R
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQM----R 56
Query: 633 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLI 690
E E+L KL+H N+V + + ++ + EF GSL VL L + LI
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
+ D GM +L IVH ++K N++ + + + + K+ DFG ++ + +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 751 GTLPWMAPELLNGSSSKV------SEKVDVFSFGIVLWEILTGEEP 790
GT ++ P++ + + VD++S G+ + TG P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 79/284 (27%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 575 QIIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTL 628
+ ++ D E + ELG G FG VY K + T A K I+ +E L
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-------SEEELE- 61
Query: 629 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 688
++ E EIL+ HP +V G G L + EF G++ ++L +R L +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 689 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRN 742
++ + +LHSK I+H DLK N+L+ L+ I ++ DFG+S KR+
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDI----RLADFGVSAKNLKTLQKRD 175
Query: 743 TLVTGGVRGTLPWMAPELLNGSSSKVS---EKVDVFSFGIVLWEILTGEEPYANMHYGAI 799
+ + GT WMAPE++ + K + K D++S GI L E+ E P+ ++ +
Sbjct: 176 SFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230
Query: 800 IGGIVNNTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTE 840
+ I + PP P E+R ++ +P RPS +
Sbjct: 231 LLKIAKS--DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 45/287 (15%)
Query: 586 KELGSGTFGTVYH-GKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 643
K LG G+ GTV G ++G VA+KR+ E ++L++ HP
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----------IALMEIKLLTESDDHP 69
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------IAMDAAF 697
NV+ +Y L E N +L+ ++ SK + K + A
Sbjct: 70 NVIRYYCSETTD--RFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC---------KVGDFGLSKIKRN-----T 743
G+ +LHS I+H DLK N+LV+ + DFGL K +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 744 LVTGGVRGTLPWMAPELLNGSSS-----KVSEKVDVFSFGIVLWEILT-GEEPYA--NMH 795
GT W APELL S++ +++ +D+FS G V + IL+ G+ P+
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 796 YGAIIGGIVN-NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
II GI + + ++ +E L+ Q DP+ RP+ ++
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 76/269 (28%), Positives = 118/269 (43%), Gaps = 29/269 (10%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKS-CFTGRSSEQERLTLEFWREAEI 636
ED E + LG G FG VY + + + +A+K + K+ Q R RE EI
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR------REVEI 62
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
S L HPN++ YG D + + E+ G++ L + ++R I A
Sbjct: 63 QSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGT 752
+ Y HSK ++H D+K +NLL+ + K+ DFG S +R L GT
Sbjct: 121 -ALSYCHSKRVIHRDIKPENLLLGSAGEL----KIADFGWSVHAPSSRRTDLC-----GT 170
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
L ++ PE++ G EKVD++S G++ +E L G+ P+ Y I
Sbjct: 171 LDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--F 226
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P F R L+ + +P RP E+
Sbjct: 227 PDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-39
Identities = 69/273 (25%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 585 LKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
+ LG+G FG V + G VAIK+ ++ +ER E +I+ KL+H
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS---PKNRERWC----LEIQIMKKLNH 71
Query: 643 PNVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERH--LDRRKRLIIAMDAA 696
PNVV+ V E+ G LR L E L + D +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
+ YLH I+H DLK +N+++ K+ D G +K + GTL ++
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
APELL K + VD +SFG + +E +TG P+ G V + +
Sbjct: 191 APELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 817 DSEWRL-LMEQCWAPDPVVRPSFTEIARRLRVM 848
D + P+ + ++ R L+ M
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-39
Identities = 79/284 (27%), Positives = 126/284 (44%), Gaps = 34/284 (11%)
Query: 570 DISTLQIIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ 623
D ++ +D E+ L+E+G G+FG VY + VAIK++ ++G+ S +
Sbjct: 40 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNE 96
Query: 624 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 683
+ + +E L KL HPN + + G T V E+ GS +L ++ L
Sbjct: 97 KWQDII--KEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYC-LGSASDLLEVHKKPL 151
Query: 684 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KR 741
+ + A G+ YLHS N++H D+K N+L++ + K+GDFG + I
Sbjct: 152 QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV----KLGDFGSASIMAPA 207
Query: 742 NTLVTGGVRGTLPWMAPELLNGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMHYGAII 800
N+ V GT WMAPE++ KVDV+S GI E+ + P NM+ + +
Sbjct: 208 NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262
Query: 801 GGIVNNTLRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTE 840
I N P W R ++ C P RP+
Sbjct: 263 YHIAQN----ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 48/286 (16%)
Query: 577 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+K +DLE + ELG G +G V G +A+KRI+ T S EQ+RL +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLL----MDL 56
Query: 635 EI-LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL---- 689
+I + + P V FYG + G + E M + SL ++ +D+ + +
Sbjct: 57 DISMRTVDCPFTVTFYGALFR--EGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDI 110
Query: 690 --IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-----KIKR 741
IA+ +E+LHSK +++H D+K N+L+N + K+ DFG+S + +
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQV----KMCDFGISGYLVDDVAK 166
Query: 742 NTLVTGGVRGTLPWMAPELLNGSSSKV--SEKVDVFSFGIVLWEILTGEEPYANM-HYGA 798
+ G P+MAPE +N ++ S K D++S GI + E+ PY +
Sbjct: 167 DIDA-----GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
Query: 799 IIGGIVNNTLRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTE 840
+ +V P P ++ QC + RP++ E
Sbjct: 222 QLKQVVEE----PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 39/274 (14%)
Query: 579 NEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
E +L+++G G+FG V+ G VAIK I ++ + + +E +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE------EAEDEIE-DIQQEITV 73
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
LS+ P V +YG L + E++ GS +L + LD + I +
Sbjct: 74 LSQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREIL 129
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 750
G++YLHS+ +H D+K N+L++ + K+ DFG++ +IKRNT V
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFV----- 180
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
GT WMAPE++ S K D++S GI E+ GE P++ +H ++ I N
Sbjct: 181 GTPFWMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN---N 235
Query: 811 PVPGFCDSEW----RLLMEQCWAPDPVVRPSFTE 840
P P + + + +E C +P RP+ E
Sbjct: 236 P-PTL-EGNYSKPLKEFVEACLNKEPSFRPTAKE 267
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 31/225 (13%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ +++G G GTVY T VAI+++ +Q + L E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-------QQPKKELII-NEILV 70
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+ + +PN+V + G L V E++ GSL V+ E +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 750
+E+LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV----- 177
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 795
GT WMAPE++ + KVD++S GI+ E++ GE PY N +
Sbjct: 178 GTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D + + LG G FG VY + + +A+K + KS + + +L RE EI
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLR----REIEIQ 68
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
S L HPN++ Y D + + EF G L L R ++R + A
Sbjct: 69 SHLRHPNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD- 125
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGTL 753
+ Y H + ++H D+K +NLL+ K + K+ DFG S ++R T+ GTL
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGEL----KIADFGWSVHAPSLRRRTMC-----GTL 176
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813
++ PE++ G + EKVD++ G++ +E L G P+ + + IVN L+ P
Sbjct: 177 DYLPPEMIEGKTH--DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FP 232
Query: 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
F + L+ + P R +
Sbjct: 233 PFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 36/273 (13%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
L+ ++G G+ G V + + + VA+K + +Q+R L F E I
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-------KQQRRELLF-NEVVI 95
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+ H NVV Y G L + EF+ G+L ++ + L+ + +
Sbjct: 96 MRDYQHFNVVEMYKSYLVG--EELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVL 151
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 750
+ YLH++ ++H D+K D++L+ L + K+ DFG KR +LV
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRV----KLSDFGFCAQISKDVPKRKSLV----- 202
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
GT WMAPE+++ S + +VD++S GI++ E++ GE PY + + + ++ P
Sbjct: 203 GTPYWMAPEVISRSLY--ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--P 258
Query: 811 PV---PGFCDSEWRLLMEQCWAPDPVVRPSFTE 840
P R +E+ DP R + E
Sbjct: 259 PKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 32/280 (11%)
Query: 577 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
EDL++L E+G G +G+V K G +A+KRI+ T EQ++L +
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLL----MDL 71
Query: 635 EILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL---- 689
+++ + P +V FYG + G E M + S K + +
Sbjct: 72 DVVMRSSDCPYIVQFYGALFR--EGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEI 126
Query: 690 --IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 746
I + + +L I+H D+K N+L++ I K+ DFG+S +++
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI----KLCDFGISGQLVDSIAK 182
Query: 747 GGVRGTLPWMAPELLNGSSSKV--SEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGI 803
G P+MAPE ++ S+S+ + DV+S GI L+E+ TG PY + + +
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
Query: 804 VNN---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTE 840
V L + + C D RP + E
Sbjct: 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-38
Identities = 48/242 (19%), Positives = 91/242 (37%), Gaps = 37/242 (15%)
Query: 566 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 625
+ ++ I ++ L G F + + A+K+ +KS + +
Sbjct: 30 INDYRI-------------IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKS 76
Query: 626 LTLEFW---------REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 676
+ E +I++ + + + G++ + + + E+M N S+
Sbjct: 77 NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY--DEVYIIYEYMENDSILKFD 134
Query: 677 LSKERHLDRRKRLIIAMDAAF-------GMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPI 728
I Y+H+ KNI H D+K N+L++ +
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV--- 191
Query: 729 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
K+ DFG S+ + + G RGT +M PE + SS KVD++S GI L+ +
Sbjct: 192 -KLSDFGESEYMVDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
Query: 789 EP 790
P
Sbjct: 250 VP 251
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 28/272 (10%)
Query: 577 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+K++D E++ ELG+G G V+ K G +A K I + + + ++ RE
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQII----REL 82
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++L + + P +V FYG G ++ E M GSL +L K + + +++
Sbjct: 83 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIA 139
Query: 695 AAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFG----LSKIKRNTLVTGGV 749
G+ YL K I+H D+K N+LVN + I K+ DFG L N+ V
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV---- 191
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809
GT +M+PE L G+ S + D++S G+ L E+ G P +
Sbjct: 192 -GTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ D + E+
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 51/288 (17%)
Query: 580 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D E + +GSG V + VAIKRI Q + E +E + +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE------KCQTSMD-ELLKEIQAM 67
Query: 638 SKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL------ 689
S+ HHPN+V++Y VV L V + + GS+ ++ + + +
Sbjct: 68 SQCHHPNIVSYYTSFVV----KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 690 -IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS----------- 737
I + G+EYLH +H D+K N+L+ + ++ DFG+S
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSV----QIADFGVSAFLATGGDITR 179
Query: 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 797
R T V GT WMAPE++ K D++SFGI E+ TG PY
Sbjct: 180 NKVRKTFV-----GTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233
Query: 798 AIIGGIVNN---TLRPPVPGFC-DSEW----RLLMEQCWAPDPVVRPS 837
++ + N +L V ++ R ++ C DP RP+
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 8/208 (3%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LGSG G V R T VAI+ I K F S+ + L E EIL KL+HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
++ V E M G L ++ +R + +L ++YLH
Sbjct: 201 CIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLH 256
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG 763
I+H DLK +N+L++ ++ I K+ DFG SKI T + + GT ++APE+L
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315
Query: 764 SSSKV-SEKVDVFSFGIVLWEILTGEEP 790
+ + VD +S G++L+ L+G P
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-37
Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 29/231 (12%)
Query: 580 EDLEELKELGSG--TFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
E L +G G TV K G V ++RI + E +T E
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE-----ACSNEMVT-FLQGELH 78
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM-- 693
+ +HPN+V + L VT FM GS + ++ +D L IA
Sbjct: 79 VSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYIL 134
Query: 694 -DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVT 746
++Y+H VH +K ++L+++ + + + ++ +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKV----YLSGLRSNLSMISHGQRQRVVHD 190
Query: 747 GGVR--GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH 795
LPW++PE+L + K D++S GI E+ G P+ +M
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 69/276 (25%), Positives = 112/276 (40%), Gaps = 36/276 (13%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED + LG G+F VY + T +VAIK I K + + + E +I
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKK-----AMYKAGMVQRVQNEVKIH 65
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERHLD-RRKRLIIA 692
+L HP+++ Y +D + V E NG + L ++ + R +
Sbjct: 66 CQLKHPSILELYNYFED------SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 750
GM YLHS I+H DL NLL+ I K+ DFGL+ L +
Sbjct: 120 QIIT-GMLYLHSHGILHRDLTLSNLLLTRNMNI----KIADFGLA----TQLKMPHEKHY 170
Query: 751 ---GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807
GT +++PE+ S+ + DV+S G + + +L G P+ + +V
Sbjct: 171 TLCGTPNYISPEIATRSAH--GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD 228
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+P F E + L+ Q +P R S + +
Sbjct: 229 YE--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 65/221 (29%), Positives = 95/221 (42%), Gaps = 34/221 (15%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
K LGSG G V R T VAIK I K F S+ + L E EIL KL+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 697
++ V E M G L D+ ++
Sbjct: 76 CIIKIKNFFDA---EDYYIVLELMEGGEL----------FDK----VVGNKRLKEATCKL 118
Query: 698 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
++YLH I+H DLK +N+L++ ++ I K+ DFG SKI T + +
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLC 177
Query: 751 GTLPWMAPELLNGSSSKV-SEKVDVFSFGIVLWEILTGEEP 790
GT ++APE+L + + VD +S G++L+ L+G P
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-36
Identities = 79/274 (28%), Positives = 121/274 (44%), Gaps = 33/274 (12%)
Query: 578 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 631
K L E+ K+LGSG +G V + + T AIK I+K+ + S+ +
Sbjct: 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK------LL 84
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KRLI 690
E +L L HPN++ Y +D L V E G L ++ + + + +I
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFEDKRNYYL--VMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
+ + + YLH NIVH DLK +NLL+ K+ I K+ DFGLS + N
Sbjct: 143 KQVLSG--VTYLHKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQKKMKERL 199
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
GT ++APE+L K EK DV+S G++L+ +L G P+ I+ +
Sbjct: 200 GTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT- 255
Query: 811 PVPGFCDSEWRL-------LMEQCWAPDPVVRPS 837
F EW+ L++Q D R S
Sbjct: 256 ----FDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 3e-36
Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 10/173 (5%)
Query: 680 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK- 738
+ L + + A GME+L S+ +H DL N+L++ K+ + K+ DFGL++
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKICDFGLARD 242
Query: 739 IKRNTLVTGGVRGTLP--WMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795
I ++ LP WMAPE + + + DV+SFG++LWEI + G PY +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+ R P + E M CW +P RP+F+E+ L +
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 42/171 (24%), Positives = 61/171 (35%), Gaps = 21/171 (12%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
+ L+ K LG G FG V G VA+K +K+ ++ E
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----ATHSEH--RALMS 74
Query: 633 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
E +IL + HH NVV G PGG L + EF G+L L SK R + +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSK-----RNEFVPY 128
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742
A + + DLK + V + LS ++
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 66/267 (24%), Positives = 106/267 (39%), Gaps = 35/267 (13%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ LG G F + T A K + KS + + E I L H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 75
Query: 644 NVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699
+VV F+G +D V E SL + ++ + R + G
Sbjct: 76 HVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GC 128
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLP 754
+YLH ++H DLK NL +N + K+GDFGL+ + G R GT
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEV----KIGDFGLA----TKVEYDGERKKVLCGTPN 180
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814
++APE+L+ S +VDV+S G +++ +L G+ P+ I N +P
Sbjct: 181 YIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPK 236
Query: 815 FCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ L+++ DP RP+ E+
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINEL 263
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E ++ +G+GT+G VY G+ T AIK + + E+E E +E +L K
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEE----EIKQEINMLKKY 77
Query: 641 -HHPNVVAFYG----VVQDGPGGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMD 694
HH N+ +YG G L V EF GS+ ++ +K L I +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGG 748
G+ +LH ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 749 VRGTLPWMAPELLNGSSSKVS---EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805
GT WMAPE++ + + K D++S GI E+ G P +MH + I
Sbjct: 191 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248
Query: 806 NTLRPPVPGFCDSEW----RLLMEQCWAPDPVVRPSFTEI 841
N P P +W + +E C + RP+ ++
Sbjct: 249 N---PA-PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 69/329 (20%), Positives = 122/329 (37%), Gaps = 55/329 (16%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+ L + L G F VY + G + A+KR+ E+ R + +E
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAII---QEV 76
Query: 635 EILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMV-----NGSLRHVLLSKERH--LDRR 686
+ KL HPN+V F G + EF++ G L L E L
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 687 KRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744
L I ++++H + I+H DLK +NLL++ + I K+ DFG + +
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI----KLCDFGSATTISHYP 192
Query: 745 VTGG-------------VRGTLPWMAPELLNGSSSK-VSEKVDVFSFGIVLWEILTGEEP 790
T + PE+++ S+ + EK D+++ G +L+ + + P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 791 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850
+ IVN P + + L+ +P R S E+ +L+ ++A
Sbjct: 253 F----EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 851 AC-------------QTKSHGHQVQNQVP 866
A Q +G ++ P
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 62/283 (21%), Positives = 114/283 (40%), Gaps = 43/283 (15%)
Query: 577 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+ DLE L E+GSGT G V+ + G +A+K+++ +G E +R+ +
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRIL----MDL 74
Query: 635 EILSKLH-HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
+++ K H P +V +G + E M + + + R + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 694 DAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNTLVTG 747
+ YL K ++H D+K N+L++ + I K+ DFG+S ++
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQI----KLCDFGISGRLVDDKAKDRSA-- 185
Query: 748 GVRGTLPWMAPELLNGSSSKV---SEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGI 803
G +MAPE ++ + DV+S GI L E+ TG+ PY N ++ +
Sbjct: 186 ---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 804 VNN---TLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTE 840
+ L + F ++ C D RP + +
Sbjct: 243 LQEEPPLLPGHMGFSGDFQS-----FVKDCLTKDHRKRPKYNK 280
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 66/265 (24%), Positives = 107/265 (40%), Gaps = 27/265 (10%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ LG G F + T A K + KS + + E I L H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 101
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 703
+VV F+G +D + V E SL + ++ + R + G +YLH
Sbjct: 102 HVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYLH 158
Query: 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMAP 758
++H DLK NL +N + K+GDFGL+ + G R GT ++AP
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEV----KIGDFGLA----TKVEYDGERKKVLCGTPNYIAP 210
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDS 818
E+L+ S +VDV+S G +++ +L G+ P+ I N +P +
Sbjct: 211 EVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINP 266
Query: 819 EWRLLMEQCWAPDPVVRPSFTEIAR 843
L+++ DP RP+ E+
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLN 291
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-36
Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 32/274 (11%)
Query: 578 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 631
+ + LG G+FG V K + T A+K I K ++ ++
Sbjct: 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-----LL 74
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KRLI 690
RE ++L +L HPN++ Y +D G V E G L ++S++R + R+I
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 132
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
+ + + Y+H IVH DLK +NLL+ K I ++ DFGLS +
Sbjct: 133 RQVLSG--ITYMHKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKI 189
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
GT ++APE+L+G EK DV+S G++L+ +L+G P+ GA I+ +
Sbjct: 190 GTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKG 242
Query: 811 PVPGFCDSEWRL-------LMEQCWAPDPVVRPS 837
F +W+ L+ + P +R S
Sbjct: 243 K-YTFELPQWKKVSESAKDLIRKMLTYVPSMRIS 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
E + L++LG G++G+VY + T VAIK++ + E +E I
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-------VESDLQ---EIIKEISI 77
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+ + P+VV +YG L V E+ GS+ ++ + + L + I
Sbjct: 78 MQQCDSPHVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 750
G+EYLH +H D+K N+L+N + K+ DFG++ KRNT++
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHA----KLADFGVAGQLTDTMAKRNTVI----- 186
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
GT WMAPE++ + D++S GI E+ G+ PYA++H I I N
Sbjct: 187 GTPFWMAPEVIQEIG--YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN---- 240
Query: 811 PVPGFCDSE-W----RLLMEQCWAPDPVVRPSFTE 840
P P F E W ++QC P R + T+
Sbjct: 241 PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 27/227 (11%)
Query: 577 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 630
K + +E+ +ELGSG F V + + T + A K IKK R +E
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE- 63
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
RE IL ++ H NV+ + V ++ L + E + G L L KE +
Sbjct: 64 -REVSILRQVLHHNVITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEE----- 115
Query: 691 IAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743
+A G+ YLH+K I HFDLK +N+++ K+ P K+ DFGL+ +
Sbjct: 116 ---EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 744 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
+ + GT ++APE++N + + D++S G++ + +L+G P
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 29/229 (12%)
Query: 576 IIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLE 629
+ + E++++ +ELGSG F V + + T A K IKK R +E
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
RE IL ++ HPNV+ + V ++ L + E + G L L KE +
Sbjct: 63 --REVSILKEIQHPNVITLHEVYENKTDVIL--ILELVAGGELFDFLAEKESLTEE---- 114
Query: 690 IIAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKR 741
+A G+ YLHS I HFDLK +N+++ ++ +P K+ DFGL+ KI
Sbjct: 115 ----EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 742 NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
GT ++APE++N + + D++S G++ + +L+G P
Sbjct: 171 GNEFKNIF-GTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 216
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-35
Identities = 44/292 (15%), Positives = 84/292 (28%), Gaps = 43/292 (14%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 629
+ ++ + LG G F VY + +K K + E T
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGT-- 115
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK----ERHLDR 685
+ E L + FY V E G+L + + E+ + +
Sbjct: 116 --QLMERLKPSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 686 RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC-------KVGDFGLSK 738
+ AM + +E +H I+H D+K DN ++ + + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 739 IKR----NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 794
+ T+ T T + E+L+ + ++D F ++ +L G
Sbjct: 232 DMKLFPKGTIFT-AKCETSGFQCVEMLSNKPW--NYQIDYFGVAATVYCMLFGTYMKVKN 288
Query: 795 HYGAIIGGIVNNTLRPPVPGFCDSE-WRLLMEQCWAPDPVVRPSFTEIARRL 845
G + W ++ R+
Sbjct: 289 EGGECK-------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-35
Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 32/279 (11%)
Query: 578 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLE-- 629
K + E ++LGSG +G V K + AIK IKKS F + +E
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 630 ---FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 686
+ E +L L HPN++ + V +D L VTEF G L ++++ + +
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL--VTEFYEGGELFEQIINRHKFDECD 147
Query: 687 -KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 745
++ + + + YLH NIVH D+K +N+L+ K+ + I K+ DFGLS
Sbjct: 148 AANIMKQILSG--ICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSFFSKDYK 204
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805
GT ++APE+L ++ K DV+S G++++ +L G P+ G I+
Sbjct: 205 LRDRLGTAYYIAPEVLKKKYNE---KCDVWSCGVIMYILLCGYPPF----GGQNDQDIIK 257
Query: 806 NTLRPPVPGFCDSEWRL-------LMEQCWAPDPVVRPS 837
+ F ++W+ L++ D R +
Sbjct: 258 KVEK-GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT 295
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ELG G F V + T + A K I + R + + REA I KL HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 65
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 697
N+V + +Q+ V + + G L + I+A DA+
Sbjct: 66 NIVRLHDSIQEE--SFHYLVFDLVTGGEL----------FED----IVAREFYSEADASH 109
Query: 698 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
+ Y HS IVH +LK +NLL+ K + K+ DFGL+ ++ G
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 168
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
GT +++PE+L S+ VD+++ G++L+ +L G P
Sbjct: 169 GTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPP 206
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 47/233 (20%)
Query: 577 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 630
++ ++ + + LGSG F V+ K R T A+K IKKS SS
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS--------L 53
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
E +L K+ H N+V + + V + + G L DR I
Sbjct: 54 ENEIAVLKKIKHENIVTLEDIYEST--THYYLVMQLVSGGEL----------FDR----I 97
Query: 691 IAM------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737
+ DA+ ++YLH IVH DLK +NLL + I + DFGLS
Sbjct: 98 LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLS 156
Query: 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
K+++N +++ GT ++APE+L S+ VD +S G++ + +L G P
Sbjct: 157 KMEQNGIMSTAC-GTPGYVAPEVLAQKP--YSKAVDCWSIGVITYILLCGYPP 206
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 64/230 (27%), Positives = 110/230 (47%), Gaps = 27/230 (11%)
Query: 574 LQIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 627
++ K + +E+ +ELGSG F V + + T + A K IKK R
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 628 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 687
+E RE IL ++ HPN++ + V ++ L + E + G L L KE +
Sbjct: 62 IE--REVSILRQVLHPNIITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEE-- 115
Query: 688 RLIIAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740
+A G+ YLH+K I HFDLK +N+++ K+ P K+ DFGL+
Sbjct: 116 ------EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 741 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
+ + + GT ++APE++N + + D++S G++ + +L+G P
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASP 217
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 576 IIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLE 629
+ E LG G+FG V K R T + A+K I K+ + +
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST------ 67
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KR 688
RE E+L KL HPN++ + +++D + V E G L ++ ++R + R
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYI--VGELYTGGELFDEIIKRKRFSEHDAAR 125
Query: 689 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG 748
+I + + + Y+H NIVH DLK +N+L+ K+ I K+ DFGLS +
Sbjct: 126 IIKQVFSG--ITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKD 182
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808
GT ++APE+L G EK DV+S G++L+ +L+G P+ YG I+
Sbjct: 183 RIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPF----YGKNEYDILKRVE 235
Query: 809 RPPVPGFCDSEWRL-------LMEQCWAPDPVVRPS 837
F +WR L+ + P +R +
Sbjct: 236 TGK-YAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 69/235 (29%), Positives = 103/235 (43%), Gaps = 45/235 (19%)
Query: 575 QIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTL 628
+ E LG G+FG V K R T + A+K I K+ + +
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST----- 67
Query: 629 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 688
RE E+L KL HPN++ + +++D + V E G L D
Sbjct: 68 -ILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGELYTGGEL----------FDE--- 111
Query: 689 LIIA------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735
II DAA + Y+H NIVH DLK +N+L+ K+ I K+ DFG
Sbjct: 112 -IIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFG 169
Query: 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
LS + GT ++APE+L G+ + K DV+S G++L+ +L+G P
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 47/232 (20%)
Query: 578 KNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFW 631
D+ + +G G++G V +GT A K+I K + +R
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVDRF----K 54
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
+E EI+ L HPN++ Y +D + V E G L +R ++
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFEDN--TDIYLVMELCTGGEL----------FER----VV 98
Query: 692 A------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
DAA M Y H N+ H DLK +N L P P+ K+ DFGL+
Sbjct: 99 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAA 157
Query: 739 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
+ + GT +++P++L G + D +S G++++ +L G P
Sbjct: 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGP---ECDEWSAGVMMYVLLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 50/236 (21%)
Query: 578 KNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFW 631
+++L ++LGSG FG V+ + R + + IK I K RS +
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD----RSQVPME---QIE 68
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
E E+L L HPN++ + V +D + V E G L L+R I+
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVMETCEGGEL----------LER----IV 112
Query: 692 A----------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734
+ A M Y HS+++VH DLK +N+L P PI K+ DF
Sbjct: 113 SAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDF 171
Query: 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
GL+++ ++ + GT +MAPE+ V+ K D++S G+V++ +LTG P
Sbjct: 172 GLAELFKSDEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ELGSG F V + +GT + A K IKK + R +E RE IL ++ HP
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE--REVNILREIRHP 68
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF------ 697
N++ + + ++ L + E + G L L KE + +A
Sbjct: 69 NIITLHDIFENKTDVVL--ILELVSGGELFDFLAEKESLTED--------EATQFLKQIL 118
Query: 698 -GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
G+ YLHSK I HFDLK +N+++ K+ P K+ DFG++ + GT ++
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
APE++N + + D++S G++ + +L+G P
Sbjct: 179 APEIVNYEP--LGLEADMWSIGVITYILLSGASP 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 70/330 (21%), Positives = 113/330 (34%), Gaps = 80/330 (24%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKS----------------------- 614
D E ++ +G G FG V+ K + + AIKRI+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 615 ---------------------------CFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647
T + + N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGMEYLHSK 705
P L + +L+ + + DR + I + A +E+LHSK
Sbjct: 126 QLQPSS--PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--------------KRNTLVTGGVRG 751
++H DLK N+ + D + KVGDFGL TG V G
Sbjct: 184 GLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-G 238
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
T +M+PE ++G++ S KVD+FS G++L+E+L II + N P
Sbjct: 239 TKLYMSPEQIHGNN--YSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKF-PL 293
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ + ++++ +P P RP T+I
Sbjct: 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-33
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ELG G F V + T + A K I + R + + REA I KL HP
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 88
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 697
N+V + +Q+ V + + G L + I+A DA+
Sbjct: 89 NIVRLHDSIQEE--SFHYLVFDLVTGGEL----------FED----IVAREFYSEADASH 132
Query: 698 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 750
+ Y HS IVH +LK +NLL+ K + K+ DFGL+ ++ G
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 191
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
GT +++PE+L S+ VD+++ G++L+ +L G P
Sbjct: 192 GTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPP 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 36/296 (12%), Positives = 71/296 (23%), Gaps = 49/296 (16%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ L G V+ + A+K RS + ++L
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER-----LHEATFAAARLLGE 122
Query: 644 NVVAFYG------------------VVQDGPGGTLATVTEFMV-----------NGSLRH 674
+ Q PG V +++ S
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 675 VLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734
+ I+ L SK +VH DNL + + +GD
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL----MLGDV 238
Query: 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 794
+ + E LN S++ + ++ + G+ ++ + P+ +
Sbjct: 239 SALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 795 HYGAIIGGIVNNTLRPPVPGFCDSEW-------RLLMEQCWAPDPVVRPSFTEIAR 843
G + P + L+ + D R E
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ +G G F V R T A+K + + FT + REA I L HP
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE---DLKREASICHMLKHP 86
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA----------M 693
++V G L V EFM L I+
Sbjct: 87 HIVELLETYSSD--GMLYMVFEFMDGADL----------CFE----IVKRADAGFVYSEA 130
Query: 694 DAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV 745
A+ M Y H NI+H D+K +L+ K+ P+ K+G FG++ + + LV
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLV 189
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
GG GT +MAPE++ + VDV+ G++L+ +L+G P
Sbjct: 190 AGGRVGTPHFMAPEVVKREP--YGKPVDVWGCGVILFILLSGCLP 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 57/245 (23%), Positives = 91/245 (37%), Gaps = 48/245 (19%)
Query: 569 FDISTLQIIKNEDLEEL-----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSS 621
L E+ KELG G F V + T + A K +KK
Sbjct: 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR 72
Query: 622 EQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE 680
E E +L P V+ + V ++ L + E+ G +
Sbjct: 73 A------EILHEIAVLELAKSCPRVINLHEVYENTSEIIL--ILEYAAGGEI-------- 116
Query: 681 RHLDRRKRLIIA--------MDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPI 725
+ D G+ YLH NIVH DLK N+L++ P+
Sbjct: 117 --FSL----CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL 170
Query: 726 RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785
I K+ DFG+S+ + + GT ++APE+LN ++ D+++ GI+ + +L
Sbjct: 171 GDI-KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDP--ITTATDMWNIGIIAYMLL 227
Query: 786 TGEEP 790
T P
Sbjct: 228 THTSP 232
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 70/232 (30%), Positives = 105/232 (45%), Gaps = 48/232 (20%)
Query: 578 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 631
+ L + ELG G VY K +GT A+K +KK+ +++ +
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIV----R 96
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
E +L +L HPN++ + + +L V E + G L DR I+
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTEISL--VLELVTGGEL----------FDR----IV 140
Query: 692 AM------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
DAA + YLH IVH DLK +NLL P P+ K+ DFGLSK
Sbjct: 141 EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSK 199
Query: 739 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
I + ++ V GT + APE+L G + +VD++S GI+ + +L G EP
Sbjct: 200 IVEHQVLMKTVCGTPGYCAPEILRGCA--YGPEVDMWSVGIITYILLCGFEP 249
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEILSKL-H 641
+ LG G V + T + A+K I + S+E+ + L +E +IL K+
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 642 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA--MDAAFGM 699
HPN++ + L V + M G L L K ++ R I+ ++ +
Sbjct: 83 HPNIIQLKDTYETNTFFFL--VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV---I 137
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 759
LH NIVH DLK +N+L++ I K+ DFG S V GT ++APE
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNI----KLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 760 LLNGSSSKV----SEKVDVFSFGIVLWEILTGEEP 790
++ S + ++VD++S G++++ +L G P
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 56/251 (22%), Positives = 89/251 (35%), Gaps = 53/251 (21%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+G G++G V T AIK + K+ + + E ++ KLHHP
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE---RIKTEVRLMKKLHHP 88
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM---------- 693
N+ Y V +D + V E G L L + + +
Sbjct: 89 NIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 694 ----------------------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDP 724
+ + YLH++ I H D+K +N L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNK 205
Query: 725 IRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMAPELLNGSSSKVSEKVDVFSFGI 779
I K+ DFGLSK GT ++APE+LN ++ K D +S G+
Sbjct: 206 SFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 780 VLWEILTGEEP 790
+L +L G P
Sbjct: 265 LLHLLLMGAVP 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 58/318 (18%), Positives = 116/318 (36%), Gaps = 42/318 (13%)
Query: 493 SGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRL 552
SG F++ +R I + + ++ QS + ++ + + +
Sbjct: 9 SGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKG 68
Query: 553 DLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGT--DVAIKR 610
+ + + + D + +G G V R T + A+K
Sbjct: 69 TENLYFQSMGPEDELPDWAAAKEFYQKYDPK--DVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 611 IKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLATVTEFMVN 669
++ + + E + RE IL ++ HP+++ + L V + M
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL--VFDLMRK 184
Query: 670 GSLRHVLLSKERHLDRRKRLIIAM------DAAF-------GMEYLHSKNIVHFDLKCDN 716
G L D + + + +LH+ NIVH DLK +N
Sbjct: 185 GEL----------FDY----LTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 717 LLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV----SEKV 772
+L++ I ++ DFG S + GT ++APE+L S + ++V
Sbjct: 231 ILLDDNMQI----RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 773 DVFSFGIVLWEILTGEEP 790
D+++ G++L+ +L G P
Sbjct: 287 DLWACGVILFTLLAGSPP 304
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-32
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ELG G F V + A I + R ++ REA I L HP
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK------LEREARICRLLKHP 70
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 697
N+V + + + G + + + G L + I+A DA+
Sbjct: 71 NIVRLHDSISEE--GHHYLIFDLVTGGEL----------FED----IVAREYYSEADASH 114
Query: 698 GM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGV 749
+ + H +VH +LK +NLL+ K + K+ DFGL+ ++ G
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLAIEVEGEQQAWFGF 173
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
GT +++PE+L + VD+++ G++L+ +L G P
Sbjct: 174 AGTPGYLSPEVLRKDP--YGKPVDLWACGVILYILLVGYPP 212
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 45/225 (20%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 580 EDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWRE 633
++L E ++LG G FG V+ + K +K + ++Q + +E
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLV----KKE 51
Query: 634 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
IL+ H N++ + + + + EF+ + + + L+ R
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVM--IFEFISGLDIFERINTSAFELNER------- 102
Query: 694 DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLV 745
+ +++LHS NI HFD++ +N++ + I K+ +FG + ++K
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS-STI-KIIEFGQARQLKPGDNF 160
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
+ APE+ VS D++S G +++ +L+G P
Sbjct: 161 RLLF-TAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINP 202
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 51/274 (18%), Positives = 103/274 (37%), Gaps = 46/274 (16%)
Query: 585 LKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ G G +Y D V +K + +G + Q E + L
Sbjct: 85 KGCIAHGGLGWIY----LALDRNVNGRPVVLKGLV---HSGDAEAQAM----AMAERQFL 133
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNG-SLRHVLLSKERHLDRRKRLIIAM 693
+++ HP++V + V+ V E+ V G SL+ + L + + +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSK---GQKLPVAEAIAYLL 189
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 753
+ + YLHS +V+ DLK +N+++ ++ + K+ D G G + GT
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT-EEQL----KLIDLG---AVSRINSFGYLYGTP 241
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813
+ APE++ + + D+++ G L + G + G+ +
Sbjct: 242 GFQAPEIVRTGPTVAT---DIYTVGRTLAALTLDLPTRN----GRYVDGLPEDDPVLKTY 294
Query: 814 GFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLR 846
+ L+ + PDP R + E++ +L
Sbjct: 295 D----SYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 71/282 (25%), Positives = 114/282 (40%), Gaps = 36/282 (12%)
Query: 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFW------------ 631
E+G G++G V T A+K + K ++ R
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 632 ------REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---H 682
+E IL KL HPNVV V+ D L V E + G + V + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSED 137
Query: 683 LDRRK-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-K 740
R + +I G+EYLH + I+H D+K NLLV I K+ DFG+S K
Sbjct: 138 QARFYFQDLIK-----GIEYLHYQKIIHRDIKPSNLLVGEDGHI----KIADFGVSNEFK 188
Query: 741 RNTLVTGGVRGTLPWMAPELLNGSSSKVS-EKVDVFSFGIVLWEILTGEEPYANMHYGAI 799
+ + GT +MAPE L+ + S + +DV++ G+ L+ + G+ P+ + +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
I + L P + + L+ + +P R EI
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-31
Identities = 51/221 (23%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 577 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 630
+K + + +ELGSG FG V+ + T K I ++ +
Sbjct: 44 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTV---- 95
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
E I+++LHHP ++ + +D L + EF+ G L + +++ + + +
Sbjct: 96 KNEISIMNQLHHPKLINLHDAFEDKYEMVL--ILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGV 749
A G++++H +IVH D+K +N++ K + K+ DFGL+ K+ + +V
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA-SSV-KIIDFGLATKLNPDEIVKVTT 211
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
T + APE+++ V D+++ G++ + +L+G P
Sbjct: 212 -ATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 48/276 (17%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
LK +G G F V + G +VAIK I K+ + ++L RE I+ L+H
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLF----REVRIMKILNH 73
Query: 643 PNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDA 695
PN+V + V++ T T + E+ G + L++ R R K R I++
Sbjct: 74 PNIVKLFEVIE-----TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--- 125
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----G 751
++Y H K IVH DLK +NLL++ I K+ DFG S N GG G
Sbjct: 126 --AVQYCHQKRIVHRDLKAENLLLDADMNI----KIADFGFS----NEFTVGGKLDAFCG 175
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNT 807
P+ APEL G +VDV+S G++L+ +++G P+ N+ ++ G
Sbjct: 176 APPYAAPELFQGKKY-DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--- 231
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
+P + ++ L+++ +P+ R + +I +
Sbjct: 232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 74/270 (27%), Positives = 112/270 (41%), Gaps = 37/270 (13%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ LG G +G V R T VA+K + E + +E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK------KEICINKMLNHE 65
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 699
NVV FYG ++G E+ G L + +R ++A G+
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---GTLPWM 756
YLH I H D+K +NLL++ +D + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNL----KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTG----EEPYANMH-YGAIIGGIVNNTLRPP 811
APELL +E VDV+S GIVL +L G ++P + Y P
Sbjct: 175 APELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---LNP 230
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
DS L+ + +P R + +I
Sbjct: 231 WKKI-DSAPLALLHKILVENPSARITIPDI 259
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 577 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 630
IK++ + + +ELG+G FG V+ R T + A K + S++E +
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETV---- 201
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
+E + +S L HP +V + +D + + EFM G L + + + + +
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVM--IYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGV 749
G+ ++H N VH DLK +N++ K K+ DFGL+ + V
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLTAHLDPKQSVKVTT 317
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
GT + APE+ G V D++S G++ + +L+G P
Sbjct: 318 -GTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSP 355
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 45/276 (16%)
Query: 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
LG G++G V A+K +KK + + + +E ++L +L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHK 66
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL-----------IIA 692
NV+ V+ + + V E+ V G +L KR +I
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE----KRFPVCQAHGYFCQLID 120
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 750
G+EYLHS+ IVH D+K NLL+ + K+ G+++ R
Sbjct: 121 -----GLEYLHSQGIVHKDIKPGNLLLTTGGTL----KISALGVAEALHPFAADDTCRTS 171
Query: 751 -GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVN 805
G+ + PE+ NG + KVD++S G+ L+ I TG P+ N++ + I G
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231
Query: 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+PG C L++ +P R S +I
Sbjct: 232 ------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 68/268 (25%), Positives = 111/268 (41%), Gaps = 33/268 (12%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH- 641
LG G FGTV+ G VAIK I ++ G S + +T E +L K+
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP--LEVALLWKVGA 93
Query: 642 ---HPNVVAFYGVVQDGPGGTLATVTEFMVNGS-LRHVLLSKER---HLDRRK-RLIIAM 693
HP V+ + G L V E + L + K R ++A
Sbjct: 94 GGGHPGVIRLLDWFETQEGFML--VLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA- 150
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 753
+++ HS+ +VH D+K +N+L+ D R K+ DFG + + T GT
Sbjct: 151 ----AIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDFD-GTR 202
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813
+ PE ++ + V+S GI+L++++ G+ P+ I+ ++ P
Sbjct: 203 VYSPPEWISRHQYH-ALPATVWSLGILLYDMVCGDIPFE--RDQEILEAELH------FP 253
Query: 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ L+ +C AP P RPS EI
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 5e-30
Identities = 34/292 (11%), Positives = 82/292 (28%), Gaps = 49/292 (16%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTG--------------------RSSEQ 623
LG + T + + ++ +Q
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 624 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVN-----GSLRHVLLS 678
++ L F +++ ++ +D + + M + G + S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 679 KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
+ L RL + + + LH +VH L+ +++++ + + + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV----FLTGFEHLV 254
Query: 739 IKRNTLVTGGVRGTLPWMAPELLNGSS---------SKVSEKVDVFSFGIVLWEILTGEE 789
+ V + + PEL + + ++ D ++ G+V++ I +
Sbjct: 255 -RDGARVV--SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 790 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P I + P R L+E R +
Sbjct: 312 PITKDAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQA 357
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-30
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 46/227 (20%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
+ + + LG G FG V+ + T +A K IK ++E + E +++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEV----KNEISVMN 141
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA------ 692
+L H N++ Y + L V E++ G L DR II
Sbjct: 142 QLDHANLIQLYDAFESKNDIVL--VMEYVDGGEL----------FDR----IIDESYNLT 185
Query: 693 -MDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT 743
+D G+ ++H I+H DLK +N+L +D + I K+ DFGL++ K
Sbjct: 186 ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA-KQI-KIIDFGLARRYKPRE 243
Query: 744 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
+ GT ++APE++N VS D++S G++ + +L+G P
Sbjct: 244 KLKVNF-GTPEFLAPEVVNYDF--VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 60/270 (22%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
+ LGSG FG V+ + +V +K IKK ++ + E ILS++ H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGS-LRHVLLSKER---HLDRRK-RLIIAMDAAF 697
N++ + ++ G V E +G L + R L R +++
Sbjct: 89 ANIIKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS----- 141
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTL 753
+ YL K+I+H D+K +N+++ I K+ DFG + L G + GT+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTI----KLIDFGSA----AYLERGKLFYTFCGTI 193
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813
+ APE+L G+ + E ++++S G+ L+ ++ E P+ + ++ P
Sbjct: 194 EYCAPEVLMGNPYRGPE-LEMWSLGVTLYTLVFEENPFCE--LEETVEAAIH------PP 244
Query: 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIAR 843
E L+ P P R + ++
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
+ +LG G TVY + VAIK I + +R F RE S+L H
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKR----FEREVHNSSQLSH 70
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
N+V+ V ++ V E+ + G +L + L + G+++
Sbjct: 71 QNIVSMIDVDEED--DCYYLVMEY-IEGPTLSE-YIESHGPLSVDTAINFTNQILDGIKH 126
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPWMAPE 759
H IVH D+K N+L++ + K+ DFG++K T +T V GT+ + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTL----KIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
G E D++S GIVL+E+L GE P+
Sbjct: 183 QAKGE--ATDECTDIYSIGIVLYEMLVGEPPF 212
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 74/270 (27%), Positives = 112/270 (41%), Gaps = 37/270 (13%)
Query: 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ LG G +G V R VA+K + E + +E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK------KEICINKMLNHE 65
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 699
NVV FYG ++G E+ G L + +R ++A G+
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---GTLPWM 756
YLH I H D+K +NLL++ +D + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNL----KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTG----EEPYANMH-YGAIIGGIVNNTLRPP 811
APELL +E VDV+S GIVL +L G ++P + Y T P
Sbjct: 175 APELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNP 230
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
DS L+ + +P R + +I
Sbjct: 231 WKKI-DSAPLALLHKILVENPSARITIPDI 259
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 3e-29
Identities = 36/295 (12%), Positives = 79/295 (26%), Gaps = 42/295 (14%)
Query: 582 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSS--------EQERLTLEFW 631
L LG + T + + ++ + RL
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 632 REAEILSKLH---------HPNVVAFYGVVQDGPGGTLATVTEFM--VNGSLRHVL---- 676
+ + L P V D + + + +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 677 --LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734
S + L RL + + + LH +VH L+ +++++ + + + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV----FLTGF 255
Query: 735 GLSKIKRNTLVT--GGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEE 789
+ V+ G A +L + ++ D ++ G+ ++ I +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 790 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
P + I + P P R L+E R +
Sbjct: 316 PNTDDAALGGSEWIFRSCKNIPQP------VRALLEGFLRYPKEDRLLPLQAMET 364
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 51/287 (17%)
Query: 585 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
+ LG G V+ D VA+K + ++ S R F REA+ +
Sbjct: 17 GEILGFGGMSEVH----LARDLRDHRDVAVK-VLRADLARDPSFYLR----FRREAQNAA 67
Query: 639 KLHHPNVVAFY--GVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDA 695
L+HP +VA Y G + G V E+ V+G +LR ++ E + ++ + + DA
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRD-IVHTEGPMTPKRAIEVIADA 125
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV----TGGVRG 751
+ + H I+H D+K N++++ + + KV DFG+++ ++ T V G
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAV----KVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--------ANMHYGAIIGGI 803
T +++PE G V + DV+S G VL+E+LTGE P+ A H
Sbjct: 182 TAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-------- 231
Query: 804 VNNTLRPP---VPGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLR 846
V PP G ++ ++ + A +P R + E+ L
Sbjct: 232 VREDPIPPSARHEGL-SADLDAVVLKALAKNPENRYQTAAEMRADLV 277
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 54/240 (22%)
Query: 580 EDLEELKE--LGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
ED+ +L+E LG G V T + A+K I+K RS +RE E
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--------VFREVE 62
Query: 636 ILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM- 693
+L + H NV+ ++ V E M GS+ L I
Sbjct: 63 MLYQCQGHRNVLELIEFFEEED--RFYLVFEKMRGGSI----------LSH----IHKRR 106
Query: 694 -----DAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741
+A+ + ++LH+K I H DLK +N+L + + P+ K+ DF L +
Sbjct: 107 HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIK 165
Query: 742 NTLVTGGVR--------GTLPWMAPELLNGSSSKVS---EKVDVFSFGIVLWEILTGEEP 790
+ G+ +MAPE++ S + S ++ D++S G++L+ +L+G P
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 585 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
+ +G G G VY D VA+K + ++ + + R REA
Sbjct: 39 RRLVGRGGMGDVY----EAEDTVRERIVALKLMSET-LSSDPVFRTR----MQREARTAG 89
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAF 697
+L P+VV + + G L +NG L +L ++ L + + I
Sbjct: 90 RLQEPHVVPIHDFGEID--GQLYVDMRL-INGVDLAA-MLRRQGPLAPPRAVAIVRQIGS 145
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPW 755
++ H+ H D+K +N+LV+ D + DFG++ + +T G GTL +
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADDFA----YLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
MAPE + S + + D+++ VL+E LTG PY
Sbjct: 202 MAPERFSESH--ATYRADIYALTCVLYECLTGSPPY 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 49/226 (21%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 642
+++G G++ + T + A+K I KS E EIL + H
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------------EEIEILLRYGQH 75
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAA 696
PN++ V DG + VTE M G L LD+ I+ +A+
Sbjct: 76 PNIITLKDVYDDGKYVYV--VTELMKGGEL----------LDK----ILRQKFFSEREAS 119
Query: 697 FGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTG 747
+ EYLH++ +VH DLK N+L + ++ DFG +K R N L+
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN 793
T ++APE+L D++S G++L+ +LTG P+AN
Sbjct: 180 PC-YTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFAN 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 51/238 (21%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 642
+ LG G G V R T A+K + S + +E + +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------------KARQEVDHHWQASGG 81
Query: 643 PNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERHLDRRKRLIIA-------- 692
P++V V ++ G + E M G L R I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----------FSR----IQERGDQAFTE 127
Query: 693 MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 745
+AA M ++LHS NI H D+K +NLL K+ + K+ DFG +K +
Sbjct: 128 REAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNAL 186
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 803
T ++APE+L K + D++S G++++ +L G P+ + AI G+
Sbjct: 187 QTPC-YTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 73/273 (26%), Positives = 113/273 (41%), Gaps = 37/273 (13%)
Query: 583 EELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+ +K++GSG FG K VA+K I++ E + RE L
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQ----REIINHRSL 73
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAA 696
HPN+V F V+ LA + E+ G L + + R R + +++
Sbjct: 74 RHPNIVRFKEVILTP--THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS---- 127
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLP 754
G+ Y HS I H DLK +N L++ R K+ DFG SK + + GT
Sbjct: 128 -GVSYCHSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKS--TVGTPA 182
Query: 755 WMAPELLNGSSSK--VSEKVDVFSFGIVLWEILTG----EEPYANMHYGAIIGGIVNNTL 808
++APE+L + + DV+S G+ L+ +L G E+P Y I I++
Sbjct: 183 YIAPEVLLR---QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P E L+ + + DP R S EI
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 31/266 (11%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
LGSG FG+VY G VAIK ++K + + E +L K+
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP--MEVVLLKKVSS 105
Query: 643 --PNVVAFYGVVQDGPGGTLATVTEFMVN-GSLRHVLLSKER---HLDRRK-RLIIAMDA 695
V+ + L + E L + + L R ++
Sbjct: 106 GFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLE--- 160
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 755
+ + H+ ++H D+K +N+L+ D R K+ DFG + ++T+ T GT +
Sbjct: 161 --AVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTRVY 214
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
PE + V+S GI+L++++ G+ P+ + II G V
Sbjct: 215 SPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQVF------FRQR 265
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEI 841
SE + L+ C A P RP+F EI
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEI 291
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 56/239 (23%)
Query: 577 IKNEDLEEL-------KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 627
+K+ + K LG G+F + + A+K I K R +
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQ-- 53
Query: 628 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 686
+E L HPN+V + V D V E + G L +R
Sbjct: 54 ----KEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMELLNGGEL----------FER- 96
Query: 687 KRLIIAM------DAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733
I +A++ M ++H +VH DLK +NLL ++ I K+ D
Sbjct: 97 ---IKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIID 152
Query: 734 FGLSKIKR--NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
FG +++K N + TL + APELLN + E D++S G++L+ +L+G+ P
Sbjct: 153 FGFARLKPPDNQPLKTPC-FTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 67/270 (24%), Positives = 117/270 (43%), Gaps = 41/270 (15%)
Query: 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
LG GTFG V G+ + G VA+K + + ++ RE + L HP
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIK----REIQNLKLFRHP 71
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 699
+++ Y V+ V E++ G L + R RR + I++ +
Sbjct: 72 HIIKLYQVISTP--TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AV 124
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLPW 755
+Y H +VH DLK +N+L++ K+ DFGLS N + G G+ +
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNA----KIADFGLS----NMMSDGEFLRTSCGSPNY 176
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNTLRPP 811
APE+++G E VD++S G++L+ +L G P+ ++ + I GG+
Sbjct: 177 AAPEVISGRLYAGPE-VDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY------ 229
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+P + + L+ DP+ R + +I
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDI 259
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 77/269 (28%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED + K LG G+F TV + T AIK ++K + ++ +T RE +++
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVT----RERDVM 84
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIA-MDA 695
S+L HP V Y QD L + NG L + K D R A + +
Sbjct: 85 SRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAEIVS 141
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--------KRNTLVTG 747
A EYLH K I+H DLK +N+L+N I ++ DFG +K+ + N+ V
Sbjct: 142 AL--EYLHGKGIIHRDLKPENILLNEDMHI----QITDFGTAKVLSPESKQARANSFV-- 193
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNN 806
GT +++PELL S+ S D+++ G ++++++ G P A Y I I+
Sbjct: 194 ---GTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKL 247
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVR 835
P F + R L+E+ D R
Sbjct: 248 EYDFP-EKF-FPKARDLVEKLLVLDATKR 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 20/262 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ E L+ +G G+FG V + T A+K + K R + R +E +I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER--NEVRNVF---KELQIM 69
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIAMDAA 696
L HP +V + QD + V + ++ G LR+ L + H +L I +
Sbjct: 70 QGLEHPFLVNLWYSFQDE--EDMFMVVDLLLGGDLRY-HLQQNVHFKEETVKLFIC-ELV 125
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
++YL ++ I+H D+K DN+L++ + + DF ++ + + GT P+M
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHV----HITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 757 APELLNGSSSKV-SEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--P 813
APE+ + S VD +S G+ +E+L G PY IV+ V P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI-RSSTSSKEIVHTFETTVVTYP 240
Query: 814 GFCDSEWRLLMEQCWAPDPVVR 835
E L+++ P+P R
Sbjct: 241 SAWSQEMVSLLKKLLEPNPDQR 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 50/238 (21%)
Query: 586 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 642
+ LG G G V + T A+K ++ + RE E+ +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQC 114
Query: 643 PNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERHLDRRKRLIIA-------- 692
P++V V ++ G V E + G L R I
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----------FSR----IQDRGDQAFTE 160
Query: 693 MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 745
+A+ M +YLHS NI H D+K +NLL K P + K+ DFG +K +
Sbjct: 161 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTDFGFAKETTSHNS 219
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 803
T ++APE+L K + D++S G++++ +L G P+ + H AI G+
Sbjct: 220 LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 42/270 (15%)
Query: 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+ LG G+FG V VA+K I + +S R+ RE L L HP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVE----REISYLKLLRHP 69
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 699
+++ Y V+ + V E+ G L ++ K+R RR + II +
Sbjct: 70 HIIKLYDVITTP--TDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AI 121
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLPW 755
EY H IVH DLK +NLL++ + K+ DFGLS N + G G+ +
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNV----KIADFGLS----NIMTDGNFLKTSCGSPNY 173
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY--ANMH--YGAIIGGIVNNTLRPP 811
APE++NG E VDV+S GIVL+ +L G P+ + + + +
Sbjct: 174 AAPEVINGKLYAGPE-VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY------V 226
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+P F + L+ + DP+ R + EI
Sbjct: 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEI 256
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 6e-26
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 31/222 (13%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ E+L+++G GT+GTV+ K R T VA+KR++ + E + RE +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDA 695
+L H N+V + V+ TL V EF + L+ S LD K + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT-LVTGGV 749
G+ + HS+N++H DLK NLL+N + K+ +FGL++ ++ + V
Sbjct: 113 --GLGFCHSRNVLHRDLKPQNLLINRNGEL----KLANFGLARAFGIPVRCYSAEVV--- 163
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
TL + P++L G + S +D++S G + E+ P
Sbjct: 164 --TLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 56/257 (21%), Positives = 97/257 (37%), Gaps = 32/257 (12%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
++ +D E LK +G G F V K + T A+K + K R E F E
Sbjct: 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG-EVSC----FREER 112
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIAM 693
++L + + QD L V E+ V G L +L + R +A
Sbjct: 113 DVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA- 169
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-------IKRNTLVT 746
+ ++ +H VH D+K DN+L++ I ++ DFG ++ V
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI----RLADFGSCLKLRADGTVRSLVAV- 224
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEK-----VDVFSFGIVLWEILTGEEPYANMHYGAIIG 801
GT +++PE+L D ++ G+ +E+ G+ P+ G
Sbjct: 225 ----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
Query: 802 GIVNNTLRPPVPGFCDS 818
IV+ +P +
Sbjct: 281 KIVHYKEHLSLPLVDEG 297
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 67/253 (26%), Positives = 111/253 (43%), Gaps = 31/253 (12%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+K ED E +K +G G FG V + + T A+K + K RS + FW E
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS-DSAF----FWEER 120
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-M 693
+I++ + P VV + QD L V E+M G L + L+S ++ R A +
Sbjct: 121 DIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEV 177
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-------IKRNTLVT 746
A + +HS +H D+K DN+L++ + K+ DFG ++ +T V
Sbjct: 178 VLAL--DAIHSMGFIHRDVKPDNMLLDKSGHL----KLADFGTCMKMNKEGMVRCDTAV- 230
Query: 747 GGVRGTLPWMAPELLNGSSSKVS--EKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804
GT +++PE+L + D +S G+ L+E+L G+ P+ I+
Sbjct: 231 ----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286
Query: 805 NNTLRPPVPGFCD 817
N+ P D
Sbjct: 287 NHKNSLTFPDDND 299
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 41/270 (15%)
Query: 586 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
LG GTFG V GK G VA+K + + ++ RE + L HP
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIR----REIQNLKLFRHP 76
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 699
+++ Y V+ + V E++ G L + R RR + I++ G+
Sbjct: 77 HIIKLYQVISTP--SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GV 129
Query: 700 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLPW 755
+Y H +VH DLK +N+L++ K+ DFGLS N + G G+ +
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNA----KIADFGLS----NMMSDGEFLRTSCGSPNY 181
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTG----EEPYANMHYGAIIGGIVNNTLRPP 811
APE+++G E VD++S G++L+ +L G ++ + + I GI
Sbjct: 182 AAPEVISGRLYAGPE-VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------Y 234
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P + + L++ DP+ R + +I
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDI 264
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 61/256 (23%), Positives = 104/256 (40%), Gaps = 32/256 (12%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+ ED E LK +G G FG V K + D A+K + K R+ E F E
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA-ETAC----FREER 125
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++L + + QD L V ++ V G L L + + +
Sbjct: 126 DVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLT-------LLSKFEDRLPEEM 176
Query: 695 AAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLV 745
A F ++ +H + VH D+K DN+L+++ I ++ DFG ++ T+
Sbjct: 177 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI----RLADFGSCLKLMEDGTVQ 232
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSE---KVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 802
+ GT +++PE+L + D +S G+ ++E+L GE P+ G
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 803 IVNNTLRPPVPGFCDS 818
I+N+ R P
Sbjct: 293 IMNHKERFQFPTQVTD 308
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE---RLTLEFWREA 634
E E++ ++G G++G V+ + R T VAIK+ S + ++ L RE
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIAL---REI 53
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK-RLIIAM 693
+L +L HPN+V V + L V E+ + ++ H L +R + + I
Sbjct: 54 RMLKQLKHPNLVNLLEVFRRK--RRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVR 750
+ + H N +H D+K +N+L+ I K+ DFG ++ + V
Sbjct: 111 TLQ-AVNFCHKHNCIHRDVKPENILITKHSVI----KLCDFGFARLLTGPSDYY-DDEV- 163
Query: 751 GTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T W +PELL G ++ VDV++ G V E+L+G
Sbjct: 164 ATR-WYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 31/221 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ + +LG GT+G VY T+ VAIKRI+ E+E + RE +L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+L H N++ V+ L + E+ + L ++++D+ + + + +F
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHL--IFEYA-----ENDL---KKYMDKNPDVSMRVIKSF 137
Query: 698 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPI-RPICKVGDFGLSK---IKRNTLVTG 747
G+ + HS+ +H DLK NLL+++ D P+ K+GDFGL++ I T
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-TH 196
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ TL + PE+L G S S VD++S + E+L
Sbjct: 197 EII-TLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 53/228 (23%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD-VAIKRIKK-SCFTGRSSEQERLTLEFWREAEILSKL 640
K +G+G+FG V+ K +D VAIK++ + F R E +I+ +
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------------ELQIMRIV 89
Query: 641 HHPNVVA----FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
HPNVV FY L V E++ ++ RH + K+ M
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRAS----RHYAKLKQ---TMPML 141
Query: 697 F----------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRN 742
+ Y+HS I H D+K NLL++ P + K+ DFG +KI + N
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPN 198
Query: 743 T--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ + R APEL+ G ++ + +D++S G V+ E++ G+
Sbjct: 199 VSYICSRYYR------APELIFG-ATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 588 LGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
+G GT+G VY K + D A+K+I+ +++ RE +L +L HP
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG----------TGISMSACREIALLRELKHP 78
Query: 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMDAAF---- 697
NV++ V + + ++ L H++ + + +L M +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 698 --GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNTLVTGGVR 750
G+ YLH+ ++H DLK N+LV + P R K+ D G ++ +K + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 751 GTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T W APELL G + ++ +D+++ G + E+LT E
Sbjct: 198 -TF-WYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKK-SCFTGRSSEQERLTLEFWREAEILSK 639
+ K +G+G+FG VY K G VAIK++ + F R E +I+ K
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------------ELQIMRK 103
Query: 640 LHHPNVVA----FYGVVQDGPGGTLATVTEFM---VNGSLRHVLLSKERHLDRRKRLIIA 692
L H N+V FY + L V +++ V RH +K+ +L +
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 162
Query: 693 MDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTG 747
+ + Y+HS I H D+K NLL++ P + K+ DFG +K + R
Sbjct: 163 ----YQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ + + APEL+ G ++ + +DV+S G VL E+L G+
Sbjct: 216 YI-CSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 60/262 (22%), Positives = 93/262 (35%), Gaps = 75/262 (28%)
Query: 572 STLQIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQER 625
S LQI KN +++ + LG G G V + T A+K ++
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------- 54
Query: 626 LTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERH 682
+ RE E+ + P++V V ++ G V E + G L
Sbjct: 55 --PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL---------- 102
Query: 683 LDRRKRLIIA--------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRP 727
R I +A+ M +YLHS NI H D+K +NLL K P
Sbjct: 103 FSR----IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 158
Query: 728 ICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
+ K+ DFG A E K D++S G++++ +L G
Sbjct: 159 L-KLTDFGF--------------------AKETTGEKYDK---SCDMWSLGVIMYILLCG 194
Query: 788 EEPYANMHYGAIIGGIVNNTLR 809
P+ + H AI G+
Sbjct: 195 YPPFYSNHGLAISPGMKTRIRM 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
E L+++G GT+G VY + G A+K+I+ E E + RE IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAA 696
+L H N+V Y V+ L V E + + L+ +L E L+ K ++ +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL--VFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN- 111
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT-LVTGGVR 750
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ +++ T +
Sbjct: 112 -GIAYCHDRRVLHRDLKPQNLLINREGEL----KIADFGLARAFGIPVRKYTHEIV---- 162
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
TL + AP++L G S K S +D++S G + E++ G
Sbjct: 163 -TLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 24/215 (11%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
E ++L+++G GT+G VY K G VA+KRI+ +E E + RE +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAA 696
+LHHPN+V+ V+ TL V EFM L+ VL + L K + +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTL--VFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR- 130
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGTL 753
G+ + H I+H DLK NLL+N + K+ DFGL++ I + V TL
Sbjct: 131 -GVAHCHQHRILHRDLKPQNLLINSDGAL----KLADFGLARAFGIPVRSYTHEVV--TL 183
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ AP++L G S K S VD++S G + E++TG+
Sbjct: 184 WYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 67/273 (24%), Positives = 104/273 (38%), Gaps = 32/273 (11%)
Query: 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWR 632
Q + + + LG G FG V + R T A K+++K R E L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN----- 233
Query: 633 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 692
E +IL K++ VV+ + L V M G L+ H+ +
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLKF-------HIYHMGQAGFP 284
Query: 693 MD-AAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744
A F G+E LH + IV+ DLK +N+L++ IR I D GL+
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIR-IS---DLGLAVHVPEGQ 340
Query: 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804
G GT+ +MAPE++ S D ++ G +L+E++ G+ P+ +
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFS--PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
Query: 805 NNTLRPPV--PGFCDSEWRLLMEQCWAPDPVVR 835
P + R L Q DP R
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 64/258 (24%), Positives = 112/258 (43%), Gaps = 20/258 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ + +K LG+G+FG V K + + A+K + K + + E TL E IL
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEH-TLN---EKRIL 95
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
++ P +V +D L V E++ G + L + A
Sbjct: 96 QAVNFPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVL 152
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
EYLHS ++++ DLK +NLL++ + I +V DFG +K + T + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYI----QVTDFGFAKRVKGR--TWTLCGTPEALA 206
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817
PE++ + VD ++ G++++E+ G P+ I IV+ +R P
Sbjct: 207 PEIILSKGYNKA--VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFS 262
Query: 818 SEWRLLMEQCWAPDPVVR 835
S+ + L+ D R
Sbjct: 263 SDLKDLLRNLLQVDLTKR 280
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE---RLTLEFWREA 634
E E L +G G++G V + + T VAIK+ S + + ++ + RE
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAM---REI 75
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIA 692
++L +L H N+V V + L V EF+ + ++ L LD + ++ +
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWYL--VFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGV 749
+ G+ + HS NI+H D+K +N+LV+ + K+ DFG ++ V
Sbjct: 133 IIN--GIGFCHSHNIIHRDIKPENILVSQSGVV----KLCDFGFARTLAAPGEVY-DDEV 185
Query: 750 RGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T W APELL G K + VDV++ G ++ E+ GE
Sbjct: 186 -ATR-WYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ E+L LG G F TVY + + T+ VAIK+IK RS ++ + RE ++L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLL 66
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDA 695
+L HPN++ +L V +FM L ++ L K ++
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISL--VFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT-LVTGGV 749
G+EYLH I+H DLK +NLL++ + K+ DFGL+K + T V
Sbjct: 124 --GLEYLHQHWILHRDLKPNNLLLDENGVL----KLADFGLAKSFGSPNRAYTHQVV--- 174
Query: 750 RGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T W APELL G + VD+++ G +L E+L
Sbjct: 175 --TR-WYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRV 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 31/265 (11%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D + LK LG GTFG V + + T A+K ++K + E E + +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTE----SRVL 59
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMDA 695
HP + A Q L V E+ G L H LS+ER R R A +
Sbjct: 60 QNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFH--LSRERVFTEERARFYGA-EI 114
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----- 750
+EYLHS+++V+ D+K +NL+++ I K+ DFGL K ++ G
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHI----KITDFGLCKEG----ISDGATMKTFC 166
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810
GT ++APE+L + + VD + G+V++E++ G P+ N + + I+ +R
Sbjct: 167 GTPEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR- 223
Query: 811 PVPGFCDSEWRLLMEQCWAPDPVVR 835
P E + L+ DP R
Sbjct: 224 -FPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 580 EDLEELKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREA 634
E E L+ LG G +G V+ T A+K +KK+ + + T E
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH-TKA---ER 72
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIA 692
IL ++ HP +V Q G G L + E++ G L L +E +A
Sbjct: 73 NILEEVKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQ--LEREGIFMEDTACFYLA 128
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 750
+ + + +LH K I++ DLK +N+++N + + K+ DFGL K + G
Sbjct: 129 -EISMALGHLHQKGIIYRDLKPENIMLNHQGHV----KLTDFGLCKES----IHDGTVTH 179
Query: 751 ---GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807
GT+ +MAPE+L S + VD +S G +++++LTG P+ + I I+
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRA--VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVR 835
L +P + E R L+++ + R
Sbjct: 238 LN--LPPYLTQEARDLLKKLLKRNAASR 263
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 73/260 (28%), Positives = 130/260 (50%), Gaps = 24/260 (9%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D + L+ LG+G+FG V+ + R A+K +KK R + E T + E +L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEH-TND---ERLML 60
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIAMDAA 696
S + HP ++ +G QD + + +++ G L LL K + + A +
Sbjct: 61 SIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAA-EVC 116
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
+EYLHSK+I++ DLK +N+L++ I K+ DFG +K + T + GT ++
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHI----KITDFGFAKYVPDV--TYTLCGTPDYI 170
Query: 757 APELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
APE+++ +K +D +SFGI+++E+L G P+ + + I+N LR P F
Sbjct: 171 APEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPF 225
Query: 816 CDSEWRLLMEQCWAPDPVVR 835
+ + + L+ + D R
Sbjct: 226 FNEDVKDLLSRLITRDLSQR 245
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 70/331 (21%), Positives = 132/331 (39%), Gaps = 34/331 (10%)
Query: 516 METHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQ 575
M H + E + + + +L TA + +
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLT-----------GHAE 49
Query: 576 IIKNEDLEELKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEF 630
+ E+ E LK LG+G +G V+ T A+K +KK+ ++ E T
Sbjct: 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-TRT- 107
Query: 631 WREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKR 688
E ++L + P +V + Q L + +++ G L LS+ +
Sbjct: 108 --ERQVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFT-HLSQRERFTEHEVQ 162
Query: 689 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVT 746
+ + + +E+LH I++ D+K +N+L++ + + DFGLSK + T
Sbjct: 163 IYVG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHV----VLTDFGLSKEFVADETERA 217
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806
GT+ +MAP+++ G S + VD +S G++++E+LTG P+ I
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277
Query: 807 TLRPPV--PGFCDSEWRLLMEQCWAPDPVVR 835
L+ P + + L+++ DP R
Sbjct: 278 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 37/281 (13%), Positives = 76/281 (27%), Gaps = 57/281 (20%)
Query: 585 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
L G W+ D VA+ + + + + E LS
Sbjct: 36 LIFHGGVPPLQF----WQALDTALDRQVALTFVD-----PQGVLPDDVLQETLSRTLRLS 86
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 698
++ P V VV GG + V E++ GSL+ V + + A
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLV--VAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAA 141
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAP 758
+ H + + V++ + + M
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDV----VLAYPAT-------------------MPD 178
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP----- 813
+ + D+ G L+ +L P + + +T P+
Sbjct: 179 ---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229
Query: 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854
+ + + D +R + T + + + A +T
Sbjct: 230 RDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRT 270
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-23
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E +L +LG GT+ TVY GK + TD VA+K I R +E RE +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLL 54
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDA 695
L H N+V + ++ TL V E++ + L+ L ++ K + +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTL--VFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL-- 109
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGT 752
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ I T V T
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGEL----KLADFGLARAKSIPTKTYDNEVV--T 163
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
L + P++L G S+ S ++D++ G + +E+ TG
Sbjct: 164 LWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGR 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 21/219 (9%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ + + LG G FG V+ + + T A K++ K R Q + E +IL
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-----EKKIL 239
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLR---HVLLSKERHLD-RRKRLIIAM 693
+K+H +V+ + L V M G +R + + R A
Sbjct: 240 AKVHSRFIVSLAYAFETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA- 296
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGT 752
G+E+LH +NI++ DLK +N+L++ +R I D GL+ +K T G GT
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR-IS---DLGLAVELKAGQTKTKGYAGT 352
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+MAPELL G S VD F+ G+ L+E++ P+
Sbjct: 353 PGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGPF 389
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 37/224 (16%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE----RLTLEFWRE 633
++L++LG+GT+ TVY G + T VA+K +K + E + RE
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAI---RE 53
Query: 634 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
++ +L H N+V Y V+ TL V EFM + L+ + + + L + +
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTL--VFEFM-DNDLKK-YMDSRTVGNTPRGLELNL 109
Query: 694 DAAF------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTL 744
F G+ + H I+H DLK NLL+N + + K+GDFGL++ I NT
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQL----KLGDFGLARAFGIPVNTF 165
Query: 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ V TL + AP++L G S S +D++S G +L E++TG+
Sbjct: 166 SSEVV--TLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGK 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 79/266 (29%), Positives = 117/266 (43%), Gaps = 32/266 (12%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ E LK LG GTFG V K + T A+K +KK + LT E +L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVL 202
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMDA 695
HP + A Q L V E+ G L H LS+ER R R A +
Sbjct: 203 QNSRHPFLTALKYSFQT--HDRLCFVMEYANGGELFFH--LSRERVFSEDRARFYGA-EI 257
Query: 696 AFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---- 750
++YLHS KN+V+ DLK +NL+++ I K+ DFGL K + G
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHI----KITDFGLCKEG----IKDGATMKTF 309
Query: 751 -GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809
GT ++APE+L + + VD + G+V++E++ G P+ N + + I+ +R
Sbjct: 310 CGTPEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVR 835
P E + L+ DP R
Sbjct: 368 --FPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 35/268 (13%)
Query: 580 EDLEELKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREA 634
E LK LG G+FG V+ A+K +KK+ R E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKM-----ER 77
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIA 692
+IL +++HP +V + Q G L + +F+ G L LSKE + +A
Sbjct: 78 DILVEVNHPFIVKLHYAFQTE--GKLYLILDFLRGGDLFTR--LSKEVMFTEEDVKFYLA 133
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 750
+ A +++LHS I++ DLK +N+L++ + I K+ DFGLSK + +
Sbjct: 134 -ELALALDHLHSLGIIYRDLKPENILLDEEGHI----KLTDFGLSKES----IDHEKKAY 184
Query: 751 ---GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807
GT+ +MAPE++N S D +SFG++++E+LTG P+ + I+
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVR 835
L +P F E + L+ + +P R
Sbjct: 243 LG--MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 53/235 (22%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW-----R 632
E + E+G G +GTVY + + VA+K ++ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV--------PNGGGGGGGLPISTVR 60
Query: 633 EAEILSKLH---HPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRR 686
E +L +L HPNVV V V E + L +LD+
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDL---RTYLDKA 112
Query: 687 KRLIIAMDAA--------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
+ + G+++LH+ IVH DLK +N+LV + K+ DFGL++
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV----KLADFGLAR 168
Query: 739 I----KRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
I T +V TL + APE+L S + VD++S G + E+ +
Sbjct: 169 IYSYQMALTPVVV-----TLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-22
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E+L ++G GTFG V+ + R T VA+K++ +E+E + RE +IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 638 SKLHHPNVVAFYGVV------QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRL 689
L H NVV + + G++ V +F + L +L + KR+
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNT 743
+ + G+ Y+H I+H D+K N+L+ + K+ DFGL++ +
Sbjct: 130 MQMLLN--GLYYIHRNKILHRDMKAANVLITRDGVL----KLADFGLARAFSLAKNSQPN 183
Query: 744 LVTGGVRGTLPWM-APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T V TL W PELL G +D++ G ++ E+ T
Sbjct: 184 RYTNRVV-TL-WYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 47/224 (20%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D + +++LG G + V+ + V +K +K +++ RE +IL
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIK---REIKIL 84
Query: 638 SKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMD 694
L PN++ +V+D T A V E + N + + L+ D
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-------------D 131
Query: 695 AAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVT 746
F ++Y HS I+H D+K N++++ + + D+GL++
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI---DWGLAEFYHPGQEYN 188
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790
V + + PELL +D++S G +L ++ +EP
Sbjct: 189 VRV-ASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-21
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D + +G G FG VY + T A+K + K + + E L L E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALN---ERIML 243
Query: 638 SKLH---HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
S + P +V L+ + + M G L + LS+ A +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHY-HLSQHGVFSEADMRFYAAE 300
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
G+E++H++ +V+ DLK N+L++ +R I D GL+ V GT
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVR-IS---DLGLACDFSKKKPHASV-GTHG 355
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
+MAPE+L D FS G +L+++L G P+
Sbjct: 356 YMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPF 391
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 33/223 (14%)
Query: 583 EELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSS---EQERLTLEFWREAEI 636
+ + SG++G V + G VAIKR+ + GR+ L RE +
Sbjct: 25 TVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHL-DRRKRLIIA 692
L+ HHPN++ + + VTE M L V+ + + + + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM- 140
Query: 693 MDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS-KIKRNTLV 745
+ G+ LH +VH DL N+L+ + DF L+ + +
Sbjct: 141 ----YHILLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADANK 190
Query: 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T V + APEL+ ++ VD++S G V+ E+ +
Sbjct: 191 THYV-THRWYRAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 59/236 (25%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD------VAIKRI--KKSCFTGRSSEQERLTLEFWREA 634
+LK LG G G V + D VAIK+I L RE
Sbjct: 14 MDLKPLGCGGNGLV----FSAVDNDCDKRVAIKKIVLTDPQSVKH-------AL---REI 59
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLAT------------VTEFMVNGSLRHVLLSKERH 682
+I+ +L H N+V + ++ V E+M + +L +
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPL 117
Query: 683 LDRRKRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGL 736
L+ RL + + G++Y+HS N++H DLK NL +N +D K+GDFGL
Sbjct: 118 LEEHARLFM-----YQLLRGLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGL 167
Query: 737 SKI-----KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787
++I ++ G+ T + +P LL S + ++ +D+++ G + E+LTG
Sbjct: 168 ARIMDPHYSHKGHLSEGL-VTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 580 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ E + E+G G +G V+ K G VA+KR++ + +E + L RE +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 637 LSKLH---HPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLI 690
L L HPNVV + V V E + L +LD+
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDL---TTYLDKVPEPG 116
Query: 691 IAMDAA--------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742
+ + G+++LHS +VH DLK N+LV I K+ DFGL++I
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI----KLADFGLARIYSF 172
Query: 743 TL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ +T V TL + APE+L S + VD++S G + E+ +
Sbjct: 173 QMALTSVVV-TLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 2e-20
Identities = 76/385 (19%), Positives = 137/385 (35%), Gaps = 59/385 (15%)
Query: 437 WSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSR 496
F+ D+ R V + D D + + ++ G + + + G
Sbjct: 227 TFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEY 286
Query: 497 INFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPT 556
N + + E ++ ++ + D R+ L
Sbjct: 287 FNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRD----RMKL-- 340
Query: 557 AGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKS 614
D L LG G+FG V + +GTD A+K +KK
Sbjct: 341 -----------------------TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD 377
Query: 615 CFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL- 672
+ E E +L+ P + + Q L V E++ G L
Sbjct: 378 VVIQDD-DVECT----MVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLM 430
Query: 673 RHVLLSKERHLD-RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731
H + + A + A G+ +L SK I++ DLK DN++++ + I K+
Sbjct: 431 YH--IQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI----KI 483
Query: 732 GDFGLSKIKRNTLVTGGVR-----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786
DFG+ K + GV GT ++APE++ S VD ++FG++L+E+L
Sbjct: 484 ADFGMCKEN----IWDGVTTKTFCGTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLA 537
Query: 787 GEEPYANMHYGAIIGGIVNNTLRPP 811
G+ P+ + I+ + + P
Sbjct: 538 GQAPFEGEDEDELFQSIMEHNVAYP 562
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 53/252 (21%), Positives = 95/252 (37%), Gaps = 68/252 (26%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
K LG+G+FG V G A+K++ + R RE +I+ L
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVL---------QDPRYKN---RELDIMKVL 57
Query: 641 HHPNVVA----FYGVVQDGPGGTLAT--------------------------------VT 664
H N++ FY + P +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 665 EFM---VNGSLRHVLLSKERHLDRRKRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNL 717
E++ ++ L+ + S + I + + ++HS I H D+K NL
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYI-----YQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 718 LVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFS 776
LVN KD +C DFG +K + + + + + APEL+ G +++ + +D++S
Sbjct: 173 LVNSKDNTLKLC---DFGSAKKLIPSEPSVAYI-CSRFYRAPELMLG-ATEYTPSIDLWS 227
Query: 777 FGIVLWEILTGE 788
G V E++ G+
Sbjct: 228 IGCVFGELILGK 239
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+K ED K LG G+FG V+ +++ T+ AIK +KK + E E
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-DVECT----MVEK 68
Query: 635 EILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLII 691
+LS HP + + Q L V E++ G L H + D R
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYH--IQSCHKFDLSRATFYA 124
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR- 750
A + G+++LHSK IV+ DLK DN+L++ I K+ DFG+ K + G +
Sbjct: 125 A-EIILGLQFLHSKGIVYRDLKLDNILLDKDGHI----KIADFGMCKEN----MLGDAKT 175
Query: 751 ----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806
GT ++APE+L G S VD +SFG++L+E+L G+ P+ + I +
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHS--VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVR 835
P + + E + L+ + + +P R
Sbjct: 234 NPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRI-KKSCFTGRSSEQERLTLEFWREAEILSK 639
+ + G GTFGTV GK + G VAIK++ + F R L + + L+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------EL---QIMQDLAV 75
Query: 640 LHHPNVVA----FYGVVQDGPGGT-LATVTEFM---VNGSLRHVLLSKERHLDRRKRLII 691
LHHPN+V FY + + L V E++ ++ R+ + ++ +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 692 AMDAAF----GMEYLH--SKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKI-KRN 742
F + LH S N+ H D+K N+LVN D K+ DFG +K +
Sbjct: 136 -----FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD-----GTLKLCDFGSAKKLSPS 185
Query: 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ + + APEL+ G + + VD++S G + E++ GE
Sbjct: 186 EPNVAYI-CSRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-20
Identities = 62/278 (22%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREA 634
+ +D + L+ +G G++ V + + TD A+K +KK + + + E
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-DIDWV----QTEK 60
Query: 635 EILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLII 691
+ + +HP +V + Q L V E++ G L H + ++R L R
Sbjct: 61 HVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFH--MQRQRKLPEEHARFYS 116
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR- 750
A + + + YLH + I++ DLK DN+L++ + I K+ D+G+ K + G
Sbjct: 117 A-EISLALNYLHERGIIYRDLKLDNVLLDSEGHI----KLTDYGMCKEG----LRPGDTT 167
Query: 751 ----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG---- 802
GT ++APE+L G S VD ++ G++++E++ G P+ +
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225
Query: 803 -----IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 835
I+ +R +P + +++ DP R
Sbjct: 226 YLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-20
Identities = 67/245 (27%), Positives = 111/245 (45%), Gaps = 30/245 (12%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+ ++ E ++ LG G+FG V + + T A+K +KK + E E
Sbjct: 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD-DVECT----MTEK 74
Query: 635 EILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLII 691
ILS +HP + + Q L V EF+ G L H + K R D R R
Sbjct: 75 RILSLARNHPFLTQLFCCFQ--TPDRLFFVMEFVNGGDLMFH--IQKSRRFDEARARFYA 130
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR- 750
A + + +LH K I++ DLK DN+L++ + K+ DFG+ K + GV
Sbjct: 131 A-EIISALMFLHDKGIIYRDLKLDNVLLDHEGHC----KLADFGMCKEG----ICNGVTT 181
Query: 751 ----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806
GT ++APE+L + VD ++ G++L+E+L G P+ + + I+N+
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPA--VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
Query: 807 TLRPP 811
+ P
Sbjct: 240 EVVYP 244
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 30/242 (12%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D L LG G+FG V + +GTD A+K +KK + E E +L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-DVECT----MVEKRVL 74
Query: 638 SK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMD 694
+ P + + Q L V E++ G L H + + A +
Sbjct: 75 ALPGKPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLMYH--IQQVGRFKEPHAVFYAA-E 129
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---- 750
A G+ +L SK I++ DLK DN++++ + I K+ DFG+ K + GV
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI----KIADFGMCKEN----IWDGVTTKTF 181
Query: 751 -GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809
GT ++APE++ S VD ++FG++L+E+L G+ P+ + I+ + +
Sbjct: 182 CGTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 239
Query: 810 PP 811
P
Sbjct: 240 YP 241
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 583 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+GSG +G+V K G VAIK++ + F + RE +L +
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAY-----RELLLLKHM 80
Query: 641 HHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
H NV+ V P +L V FM L+ ++ + + + + ++
Sbjct: 81 QHENVIGLLDVFT--PASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLV--- 132
Query: 695 AAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGG 748
+ G++Y+HS +VH DLK NL VN C K+ DFGL++ + TG
Sbjct: 133 --YQMLKGLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLARHADAEM-TGY 183
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
V T + APE++ S ++ VD++S G ++ E+LTG+
Sbjct: 184 V-VTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 41/300 (13%)
Query: 568 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQER 625
N S+ K D LK +G G+FG V + + +V A+K ++K + E++
Sbjct: 26 NLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-EEKH 84
Query: 626 LTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHL 683
+ E +L K + HP +V + Q L V +++ G L H L +ER
Sbjct: 85 -IMS---ERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYINGGELFYH--LQRERCF 136
Query: 684 D-RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742
R R A + A + YLHS NIV+ DLK +N+L++ + I + DFGL K
Sbjct: 137 LEPRARFYAA-EIASALGYLHSLNIVYRDLKPENILLDSQGHI----VLTDFGLCKEN-- 189
Query: 743 TLVTGGVR-----GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 797
+ GT ++APE+L+ + VD + G VL+E+L G P+ + +
Sbjct: 190 --IEHNSTTSTFCGTPEYLAPEVLHKQPYDRT--VDWWCLGAVLYEMLYGLPPFYSRNTA 245
Query: 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSH 857
+ I+N L+ + + R L+E D +RL + KSH
Sbjct: 246 EMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDR---------TKRLGAKDDFMEIKSH 294
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 41/275 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D + L+ +G G++ V + + TD A++ +KK + + + E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE-DIDWV----QTEKHVF 106
Query: 638 SK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMD 694
+ +HP +V + Q L V E++ G L H + ++R L R A +
Sbjct: 107 EQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFH--MQRQRKLPEEHARFYSA-E 161
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---- 750
+ + YLH + I++ DLK DN+L++ + I K+ D+G+ K + G
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHI----KLTDYGMCKEG----LRPGDTTSTF 213
Query: 751 -GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG------- 802
GT ++APE+L G S VD ++ G++++E++ G P+ +
Sbjct: 214 CGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271
Query: 803 --IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR 835
I+ +R +P + +++ DP R
Sbjct: 272 QVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 585 LKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
L+ +GSG +G V G VAIK++ + F + RE +L + H
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAY-----RELRLLKHMRH 83
Query: 643 PNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
NV+ V P TL V FM L ++ ++ DR + L+ M
Sbjct: 84 ENVIGLLDVFT--PDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQM--L 138
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGTLP 754
G+ Y+H+ I+H DLK NL VN C K+ DFGL++ + + TG V T
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLARQADSEM-TGYV-VTRW 190
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ APE++ + + ++ VD++S G ++ E++TG+
Sbjct: 191 YRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 49/231 (21%)
Query: 583 EELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
+ LG G +G V H G VAIK+I F R TL RE +IL
Sbjct: 14 QLKSLLGEGAYGVVCSATHKP-TGEIVAIKKI--EPFDKPLFAL-R-TL---REIKILKH 65
Query: 640 LHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
H N++ + + + + E M + H ++S + D + I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFI----- 118
Query: 697 F----GMEYLHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFGLS-KIKRNTLVTG 747
+ ++ LH N++H DLK NLL+N LK +C DFGL+ I +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK-----VC---DFGLARIIDESAADNS 170
Query: 748 GVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
G M APE++ +S+K S +DV+S G +L E+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 583 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+ L +GSG +G+V G VA+K++ + F +S + T RE +L +
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PF--QSIIHAKRTY---RELRLLKHM 85
Query: 641 HHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
H NV+ V P +L VT M L +++ ++ D + LI +
Sbjct: 86 KHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI- 141
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGT 752
G++Y+HS +I+H DLK NL VN C K+ DFGL++ + + TG V T
Sbjct: 142 -LRGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLARHTADEM-TGYV-AT 192
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ APE++ + ++ VD++S G ++ E+LTG
Sbjct: 193 RWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 585 LKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
LK +GSG G V + +VAIK++ + F ++ + RE ++ ++H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAY-----RELVLMKCVNH 83
Query: 643 PNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
N++ V P +L V E M + +L V+ + H +R L+ M
Sbjct: 84 KNIIGLLNVFT--PQKSLEEFQDVYIVMELM-DANLCQVIQMELDH-ERMSYLLYQM--L 137
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS-KIKRNTLVTGGVRGTL 753
G+++LHS I+H DLK N++V C K+ DFGL+ + ++T V T
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYV-VTR 190
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ APE++ E VD++S G ++ E++ G
Sbjct: 191 YYRAPEVI--LGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 583 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
L +G G +G V + VAIK+I S F ++ Q R TL RE +IL +
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQ-R-TL---REIKILLRF 82
Query: 641 HHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
H N++ +++ + V + M L +L ++ D + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQI--LR 139
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKI-----KRNTLVTGGVR 750
G++Y+HS N++H DLK NLL+N C K+ DFGL+++ +T V
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLTEYV- 192
Query: 751 GTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
T + APE++ +S ++ +D++S G +L E+L+
Sbjct: 193 ATRWYRAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+ LK +GSG G V D VAIK++ + F ++ + RE ++ +
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY-----RELVLMKCV 118
Query: 641 HHPNVVAFYGVVQDGPGGT----LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+H N+++ V + V E M + ++ E +R L+ M
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLC- 175
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGTLP 754
G+++LHS I+H DLK N++V C K+ DFGL++ + + T
Sbjct: 176 -GIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ APE++ E VD++S G ++ E++ +
Sbjct: 229 YRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 6e-16
Identities = 50/251 (19%), Positives = 94/251 (37%), Gaps = 57/251 (22%)
Query: 583 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+G G++G VY + K +VAIK++ + F + R L RE IL++L
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCK-R-IL---REITILNRL 82
Query: 641 HHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
++ Y ++ V E + L+ + + + + I+ +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL-----Y 136
Query: 698 ----GMEYLHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFGLS------------ 737
G ++H I+H DLK N L+N +K +C DFGL+
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVK-----VC---DFGLARTINSEKDTNIV 188
Query: 738 -KIKRNTLVTGGVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWEILT 786
++ N + + APEL+ ++ +D++S G + E+L
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL-LQENYTKSIDIWSTGCIFAELLN 247
Query: 787 GEEPYANMHYG 797
+ + N
Sbjct: 248 MLQSHINDPTN 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 56/254 (22%), Positives = 92/254 (36%), Gaps = 58/254 (22%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E +G+G++G V + VAIK+I R E RE IL++L
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI------LRVFEDLIDCKRILREIAILNRL 109
Query: 641 HHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+H +VV +V V E + + + + + + ++ +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL-----Y 163
Query: 698 ----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS-------------- 737
G++Y+HS I+H DLK N LVN C KV DFGL+
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQD------CSVKVCDFGLARTVDYPENGNSQLP 217
Query: 738 ----KIKRNTLVTGGVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWE 783
+ N + + + APEL+ +E +DV+S G + E
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIGCIFAE 276
Query: 784 ILTGEEPYANMHYG 797
+L + H
Sbjct: 277 LLNMIKENVAYHAD 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 63/242 (26%)
Query: 583 EELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
E +K+LG G +G V + G VA+K+I F + Q R T RE IL++
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFD-AFQNSTDAQ-R-TF---REIMILTE 64
Query: 640 LH-HPNVVAFYGVVQDGPGGTLATVTEFM---VNGSLRHVLLSKERH------LDRRKRL 689
L H N+V V++ + V ++M ++ +R +L L +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIK---- 120
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS---------- 737
++YLHS ++H D+K N+L+N + C KV DFGLS
Sbjct: 121 --------VIKYLHSGGLLHRDMKPSNILLNAE------CHVKVADFGLSRSFVNIRRVT 166
Query: 738 --KIKRNTLVTGGVRGTLPWM----------APELLNGSSSKVSEKVDVFSFGIVLWEIL 785
T P + APE+L S+K ++ +D++S G +L EIL
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEIL 225
Query: 786 TG 787
G
Sbjct: 226 CG 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 6e-14
Identities = 48/280 (17%), Positives = 78/280 (27%), Gaps = 67/280 (23%)
Query: 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+ E L+ +++G G FG V+ T VAIK I + ++ E E
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 635 EILSKLH---------HPNVVAFYG--VVQDG--------------------------PG 657
I +L + VQ
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDN 716
L V EF G + +K L K I + + H DL N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKS--ILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 717 LLVNLKDPIRPICKVG----------------DFGLSKIKRNTLVTGGVRGTLPWMAPEL 760
+L+ + + D+ LS+++R+ G V M +L
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDL 248
Query: 761 LNGSSSKVSEKVDVFSF-GIVLWEILTGEEPYAN---MHY 796
G + D++ PY+N +HY
Sbjct: 249 FTGDGDY---QFDIYRLMKKENNNRWGEYHPYSNVLWLHY 285
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 48/216 (22%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 585 LKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH- 641
+++LG G F TV+ K T VA+K ++ ++E E L+ +A+ +
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 642 -HPNVVAFYGVVQ-DGPGGT-LATVTEFMVNGSLRHVL-LSKER--HLDRRKRLIIAMDA 695
+++ GP G + V E + +L ++ + R L K+ I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQL 140
Query: 696 AFGMEYLHSK-NIVHFDLKCDNLLVNLKDP--IRPICKVGDFGLSKIKRNTLVTGGVRGT 752
G++Y+H + I+H D+K +N+L+ + D K+ D G + T
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ--T 198
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ +PE+L G+ D++S +++E++TG+
Sbjct: 199 REYRSPEVLLGA--PWGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 41/233 (17%)
Query: 574 LQIIKNEDL----EELKELGSGTFGTVY--HGKWRGTDVAIKRIK-KSCFTGRSSEQERL 626
+ ++ + E LK +G G+FG V + VA+K ++ + F Q
Sbjct: 87 YVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAE 142
Query: 627 TLEFWREAEILSKL------HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-LSK 679
E IL L + NV+ + E + + +L ++ +K
Sbjct: 143 ------EIRILEHLRKQDKDNTMNVIHMLENFTFR--NHICMTFELL-SMNLYELIKKNK 193
Query: 680 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739
+ A ++ LH I+H DLK +N+L LK R KV DFG S
Sbjct: 194 FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL--LKQQGRSGIKVIDFGSSCY 251
Query: 740 KRNTLVTGGV----RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ + T R APE++ G ++ +D++S G +L E+LTG
Sbjct: 252 EHQRVYTYIQSRFYR------APEVILG--ARYGMPIDMWSLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 39/171 (22%)
Query: 586 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH- 642
+++GSG+FG +Y G G +VAIK + + L E++I +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECV--------KTKHPQLH--IESKIYKMMQGG 64
Query: 643 ---PNVVAF------YGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
P + +V + GP SL + R + L++
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELLGP--------------SLEDLFNFCSRKFSLKTVLLL 110
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742
A +EY+HSKN +H D+K DN L+ L + + DFGL+K R+
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRD 160
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 33/169 (19%)
Query: 586 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH- 642
K++G G FG + GK + VAIK S +L LE +R + L
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLE-YRFYKQLGSGDGI 67
Query: 643 PNVVAF------YGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
P V F +V + GP SL + +R + L+IA+
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGP--------------SLEDLFDLCDRTFSLKTVLMIAIQ 113
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP-ICKVGDFGLSKIKRN 742
MEY+HSKN+++ D+K +N L+ + + DF L+K +
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 2e-10
Identities = 77/646 (11%), Positives = 174/646 (26%), Gaps = 153/646 (23%)
Query: 149 HGDSEAEPTNFSYNGPSAIP----------QRYHSEQIPRE---QTE-KNRLSKSDDSFG 194
H D E + Y + + +P+ + E + + D G
Sbjct: 6 HMDFETGEHQYQYK--DILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63
Query: 195 SQFLISQALSDGSKPIRESVDKLHSGN----MASETEQSVAPAKQQ----------YTNL 240
+ L LS + +++ V+++ N M+ + P+ Y +
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 241 QKVEDGHAQ-LRKHKEFADKINKINSNG--SEDGLQSSLGKSELTQVVPKSAD-----DC 292
Q + L+ + + + ++ DG+ S GK+ + V S D
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS-GKTWVALDVCLSYKVQCKMDF 182
Query: 293 EV--TKIRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNG 350
++ ++ ++ E L + + + I A
Sbjct: 183 KIFWLNLKNCNSPETVL-EMLQKLLY----QIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 351 NDNKGQAQSL-----AQKENSVRAVSPG--------DSSIA-VVSPEGDILIDINDR--- 393
+K L Q + A + + +S I ++
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 394 FPRDFLSDIFTKA------RISENIAGVSPMHGD--GAVLSWNVENHDPRRWSYFRNLAQ 445
D + + K + + +P + W ++++
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR-----DGLATWDNWKHVNC 352
Query: 446 DEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLK--PDGSVMPQSGSRINFDEGS 503
D+ + S L +E + L P + +P + + +
Sbjct: 353 DKLTTI-----------IESSLNVLEPAEYRKM-FDRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 504 QRESSSIV----GPSTMETHPDYSRSELKG-----NESLQSEVVNHRIQESDYEEGR-LD 553
+ + +V S +E P S + L++E HR Y + D
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD 460
Query: 554 LPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKK 613
P +D + +G +H +K
Sbjct: 461 SDDLIPPYLDQYFYSH------------------IG-------HH------------LKN 483
Query: 614 SCFTGRSSEQERLTLEF-WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL 672
R + + L+F + E K+ H + G L T+ +
Sbjct: 484 IEHPERMTLFRMVFLDFRFLEQ----KIRHD------STAWNASGSILNTLQQLKF---Y 530
Query: 673 RHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDN 716
+ + + +R I+ + SK +++ L ++
Sbjct: 531 KPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 7e-05
Identities = 50/295 (16%), Positives = 88/295 (29%), Gaps = 71/295 (24%)
Query: 445 QDEFSRKDVSLMD-QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFD--E 501
+D F + D QD S L+ E +D+ + D SG+ F
Sbjct: 26 EDAF-VDNFDCKDVQDMP--KSILSKEE----IDHII--MSKD----AVSGTLRLFWTLL 72
Query: 502 GSQRESSSIVGPSTMETH-PDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIP 560
Q +V E +Y L +++E + Y E R L
Sbjct: 73 SKQ---EEMVQKFVEEVLRINYKF--LM--SPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125
Query: 561 LVDLALGNFDISTLQIIKNEDLEE-LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGR 619
+++S LQ L + L EL + G G+ K+
Sbjct: 126 FAK-----YNVSRLQPYLK--LRQALLELRPAKNVLI-DGV-LGSG-------KTWVALD 169
Query: 620 SSEQERLTLE-----FW------REA----EILSKLHHPNVVAFYGVVQDGPGGTLATVT 664
++ + FW E+L KL + + + D +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNIKLRIH 228
Query: 665 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIV-HFDLKCDNLL 718
+ LR LL + + L++ ++ + + F+L C LL
Sbjct: 229 S--IQAELRR-LLKSKPY---ENCLLVLLN-------VQNAKAWNAFNLSCKILL 270
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 32/170 (18%), Positives = 55/170 (32%), Gaps = 25/170 (14%)
Query: 586 KELGSGTFGTVYHG-KWRGTDVAIKRIKKSCFTGRSSEQ------------ERLTLEFWR 632
+G G FG +Y V + + ++ W
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 633 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMV----NGSLRHVLLSKERHLDRRKR 688
L L P G FM+ L+ + + + R+
Sbjct: 101 RTRKLKYLGVPKYWGS------GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 689 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
L +++ +EY+H VH D+K NLL+N K+P + D+GL+
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP--DQVYLVDYGLAY 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 51/266 (19%), Positives = 90/266 (33%), Gaps = 75/266 (28%)
Query: 585 LKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-- 640
+++LG G F TV+ VA+K + KS + E +L +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--------DEIRLLKSVRN 92
Query: 641 ---HHPN---VVAFYGVVQ-DGPGGT-LATVTEFMVNG-SLRHVL-LSKERHLDRRKRLI 690
+ PN VV + G GT + V E + G L + S + L
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK 150
Query: 691 IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPI------------------------ 725
I G++YLH+K I+H D+K +N+L+++ +
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 726 ---------------------RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 764
+ K+ D G + T + + E+L G
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIG- 267
Query: 765 SSKVSEKVDVFSFGIVLWEILTGEEP 790
S + D++S + +E+ TG+
Sbjct: 268 -SGYNTPADIWSTACMAFELATGDYL 292
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 38/254 (14%), Positives = 73/254 (28%), Gaps = 66/254 (25%)
Query: 516 METHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQ 575
M H +S G E+L + + ++ LP G L D + + +
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMTTSLEA---------LP-TGTVLTDKSGRQWKL---- 46
Query: 576 IIKNEDLEELKELGSGTFGTVYHG----------KWRGTDVAIK--RIKKSCFTGRSSEQ 623
G +Y + ++K F ++ Q
Sbjct: 47 ---------KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 624 ERLTLEFWREAEILSKLHHPNVVAFYG----------VVQDGPGGTLATVTEFMVNG--- 670
+ + L + G +V G +L + V+
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA--LDVSPKHV 155
Query: 671 -SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729
S R VL R LD +E+LH VH ++ +N+ V+ +D +
Sbjct: 156 LSERSVLQVACRLLDA-------------LEFLHENEYVHGNVTAENIFVDPED--QSQV 200
Query: 730 KVGDFGLSKIKRNT 743
+ +G + +
Sbjct: 201 TLAGYGFAFRYCPS 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 586 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-H 642
+++GSG+FG +Y G +VAIK + + L E++I L
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKHPQLL--YESKIYRILQGG 62
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
+ +G L V + + G SL + R L + L++A +E+
Sbjct: 63 TGIPNVRWFGVEGDYNVL--VMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743
+HSK+ +H D+K DN L+ L + + DFGL+K R+T
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDT 159
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 39/173 (22%), Positives = 63/173 (36%), Gaps = 41/173 (23%)
Query: 586 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH- 642
+ +G G+FG ++ G VAIK R S+ +L E L
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLR----DEYRTYKLLAGC 65
Query: 643 ---PNVVAFYGVVQD---------GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
PNV ++G GP SL +L R + +
Sbjct: 66 TGIPNVY-YFGQEGLHNVLVIDLLGP--------------SLEDLLDLCGRKFSVKTVAM 110
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP-ICKVGDFGLSKIKRN 742
A ++ +H K++V+ D+K DN L+ + + V DFG+ K R+
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 39/233 (16%)
Query: 574 LQIIKNEDL----EELKELGSGTFGTVYHGKWRGTD--VAIKRIK-KSCFTGRSSEQERL 626
+ E E +G G+FG V R VAIK IK K F ++ E
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQIEVR 102
Query: 627 TLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER----- 681
LE + + K + +V L V E + + +L +L +
Sbjct: 103 LLELMNKHDTEMKYY---IVHLKRHFMFR--NHLCLVFEML-SYNLYDLL--RNTNFRGV 154
Query: 682 HLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739
L+ ++ A + +L + +I+H DLK +N+L L +P R K+ DFG S
Sbjct: 155 SLNLTRK--FAQQMCTALLFLATPELSIIHCDLKPENIL--LCNPKRSAIKIVDFGSSCQ 210
Query: 740 KRNTLVTGGV----RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE 788
+ R +PE+L G +D++S G +L E+ TGE
Sbjct: 211 LGQRIYQYIQSRFYR------SPEVLLGM--PYDLAIDMWSLGCILVEMHTGE 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 39/170 (22%), Positives = 61/170 (35%), Gaps = 28/170 (16%)
Query: 586 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEF------------- 630
K++GSG FG +Y + A +K E L E
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRVAKKDCIK 97
Query: 631 -WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKR 688
W E + L L P G+ + V E + G L+ + + +
Sbjct: 98 KWIERKQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTV 153
Query: 689 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
L + + +EY+H VH D+K NLL+ K+P + D+GLS
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP--DQVYLADYGLSY 201
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 56/260 (21%), Positives = 88/260 (33%), Gaps = 77/260 (29%)
Query: 574 LQIIKNEDLEE----LKELGSGTFGTV---YHGKWRGTDVAIKRIK-KSCFTGRSSEQER 625
L + L + LG G FG V K G VA+K +K + E R
Sbjct: 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC----EAAR 59
Query: 626 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT---------VTEFMVNGSLRHVL 676
E ++L L+ + + + VQ L V E ++ S +
Sbjct: 60 S------EIQVLEHLNTTDPNSTFRCVQ-----MLEWFEHHGHICIVFE-LLGLSTYDFI 107
Query: 677 ---------LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN------- 720
L R + ++ +++ +LHS + H DLK +N+L
Sbjct: 108 KENGFLPFRLDHIRKM--AYQICKSVN------FLHSNKLTHTDLKPENILFVQSDYTEA 159
Query: 721 --------LKDPIRPICKVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKV 768
+ I P KV DFG + + T R APE++
Sbjct: 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR------APEVILA--LGW 211
Query: 769 SEKVDVFSFGIVLWEILTGE 788
S+ DV+S G +L E G
Sbjct: 212 SQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 54/260 (20%), Positives = 85/260 (32%), Gaps = 77/260 (29%)
Query: 574 LQIIKNEDLEE----LKELGSGTFGTVY----HGKWRGTDVAIKRIK-KSCFTGRSSEQE 624
L + L+E + LG GTFG V H + + VA+K I+ + E
Sbjct: 9 LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHAR-GKSQVALKIIRNVGKYR----EAA 63
Query: 625 RLTLEFWREAEILSKL--------HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 676
RL E +L K+ V G + E ++ + L
Sbjct: 64 RL------EINVLKKIKEKDKENKFL--CVLMSDWFNFH--GHMCIAFE-LLGKNTFEFL 112
Query: 677 ---------LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN------- 720
L RH+ +L A+ +LH + H DLK +N+L
Sbjct: 113 KENNFQPYPLPHVRHM--AYQLCHALR------FLHENQLTHTDLKPENILFVNSEFETL 164
Query: 721 --------LKDPIRPICKVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKV 768
K +V DFG + + T R PE++
Sbjct: 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR------PPEVILE--LGW 216
Query: 769 SEKVDVFSFGIVLWEILTGE 788
++ DV+S G +L+E G
Sbjct: 217 AQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 49/257 (19%), Positives = 95/257 (36%), Gaps = 67/257 (26%)
Query: 574 LQIIKNEDLEE----LKELGSGTFGTVY--HGKWRGTDVAIKRIK-KSCFTGRSSEQERL 626
K L ++++G GTFG V A+K ++ +T ++
Sbjct: 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKI 80
Query: 627 TLEFWREAEILSKL-----HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL----- 676
EA+IL K+ ++ N+V ++G + + E + SL ++
Sbjct: 81 ------EADILKKIQNDDINNNNIVKYHGKFMY--YDHMCLIFE-PLGPSLYEIITRNNY 131
Query: 677 ----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN------------ 720
+ + ++ A++ YL ++ H DLK +N+L++
Sbjct: 132 NGFHIEDIKLYCI--EILKALN------YLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 721 ---------LKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 771
+ K+ DFG + K + + + T + APE++
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGS--IINTRQYRAPEVILN--LGWDVS 239
Query: 772 VDVFSFGIVLWEILTGE 788
D++SFG VL E+ TG
Sbjct: 240 SDMWSFGCVLAELYTGS 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 867 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.75 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.95 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.89 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.71 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.13 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.07 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.0 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.77 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.65 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 96.47 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.16 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.16 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.13 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 95.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.47 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.88 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 93.85 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 93.74 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 93.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.47 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 91.32 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 90.81 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 90.39 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 90.27 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 90.14 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 89.54 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 89.37 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 89.18 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 88.91 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 88.69 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 88.69 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 88.42 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 88.06 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 87.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 87.05 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 86.98 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 86.95 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 86.43 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 85.99 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 85.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 85.5 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 85.41 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 85.31 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 85.18 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 85.04 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 85.02 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 84.68 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 84.36 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 84.34 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 84.26 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 83.63 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 83.58 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 83.05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 83.0 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 82.84 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 82.8 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 82.56 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 82.41 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 82.25 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 81.87 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 81.62 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 81.13 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=442.07 Aligned_cols=266 Identities=32% Similarity=0.520 Sum_probs=221.6
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
..|+|..++|++.++||+|+||+||+|++.+ .||||+++.... ......+|.+|+.+|++++|||||++++++
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~------~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDP------TPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3568899999999999999999999999865 599999875321 123356799999999999999999999998
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.++ .++||||||++|+|.+++......+++..++.|+.||+.||+|||+++||||||||+||||+.++ .+||+
T Consensus 102 ~~~---~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~----~~Ki~ 174 (307)
T 3omv_A 102 TKD---NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL----TVKIG 174 (307)
T ss_dssp CSS---SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE----EEEEC
T ss_pred ECC---eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC----cEEEe
Confidence 653 57999999999999999987777899999999999999999999999999999999999999665 56999
Q ss_pred ecCCcccccC---ccccCCcCCCCCccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 733 DFGLSKIKRN---TLVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 733 DFGLA~~~~~---~~~~s~~~GT~~Y~APEvl~g~-~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
|||+|+.... .......+||+.|||||++.+. ...++.++|||||||+||||+||+.||........+..++....
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~ 254 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY 254 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 9999986432 2223456799999999999753 34589999999999999999999999988776655555555444
Q ss_pred CC----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 809 RP----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 809 r~----~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
.. ..+..+++.+.+||.+||+.+|++||||.+|+++|+.+..+.
T Consensus 255 ~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 255 ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 32 345678999999999999999999999999999999886544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=436.53 Aligned_cols=262 Identities=35% Similarity=0.577 Sum_probs=223.8
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCcee
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 646 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIV 646 (867)
++.|..++|.+.+.||+|+||+||+|++. +..||||+++.. ......+|.+|+.+|++++|||||
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--------~~~~~~~f~~E~~il~~l~HpnIV 78 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKDFHREAELLTNLQHEHIV 78 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--------CHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--------ChHHHHHHHHHHHHHHhCCCCCCc
Confidence 35678899999999999999999999873 567999999642 122346799999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhccc------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCC
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKC 714 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKP 714 (867)
+++|+|.+.. .++||||||++|+|.+++.... ..+++..++.|+.||+.||.|||+++||||||||
T Consensus 79 ~l~g~~~~~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp 156 (299)
T 4asz_A 79 KFYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 156 (299)
T ss_dssp CEEEEECSSS--SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cEEEEEeeCC--EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCH
Confidence 9999998854 8999999999999999996532 4699999999999999999999999999999999
Q ss_pred cceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCC
Q 002908 715 DNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP 790 (867)
Q Consensus 715 sNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~P 790 (867)
+||||+.++ .+||+|||+|+..... .......||+.|||||++. ...++.++|||||||+||||+| |+.|
T Consensus 157 ~NILl~~~~----~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~--~~~~~~k~DVwS~Gvvl~Ellt~G~~P 230 (299)
T 4asz_A 157 RNCLVGENL----LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSLGVVLWEIFTYGKQP 230 (299)
T ss_dssp GGEEECGGG----CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred hhEEECCCC----cEEECCcccceecCCCCceeecCceecChhhcCHHHHc--CCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999765 4699999999854322 2223456899999999998 4568999999999999999999 8999
Q ss_pred CCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 791 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 791 F~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
|......+.+..+... .+++.|..+++++.+||.+||+.||.+|||+.+|++.|+.+..+.
T Consensus 231 f~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 231 WYQLSNNEVIECITQG-RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp TTTSCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 9998888777766554 456678889999999999999999999999999999999987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=438.71 Aligned_cols=262 Identities=35% Similarity=0.570 Sum_probs=219.5
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI 645 (867)
....|..++|.+.++||+|+||+||+|++. ++.||||+++.. .+....+|.+|+.+|++++||||
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--------~~~~~~~f~~E~~il~~l~HpnI 105 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------SESARQDFQREAELLTMLQHQHI 105 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--------SHHHHHHHHHHHHHHTTCCCTTB
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--------CHHHHHHHHHHHHHHHhCCCCCC
Confidence 445678889999999999999999999874 567999999642 12334679999999999999999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhccc--------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 711 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~--------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrD 711 (867)
|+++++|.+.. .++||||||++|+|.+++.... .++++.+++.|+.||+.||+|||+++|||||
T Consensus 106 V~l~g~~~~~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 183 (329)
T 4aoj_A 106 VRFFGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD 183 (329)
T ss_dssp CCEEEEECSSS--SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CcEEEEEEECC--EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccc
Confidence 99999998854 8999999999999999986432 4589999999999999999999999999999
Q ss_pred CCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-C
Q 002908 712 LKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 787 (867)
Q Consensus 712 LKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-G 787 (867)
|||+||||+.++ .+||+|||+|+..... .......||+.|||||++. ...++.++|||||||+||||+| |
T Consensus 184 LKp~NILl~~~~----~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~--~~~~~~~sDvwS~Gvvl~Ellt~G 257 (329)
T 4aoj_A 184 LATRNCLVGQGL----VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFTYG 257 (329)
T ss_dssp CCGGGEEEETTT----EEEECCCC----------------CCCCGGGCCHHHHT--TCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccHhhEEECCCC----cEEEcccccceeccCCCcceecCcccccccccChhhhc--CCCCCccccccchHHHHHHHHcCC
Confidence 999999999654 5699999999854322 2233467999999999998 5568999999999999999999 8
Q ss_pred CCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 788 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 788 k~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
+.||......+.+..+.. ..+++.|..+++++.+||.+||+.||++||||.+|+++|+.+...
T Consensus 258 ~~Pf~~~~~~~~~~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 258 KQPWYQLSNTEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CCTTCSSCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCHHHHHHHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 999999888777766554 456778889999999999999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=432.88 Aligned_cols=260 Identities=34% Similarity=0.547 Sum_probs=222.0
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI 645 (867)
.+++|..+++++.++||+|+||+||+|++. ++.||||+++..... ....+|.+|+.++++++||||
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-------~~~~~f~~E~~il~~l~HpNI 91 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-------PLREEFRHEAMLRARLQHPNV 91 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--------CHHHHHHHHHHHHHCCCTTB
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-------HHHHHHHHHHHHHHhCCCCCC
Confidence 455778889999999999999999999973 467999999753211 123578999999999999999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhcc---------------cccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 710 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~---------------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHr 710 (867)
|+++|+|.+.. .++||||||++|+|.+++... ...+++..++.|+.||+.||+|||+++||||
T Consensus 92 V~l~g~~~~~~--~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR 169 (308)
T 4gt4_A 92 VCLLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHK 169 (308)
T ss_dssp CCEEEEECSSS--SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred CCcceEEEECC--EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999998854 889999999999999999543 2458999999999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-
Q 002908 711 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT- 786 (867)
Q Consensus 711 DLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT- 786 (867)
||||+||||+.++. +||+|||+|+..... .......||+.|||||++. ...++.++|||||||+||||+|
T Consensus 170 DLK~~NILl~~~~~----~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~--~~~~s~ksDVwSfGvvl~El~t~ 243 (308)
T 4gt4_A 170 DLATRNVLVYDKLN----VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSY 243 (308)
T ss_dssp CCSGGGEEECGGGC----EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CccccceEECCCCC----EEECCcccceeccCCCceeEecccccCCcccCHHHHh--CCCCCccchhhhHHHHHHHHHhC
Confidence 99999999997654 699999999854322 2334567999999999998 4568999999999999999999
Q ss_pred CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 787 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 787 Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
|..||.+....+....+.. ..+++.|..+++.+.+||.+||+.||.+||||.+|+++|+.+
T Consensus 244 g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 244 GLQPYCGYSNQDVVEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TCCTTTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8999999888777766554 456677889999999999999999999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=438.93 Aligned_cols=253 Identities=23% Similarity=0.424 Sum_probs=214.3
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|++. |+.||||++...... ......+.+|+.+|++|+|||||+++++|.+..
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 96 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS------SKEREESRREVAVLANMKHPNIVQYRESFEENG 96 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC------HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 478999999999999999999984 889999999765322 223467889999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
.+|||||||+||+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|. +||+|||
T Consensus 97 --~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~----vKl~DFG 170 (350)
T 4b9d_A 97 --SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT----VQLGDFG 170 (350)
T ss_dssp --EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC----EEECSTT
T ss_pred --EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC----EEEcccc
Confidence 999999999999999999654 356799999999999999999999999999999999999997764 5999999
Q ss_pred CcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 736 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 736 LA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
+|+...... .....+||+.|||||++.+ ..++.++|||||||+||+|+||+.||.+.+....+..+..... ++.+.
T Consensus 171 la~~~~~~~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~~ 247 (350)
T 4b9d_A 171 IARVLNSTVELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSL 247 (350)
T ss_dssp EESCCCHHHHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCT
T ss_pred cceeecCCcccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCc
Confidence 998665432 2344679999999999984 5689999999999999999999999999888888888777654 35567
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+++++.+||.+||+.||.+|||+.|++++-+
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 78999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=435.61 Aligned_cols=268 Identities=25% Similarity=0.377 Sum_probs=225.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.+.|++.++||+|+||+||+|+++ |+.||||+++...+ +.+|+.+|+.++|||||+++++|.+..
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 457999999999999999999984 88999999976432 236899999999999999999998855
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+|||||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+||||+.+|. .+||+|||+
T Consensus 124 --~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---~vKl~DFGl 197 (336)
T 4g3f_A 124 --WVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS---RAALCDFGH 197 (336)
T ss_dssp --EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC---CEEECCCTT
T ss_pred --EEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC---EEEEeeCCC
Confidence 899999999999999999643 56999999999999999999999999999999999999997763 369999999
Q ss_pred cccccCcc------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC-
Q 002908 737 SKIKRNTL------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR- 809 (867)
Q Consensus 737 A~~~~~~~------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr- 809 (867)
|+...... .....+||+.|||||++.+ ..++.++|||||||+||+|+||+.||...........+......
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~ 275 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 275 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc
Confidence 98654321 2234679999999999984 56889999999999999999999999887766666666665433
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCCCCCCcccCCCCC
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGHQVQNQVPK 867 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~~~~~~v~~q~Pk 867 (867)
...+..+++.+.+||.+||+.||.+|||+.||+++|.........-.+.|...-+-||
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 2356778999999999999999999999999999999988877766666655555554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=431.61 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=222.4
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++++.||+|+||+||+|++ +++.||||++.+.... .+.....+.+|+.+|+.++|||||+++++|.+.
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 346899999999999999999998 4788999999764321 112245688999999999999999999999985
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. .+|||||||+||+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+||||+.++. +||+|||
T Consensus 105 ~--~~yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~----vKl~DFG 177 (311)
T 4aw0_A 105 E--KLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH----IQITDFG 177 (311)
T ss_dssp S--EEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC----EEECCCT
T ss_pred C--EEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC----EEEEEcC
Confidence 4 99999999999999999964 456999999999999999999999999999999999999997764 5999999
Q ss_pred CcccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 736 LSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 736 LA~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
+|+.... .......+||+.|||||++.+ ..++.++|||||||+||+|+||+.||.+.+.......+....+ ..
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~~ 253 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--DF 253 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CC
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CC
Confidence 9986532 223456789999999999984 4578999999999999999999999999888888888877654 45
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+..+++++++||.+||+.||.+|||+.|++.+-+-..-+..
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F 294 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCc
Confidence 66789999999999999999999999998766555544444
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=435.90 Aligned_cols=267 Identities=31% Similarity=0.509 Sum_probs=227.3
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC-Cc
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PN 644 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H-PN 644 (867)
.-|+|..++|++.+.||+|+||+||+|.+.+ +.||||+++... . ......|.+|+.+|.+++| ||
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-----~--~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----T--HSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-----C--HHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-----C--hHHHHHHHHHHHHHHHcCCCCc
Confidence 3468899999999999999999999999853 469999987432 1 1224678999999999976 89
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeec
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 709 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIH 709 (867)
||+++|+|... ...++||||||++|+|.+++.... ..+++..++.|+.||+.||+|||+++|||
T Consensus 130 IV~l~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiH 208 (353)
T 4ase_A 130 VVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 208 (353)
T ss_dssp BCCEEEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeec
Confidence 99999998653 236899999999999999996432 34899999999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 710 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 710 rDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
|||||+|||++.++ .+||+|||+|+..... .......||+.|||||++. ...++.++|||||||+||||+|
T Consensus 209 RDLK~~NILl~~~~----~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~--~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 209 RDLAARNILLSEKN----VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp SCCSGGGEEECGGG----CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTT
T ss_pred CccCccceeeCCCC----CEEECcchhhhhcccCCCceeeccccccccccCHHHHh--cCCCCCcccEeehHHHHHHHHh
Confidence 99999999999766 4699999999854322 2334567899999999998 4568999999999999999998
Q ss_pred -CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 787 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 787 -Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
|+.||.+......+...+....+++.|..+++++.++|.+||+.||.+||||.+|+++|+.+..+..
T Consensus 283 ~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 283 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 9999998776666666677777888899999999999999999999999999999999998866543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=418.35 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=202.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||+||+|++ +|+.||||++....... ......+.+|+.+|+.++|||||++++++.+..
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-----SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD- 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-
Confidence 5899999999999999999998 48899999997654322 222456889999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+|+||||| +|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 87 -~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~----vkl~DFGla 159 (275)
T 3hyh_A 87 -EIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN----VKIADFGLS 159 (275)
T ss_dssp -EEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC----EEECCSSCC
T ss_pred -EEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC----EEEeecCCC
Confidence 899999999 78999988644 56999999999999999999999999999999999999997664 599999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCc
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s 817 (867)
+...........+||+.|||||++.+.. .++.++|||||||+||+|+||+.||...........+..... +.+..++
T Consensus 160 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~-y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--~~p~~~s 236 (275)
T 3hyh_A 160 NIMTDGNFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--TLPKFLS 236 (275)
T ss_dssp ---------------CTTSCHHHHSSSS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTSC
T ss_pred eecCCCCccCCeeECcccCChhhhcCCC-CCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CCCCCCC
Confidence 8766555555678999999999998532 346899999999999999999999998887777777766543 4567789
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 818 SEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 818 ~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+++.+||.+||+.||.+|||+.|++++-+-
T Consensus 237 ~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 237 PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 999999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=431.17 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=215.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.+.|+++++||+|+||+||+|+++ |+.||||++....... ...+.+|+.+|+.++|||||+++++|.+..
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--------GGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--------HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357999999999999999999994 8889999997543221 134678999999999999999999999855
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+|||||||+||+|.+++.. ..+++..+..++.||+.||+|||++|||||||||+||||+.+|. +||+|||+
T Consensus 145 --~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~----vKl~DFGl 216 (346)
T 4fih_A 145 --ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR----VKLSDFGF 216 (346)
T ss_dssp --EEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----EEECCCTT
T ss_pred --EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC----EEEecCcC
Confidence 99999999999999998853 46999999999999999999999999999999999999997764 59999999
Q ss_pred cccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-CCCCCC
Q 002908 737 SKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVPG 814 (867)
Q Consensus 737 A~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l-r~~ip~ 814 (867)
|+.... .......+||+.|||||++. ...|+.++|||||||+||||++|+.||.+......+..+..... ..+.+.
T Consensus 217 a~~~~~~~~~~~~~~GTp~YmAPEvl~--~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 294 (346)
T 4fih_A 217 CAQVSKEVPRRKSLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 294 (346)
T ss_dssp CEECCSSSCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGG
T ss_pred ceecCCCCCcccccccCcCcCCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccc
Confidence 986543 33445678999999999998 45689999999999999999999999998887777766655432 233345
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+++++.+||.+||+.||.+|||+.|++++-+-
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 689999999999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=415.04 Aligned_cols=253 Identities=30% Similarity=0.461 Sum_probs=208.7
Q ss_pred cCCe-eEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 579 NEDL-EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdy-qilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..+| ++.++||+|+||+||+|.+. +..||||++...... ......|.+|+.+|++|+|||||+++++|.+.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence 3455 67788999999999999984 778999999764321 22346789999999999999999999998642
Q ss_pred --CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCCcceEecc-CCCCCCcEE
Q 002908 656 --PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNL-KDPIRPICK 730 (867)
Q Consensus 656 --~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~G--IIHrDLKPsNILLd~-dg~~~~~vK 730 (867)
....++||||||++|+|.+++.. ...+++..+..|+.||+.||+|||+++ ||||||||+||||+. +| .+|
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g----~vK 172 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----SVK 172 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS----CEE
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC----CEE
Confidence 23478999999999999999964 457999999999999999999999998 999999999999974 44 469
Q ss_pred EeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-CC
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-LR 809 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-lr 809 (867)
|+|||+|+...... ....+||+.|||||++.+ .++.++|||||||+||+|+||+.||........+...+... ..
T Consensus 173 l~DFGla~~~~~~~-~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~ 248 (290)
T 3fpq_A 173 IGDLGLATLKRASF-AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248 (290)
T ss_dssp ECCTTGGGGCCTTS-BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred EEeCcCCEeCCCCc-cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC
Confidence 99999998654433 345679999999999873 48999999999999999999999998765554444434333 33
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
...+..+++++.+||.+||+.||.+|||+.+++++.+
T Consensus 249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 3455667899999999999999999999999988643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=433.25 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=216.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.+.|+++++||+|+||+||+|++. |+.||||++....... ...+.+|+.+|+.++|||||+++++|.+..
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--------GGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 367999999999999999999994 8889999997543221 134778999999999999999999999855
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+|||||||+||+|.+++. ...+++..+..|+.||+.||+|||++|||||||||+||||+.+|. +||+|||+
T Consensus 222 --~~~iVmEy~~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~----vKl~DFGl 293 (423)
T 4fie_A 222 --ELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR----VKLSDFGF 293 (423)
T ss_dssp --EEEEEEECCTTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC----EEECCCTT
T ss_pred --EEEEEEeCCCCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC----EEEecCcc
Confidence 9999999999999999884 346999999999999999999999999999999999999997764 59999999
Q ss_pred cccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-CCCCCC
Q 002908 737 SKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPVPG 814 (867)
Q Consensus 737 A~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l-r~~ip~ 814 (867)
|+.... .......+||+.|||||++. ...|+.++|||||||+||+|++|+.||.+......+..+..... ....+.
T Consensus 294 a~~~~~~~~~~~~~~GTp~YmAPEvl~--~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 371 (423)
T 4fie_A 294 CAQVSKEVPRRKSLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 371 (423)
T ss_dssp CEECCSSCCCBCCCEECTTTCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTT
T ss_pred ceECCCCCccccccccCcCcCCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccc
Confidence 986543 33445678999999999998 45689999999999999999999999998887777776665432 334456
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+++++.+||.+||+.||.+|||+.|++++-+-
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 789999999999999999999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=421.54 Aligned_cols=253 Identities=28% Similarity=0.404 Sum_probs=210.4
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
+..++|++++.||+|+||+||+|++ .++.||||+++........ ..++.+|+.+|++++|||||+++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------RVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------CC------CCCCCCCCTTEECEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------HHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 4457899999999999999999987 2567999999765432111 1246789999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+.+.. .+|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||++.+|. +||
T Consensus 95 ~~~~~--~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~----vKl 167 (304)
T 3ubd_A 95 FQTEG--KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH----IKL 167 (304)
T ss_dssp EEETT--EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC----EEE
T ss_pred EEECC--EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC----EEe
Confidence 99854 99999999999999999864 456999999999999999999999999999999999999997765 599
Q ss_pred eecCCccccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 732 GDFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 732 ~DFGLA~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
+|||+|+... ........+||+.|||||++. ...++.++|||||||+||+|+||+.||.+.+..+.+..+.....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~--~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-- 243 (304)
T 3ubd_A 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-- 243 (304)
T ss_dssp ESSEEEEC-----CCCCSCCCCGGGCCHHHHH--TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--
T ss_pred cccccceeccCCCccccccccCcccCCHHHhc--cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--
Confidence 9999998543 333445678999999999998 45678999999999999999999999999888888888776654
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLR 846 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq 846 (867)
+.|..+++++.+||.+||+.||.+||| ++|++++-+
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 456788999999999999999999998 578877654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=406.10 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=202.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC--
Q 002908 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG-- 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~-- 657 (867)
.+|.+.++||+|+||+||+|+++|+.||||+++... .. ...+..|+..+..++|||||+++++|.....
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~-------~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG-------HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-------hh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence 468899999999999999999999999999986421 11 1223356666678999999999999976432
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCCcceEeccCCCCCCcE
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~--------GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
..++||||||++|+|.+++.. ..+++..++.|+.|++.||+|||++ +||||||||+||||+.++. +
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~----~ 147 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT----C 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC----E
T ss_pred eEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC----E
Confidence 368999999999999999954 4689999999999999999999987 9999999999999997664 6
Q ss_pred EEeecCCcccccCcc-----ccCCcCCCCCccCccccccCC----CCCChhhHHHHHHHHHHHHHhCCCCCCCC------
Q 002908 730 KVGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSS----SKVSEKVDVFSFGIVLWEILTGEEPYANM------ 794 (867)
Q Consensus 730 KL~DFGLA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~----~~~S~kSDVWSLGvLLyELLTGk~PF~~~------ 794 (867)
||+|||+|+...... ......||+.|||||++.+.. ..++.++|||||||+||||+||.+||...
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 999999998654322 223457999999999997532 13678999999999999999997765321
Q ss_pred ---------ChhHHHHhHhhcCCCCCCCCC-----CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 795 ---------HYGAIIGGIVNNTLRPPVPGF-----CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 795 ---------~~~e~l~~iv~~~lr~~ip~~-----~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
........+....+++++|.. ++..+.+||.+||+.||.+||||.+|++.|+.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 112334445556666666543 345789999999999999999999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=402.90 Aligned_cols=249 Identities=29% Similarity=0.460 Sum_probs=189.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC-
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP- 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~- 656 (867)
++|++++.||+|+||+||+|+++ |+.||||+++... .+.....+.+|+.+|++|+|||||+++++|.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 46999999999999999999984 8889999997532 1233457889999999999999999999986532
Q ss_pred ---------CCeEEEEEEeecCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 657 ---------GGTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 657 ---------~~~l~LVmEy~~ggSL~d~L~~~~--~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
...+|+|||||++++|.+++.... ...++..++.|+.||+.||+|||++|||||||||+||||+.++.
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~- 156 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV- 156 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc-
Confidence 235799999999999999996543 34567778999999999999999999999999999999997764
Q ss_pred CCcEEEeecCCcccccCcc-------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 002908 726 RPICKVGDFGLSKIKRNTL-------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 792 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~~~-------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~ 792 (867)
+||+|||+|+...... .....+||+.|||||++.+ ..++.++|||||||+||||++ ||.
T Consensus 157 ---vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 157 ---VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp ---EEECCCCCC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred ---EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 5999999998654321 1234579999999999984 568999999999999999996 776
Q ss_pred CCChh-HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 793 NMHYG-AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 793 ~~~~~-e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..... ..+..+.... .++.....++.+.+||.+||+.||.+|||+.+++++-
T Consensus 229 ~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 229 TQMERVRTLTDVRNLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp SHHHHHHHHHHHHTTC-CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CccHHHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 53222 2222222222 1222223456788999999999999999999998853
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=408.92 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=210.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC-
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG- 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~- 655 (867)
.++|++++.||+|+||+||+|++ +|+.||||+++.... .......+++|+.+|+.|+|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD------VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc------chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 36899999999999999999998 488999999975321 123346788999999999999999999987642
Q ss_pred ---CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 656 ---PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 656 ---~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
..+.+||||||| +|+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.+|. +||+
T Consensus 127 ~~~~~~~~~ivmE~~-~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~----~Ki~ 200 (398)
T 4b99_A 127 PYGEFKSVYVVLDLM-ESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE----LKIG 200 (398)
T ss_dssp CTTTCCCEEEEEECC-SEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC----EEEC
T ss_pred ccccCCEEEEEEeCC-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC----EEEe
Confidence 235899999999 4789888854 457999999999999999999999999999999999999997765 5999
Q ss_pred ecCCcccccC-----ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC
Q 002908 733 DFGLSKIKRN-----TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 733 DFGLA~~~~~-----~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~ 807 (867)
|||+|+.... .......+||+.|||||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 9999985432 2233457899999999998853 357899999999999999999999999888777666554432
Q ss_pred CCCCC-----------------------------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 808 LRPPV-----------------------------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 808 lr~~i-----------------------------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..++. ...+++++.+||.+||+.||.+|||+.|+++|-+-
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 21110 12467889999999999999999999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=416.73 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=220.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||+||+|.+ +|+.||||++.... ......+.+|+.+|+.|+|||||+++++|.+..
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 227 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN- 227 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-
Confidence 6899999999999999999998 47889999997532 112356789999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.++||||||+||+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.+.. ..+||+|||+|
T Consensus 228 -~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~--~~vKl~DFG~a 304 (573)
T 3uto_A 228 -EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLT 304 (573)
T ss_dssp -EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC--CCEEECCCSSC
T ss_pred -EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCC--CCEEEeeccce
Confidence 999999999999999999766677999999999999999999999999999999999999986532 35799999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC--CCCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPGF 815 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~--ip~~ 815 (867)
+...........+||+.|||||++.+ ..++.++|||||||+||+|++|..||.+......+..+....+..+ ....
T Consensus 305 ~~~~~~~~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 382 (573)
T 3uto_A 305 AHLDPKQSVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382 (573)
T ss_dssp EECCTTSEEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT
T ss_pred eEccCCCceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC
Confidence 97766555556789999999999984 5689999999999999999999999999988888888777655433 3356
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+++++.+||.+||+.||.+|||+.|+++|-+
T Consensus 383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 8999999999999999999999999998644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=390.73 Aligned_cols=247 Identities=19% Similarity=0.239 Sum_probs=195.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccc
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 653 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~ 653 (867)
++|++.++||+|+||+||+|+++ ++.||||.+.... . ..++.+|+++|+.+ +|||||+++++|.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~------~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----H------PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----C------HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----C------HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 67999999999999999999863 5679999986431 1 23567899999998 6999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. .+++|||||++++|.+++. .+++..+..++.||+.||+|||++|||||||||+|||++.+. ..+||+|
T Consensus 91 ~~~--~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~---~~~kl~D 161 (361)
T 4f9c_A 91 KND--HVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL---KKYALVD 161 (361)
T ss_dssp ETT--EEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT---TEEEECC
T ss_pred ECC--EEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC---CeEEECc
Confidence 855 9999999999999999883 589999999999999999999999999999999999998652 3579999
Q ss_pred cCCcccccCcc-----------------------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHH
Q 002908 734 FGLSKIKRNTL-----------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI 784 (867)
Q Consensus 734 FGLA~~~~~~~-----------------------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyEL 784 (867)
||+|+...... .....+||+.|+|||++.+ ...++.++||||+||++|+|
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-CPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCCccchhhhHHHHHHH
Confidence 99997543211 1123569999999999985 34578999999999999999
Q ss_pred HhCCCCCCCCCh-hHHHHhHhhc----------------------------------------------------CCCCC
Q 002908 785 LTGEEPYANMHY-GAIIGGIVNN----------------------------------------------------TLRPP 811 (867)
Q Consensus 785 LTGk~PF~~~~~-~e~l~~iv~~----------------------------------------------------~lr~~ 811 (867)
++|+.||..... ...+..+..- ....+
T Consensus 241 l~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 241 LSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred HHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 999999955332 2222211100 00011
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....+++++.+||.+||+.||.+|||++|+++|.+
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 22356889999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=371.54 Aligned_cols=264 Identities=40% Similarity=0.694 Sum_probs=219.0
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
..+...+|++.+.||+|+||+||+|+++++.||||++..... ......++.+|+.++++++||||+++++++..
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF------HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 367788999999999999999999999999999999975432 12334678899999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCCcceEeccCCCCCCcEE
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~--~~Lse~~~l~Ia~QIa~ALayLHs~G--IIHrDLKPsNILLd~dg~~~~~vK 730 (867)
.. ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+|
T Consensus 106 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~----~~k 179 (309)
T 3p86_A 106 PP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY----TVK 179 (309)
T ss_dssp TT--CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC----CEE
T ss_pred CC--ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC----cEE
Confidence 55 7899999999999999986543 34999999999999999999999999 99999999999999765 459
Q ss_pred EeecCCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 731 VGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 731 L~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
|+|||+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|..||...........+......
T Consensus 180 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 257 (309)
T 3p86_A 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 257 (309)
T ss_dssp ECCCC-----------------CCTTSCHHHHT--TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC
T ss_pred ECCCCCCccccccccccccCCCCccccChhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9999999854332 2233456999999999998 445788999999999999999999999998887777776666667
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
...+..+++.+.+||.+||+.+|.+|||+.++++.|+.+....
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 7788889999999999999999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.33 Aligned_cols=262 Identities=36% Similarity=0.625 Sum_probs=213.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
.+..++|++.+.||+|+||.||+|.+.++.||||+++..... ........+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE----DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcc----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456789999999999999999999999999999998754321 1122345688999999999999999999999875
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCCcceEeccCCC----CCCc
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN---IVHFDLKCDNLLVNLKDP----IRPI 728 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~G---IIHrDLKPsNILLd~dg~----~~~~ 728 (867)
. ..++||||+++++|.+++. ...+++..++.++.|++.||.|||++| |+||||||+|||++.... ....
T Consensus 79 ~--~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 79 P--NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp ----CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred C--ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 4 7899999999999999884 457899999999999999999999999 999999999999986432 2456
Q ss_pred EEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 729 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
++|+|||++........ ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 155 ~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231 (271)
T ss_dssp EEECCCCC--------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC
T ss_pred eEEccCCcccccccccc-cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC
Confidence 89999999986544332 24568999999999984 4579999999999999999999999999888777777777777
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+.+..+++.+.++|.+||+.+|.+|||+.+++++|+.+
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 7788888999999999999999999999999999999753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=353.42 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=224.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
.+..++|++.+.||+|+||.||+|+++++.||||+++.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW------STRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC------CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc------CHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 56678999999999999999999999999999999976421 122345788999999999999999999999886
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccc-cCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCCcceEeccCCCCCCcEEEe
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~-~Lse~~~l~Ia~QIa~ALayLHs~G--IIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.....++||||+++++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++. ++|+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~----~~l~ 155 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT----ARIS 155 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC----EEEE
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc----eeEE
Confidence 55688999999999999999976543 5899999999999999999999999 999999999999997664 4888
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~-~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
|||++..... ....+|+.|+|||++.+.. ..++.++|||||||++|+|++|..||...........+......+.
T Consensus 156 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T 3kmu_A 156 MADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231 (271)
T ss_dssp GGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred eccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC
Confidence 8888754322 2345899999999997532 2234589999999999999999999999888888777777778888
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.+..+++.+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 88899999999999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=352.98 Aligned_cols=259 Identities=32% Similarity=0.606 Sum_probs=222.1
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
+.+..++|++.+.||+|+||.||+|.+ .+..||||++...... ...+.+|+.++++++||||+++++++.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 357788999999999999999999999 5778999999754321 145789999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. ..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 76 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~----~kl~D 149 (269)
T 4hcu_A 76 EQA--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV----IKVSD 149 (269)
T ss_dssp SSS--SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC----EEECC
T ss_pred cCC--ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC----EEecc
Confidence 754 799999999999999999777777999999999999999999999999999999999999987654 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||++....... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||...........+.. ....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~ 226 (269)
T 4hcu_A 150 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRL 226 (269)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCC
T ss_pred ccccccccccccccccCcccccccCCHHHhc--CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-CccC
Confidence 99998554322 223445678899999998 4558999999999999999999 9999998887776665544 3455
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
..+..+++.+.+++.+||+.+|.+|||+.+++++|+.+...
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 56677899999999999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=370.25 Aligned_cols=267 Identities=30% Similarity=0.490 Sum_probs=223.5
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCc
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 644 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPN 644 (867)
..+.+..++|++.+.||+|+||.||+|.+. ++.||||+++... .......+.+|+.++.++ +|||
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-------CHHHHHHHHHHHHHHHhhcCCcc
Confidence 455788899999999999999999999863 3679999997432 122245788999999999 7899
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhcccc-------------------------------------------
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER------------------------------------------- 681 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~------------------------------------------- 681 (867)
|+++++++.... ...++||||+++++|.+++.....
T Consensus 88 iv~~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 88 VVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp BCCEEEEECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred eeeeeeeeecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 999999987643 358999999999999999865432
Q ss_pred ----------------------cCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 682 ----------------------HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 682 ----------------------~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~----~kl~Dfg~a~~ 242 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV----VKICDFGLARD 242 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC----EEECCCGGGSC
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc----EEEEeccceee
Confidence 2899999999999999999999999999999999999997654 59999999985
Q ss_pred ccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 740 KRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 740 ~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
.... .......||+.|+|||++. ...++.++|||||||++|+|+| |..||............+........+..
T Consensus 243 ~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (359)
T 3vhe_A 243 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 320 (359)
T ss_dssp TTSCTTCEEC--CEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT
T ss_pred ecccccchhccccCCCceeEChhhhc--CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCC
Confidence 4222 2233456788999999998 4568899999999999999998 99999887766666666666667777888
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+++.+.++|.+||+.+|.+|||+.+++++|+.+..+..
T Consensus 321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 358 (359)
T 3vhe_A 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358 (359)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999887643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=412.06 Aligned_cols=258 Identities=23% Similarity=0.296 Sum_probs=211.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|+++++||+|+||+||+|++ +|+.||||++.+....... ..........++.+++.++|||||+++++|.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~--~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh--hHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 34567899999999999999999998 4788999999765332111 1222333445577778889999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. .+|||||||+||+|..++.. ...+++..+..++.||+.||.|||++|||||||||+||||+.+|. +||+|
T Consensus 263 ~~~--~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~----vKL~D 335 (689)
T 3v5w_A 263 TPD--KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH----VRISD 335 (689)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC----EEECC
T ss_pred ECC--EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC----EEecc
Confidence 855 99999999999999999964 456999999999999999999999999999999999999997775 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh---hHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY---GAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~---~e~l~~iv~~~lr~ 810 (867)
||+|+...... ....+||+.|||||++.+ ...++.++|||||||+||+|++|.+||..... ......+... ..
T Consensus 336 FGlA~~~~~~~-~~t~~GTp~YmAPEvl~~-~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~ 411 (689)
T 3v5w_A 336 LGLACDFSKKK-PHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AV 411 (689)
T ss_dssp CTTCEECSSCC-CCSCCSCGGGCCHHHHST-TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CC
T ss_pred cceeeecCCCC-CCCccCCcCccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CC
Confidence 99998665433 345689999999999963 34578999999999999999999999975332 2333344433 34
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLR 846 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq 846 (867)
..+..+++++.+||.+||+.||.+|++ +.+|++|.+
T Consensus 412 ~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 556788999999999999999999997 789887764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=367.45 Aligned_cols=263 Identities=35% Similarity=0.581 Sum_probs=221.7
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
..+..++|++.+.||+|+||.||+|.+. +..||||+++... .......|.+|+.+++.++||||++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 116 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-------TERQRRDFLSEASIMGQFDHPNIIRLE 116 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3567889999999999999999999983 3459999997432 123346788999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++.... ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~ 190 (325)
T 3kul_A 117 GVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL----VC 190 (325)
T ss_dssp EEECGGG--CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CE
T ss_pred EEEEeCC--ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC----CE
Confidence 9998744 88999999999999999977667899999999999999999999999999999999999998665 46
Q ss_pred EEeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHh
Q 002908 730 KVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 804 (867)
Q Consensus 730 KL~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv 804 (867)
+|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 999999998654321 2223346778999999983 457899999999999999999 999999888777666554
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 805 ~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
. ....+.+..+++.+.+||.+||+.+|.+|||+.++++.|+.+.....
T Consensus 269 ~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 269 E-GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred c-CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 4 45666777899999999999999999999999999999999876544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=355.90 Aligned_cols=269 Identities=37% Similarity=0.661 Sum_probs=224.1
Q ss_pred ccccccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 572 STLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 572 ~~l~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
..++.+..++|++.+.||+|+||.||+|++ .++.||||++........ .........+.+|+.+++.++||||++++
T Consensus 11 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 11 SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE-TEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp -CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCC-HHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 345567789999999999999999999998 478899999875432211 11111125788999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCCcceEeccCCC-CC
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDP-IR 726 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~G--IIHrDLKPsNILLd~dg~-~~ 726 (867)
+++.+.. ++||||+++++|.+++......+++..++.++.|++.||+|||++| |+||||||+|||++.++. ..
T Consensus 90 ~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 90 GLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp EEETTTT----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred eeecCCC----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCc
Confidence 9997744 6899999999999998777778999999999999999999999999 999999999999987663 33
Q ss_pred CcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH--HHhHh
Q 002908 727 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI--IGGIV 804 (867)
Q Consensus 727 ~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~--l~~iv 804 (867)
..++|+|||++...... .....||+.|+|||++.+....++.++|||||||++|+|++|..||........ ...+.
T Consensus 166 ~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 243 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243 (287)
T ss_dssp CCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred eeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence 45799999999854432 234569999999999965566678999999999999999999999987654433 44555
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 805 ~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
........+..+++.+.++|.+||+.+|.+|||+.++++.|+.
T Consensus 244 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 6666777888899999999999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=368.66 Aligned_cols=254 Identities=26% Similarity=0.464 Sum_probs=219.1
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||+|.+ +|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL------NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 356899999999999999999998 588999999976432 123346688999999999999999999999875
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 87 ~--~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~----~kl~DFG 159 (328)
T 3fe3_A 87 K--TLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN----IKIADFG 159 (328)
T ss_dssp S--EEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC----EEECSTT
T ss_pred C--EEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC----EEEeecc
Confidence 4 899999999999999998644 46999999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
++............+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.........+....+. .+..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~p~~ 236 (328)
T 3fe3_A 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFY 236 (328)
T ss_dssp CCGGGSSSCGGGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTT
T ss_pred CceecCCCCccccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCC
Confidence 99866555555567899999999999853 22358999999999999999999999998888877777766543 4567
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 89999999999999999999999999987553
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=360.16 Aligned_cols=264 Identities=34% Similarity=0.528 Sum_probs=215.0
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
..+...+|++++.||+|+||.||+|++ .++.||||++... .......+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~ 76 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------TEEHLRDFEREIEILKSLQHDNIVKY 76 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 456778999999999999999999985 4778999998642 12334678899999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCc
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~ 728 (867)
++++.......+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~----~ 152 (295)
T 3ugc_A 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----R 152 (295)
T ss_dssp EEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----E
T ss_pred EEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC----e
Confidence 999865434468999999999999999977767799999999999999999999999999999999999999765 4
Q ss_pred EEEeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-------
Q 002908 729 CKVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------- 797 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~------- 797 (867)
++|+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|+||..||......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 230 (295)
T 3ugc_A 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230 (295)
T ss_dssp EEECCCCSCC-------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCT
T ss_pred EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcC
Confidence 6999999998654321 1223346778999999984 46899999999999999999999998653221
Q ss_pred --------HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 798 --------AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 798 --------e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
...........+.+.+..+++.+.++|.+||+.+|.+|||+.++++.|+.+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0122334445566778889999999999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.92 Aligned_cols=264 Identities=25% Similarity=0.360 Sum_probs=213.3
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCC------------------hHHHHHHHHHHHHHHH
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRS------------------SEQERLTLEFWREAEI 636 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~------------------~~~e~~~~eflrEiei 636 (867)
+..++|++.+.||+|+||.||+|.+ .++.||||++......... .........+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4457899999999999999999988 4788999999765322110 0011223568899999
Q ss_pred HHhCCCCceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcc
Q 002908 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 716 (867)
Q Consensus 637 Lk~L~HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsN 716 (867)
++.++||||+++++++.......+++||||+++++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999875566899999999999998865 34579999999999999999999999999999999999
Q ss_pred eEeccCCCCCCcEEEeecCCcccccCc-cccCCcCCCCCccCccccccCCCC-CChhhHHHHHHHHHHHHHhCCCCCCCC
Q 002908 717 LLVNLKDPIRPICKVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSK-VSEKVDVFSFGIVLWEILTGEEPYANM 794 (867)
Q Consensus 717 ILLd~dg~~~~~vKL~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~-~S~kSDVWSLGvLLyELLTGk~PF~~~ 794 (867)
||++.++. +||+|||++...... .......||+.|+|||++.+.... ++.++|||||||++|+|++|..||...
T Consensus 168 il~~~~~~----~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 168 LLVGEDGH----IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp EEECTTSC----EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEECCCCC----EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99997664 599999999865432 223455799999999999753322 478999999999999999999999988
Q ss_pred ChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 795 HYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 795 ~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
........+.......+....+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 7766666666666555555678999999999999999999999999988755
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.85 Aligned_cols=266 Identities=31% Similarity=0.490 Sum_probs=224.5
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCc
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 644 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~-------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPN 644 (867)
..+.+..++|++.+.||+|+||.||+|.+ .+..||||+++... . ......+.+|+.+++++ +|||
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~~E~~~l~~l~~h~~ 88 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----H---LTEREALMSELKVLSYLGNHMN 88 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----C---HHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----h---HHHHHHHHHHHHHHhhcccCCC
Confidence 34567889999999999999999999986 24679999997432 1 12236788999999999 8999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhcccc-----------------cCCHHHHHHHHHHHHHHHHHHHHCCe
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-----------------HLDRRKRLIIAMDAAFGMEYLHSKNI 707 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~-----------------~Lse~~~l~Ia~QIa~ALayLHs~GI 707 (867)
|+++++++.... ..++||||+++++|.+++..... .+++..++.++.||+.||.|||++||
T Consensus 89 i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 166 (313)
T 1t46_A 89 IVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (313)
T ss_dssp BCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eeeEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 999999998754 78999999999999999865432 48999999999999999999999999
Q ss_pred eccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHH
Q 002908 708 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEI 784 (867)
Q Consensus 708 IHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyEL 784 (867)
+||||||+|||++.++ .++|+|||++....... ......+|+.|+|||++. ...++.++|||||||++|+|
T Consensus 167 ~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el 240 (313)
T 1t46_A 167 IHRDLAARNILLTHGR----ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWEL 240 (313)
T ss_dssp CCSCCSGGGEEEETTT----EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHH
T ss_pred ecCCCccceEEEcCCC----CEEEccccccccccccccceeccCCCCcceeeChHHhc--CCCCChHHHHHHHHHHHHHH
Confidence 9999999999998665 46999999998654332 223445678899999998 45689999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 785 LT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 785 LT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+| |..||.....................+..++..+.++|.+||+.+|.+|||+.+++++|+.+...+.
T Consensus 241 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 241 FSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 99 9999988776666666666666666777889999999999999999999999999999999877654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=350.86 Aligned_cols=259 Identities=35% Similarity=0.560 Sum_probs=218.3
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
+.+..++|++++.||+|+||.||++.+. +..||||+++..... ..++.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---------HHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 4577889999999999999999999985 557999999754321 245788999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 90 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~----~kl~D 163 (283)
T 3gen_A 90 KQR--PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV----VKVSD 163 (283)
T ss_dssp SSS--SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC----EEECS
T ss_pred cCC--CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC----EEEcc
Confidence 754 899999999999999999776677999999999999999999999999999999999999996664 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCC
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |+.||...........+.. ....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~ 240 (283)
T 3gen_A 164 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRL 240 (283)
T ss_dssp TTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCC
T ss_pred ccccccccccccccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-ccCC
Confidence 99998554322 2223446788999999984 457999999999999999998 9999998887766655443 4455
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
..+..+++.+.++|.+||+.+|.+|||+.+++++|+.+...
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 56677899999999999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=349.16 Aligned_cols=256 Identities=34% Similarity=0.593 Sum_probs=217.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.+..++|++.+.||+|+||.||+|.+. +..||||+++..... ..++.+|+.++..++||||+++++++..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---------EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 467789999999999999999999986 457999999754321 1457889999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~----~~l~Df 148 (268)
T 3sxs_A 75 EY--PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC----VKVSDF 148 (268)
T ss_dssp SS--SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC----EEECCT
T ss_pred CC--ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC----EEEccC
Confidence 54 899999999999999999777777999999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 735 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 735 GLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
|++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.. .....
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 225 (268)
T 3sxs_A 149 GMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLY 225 (268)
T ss_dssp TCEEECCTTCEEECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCC
T ss_pred ccceecchhhhhcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-CCCCC
Confidence 9998544322 2234456778999999984 457889999999999999999 9999998877766655443 33455
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.+..+++.+.+++.+||+.+|.+|||+.+++++|+.+.
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 56678999999999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=370.06 Aligned_cols=264 Identities=28% Similarity=0.499 Sum_probs=220.7
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 644 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPN 644 (867)
+.+..++|++.+.||+|+||.||+|++. +..||||+++... .+.....+.+|+.+++.+ +|||
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpn 148 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKN 148 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-------BHHHHHHHHHHHHHHHHSCCCTT
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-------CHHHHHHHHHHHHHHHHhcCCCC
Confidence 3566789999999999999999999873 2459999997431 223346788999999999 8999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeec
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 709 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIH 709 (867)
|++++++|.... .+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|
T Consensus 149 Iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 226 (370)
T 2psq_A 149 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 226 (370)
T ss_dssp BCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EeeEEEEEccCC--CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999998754 8999999999999999986532 35899999999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 710 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 710 rDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
|||||+|||++.++. +||+|||+++...... ......+|+.|+|||++. ...++.++|||||||++|+|++
T Consensus 227 rDlkp~NIll~~~~~----~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwslG~il~ellt 300 (370)
T 2psq_A 227 RDLAARNVLVTENNV----MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 300 (370)
T ss_dssp SCCCGGGEEECTTCC----EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH--TCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccchhhEEECCCCC----EEEccccCCcccCcccceecccCCCcccceECHhHhc--CCCCCcHHHHHHHHHHHHHHHc
Confidence 999999999997664 5999999998543321 223345678999999998 4568999999999999999999
Q ss_pred -CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 787 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 787 -Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
|..||...........+ ....+.+.+..++..+.++|.+||+.+|.+|||+.++++.|+.+...+..
T Consensus 301 ~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 301 LGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp TSCCSSTTCCGGGHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 99999987766655543 44455667778999999999999999999999999999999998876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=361.79 Aligned_cols=258 Identities=33% Similarity=0.529 Sum_probs=214.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||+||+|.+. ++.||+|++... .......|.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 77 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--------DEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence 456789999999999999999999984 788999988532 1233467889999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. ..++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 78 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~----~kl~D 151 (310)
T 3s95_A 78 KDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN----VVVAD 151 (310)
T ss_dssp ETT--EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC----EEECC
T ss_pred cCC--eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC----EEEee
Confidence 854 899999999999999999876778999999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCcccc---------------CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH
Q 002908 734 FGLSKIKRNTLVT---------------GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 798 (867)
Q Consensus 734 FGLA~~~~~~~~~---------------s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e 798 (867)
||++......... ....||+.|+|||++. ...++.++|||||||++|+|++|..||.......
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhc--CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 9999854332211 1456999999999998 4568899999999999999999999986533211
Q ss_pred -----HHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 799 -----IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 799 -----~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
....... ...+..+++.+.++|.+||+.+|.+|||+.++++.|+.+.....
T Consensus 230 ~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 230 MDFGLNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp TTSSBCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhhhhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1111111 12345678889999999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=373.82 Aligned_cols=262 Identities=36% Similarity=0.595 Sum_probs=222.5
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
.+.+..++|++.+.||+|+||.||+|.+. ++.||||+++... .......|.+|+.+++.++||||++++++
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-------CHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-------CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34677889999999999999999999994 7889999987431 12234568899999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+.... ..++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 181 ~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~----~~kl 254 (377)
T 3cbl_A 181 CTQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKI 254 (377)
T ss_dssp ECSSS--SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEE
T ss_pred EecCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC----cEEE
Confidence 98754 78999999999999999987777799999999999999999999999999999999999999765 4699
Q ss_pred eecCCcccccCcccc---CCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 732 GDFGLSKIKRNTLVT---GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~---s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
+|||+++........ ....+++.|+|||++. ...++.++|||||||++|||+| |..||........... +...
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-~~~~ 331 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALN--YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKG 331 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-HHTT
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcC
Confidence 999999854332211 1123567899999998 3457899999999999999998 9999998877665544 4455
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
.+.+.+..+++.+.+||.+||+.+|.+|||+.++++.|+.+...
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 66777888999999999999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.64 Aligned_cols=267 Identities=32% Similarity=0.480 Sum_probs=221.4
Q ss_pred ccccccccCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCC
Q 002908 572 STLQIIKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 643 (867)
Q Consensus 572 ~~l~~I~~sdyqilk~LG~GafG~VYka~~-------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HP 643 (867)
...+.+..++|++.+.||+|+||.||+|.+ .+..||||+++... .......+.+|+.++.++ +||
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp 109 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-------DSSEREALMSELKMMTQLGSHE 109 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCT
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-------CHHHHHHHHHHHHHHHhhcCCC
Confidence 345678889999999999999999999997 24569999997432 112235688999999999 899
Q ss_pred ceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccc----------------------cCCHHHHHHHHHHHHHHHHH
Q 002908 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER----------------------HLDRRKRLIIAMDAAFGMEY 701 (867)
Q Consensus 644 NIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~----------------------~Lse~~~l~Ia~QIa~ALay 701 (867)
||+++++++.... ..++||||+++++|.+++..... .+++..++.++.||+.||.|
T Consensus 110 ~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 187 (344)
T 1rjb_A 110 NIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187 (344)
T ss_dssp TBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CeeeEEEEEeeCC--ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 9999999998754 88999999999999999965432 37999999999999999999
Q ss_pred HHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHH
Q 002908 702 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFG 778 (867)
Q Consensus 702 LHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLG 778 (867)
||++||+||||||+|||++.++ .++|+|||++....... ......+|+.|+|||++.+ ..++.++||||||
T Consensus 188 LH~~~ivH~Dikp~NIll~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG 261 (344)
T 1rjb_A 188 LEFKSCVHRDLAARNVLVTHGK----VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYG 261 (344)
T ss_dssp HHHTTEEETTCSGGGEEEETTT----EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHH
T ss_pred HHhCCcccCCCChhhEEEcCCC----cEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--CCCChhHhHHHHH
Confidence 9999999999999999999665 56999999998543221 2234457788999999983 4589999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 779 IVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 779 vLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
|++|+|+| |..||............+......+.+..+++.+.+||.+||+.+|.+|||+.+++++|+.+.....
T Consensus 262 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 262 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 99999998 9999988776666666677777777788899999999999999999999999999999999866544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=370.55 Aligned_cols=261 Identities=24% Similarity=0.334 Sum_probs=220.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. |..||||+++.......... .....+.+|+.+|+.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG--VCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccch--hHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 467999999999999999999984 78899999987543321110 11246778999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.....+||+|||+
T Consensus 89 --~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 --DVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp --EEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred --EEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 89999999999999999854 456999999999999999999999999999999999999987764444689999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC--CCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~--ip~ 814 (867)
+.............||+.|+|||++. ...++.++|||||||++|+|++|..||.+.........+....+..+ ...
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ceEcCCCCccccCCCCccEECchHHc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 98766554455667999999999998 45678999999999999999999999999888777777766554332 224
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+++.+.+||.+||..||.+|||+.+++++.+
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 67899999999999999999999999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=358.86 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=214.4
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+...+|++.+.||+|+||.||+|.+. ++.||||+++...... ....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-------PVDVQMREFEVLKKLNHKNIVKLFAIEE 77 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-------hHHHHHHHHHHHHhcCCCCcceEEEEee
Confidence 355678999999999999999999995 7889999997543221 1345678999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccc--cCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~--~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.......++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+.........+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp CTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEE
Confidence 7666688999999999999999975443 38999999999999999999999999999999999998433334456799
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccC------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHH
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS------SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIG 801 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~------~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~----~e~l~ 801 (867)
+|||+++............||+.|+|||++... ...++.++|||||||++|+|++|..||..... ...+.
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred ccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 999999876655555566799999999998521 35678899999999999999999999975332 23333
Q ss_pred hHhhcCCC-------------------C----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 802 GIVNNTLR-------------------P----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 802 ~iv~~~lr-------------------~----~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.+...... . .....++..+.++|.+||+.||++|||+.++++++.+..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 33332211 0 112234567899999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.83 Aligned_cols=262 Identities=32% Similarity=0.550 Sum_probs=218.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
.+..++|++.+.||+|+||.||+|++.+ +.||||+++... .......+.+|+.+++.++||||+++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~ 115 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKL 115 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 4567899999999999999999999854 679999997432 12334678899999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhccc-----------------------ccCCHHHHHHHHHHHHHHHHHHHHC
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------------------RHLDRRKRLIIAMDAAFGMEYLHSK 705 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-----------------------~~Lse~~~l~Ia~QIa~ALayLHs~ 705 (867)
++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++
T Consensus 116 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 116 LGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEccCC--ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99998754 8899999999999999986532 5689999999999999999999999
Q ss_pred CeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHH
Q 002908 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 782 (867)
Q Consensus 706 GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLy 782 (867)
||+||||||+|||++.++. +||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~----~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ 267 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMV----VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLW 267 (343)
T ss_dssp TCCCSCCSGGGEEECGGGC----EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH
T ss_pred CeecCCCCcceEEECCCCe----EEEeecCCCcccccCccccccCCCcccceecChhhhcc--CCcCcccccHHHHHHHH
Confidence 9999999999999997664 599999999754322 12234457889999999984 45899999999999999
Q ss_pred HHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 783 EILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 783 ELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+|++ |..||...........+... .....+..+++.+.++|.+||+.+|.+|||+.+++++|+.+.....
T Consensus 268 el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 268 EIFSYGLQPYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HHHhcCCCcCCCCChHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 9999 99999988877766655544 3345667889999999999999999999999999999998765443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=365.88 Aligned_cols=270 Identities=30% Similarity=0.523 Sum_probs=225.7
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECC---------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCC
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 643 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G---------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HP 643 (867)
.+.+..++|++.+.||+|+||.||+|++.+ ..||||+++... .+.....+.+|+.+++.+ +||
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp 135 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHK 135 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-------CHHHHHHHHHHHHHHHHhcCCc
Confidence 446788999999999999999999999732 469999997531 123346788999999999 899
Q ss_pred ceeeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCee
Q 002908 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 708 (867)
Q Consensus 644 NIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GII 708 (867)
||+++++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+
T Consensus 136 nIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 213 (382)
T 3tt0_A 136 NIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 213 (382)
T ss_dssp TBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hhhhheeeeccCC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 9999999998754 7899999999999999986543 3589999999999999999999999999
Q ss_pred ccCCCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHH
Q 002908 709 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785 (867)
Q Consensus 709 HrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELL 785 (867)
||||||+|||++.++ .+||+|||+++..... .......+|+.|+|||++. ...++.++|||||||++|+|+
T Consensus 214 H~Dlkp~NIll~~~~----~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~ell 287 (382)
T 3tt0_A 214 HRDLAARNVLVTEDN----VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIF 287 (382)
T ss_dssp CSCCCGGGEEECTTC----CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCcceEEEcCCC----cEEEcccCcccccccccccccccCCCCCcceeCHHHhc--CCCCCchhHHHHHHHHHHHHH
Confidence 999999999999765 4699999999855432 2223345788999999998 456899999999999999999
Q ss_pred h-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCCCCCC
Q 002908 786 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGH 859 (867)
Q Consensus 786 T-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~~~~~ 859 (867)
+ |..||...........+ ........+..+++.+.+||.+||+.+|.+|||+.+++++|+.+...........
T Consensus 288 t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 288 TLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp TTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred hCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 9 99999988776665544 4445566677899999999999999999999999999999999988776655544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=357.72 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=211.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|++.+.||+|+||.||+|.+ +++.||||++....... ...+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--------HHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 46799999999999999999987 57889999997543221 245778999999999999999999998855
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 91 --~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~----~kl~Dfg~ 162 (297)
T 3fxz_A 91 --ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGF 162 (297)
T ss_dssp --EEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----EEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC----EEEeeCCC
Confidence 89999999999999998854 36899999999999999999999999999999999999997764 59999999
Q ss_pred cccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc-CCCCCCCC
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPG 814 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~-~lr~~ip~ 814 (867)
+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... ......+.
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T 3fxz_A 163 CAQITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (297)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGG
T ss_pred ceecCCcccccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Confidence 8854432 23345679999999999984 56789999999999999999999999887766555444433 23444566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 78999999999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=376.05 Aligned_cols=257 Identities=35% Similarity=0.607 Sum_probs=220.3
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+.+..++|++.+.||+|+||.||+|.++++.||||+++... ....|.+|+.+|++++||||+++++++..
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----------TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----------HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 46778899999999999999999999999999999997532 12568899999999999999999999866
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccc-cCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~-~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
. ...+++||||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 258 ~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kl~D 332 (450)
T 1k9a_A 258 E-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSD 332 (450)
T ss_dssp T-TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS----CEEECC
T ss_pred C-CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC----CEEEee
Confidence 4 2368999999999999999976544 379999999999999999999999999999999999999765 469999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
||+++....... ...+++.|+|||++. ...++.++|||||||+||+|+| |..||...........+ ....+.+.
T Consensus 333 fG~a~~~~~~~~--~~~~~~~y~aPE~~~--~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~ 407 (450)
T 1k9a_A 333 FGLTKEASSTQD--TGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDA 407 (450)
T ss_dssp CTTCEECC--------CCCTTTSCHHHHH--SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-HTTCCCCC
T ss_pred CCCccccccccc--CCCCCcceeCHHHhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCC
Confidence 999985433222 235788999999998 4568999999999999999999 99999988776666554 44566778
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
+..+++.+.+||.+||+.+|.+|||+.++++.|+.+...
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 888999999999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=359.89 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=218.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. +..||||+++......... ......+.+|+.+|+.++||||+++++++....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 457999999999999999999984 7889999998654322110 011346788999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.....+||+|||+
T Consensus 88 --~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 88 --DVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp --EEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred --EEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 89999999999999999854 456999999999999999999999999999999999999998775555789999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC--CC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i--p~ 814 (867)
+.............||+.|+|||++. ...++.++|||||||++|+|++|..||...........+.......+. ..
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 165 AHKIDFGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp CEECCTTSCCCCCCSCTTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CeECCCCCccccccCCcCcCCceeec--CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 98765444444567999999999998 456789999999999999999999999988777766666554433221 24
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 67889999999999999999999999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.05 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=221.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQEES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence 578999999999999999999984 788999999764321 223456889999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. ...++|+|||+
T Consensus 79 --~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~~~~kl~Dfg~ 154 (284)
T 3kk8_A 79 --FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK-GAAVKLADFGL 154 (284)
T ss_dssp --EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSST-TCCEEECCCTT
T ss_pred --EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCC-CCcEEEeecee
Confidence 889999999999998888543 56899999999999999999999999999999999999987664 24579999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC--C
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--G 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip--~ 814 (867)
+.............||+.|+|||++. ...++.++||||||+++|+|++|..||...........+.......+.+ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred eEEcccCccccCCCCCcCCcCchhhc--CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence 98766555555677999999999998 4557899999999999999999999999888877777766665544433 4
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+++.+.+||.+||+.+|.+|||+.+++++.+-.
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence 6789999999999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.86 Aligned_cols=267 Identities=30% Similarity=0.516 Sum_probs=222.6
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI 645 (867)
.+..+..++|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.++||||
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnI 136 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------SEQDELDFLMEALIISKFNHQNI 136 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-------ChhhHHHHHHHHHHHHhCCCCCC
Confidence 456778899999999999999999999963 4579999986431 12223568899999999999999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhccc------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEe
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 719 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILL 719 (867)
+++++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 137 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 214 (367)
T 3l9p_A 137 VRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 214 (367)
T ss_dssp CCEEEEECSSS--SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CeEEEEEecCC--CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE
Confidence 99999998754 7899999999999999986543 458999999999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEeecCCcccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002908 720 NLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMH 795 (867)
Q Consensus 720 d~dg~~~~~vKL~DFGLA~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~ 795 (867)
+.++.. ..+||+|||+++.... ........+|+.|+|||++. ...++.++|||||||++|+|++ |..||....
T Consensus 215 ~~~~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 215 TCPGPG-RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp SCSSTT-CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCCCC-ceEEECCCccccccccccccccCCCcCCcccEECHHHhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 976642 4579999999974321 12223345789999999998 4568999999999999999998 999999887
Q ss_pred hhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 796 YGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 796 ~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
.......+.. ......+..++..+.+||.+||+.+|.+|||+.+|+++|+.+....
T Consensus 292 ~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 292 NQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 7766655444 3455567788999999999999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=366.54 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=220.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. +..||||++...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 468999999999999999999984 788999999764321 222456889999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||+
T Consensus 102 --~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~-~~~~kl~DfG~ 177 (362)
T 2bdw_A 102 --FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK-GAAVKLADFGL 177 (362)
T ss_dssp --EEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSST-TCCEEECCCTT
T ss_pred --EEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCC-CCCEEEeecCc
Confidence 899999999999999988643 46899999999999999999999999999999999999987653 24579999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC--C
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--G 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip--~ 814 (867)
+.............||+.|+|||++. ...++.++|||||||++|+|++|..||...........+....+..+.+ .
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLK--KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred ceEecCCcccccCCCCccccCHHHHc--cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 98766554445667999999999998 4467899999999999999999999999888777777777665554433 3
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 256 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 578999999999999999999999999988654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=342.79 Aligned_cols=257 Identities=32% Similarity=0.619 Sum_probs=219.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.+..++|++.+.||+|+||.||+|.+ .+..||||++...... ...+.+|+.+++.++||||+++++++..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---------HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 56778999999999999999999998 5678999999754321 1457889999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~----~kl~df 148 (267)
T 3t9t_A 75 QA--PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV----IKVSDF 148 (267)
T ss_dssp SS--SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC----EEECCT
T ss_pred CC--CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC----EEEccc
Confidence 54 789999999999999999776677999999999999999999999999999999999999987654 599999
Q ss_pred CCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 735 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 735 GLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
|++....... ......+++.|+|||++. ...++.++||||||+++|+|++ |..||...........+.. .....
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~ 225 (267)
T 3t9t_A 149 GMTRFVLDDQYTSSTGTKFPVKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLY 225 (267)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCC
T ss_pred ccccccccccccccccccccccccChhhhc--CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCC
Confidence 9998653321 223345778899999998 3457899999999999999999 8999998877666655444 34455
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.+..++..+.+++.+||+.+|.+|||+.+++++|+.+..
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 567789999999999999999999999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=362.50 Aligned_cols=255 Identities=19% Similarity=0.231 Sum_probs=218.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. +..||+|+++... . ....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------T---DQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------H---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------c---cHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 468999999999999999999984 7889999986421 1 1245778999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+
T Consensus 75 --~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~--~~~~kl~Dfg~ 150 (321)
T 1tki_A 75 --ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQ 150 (321)
T ss_dssp --EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS--CCCEEECCCTT
T ss_pred --EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC--CCCEEEEECCC
Confidence 89999999999999999976666799999999999999999999999999999999999998642 23579999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC--CC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i--p~ 814 (867)
+.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......+. ..
T Consensus 151 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T 1tki_A 151 ARQLKPGDNFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CeECCCCCccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence 987655444445668999999999984 45789999999999999999999999998888877777766554332 23
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.++..+.+||.+||..||.+|||+.+++++.+-.
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 6789999999999999999999999999988754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=353.71 Aligned_cols=265 Identities=26% Similarity=0.331 Sum_probs=215.1
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
..+..++|++.+.||+|+||.||+|++ .+..||||++..... ..+.....+.+|+.+++.++||||+++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-----EKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-----CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-----ccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 345678999999999999999999998 478899999865422 1234456788999999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.... ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+
T Consensus 81 ~~~~--~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~----~kl~ 153 (294)
T 4eqm_A 81 EEDD--CYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT----LKIF 153 (294)
T ss_dssp ECSS--EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----EEEC
T ss_pred eeCC--eEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----EEEE
Confidence 8754 899999999999999998643 46999999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 733 DFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 733 DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...................
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (294)
T 4eqm_A 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN 231 (294)
T ss_dssp CCSSSTTC-------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC
T ss_pred eCCCccccccccccccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC
Confidence 999998654322 2234568999999999984 457889999999999999999999999887766555544443321
Q ss_pred ---CCCCCCcHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHHHHhc
Q 002908 811 ---PVPGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLRVMSAACQ 853 (867)
Q Consensus 811 ---~ip~~~s~eL~dLI~kCLq~DPeeRP-Sa~ELLe~Lq~l~~a~s 853 (867)
..+..+++.+.++|.+||+.+|.+|| +++++.+.|+.+.....
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 23456789999999999999999998 99999998887654433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.52 Aligned_cols=263 Identities=18% Similarity=0.218 Sum_probs=216.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~ 652 (867)
.+..++|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.+ .|+|++++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----------HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 45678899999999999999999996 5889999998654221 2466789999999 799999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC-CCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP-IRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~-~~~~vKL 731 (867)
.... ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ....++|
T Consensus 76 ~~~~--~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 76 QEGL--HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EETT--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CCCc--eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 8754 899999999 99999999776677999999999999999999999999999999999999987763 3455899
Q ss_pred eecCCcccccCcc--------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---hhHHH
Q 002908 732 GDFGLSKIKRNTL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAII 800 (867)
Q Consensus 732 ~DFGLA~~~~~~~--------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~---~~e~l 800 (867)
+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.... .....
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 230 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL--GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhc--CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence 9999998654322 234456999999999998 4557999999999999999999999998743 22333
Q ss_pred HhHhhcCCCC---CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 801 GGIVNNTLRP---PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 801 ~~iv~~~lr~---~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
..+....... .....+++.+.+++.+||+.+|.+||++.+|++.|+.+.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 231 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 3322221111 1234678999999999999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.45 Aligned_cols=259 Identities=33% Similarity=0.591 Sum_probs=208.7
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..++|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 566789999999999999999999884 3459999886421 2233467889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.+ +..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .++
T Consensus 84 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~k 156 (281)
T 1mp8_A 84 VITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVK 156 (281)
T ss_dssp EECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEE
T ss_pred EEcc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC----CEE
Confidence 9854 367899999999999999976666799999999999999999999999999999999999999765 469
Q ss_pred EeecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 731 VGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 731 L~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
|+|||++....... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||...........+...
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~- 233 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG- 233 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred ECccccccccCcccccccccCCCcccccChhhcc--cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-
Confidence 99999998654322 122334678899999998 4567899999999999999997 99999887776666555443
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
...+.+..+++.+.++|.+||+.+|.+|||+.++++.|+.+...
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 34556778899999999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=363.16 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=215.6
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+..++|++++.||+|+||.||+|++. ++.||||+++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 35678999999999999999999984 788999999754211 11123567789999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|. +||+||
T Consensus 77 ~~--~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~----vkL~DF 149 (337)
T 1o6l_A 77 HD--RLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH----IKITDF 149 (337)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC----EEECCC
T ss_pred CC--EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC----EEEeec
Confidence 55 89999999999999988854 456899999999999999999999999999999999999997764 599999
Q ss_pred CCcccc-cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 735 GLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 735 GLA~~~-~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
|+++.. .........+||+.|+|||++. ...++.++|||||||++|+|++|..||...........+..... ..+
T Consensus 150 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p 225 (337)
T 1o6l_A 150 GLCKEGISDGATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFP 225 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGS--SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCC
T ss_pred cchhhcccCCCcccccccChhhCChhhhc--CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCC
Confidence 999853 2233344567999999999998 44578999999999999999999999998887777777666544 345
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
..+++.+.+||.+||+.+|.+|| ++.+++++.+
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 67899999999999999999999 8999988754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.94 Aligned_cols=262 Identities=30% Similarity=0.497 Sum_probs=214.1
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
..+...+|++.+.||+|+||.||+|++ .++.||||+++.... ......+.+|+.+++.++||||+++
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-------GNHIADLKKEIEILRNLYHENIVKY 88 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------CCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-------chhHHHHHHHHHHHHhCCCCCeeee
Confidence 345567899999999999999999985 478899999975421 1123567899999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCc
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~ 728 (867)
++++.......+++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~----~ 164 (302)
T 4e5w_A 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----Q 164 (302)
T ss_dssp EEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----E
T ss_pred eeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC----C
Confidence 999987655678999999999999999976667799999999999999999999999999999999999998765 4
Q ss_pred EEEeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC----------
Q 002908 729 CKVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM---------- 794 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~---------- 794 (867)
++|+|||++....... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..|+...
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 242 (302)
T 4e5w_A 165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242 (302)
T ss_dssp EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred EEECcccccccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC
Confidence 6999999998654322 2234557888999999984 45789999999999999999999886432
Q ss_pred ----ChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 795 ----HYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 795 ----~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
................+.+..+++.+.+||.+||+.+|.+|||+.++++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 243 THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1122233344455566777889999999999999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=373.06 Aligned_cols=263 Identities=33% Similarity=0.555 Sum_probs=224.0
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
..+.+..++|++.+.||+|+||.||+|.+. +..||||+++.... ....|.+|+.+|+.++||||++++++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---------CHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---------cHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 345788899999999999999999999995 67899999975321 13578899999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
+.. ..+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+|
T Consensus 252 ~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~k 324 (454)
T 1qcf_A 252 VTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL----VCK 324 (454)
T ss_dssp ECS---SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC----CEE
T ss_pred EeC---CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC----cEE
Confidence 863 26899999999999999997543 4689999999999999999999999999999999999999665 469
Q ss_pred EeecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 731 VGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 731 L~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
|+|||+++...... ......+|..|+|||++. ...++.++|||||||+||+|+| |+.||...........+. ..
T Consensus 325 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~ 401 (454)
T 1qcf_A 325 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RG 401 (454)
T ss_dssp ECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HT
T ss_pred EeeCCCceEcCCCceeccCCCcccccccCHHHhc--cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999998654322 223345678899999998 4568999999999999999999 999999988777666544 45
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
.+.+.+..+++.+.+||.+||+.+|.+|||+.+|++.|+.+......
T Consensus 402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 66777888999999999999999999999999999999988665543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=350.22 Aligned_cols=261 Identities=31% Similarity=0.487 Sum_probs=218.2
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceee
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVr 647 (867)
..+...+|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.++||||++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-------SPSELRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCceee
Confidence 3567789999999999999999999872 3679999986431 1233467889999999999999999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhccc-----------------------ccCCHHHHHHHHHHHHHHHHHHHH
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------------------RHLDRRKRLIIAMDAAFGMEYLHS 704 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-----------------------~~Lse~~~l~Ia~QIa~ALayLHs 704 (867)
+++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 91 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 91 LYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp EEEEECSSS--SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCC--ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 999998754 7899999999999999986532 348999999999999999999999
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHH
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVL 781 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLL 781 (867)
+||+||||||+|||++.++ .++|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++
T Consensus 169 ~~ivH~dikp~NIli~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il 242 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGR----KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLL 242 (314)
T ss_dssp TTEECCCCSGGGEEEETTT----EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHH
T ss_pred CCCcccccchheEEEcCCC----CEEEccccccccccccccceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHH
Confidence 9999999999999999665 46999999998543221 2233456788999999984 4578999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 782 WEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 782 yELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
|+|++ |..||...........+ ........+..+++.+.++|.+||+.+|.+|||+.+++++|+.+...
T Consensus 243 ~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 243 WEIVTLGGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHh-hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99999 99999887766655443 34445666778899999999999999999999999999999998653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.53 Aligned_cols=265 Identities=31% Similarity=0.517 Sum_probs=222.6
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCc
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 644 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPN 644 (867)
....+..++|++.+.||+|+||.||+|.+.+ ..||||+++... .......+.+|+.+++.+ +|||
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 111 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-------HADEKEALMSELKIMSHLGQHEN 111 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-------ChHHHHHHHHHHHHHHhhcCCCC
Confidence 3457788999999999999999999999842 369999997532 122246788999999999 8999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhcc-------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK-------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 711 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~-------------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrD 711 (867)
|+++++++.... ..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus 112 iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 189 (333)
T 2i1m_A 112 IVNLLGACTHGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189 (333)
T ss_dssp BCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eeeEEEEEecCC--ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCC
Confidence 999999998754 889999999999999998643 23579999999999999999999999999999
Q ss_pred CCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-C
Q 002908 712 LKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-G 787 (867)
Q Consensus 712 LKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-G 787 (867)
|||+|||++.++ .++|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|+| |
T Consensus 190 lkp~NIl~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g 263 (333)
T 2i1m_A 190 VAARNVLLTNGH----VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLG 263 (333)
T ss_dssp CSGGGCEEEGGG----EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cccceEEECCCC----eEEECccccccccccccceeecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCC
Confidence 999999998665 46999999998543221 2233456788999999983 458899999999999999999 9
Q ss_pred CCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 788 EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 788 k~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
..||.....................+..+++.+.++|.+||+.+|.+|||+.+++++|+.+....
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 264 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 99998877666666666666777777788999999999999999999999999999999987654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=351.00 Aligned_cols=266 Identities=31% Similarity=0.501 Sum_probs=220.7
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCce
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 645 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNI 645 (867)
.+.+..++|++.+.||+|+||.||+|.+. ++.||||+++... .......+.+|+.++..+ +||||
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-------CcHHHHHHHHHHHHHHhcccCCCe
Confidence 34567889999999999999999999862 4679999997532 122235788999999999 69999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhcccc---------------cCCHHHHHHHHHHHHHHHHHHHHCCeecc
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---------------HLDRRKRLIIAMDAAFGMEYLHSKNIVHF 710 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~---------------~Lse~~~l~Ia~QIa~ALayLHs~GIIHr 710 (867)
+++++++... ....++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||
T Consensus 94 v~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~ 172 (316)
T 2xir_A 94 VNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172 (316)
T ss_dssp CCEEEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eeEEEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 9999998764 3468999999999999999965433 28999999999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-
Q 002908 711 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT- 786 (867)
Q Consensus 711 DLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT- 786 (867)
||||+|||++.++. ++|+|||++...... .......+|+.|+|||++. ...++.++|||||||++|+|+|
T Consensus 173 dikp~Nil~~~~~~----~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 173 DLAARNILLSEKNV----VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp CCSGGGEEECGGGC----EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cCccceEEECCCCC----EEECCCccccccccCccceeccCCCcceeecCchhhc--cccccchhHHHHHHHHHHHHHhC
Confidence 99999999986654 599999999854322 2223455788999999998 4568899999999999999998
Q ss_pred CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 787 GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 787 Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
|..||............+........+..+++.+.++|.+||+.+|.+|||+.+++++|+.+..+..
T Consensus 247 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 9999988765555545555555566677889999999999999999999999999999999877654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.86 Aligned_cols=257 Identities=30% Similarity=0.363 Sum_probs=206.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
....++|++++.||+|+||+||+|.+ +++.||||+++.... .+.....+.+|+.+++.++||||+++++++..
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE------DEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc------cchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 33457899999999999999999998 578899999975321 22234567899999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||++ ++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 91 ~~--~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~----~kl~Df 163 (311)
T 3niz_A 91 ER--CLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA----LKLADF 163 (311)
T ss_dssp SS--CEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEECCC
T ss_pred CC--EEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC----EEEccC
Confidence 54 8999999996 5888888766677999999999999999999999999999999999999997764 599999
Q ss_pred CCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC--
Q 002908 735 GLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP-- 811 (867)
Q Consensus 735 GLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~-- 811 (867)
|++...... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...........+......+.
T Consensus 164 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 164 GLARAFGIPVRSYTHEVVTLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242 (311)
T ss_dssp TTCEETTSCCC---CCCCCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred cCceecCCCcccccCCcccCCcCCHHHhcC-CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence 999865422 22334568999999999874 24578999999999999999999999988766555444432111100
Q ss_pred --------------------------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 812 --------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 812 --------------------------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....+++++.+||.+||+.||.+|||+.+++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 11235788999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.13 Aligned_cols=264 Identities=34% Similarity=0.596 Sum_probs=216.9
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECC------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
..+..++|++.+.||+|+||.||+|.+.. ..||||+++... .+.....+.+|+.+++.++||||+++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~ 111 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRL 111 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 36778899999999999999999998742 349999987432 12234578899999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCc
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~ 728 (867)
++++.... ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 112 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~----~ 185 (333)
T 1mqb_A 112 EGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----V 185 (333)
T ss_dssp EEEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----C
T ss_pred EEEEecCC--CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC----c
Confidence 99998744 89999999999999999977667899999999999999999999999999999999999999665 4
Q ss_pred EEEeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhH
Q 002908 729 CKVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 803 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~i 803 (867)
+||+|||++....... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||...........+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 263 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhcc--cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 6999999998643321 112234678899999998 4568899999999999999999 99999888776666554
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 804 v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
.. ..+.+.+..++..+.++|.+||+.+|.+||++.++++.|+.+......
T Consensus 264 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 264 ND-GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp HT-TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred HC-CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 43 445566778899999999999999999999999999999998765543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=344.49 Aligned_cols=267 Identities=34% Similarity=0.558 Sum_probs=223.2
Q ss_pred ccccCCeeEEE-EeeecCcEEEEEEEE----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELK-ELGSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk-~LG~GafG~VYka~~----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..++|.+.+ .||+|+||.||+|.+ .+..||||+++... .......+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-------chhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 45677888887 999999999999986 36779999997531 1233467889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.. ...++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .++
T Consensus 78 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~k 150 (287)
T 1u59_A 78 VCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAK 150 (287)
T ss_dssp EEES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT----EEE
T ss_pred EecC---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC----CEE
Confidence 9943 368999999999999999976667799999999999999999999999999999999999999665 469
Q ss_pred EeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||++....... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||...........+..
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~ 228 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhc--cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence 99999998653221 122334688999999997 3457899999999999999999 9999988777665554443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCCCCCC
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGH 859 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~~~~~ 859 (867)
..+...+..+++.+.++|.+||+.+|.+||++.+++++|+.+..+........
T Consensus 229 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 229 -GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred -CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 44556677899999999999999999999999999999999988777555443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.18 Aligned_cols=262 Identities=35% Similarity=0.590 Sum_probs=205.6
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
..+|..++|++.+.||+|+||.||+|.+.+ .||||+++.... .......|.+|+.+++.++||||+++++++.
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 90 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP------TPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC------CHHHHHHHHHHHHHHHhCCCCcEEEEEeecc
Confidence 457888999999999999999999998765 599999975421 1233467889999999999999999999764
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|
T Consensus 91 ~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~----~~kl~D 163 (289)
T 3og7_A 91 AP---QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN----TVKIGD 163 (289)
T ss_dssp SS---SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT----EEEECC
T ss_pred CC---ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC----CEEEcc
Confidence 42 57899999999999999977777899999999999999999999999999999999999999765 469999
Q ss_pred cCCcccccC---ccccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc-CC
Q 002908 734 FGLSKIKRN---TLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TL 808 (867)
Q Consensus 734 FGLA~~~~~---~~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~-~l 808 (867)
||++..... ........||+.|+|||++.. ....++.++|||||||++|+|++|+.||............+.. ..
T Consensus 164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (289)
T 3og7_A 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243 (289)
T ss_dssp CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC
T ss_pred ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc
Confidence 999975432 222234568999999999862 2345788999999999999999999999886655544444333 22
Q ss_pred CCC---CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 809 RPP---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 809 r~~---ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
... ....+++.+.+||.+||+.+|.+|||+.++++.|+.+.
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 222 23467899999999999999999999999999998763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.62 Aligned_cols=262 Identities=24% Similarity=0.312 Sum_probs=208.6
Q ss_pred cCCCCCccccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CC
Q 002908 566 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 642 (867)
Q Consensus 566 ~~~fd~~~l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~H 642 (867)
...+++.....+..++|++.++||+|+||+||+|.+. ++.||||++..... . ......+..|+..+..+ +|
T Consensus 43 ~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~---~~~~~~~~~e~~~~~~~~~h 116 (311)
T 3p1a_A 43 SPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR---G---PKDRARKLAEVGSHEKVGQH 116 (311)
T ss_dssp CTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC---S---HHHHHHHHHHHHHHHHHCCC
T ss_pred CCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc---C---hHHHHHHHHHHHHHHHhcCC
Confidence 3456666666777789999999999999999999994 88899999864321 1 11223445566566555 89
Q ss_pred CceeeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccC
Q 002908 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 722 (867)
Q Consensus 643 PNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~d 722 (867)
|||++++++|.+.. .+++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 117 ~~iv~l~~~~~~~~--~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~ 193 (311)
T 3p1a_A 117 PCCVRLEQAWEEGG--ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR 193 (311)
T ss_dssp TTBCCEEEEEEETT--EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG
T ss_pred CcEEEEEEEEEeCC--EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC
Confidence 99999999998854 899999999 789999887777789999999999999999999999999999999999999876
Q ss_pred CCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHh
Q 002908 723 DPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 802 (867)
Q Consensus 723 g~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~ 802 (867)
+. +||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..|+.... ....
T Consensus 194 ~~----~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~ 263 (311)
T 3p1a_A 194 GR----CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQ 263 (311)
T ss_dssp GC----EEECCCTTCEECC------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHH
T ss_pred CC----EEEccceeeeecccCCCCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHH
Confidence 64 59999999987665555555679999999999874 47899999999999999999977665432 2233
Q ss_pred HhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 803 iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+.........+..+++.+.+||.+||+.+|.+|||+.+++++.+
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 264 LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp HTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 33333333345568899999999999999999999999987643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=355.58 Aligned_cols=264 Identities=32% Similarity=0.533 Sum_probs=217.8
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+..++|++.+.||+|+||.||+|++ .+..||||++.... ......+.+|+.+++.++||||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--------PDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--------HHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 46678999999999999999999985 46789999986431 22245688999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++........++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~----~ 166 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH----V 166 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE----E
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC----E
Confidence 998765566899999999999999999766667999999999999999999999999999999999999997654 6
Q ss_pred EEeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--------
Q 002908 730 KVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-------- 797 (867)
Q Consensus 730 KL~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-------- 797 (867)
+|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 244 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence 999999998653322 2233457888999999984 45789999999999999999999998653322
Q ss_pred ------HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 798 ------AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 798 ------e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
.............+.+..+++.+.+||.+||+.+|.+|||+.+++++|+.+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp --CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 22333445555667778899999999999999999999999999999998865444
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.05 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=213.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||+||+|.+ +++.||||++.......... .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 96 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG---LSTEDLKREASICHMLKHPHIVELLETYS 96 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSS---CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccccc---chHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34457899999999999999999998 47889999997532211110 01346789999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~---~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
... .+++||||+++++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+|
T Consensus 97 ~~~--~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~-~~~vk 173 (351)
T 3c0i_A 97 SDG--MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN-SAPVK 173 (351)
T ss_dssp ETT--EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSST-TCCEE
T ss_pred eCC--EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCC-CCcEE
Confidence 854 8999999999999988775432 35899999999999999999999999999999999999987654 24579
Q ss_pred EeecCCcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 731 VGDFGLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 731 L~DFGLA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ......+......
T Consensus 174 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 174 LGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYK 250 (351)
T ss_dssp ECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCC
T ss_pred EecCcceeEecCCCeeecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCC
Confidence 99999998654432 2345679999999999984 457899999999999999999999998753 3444455544433
Q ss_pred CCC--CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 810 PPV--PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 810 ~~i--p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
... ...+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 221 24578999999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=359.87 Aligned_cols=261 Identities=26% Similarity=0.364 Sum_probs=208.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
.+...+|++.+.||+|+||.||+|++.++.||||+++... .....+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---------KQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred ccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---------hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 4677899999999999999999999999999999996431 1123455689999999999999999998764
Q ss_pred C--CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC----------CeeccCCCCcceEeccCC
Q 002908 656 P--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK----------NIVHFDLKCDNLLVNLKD 723 (867)
Q Consensus 656 ~--~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~----------GIIHrDLKPsNILLd~dg 723 (867)
. ...+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 3 3357999999999999999854 4589999999999999999999999 999999999999998665
Q ss_pred CCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-
Q 002908 724 PIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHY- 796 (867)
Q Consensus 724 ~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~---~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~- 796 (867)
.+||+|||+++...... ......||+.|+|||++.+.. ..++.++|||||||++|+|+||+.||.+...
T Consensus 169 ----~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 169 ----TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp ----CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred ----eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 46999999997543322 223456899999999997521 2356789999999999999999999965321
Q ss_pred ---------------hHHHHhHhhcCCCCCCCCC-----CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 797 ---------------GAIIGGIVNNTLRPPVPGF-----CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 797 ---------------~e~l~~iv~~~lr~~ip~~-----~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
......+.....++..+.. .++.+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1222222333333333321 245699999999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=341.08 Aligned_cols=262 Identities=33% Similarity=0.561 Sum_probs=219.7
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
-+.+..++|++.+.||+|+||.||+|.+. +..||||+++..... ...+.+|+.+++.++||||+++++++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYAVV 77 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---------HHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 35677899999999999999999999985 567999999753211 24678899999999999999999998
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|
T Consensus 78 ~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~----~kl 150 (279)
T 1qpc_A 78 TQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS----CKI 150 (279)
T ss_dssp CSS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC----EEE
T ss_pred cCC---CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC----EEE
Confidence 643 5789999999999999986543 36999999999999999999999999999999999999996654 599
Q ss_pred eecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCC
Q 002908 732 GDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~l 808 (867)
+|||++....... ......++..|+|||++. ...++.++|||||||++|+|++ |..||...........+. ...
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~ 227 (279)
T 1qpc_A 151 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGY 227 (279)
T ss_dssp CCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTC
T ss_pred CCCcccccccCcccccccCCCCccCccChhhhc--cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-ccc
Confidence 9999998654332 223345678899999997 3457899999999999999999 999999887766665544 344
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
....+..+++.+.+++.+||+.+|.+|||+.++++.|+.+......
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 5566778899999999999999999999999999999999876553
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.51 Aligned_cols=262 Identities=24% Similarity=0.279 Sum_probs=213.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|++.+.||+|+||.||+|.+. +..||||++........ .......+.+|+.+++.++||||+++++++.+..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI---NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc---CHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 468999999999999999999984 67899999975432111 1123467889999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcc---------------------------------------cccCCHHHHHHHHHHHHH
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSK---------------------------------------ERHLDRRKRLIIAMDAAF 697 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~---------------------------------------~~~Lse~~~l~Ia~QIa~ 697 (867)
..++||||+++++|.+++... ...+++..++.++.||+.
T Consensus 102 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 102 --YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp --EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred --eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 899999999999999988421 123467888899999999
Q ss_pred HHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc-----cccCCcCCCCCccCccccccCCCCCChhh
Q 002908 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKV 772 (867)
Q Consensus 698 ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~-----~~~s~~~GT~~Y~APEvl~g~~~~~S~kS 772 (867)
||.|||++||+||||||+|||++.++. ..+||+|||++...... .......||+.|+|||++.+....++.++
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKS--FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSS--CCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCC--ceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999999999999999999986653 35799999999854221 12234568999999999986556789999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC--CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 773 DVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG--FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 773 DVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~--~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
|||||||++|+|++|+.||...........+.......+.+. .+++.+.+||.+||+.+|.+||++.+++++.+-
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 999999999999999999999888887777777665544433 478999999999999999999999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.88 Aligned_cols=258 Identities=35% Similarity=0.592 Sum_probs=209.9
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
..+..++|++.+.||+|+||.||++.+.++.||||++... .....|.+|+.++++++||||+++++++.+
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----------SERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3567789999999999999999999999999999998532 113568899999999999999999999875
Q ss_pred CCCCeEEEEEEeecCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCCcceEeccCCCCCCcE
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHS---KNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~--~~Lse~~~l~Ia~QIa~ALayLHs---~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+
T Consensus 73 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~~ 145 (307)
T 2eva_A 73 ----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT---VL 145 (307)
T ss_dssp ----TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT---EE
T ss_pred ----CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC---EE
Confidence 4689999999999999997544 347899999999999999999999 89999999999999986653 36
Q ss_pred EEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhhcCC
Q 002908 730 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTL 808 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~~~l 808 (867)
||+|||++....... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||....... ..........
T Consensus 146 kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (307)
T 2eva_A 146 KICDFGTACDIQTHM--TNNKGSAAWMAPEVFE--GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221 (307)
T ss_dssp EECCCCC--------------CCTTSSCHHHHT--CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC
T ss_pred EEccccccccccccc--ccCCCCCceEChhhhC--CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC
Confidence 999999997544322 2345899999999998 4567899999999999999999999997643322 2222233444
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
.++.+..++..+.++|.+||+.+|.+|||+.++++.|+.+.....
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 556667889999999999999999999999999999999876554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.63 Aligned_cols=252 Identities=26% Similarity=0.354 Sum_probs=203.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
++|++++.||+|+||.||+|.+. ++.||||++....... .....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG------CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc------ccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--
Confidence 57999999999999999999984 7889999997543211 11245778999999999999999999998754
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----~kl~Dfg~~~ 148 (288)
T 1ob3_A 74 RLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE----LKIADFGLAR 148 (288)
T ss_dssp CEEEEEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC----EEECCTTHHH
T ss_pred eEEEEEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC----EEEeECcccc
Confidence 8999999996 5999888766677999999999999999999999999999999999999997664 5999999998
Q ss_pred cccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC--------
Q 002908 739 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 809 (867)
Q Consensus 739 ~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr-------- 809 (867)
..... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||...........+......
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 149 AFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp HHCC---------CCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccCccccccccccccccccCchheeC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 54322 22234568999999999974 345789999999999999999999999987766555444321100
Q ss_pred --------C-----------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 810 --------P-----------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 810 --------~-----------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
. .....+++.+.+||.+||+.||.+|||+.+++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0 01234789999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.68 Aligned_cols=256 Identities=28% Similarity=0.504 Sum_probs=201.8
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh--CCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK--LHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~--L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||+|.++++.||||++.... ...+.+|.+++.. ++||||+++++++.
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----------EKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----------chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 4556899999999999999999999999999999986421 1344566667766 79999999999865
Q ss_pred cC--CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHH--------HCCeeccCCCCcceEeccCC
Q 002908 654 DG--PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH--------SKNIVHFDLKCDNLLVNLKD 723 (867)
Q Consensus 654 ~~--~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLH--------s~GIIHrDLKPsNILLd~dg 723 (867)
.. .....++||||+++++|.+++. ...+++..++.++.||+.||+||| +.||+||||||+|||++.++
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred cccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 42 2346899999999999999994 346899999999999999999999 99999999999999999665
Q ss_pred CCCCcEEEeecCCcccccCccc-----cCCcCCCCCccCccccccCCC----CCChhhHHHHHHHHHHHHHhC-------
Q 002908 724 PIRPICKVGDFGLSKIKRNTLV-----TGGVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTG------- 787 (867)
Q Consensus 724 ~~~~~vKL~DFGLA~~~~~~~~-----~s~~~GT~~Y~APEvl~g~~~----~~S~kSDVWSLGvLLyELLTG------- 787 (867)
.+||+|||++........ .....||+.|+|||++.+... .++.++|||||||++|+|++|
T Consensus 151 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 151 ----QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp ----CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred ----CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 469999999975433221 223469999999999985322 345799999999999999999
Q ss_pred ---CCCCCCCCh-----hHHHHhHhhcCCCCCCCC-----CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 788 ---EEPYANMHY-----GAIIGGIVNNTLRPPVPG-----FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 788 ---k~PF~~~~~-----~e~l~~iv~~~lr~~ip~-----~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..||..... .............+..+. .+++.+.+||.+||+.||.+|||+.++++.|+.+
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 888855322 222222222233333332 2457899999999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.75 Aligned_cols=257 Identities=35% Similarity=0.606 Sum_probs=211.7
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+.+..++|++.+.||+|+||.||++.++++.||||+++... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 35677899999999999999999999999999999986431 13568899999999999999999998765
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccc-cCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~-~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
. .+..++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----~~l~D 160 (278)
T 1byg_A 86 E-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV----AKVSD 160 (278)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC----EEECC
T ss_pred C-CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc----EEEee
Confidence 3 2368999999999999999865443 4899999999999999999999999999999999999997654 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
||++....... ....+++.|+|||++. ...++.++||||||+++|+|++ |..||...........+. .......
T Consensus 161 fg~~~~~~~~~--~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~ 235 (278)
T 1byg_A 161 FGLTKEASSTQ--DTGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDA 235 (278)
T ss_dssp CCC--------------CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCC
T ss_pred ccccccccccc--cCCCccccccCHHHhC--CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCC
Confidence 99998554332 2235788999999998 4567899999999999999998 999998877666555443 3445666
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
+..+++.+.++|.+||+.+|.+|||+.++++.|+.+...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 778899999999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=350.89 Aligned_cols=261 Identities=24% Similarity=0.327 Sum_probs=218.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. ++.||||+++......... ......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 467999999999999999999984 7889999998654332111 011356789999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.....++|+|||+
T Consensus 89 --~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 89 --DVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp --EEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred --EEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 89999999999999999864 456899999999999999999999999999999999999998775445689999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC--CCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~--ip~ 814 (867)
+.............||+.|+|||++. ...++.++|||||||++|+|++|..||...........+.......+ ...
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ceecCccccccccCCCCCccCccccc--CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 98765544445567999999999998 45678999999999999999999999998887777666655443322 124
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 67889999999999999999999999998644
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=365.04 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=209.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~ 652 (867)
.+..++|++++.||+|+||.||+|++. ++.||||+++.... ........+.+|..++..+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-----LQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-----cchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 456789999999999999999999984 78899999975421 1122245677899999988 799999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.+.. .+++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 94 ~~~~--~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~----ikL~ 166 (353)
T 3txo_A 94 QTPD--RLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH----CKLA 166 (353)
T ss_dssp ECSS--EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC----EEEC
T ss_pred EeCC--EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC----EEEc
Confidence 8855 89999999999999998854 356999999999999999999999999999999999999997764 5999
Q ss_pred ecCCccccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 733 DFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 733 DFGLA~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... .
T Consensus 167 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~ 242 (353)
T 3txo_A 167 DFGMCKEGICNGVTTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--V 242 (353)
T ss_dssp CCTTCBCSCC---------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C
T ss_pred cccceeecccCCccccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--C
Confidence 999998532 2333445679999999999984 4578899999999999999999999999888888888777654 3
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCH------HHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSF------TEIARRLR 846 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa------~ELLe~Lq 846 (867)
.+..+++.+.+||.+||+.+|.+||++ .+++++.+
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 456789999999999999999999998 78877654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.93 Aligned_cols=260 Identities=30% Similarity=0.575 Sum_probs=212.7
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC--Cce----EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceee
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~----VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVr 647 (867)
...+..++|++.+.||+|+||.||+|++. ++. ||+|.++... ......+|.+|+.++++++||||++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~ 81 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCR 81 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCC
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-------CHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 44677889999999999999999999983 443 5777765321 1223467889999999999999999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
++++|... ..++||+|+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~---- 154 (327)
T 3poz_A 82 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---- 154 (327)
T ss_dssp EEEEEESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT----
T ss_pred EEEEEecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC----
Confidence 99999874 47789999999999999987777899999999999999999999999999999999999999766
Q ss_pred cEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhH
Q 002908 728 ICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 803 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~i 803 (867)
.+||+|||+++...... ......+|+.|+|||++. ...++.++|||||||++|+|+| |..||...........
T Consensus 155 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~- 231 (327)
T 3poz_A 155 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI- 231 (327)
T ss_dssp EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-
T ss_pred CEEEccCcceeEccCCcccccccCCCccccccChHHhc--cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-
Confidence 46999999998543322 222344678999999998 4568999999999999999999 9999988776655443
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 804 v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+......+.+..++..+.+++.+||+.+|.+||++.+++++|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 44445566677889999999999999999999999999999998864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=353.33 Aligned_cols=260 Identities=21% Similarity=0.255 Sum_probs=211.6
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 653 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~ 653 (867)
+...+|++.+.||+|+||.||+|.+ +++.||||++...... ..+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----------PQLHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----------CCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----------HHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 4457899999999999999999997 5888999998754221 2467899999999 8999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC-CCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP-IRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~-~~~~vKL~ 732 (867)
... ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ....++|+
T Consensus 76 ~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 76 CGK--YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp ETT--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred cCC--ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 854 899999999 99999999766678999999999999999999999999999999999999997763 22347999
Q ss_pred ecCCcccccCccc--------cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHH
Q 002908 733 DFGLSKIKRNTLV--------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIG 801 (867)
Q Consensus 733 DFGLA~~~~~~~~--------~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---e~l~ 801 (867)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ....
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 9999986433221 235679999999999984 56799999999999999999999999874432 2233
Q ss_pred hHhhcCCCCCC---CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 802 GIVNNTLRPPV---PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 802 ~iv~~~lr~~i---p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
.+.......+. ...++ .+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus 231 ~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 231 KIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 32222111111 12345 8999999999999999999999999999987765
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=359.49 Aligned_cols=256 Identities=26% Similarity=0.352 Sum_probs=202.4
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
...++|++++.||+|+||+||++++ +++.||||++...... ...+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---------DENVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---------CHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---------cHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 3457899999999999999999998 4788999999754221 1346789999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+||
T Consensus 88 ~~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~--~~~kl~Df 162 (361)
T 3uc3_A 88 PT--HLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA--PRLKICDF 162 (361)
T ss_dssp SS--EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSS--CCEEECCC
T ss_pred CC--EEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--ceEEEeec
Confidence 54 89999999999999998854 346999999999999999999999999999999999999986653 24799999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhHhhcCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVS-EKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTLR 809 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S-~kSDVWSLGvLLyELLTGk~PF~~~~~----~e~l~~iv~~~lr 809 (867)
|+++............||+.|+|||++.+ ..+. .++|||||||++|+|++|+.||..... ...+..+......
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 240 (361)
T 3uc3_A 163 GYSKSSVLHSQPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240 (361)
T ss_dssp CCC---------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC
T ss_pred CccccccccCCCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC
Confidence 99985443333445679999999999984 3344 459999999999999999999977443 3444455555555
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+....+++.+.+||.+||+.+|.+|||+.+++++.+-.
T Consensus 241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 555557899999999999999999999999999987753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=366.67 Aligned_cols=261 Identities=33% Similarity=0.573 Sum_probs=210.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+...+|++.+.||+|+||.||+|++. +..||||+++... .+.....|.+|+.++++++||||+++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~ 113 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-------TEKQRRDFLGEASIMGQFDHPNIIRLEG 113 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 566788999999999999999999874 5679999987531 1233467899999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.... ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 114 ~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~k 187 (373)
T 2qol_A 114 VVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL----VCK 187 (373)
T ss_dssp EECSSS--SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEE
T ss_pred EEeeCC--ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC----CEE
Confidence 998754 88999999999999999987777899999999999999999999999999999999999998665 469
Q ss_pred EeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||+++...... ......+++.|+|||++. ...++.++|||||||++|+|++ |+.||...........+.
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~- 264 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD- 264 (373)
T ss_dssp ECCC----------------------CTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhc--cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999998654321 112223567899999998 4568999999999999999998 999998887766655543
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
...+.+.+..++..+.++|.+||+.+|.+||++.++++.|+.+....
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 44455667788999999999999999999999999999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.87 Aligned_cols=259 Identities=32% Similarity=0.558 Sum_probs=214.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G-----~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..++|++.+.||+|+||.||+|.+.+ ..||||+++... .......+.+|+.+++.++||||+++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-------TLDNKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-------CHHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-------CchHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4567899999999999999999998742 349999987532 1223467889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.+. ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .++
T Consensus 81 ~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~k 153 (281)
T 3cc6_A 81 IIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE----CVK 153 (281)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT----EEE
T ss_pred EEcCC---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC----cEE
Confidence 98753 46899999999999999977667799999999999999999999999999999999999999765 469
Q ss_pred EeecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 731 VGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 731 L~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
|+|||++....... ......+++.|+|||++. ...++.++|||||||++|+|++ |+.||...........+.. .
T Consensus 154 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-~ 230 (281)
T 3cc6_A 154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-G 230 (281)
T ss_dssp ECCCCGGGCC---------CCCCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-T
T ss_pred eCccCCCcccccccccccccCCCCcceeCchhhc--cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-C
Confidence 99999998654322 223345778899999997 4567899999999999999998 9999987766665544433 3
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
...+.+..+++.+.++|.+||+.+|.+|||+.+++++|+.+...
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 231 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 44556677899999999999999999999999999999998654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.50 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=214.3
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||++.+. ++.||||+++.......... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRG--VSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS--BCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccc--hHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 357999999999999999999994 78899999987544322111 11356789999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.....++|+|||+
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 82 --DVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp --EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred --eEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 89999999999999999854 456899999999999999999999999999999999999998775556789999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC--CCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~--ip~ 814 (867)
+.............+++.|+|||++. ...++.++||||||+++|+|++|..||...........+.......+ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 159 AHKIEAGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp CEECC--------CCCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ceeccCCCcccccCCCcCccCcceec--CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence 98665444444556899999999998 45678999999999999999999999998877666665554433222 124
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+++.+.+++.+||+.+|.+|||+.+++++.+-
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 678899999999999999999999999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.10 Aligned_cols=253 Identities=26% Similarity=0.327 Sum_probs=203.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||+||+|.+ +++.||||+++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHSDK- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc------CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-
Confidence 5799999999999999999998 4788999999765322 122356778999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+. +++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 75 -~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~----~kl~Dfg~~ 148 (292)
T 3o0g_A 75 -KLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE----LKLANFGLA 148 (292)
T ss_dssp -EEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECCCTTC
T ss_pred -EEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC----EEEeecccc
Confidence 8999999996 5666666665677999999999999999999999999999999999999997664 599999999
Q ss_pred ccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC-CCCCChhHHHHhHhhcCCC------
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNNTLR------ 809 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~P-F~~~~~~e~l~~iv~~~lr------ 809 (867)
...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..| |........+..+......
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred eecCCccccccCCccccCCcChHHHcC-CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 865432 23344568999999999974 23478999999999999999988777 5555555444443321110
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 ---------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 ---------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
......+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 0112246889999999999999999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.86 Aligned_cols=262 Identities=26% Similarity=0.326 Sum_probs=204.4
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC---CCCceeeEe
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFY 649 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L---~HPNIVrL~ 649 (867)
..+..++|++.+.||+|+||+||+|++ +++.||||++............ ...+.+|+.+++.+ .||||++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL---PISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCC---CHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccccc---chhHHHHHHHHHHHhhcCCCCeEEee
Confidence 345578999999999999999999997 5788999999754322111111 12344566666655 599999999
Q ss_pred cccccCCC---CeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 650 GVVQDGPG---GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 650 g~~~~~~~---~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
+++..... ...++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~- 158 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT- 158 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC-
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC-
Confidence 99876432 25789999995 69999886544 34999999999999999999999999999999999999987664
Q ss_pred CCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 726 RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
+||+|||++.............||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+..
T Consensus 159 ---~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 159 ---VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL--QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp ---EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHH--TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred ---EEEeeCccccccCCCcccCCccccccccCchHHc--CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5999999998766555555667999999999998 44578999999999999999999999998887766655543
Q ss_pred cCCCCC-------------------------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 806 NTLRPP-------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 806 ~~lr~~-------------------------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....++ ....+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 211111 01246789999999999999999999999988654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=350.55 Aligned_cols=265 Identities=29% Similarity=0.488 Sum_probs=217.4
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+....|++++.||+|+||.||++.+ +++.||||+++... .......+.+|+.+++.++||||++++
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSGWKQEIDILRTLYHEHIIKYK 99 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCcchhhEE
Confidence 34444559999999999999999876 46789999997531 123346788999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++.......+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~----~ 173 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL----V 173 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC----E
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC----E
Confidence 99987655689999999999999999854 34899999999999999999999999999999999999997654 5
Q ss_pred EEeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh--------
Q 002908 730 KVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-------- 797 (867)
Q Consensus 730 KL~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-------- 797 (867)
+|+|||++....... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 251 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccc
Confidence 999999998654322 2233457888999999984 45789999999999999999999998653221
Q ss_pred ------HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCC
Q 002908 798 ------AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 855 (867)
Q Consensus 798 ------e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~ 855 (867)
......+......+.+..+++.+.+||.+||+.+|.+|||+.++++.|+.+.......
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 252 QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp CHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1223344555667778889999999999999999999999999999999998776543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=349.89 Aligned_cols=264 Identities=31% Similarity=0.489 Sum_probs=204.7
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G-----~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..++|++.+.||+|+||.||+|.+.. ..||||+++..... ......+.+|+.+++.++||||+++++
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA------SSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC------HHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 4667899999999999999999998742 26999999754221 122467889999999999999999999
Q ss_pred ccccCCCC----eEEEEEEeecCCchhhhhhccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEecc
Q 002908 651 VVQDGPGG----TLATVTEFMVNGSLRHVLLSKE-----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL 721 (867)
Q Consensus 651 ~~~~~~~~----~l~LVmEy~~ggSL~d~L~~~~-----~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~ 721 (867)
++...... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC
Confidence 98764321 2389999999999999885432 25899999999999999999999999999999999999997
Q ss_pred CCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChh
Q 002908 722 KDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYG 797 (867)
Q Consensus 722 dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~ 797 (867)
++. +||+|||++....... ......+++.|+|||++. ...++.++|||||||++|+|++ |..||......
T Consensus 173 ~~~----~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 173 DMT----VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp TSC----EEECCCCC-----------------CCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CCC----EEEeeccccccccccccccccccccCcccccCchhhc--CCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 654 5999999998543321 122344678899999998 4568899999999999999999 99999988777
Q ss_pred HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 798 e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
.....+... .....+..+++.+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 247 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 247 EIYNYLIGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp GHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 766655543 345556678999999999999999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=343.18 Aligned_cols=260 Identities=34% Similarity=0.587 Sum_probs=220.7
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
+.+...+|++.+.||+|+||.||+|.+. +..||||++.... . ....+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~----~~~~~~~E~~~l~~l~h~~i~~~~~~~ 78 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----M----EVEEFLKEAAVMKEIKHPNLVQLLGVC 78 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-----T----HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-----H----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4577889999999999999999999995 7789999996431 1 135678999999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.... ..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|
T Consensus 79 ~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~----~~l 152 (288)
T 3kfa_A 79 TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL----VKV 152 (288)
T ss_dssp CSSS--SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC----EEE
T ss_pred ccCC--CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC----EEE
Confidence 8754 899999999999999998653 356899999999999999999999999999999999999987664 599
Q ss_pred eecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCC
Q 002908 732 GDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~l 808 (867)
+|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||........... +....
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~ 229 (288)
T 3kfa_A 153 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDY 229 (288)
T ss_dssp CCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTC
T ss_pred ccCccceeccCCccccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccC
Confidence 9999998654322 2233456788999999984 458899999999999999999 9999988776655544 34445
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
....+..+++.+.+|+.+||+.+|.+|||+.++++.|+.+....
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 56677788999999999999999999999999999999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.31 Aligned_cols=258 Identities=29% Similarity=0.527 Sum_probs=211.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--Cce----EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~----VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
.+..++|++.+.||+|+||.||+|.+. +.. ||+|++........ ...+.+|+.+++.++||||++++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~ 81 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-------FQAVTDHMLAIGSLDHAHIVRLL 81 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-------BCSCCHHHHHHHTCCCTTBCCEE
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-------HHHHHHHHHHHhcCCCCCcCeEE
Confidence 466789999999999999999999984 444 77777654321111 13456789999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++.+. ..++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 82 ~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~----~ 154 (325)
T 3kex_A 82 GLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ----V 154 (325)
T ss_dssp EEECBS---SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC----E
T ss_pred EEEcCC---ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe----E
Confidence 998643 688999999999999999776678999999999999999999999999999999999999987664 5
Q ss_pred EEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
||+|||+++...... ......+|..|+|||++. ...++.++|||||||++|+|+| |..||...........+ .
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~ 231 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH--FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-E 231 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-H
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhc--cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-H
Confidence 999999998653322 223455788999999998 4458999999999999999999 99999887766555443 3
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.......+..++..+.++|.+||+.+|.+|||+.+++++|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 344555666788899999999999999999999999999999854
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=347.37 Aligned_cols=262 Identities=29% Similarity=0.471 Sum_probs=210.9
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC--C-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--G-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~--G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI 645 (867)
..+..++|++.+.||+|+||.||+|.+. + ..||+|++.... ......+.+|+.+++.++||||
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i 74 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--------RNYSESFFEAASMMSKLSHKHL 74 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--------GGGHHHHHHHHHHHHTSCCTTB
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--------HHHHHHHHHHHHHHHhCCCCCE
Confidence 3567889999999999999999999874 3 469999986432 1223568899999999999999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
+++++++.... ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++..
T Consensus 75 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 152 (289)
T 4fvq_A 75 VLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152 (289)
T ss_dssp CCEEEEECCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBG
T ss_pred eEEEEEEEeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcc
Confidence 99999998754 7899999999999999998776679999999999999999999999999999999999999877642
Q ss_pred ----CCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCChhHHH
Q 002908 726 ----RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG-EEPYANMHYGAII 800 (867)
Q Consensus 726 ----~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTG-k~PF~~~~~~e~l 800 (867)
...++|+|||++....... ...+|+.|+|||++.+ ...++.++|||||||++|+|++| .+||.........
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~ 228 (289)
T 4fvq_A 153 KTGNPPFIKLSDPGISITVLPKD---ILQERIPWVPPECIEN-PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228 (289)
T ss_dssp GGTBCCEEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHC-GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred cccccceeeeccCcccccccCcc---ccCCcCcccCHHHhCC-CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence 1237999999997544322 2347889999999984 24579999999999999999995 5556555544333
Q ss_pred HhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 801 GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 801 ~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
. .... ....+...++.+.+||.+||+.+|.+|||+.+++++|+.+..+..
T Consensus 229 ~-~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 229 Q-FYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp H-HHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred H-Hhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 3 2222 233445567889999999999999999999999999999876544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=342.32 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=206.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||++.+. +..||||++........ ...+.+|+.+++.++||||+++++++....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-------MEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-------HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-------HHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 468999999999999999999984 78899999976532211 356778999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~---~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ ....++|+|
T Consensus 94 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~-~~~~~kl~D 170 (285)
T 3is5_A 94 --NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-PHSPIKIID 170 (285)
T ss_dssp --EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-TTCCEEECC
T ss_pred --eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-CCCCEEEEe
Confidence 899999999999999988543 36799999999999999999999999999999999999996543 234679999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC-
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV- 812 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i- 812 (867)
||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....................
T Consensus 171 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (285)
T 3is5_A 171 FGLAELFKSDEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE 247 (285)
T ss_dssp CCCCCC----------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-
T ss_pred eecceecCCcccCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc
Confidence 999986655444455679999999999863 4789999999999999999999999988777666555444333222
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
...+++.+.+||.+||+.||.+|||+.+++++.
T Consensus 248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 234789999999999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.13 Aligned_cols=267 Identities=24% Similarity=0.407 Sum_probs=206.4
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
......+|++.+.||+|+||.||+|.+ ++..||||+++..... .......+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-----DAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 344567899999999999999999997 4888999999753221 123346788999999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
.... ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +
T Consensus 102 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~----~ 175 (310)
T 2wqm_A 102 IEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV----V 175 (310)
T ss_dssp EETT--EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----E
T ss_pred EcCC--cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC----E
Confidence 8854 89999999999999998854 2456899999999999999999999999999999999999997664 5
Q ss_pred EEeecCCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh--hHHHHhHhhc
Q 002908 730 KVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY--GAIIGGIVNN 806 (867)
Q Consensus 730 KL~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~--~e~l~~iv~~ 806 (867)
+|+|||++...... .......+++.|+|||++. ...++.++|||||||++|+|++|..||..... ......+...
T Consensus 176 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 253 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 253 (310)
T ss_dssp EECCC------------------CCSSCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT
T ss_pred EEEeccceeeecCCCccccccCCCeeEeChHHhC--CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc
Confidence 99999999854432 2223456899999999998 45688999999999999999999999976432 2333333333
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
.........+++.+.++|.+||+.||.+|||+.++++.|+.+......
T Consensus 254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 333333467899999999999999999999999999999999876653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.61 Aligned_cols=264 Identities=33% Similarity=0.535 Sum_probs=217.3
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEE--CCce--EEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceee
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVA 647 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~--~G~~--VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVr 647 (867)
..+.+..++|++.+.||+|+||.||+|++ .+.. ||||.++... .......+.+|+.+++++ +||||++
T Consensus 18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCC
T ss_pred ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-------chHHHHHHHHHHHHHHhccCCCchhh
Confidence 34567789999999999999999999987 3554 5999887432 112235678899999999 8999999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL 712 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDL 712 (867)
+++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||
T Consensus 91 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 168 (327)
T 1fvr_A 91 LLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 168 (327)
T ss_dssp EEEEEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred hceeeeeCC--ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 999998854 8999999999999999986543 46899999999999999999999999999999
Q ss_pred CCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCC
Q 002908 713 KCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPY 791 (867)
Q Consensus 713 KPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF 791 (867)
||+|||++.++ .++|+|||++.............+++.|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 169 kp~NIl~~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf 242 (327)
T 1fvr_A 169 AARNILVGENY----VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPY 242 (327)
T ss_dssp SGGGEEECGGG----CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccceEEEcCCC----eEEEcccCcCccccccccccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCC
Confidence 99999998765 459999999975433333334457889999999973 457899999999999999998 99999
Q ss_pred CCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 792 ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 792 ~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
...........+.. ......+..+++.+.+||.+||+.+|.+|||+.+++++|+.+....
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 243 CGMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp TTCCHHHHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCcHHHHHHHhhc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 98877666655443 3455666778999999999999999999999999999999987643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=340.31 Aligned_cols=260 Identities=30% Similarity=0.539 Sum_probs=212.9
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--C---ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 581 DLEELKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~~--G---~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
.|.+.++||+|+||.||+|.+. + ..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-------EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-------cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 4677899999999999999872 2 269999986421 122346788999999999999999999999764
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ...++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||
T Consensus 95 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~----~kl~Dfg 169 (298)
T 3pls_A 95 E-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT----VKVADFG 169 (298)
T ss_dssp S-SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC----EEECCTT
T ss_pred C-CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc----EEeCcCC
Confidence 3 3458999999999999999876778999999999999999999999999999999999999986654 5999999
Q ss_pred CcccccCc-----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCC-CCCCCCChhHHHHhHhhcCCC
Q 002908 736 LSKIKRNT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE-EPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 736 LA~~~~~~-----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk-~PF~~~~~~e~l~~iv~~~lr 809 (867)
++...... .......+|+.|+|||.+. ...++.++|||||||++|+|++|. +||.......... .......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~ 246 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQ--TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-FLAQGRR 246 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT--TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-HHHTTCC
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhc--cCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-HhhcCCC
Confidence 99754322 1223445788999999998 456899999999999999999955 4555554444443 3444455
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCC
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 855 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~ 855 (867)
.+.+..+++.+.+++.+||+.+|.+|||+.++++.|+.+.......
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 6667788999999999999999999999999999999998876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=368.74 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=217.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||+||+|.+ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL------SARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 46899999999999999999988 488899999976432 2223456889999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+.+++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.+.. ...+||+|||+
T Consensus 84 --~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~-~~~vkL~DFG~ 159 (444)
T 3soa_A 84 --HHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK-GAAVKLADFGL 159 (444)
T ss_dssp --EEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSST-TCCEEECCCSS
T ss_pred --EEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCC-CCcEEEccCce
Confidence 899999999999999988654 46999999999999999999999999999999999999986432 24579999999
Q ss_pred cccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC--
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP-- 813 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip-- 813 (867)
+...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||...........+....+..+.+
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLR--KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred eEEecCCCceeecccCCcccCCHHHhc--CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc
Confidence 9865432 2334567999999999998 4467899999999999999999999999988888887777766654443
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+++.+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 46799999999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=363.47 Aligned_cols=254 Identities=20% Similarity=0.320 Sum_probs=215.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... . .....+.+|+.+|+.++||||+++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----P---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----H---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----h---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 367999999999999999999984 7889999987531 1 11246789999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+
T Consensus 122 --~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~--~~vkL~DFG~ 197 (387)
T 1kob_A 122 --EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGL 197 (387)
T ss_dssp --EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC--CCEEECCCTT
T ss_pred --EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCC--CceEEEeccc
Confidence 899999999999999999766667999999999999999999999999999999999999985432 3579999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--CCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--PVPG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~--~ip~ 814 (867)
+.............||+.|+|||++. ...++.++|||||||++|+|++|..||........+..+....... ....
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 275 (387)
T 1kob_A 198 ATKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 275 (387)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHT--TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred ceecCCCcceeeeccCCCccCchhcc--CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 98765544344456999999999998 4567899999999999999999999999888777776666554432 2335
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 67999999999999999999999999998743
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=340.03 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=214.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. +..||+|++....... ...+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--------VDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 457999999999999999999985 5679999997643221 356788999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+..++ ....++|+|||+
T Consensus 80 --~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 80 --DIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGL 155 (277)
T ss_dssp --EEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECCCTT
T ss_pred --eEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcEEEEeccc
Confidence 89999999999999988854 45689999999999999999999999999999999999994322 234579999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC--C
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--G 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip--~ 814 (867)
+.............+|+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.......+.. .
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (277)
T 3f3z_A 156 AARFKPGKMMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL 232 (277)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred ceeccCccchhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh
Confidence 987655555556679999999999874 37889999999999999999999999988877777766665443322 2
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+++.+.++|.+||+.+|.+|||+.+++++.+-.
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 5789999999999999999999999999876643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=347.86 Aligned_cols=261 Identities=32% Similarity=0.518 Sum_probs=217.4
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCcee
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 646 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIV 646 (867)
.+.+..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++||||+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-------CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 44677899999999999999999999864 4679999986431 122245688999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcce
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 717 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNI 717 (867)
++++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 92 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NI 169 (322)
T 1p4o_A 92 RLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 169 (322)
T ss_dssp CEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred eeEEEEccCC--ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceE
Confidence 9999998754 7899999999999999986432 3568999999999999999999999999999999999
Q ss_pred EeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCC
Q 002908 718 LVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYAN 793 (867)
Q Consensus 718 LLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~ 793 (867)
|++.++. ++|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 170 li~~~~~----~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 170 MVAEDFT----VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp EECTTCC----EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred EEcCCCe----EEECcCccccccccccccccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 9997654 5999999997543221 1223346888999999983 457899999999999999999 8999998
Q ss_pred CChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 794 MHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 794 ~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.........+.... ....+..++..+.++|.+||+.+|.+|||+.+++++|+....
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 244 LSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp SCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 87776666555443 345567789999999999999999999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=352.42 Aligned_cols=256 Identities=28% Similarity=0.398 Sum_probs=206.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..++|++.+.||+|+||.||++++ .++.||||+++...... .......+.+|+.+|+.++||||+++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR----NAKDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh----hhhHHHHHHHHHHHHHhCCCCCccceeE
Confidence 45678999999999999999999987 47789999997643221 1122345778999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.... .+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 89 ~~~~~~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~----~k 161 (327)
T 3a62_A 89 AFQTGG--KLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH----VK 161 (327)
T ss_dssp EEECSS--CEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC----EE
T ss_pred EEEcCC--EEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc----EE
Confidence 998854 89999999999999998854 356899999999999999999999999999999999999997664 59
Q ss_pred EeecCCccccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 731 VGDFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 731 L~DFGLA~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
|+|||+++... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~- 238 (327)
T 3a62_A 162 LTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL- 238 (327)
T ss_dssp ECCCSCC----------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-
T ss_pred EEeCCcccccccCCccccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-
Confidence 99999997532 2223345679999999999984 4578999999999999999999999998887777777666543
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
..+..++..+.+||.+||+.+|.+|| ++.+++++.+
T Consensus 239 -~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 239 -NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred -CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 44567899999999999999999999 7889988755
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=356.66 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=216.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
...|++.+.||+|+||.||+|++ +++.||||++..... ........+.+|+.+++.++||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-----cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 35699999999999999999997 588899999975421 22334567889999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+. |+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 128 --~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~DfG~ 200 (348)
T 1u5q_A 128 --TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGS 200 (348)
T ss_dssp --EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT----EEEECCCTT
T ss_pred --eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC----CEEEeeccC
Confidence 8999999996 688888866667899999999999999999999999999999999999999665 469999999
Q ss_pred cccccCccccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
+...... ....||+.|+|||++.+ ....++.++|||||||++|+|++|..||...........+.........+..
T Consensus 201 a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (348)
T 1u5q_A 201 ASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 277 (348)
T ss_dssp CBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred ceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Confidence 9865432 34569999999999853 2456788999999999999999999999888777766666665555455667
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
+++.+.+||.+||+.+|.+|||+.+++++.+-.
T Consensus 278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 899999999999999999999999999876653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=349.46 Aligned_cols=265 Identities=28% Similarity=0.492 Sum_probs=220.1
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCC
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 643 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HP 643 (867)
.+.+..++|++.+.||+|+||.||+|.+. +..||||+++... .+.....+.+|+.+++.+ +||
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp 101 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHK 101 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-------cHHHHHHHHHHHHHHHHhhcCC
Confidence 34667899999999999999999999873 4569999987432 123346788999999999 899
Q ss_pred ceeeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCee
Q 002908 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 708 (867)
Q Consensus 644 NIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GII 708 (867)
||+++++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+
T Consensus 102 ~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 179 (334)
T 2pvf_A 102 NIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179 (334)
T ss_dssp TBCCEEEEECSSS--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CEeeEEEEEccCC--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999998754 8899999999999999986543 2489999999999999999999999999
Q ss_pred ccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHH
Q 002908 709 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785 (867)
Q Consensus 709 HrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELL 785 (867)
||||||+|||++.++. +||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 180 H~Dlkp~NIll~~~~~----~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell 253 (334)
T 2pvf_A 180 HRDLAARNVLVTENNV----MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIF 253 (334)
T ss_dssp CSCCSGGGEEECTTCC----EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHH
T ss_pred CCCCccceEEEcCCCC----EEEccccccccccccccccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHH
Confidence 9999999999996654 5999999998554321 2233456788999999973 45789999999999999999
Q ss_pred h-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 786 T-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 786 T-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
+ |..||...........+.. ......+..++..+.++|.+||+.+|.+|||+.++++.|+.+......
T Consensus 254 t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 254 TLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp TTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred hCCCCCcCcCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 9 9999988876665554443 345566778899999999999999999999999999999999876553
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.11 Aligned_cols=263 Identities=34% Similarity=0.571 Sum_probs=212.9
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC---Cc--eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR---GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~---G~--~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
..+..++|++.+.||+|+||.||+|++. ++ .||||+++..... .......+.+|+.+++.++||||++++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAMDDFIREVNAMHSLDHRNLIRLY 87 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-----CHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 3566789999999999999999999873 22 5899998754322 123346788999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++... ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 88 ~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~----~~ 160 (291)
T 1u46_A 88 GVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LV 160 (291)
T ss_dssp EEECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT----EE
T ss_pred EEEccC---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC----CE
Confidence 999864 37899999999999999977667799999999999999999999999999999999999998765 46
Q ss_pred EEeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHh
Q 002908 730 KVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIV 804 (867)
Q Consensus 730 KL~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv 804 (867)
+|+|||++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 238 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238 (291)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred EEccccccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence 999999998653321 1223457788999999984 457899999999999999999 999999988888777777
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 805 ~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
......+.+..++..+.++|.+||+.+|.+|||+.+++++|+.+...
T Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 77667777788999999999999999999999999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=353.77 Aligned_cols=252 Identities=26% Similarity=0.429 Sum_probs=214.9
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+..++|++++.||+|+||.||+++. +|+.||||+++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 4457899999999999999999998 4788999999754211 11123456789999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|. +||+||
T Consensus 78 ~~--~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~----~kL~Df 150 (318)
T 1fot_A 78 AQ--QIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH----IKITDF 150 (318)
T ss_dssp SS--EEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC----EEECCC
T ss_pred CC--EEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC----EEEeec
Confidence 54 89999999999999999864 356899999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
|+++..... ....+||+.|+|||++. ...++.++|||||||++|+|++|..||...........+..... ..+.
T Consensus 151 g~a~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~ 224 (318)
T 1fot_A 151 GFAKYVPDV--TYTLCGTPDYIAPEVVS--TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPP 224 (318)
T ss_dssp SSCEECSSC--BCCCCSCTTTCCHHHHT--TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCT
T ss_pred CcceecCCc--cccccCCccccCHhHhc--CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCC
Confidence 999865443 23467999999999998 45678899999999999999999999998887777777776644 3456
Q ss_pred CCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
.+++.+.++|.+||+.+|.+|| ++.+++++.+
T Consensus 225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 7899999999999999999999 8999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=340.26 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=213.9
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
...++|++.+.||+|+||.||+|.+. +..||||++..... ........+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-----chhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 45678999999999999999999985 56799999965321 112224568899999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~----~~l~Df 153 (279)
T 3fdn_A 81 AT--RVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE----LKIADF 153 (279)
T ss_dssp SS--EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC----EEECSC
T ss_pred CC--EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC----EEEEec
Confidence 54 899999999999999988543 56899999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
|++....... .....|++.|+|||++. ...++.++||||||+++|+|++|..||...........+.... ...+.
T Consensus 154 g~~~~~~~~~-~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 228 (279)
T 3fdn_A 154 GWSVHAPSSR-RTDLCGTLDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPD 228 (279)
T ss_dssp CEESCC---------CCCCTTCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCT
T ss_pred cccccCCccc-ccccCCCCCccCHhHhc--cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC--CCCCC
Confidence 9986544332 23456899999999998 4557889999999999999999999999888777666655433 34566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
.+++.+.+||.+||+.+|.+|||+.+++++.+-....
T Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 229 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 7899999999999999999999999999998765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=359.96 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=208.7
Q ss_pred eEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeE
Q 002908 583 EELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 583 qilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l 660 (867)
...+.||+|+||.||+|.+ .++.||||+++.... .....+.+|+.+|+.++||||+++++++.... .+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~ 161 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--------KDKEEVKNEISVMNQLDHANLIQLYDAFESKN--DI 161 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--------HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EE
Confidence 3467899999999999998 478899999975321 12356889999999999999999999998854 89
Q ss_pred EEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 661 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 661 ~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+..++ ...+||+|||++...
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD--AKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT--TTEEEECCCSSCEEC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC--CCcEEEEeCCCceec
Confidence 999999999999999877667799999999999999999999999999999999999995432 235799999999876
Q ss_pred cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC--CCCCcH
Q 002908 741 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PGFCDS 818 (867)
Q Consensus 741 ~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i--p~~~s~ 818 (867)
..........||+.|+|||++. ...++.++|||||||++|+|++|..||........+..+.......+. ...+++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVN--YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHT--TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred CCccccccccCCCcEeChhhcc--CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 6555455567999999999997 456789999999999999999999999998887777777765543332 246789
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 819 EWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 819 eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+.+||.+||+.+|.+|||+.+++++.+-
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence 99999999999999999999999986553
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.45 Aligned_cols=254 Identities=28% Similarity=0.359 Sum_probs=206.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. ++.||||++...... .....+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-------chHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 468999999999999999999984 788999999754221 12245778999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 79 --~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~----~kl~Dfg~ 151 (323)
T 3tki_A 79 --IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN----LKISDFGL 151 (323)
T ss_dssp --EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC----EEECCCTT
T ss_pred --eEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC----EEEEEeec
Confidence 89999999999999998853 446999999999999999999999999999999999999997664 59999999
Q ss_pred cccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhhcCCCCCC
Q 002908 737 SKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRPPV 812 (867)
Q Consensus 737 A~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~~~lr~~i 812 (867)
+..... ........||+.|+|||++.+. ...+.++|||||||++|+|++|+.||....... ..............
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc
Confidence 985432 1223356799999999999842 224779999999999999999999998765432 22233333333333
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
...+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 45678999999999999999999999999887654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=342.15 Aligned_cols=260 Identities=30% Similarity=0.528 Sum_probs=211.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~G-----~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
..+|++.+.||+|+||.||+|.+.. ..||||.+.... .......+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-------CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 3468999999999999999998732 248999886421 2233467889999999999999999999865
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. .+..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .++|+|
T Consensus 97 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~----~~kl~D 171 (298)
T 3f66_A 97 RS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF----TVKVAD 171 (298)
T ss_dssp CS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC----CEEECS
T ss_pred cC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC----CEEECc
Confidence 43 3478899999999999999977677799999999999999999999999999999999999998665 459999
Q ss_pred cCCcccccCcc-----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 734 FGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 734 FGLA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
||++....... ......+|+.|+|||.+. ...++.++|||||||++|+|++ |.+||...........+.. .
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~-~ 248 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-G 248 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT-T
T ss_pred ccccccccccchhccccccCCCCCccccChHHhc--CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc-C
Confidence 99998543322 223345778899999998 4468899999999999999999 6677776665555444433 3
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
.....+..++..+.+++.+||+.+|.+|||+.++++.|+.+.....
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 3455567789999999999999999999999999999999887554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=358.73 Aligned_cols=259 Identities=21% Similarity=0.353 Sum_probs=207.5
Q ss_pred ccccCCeeEEEEeeec--CcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 576 IIKNEDLEELKELGSG--TFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 576 ~I~~sdyqilk~LG~G--afG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
....++|++++.||+| +||.||+|++. ++.||||+++..... ......+.+|+.+++.++|||||+++++
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS------NEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC------hHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3456789999999999 99999999994 788999999764321 2345677889999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
+.... .+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++
T Consensus 95 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~----~k 168 (389)
T 3gni_B 95 FIADN--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK----VY 168 (389)
T ss_dssp EEETT--EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----EE
T ss_pred EEECC--EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC----EE
Confidence 98854 899999999999999998654 356999999999999999999999999999999999999997664 59
Q ss_pred EeecCCcccccCc--------cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHh
Q 002908 731 VGDFGLSKIKRNT--------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 802 (867)
Q Consensus 731 L~DFGLA~~~~~~--------~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~ 802 (867)
|+|||.+...... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||...........
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 248 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248 (389)
T ss_dssp ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999988632211 11123468899999999986446789999999999999999999999987655444333
Q ss_pred HhhcCC--------------------------------------------CCCCCCCCcHHHHHHHHHhhcCCCCCCCCH
Q 002908 803 IVNNTL--------------------------------------------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSF 838 (867)
Q Consensus 803 iv~~~l--------------------------------------------r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa 838 (867)
+..... ..+.+..+++.+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 222111 112334578889999999999999999999
Q ss_pred HHHHHHHH
Q 002908 839 TEIARRLR 846 (867)
Q Consensus 839 ~ELLe~Lq 846 (867)
.+++++.+
T Consensus 329 ~ell~hp~ 336 (389)
T 3gni_B 329 STLLNHSF 336 (389)
T ss_dssp HHHTTSGG
T ss_pred HHHhcCHH
Confidence 99997743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=360.07 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=215.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+..++|++++.||+|+||.||++++. ++.||||++...... .......+.+|+.+|+.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-----cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44578999999999999999999984 788999999754211 11123567889999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|. +||+||
T Consensus 113 ~~--~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~----~kL~DF 185 (350)
T 1rdq_E 113 NS--NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY----IQVTDF 185 (350)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECCC
T ss_pred CC--EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC----EEEccc
Confidence 54 899999999999999998643 46899999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPG 814 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~ 814 (867)
|+++..... ....+||+.|+|||++. ...++.++|||||||++|+|++|..||...........+..... ..+.
T Consensus 186 g~a~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~ 259 (350)
T 1rdq_E 186 GFAKRVKGR--TWTLCGTPEALAPEIIL--SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPS 259 (350)
T ss_dssp TTCEECSSC--BCCCEECGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCT
T ss_pred ccceeccCC--cccccCCccccCHHHhc--CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCC
Confidence 999865443 23457999999999998 45678999999999999999999999998888777777776644 4566
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq 846 (867)
.+++.+.++|.+||+.||.+||+ +.+++++.+
T Consensus 260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 78999999999999999999998 899987764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=348.99 Aligned_cols=267 Identities=30% Similarity=0.527 Sum_probs=218.5
Q ss_pred ccccccccCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc
Q 002908 572 STLQIIKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 644 (867)
Q Consensus 572 ~~l~~I~~sdyqilk~LG~GafG~VYka~~-------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN 644 (867)
..++.+..++|++.+.||+|+||.||+|.+ .+..||||++.... .......+.+|+.+++.++|||
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ 94 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------SEQDELDFLMEALIISKFNHQN 94 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-------CHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-------chhhHHHHHHHHHHHhhCCCCC
Confidence 456678889999999999999999999984 35679999986321 1223457889999999999999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhccc------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceE
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 718 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNIL 718 (867)
|+++++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 95 iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIl 172 (327)
T 2yfx_A 95 IVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 172 (327)
T ss_dssp BCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCeEEEEEcCCC--CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEE
Confidence 999999998754 7899999999999999996543 35899999999999999999999999999999999999
Q ss_pred eccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCC
Q 002908 719 VNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANM 794 (867)
Q Consensus 719 Ld~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~ 794 (867)
++.++.. ..++|+|||++...... .......+|+.|+|||++. ...++.++|||||||++|+|+| |..||...
T Consensus 173 i~~~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 173 LTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp ESCSSTT-CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EecCCCc-ceEEECccccccccccccccccCCCcCCCcceeCHhHhc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 9966532 45799999999743221 1222345788999999997 3457899999999999999998 99999887
Q ss_pred ChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 795 HYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 795 ~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
........+.. ......+..++..+.++|.+||+.+|.+||++.+++++|+.+...
T Consensus 250 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 250 SNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 76665554443 344556678899999999999999999999999999999998653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=368.90 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=218.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|.+. ++.||||++......... ...+.+|+.+|++++||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------TSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH------HHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 468999999999999999999984 788999999754322211 356789999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+. ...+||+|||+
T Consensus 95 --~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~-~~~~kl~Dfg~ 170 (486)
T 3mwu_A 95 --SFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK-DCDIKIIDFGL 170 (486)
T ss_dssp --EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSST-TCCEEECSCSC
T ss_pred --EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCC-CCCEEEEECCc
Confidence 899999999999999888544 56999999999999999999999999999999999999976542 34679999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC--C
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--G 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip--~ 814 (867)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+....+..+.+ .
T Consensus 171 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (486)
T 3mwu_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (486)
T ss_dssp TTTBCCC----CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG
T ss_pred CeECCCCCccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC
Confidence 987655554556679999999999984 37899999999999999999999999988888887777766554443 4
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.+++.+.+||.+||+.+|.+|||+.+++++.+-..
T Consensus 248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 57899999999999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.38 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=198.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||+|.+ +++.||||+++... ........+..+...++.++||||+++++++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV------NSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc------CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 45678999999999999999999998 58889999997532 11222333445555678889999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCCCCCcE
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
... ..++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+
T Consensus 77 ~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~----~~ 149 (290)
T 3fme_A 77 REG--DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG----QV 149 (290)
T ss_dssp CSS--SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC----CE
T ss_pred ccC--CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC----CE
Confidence 754 8999999996 588776643 456799999999999999999999998 999999999999999765 46
Q ss_pred EEeecCCcccccCccccCCcCCCCCccCcccccc--CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhHhhc
Q 002908 730 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG--SSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNN 806 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g--~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~-~~e~l~~iv~~ 806 (867)
+|+|||++.............||+.|+|||++.. ....++.++|||||||++|+|++|..||.... ...........
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (290)
T 3fme_A 150 KMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 229 (290)
T ss_dssp EBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS
T ss_pred EEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc
Confidence 9999999986655544455579999999999732 14567899999999999999999999998643 33444444554
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.........+++.+.++|.+||+.+|.+|||+.+++++.+-..
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 230 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 4444445578999999999999999999999999999766543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.12 Aligned_cols=271 Identities=18% Similarity=0.162 Sum_probs=207.8
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHH------HHHHHHHHHHHHHhCC
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQER------LTLEFWREAEILSKLH 641 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~------~~~eflrEieiLk~L~ 641 (867)
..+...+|++.+.||+|+||.||+|.+. ++.||||++..... ....+. ....+..|+..+..++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~ 106 (364)
T 3op5_A 30 TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTELKFYQRAAKPEQIQKWIRTRKLK 106 (364)
T ss_dssp ECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH---HHHHHHHHHHHHCCHHHHHHHHHHTTCS
T ss_pred eccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch---hHHHHHHHHHhhhhhHHHHHHHHHhhcc
Confidence 3456779999999999999999999884 36799999875321 000110 0122445667788889
Q ss_pred CCceeeEecccccCC--CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEe
Q 002908 642 HPNVVAFYGVVQDGP--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 719 (867)
Q Consensus 642 HPNIVrL~g~~~~~~--~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILL 719 (867)
||||+++++++.... ....++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 107 h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 107 YLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185 (364)
T ss_dssp CCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEE
Confidence 999999999987642 24689999999 999999997766789999999999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEeecCCcccccCccc--------cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 002908 720 NLKDPIRPICKVGDFGLSKIKRNTLV--------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791 (867)
Q Consensus 720 d~dg~~~~~vKL~DFGLA~~~~~~~~--------~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF 791 (867)
+.+. ...+||+|||+++....... .....||+.|+|||++. ...++.++|||||||+||+|+||+.||
T Consensus 186 ~~~~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 186 NYKN--PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN--GVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp ESSC--TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred ecCC--CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC--CCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 8332 23569999999975433211 12345999999999998 445899999999999999999999999
Q ss_pred CCCChhHHHHhHhhcCCCC---------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 792 ANMHYGAIIGGIVNNTLRP---------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 792 ~~~~~~e~l~~iv~~~lr~---------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
................... .....++..+.+++..||+.+|.+||++.+|++.|+.+.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp GGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 8643222111111100000 0124678999999999999999999999999999999887654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.40 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=210.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~ 652 (867)
.+..++|++++.||+|+||.||+|++. ++.||||+++..... .......+.+|..++..+ +||||+++++++
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-----DDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC-----SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc-----chHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 345678999999999999999999984 788999999865432 122345677899999988 899999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.+.. .+++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 80 ~~~~--~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~----~kL~ 152 (345)
T 3a8x_A 80 QTES--RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH----IKLT 152 (345)
T ss_dssp ECSS--EEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC----EEEC
T ss_pred EeCC--EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC----EEEE
Confidence 8854 89999999999999998864 356999999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccc-cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHh
Q 002908 733 DFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM---------HYGAIIGG 802 (867)
Q Consensus 733 DFGLA~~~-~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~---------~~~e~l~~ 802 (867)
|||+++.. .........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ........
T Consensus 153 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 153 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred eccccccccCCCCcccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 99999853 22333455679999999999984 56789999999999999999999999652 22233334
Q ss_pred HhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCH------HHHHHHHH
Q 002908 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSF------TEIARRLR 846 (867)
Q Consensus 803 iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa------~ELLe~Lq 846 (867)
+.... ...+..++..+.+||.+||+.||.+||++ .+++.+.+
T Consensus 231 i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 231 ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred HHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 44433 34566789999999999999999999985 77776654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=372.52 Aligned_cols=258 Identities=34% Similarity=0.599 Sum_probs=220.9
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
.+.+...+|++.+.||+|+||.||+|.+. +..||||+++.... ...+|.+|+.+|++++||||++++++
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---------chHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 35678899999999999999999999995 77899999975321 13568899999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
|.... .+++||||+++++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 285 ~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----~~k 358 (495)
T 1opk_A 285 CTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH----LVK 358 (495)
T ss_dssp ECSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG----CEE
T ss_pred EecCC--cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC----cEE
Confidence 98754 789999999999999999753 35689999999999999999999999999999999999998765 469
Q ss_pred EeecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 731 VGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 731 L~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
|+|||+++...... ......++..|+|||++. ...++.++|||||||+||+|+| |..||........... +...
T Consensus 359 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~ 435 (495)
T 1opk_A 359 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKD 435 (495)
T ss_dssp ECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTT
T ss_pred EeecccceeccCCceeecCCCcCCcceeCHhHHh--cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcC
Confidence 99999998654322 223345678899999998 4458899999999999999999 9999998877665544 4556
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.+.+.+..+++.+.+||.+||+.+|.+|||+.+|++.|+.+.
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 677778889999999999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=368.84 Aligned_cols=261 Identities=34% Similarity=0.579 Sum_probs=217.1
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G-~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
.+.+..++|++.+.||+|+||.||+|.+.+ ..||||+++..... ...|.+|+.+|++++||||+++++++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~ 248 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVV 248 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 356788899999999999999999999964 57999999754211 24688999999999999999999998
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.. ...++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 249 ~~---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kl 321 (452)
T 1fmk_A 249 SE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----VCKV 321 (452)
T ss_dssp CS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEEE
T ss_pred cC---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC----CEEE
Confidence 76 2678999999999999999653 35689999999999999999999999999999999999998665 4699
Q ss_pred eecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCC
Q 002908 732 GDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 732 ~DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~l 808 (867)
+|||+++...... ......++..|+|||++. ...++.++|||||||+||+|++ |..||.+.........+ ....
T Consensus 322 ~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~ 398 (452)
T 1fmk_A 322 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGY 398 (452)
T ss_dssp CCCCTTC--------------CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTC
T ss_pred CCCccceecCCCceecccCCcccccccCHhHHh--cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCC
Confidence 9999998654321 223345778899999998 4568999999999999999999 99999988877766554 4456
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+.+.+..+++.+.+||.+||+.+|.+|||+.+|++.|+.+.....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 677788899999999999999999999999999999998765443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=368.77 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=215.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|++. +..||||+++........ ...+.+|+.+++.++||||++++++|....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS------NSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT------THHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH------HHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 457999999999999999999984 778999999865432211 246778999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++|||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+. ...+||+|||+
T Consensus 110 --~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~-~~~~kl~DfG~ 185 (494)
T 3lij_A 110 --NYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK-DALIKIVDFGL 185 (494)
T ss_dssp --EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSST-TCCEEECCCTT
T ss_pred --EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCC-CCcEEEEECCC
Confidence 899999999999999888543 56899999999999999999999999999999999999986553 34679999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC--C
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP--G 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip--~ 814 (867)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+....+..+.+ .
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred CeECCCCccccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence 987665555556779999999999863 47899999999999999999999999988888888777766654433 4
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.+++.+.+||.+||+.+|.+|||+.+++++.+-.
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 6789999999999999999999999999886654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=365.55 Aligned_cols=265 Identities=26% Similarity=0.354 Sum_probs=202.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
...++|.+.+.||+|+||.||+|.+. ++.||||++..................+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34578999999999999999999984 6789999998754433222223333457899999999999999999999864
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
. ..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ...+||+||
T Consensus 212 ~---~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~-~~~~kl~DF 286 (419)
T 3i6u_A 212 E---DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE-DCLIKITDF 286 (419)
T ss_dssp S---EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSS-SCCEEECCS
T ss_pred C---ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCC-cceEEEeec
Confidence 3 57899999999999998854 456999999999999999999999999999999999999986553 246799999
Q ss_pred CCcccccCccccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH-HhHhhcCCCC--
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVNNTLRP-- 810 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l-~~iv~~~lr~-- 810 (867)
|+++............||+.|+|||++.+ ....++.++|||||||++|+|++|..||........+ ..+.......
T Consensus 287 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 287 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp STTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred ccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 99987665555556779999999999863 2356788999999999999999999999765443222 2222222221
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.....+++.+.+||.+||+.+|.+|||+.+++++.+
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 112457899999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.76 Aligned_cols=265 Identities=31% Similarity=0.486 Sum_probs=209.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..++|.+.+.||+|+||.||+|.+. +..||||+++.... .......+.+|+.+++.++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS------SQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC------CHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc------chhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 466789999999999999999999873 34699999875421 1233467889999999999999999999
Q ss_pred ccccCCCC---eEEEEEEeecCCchhhhhhc-----ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccC
Q 002908 651 VVQDGPGG---TLATVTEFMVNGSLRHVLLS-----KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 722 (867)
Q Consensus 651 ~~~~~~~~---~l~LVmEy~~ggSL~d~L~~-----~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~d 722 (867)
++...... ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC
Confidence 98764322 46999999999999998842 33569999999999999999999999999999999999999976
Q ss_pred CCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhH
Q 002908 723 DPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGA 798 (867)
Q Consensus 723 g~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e 798 (867)
+. ++|+|||++....... ......+++.|+|||.+. ...++.++|||||||++|+|++ |..||.......
T Consensus 184 ~~----~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 184 MT----VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp SC----EEECSCSCC----------------CCGGGSCHHHHH--SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred Cc----EEEeecCcceecccccccCcccccCCCccccCchhhc--CCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 54 6999999997543321 122344778999999998 4568999999999999999999 999998877766
Q ss_pred HHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 799 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 799 ~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
....+... .....+..+++.+.++|.+||+.+|.+|||+.+++++|+.+.....
T Consensus 258 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 258 MYDYLLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 66554443 3455667889999999999999999999999999999999887654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=359.46 Aligned_cols=255 Identities=27% Similarity=0.359 Sum_probs=198.7
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 654 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~ 654 (867)
...+|++++.||+|+||.||+|.+ +++.||||++.... ........+.+|+.++..+. ||||+++++++..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF------QNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc------cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 346899999999999999999998 47889999986431 11233456789999999997 9999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.....+++|||||. ++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 81 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~----~kl~DF 153 (388)
T 3oz6_A 81 DNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH----VKVADF 153 (388)
T ss_dssp TTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEECCC
T ss_pred CCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC----EEecCC
Confidence 65668999999996 688888853 46899999999999999999999999999999999999997664 599999
Q ss_pred CCcccccC----------------------ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 002908 735 GLSKIKRN----------------------TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 792 (867)
Q Consensus 735 GLA~~~~~----------------------~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~ 792 (867)
|+++.... ........||+.|+|||++.+ ...++.++|||||||++|+|++|++||.
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-STKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-CCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 99975422 111233569999999999975 3568999999999999999999999999
Q ss_pred CCChhHHHHhHhhcCCCC---------------------------------------------CCCCCCcHHHHHHHHHh
Q 002908 793 NMHYGAIIGGIVNNTLRP---------------------------------------------PVPGFCDSEWRLLMEQC 827 (867)
Q Consensus 793 ~~~~~e~l~~iv~~~lr~---------------------------------------------~ip~~~s~eL~dLI~kC 827 (867)
+......+..+......+ ..+..+++.+.+||.+|
T Consensus 233 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 887766555543211110 01125688999999999
Q ss_pred hcCCCCCCCCHHHHHHHHH
Q 002908 828 WAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 828 Lq~DPeeRPSa~ELLe~Lq 846 (867)
|+.||.+|||+.+++++.+
T Consensus 313 L~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 313 LQFNPNKRISANDALKHPF 331 (388)
T ss_dssp CCSSGGGSCCHHHHTTSTT
T ss_pred hccCcccCCCHHHHhCCHH
Confidence 9999999999999998854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.72 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=211.6
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||+|.+ +++.||||++...... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-----KSDMHMRVEREISYLKLLRHPHIIKLYDVITTP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-----chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 347899999999999999999998 5788999999753211 111124678999999999999999999999885
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 82 ~--~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~----~kl~DFG 153 (336)
T 3h4j_B 82 T--DIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN----VKIADFG 153 (336)
T ss_dssp S--EEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC----EEECCSS
T ss_pred C--EEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC----EEEEEec
Confidence 4 899999999 78998888543 56999999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
++............+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...........+.. .....+..
T Consensus 154 ~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~ 230 (336)
T 3h4j_B 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVYVMPDF 230 (336)
T ss_dssp CTBTTTTSBTTCCCTTSTTTSCGGGSCCSG-GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS--SCCCCCTT
T ss_pred cceeccCCcccccccCCcCcCCHHHHcCCC-CCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCCCccc
Confidence 998766555556677999999999998532 237899999999999999999999987654433322222 12345667
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
+++.+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 899999999999999999999999999987753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=350.98 Aligned_cols=260 Identities=30% Similarity=0.574 Sum_probs=211.1
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC--CceE----EEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceee
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDV----AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~V----AVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVr 647 (867)
...+...+|++++.||+|+||.||+|.+. ++.| |+|.+...... .....+.+|+.+++.++||||++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~ 81 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-------KANKEILDEAYVMASVDNPHVCR 81 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC-------CCHHHHHHHHHHHTTCCBTTBCC
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH-------HHHHHHHHHHHHHHhCCCCCeeE
Confidence 34577889999999999999999999983 5544 66665432211 11356788999999999999999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
+++++... ..++||+|+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---- 154 (327)
T 3lzb_A 82 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---- 154 (327)
T ss_dssp CCEEEESS---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT----
T ss_pred EEEEEecC---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC----
Confidence 99999864 47889999999999999987777899999999999999999999999999999999999998765
Q ss_pred cEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhH
Q 002908 728 ICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 803 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~i 803 (867)
.++|+|||++....... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||...........
T Consensus 155 ~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~- 231 (327)
T 3lzb_A 155 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI- 231 (327)
T ss_dssp EEEECCTTC----------------CCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-
T ss_pred CEEEccCcceeEccCccccccccCCCccccccCHHHHc--CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-
Confidence 46999999998643322 222344678899999998 4568899999999999999999 9999988776665544
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 804 v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+......+.+..++..+.++|.+||+.+|.+||++.++++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 44445566677889999999999999999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=348.45 Aligned_cols=253 Identities=28% Similarity=0.395 Sum_probs=192.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||.||+|.+. ++.||||+++....... ...+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-------PSTAIREISLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-------CHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-------HHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence 468999999999999999999884 78899999975432111 245678999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKE-----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~-----~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 77 --~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~----~kl 149 (317)
T 2pmi_A 77 --KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ----LKL 149 (317)
T ss_dssp --EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEE
T ss_pred --eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC----EEE
Confidence 8999999996 68988875432 45899999999999999999999999999999999999997664 599
Q ss_pred eecCCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC-
Q 002908 732 GDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR- 809 (867)
Q Consensus 732 ~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr- 809 (867)
+|||++...... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...........+......
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 150 GDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred CcCccceecCCCcccCCCCcccccccCchHhhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999999865432 22334568999999999974 245789999999999999999999999988776655544321100
Q ss_pred -------------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 -------------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 -------------------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
...+..++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 0112246789999999999999999999999988644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.57 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=211.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||++.+ +++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 46899999999999999999998 4788999999754321 223467889999999999999999999886544
Q ss_pred CCeEEEEEEeecCCchhhhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCCcceEeccCCCCCCc
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~---~~Lse~~~l~Ia~QIa~ALayLHs~G-----IIHrDLKPsNILLd~dg~~~~~ 728 (867)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~---- 154 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---- 154 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC----
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC----
Confidence 558999999999999999986533 34899999999999999999999999 999999999999997654
Q ss_pred EEEeecCCcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC
Q 002908 729 CKVGDFGLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~ 807 (867)
++|+|||++....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 232 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232 (279)
T ss_dssp EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred EEEecCchheeeccccccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence 5999999998654321 1223458999999999984 467899999999999999999999999887766665555443
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
....+..++..+.++|.+||+.+|.+|||+.+++++++.
T Consensus 233 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 233 -FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 345666789999999999999999999999999987653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.45 Aligned_cols=261 Identities=32% Similarity=0.521 Sum_probs=214.6
Q ss_pred ccccCCeeEEE-EeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELK-ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk-~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+...+|++.+ .||+|+||.||+|.+. +..||||+++... .......++.+|+.+++.++||||+++++
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc------cCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45667899998 9999999999999762 5679999997542 12233467889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.. ...++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++
T Consensus 86 ~~~~---~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~----~~k 157 (291)
T 1xbb_A 86 ICEA---ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAK 157 (291)
T ss_dssp EEES---SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----EEE
T ss_pred EECC---CCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC----cEE
Confidence 9943 368899999999999999864 35689999999999999999999999999999999999999765 469
Q ss_pred EeecCCcccccCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~- 234 (291)
T 1xbb_A 158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE- 234 (291)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-
T ss_pred EccCCcceeeccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 999999985533211 122346788999999973 457889999999999999999 999999877766554443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
.......+..+++.+.++|.+||+.+|.+||++.++++.|+.+.....
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 235 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 344566677889999999999999999999999999999999987554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.60 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=205.3
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~ 655 (867)
.++|++.+.||+|+||.||+|.+. ++.||||+++..... ......+.+|+..+..+ +||||+++++++.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG------SVDEQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT------SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc------cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 468999999999999999999994 888999999754221 11235678899999999 899999999999885
Q ss_pred CCCeEEEEEEeecCCchhhhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC--------
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP-------- 724 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~---~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~-------- 724 (867)
. ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 84 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 84 D--HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp T--EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred C--eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 4 8999999999999999986542 56899999999999999999999999999999999999986651
Q ss_pred -------CCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh
Q 002908 725 -------IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG 797 (867)
Q Consensus 725 -------~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~ 797 (867)
....++|+|||++....... ...||+.|+|||++.+ ...++.++|||||||++|+|++|.+++.....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQE-NYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTT-CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred ccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcC-CCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 33468999999998655432 2358999999999984 33567899999999999999999887754432
Q ss_pred HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 798 AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 798 e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
...+. ....+..+..+++.+.++|.+||+.||.+|||+.+++++.+
T Consensus 237 --~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 237 --WHEIR-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp --HHHHH-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred --HHHHH-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 22222 23345566788999999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=359.21 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=212.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~ 652 (867)
.+..++|++.+.||+|+||.||+|+++ ++.||||+++..... .+.....+..|..++..+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-----hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 456789999999999999999999984 788999999764211 011134567788899876 899999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.+.. .+++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|. +||+
T Consensus 88 ~~~~--~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~----vkL~ 160 (345)
T 1xjd_A 88 QTKE--NLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH----IKIA 160 (345)
T ss_dssp ECSS--EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC----EEEC
T ss_pred EeCC--EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC----EEEe
Confidence 8854 89999999999999998864 356899999999999999999999999999999999999997764 5999
Q ss_pred ecCCccccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 733 DFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 733 DFGLA~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ..
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~ 236 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PF 236 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CC
Confidence 999998532 2233456779999999999984 457899999999999999999999999888877777766654 34
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHH-HHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFT-EIARRL 845 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~-ELLe~L 845 (867)
.+..+++.+.+||.+||+.+|.+||++. +++++.
T Consensus 237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 5667899999999999999999999997 776543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.27 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=190.3
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+ .++.||||++...... .......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-----KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-----hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 35799999999999999999998 5888999999753211 1112356889999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||+
T Consensus 85 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~----~kl~dfg~ 158 (278)
T 3cok_A 85 --YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN----IKIADFGL 158 (278)
T ss_dssp --EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC----EEECCCTT
T ss_pred --eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC----EEEEeecc
Confidence 899999999999999999776678999999999999999999999999999999999999997654 59999999
Q ss_pred cccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 737 SKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 737 A~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~ 234 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSF 234 (278)
T ss_dssp CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC--CCCCTT
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--cCCccc
Confidence 9865422 22234568999999999983 457889999999999999999999998766554444433322 334567
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
++..+.++|.+||+.||.+|||+.+++++.+
T Consensus 235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 8999999999999999999999999988644
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=346.65 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=204.3
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
...++|++.+.||+|+||.||+|++ .++.||||+++.... ........+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-----RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-----TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-----CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 3457899999999999999999997 478899999976432 223445678899999999999999999999875
Q ss_pred CCC--CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 655 GPG--GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 655 ~~~--~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
... ...++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~----~kl~ 158 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA----VKVM 158 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC----EEEC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC----EEEe
Confidence 322 2459999999999999998643 46899999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 733 DFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 733 DFGLA~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||.................
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 236 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHH--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhc--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC
Confidence 99999854332 1223456899999999998 45689999999999999999999999998887766655555443
Q ss_pred CCC--CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 809 RPP--VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 809 r~~--ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.++ ....++..+.++|.+||+.||.+||+..+++.+-.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 322 13457899999999999999999997666554433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=362.09 Aligned_cols=257 Identities=23% Similarity=0.405 Sum_probs=213.0
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
..+..++|++++.||+|+||.||++.+. ++.||||++...... .......+.+|+.+|+.++||||++++++|
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-----ERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-----cHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3566789999999999999999999984 677999999754211 111235678999999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.+.. .+++||||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|. ++|+
T Consensus 85 ~~~~--~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~----vkL~ 157 (384)
T 4fr4_A 85 QDEE--DMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH----VHIT 157 (384)
T ss_dssp ECSS--EEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEEC
T ss_pred EeCC--EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC----EEEe
Confidence 8854 89999999999999998864 456999999999999999999999999999999999999997764 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---hhHHHHhHhhcCC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMH---YGAIIGGIVNNTL 808 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~-~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~---~~e~l~~iv~~~l 808 (867)
|||++............+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.... .......+...
T Consensus 158 DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-- 235 (384)
T 4fr4_A 158 DFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-- 235 (384)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--
T ss_pred ccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--
Confidence 99999876655555677899999999999742 3457889999999999999999999997533 22333333332
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCC-HHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPS-FTEIARRL 845 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPS-a~ELLe~L 845 (867)
....+..+++.+.+||.+||+.+|.+||+ +.+++.+.
T Consensus 236 ~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp 273 (384)
T 4fr4_A 236 VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273 (384)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence 34456678999999999999999999998 78777643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.79 Aligned_cols=257 Identities=23% Similarity=0.398 Sum_probs=207.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||+|.+. ++.||||++..... ........+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-----RSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-----cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 455689999999999999999999984 88999999975321 11122456789999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 82 ~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~~l~d 154 (276)
T 2h6d_A 82 TPT--DFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN----AKIAD 154 (276)
T ss_dssp CSS--EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC----EEECC
T ss_pred cCC--eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC----EEEee
Confidence 754 899999999999999998643 46899999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
||++.............+++.|+|||++.+. ...+.++||||||+++|+|++|..||...........+.... ...+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~ 231 (276)
T 2h6d_A 155 FGLSNMMSDGEFLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIP 231 (276)
T ss_dssp CCGGGCCCC-------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCC
T ss_pred cccccccCCCcceecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--ccCc
Confidence 9999866554444455689999999999842 223689999999999999999999999887776666655443 3345
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..++..+.++|.+||+.+|.+|||+.+++++.+-
T Consensus 232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 6788999999999999999999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=357.33 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=213.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~ 652 (867)
.+..++|++++.||+|+||.||+|++. ++.||||+++..... .......+..|..++..+ .||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----cchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 456789999999999999999999995 577999999764221 111234567899999987 799999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.+.. .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|. +||+
T Consensus 91 ~~~~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~----vkL~ 163 (353)
T 2i0e_A 91 QTMD--RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH----IKIA 163 (353)
T ss_dssp ECSS--EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC----EEEC
T ss_pred EcCC--EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc----EEEE
Confidence 8854 899999999999999988643 46999999999999999999999999999999999999997764 5999
Q ss_pred ecCCccccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 733 DFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 733 DFGLA~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
|||+++... ........+||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+..... .
T Consensus 164 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~ 239 (353)
T 2i0e_A 164 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--A 239 (353)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHT--TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C
T ss_pred eCCcccccccCCcccccccCCccccChhhhc--CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--C
Confidence 999998532 233345677999999999998 45578999999999999999999999999888887777776654 3
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLR 846 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq 846 (867)
.+..+++.+.+||.+||+.+|.+||+ +.+++++.+
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 45678999999999999999999995 688877643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=368.81 Aligned_cols=265 Identities=29% Similarity=0.400 Sum_probs=219.1
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCC-----ChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGR-----SSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~-----~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
..++|+++++||+|+||+||+|.+. +..||||+++....... ....+.....+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999984 67899999986543211 0111123467889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.+.. .+++|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+|
T Consensus 114 ~~~~~~--~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~-~~~~k 189 (504)
T 3q5i_A 114 VFEDKK--YFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS-LLNIK 189 (504)
T ss_dssp EEECSS--EEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTC-CSSEE
T ss_pred EEEcCC--EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCC-CccEE
Confidence 998854 899999999999999988543 56999999999999999999999999999999999999997663 24679
Q ss_pred EeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
|+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+....+..
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999999987665555556679999999999873 47899999999999999999999999988888888777766544
Q ss_pred CCC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 811 PVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 811 ~ip--~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
+.+ ..+++.+.+||.+||+.+|.+|||+.+++++.+-..
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 332 467899999999999999999999999999877543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.28 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=201.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||.||+|.+. ++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR- 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc------cchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-
Confidence 67999999999999999999984 7889999986532 12334467789999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+++++|..++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++
T Consensus 76 -~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~ 149 (311)
T 4agu_A 76 -RLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS----VIKLCDFGFA 149 (311)
T ss_dssp -EEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTC
T ss_pred -eEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC----CEEEeeCCCc
Confidence 8999999999988888764 345689999999999999999999999999999999999999766 4599999999
Q ss_pred ccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc----------
Q 002908 738 KIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN---------- 806 (867)
Q Consensus 738 ~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~---------- 806 (867)
..... ........+|+.|+|||++.+ ...++.++|||||||++|+|++|..||...........+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 150 RLLTGPSDYYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp EECC------------GGGCCHHHHHT-CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhccCcccccCCCcCCccccChHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 86542 222334568999999999974 245789999999999999999999999887765544332211
Q ss_pred ---------CCCCCCC----------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 807 ---------TLRPPVP----------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 807 ---------~lr~~ip----------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....+.+ ..++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 0111111 246888999999999999999999999998744
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=367.67 Aligned_cols=255 Identities=28% Similarity=0.389 Sum_probs=207.8
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++++.||+|+||.||+|.+ .++.||||+++..... .......+.+|+.+++.++||||++++++|.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-----hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 45668899999999999999999998 4788999999754221 1122356778999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
... .+++||||+++++|..++.. ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++. +||+
T Consensus 219 ~~~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~----~kl~ 291 (446)
T 4ejn_A 219 THD--RLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH----IKIT 291 (446)
T ss_dssp ETT--EEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC----EEEC
T ss_pred eCC--EEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC----EEEc
Confidence 855 89999999999999988854 4579999999999999999999998 99999999999999997664 5999
Q ss_pred ecCCccccc-CccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 733 DFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 733 DFGLA~~~~-~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
|||+++... .........||+.|+|||++. ...++.++|||||||+||+|++|+.||...........+......
T Consensus 292 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-- 367 (446)
T 4ejn_A 292 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-- 367 (446)
T ss_dssp CCCCCCTTCC-----CCSSSCGGGCCHHHHH--TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--
T ss_pred cCCCceeccCCCcccccccCCccccCHhhcC--CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC--
Confidence 999998532 233344567999999999998 456899999999999999999999999988887777777665443
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
.+..+++.+.+||.+||+.||.+|| ++.+++++.+
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 4567899999999999999999999 9999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=353.50 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=218.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~ 655 (867)
.++|++.+.||+|+||.||+|.+. |+.||||++............+.....+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 367999999999999999999984 88999999976543222233345566788999999999 799999999999875
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||
T Consensus 173 ~--~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~----ikl~DfG 245 (365)
T 2y7j_A 173 S--FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ----IRLSDFG 245 (365)
T ss_dssp S--EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC----EEECCCT
T ss_pred C--EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC----EEEEecC
Confidence 4 89999999999999998864 356899999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccC----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~----~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
++.............||+.|+|||++.+. ...++.++|||||||++|+|++|..||...........+........
T Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred cccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99866554445567799999999998642 23578899999999999999999999988777666666665554433
Q ss_pred CC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 812 VP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 812 ip--~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.+ ..++..+.+||.+||+.||.+|||+.+++++.
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 22 45788899999999999999999999998864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=369.65 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=215.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++++.||+|+||.||+|++. ++.||||+++....... .....+.+|+.+++.++||||++++++|.
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-----SDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----CCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 355689999999999999999999984 77899999975321100 01134678999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. .+++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 140 ~~~--~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~----ikL~D 211 (410)
T 3v8s_A 140 DDR--YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH----LKLAD 211 (410)
T ss_dssp CSS--EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECC
T ss_pred ECC--EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC----EEEec
Confidence 854 89999999999999998853 46899999999999999999999999999999999999997764 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccCCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC--
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSS--KVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-- 807 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~--~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-- 807 (867)
||+++...... .....+||+.|+|||++.+... .++.++|||||||+||+|++|..||...........++...
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc
Confidence 99998654332 2345679999999999985322 26789999999999999999999999888877777776543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLRV 847 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPee--RPSa~ELLe~Lq~ 847 (867)
...+....+++.+.+||.+||+.+|.+ ||++.+|+++.+-
T Consensus 292 ~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 292 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 334444578999999999999999988 9999999988654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=361.89 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=208.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~ 652 (867)
.+..++|+++++||+|+||.||+|++. ++.||||+++....... .....+.+|..+|.++ +||||++++++|
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~-----~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-----EDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-----HHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 456789999999999999999999984 67899999987543321 1224566888899877 899999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.+.. .+++||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|. +||+
T Consensus 123 ~~~~--~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~----ikL~ 195 (396)
T 4dc2_A 123 QTES--RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH----IKLT 195 (396)
T ss_dssp ECSS--EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC----EEEC
T ss_pred EECC--EEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC----EEEe
Confidence 8854 89999999999999988864 356999999999999999999999999999999999999997764 5999
Q ss_pred ecCCccc-ccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---------hhHHHHh
Q 002908 733 DFGLSKI-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH---------YGAIIGG 802 (867)
Q Consensus 733 DFGLA~~-~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~---------~~e~l~~ 802 (867)
|||+++. ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......
T Consensus 196 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 196 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred ecceeeecccCCCccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 9999985 333344556789999999999984 567899999999999999999999996432 1223334
Q ss_pred HhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCH------HHHHHHHH
Q 002908 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSF------TEIARRLR 846 (867)
Q Consensus 803 iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa------~ELLe~Lq 846 (867)
+... ....+..++..+.+||.+||+.||.+||++ .+++++.+
T Consensus 274 i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 274 ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp HHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred Hhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 4443 344566789999999999999999999985 67776654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.34 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=208.7
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
.|...+.||+|+||.||+|++ .|+.||||++...... ....+.+|+.+++.++||||+++++++....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 115 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--------RRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-- 115 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------SHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--------HHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 477888999999999999998 4889999999754211 1245778999999999999999999998855
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~----~kl~Dfg~~~ 189 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR----VKLSDFGFCA 189 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----EEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc----EEEeeeeeee
Confidence 89999999999999998853 46899999999999999999999999999999999999997664 5999999998
Q ss_pred cccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC-CCCCCCC
Q 002908 739 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-PPVPGFC 816 (867)
Q Consensus 739 ~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr-~~ip~~~ 816 (867)
..... .......||+.|+|||++. ...++.++|||||||++|+|++|..||...........+...... ......+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVIS--RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGS
T ss_pred ecccCccccccccCCccccCHhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccC
Confidence 65432 2334567999999999998 456789999999999999999999999887776666555543321 2223457
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
++.+.++|.+||+.+|.+|||+.+++++.+-
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 8999999999999999999999999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=369.08 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=222.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||+|.+ +++.||||++......... ....+.+|+.++++++||||+++++++.
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT-----DKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSS-----CHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccch-----HHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 44567899999999999999999998 4788999999765432211 1356789999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|
T Consensus 97 ~~~--~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~D 172 (484)
T 3nyv_A 97 DKG--YFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIID 172 (484)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECC
T ss_pred eCC--EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-CCCcEEEEe
Confidence 854 899999999999999988643 4689999999999999999999999999999999999996433 234679999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+....+..+.+
T Consensus 173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 249 (484)
T 3nyv_A 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP 249 (484)
T ss_dssp TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred eeeeEEcccccccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 999986655444444569999999999974 47899999999999999999999999988888888877776655443
Q ss_pred --CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 814 --GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 814 --~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
..+++.+.+||.+||+.+|.+|||+.+++++.+-..
T Consensus 250 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 250 QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 457899999999999999999999999999887644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=350.79 Aligned_cols=259 Identities=25% Similarity=0.309 Sum_probs=200.5
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
...++|++.+.||+|+||+||+|.+ +++.||||+++.... .......+.+|+.+++.++||||+++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE------EEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc------ccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence 4457899999999999999999987 478899999975422 22234567789999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCC-CCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg-~~~~~vKL~D 733 (867)
.. ..++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .....+||+|
T Consensus 105 ~~--~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 105 NH--RLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp TT--EEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred CC--EEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 54 8999999996 5999888543 4589999999999999999999999999999999999997655 3455689999
Q ss_pred cCCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 734 FGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 734 FGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
||++...... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||........+..+......++.
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcC-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 9999854322 22334568999999999974 235789999999999999999999999988776665555432111110
Q ss_pred ----------------------------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 813 ----------------------------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 813 ----------------------------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+..+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 0116788999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.85 Aligned_cols=258 Identities=24% Similarity=0.328 Sum_probs=209.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC--CceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--PNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H--PNIVrL~g~~ 652 (867)
.+...+|++++.||+|+||.||++.+ .++.||||++..... .......+.+|+.+|..++| |||+++++++
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc------chHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 35567899999999999999999988 467899999975421 22334678899999999986 9999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.... ..++|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+
T Consensus 79 ~~~~--~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-----~~~kl~ 149 (343)
T 3dbq_A 79 ITDQ--YIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-----GMLKLI 149 (343)
T ss_dssp ECSS--EEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-----TEEEEC
T ss_pred eeCC--EEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-----CcEEEe
Confidence 8754 89999995 58899999864 456899999999999999999999999999999999999972 247999
Q ss_pred ecCCcccccCcc---ccCCcCCCCCccCcccccc---------CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HH
Q 002908 733 DFGLSKIKRNTL---VTGGVRGTLPWMAPELLNG---------SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AI 799 (867)
Q Consensus 733 DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g---------~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~ 799 (867)
|||++....... ......||+.|+|||++.+ ....++.++|||||||++|+|++|+.||...... ..
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 229 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence 999998654322 2234569999999999863 1256789999999999999999999999875433 44
Q ss_pred HHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 800 l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
...+.........+...+..+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 4555555666677778889999999999999999999999999987753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.55 Aligned_cols=265 Identities=33% Similarity=0.516 Sum_probs=215.6
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceee
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~------~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVr 647 (867)
...+...+|++++.||+|+||.||++.+ .++.||||++.... ......+.+|+.+++.++||||++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~ 106 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------EEHLRDFEREIEILKSLQHDNIVK 106 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--------SHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeee
Confidence 3456678899999999999999999985 47789999986421 122457889999999999999999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
+++++.......+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~---- 182 (326)
T 2w1i_A 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---- 182 (326)
T ss_dssp EEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT----
T ss_pred EEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC----
Confidence 9999876555578999999999999999977666799999999999999999999999999999999999999765
Q ss_pred cEEEeecCCcccccCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh------
Q 002908 728 ICKVGDFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------ 797 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~------ 797 (867)
.++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|+||..||......
T Consensus 183 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~ 260 (326)
T 2w1i_A 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260 (326)
T ss_dssp EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC
T ss_pred cEEEecCcchhhccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc
Confidence 469999999986543221 223446778999999984 45789999999999999999999998643111
Q ss_pred ---------HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 798 ---------AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 798 ---------e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
..+...+....+.+.+..+++.+.++|.+||+.+|.+|||+.++++.|+.+....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 261 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp TTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1122334444556677789999999999999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.14 Aligned_cols=253 Identities=26% Similarity=0.335 Sum_probs=195.3
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||+|.+. ++.||||+++... ....+.+|+.+++.++||||+++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----------hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 4568999999999999999999995 6779999997532 124567899999999999999999999885
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||
T Consensus 121 ~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~-~~~~~kl~Dfg 196 (349)
T 2w4o_A 121 T--EISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA-PDAPLKIADFG 196 (349)
T ss_dssp S--EEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS-TTCCEEECCCC
T ss_pred C--eEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC-CCCCEEEccCc
Confidence 4 89999999999999998864 34689999999999999999999999999999999999998522 13457999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhhcCCCC--CC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRP--PV 812 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~~~lr~--~i 812 (867)
++.............||+.|+|||++. ...++.++|||||||++|+|++|..||....... ....+....... +.
T Consensus 197 ~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 274 (349)
T 2w4o_A 197 LSKIVEHQVLMKTVCGTPGYCAPEILR--GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274 (349)
T ss_dssp ----------------CGGGSCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT
T ss_pred cccccCcccccccccCCCCccCHHHhc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch
Confidence 998665544444567999999999998 4467899999999999999999999997765544 444444443332 22
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
...++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 3567899999999999999999999999988644
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=336.31 Aligned_cols=262 Identities=22% Similarity=0.276 Sum_probs=208.8
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.+++.++|++++..+.++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----------CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----------hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 457899999999999999999997 5889999998754221 2467899999999998877666665432
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+|||
T Consensus 77 -~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl~Dfg 153 (296)
T 3uzp_A 77 -GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFG 153 (296)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCT
T ss_pred -CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCC-CCCeEEEeeCC
Confidence 34889999999 9999999976667899999999999999999999999999999999999995211 12346999999
Q ss_pred CcccccCccc--------cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh---hHHHHhHh
Q 002908 736 LSKIKRNTLV--------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY---GAIIGGIV 804 (867)
Q Consensus 736 LA~~~~~~~~--------~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~---~e~l~~iv 804 (867)
++........ .....||+.|+|||++. ...++.++|||||||++|+|++|+.||..... ......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence 9986543321 23456999999999998 45589999999999999999999999976432 12222222
Q ss_pred hcCCCCC---CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 805 NNTLRPP---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 805 ~~~lr~~---ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
......+ ....+++.+.+++.+||+.+|.+|||+.++++.|+.+......
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 2211111 2356789999999999999999999999999999999876653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=346.69 Aligned_cols=250 Identities=29% Similarity=0.447 Sum_probs=195.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC-
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP- 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~- 656 (867)
++|++.+.||+|+||.||+|++ +++.||||+++.... +.....+.+|+.+|++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-------ELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-------TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 5799999999999999999998 478899999975421 112356889999999999999999999875432
Q ss_pred ------------------------------------------------------CCeEEEEEEeecCCchhhhhhccc--
Q 002908 657 ------------------------------------------------------GGTLATVTEFMVNGSLRHVLLSKE-- 680 (867)
Q Consensus 657 ------------------------------------------------------~~~l~LVmEy~~ggSL~d~L~~~~-- 680 (867)
...+++||||+++++|.+++....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 124899999999999999986543
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc-------------cccC
Q 002908 681 RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-------------LVTG 747 (867)
Q Consensus 681 ~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~-------------~~~s 747 (867)
...++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ....
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCCTTCEECSCC--------------CCC
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC----CEEEeecCcccccccchhhcccccccccccccc
Confidence 3467778899999999999999999999999999999999766 4699999999865432 1223
Q ss_pred CcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHh
Q 002908 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQC 827 (867)
Q Consensus 748 ~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kC 827 (867)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..|+... ......... ...+......++.+.+||.+|
T Consensus 235 ~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN-LKFPLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCC-CGGGSCHHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT-TCCCHHHHHHCHHHHHHHHHH
T ss_pred ccCCCcCccChHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc-cCCCcccccCChhHHHHHHHH
Confidence 4569999999999984 46789999999999999999987764221 111222221 111112233467789999999
Q ss_pred hcCCCCCCCCHHHHHHHH
Q 002908 828 WAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 828 Lq~DPeeRPSa~ELLe~L 845 (867)
|+.||.+|||+.+++++.
T Consensus 310 l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENA 327 (332)
T ss_dssp HCSSGGGSCCHHHHHHST
T ss_pred ccCCCCcCCCHHHHhhch
Confidence 999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=362.99 Aligned_cols=268 Identities=22% Similarity=0.297 Sum_probs=215.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+...+|++.+.||+|+||.||+|++. ++.||||+++...... ....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 77 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-------PVDVQMREFEVLKKLNHKNIVKLFAIEE 77 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-------hHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence 345678999999999999999999995 7889999997543221 1345678999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccc--cCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~--~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.......++||||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+..+......+||
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEE
Confidence 7666688999999999999999865433 38999999999999999999999999999999999998433334456899
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccC------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCC----hhHHHH
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS------SSKVSEKVDVFSFGIVLWEILTGEEPYANMH----YGAIIG 801 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~------~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~----~~e~l~ 801 (867)
+|||+++............||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.... ....+.
T Consensus 158 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 999999876655555567799999999998631 1346789999999999999999999996532 234444
Q ss_pred hHhhcCCC-------------------CC----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 802 GIVNNTLR-------------------PP----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 802 ~iv~~~lr-------------------~~----ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.+...... .+ ....++..+.+++.+||+.||++||++.++++.++.+..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 44433211 01 112345678899999999999999999999999988765
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=355.16 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=209.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~ 655 (867)
.++|++.+.||+|+||.||+|.+. ++.||||++..... .+.+|++++.++ +||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------------DPTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------------CCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------------ChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 467999999999999999999984 78899999975421 123577788777 799999999999885
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. .+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+.........+||+|||
T Consensus 89 ~--~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 89 K--YVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp S--EEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred C--EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 4 899999999999999988643 5699999999999999999999999999999999999996554334568999999
Q ss_pred CcccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC---ChhHHHHhHhhcCCCCC
Q 002908 736 LSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM---HYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 736 LA~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~---~~~e~l~~iv~~~lr~~ 811 (867)
++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ........+.......+
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 243 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence 9985433 223345678999999999984 34788999999999999999999999763 34455555555544332
Q ss_pred --CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 812 --VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 812 --ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
....+++.+.+||.+||+.||.+|||+.+++++.+-..
T Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 23568999999999999999999999999999887643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=334.83 Aligned_cols=261 Identities=23% Similarity=0.278 Sum_probs=217.7
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCC-hHHHHHHHHHHHHHHHHHhCC-CCceeeEecccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRS-SEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 653 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~-~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~ 653 (867)
..++|++.+.||+|+||.||+|.+ +++.||||++......... .........+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999998 4788999999764321111 223445567889999999995 999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||+|+|||++.++. ++|+|
T Consensus 95 ~~~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~kl~d 167 (298)
T 1phk_A 95 TNT--FFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN----IKLTD 167 (298)
T ss_dssp CSS--EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC----EEECC
T ss_pred cCC--eEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc----EEEec
Confidence 744 89999999999999999864 356899999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCcccccc----CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNG----SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g----~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
||++.............+++.|+|||++.+ ....++.++||||||+++|+|++|..||...........+......
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 999986655444455678999999999852 1345788999999999999999999999888777766666666554
Q ss_pred CCCC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 810 PPVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 810 ~~ip--~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.+.+ ..++..+.++|.+||+.+|.+|||+.+++++.
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 4433 35789999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=370.67 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=215.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|+++++||+|+||+||+|++. ++.||||+++..... .......+.+|+.++..++||||++++++|.
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-----KRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-----HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh-----hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 356689999999999999999999984 678999999753211 0111123778999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. .+++|||||++++|.+++......+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|
T Consensus 145 ~~~--~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~----vkL~D 218 (437)
T 4aw2_A 145 DDN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH----IRLAD 218 (437)
T ss_dssp CSS--EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECC
T ss_pred eCC--EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC----EEEcc
Confidence 854 899999999999999999776678999999999999999999999999999999999999997764 59999
Q ss_pred cCCcccccCc--cccCCcCCCCCccCcccccc---CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 734 FGLSKIKRNT--LVTGGVRGTLPWMAPELLNG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 734 FGLA~~~~~~--~~~s~~~GT~~Y~APEvl~g---~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
||+++..... ......+||+.|+|||++.+ ....++.++|||||||++|||++|+.||...........++....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 9999754332 22334679999999999862 234578999999999999999999999999888777777665332
Q ss_pred CCCCC---CCCcHHHHHHHHHhhcCCCCC--CCCHHHHHHHHHH
Q 002908 809 RPPVP---GFCDSEWRLLMEQCWAPDPVV--RPSFTEIARRLRV 847 (867)
Q Consensus 809 r~~ip---~~~s~eL~dLI~kCLq~DPee--RPSa~ELLe~Lq~ 847 (867)
....+ ..+++.+.+||++||..+|.+ ||++++++++.+-
T Consensus 299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 22223 458999999999999988888 9999999987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.86 Aligned_cols=262 Identities=22% Similarity=0.276 Sum_probs=204.4
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.+++.++|++++..+.++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----------CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----------hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 457899999999999999999997 5788999987653221 2466799999999998877776665432
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+|||
T Consensus 77 -~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg 153 (296)
T 4hgt_A 77 -GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFG 153 (296)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG-GTTCEEECCCT
T ss_pred -CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC-CCCeEEEecCc
Confidence 34889999999 9999999976667799999999999999999999999999999999999993211 12346999999
Q ss_pred CcccccCcc--------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHhHh
Q 002908 736 LSKIKRNTL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGIV 804 (867)
Q Consensus 736 LA~~~~~~~--------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---e~l~~iv 804 (867)
++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...... .....+.
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhc--CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 998654322 123456899999999998 445899999999999999999999999764322 2222222
Q ss_pred hcCCCCC---CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 805 NNTLRPP---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 805 ~~~lr~~---ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
......+ ....+++.+.++|.+||+.+|.+|||+.++++.|+.+......
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 2211111 1245789999999999999999999999999999999877654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.59 Aligned_cols=261 Identities=27% Similarity=0.368 Sum_probs=203.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. ++.||||++..................+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 468999999999999999999984 68899999976543221122222335678999999999999999999998764
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ...++|+|||+
T Consensus 88 --~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~-~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 --DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE-DCLIKITDFGH 163 (322)
T ss_dssp --SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSS-SCCEEECCCTT
T ss_pred --ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCC-CCeEEEccCcc
Confidence 37999999999999998853 456899999999999999999999999999999999999987653 24579999999
Q ss_pred cccccCccccCCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhhcCCCC--CC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRP--PV 812 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~~~lr~--~i 812 (867)
+.............||+.|+|||++.+ ....++.++|||||||++|+|++|..||....... ....+....... ..
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 987654433334568999999999742 23457889999999999999999999997654332 222222222211 11
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
...++..+.+||.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 24578999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.89 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=214.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||+|.+. +..||||++...... .......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-----KEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-----hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 345678999999999999999999984 677999999753211 1112356789999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 85 ~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~kl~D 157 (284)
T 2vgo_A 85 DRK--RIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE----LKIAD 157 (284)
T ss_dssp CSS--EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC----EEECC
T ss_pred cCC--EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC----EEEec
Confidence 754 899999999999999988643 46899999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
||++....... .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.... ...+
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~ 232 (284)
T 2vgo_A 158 FGWSVHAPSLR-RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFP 232 (284)
T ss_dssp CTTCEECSSSC-BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCC
T ss_pred ccccccCcccc-cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--cCCC
Confidence 99987554322 234568999999999984 457889999999999999999999999887766666555443 3455
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..++..+.++|.+||+.+|.+||++.+++++.+-.
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 67899999999999999999999999999986654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.13 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=208.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.....+|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWD 74 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence 344578999999999999999999995 8899999997532 24567999999999999999999875
Q ss_pred c--------------CCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceE
Q 002908 654 D--------------GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 718 (867)
Q Consensus 654 ~--------------~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNIL 718 (867)
. .....+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence 4 1134689999999999999998654 357999999999999999999999999999999999999
Q ss_pred eccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH
Q 002908 719 VNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 798 (867)
Q Consensus 719 Ld~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e 798 (867)
++.++ .++|+|||++.............+|+.|+|||++. ...++.++|||||||++|+|++|..||... ..
T Consensus 155 ~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~ 226 (284)
T 2a19_B 155 LVDTK----QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS--SQDYGKEVDLYALGLILAELLHVCDTAFET--SK 226 (284)
T ss_dssp EEETT----EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH--CSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HH
T ss_pred EcCCC----CEEECcchhheeccccccccccCCcccccChhhhc--cCCCcchhhhHHHHHHHHHHHhcCCcchhH--HH
Confidence 99765 46999999998665544445567999999999998 455789999999999999999999887432 11
Q ss_pred HHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 799 IIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 799 ~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
....+.. ...+..++..+.++|.+||+.+|.+|||+.+++++|+.+.....
T Consensus 227 ~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 227 FFTDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHHHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 2222222 22445678999999999999999999999999999998865443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=368.80 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=219.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|.+.+.||+|+||.||+|.+. |+.||||++...... .......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-----SLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-----HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455678999999999999999999984 889999999753211 1122356889999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... .+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 87 ~~~--~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~----vkL~D 159 (476)
T 2y94_A 87 TPS--DIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN----AKIAD 159 (476)
T ss_dssp CSS--EEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC----EEECC
T ss_pred ECC--EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC----eEEEe
Confidence 854 89999999999999999864 456999999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
||++............+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...........+..... ..+
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p 236 (476)
T 2y94_A 160 FGLSNMMSDGEFLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--YTP 236 (476)
T ss_dssp CSSCEECCTTCCBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--CCC
T ss_pred ccchhhccccccccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--CCC
Confidence 9999876554445566799999999999853 2347899999999999999999999998887777777665543 345
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 237 ~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 237 QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 6789999999999999999999999999997664
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.10 Aligned_cols=258 Identities=33% Similarity=0.516 Sum_probs=203.4
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
.+..++|++.+.||+|+||.||+|.+ +++.||||++........ ...+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-------CCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred HHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-------HHHHHHHHHHHHhccCCCccceEEEEec
Confidence 45668899999999999999999987 478899999975432211 1257889999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCCcceEeccCCCCCCc
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSK---NIVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~---~~Lse~~~l~Ia~QIa~ALayLHs~---GIIHrDLKPsNILLd~dg~~~~~ 728 (867)
.. ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.
T Consensus 99 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~---- 172 (326)
T 3uim_A 99 PT--ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---- 172 (326)
T ss_dssp SS--CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC----
T ss_pred CC--ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC----
Confidence 54 7889999999999999986543 3499999999999999999999999 9999999999999996654
Q ss_pred EEEeecCCcccccC--ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC----h----hH
Q 002908 729 CKVGDFGLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH----Y----GA 798 (867)
Q Consensus 729 vKL~DFGLA~~~~~--~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~----~----~e 798 (867)
++|+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... . ..
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 59999999986532 223344569999999999974 457899999999999999999999995211 0 01
Q ss_pred HHHhHhhc---------CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 799 IIGGIVNN---------TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 799 ~l~~iv~~---------~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
........ ......+...+..+.+++.+||+.+|.+|||+.+++++|+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 11111111 111112222347799999999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=352.21 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=205.6
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..++|++.+.||+|+||.||+|.+. ++.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--------QGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--------SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 3467888999999999999999984 78899998864321 12356789999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~---~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 109 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~D 182 (321)
T 2qkw_B 109 --EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF----VPKITD 182 (321)
T ss_dssp --CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC----CEEECC
T ss_pred --eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC----CEEEee
Confidence 8899999999999999986443 3589999999999999999999999999999999999998665 459999
Q ss_pred cCCcccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH---H----HhH
Q 002908 734 FGLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI---I----GGI 803 (867)
Q Consensus 734 FGLA~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~---l----~~i 803 (867)
||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ . ...
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred cccccccccccccccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 999975432 122234458999999999974 4578999999999999999999999976432211 0 000
Q ss_pred h--------hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 804 V--------NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 804 v--------~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
. ........+..++..+.+++.+||+.+|.+|||+.+++++|+.+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 0 1111112223346779999999999999999999999999998865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.17 Aligned_cols=261 Identities=31% Similarity=0.543 Sum_probs=202.6
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC--CCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL--HHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L--~HPNIVrL~g~~ 652 (867)
.....++|++.+.||+|+||.||+|.++++.||||++.... ...+.+|.+++..+ +||||+++++++
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----------EASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----------cchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 34456789999999999999999999999999999986431 12334455565554 899999999998
Q ss_pred ccCCC--CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC--------CeeccCCCCcceEeccC
Q 002908 653 QDGPG--GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLK 722 (867)
Q Consensus 653 ~~~~~--~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~--------GIIHrDLKPsNILLd~d 722 (867)
..... ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.+
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 76522 488999999999999999953 4689999999999999999999998 99999999999999976
Q ss_pred CCCCCcEEEeecCCcccccCccc-----cCCcCCCCCccCccccccCCCCCC----hhhHHHHHHHHHHHHHhC------
Q 002908 723 DPIRPICKVGDFGLSKIKRNTLV-----TGGVRGTLPWMAPELLNGSSSKVS----EKVDVFSFGIVLWEILTG------ 787 (867)
Q Consensus 723 g~~~~~vKL~DFGLA~~~~~~~~-----~s~~~GT~~Y~APEvl~g~~~~~S----~kSDVWSLGvLLyELLTG------ 787 (867)
+ .+||+|||++........ .....||+.|+|||++.+...... .++|||||||++|+|+||
T Consensus 179 ~----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 179 G----TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp S----CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred C----CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 6 469999999975433221 124569999999999974322211 249999999999999999
Q ss_pred ----CCCCCCCCh-----hHHHHhHhhcCCCCCCCC-----CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 788 ----EEPYANMHY-----GAIIGGIVNNTLRPPVPG-----FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 788 ----k~PF~~~~~-----~e~l~~iv~~~lr~~ip~-----~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
..||..... ......+.....++..+. .+++.+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 667654321 222222333333444443 45678999999999999999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=357.20 Aligned_cols=254 Identities=25% Similarity=0.323 Sum_probs=198.9
Q ss_pred cCCeeEE-EEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHH-hCCCCceeeEeccccc
Q 002908 579 NEDLEEL-KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHHPNVVAFYGVVQD 654 (867)
Q Consensus 579 ~sdyqil-k~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk-~L~HPNIVrL~g~~~~ 654 (867)
.++|.+. +.||+|+||+||++.+. ++.||||++... ..+.+|+.++. .++||||++++++|..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 3567776 78999999999999984 788999999632 24557787774 4589999999998864
Q ss_pred --CCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 655 --GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 655 --~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.....+++|||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+. ...+||
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~~~~kl 205 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP-NAILKL 205 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSST-TCCEEE
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCC-CccEEE
Confidence 22347899999999999999997543 46999999999999999999999999999999999999997432 346799
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh----HHHHhHhhcC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG----AIIGGIVNNT 807 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~----e~l~~iv~~~ 807 (867)
+|||+++...........+||+.|+|||++. ...++.++|||||||+||+|++|..||...... .....+....
T Consensus 206 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp CCCTTCEECC-----------CTTCCGGGSC--CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred EecccccccCCCCccccCCCCCCccCHhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 9999998665444445567899999999997 456889999999999999999999999765432 1333444444
Q ss_pred CCCCC--CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 808 LRPPV--PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 808 lr~~i--p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
+..+. ...++..+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 43333 246899999999999999999999999999988764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=366.24 Aligned_cols=259 Identities=22% Similarity=0.283 Sum_probs=213.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++++.||+|+||.||++++ +++.||||++++... ........+.+|..++..++||||++++++|.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~-----~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM-----LKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45678999999999999999999998 478899999975311 11112234778999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
+.. .+++||||+++++|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 132 ~~~--~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~----vkL~D 205 (412)
T 2vd5_A 132 DEN--YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH----IRLAD 205 (412)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECC
T ss_pred eCC--EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC----EEEee
Confidence 854 899999999999999999766667999999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCcc--ccCCcCCCCCccCccccccC-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc
Q 002908 734 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGS-----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806 (867)
Q Consensus 734 FGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~-----~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~ 806 (867)
||+++...... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...........++..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99998654322 23346799999999998731 235789999999999999999999999988877776666643
Q ss_pred C--CC-CCCCCCCcHHHHHHHHHhhcCCCCCC---CCHHHHHHHHH
Q 002908 807 T--LR-PPVPGFCDSEWRLLMEQCWAPDPVVR---PSFTEIARRLR 846 (867)
Q Consensus 807 ~--lr-~~ip~~~s~eL~dLI~kCLq~DPeeR---PSa~ELLe~Lq 846 (867)
. .. +..+..+++.+.+||.+||. +|.+| |++.+++++-+
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 2 22 22345789999999999999 99998 69999987755
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.70 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=216.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.-..+.|++++.||+|+||.||+|.+ .++.||||++....... ....+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 90 (303)
T 3a7i_A 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-------EIEDIQQEITVLSQCDSPYVTKYYGSYL 90 (303)
T ss_dssp ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-------THHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-------HHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 34457799999999999999999988 47889999997643221 1356789999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 91 ~~~--~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~kl~D 162 (303)
T 3a7i_A 91 KDT--KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE----VKLAD 162 (303)
T ss_dssp ETT--EEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECC
T ss_pred cCC--eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC----EEEee
Confidence 754 89999999999999998853 56899999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 734 FGLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 734 FGLA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...........+.. ......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 239 (303)
T 3a7i_A 163 FGVAGQLTDTQIKRNTFVGTPFWMAPEVIK--QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTL 239 (303)
T ss_dssp CTTCEECBTTBCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCC
T ss_pred cccceecCccccccCccCCCcCccCHHHHh--cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCCC
Confidence 99998654322 234456899999999998 45678899999999999999999999988776655544433 334556
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+..++..+.+||.+||+.+|.+|||+.+++++.+-...
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 67789999999999999999999999999998776544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=337.64 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=206.1
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+.....++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~ 91 (314)
T 3com_A 22 SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVVKYYG 91 (314)
T ss_dssp --------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----------CHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----------HHHHHHHHHHHHhCCCCCCccEEE
Confidence 344556788999999999999999999985 78899999975321 245778999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.... ..++||||+.+++|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||++.++. ++
T Consensus 92 ~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~k 165 (314)
T 3com_A 92 SYFKNT--DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH----AK 165 (314)
T ss_dssp EEEETT--EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----EE
T ss_pred EEEeCC--EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC----EE
Confidence 998754 899999999999999998766678999999999999999999999999999999999999997664 59
Q ss_pred EeecCCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-
Q 002908 731 VGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL- 808 (867)
Q Consensus 731 L~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l- 808 (867)
|+|||++...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (314)
T 3com_A 166 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP 243 (314)
T ss_dssp ECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred EeecccchhhhhhccccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc
Confidence 9999999755432 22334568999999999984 4578899999999999999999999988776555444333321
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
....+..++..+.+||.+||+.+|.+|||+.+++++.+-
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 223345678999999999999999999999999886553
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=372.64 Aligned_cols=259 Identities=35% Similarity=0.583 Sum_probs=220.5
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G-~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
+.+..++|++.+.||+|+||.||+|.+.+ ..||||+++..... ...|.+|+.+|+.++||||+++++++.
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 46778899999999999999999999964 67999999754211 246889999999999999999999987
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
+ ...++||||+.+++|.+++... ...+++..++.|+.||+.||+|||+++|+||||||+|||++.++ .+||+
T Consensus 333 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----~~kl~ 405 (535)
T 2h8h_A 333 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----VCKVA 405 (535)
T ss_dssp S---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEEEC
T ss_pred e---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC----cEEEc
Confidence 6 2689999999999999999653 35689999999999999999999999999999999999998665 46999
Q ss_pred ecCCcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCC
Q 002908 733 DFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 733 DFGLA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr 809 (867)
|||+++...... ......++..|+|||++. ...++.++|||||||+||+|++ |..||......+....+ ....+
T Consensus 406 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~ 482 (535)
T 2h8h_A 406 DFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYR 482 (535)
T ss_dssp CTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-HTTCC
T ss_pred ccccceecCCCceecccCCcCcccccCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCC
Confidence 999998654322 223345678899999998 4568999999999999999999 99999988877766554 44566
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
.+.+..++..+.+||.+||+.+|++|||+.+|++.|+.+....
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 7777889999999999999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=350.42 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=201.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||.||+|.+. ++.||||+++..... .....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK- 73 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-------ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-
Confidence 57999999999999999999984 788999999643211 11123457899999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 74 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~----~kl~Dfg~a 147 (324)
T 3mtl_A 74 -SLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE----LKLADFGLA 147 (324)
T ss_dssp -CEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC----EEECSSSEE
T ss_pred -EEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC----EEEccCccc
Confidence 8999999995 6899988777778999999999999999999999999999999999999997764 599999999
Q ss_pred ccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC-----
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP----- 811 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~----- 811 (867)
...... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 148 RAKSIPTKTYDNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp ECC------------CGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCccccccccCcccccChhhhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 854322 22234568999999999875 24578999999999999999999999998877665554433211110
Q ss_pred -----------------------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 812 -----------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 812 -----------------------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
....+++.+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 0124678899999999999999999999999876643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.88 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=203.4
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHH-HHhCCCCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI-LSKLHHPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEiei-Lk~L~HPNIVrL~g~~ 652 (867)
.+..++|++++.||+|+||.||+|++. +..||||+++....... .....+.+|..+ ++.++||||+++++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-----~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-----KEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-----HHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 456789999999999999999999984 67799999987543221 123445667766 4678999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.+.. .+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|. +||+
T Consensus 109 ~~~~--~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~----ikL~ 181 (373)
T 2r5t_A 109 QTAD--KLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH----IVLT 181 (373)
T ss_dssp ECSS--EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----EEEC
T ss_pred EeCC--EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC----EEEe
Confidence 8854 99999999999999998854 456899999999999999999999999999999999999997764 5999
Q ss_pred ecCCcccc-cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC
Q 002908 733 DFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811 (867)
Q Consensus 733 DFGLA~~~-~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ 811 (867)
|||+++.. .........+||+.|+|||++. ...++.++|||||||++|+|++|..||...........+......
T Consensus 182 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-- 257 (373)
T 2r5t_A 182 DFGLCKENIEHNSTTSTFCGTPEYLAPEVLH--KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ-- 257 (373)
T ss_dssp CCCBCGGGBCCCCCCCSBSCCCCCCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC--
T ss_pred eCccccccccCCCccccccCCccccCHHHhC--CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC--
Confidence 99999853 3333445678999999999998 456889999999999999999999999998888877777766443
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCHH
Q 002908 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFT 839 (867)
Q Consensus 812 ip~~~s~eL~dLI~kCLq~DPeeRPSa~ 839 (867)
.+..++..+.+||.+||+.||.+||++.
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 4567899999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=334.72 Aligned_cols=256 Identities=25% Similarity=0.325 Sum_probs=215.7
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
....+|++.+.||+|+||.||++.+. ++.||+|++...... .......+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-----KPHQREKMSMEISIHRSLAHQHVVGFHGFFED 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-----CHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 44578999999999999999999985 678999999764322 12234568889999999999999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 87 ~~--~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~kl~df 159 (294)
T 2rku_A 87 ND--FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE----VKIGDF 159 (294)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEECCC
T ss_pred CC--EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC----EEEEec
Confidence 54 89999999999999998753 356899999999999999999999999999999999999997654 599999
Q ss_pred CCcccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 735 GLSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 735 GLA~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
|++..... ........||+.|+|||++. ...++.++||||||+++|+|++|..||...........+.... ...+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~ 235 (294)
T 2rku_A 160 GLATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIP 235 (294)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHT--TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCC
T ss_pred cCceecccCccccccccCCCCcCCcchhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--CCCc
Confidence 99985432 22334456899999999998 4457889999999999999999999999887766665555443 3456
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+++.+.++|.+||+.+|.+|||+.+++++.+-.
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 67899999999999999999999999999987654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.19 Aligned_cols=258 Identities=24% Similarity=0.322 Sum_probs=210.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++.+.||+|+||.||++.+ +++.||||+++...... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR----IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH----STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc----cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 5788999999999999999998 47789999997542211 01224568899999999999999999999865545
Q ss_pred CeEEEEEEeecCCchhhhhhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 658 GTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~-~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
...++||||+.++ |.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~----~kl~dfg~ 155 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT----LKISALGV 155 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC----EEECCCTT
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc----EEeecccc
Confidence 6899999999766 6665543 3457999999999999999999999999999999999999997664 59999999
Q ss_pred cccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 737 SKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 737 A~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
+..... ........||+.|+|||++.+....++.++|||||||++|+|++|..||...........+.... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~ 233 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAIP 233 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--CCCC
Confidence 986432 22223456899999999998544445789999999999999999999999887776666655543 3456
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+++.+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 268 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 67899999999999999999999999999887654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=345.92 Aligned_cols=257 Identities=23% Similarity=0.251 Sum_probs=206.3
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||.||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF------PITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS------CHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc------hHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 46899999999999999999998 4788999998655432211 245678999999999999999999987643
Q ss_pred ------CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 657 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 657 ------~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
.+.+++||||+. ++|...+......+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 90 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~----~k 164 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LK 164 (351)
T ss_dssp -------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EE
T ss_pred cccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC----EE
Confidence 347899999996 5888877766677999999999999999999999999999999999999997664 59
Q ss_pred EeecCCcccccC-----ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRN-----TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~-----~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||++..... ........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.........+..
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcC-CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999985432 122234568999999999874 24578999999999999999999999998877665554433
Q ss_pred cCCCCC--CCCC----------------------------CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 806 NTLRPP--VPGF----------------------------CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 806 ~~lr~~--ip~~----------------------------~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.....+ .... .++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 211111 1000 26779999999999999999999999987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=338.78 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=206.6
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 654 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~ 654 (867)
..++|++.+.||+|+||.||+|.+ .++.||||++...... ...+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---------EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---------THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---------HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 467899999999999999999999 5888999999753211 24577899999998 79999999999876
Q ss_pred CC----CCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 655 GP----GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 655 ~~----~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
.. ...+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~----~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE----V 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC----E
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC----E
Confidence 32 45889999999999999998653 357899999999999999999999999999999999999987654 5
Q ss_pred EEeecCCcccccCc-cccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 730 KVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 730 KL~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
+|+|||++...... .......||+.|+|||++.+. ...++.++|||||||++|+|++|..||...........+..
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 99999999864432 223345689999999998632 34578899999999999999999999988777666655555
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.......+..++..+.+||.+||..+|.+||++.+++++.+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 54444445678999999999999999999999999998654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=346.90 Aligned_cols=266 Identities=30% Similarity=0.395 Sum_probs=214.4
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+.+..++|++.+.||+|+||.||+|.+.+ .||||+++........ ...+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ------LKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC------CCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH------HHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 446778899999999999999999999865 5999999764322211 134567899999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++ .++|+|
T Consensus 100 ~~~--~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~----~~~l~D 172 (319)
T 2y4i_B 100 SPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG----KVVITD 172 (319)
T ss_dssp CSS--CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-------CCEECC
T ss_pred cCC--ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC----CEEEee
Confidence 754 79999999999999999977666799999999999999999999999999999999999998 33 359999
Q ss_pred cCCcccccC------ccccCCcCCCCCccCccccccC-------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 002908 734 FGLSKIKRN------TLVTGGVRGTLPWMAPELLNGS-------SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII 800 (867)
Q Consensus 734 FGLA~~~~~------~~~~s~~~GT~~Y~APEvl~g~-------~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l 800 (867)
||++..... ........|++.|+|||++.+. ...++.++|||||||++|+|++|..||.........
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999875321 1122234588999999998742 235789999999999999999999999988877766
Q ss_pred HhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 801 GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 801 ~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
..+............++..+.++|.+||+.+|.+|||+.++++.|+.+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 253 WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 66555444333344678899999999999999999999999999998876544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=338.88 Aligned_cols=252 Identities=20% Similarity=0.266 Sum_probs=204.7
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~ 652 (867)
....++|++.+.||+|+||.||+|.+ .++.||||+++... ...+.+|+.+++.++ ||||+++++++
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~ 100 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIV 100 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----------hHHHHHHHHHHHHcCCCCCEEEeeeee
Confidence 34568899999999999999999988 47889999986421 245788999999997 99999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
........++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++. .++|+
T Consensus 101 ~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~---~~kl~ 173 (330)
T 3nsz_A 101 KDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR---KLRLI 173 (330)
T ss_dssp ECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT---EEEEC
T ss_pred ccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC---EEEEE
Confidence 8865668999999999999998873 4899999999999999999999999999999999999986552 47999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHHhHh-------
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIGGIV------- 804 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~~iv------- 804 (867)
|||++.............++..|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+.
T Consensus 174 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~ 252 (330)
T 3nsz_A 174 DWGLAEFYHPGQEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252 (330)
T ss_dssp CCTTCEECCTTCCCCSCCSCGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred eCCCceEcCCCCccccccccccccChhhhcC-CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence 9999987655555556678999999999974 245789999999999999999999999543321 1111110
Q ss_pred ------hcC----------------------CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 805 ------NNT----------------------LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 805 ------~~~----------------------lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
... .....+..+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 000 011112237899999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=337.01 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=210.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|.+.+.||+|+||.||++.+. ++.||||+++..... ....+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--------RDSSLENEIAVLKKIKHENIVTLEDIYESTT 79 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--------chHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence 468999999999999999999984 888999999753211 1245778999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+...+ ....++|+|||+
T Consensus 80 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~ 155 (304)
T 2jam_A 80 --HYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMITDFGL 155 (304)
T ss_dssp --EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS-TTCCEEBCSCST
T ss_pred --EEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC-CCCCEEEccCCc
Confidence 899999999999999988543 4689999999999999999999999999999999999994322 224579999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--CCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP--PVPG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~--~ip~ 814 (867)
+....... .....||+.|+|||++. ...++.++|||||||++|+|++|..||...........+....... +...
T Consensus 156 ~~~~~~~~-~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (304)
T 2jam_A 156 SKMEQNGI-MSTACGTPGYVAPEVLA--QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD 232 (304)
T ss_dssp TCCCCCBT-THHHHSCCCBCCTTTBS--SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTT
T ss_pred ceecCCCc-cccccCCCCccChHHhc--cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccc
Confidence 97554322 22345899999999998 4568899999999999999999999999888777777666655433 3345
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 233 DISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 688999999999999999999999999987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=334.32 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=217.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
....++|++.+.||+|+||.||+|.+ .++.||||++........ ....+.+|+.++++++||||+++++++.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK------DTSTILREVELLKKLDHPNIMKLFEILE 91 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH------HHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence 34457899999999999999999998 478899999976543221 1356788999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ...++|+|
T Consensus 92 ~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~-~~~~kL~D 167 (287)
T 2wei_A 92 DSS--SFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK-DCDIKIID 167 (287)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST-TCCEEECS
T ss_pred CCC--eEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCC-cccEEEec
Confidence 754 899999999999999888543 46899999999999999999999999999999999999986553 24679999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
||++.............+|+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.......+.+
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (287)
T ss_dssp TTGGGTBCCCSSCSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred cCcceeecCCCccccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch
Confidence 999986554443344558899999999874 37889999999999999999999999888777777666665544433
Q ss_pred --CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 814 --GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 814 --~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..+++.+.++|.+||+.+|.+|||+.+++++.+-
T Consensus 245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 4678999999999999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=354.34 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=210.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC--CCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--HPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~--HPNIVrL~g~~ 652 (867)
.+...+|++.+.||+|+||.||++.+. ++.||||++..... .......+.+|+.+|+.++ ||||+++++++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc------cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 345567999999999999999999884 77899999975421 2233567889999999997 59999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.... .+++||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+
T Consensus 126 ~~~~--~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~----~~kl~ 196 (390)
T 2zmd_A 126 ITDQ--YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G----MLKLI 196 (390)
T ss_dssp ECSS--EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S----CEEEC
T ss_pred ecCC--EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C----eEEEE
Confidence 8854 8999999 5588999988654 47899999999999999999999999999999999999963 2 47999
Q ss_pred ecCCcccccCcc---ccCCcCCCCCccCccccccC---------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-hHH
Q 002908 733 DFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGS---------SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAI 799 (867)
Q Consensus 733 DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~---------~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~-~e~ 799 (867)
|||+++...... ......||+.|+|||++.+. ...++.++|||||||+||+|++|+.||..... ...
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 276 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence 999998654322 22345799999999998741 13588999999999999999999999987543 344
Q ss_pred HHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 800 l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
+..++........+...+..+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 5556666666667777889999999999999999999999999887653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.26 Aligned_cols=261 Identities=24% Similarity=0.318 Sum_probs=194.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~ 652 (867)
.+...+|++.+.||+|+||.||+|.+ .++.||||++.... ......+.+|+.++.++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--------EEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--------HHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--------hHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 55667999999999999999999998 57889999986431 223456789999999996 99999999988
Q ss_pred cc------CCCCeEEEEEEeecCCchhhhhhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCCcceEeccC
Q 002908 653 QD------GPGGTLATVTEFMVNGSLRHVLLS--KERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLK 722 (867)
Q Consensus 653 ~~------~~~~~l~LVmEy~~ggSL~d~L~~--~~~~Lse~~~l~Ia~QIa~ALayLHs~G--IIHrDLKPsNILLd~d 722 (867)
.. .....+++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.| |+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred cccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence 42 2234689999999 5788888754 3456999999999999999999999999 9999999999999976
Q ss_pred CCCCCcEEEeecCCcccccCcccc-------------CCcCCCCCccCcccccc-CCCCCChhhHHHHHHHHHHHHHhCC
Q 002908 723 DPIRPICKVGDFGLSKIKRNTLVT-------------GGVRGTLPWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGE 788 (867)
Q Consensus 723 g~~~~~vKL~DFGLA~~~~~~~~~-------------s~~~GT~~Y~APEvl~g-~~~~~S~kSDVWSLGvLLyELLTGk 788 (867)
+. +||+|||++......... ....+|+.|+|||++.. ....++.++|||||||++|+|++|.
T Consensus 175 ~~----~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 175 GT----IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp SC----EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred CC----EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence 64 699999999865432111 13458999999999832 2456789999999999999999999
Q ss_pred CCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 789 EPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 789 ~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
.||....... +.......+....++..+.+||.+||+.+|.+|||+.+++++|+.+.....
T Consensus 251 ~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 251 HPFEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp CCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CCCcchhHHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 9997654332 233344445556677889999999999999999999999999999977544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=342.76 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=200.2
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHH--HHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI--LSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEiei--Lk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||+|+++++.||||++.... ...+..|.++ +..++||||+++++.+.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----------RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----------hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 4667899999999999999999999999999999997431 1223334444 45689999999997543
Q ss_pred ---cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---------CeeccCCCCcceEecc
Q 002908 654 ---DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK---------NIVHFDLKCDNLLVNL 721 (867)
Q Consensus 654 ---~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~---------GIIHrDLKPsNILLd~ 721 (867)
......+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 2223467899999999999999854 3458999999999999999999999 9999999999999997
Q ss_pred CCCCCCcEEEeecCCcccccCc---------cccCCcCCCCCccCccccccCC-----CCCChhhHHHHHHHHHHHHHhC
Q 002908 722 KDPIRPICKVGDFGLSKIKRNT---------LVTGGVRGTLPWMAPELLNGSS-----SKVSEKVDVFSFGIVLWEILTG 787 (867)
Q Consensus 722 dg~~~~~vKL~DFGLA~~~~~~---------~~~s~~~GT~~Y~APEvl~g~~-----~~~S~kSDVWSLGvLLyELLTG 787 (867)
++ .+||+|||++...... .......||+.|+|||++.+.. ..++.++|||||||++|+|++|
T Consensus 156 ~~----~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 156 DG----TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp TS----CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CC----cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 65 4699999999754321 1122446999999999997421 2356789999999999999999
Q ss_pred CCCCCCCCh------------------hHHHHhHhhcCCCCCCCCC------CcHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 002908 788 EEPYANMHY------------------GAIIGGIVNNTLRPPVPGF------CDSEWRLLMEQCWAPDPVVRPSFTEIAR 843 (867)
Q Consensus 788 k~PF~~~~~------------------~e~l~~iv~~~lr~~ip~~------~s~eL~dLI~kCLq~DPeeRPSa~ELLe 843 (867)
..||..... ......+.....++..+.. +++.+.+||.+||+.||.+|||+.++++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 776532111 1111112222333333333 3457999999999999999999999999
Q ss_pred HHHHHHHHhcCCCC
Q 002908 844 RLRVMSAACQTKSH 857 (867)
Q Consensus 844 ~Lq~l~~a~s~~~~ 857 (867)
.|+.+.........
T Consensus 312 ~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 312 RMAELMMIWERNKS 325 (336)
T ss_dssp HHHHHHHCCCC---
T ss_pred HHHHHHHHHHhccc
Confidence 99999876665433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=347.53 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=211.6
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
+..+..++|++.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+++.++||||++++++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 99 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGA 99 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-------CHHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-------CHHHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence 44667789999999999999999999995 7889999997542 12334678899999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCCCCCcEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
+.... ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++. ++
T Consensus 100 ~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~----~k 172 (360)
T 3eqc_A 100 FYSDG--EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE----IK 172 (360)
T ss_dssp EEETT--EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC----EE
T ss_pred EEECC--EEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC----EE
Confidence 98854 899999999999999998543 4689999999999999999999996 9999999999999997664 59
Q ss_pred EeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH----------
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII---------- 800 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l---------- 800 (867)
|+|||++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.........
T Consensus 173 l~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (360)
T 3eqc_A 173 LCDFGVSGQLIDS-MANSFVGTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249 (360)
T ss_dssp ECCCCCCHHHHHH-C----CCCCTTCCHHHHT--TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------
T ss_pred EEECCCCcccccc-cccCCCCCCCeECHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc
Confidence 9999999754322 223456899999999998 456899999999999999999999999875543321
Q ss_pred --------------------------------HhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 801 --------------------------------GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 801 --------------------------------~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+............++..+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 329 (360)
T 3eqc_A 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329 (360)
T ss_dssp ------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred CCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 112222222222345788999999999999999999999999988765
Q ss_pred HH
Q 002908 849 SA 850 (867)
Q Consensus 849 ~~ 850 (867)
..
T Consensus 330 ~~ 331 (360)
T 3eqc_A 330 RS 331 (360)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.26 Aligned_cols=269 Identities=25% Similarity=0.329 Sum_probs=210.9
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
....+..++|++.+.||+|+||.||++.+ .++.||||++.... ......+.+|+.+++.++||||+++++
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 93 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--------QQDREEAQREADMHRLFNHPNILRLVA 93 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--------HHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--------HHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34467788999999999999999999997 57889999986521 223456889999999999999999999
Q ss_pred cccc--CCCCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 651 VVQD--GPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 651 ~~~~--~~~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
++.. ......++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~- 172 (317)
T 2buj_A 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ- 172 (317)
T ss_dssp EEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-
T ss_pred EEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC-
Confidence 9863 223478999999999999998865 3467999999999999999999999999999999999999987664
Q ss_pred CCcEEEeecCCcccccCccc----------cCCcCCCCCccCccccccCC-CCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 002908 726 RPICKVGDFGLSKIKRNTLV----------TGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANM 794 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~~~~----------~s~~~GT~~Y~APEvl~g~~-~~~S~kSDVWSLGvLLyELLTGk~PF~~~ 794 (867)
++|+|||++........ .....||+.|+|||++.+.. ..++.++|||||||++|+|++|..||...
T Consensus 173 ---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 249 (317)
T 2buj_A 173 ---PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249 (317)
T ss_dssp ---EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred ---EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence 59999999875432110 11234799999999987432 23688999999999999999999999542
Q ss_pred Chh-HHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 795 HYG-AIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 795 ~~~-e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
... .............+.+..++..+.++|.+||+.+|.+|||+.+++++|+.+.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 250 FQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred hcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 111 01112223344455556789999999999999999999999999999998754433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.65 Aligned_cols=256 Identities=30% Similarity=0.453 Sum_probs=203.5
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEE
Q 002908 582 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~ 661 (867)
|...+.||+|+||.||+|.++++.||||++....... .+.....+.+|+.+++.++||||+++++++.... ..+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT----TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSC----TTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcc----hHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ceE
Confidence 3344689999999999999999999999997543211 1223456889999999999999999999998754 889
Q ss_pred EEEEeecCCchhhhhhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 662 TVTEFMVNGSLRHVLLSK--ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~--~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~kl~Dfg~~~~ 182 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF----TAKISDFGLARA 182 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC----CEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC----cEEEeecccccc
Confidence 999999999999988643 34689999999999999999999999999999999999998665 459999999985
Q ss_pred ccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH----HHhHhhc------
Q 002908 740 KRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI----IGGIVNN------ 806 (867)
Q Consensus 740 ~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~----l~~iv~~------ 806 (867)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ...+...
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred cccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 4332 22334568999999999874 368899999999999999999999976543221 1111110
Q ss_pred ---CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 807 ---TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 807 ---~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
......+..++..+.+++.+||+.+|.+|||+.+++++|+.+.+
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 01112233456789999999999999999999999999998743
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.36 Aligned_cols=258 Identities=25% Similarity=0.315 Sum_probs=203.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|++.+.||+|+||.||+|.+. ++.||||+++...... ........+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch---hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999999984 7889999997543211 11222346778999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+.+ +|..++......+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 86 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~----~kl~Dfg~ 158 (346)
T 1ua2_A 86 --NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV----LKLADFGL 158 (346)
T ss_dssp --CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC----EEECCCGG
T ss_pred --ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC----EEEEeccc
Confidence 88999999965 888888766667999999999999999999999999999999999999997664 59999999
Q ss_pred cccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC----
Q 002908 737 SKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP---- 811 (867)
Q Consensus 737 A~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~---- 811 (867)
+..... ........+|+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+......+..+......+.
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTT-CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ceeccCCcccCCcccccccccCchHhhC-CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 986533 223344568999999999974 23578999999999999999999999998877666655543211110
Q ss_pred ----------------------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 812 ----------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 812 ----------------------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
....+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 013457899999999999999999999999987654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=365.24 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=200.1
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++++.||+|+||+||+|.+ +++.||||++.... .......++.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG------GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc------cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 357899999999999999999988 47889999997532 1233456788999999999999999999998653
Q ss_pred C----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 656 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 656 ~----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
. ...+++||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus 134 ~~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~----~kl 205 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKI 205 (464)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----EEE
T ss_pred CccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC----EEE
Confidence 2 2468999999965 5665553 24899999999999999999999999999999999999997664 599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC-
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP- 810 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~- 810 (867)
+|||+++............||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+....+..++.....+
T Consensus 206 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283 (464)
T ss_dssp CCCCCC-----CCCC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EEEEeeeecCCCcccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999987665545556779999999999984 468899999999999999999999999887666555444321110
Q ss_pred -------------------CCC---------CC-----------CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 811 -------------------PVP---------GF-----------CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 811 -------------------~ip---------~~-----------~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
... .. .++.+.+||.+||+.||.+|||+.|++++.+-
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 000 00 15678999999999999999999999988653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.52 Aligned_cols=255 Identities=28% Similarity=0.417 Sum_probs=208.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
....++|++.+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--------EELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--------HHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 445678999999999999999999995 78899999864321 11356788999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 87 ~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----~kl~D 160 (302)
T 2j7t_A 87 HDG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD----IRLAD 160 (302)
T ss_dssp CC---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC----EEECC
T ss_pred eCC--eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC----EEEEE
Confidence 754 899999999999999988766677999999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccC-ccccCCcCCCCCccCcccccc---CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 734 FGLSKIKRN-TLVTGGVRGTLPWMAPELLNG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 734 FGLA~~~~~-~~~~s~~~GT~~Y~APEvl~g---~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
||++..... ........||+.|+|||++.. ....++.++|||||||++|+|++|..||...........+......
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 161 FGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240 (302)
T ss_dssp CHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc
Confidence 998763221 112234568999999999841 1455788999999999999999999999988776666555544332
Q ss_pred -CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 -PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 -~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
...+..++..+.++|.+||+.+|.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 23355678999999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=346.73 Aligned_cols=263 Identities=23% Similarity=0.285 Sum_probs=204.3
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCC---hHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS---SEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~---~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
..++|++.+.||+|+||.||+|.+ .+..||||++......... .........+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 457899999999999999999987 5788999999764433221 123344577899999999999999999999985
Q ss_pred c---CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 654 D---GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 654 ~---~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
. .....+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ++
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~----~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND----IT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC----EE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC----EE
Confidence 4 22347899999996 7888888766678999999999999999999999999999999999999987664 59
Q ss_pred EeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
|+|||++.............+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...........+......+
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTT-CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcC-CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999999986555444455678999999999874 2457899999999999999999999999877665554443211110
Q ss_pred ------------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 811 ------------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 811 ------------------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.....+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 012345788999999999999999999999998755
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=346.12 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=204.8
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-----CCceeeE
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-----HPNVVAF 648 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-----HPNIVrL 648 (867)
.+..++|+++++||+|+||.||+|++ +++.||||+++.. ......+..|+.+++.+. ||||+++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---------KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---------hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 45578999999999999999999999 5788999998632 122345677999999986 9999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCC----
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD---- 723 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg---- 723 (867)
++++.... ..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++...
T Consensus 102 ~~~~~~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 102 HGKFMYYD--HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEEETT--EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cceeeECC--eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 99998854 899999999 999999986543 4589999999999999999999999999999999999998521
Q ss_pred -----------------CCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 724 -----------------PIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 724 -----------------~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
.....+||+|||++...... .....||+.|+|||++. ...++.++|||||||++|+|++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVIL--NLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHT--TCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHc--CCCCCCccchHHHHHHHHHHHH
Confidence 11346799999999865432 23456899999999998 4568899999999999999999
Q ss_pred CCCCCCCCChhHHHHhHhhcCCCCC------------------------CC--------------------CCCcHHHHH
Q 002908 787 GEEPYANMHYGAIIGGIVNNTLRPP------------------------VP--------------------GFCDSEWRL 822 (867)
Q Consensus 787 Gk~PF~~~~~~e~l~~iv~~~lr~~------------------------ip--------------------~~~s~eL~d 822 (867)
|+.||...........+.......+ .+ ...++.+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999988766554443322111100 00 112367889
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHH
Q 002908 823 LMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa~ELLe~L 845 (867)
||.+||+.||.+|||+.+++++.
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHHhcCChhhCCCHHHHhcCc
Confidence 99999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=330.32 Aligned_cols=252 Identities=28% Similarity=0.366 Sum_probs=205.5
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. ++.||||++...... .....+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-------THHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-------hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 367999999999999999999984 788999999754321 12356788999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||+
T Consensus 79 --~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~kl~dfg~ 151 (276)
T 2yex_A 79 --IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN----LKISDFGL 151 (276)
T ss_dssp --EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC----EEECCCTT
T ss_pred --EEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC----EEEeeCCC
Confidence 89999999999999998853 456899999999999999999999999999999999999997664 59999999
Q ss_pred cccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhhcCCCCCC
Q 002908 737 SKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRPPV 812 (867)
Q Consensus 737 A~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~~~lr~~i 812 (867)
+...... .......||+.|+|||++.+. ...+.++|||||||++|+|++|..||....... ..............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTT
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCc
Confidence 9754321 123345689999999999842 224779999999999999999999998765432 22333333323333
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
...+++.+.++|.+||+.+|.+|||+.+++++.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 346789999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=352.76 Aligned_cols=268 Identities=19% Similarity=0.200 Sum_probs=202.4
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHH------HHHHHHHHHHHHHHhCCC
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQE------RLTLEFWREAEILSKLHH 642 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e------~~~~eflrEieiLk~L~H 642 (867)
+..+..++|++.+.||+|+||.||+|.+. +..||||++..... ....+ .....+.+|+..+..++|
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h 107 (345)
T 2v62_A 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKWIERKQLDY 107 (345)
T ss_dssp EECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C---HHHHHHHHHHHHCCHHHHHHHHHHHTCSC
T ss_pred eccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc---chHHHHHHHHHHhhhHHHHHHHhhccccc
Confidence 34556789999999999999999999984 46799999875421 11111 112346788999999999
Q ss_pred CceeeEecccccC--CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEec
Q 002908 643 PNVVAFYGVVQDG--PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 720 (867)
Q Consensus 643 PNIVrL~g~~~~~--~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd 720 (867)
|||+++++++... .....++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 108 ~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 108 LGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG 185 (345)
T ss_dssp CCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred cCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc
Confidence 9999999998762 235899999999 999999986544 799999999999999999999999999999999999999
Q ss_pred cCCCCCCcEEEeecCCcccccCcc--------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 002908 721 LKDPIRPICKVGDFGLSKIKRNTL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYA 792 (867)
Q Consensus 721 ~dg~~~~~vKL~DFGLA~~~~~~~--------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~ 792 (867)
.++.. .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 186 ~~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 186 YKNPD--QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp SSSTT--SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred cCCCC--cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 76532 57999999997543221 1134569999999999984 468999999999999999999999996
Q ss_pred CCChh-HHHHhH---hhcCCCC-----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 793 NMHYG-AIIGGI---VNNTLRP-----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 793 ~~~~~-e~l~~i---v~~~lr~-----~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
..... ...... ....... .....+++.+.++|.+||+.+|.+||++.+|++.|+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp GGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 53221 111111 1111100 0112678999999999999999999999999999988654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=372.43 Aligned_cols=263 Identities=33% Similarity=0.542 Sum_probs=218.1
Q ss_pred ccccCCeeEEE-EeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELK-ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk-~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..+++.+.+ .||+|+||.||+|.+. +..||||+++..... .....|.+|+.+|+.++|||||++++
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~E~~il~~l~hpniv~l~~ 403 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------ADTEEMMREAQIMHQLDNPYIVRLIG 403 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-------TTHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 45566777777 8999999999999873 456999999754211 11356889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
+|... .+++||||+.+++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 404 ~~~~~---~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~vk 476 (613)
T 2ozo_A 404 VCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----YAK 476 (613)
T ss_dssp EEESS---SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEE
T ss_pred EeccC---CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC----cEE
Confidence 99763 58999999999999999977677799999999999999999999999999999999999999665 469
Q ss_pred EeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||+++...... ......+++.|+|||++. ...++.++|||||||+||||++ |+.||...........+.
T Consensus 477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~--~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~- 553 (613)
T 2ozo_A 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE- 553 (613)
T ss_dssp ECCCSTTTTCC--------------CCTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-
T ss_pred EeeccCcccccCCCceeeeccCCCCccceeCHhhhc--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-
Confidence 99999998653221 112233568899999998 4568999999999999999998 999999888777665544
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCC
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 855 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~ 855 (867)
...+.+.+..+++.+.+||.+||+.+|.+||++.+|++.|+.+.......
T Consensus 554 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 554 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 45567778889999999999999999999999999999999988766543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=356.06 Aligned_cols=260 Identities=30% Similarity=0.530 Sum_probs=206.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC---C--ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR---G--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~---G--~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
..|++.+.||+|+||.||+|.+. + ..||||.++... .......|.+|+.+++.++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-------CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 35888999999999999999873 2 358999886421 11224678899999999999999999998754
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
. .+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 162 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kL~DF 236 (373)
T 3c1x_A 162 S-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF----TVKVADF 236 (373)
T ss_dssp C-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEEECCC
T ss_pred C-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC----CEEEeec
Confidence 3 2477899999999999999977777789999999999999999999999999999999999999665 4699999
Q ss_pred CCcccccCcc-----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCC
Q 002908 735 GLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 735 GLA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~l 808 (867)
|+++...... ......+|+.|+|||++. ...++.++|||||||++|+|+| |.+||...........+.. ..
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~-~~ 313 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GR 313 (373)
T ss_dssp ---------------------CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT-TC
T ss_pred cccccccccccccccccCCCCCcccccChHHhc--CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc-CC
Confidence 9998543221 123345778899999998 4568899999999999999999 7888877665555444333 33
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQT 854 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~ 854 (867)
+...+..++..+.++|.+||+.+|.+|||+.++++.|+.+......
T Consensus 314 ~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 4556678899999999999999999999999999999999877653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.22 Aligned_cols=252 Identities=30% Similarity=0.466 Sum_probs=206.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC-
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG- 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~- 655 (867)
...|++.+.||+|+||.||+|.+. +..||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 445899999999999999999984 677999999754321 22346788999999999999999999987642
Q ss_pred -CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCCcceEec-cCCCCCCcEEE
Q 002908 656 -PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVN-LKDPIRPICKV 731 (867)
Q Consensus 656 -~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~G--IIHrDLKPsNILLd-~dg~~~~~vKL 731 (867)
....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .++|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~----~~kl 173 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----SVKI 173 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS----CEEE
T ss_pred CCCceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC----CEEE
Confidence 24578999999999999999854 356899999999999999999999999 99999999999997 444 4699
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHh-hcCCCC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV-NNTLRP 810 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv-~~~lr~ 810 (867)
+|||++........ ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||............. ......
T Consensus 174 ~Dfg~~~~~~~~~~-~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (290)
T 1t4h_A 174 GDLGLATLKRASFA-KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp CCTTGGGGCCTTSB-EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred eeCCCccccccccc-ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc
Confidence 99999975544322 33568999999999873 47899999999999999999999998855544443333 333333
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..+...++.+.+||.+||+.+|.+|||+.+++++.
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 44556778999999999999999999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=342.99 Aligned_cols=256 Identities=25% Similarity=0.329 Sum_probs=215.7
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
....+|.+.+.||+|+||.||++.+. ++.||+|++...... .......+.+|+.+++.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-----KPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 44578999999999999999999984 678999999764322 12334568899999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 113 ~~--~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~----~kl~Df 185 (335)
T 2owb_A 113 ND--FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE----VKIGDF 185 (335)
T ss_dssp SS--EEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC----EEECCC
T ss_pred CC--eEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC----EEEeec
Confidence 54 89999999999999998754 356899999999999999999999999999999999999997654 599999
Q ss_pred CCcccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 735 GLSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 735 GLA~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
|++..... ........||+.|+|||++. ...++.++|||||||++|+|++|..||...........+..... ..+
T Consensus 186 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~ 261 (335)
T 2owb_A 186 GLATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIP 261 (335)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHH--TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--CCC
T ss_pred cCceecccCcccccccCCCccccCHHHhc--cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC--CCC
Confidence 99985432 22334456899999999998 44578899999999999999999999998877666665555433 345
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
..+++.+.+||.+||+.||.+|||+.+++++.+-.
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~ 296 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 67899999999999999999999999999876643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=352.94 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=205.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+ +++.||||+++.................+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46899999999999999999987 4788999999875432221001111234667999999999999999999998754
Q ss_pred CCeEEEEEEeecCC-chhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 657 GGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 657 ~~~l~LVmEy~~gg-SL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
..++||||+.++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 103 --~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~----~kL~Dfg 175 (335)
T 3dls_A 103 --FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT----IKLIDFG 175 (335)
T ss_dssp --EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC----EEECCCT
T ss_pred --EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc----EEEeecc
Confidence 899999999776 88888854 446999999999999999999999999999999999999997654 5999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
++.............||+.|+|||++.+. ...+.++|||||||++|+|++|..||..... ... .....+..
T Consensus 176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~--~~~~~~~~ 246 (335)
T 3dls_A 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE--AAIHPPYL 246 (335)
T ss_dssp TCEECCTTCCBCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT--TCCCCSSC
T ss_pred cceECCCCCceeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh--hccCCCcc
Confidence 99876555444556799999999999842 2238899999999999999999999976321 111 12334556
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+++.+.+||.+||+.+|.+|||+.+++++.+
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 8999999999999999999999999999865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=342.77 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=210.2
Q ss_pred cccCCeeEE-EEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccc
Q 002908 577 IKNEDLEEL-KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 652 (867)
Q Consensus 577 I~~sdyqil-k~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~ 652 (867)
...++|.+. +.||+|+||.||+|.+. ++.||||+++....... ....+.+|+.++..+. ||||+++++++
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD------CRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE------CHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH------HHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 345677777 89999999999999984 88999999976432211 1356788999999995 69999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.... ..++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.... ...++|
T Consensus 99 ~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~-~~~~kL 175 (327)
T 3lm5_A 99 ENTS--EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP-LGDIKI 175 (327)
T ss_dssp ECSS--EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTT-BCCEEE
T ss_pred EeCC--eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCC-CCcEEE
Confidence 8754 899999999999999988543 367999999999999999999999999999999999999986321 245799
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC--
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-- 809 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr-- 809 (867)
+|||++.............||+.|+|||++. ...++.++|||||||++|+|++|..||...........+......
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 253 (327)
T 3lm5_A 176 VDFGMSRKIGHACELREIMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS 253 (327)
T ss_dssp CCGGGCEEC---------CCCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eeCccccccCCccccccccCCcCccCCeeec--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence 9999998765554445567999999999998 456789999999999999999999999988877766665554433
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+....+++.+.+||.+||+.+|.+|||+.+++++.+
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 3334568999999999999999999999999988754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=341.09 Aligned_cols=261 Identities=28% Similarity=0.496 Sum_probs=210.2
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh--CCCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK--LHHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~--L~HPNIVrL~g~~ 652 (867)
.....++|++.+.||+|+||.||+|.++++.||||++.... ...+.+|++++.. ++||||+++++++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----------HHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 34456789999999999999999999999999999986421 2456778888887 7899999999998
Q ss_pred ccCCC--CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHH--------HCCeeccCCCCcceEeccC
Q 002908 653 QDGPG--GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH--------SKNIVHFDLKCDNLLVNLK 722 (867)
Q Consensus 653 ~~~~~--~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLH--------s~GIIHrDLKPsNILLd~d 722 (867)
..... ...++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.||+||||||+|||++.+
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence 76532 378999999999999999854 46899999999999999999999 8999999999999999976
Q ss_pred CCCCCcEEEeecCCcccccCcc-----ccCCcCCCCCccCccccccCCC----CCChhhHHHHHHHHHHHHHhC------
Q 002908 723 DPIRPICKVGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTG------ 787 (867)
Q Consensus 723 g~~~~~vKL~DFGLA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~----~~S~kSDVWSLGvLLyELLTG------ 787 (867)
+. ++|+|||++....... ......||+.|+|||++.+... .++.++|||||||++|+|+||
T Consensus 184 ~~----~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 184 GT----CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp SC----EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CC----EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 64 6999999997554332 2244569999999999975321 233789999999999999999
Q ss_pred ----CCCCCCCC-----hhHHHHhHhhcCCCCCCCC-----CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 788 ----EEPYANMH-----YGAIIGGIVNNTLRPPVPG-----FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 788 ----k~PF~~~~-----~~e~l~~iv~~~lr~~ip~-----~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
..||.... .......+.....++..+. .++..+.+||.+||+.+|.+|||+.+++++|+.+....
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 77886542 2333333444444544443 23567999999999999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=339.70 Aligned_cols=260 Identities=22% Similarity=0.301 Sum_probs=203.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+ .++.||||++..... ........+.+|+.+++.++||||+++++++....
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-----SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-----GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-----cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 47899999999999999999998 478899999875422 22344567889999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||+
T Consensus 108 --~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~----~kl~Dfg~ 180 (309)
T 2h34_A 108 --QLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF----AYLVDFGI 180 (309)
T ss_dssp --EEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC----EEECSCCC
T ss_pred --eEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC----EEEecCcc
Confidence 89999999999999998864 356899999999999999999999999999999999999997664 59999999
Q ss_pred cccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC--CCC
Q 002908 737 SKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--PPV 812 (867)
Q Consensus 737 A~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr--~~i 812 (867)
+....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||........... +..... ...
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~ 257 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFS--ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-INQAIPRPSTV 257 (309)
T ss_dssp ----------------CCGGGCCGGGTC--C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH-HHSCCCCGGGT
T ss_pred CccccccccccccccCCCcCccCHHHHc--CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH-hccCCCCcccc
Confidence 97554322 223456899999999998 44578899999999999999999999987665433332 322222 123
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHHHHhc
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLRVMSAACQ 853 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRP-Sa~ELLe~Lq~l~~a~s 853 (867)
+..+++.+.++|.+||+.+|.+|| +++++++.|+.+.....
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 456789999999999999999999 99999999998754443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=338.40 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=201.0
Q ss_pred cCCeeEE-EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccccc
Q 002908 579 NEDLEEL-KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 654 (867)
Q Consensus 579 ~sdyqil-k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~ 654 (867)
.+.|++. +.||+|+||.||+|.+ +++.||||++...... ....+.+|+.++.++ +||||+++++++.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--------IRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--------CHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--------hHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4678885 7899999999999987 4888999999754211 124677899999985 79999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.. ..+||+||
T Consensus 83 ~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~-~~~kl~Df 158 (316)
T 2ac3_A 83 ED--RFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQV-SPVKICDF 158 (316)
T ss_dssp TT--EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSS-CSEEECCT
T ss_pred CC--EEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCc-CceEEEEc
Confidence 54 899999999999999998643 568999999999999999999999999999999999999976642 35799999
Q ss_pred CCcccccCc--------cccCCcCCCCCccCccccccCC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-------
Q 002908 735 GLSKIKRNT--------LVTGGVRGTLPWMAPELLNGSS---SKVSEKVDVFSFGIVLWEILTGEEPYANMHY------- 796 (867)
Q Consensus 735 GLA~~~~~~--------~~~s~~~GT~~Y~APEvl~g~~---~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~------- 796 (867)
|++...... .......||+.|+|||++.+.. ..++.++|||||||++|+|++|..||.....
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 998754211 1112345899999999986311 3367899999999999999999999976532
Q ss_pred --------hHHHHhHhhcCCCCCCC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 797 --------GAIIGGIVNNTLRPPVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 797 --------~e~l~~iv~~~lr~~ip--~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
......+.......+.. ..+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 239 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp --CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred cccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 22333444443332211 357889999999999999999999999998755
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.13 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=201.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|++++.||+|+||.||+|.+ +|+.||||++.... ..+....++.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 47899999999999999999998 48889999986432 12334567889999999999999999999987642
Q ss_pred ----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
...+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~----~kl~ 170 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE----LKIL 170 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEEC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC----EEEE
Confidence 13569999999 8899998854 56899999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-- 810 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~-- 810 (867)
|||+++..... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..+......+
T Consensus 171 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 171 DFGLARQADSE--MTGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp CCTTCEECCSS--CCSSCSCGGGCCTHHHHT-TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeecccccccc--cCcCcCCCCcCCHHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999865433 234568999999999985 2458899999999999999999999999877665554443211110
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 811 ---------------------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 811 ---------------------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.....+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 112356889999999999999999999999998644
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.87 Aligned_cols=253 Identities=25% Similarity=0.255 Sum_probs=202.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
....+|++.+.||+|+||+||+|.+ +++.||||++..... ...+|+.+++.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------~~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------------YKNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------------hHHHHHHHHHHcCCCCccchhheeee
Confidence 3457899999999999999999998 578899999865321 12368999999999999999998854
Q ss_pred C------------------------------------CCCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHH
Q 002908 655 G------------------------------------PGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDA 695 (867)
Q Consensus 655 ~------------------------------------~~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QI 695 (867)
. ...++++||||++ ++|.+.+.. ....+++..++.++.||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 2 2345889999996 577766642 34679999999999999
Q ss_pred HHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHH
Q 002908 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVF 775 (867)
Q Consensus 696 a~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVW 775 (867)
+.||.|||++||+||||||+|||++... ..+||+|||+++............+|+.|+|||++.+ ...++.++|||
T Consensus 151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~Diw 226 (383)
T 3eb0_A 151 FRAVGFIHSLGICHRDIKPQNLLVNSKD---NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-ATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHHTTTEECSCCCGGGEEEETTT---TEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-CSSCCTHHHHH
T ss_pred HHHHHHHHHCcCccCccCHHHEEEcCCC---CcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-CCCCCcchhhh
Confidence 9999999999999999999999997422 2579999999987655555556678999999999874 34578999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC---------------------------CCCCCCCcHHHHHHHHHhh
Q 002908 776 SFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR---------------------------PPVPGFCDSEWRLLMEQCW 828 (867)
Q Consensus 776 SLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr---------------------------~~ip~~~s~eL~dLI~kCL 828 (867)
||||++|+|++|+.||.+......+..++..... ...+..+++.+.+||.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 9999999999999999988776665554431110 0124457889999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 002908 829 APDPVVRPSFTEIARRLR 846 (867)
Q Consensus 829 q~DPeeRPSa~ELLe~Lq 846 (867)
+.+|.+|||+.+++++.+
T Consensus 307 ~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp CSSGGGSCCHHHHHTSGG
T ss_pred cCChhhCCCHHHHhcCHH
Confidence 999999999999997644
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=357.43 Aligned_cols=257 Identities=24% Similarity=0.268 Sum_probs=188.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|.+. ++.||||++.... .......++.+|+.+|+.++||||+++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF------EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 478999999999999999999884 7889999986432 12233467889999999999999999999985432
Q ss_pred ---CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 657 ---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 657 ---~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
...+|+||||+ +++|..++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.++. +||+|
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~----~kl~D 199 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS----VKVCD 199 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC----EEECC
T ss_pred cccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC----Eeecc
Confidence 25789999998 6788888753 456999999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCcc----------------------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHH
Q 002908 734 FGLSKIKRNTL----------------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEIL 785 (867)
Q Consensus 734 FGLA~~~~~~~----------------------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELL 785 (867)
||+++...... ......||+.|+|||++.. ...++.++|||||||+||||+
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHH
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-CCCCCcHhHHHHHHHHHHHHH
Confidence 99998643211 1234568999999998753 346899999999999999999
Q ss_pred h-----------CCCCCCCCCh--------------------hHHHHhHhhc----------------------CCC---
Q 002908 786 T-----------GEEPYANMHY--------------------GAIIGGIVNN----------------------TLR--- 809 (867)
Q Consensus 786 T-----------Gk~PF~~~~~--------------------~e~l~~iv~~----------------------~lr--- 809 (867)
+ |+++|.+... ...+..+... .+.
T Consensus 279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 358 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE 358 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence 9 6666655331 0111111100 000
Q ss_pred ----CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 810 ----PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 810 ----~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
......+++.+.+||.+||+.||.+|||+.|++++.+-.
T Consensus 359 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~ 401 (458)
T 3rp9_A 359 GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401 (458)
T ss_dssp CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence 001124588999999999999999999999999986543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.57 Aligned_cols=258 Identities=16% Similarity=0.151 Sum_probs=204.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC----------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCcee
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR----------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 646 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~----------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIV 646 (867)
...++|++.+.||+|+||.||+|++. ++.||||++... ..+.+|+.+++.++||||+
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchh
Confidence 34579999999999999999999984 578999998743 2467899999999999999
Q ss_pred eE---------------ecccccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Q 002908 647 AF---------------YGVVQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 710 (867)
Q Consensus 647 rL---------------~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHr 710 (867)
++ ++++... ....++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~ 183 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHG 183 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred hhhhhhccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 84 4444432 35889999999 99999999754 3679999999999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCcc--------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHH
Q 002908 711 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 782 (867)
Q Consensus 711 DLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~--------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLy 782 (867)
||||+|||++.++. ..++|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+||
T Consensus 184 Dikp~NIl~~~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 184 NVTAENIFVDPEDQ--SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCML 259 (352)
T ss_dssp CCCGGGEEEETTEE--EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCC--ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHH
Confidence 99999999996652 257999999997543221 1133468999999999984 46899999999999999
Q ss_pred HHHhCCCCCCCCC-hhHHHHhH----hhcCCCCCC----CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 783 EILTGEEPYANMH-YGAIIGGI----VNNTLRPPV----PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 783 ELLTGk~PF~~~~-~~e~l~~i----v~~~lr~~i----p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+|++|+.||.... ....+... ......... ...+++.+.+||.+||+.+|.+|||+.++++.|+.+.....
T Consensus 260 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 260 KWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 9999999998754 22222111 111111100 12468999999999999999999999999999999987655
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=345.59 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=184.4
Q ss_pred CeeEE---EEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccccc
Q 002908 581 DLEEL---KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 654 (867)
Q Consensus 581 dyqil---k~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~ 654 (867)
+|++. +.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+. ||||+++++++.+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----------EANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----------hhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 45543 67999999999999984 7889999996431 245668999999997 9999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ...++|+||
T Consensus 78 ~~--~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~kl~Df 153 (325)
T 3kn6_A 78 QL--HTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEND-NLEIKIIDF 153 (325)
T ss_dssp SS--EEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCC
T ss_pred CC--EEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCC-cccEEEecc
Confidence 54 89999999999999999864 456999999999999999999999999999999999999986653 246899999
Q ss_pred CCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-------hHHHHhHhhc
Q 002908 735 GLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-------GAIIGGIVNN 806 (867)
Q Consensus 735 GLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~-------~e~l~~iv~~ 806 (867)
|++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||..... ......+...
T Consensus 154 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~ 231 (325)
T 3kn6_A 154 GFARLKPPDNQPLKTPCFTLHYAAPELLN--QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231 (325)
T ss_dssp TTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred ccceecCCCCCcccccCCCcCccCHHHhc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence 999854332 2233456899999999998 45689999999999999999999999976432 2344444443
Q ss_pred CCCCCCC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 807 TLRPPVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 807 ~lr~~ip--~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....+.+ ..+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 3322221 257899999999999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.96 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=205.5
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|++++.||+|+||.||+|.+ ++..||||++.... .......+.+|+.++..++||||+++++++....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-------CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 36899999999999999999998 47789999986421 2233467889999999999999999999986532
Q ss_pred ---CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 657 ---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 657 ---~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
....++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~----~kl~D 171 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD----LKICD 171 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEECC
T ss_pred ccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC----EEEEe
Confidence 246899999995 689888843 46899999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCccc----cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 734 FGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 734 FGLA~~~~~~~~----~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
||++........ .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT-BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcC-CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 999986543221 234578999999998764 345789999999999999999999999887766555444321110
Q ss_pred C------------------------C-----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 810 P------------------------P-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 810 ~------------------------~-----ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+ . ....+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0 0 113467899999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.00 Aligned_cols=252 Identities=24% Similarity=0.267 Sum_probs=201.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc--
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD-- 654 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~-- 654 (867)
..+|++.+.||+|+||.||+|.+ .++.||||++.... ..+.+|+.+|+.++||||++++++|..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------RFKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------------TSCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------------hhHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 45799999999999999999999 47889999986432 112368999999999999999998853
Q ss_pred --CCCCeEEEEEEeecCCchhhhhh---cccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 655 --GPGGTLATVTEFMVNGSLRHVLL---SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 655 --~~~~~l~LVmEy~~ggSL~d~L~---~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
....++++||||+++ +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++. .+
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~---~~ 196 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA---VL 196 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT---EE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC---eE
Confidence 223357899999965 5655543 23467999999999999999999999999999999999999986542 46
Q ss_pred EEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC--
Q 002908 730 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT-- 807 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~-- 807 (867)
||+|||+++............+|+.|+|||++.+ ...++.++|||||||+||+|++|+.||.+......+..++...
T Consensus 197 kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~ 275 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275 (420)
T ss_dssp EECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EeccchhhhhcccCCCceeeeeCCCcCCHHHHcC-CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999986544444445678999999999974 2357899999999999999999999999877655554443210
Q ss_pred ---------------CCCC----------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 808 ---------------LRPP----------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 808 ---------------lr~~----------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+..+ .+..+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 0000 123467899999999999999999999999987553
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=352.09 Aligned_cols=256 Identities=14% Similarity=0.059 Sum_probs=187.5
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC--CCCceeeEeccc--
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL--HHPNVVAFYGVV-- 652 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L--~HPNIVrL~g~~-- 652 (867)
..+|++.+.||+|+||.||+|.+ +++.||||+++..... .......+.+|+.+++.| +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-----SRSELERLHEATFAAARLLGESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-----HHHHHHHHHHHHHHHHHHHC----------CBCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-----cccHHHHHHHHHHHHHHhcccChhhhhhceeEEe
Confidence 34699999999999999999998 4788999999864321 223345667775544444 699988865333
Q ss_pred -----ccCCC---------------CeEEEEEEeecCCchhhhhhcccccCCHHHH------HHHHHHHHHHHHHHHHCC
Q 002908 653 -----QDGPG---------------GTLATVTEFMVNGSLRHVLLSKERHLDRRKR------LIIAMDAAFGMEYLHSKN 706 (867)
Q Consensus 653 -----~~~~~---------------~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~------l~Ia~QIa~ALayLHs~G 706 (867)
..... ..+++||||++ ++|.+++......+.+..+ +.++.||+.||+|||++|
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 21110 35899999997 8999999766656666666 788899999999999999
Q ss_pred eeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 707 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 707 IIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
|+||||||+|||++.++. +||+|||+++....... ...+|+.|+|||++.+....++.++|||||||+||+|++
T Consensus 215 ivHrDikp~NIll~~~~~----~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGR----LMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp EEETTCSGGGEEECTTSC----EEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCCC----EEEEecceeeecCCCcc--CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999997664 69999999986654321 344679999999998533568999999999999999999
Q ss_pred CCCCCCCCChhHH--H-----HhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 787 GEEPYANMHYGAI--I-----GGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 787 Gk~PF~~~~~~e~--l-----~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
|+.||........ . ..........+....+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 9999977532210 0 0001112223333578999999999999999999999999987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.07 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=196.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|++++.||+|+||.||+|.+ .++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC------ChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 47899999999999999999988 478899999975321 1233467889999999999999999999987542
Q ss_pred ----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
....++||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 98 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~----~kl~ 169 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKIL 169 (371)
T ss_dssp STTTCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC----EEEC
T ss_pred ccccccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC----EEEE
Confidence 237899999995 57877774 35899999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-- 810 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~-- 810 (867)
|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+......+
T Consensus 170 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp CCCC----------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred EeecccccccccccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999986655444445679999999999984 467899999999999999999999999887766555544321110
Q ss_pred ------------------CC--------------CC------CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 811 ------------------PV--------------PG------FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 811 ------------------~i--------------p~------~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
.. +. ..+..+.+||.+||+.||.+|||+.+++++.+--
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 00 00 0156789999999999999999999999987753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=342.72 Aligned_cols=258 Identities=27% Similarity=0.324 Sum_probs=204.7
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
....++|++++.||+|+||.||+|.+. ++.||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD------DDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC------CchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 344578999999999999999999985 7889999986532 12333456789999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
... ..++||||+.+++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|
T Consensus 95 ~~~--~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~----~~kl~D 167 (331)
T 4aaa_A 95 KKK--RWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG----VVKLCD 167 (331)
T ss_dssp ETT--EEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEECC
T ss_pred cCC--EEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC----cEEEEe
Confidence 854 8999999998888887654 345699999999999999999999999999999999999999766 469999
Q ss_pred cCCcccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-----
Q 002908 734 FGLSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----- 807 (867)
Q Consensus 734 FGLA~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~----- 807 (867)
||++..... ........+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||...........+....
T Consensus 168 fg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 168 FGFARTLAAPGEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp CTTC------------CCCCCTTCCHHHHTT-CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCCceeecCCccccCCCcCCccccCcccccC-CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 999975433 223334568999999999974 2357899999999999999999999998877655444332210
Q ss_pred --------------CCCCC----------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 808 --------------LRPPV----------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 808 --------------lr~~i----------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
...+. ...+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 01000 12468899999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.07 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=203.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|.....||+|+||.||+|.+ ++..||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--------RYSQPLHEEIALHKHLKHKNIVQYLGSFSENG- 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----------HHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--------HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-
Confidence 3444455899999999999998 477899999975321 12356788999999999999999999998754
Q ss_pred CeEEEEEEeecCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEecc-CCCCCCcEEEeec
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPICKVGDF 734 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~--~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~-dg~~~~~vKL~DF 734 (867)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++ .++|+||
T Consensus 93 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~----~~kl~Df 167 (295)
T 2clq_A 93 -FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG----VLKISDF 167 (295)
T ss_dssp -EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC----CEEECCT
T ss_pred -cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC----CEEEeec
Confidence 8999999999999999986543 35678999999999999999999999999999999999986 43 4699999
Q ss_pred CCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhhcCCCCCC
Q 002908 735 GLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVNNTLRPPV 812 (867)
Q Consensus 735 GLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~~~lr~~i 812 (867)
|++...... .......|++.|+|||++.+....++.++|||||||++|+|++|..||....... ...........+..
T Consensus 168 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 2clq_A 168 GTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI 247 (295)
T ss_dssp TTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC
T ss_pred ccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc
Confidence 999865432 2233456899999999997544457899999999999999999999997654332 22222233445566
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+..+++.+.++|.+||+.+|.+||++.+++.+-+
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 7788999999999999999999999999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=346.13 Aligned_cols=268 Identities=20% Similarity=0.219 Sum_probs=205.1
Q ss_pred ccCCCCCccccccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-
Q 002908 565 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH- 641 (867)
Q Consensus 565 a~~~fd~~~l~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~- 641 (867)
..+.+....+..+..++|++.+.||+|+||+||+|.+ .++.||||+++.. ......+.+|+.+++.++
T Consensus 22 ~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~ 92 (397)
T 1wak_A 22 CKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---------EHYTETALDEIRLLKSVRN 92 (397)
T ss_dssp CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHH
T ss_pred CCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---------CcchHHHHHHHHHHHHHhh
Confidence 3445555566677789999999999999999999988 4788999999632 223456788999999885
Q ss_pred -------CCceeeEecccccC--CCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHC-Ceecc
Q 002908 642 -------HPNVVAFYGVVQDG--PGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHF 710 (867)
Q Consensus 642 -------HPNIVrL~g~~~~~--~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHr 710 (867)
|+||+++++++... ....+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||
T Consensus 93 ~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr 171 (397)
T 1wak_A 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171 (397)
T ss_dssp SCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC
T ss_pred cCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 78899999998721 244889999999 66666666443 36799999999999999999999998 99999
Q ss_pred CCCCcceEeccCCC---------------------------------------------CCCcEEEeecCCcccccCccc
Q 002908 711 DLKCDNLLVNLKDP---------------------------------------------IRPICKVGDFGLSKIKRNTLV 745 (867)
Q Consensus 711 DLKPsNILLd~dg~---------------------------------------------~~~~vKL~DFGLA~~~~~~~~ 745 (867)
||||+|||++.++. ....++|+|||++......
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-- 249 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-- 249 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--
Confidence 99999999986641 1136899999999865443
Q ss_pred cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh------hHHHHhHhhcCCC----------
Q 002908 746 TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY------GAIIGGIVNNTLR---------- 809 (867)
Q Consensus 746 ~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~------~e~l~~iv~~~lr---------- 809 (867)
.....||+.|+|||++.+ ..++.++|||||||+||+|++|+.||..... ...+..+......
T Consensus 250 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 250 FTEDIQTRQYRSLEVLIG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp SCSCCSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred CccCCCCCcccCChhhcC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 234568999999999984 4578999999999999999999999976432 1111111110000
Q ss_pred ------------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 ------------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 ------------------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
...+...+..+.+||.+||+.||.+|||+.+++++.+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 0112223567889999999999999999999997643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.74 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=211.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChH---------HHHHHHHHHHHHHHHHhCCCCcee
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSE---------QERLTLEFWREAEILSKLHHPNVV 646 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~---------~e~~~~eflrEieiLk~L~HPNIV 646 (867)
.+..++|++.+.||+|+||.||+|.++++.||||++........... .......+.+|+.+++.++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 34567999999999999999999999999999999976432211000 001115678999999999999999
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhh------hhcc-cccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceE
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHV------LLSK-ERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLL 718 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~------L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNIL 718 (867)
++++++.... ..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 107 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSS--EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEeeCC--eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 9999998854 89999999999999998 5432 4679999999999999999999999 99999999999999
Q ss_pred eccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCCh-hhHHHHHHHHHHHHHhCCCCCCCCCh-
Q 002908 719 VNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSE-KVDVFSFGIVLWEILTGEEPYANMHY- 796 (867)
Q Consensus 719 Ld~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~-kSDVWSLGvLLyELLTGk~PF~~~~~- 796 (867)
++.++. ++|+|||++...... ......|++.|+|||++.+.. .++. ++|||||||++|+|++|..||.....
T Consensus 185 ~~~~~~----~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 185 MDKNGR----VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp ECTTSC----EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCC-CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EcCCCc----EEEeccccccccccc-cccCCCCCcCccCchhhcCCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 997664 599999999865443 334556899999999998532 3445 99999999999999999999988766
Q ss_pred hHHHHhHhhcCCCCCCC-----------------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 797 GAIIGGIVNNTLRPPVP-----------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 797 ~e~l~~iv~~~lr~~ip-----------------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
......+.......+.. ..++..+.+||.+||+.+|.+|||+.+++++.
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 45555544443332211 56789999999999999999999999998854
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=350.15 Aligned_cols=256 Identities=22% Similarity=0.286 Sum_probs=196.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||.||+|.+. ++.||||+++... .......++.+|+.+|+.++||||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF------EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 578999999999999999999984 7789999997431 12333567889999999999999999999987642
Q ss_pred C---CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 657 G---GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 657 ~---~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
. ..+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~----~kL~D 172 (432)
T 3n9x_A 99 LLKFDELYIVLEIA-DSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS----VKVCD 172 (432)
T ss_dssp TTTCCCEEEEEECC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEECC
T ss_pred CCcCCeEEEEEecC-CcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC----EEEcc
Confidence 2 4789999998 4699988853 456999999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCcc-----------------------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC
Q 002908 734 FGLSKIKRNTL-----------------------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790 (867)
Q Consensus 734 FGLA~~~~~~~-----------------------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~P 790 (867)
||+++...... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..|
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-QENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTT-CSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-CCCCCcccccchHHHHHHHHHhcccc
Confidence 99998654321 1245678999999998753 34589999999999999999985443
Q ss_pred -----------CCCCCh-----------------hHHHHhHhh------------------------cCCCCCC-----C
Q 002908 791 -----------YANMHY-----------------GAIIGGIVN------------------------NTLRPPV-----P 813 (867)
Q Consensus 791 -----------F~~~~~-----------------~e~l~~iv~------------------------~~lr~~i-----p 813 (867)
|.+... ...+..+.. .....+. .
T Consensus 252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (432)
T 3n9x_A 252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY 331 (432)
T ss_dssp TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC
Confidence 433220 011111110 0011111 1
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 365 (432)
T 3n9x_A 332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365 (432)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence 3478999999999999999999999999987654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.88 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=191.8
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
..+..++|++.+.||+|+||.||+|.+ +++.||||++..... .....++.+|+.+++.++||||+++++++
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-------QTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-------chhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 356678999999999999999999987 578899999864321 12245678899999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhc-------ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLS-------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~-------~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
.... ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~- 159 (303)
T 2vwi_A 83 VVKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS- 159 (303)
T ss_dssp ESSS--CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC-
T ss_pred eecC--CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC-
Confidence 8855 79999999999999998853 2356899999999999999999999999999999999999997664
Q ss_pred CCcEEEeecCCcccccCc------cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH
Q 002908 726 RPICKVGDFGLSKIKRNT------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 799 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~~------~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~ 799 (867)
++|+|||++...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||........
T Consensus 160 ---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 160 ---VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp ---EEECCCHHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred ---EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 599999998754321 112345689999999998641 3478899999999999999999999988766554
Q ss_pred HHhHhhcCCC--------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 800 IGGIVNNTLR--------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 800 l~~iv~~~lr--------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.......... ......++..+.++|.+||+.||.+|||+.+++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 4433332211 1223457889999999999999999999999988643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.50 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=207.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~ 649 (867)
.+..++|++.+.||+|+||.||++++ .++.||||+++........ .....+.+|+.+|+.+ .||||++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh----hHHHHHHHHHHHHHHccCCCceeEEE
Confidence 45568999999999999999999998 5788999999754321100 0113455788899999 699999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++.... .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 126 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~----~ 198 (355)
T 1vzo_A 126 YAFQTET--KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH----V 198 (355)
T ss_dssp EEEEETT--EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----E
T ss_pred EEEeeCc--eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc----E
Confidence 9998854 899999999999999998643 46899999999999999999999999999999999999997664 5
Q ss_pred EEeecCCcccccC--ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhH
Q 002908 730 KVGDFGLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGI 803 (867)
Q Consensus 730 KL~DFGLA~~~~~--~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~----~e~l~~i 803 (867)
||+|||+++.... ........||+.|+|||++.+....++.++|||||||+||+|++|..||..... ......+
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 9999999985432 222334569999999999986555678999999999999999999999975332 2233333
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHHH
Q 002908 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLRV 847 (867)
Q Consensus 804 v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq~ 847 (867)
... ..+.+..++..+.+||.+||+.||.+|| ++.+++++++-
T Consensus 279 ~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 279 LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred hcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 322 3455667899999999999999999999 99999988754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=332.09 Aligned_cols=255 Identities=26% Similarity=0.326 Sum_probs=204.5
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC---CCCceeeEeccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVV 652 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L---~HPNIVrL~g~~ 652 (867)
.++|++.+.||+|+||.||+|.+. ++.||||+++......... ..+.+|+.+++.+ .||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP------LSTIREVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB------CTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC------chhhHHHHHHHhhhccCCCCeEeeeeee
Confidence 478999999999999999999983 6789999997654322111 2344566666655 899999999998
Q ss_pred cc---CCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCc
Q 002908 653 QD---GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 653 ~~---~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~ 728 (867)
.. ......++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~---- 158 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---- 158 (326)
T ss_dssp EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC----
T ss_pred eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC----
Confidence 62 12457899999996 69999886543 45899999999999999999999999999999999999997664
Q ss_pred EEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 729 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
++|+|||++.............+|+.|+|||++. ...++.++|||||||++|+|++|..||........+..++....
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 159 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEecCcccccccCCCCccccccccceeCHHHHh--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 5999999998765544445567999999999998 44578999999999999999999999998877666555443110
Q ss_pred C-------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 809 R-------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 809 r-------------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
. ......++..+.+||.+||+.+|.+|||+.+++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0 0122457889999999999999999999999987644
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=352.28 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=187.2
Q ss_pred CeeE-EEEeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 581 DLEE-LKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 581 dyqi-lk~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
.|++ .++||+|+||.||+|++. +..||||++...... ..+.+|+.+|+.++||||+++++++...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----------MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----------HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----------HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 3555 447999999999999974 677999999753221 3567899999999999999999999665
Q ss_pred CCCeEEEEEEeecCCchhhhhhccc--------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKE--------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~--------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
....+++||||+. ++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||+...+....
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 5668999999995 67777764221 24899999999999999999999999999999999999965544556
Q ss_pred cEEEeecCCcccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh------
Q 002908 728 ICKVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG------ 797 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~------ 797 (867)
.+||+|||+++..... .......||+.|+|||++.+ ...++.++|||||||+||+|++|..||......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTT-CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC-CCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 7899999999865432 22234678999999999984 245899999999999999999999999754331
Q ss_pred ---HHHHhHhhcCCCCC------------------------------------CCCCCcHHHHHHHHHhhcCCCCCCCCH
Q 002908 798 ---AIIGGIVNNTLRPP------------------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSF 838 (867)
Q Consensus 798 ---e~l~~iv~~~lr~~------------------------------------ip~~~s~eL~dLI~kCLq~DPeeRPSa 838 (867)
..+..+......+. .....++.+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 22222211100000 001125678999999999999999999
Q ss_pred HHHHHHHHHHH
Q 002908 839 TEIARRLRVMS 849 (867)
Q Consensus 839 ~ELLe~Lq~l~ 849 (867)
.+++++.+-..
T Consensus 329 ~e~L~hp~f~~ 339 (405)
T 3rgf_A 329 EQAMQDPYFLE 339 (405)
T ss_dssp HHHHTSGGGTS
T ss_pred HHHhcChhhcc
Confidence 99999877543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=326.02 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=197.5
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC-
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG- 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~- 655 (867)
.++|++.+.||+|+||.||+|++ .++.||||++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence 35799999999999999999998 4788999999642 12346788999999999999999999987542
Q ss_pred ----------CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 656 ----------PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 656 ----------~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
.....++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~- 154 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN- 154 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC-
Confidence 135789999999999999999776677899999999999999999999999999999999999987664
Q ss_pred CCcEEEeecCCcccccCc---------------cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC
Q 002908 726 RPICKVGDFGLSKIKRNT---------------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790 (867)
Q Consensus 726 ~~~vKL~DFGLA~~~~~~---------------~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~P 790 (867)
++|+|||++...... .......||+.|+|||++.+. ..++.++|||||||++|+|++ |
T Consensus 155 ---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 155 ---VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp ---EEECCCCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---C
T ss_pred ---EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---c
Confidence 599999999754321 112345689999999999742 357899999999999999998 5
Q ss_pred CCCCCh-hHHHHhHhhcC--CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 791 YANMHY-GAIIGGIVNNT--LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 791 F~~~~~-~e~l~~iv~~~--lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
|..... ......+.... .....+..++..+.++|.+||+.||.+|||+.+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp CSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred cCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 543222 22333333222 233345567788999999999999999999999987643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=332.99 Aligned_cols=254 Identities=21% Similarity=0.238 Sum_probs=203.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE---CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC------cee
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW---RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP------NVV 646 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~---~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP------NIV 646 (867)
.+..++|++.+.||+|+||.||+|.+ .++.||||+++.. ......+.+|+.+++.++|+ +++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---------DRYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---------CchhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 45567999999999999999999987 4788999998632 12345677899999888765 499
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 725 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~ 725 (867)
++++++.... ..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+..
T Consensus 81 ~~~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 81 QMLEWFEHHG--HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp CEEEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEE
T ss_pred eeecccccCC--cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccc
Confidence 9999998854 899999999 899999886544 468999999999999999999999999999999999999864311
Q ss_pred ---------------CCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC
Q 002908 726 ---------------RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790 (867)
Q Consensus 726 ---------------~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~P 790 (867)
...++|+|||++...... .....||+.|+|||++. ...++.++|||||||++|+|++|..|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVIL--ALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHT--TSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhh--CCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 345799999999865433 23456899999999998 44578999999999999999999999
Q ss_pred CCCCChhHHHHhHhhcCCC------------------------------------------CCCCCCCcHHHHHHHHHhh
Q 002908 791 YANMHYGAIIGGIVNNTLR------------------------------------------PPVPGFCDSEWRLLMEQCW 828 (867)
Q Consensus 791 F~~~~~~e~l~~iv~~~lr------------------------------------------~~ip~~~s~eL~dLI~kCL 828 (867)
|...........+...... .......++.+.+||.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 9887665443322111000 0011223577999999999
Q ss_pred cCCCCCCCCHHHHHHHH
Q 002908 829 APDPVVRPSFTEIARRL 845 (867)
Q Consensus 829 q~DPeeRPSa~ELLe~L 845 (867)
+.||.+|||+.+++++.
T Consensus 314 ~~dP~~Rpt~~ell~hp 330 (339)
T 1z57_A 314 EYDPAKRITLREALKHP 330 (339)
T ss_dssp CSSTTTSCCHHHHTTSG
T ss_pred CcCcccccCHHHHhcCH
Confidence 99999999999998764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=335.55 Aligned_cols=255 Identities=25% Similarity=0.326 Sum_probs=203.9
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-------KPLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-------cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 3578999999999999999999985 8889999996421 223345678999999999999999999987653
Q ss_pred C---CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 656 P---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 656 ~---~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
. ....++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+
T Consensus 82 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~----~kl~ 154 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD----LKVC 154 (353)
T ss_dssp CSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC----EEEC
T ss_pred ccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc----EEEE
Confidence 1 257899999995 689888754 46899999999999999999999999999999999999997654 5999
Q ss_pred ecCCcccccCcc-----------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 002908 733 DFGLSKIKRNTL-----------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG 801 (867)
Q Consensus 733 DFGLA~~~~~~~-----------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~ 801 (867)
|||++....... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+.
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 233 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHS-CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeecc-CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999998543221 1123468999999998864 3568999999999999999999999998877655443
Q ss_pred hHhhcCCCC------------------------C------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 802 GIVNNTLRP------------------------P------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 802 ~iv~~~lr~------------------------~------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+......+ + ....+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 332110000 0 013578899999999999999999999999987654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=342.00 Aligned_cols=258 Identities=17% Similarity=0.187 Sum_probs=205.9
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEE-----E--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---CCc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGK-----W--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPN 644 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~-----~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~---HPN 644 (867)
..+..++|++.+.||+|+||+||+|. . .++.||||+++... ..++.+|+.+++.+. |+|
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~ 128 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------PWEFYIGTQLMERLKPSMQHM 128 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------HHHHHHHHHHHHHSCGGGGGG
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------hhHHHHHHHHHHHhhhhhhhh
Confidence 35667899999999999999999994 2 57889999996431 235667888888886 999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhc----ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEec
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 720 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~----~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd 720 (867)
|+++++++.... ..++||||+++++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 129 iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 129 FMKFYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206 (365)
T ss_dssp BCCEEEEEECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred hhhhheeeecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence 999999998854 88999999999999999964 345799999999999999999999999999999999999998
Q ss_pred cC-------CCCCCcEEEeecCCcccc---cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCC
Q 002908 721 LK-------DPIRPICKVGDFGLSKIK---RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP 790 (867)
Q Consensus 721 ~d-------g~~~~~vKL~DFGLA~~~---~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~P 790 (867)
.. ......+||+|||+|+.. ..........||+.|+|||++.+ ..++.++|||||||++|+|+||+.|
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCc
Confidence 61 112346799999999643 23334455679999999999984 4588999999999999999999999
Q ss_pred CCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCC-CCHHHHHHHHHHHHHHhc
Q 002908 791 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVR-PSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 791 F~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeR-PSa~ELLe~Lq~l~~a~s 853 (867)
|......... ..... .....++.+.+++..||+.+|.+| |++.++.+.|+.+.....
T Consensus 285 f~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 285 KVKNEGGECK---PEGLF---RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp CEEEETTEEE---ECSCC---TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cccCCCCcee---echhc---cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 8653221100 00111 111347789999999999999998 789999999998876654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=328.01 Aligned_cols=255 Identities=26% Similarity=0.336 Sum_probs=199.6
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++.+.||+|+||.||+|.+. ++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--------DPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--------ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 3578999999999999999999995 788999998643 122346788999999999999999999987432
Q ss_pred ------------CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCC
Q 002908 656 ------------PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 723 (867)
Q Consensus 656 ------------~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg 723 (867)
.....++||||+. ++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 2357899999996 69998884 35689999999999999999999999999999999999997433
Q ss_pred CCCCcEEEeecCCcccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH
Q 002908 724 PIRPICKVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI 799 (867)
Q Consensus 724 ~~~~~vKL~DFGLA~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~ 799 (867)
..+||+|||++...... .......+|..|+|||++.+ ...++.++|||||||++|+|++|+.||........
T Consensus 158 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 158 ---LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp ---TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ---CeEEEccCccccccCCCcccccccccccccccccCcHHhcC-cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 35799999999865322 12223457899999999874 24688999999999999999999999998776655
Q ss_pred HHhHhhcCCC-----------------------C-----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 800 IGGIVNNTLR-----------------------P-----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 800 l~~iv~~~lr-----------------------~-----~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
...+...... . .....++..+.+||.+||+.||.+|||+.+++++.+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 5444332110 0 0123578999999999999999999999999987664
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=329.59 Aligned_cols=259 Identities=23% Similarity=0.364 Sum_probs=189.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||+|.+. ++.||||++..... .+.....+..+..+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN------KEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 345678999999999999999999994 88999999975421 1222233445556788889999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
... ..++||||+ ++.+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++. ++|+
T Consensus 95 ~~~--~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~----~kl~ 167 (318)
T 2dyl_A 95 TNT--DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ----IKLC 167 (318)
T ss_dssp CSS--EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC----EEEC
T ss_pred cCC--cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC----EEEE
Confidence 854 899999999 5566555544456799999999999999999999995 9999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCcccccc---CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhHhhcCC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNG---SSSKVSEKVDVFSFGIVLWEILTGEEPYANMH-YGAIIGGIVNNTL 808 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g---~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~-~~e~l~~iv~~~l 808 (867)
|||++.............+|+.|+|||++.+ ....++.++|||||||++|+|++|+.||.... ....+..+.....
T Consensus 168 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 168 DFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP 247 (318)
T ss_dssp CCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC
T ss_pred ECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC
Confidence 9999976544444445568999999999853 23457889999999999999999999998743 3344444443322
Q ss_pred -CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 809 -RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 809 -r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..+....+++.+.++|.+||+.||.+||++.+++++.+-
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 222234578999999999999999999999999987553
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=369.56 Aligned_cols=259 Identities=32% Similarity=0.534 Sum_probs=212.0
Q ss_pred cccCCeeEE-EEeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecc
Q 002908 577 IKNEDLEEL-KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 651 (867)
Q Consensus 577 I~~sdyqil-k~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~ 651 (867)
+....+.+. +.||+|+||.||+|.+. ++.||||+++..... .....++.+|+.+|+.++|||||+++++
T Consensus 365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~l~~~ 438 (635)
T 4fl3_A 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------PALKDELLAEANVMQQLDNPYIVRMIGI 438 (635)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC------GGGHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 344455554 48999999999999762 467999999764321 1224578899999999999999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+... ..++||||+++++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||
T Consensus 439 ~~~~---~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~----~~kL 510 (635)
T 4fl3_A 439 CEAE---SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKI 510 (635)
T ss_dssp EESS---SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEEE
T ss_pred EecC---CEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC----CEEE
Confidence 9653 57899999999999999853 45689999999999999999999999999999999999999765 4699
Q ss_pred eecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhc
Q 002908 732 GDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806 (867)
Q Consensus 732 ~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~ 806 (867)
+|||+++...... ......+|+.|+|||++. ...++.++|||||||+||+|++ |+.||...........+ ..
T Consensus 511 ~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~--~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-~~ 587 (635)
T 4fl3_A 511 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EK 587 (635)
T ss_dssp CCTTHHHHTTC-------------CGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HT
T ss_pred EEcCCccccccCccccccccCCCCceeeeChhhhc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hc
Confidence 9999998543321 122334678899999998 4568999999999999999998 99999998877665554 44
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
..+...+..+++.+.+||.+||+.+|.+||++.+|++.|+.+....
T Consensus 588 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 5566778889999999999999999999999999999999987653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=351.40 Aligned_cols=250 Identities=13% Similarity=0.033 Sum_probs=190.6
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHH---HHHHhCCCCceeeEec--
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA---EILSKLHHPNVVAFYG-- 650 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEi---eiLk~L~HPNIVrL~g-- 650 (867)
..++|++.+.||+|+||.||+|++ +++.||||++........ .....+.+|+ .+|+.++|||||++++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-----NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT-----THHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch-----HHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence 357899999999999999999997 488999999985432221 1235678899 4555568999999984
Q ss_pred -----ccccCC----------CC-----eEEEEEEeecCCchhhhhhcccc------cCCHHHHHHHHHHHHHHHHHHHH
Q 002908 651 -----VVQDGP----------GG-----TLATVTEFMVNGSLRHVLLSKER------HLDRRKRLIIAMDAAFGMEYLHS 704 (867)
Q Consensus 651 -----~~~~~~----------~~-----~l~LVmEy~~ggSL~d~L~~~~~------~Lse~~~l~Ia~QIa~ALayLHs 704 (867)
++.... .. ..++||||+ +|+|.+++..... .+++..++.|+.||+.||+|||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 433321 00 378999999 7899999865432 23358888999999999999999
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccC---------CCCCChhhHHH
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS---------SSKVSEKVDVF 775 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~---------~~~~S~kSDVW 775 (867)
+||+||||||+|||++.++ .+||+|||+++..... .....| +.|+|||++.+. ...++.++|||
T Consensus 225 ~~ivHrDikp~NIll~~~~----~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRG----GVFLTGFEHLVRDGAR--VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp TTEECSCCCGGGEEECTTC----CEEECCGGGCEETTCE--EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCC----CEEEEechhheecCCc--ccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 9999999999999999766 4699999999864432 234557 999999999843 01578999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 776 SFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 776 SLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
||||+||+|++|+.||...........+.. ....+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred HHHHHHHHHHHCCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 999999999999999976544332222221 22467899999999999999999999999997543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=366.88 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=212.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||+|++ +|+.||||++....... ......+.+|+.+|+.++||||+++++++.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-----hHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 35678899999999999999999998 48889999997542211 111345778999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
+.. .+++||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|. +||+
T Consensus 255 ~~~--~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~----vKL~ 328 (576)
T 2acx_A 255 TKD--ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH----IRIS 328 (576)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC----EEEC
T ss_pred eCC--EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC----eEEE
Confidence 854 8999999999999999886543 35999999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhHhhcCC
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY----GAIIGGIVNNTL 808 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~----~e~l~~iv~~~l 808 (867)
|||++............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+...
T Consensus 329 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-- 404 (576)
T 2acx_A 329 DLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-- 404 (576)
T ss_dssp CCTTCEECCTTCCEECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--
T ss_pred ecccceecccCccccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--
Confidence 9999987655444445679999999999984 4578999999999999999999999987542 2233333322
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
....+..+++.+.+||.+||+.||.+|| ++.+++++.+
T Consensus 405 ~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 405 PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 3445677899999999999999999999 7899987754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.63 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=208.0
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC--CCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--HPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~--HPNIVrL~g~~ 652 (867)
.+...+|++.+.||+|+||.||++.+ .++.||||++..... .......+.+|+.++..++ ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC------CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc------cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 55677899999999999999999988 477899999975421 1233467889999999997 59999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.... ..++||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+
T Consensus 98 ~~~~--~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-----~~~kL~ 168 (313)
T 3cek_A 98 ITDQ--YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-----GMLKLI 168 (313)
T ss_dssp ECSS--EEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-----TEEEEC
T ss_pred ecCC--EEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-----CeEEEe
Confidence 8854 8999999 5589999998643 56899999999999999999999999999999999999963 357999
Q ss_pred ecCCcccccCcc---ccCCcCCCCCccCccccccC---------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh-hHH
Q 002908 733 DFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGS---------SSKVSEKVDVFSFGIVLWEILTGEEPYANMHY-GAI 799 (867)
Q Consensus 733 DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~---------~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~-~e~ 799 (867)
|||++....... ......||+.|+|||++.+. ...++.++|||||||++|+|++|..||..... ...
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 999998653322 12345689999999998741 13678999999999999999999999977543 334
Q ss_pred HHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 800 l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
...+.........+..++..+.++|.+||+.+|.+||++.+++++.+-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 4455555556666777899999999999999999999999999887653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.29 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=203.9
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC------CCCceeeE
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL------HHPNVVAF 648 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L------~HPNIVrL 648 (867)
....+|++++.||+|+||.||+|.+. ++.||||+++.. ......+.+|+.+++.+ +|+||+++
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---------cchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 34568999999999999999999984 788999999642 12234566777787776 57799999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
++++.... .+++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++..
T Consensus 165 ~~~~~~~~--~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~-- 239 (429)
T 3kvw_A 165 LENFTFRN--HICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS-- 239 (429)
T ss_dssp EEEEEETT--EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSC--
T ss_pred EeecccCC--eEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCc--
Confidence 99998854 899999999 478888886543 458999999999999999999999999999999999999977642
Q ss_pred cEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC
Q 002908 728 ICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~ 807 (867)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||+||+|++|..||........+..++...
T Consensus 240 ~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~ 315 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315 (429)
T ss_dssp CEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ceEEeecccceecCCc--ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 3799999999765433 234568999999999984 457999999999999999999999998877665544433210
Q ss_pred CCC---------------------------------------------------------CCCCCCcHHHHHHHHHhhcC
Q 002908 808 LRP---------------------------------------------------------PVPGFCDSEWRLLMEQCWAP 830 (867)
Q Consensus 808 lr~---------------------------------------------------------~ip~~~s~eL~dLI~kCLq~ 830 (867)
..+ ..+...++.+.+||.+||++
T Consensus 316 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~ 395 (429)
T 3kvw_A 316 GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395 (429)
T ss_dssp CCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS
T ss_pred CCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC
Confidence 000 01123478899999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 002908 831 DPVVRPSFTEIARRLRV 847 (867)
Q Consensus 831 DPeeRPSa~ELLe~Lq~ 847 (867)
||.+|||+.|++++.+-
T Consensus 396 dP~~Rpta~e~L~Hpw~ 412 (429)
T 3kvw_A 396 DPAVRMTPGQALRHPWL 412 (429)
T ss_dssp STTTSCCHHHHHTSTTT
T ss_pred ChhhCCCHHHHhCChhh
Confidence 99999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=371.13 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=214.0
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEecc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGV 651 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~ 651 (867)
..+..++|++++.||+|+||.||+|++. ++.||||+++..... .......+..|..+|..+ .||+|++++++
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~ 410 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-----QDDDVECTMVEKRVLALPGKPPFLTQLHSC 410 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-----HTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-----cHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 3566789999999999999999999984 677999999864221 111234567889999987 69999999999
Q ss_pred cccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 652 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 652 ~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
+.+.. .++|||||+++++|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++. +||
T Consensus 411 ~~~~~--~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~----ikL 483 (674)
T 3pfq_A 411 FQTMD--RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH----IKI 483 (674)
T ss_dssp CBCSS--EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC----EEE
T ss_pred EEeCC--EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc----EEE
Confidence 98854 899999999999999998644 46999999999999999999999999999999999999997764 599
Q ss_pred eecCCcccc-cCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 732 GDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 732 ~DFGLA~~~-~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
+|||+++.. .........+||+.|+|||++. ...++.++|||||||+||||++|..||...........++....
T Consensus 484 ~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-- 559 (674)
T 3pfq_A 484 ADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-- 559 (674)
T ss_dssp CCCTTCEECCCTTCCBCCCCSCSSSCCHHHHT--CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC--
T ss_pred eecceeeccccCCcccccccCCCcccCHhhhc--CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--
Confidence 999999853 2333445677999999999998 45689999999999999999999999999888888888777654
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCH-----HHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSF-----TEIARRL 845 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa-----~ELLe~L 845 (867)
..+..+++++.+||.+||+.||.+||++ .+|+++.
T Consensus 560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 4556789999999999999999999987 7777654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=362.06 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=210.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
.+..++|++.+.||+|+||.||+|++ +|+.||||++...... .......+.+|+.+|+.++||||+++++++.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-----KRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-----hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 35567899999999999999999998 4788999999754221 1112356788999999999999999999998
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~---~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
... .+++||||++|++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|. +|
T Consensus 256 ~~~--~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~----vk 329 (543)
T 3c4z_A 256 TKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN----VR 329 (543)
T ss_dssp CSS--EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC----EE
T ss_pred eCC--EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC----EE
Confidence 854 899999999999999988654 346999999999999999999999999999999999999997764 59
Q ss_pred EeecCCcccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC----hhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMH----YGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~----~~e~l~~iv~ 805 (867)
|+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+..
T Consensus 330 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~ 407 (543)
T 3c4z_A 330 ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407 (543)
T ss_dssp ECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH
T ss_pred EeecceeeeccCCCcccccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh
Confidence 99999998654332 2344579999999999984 568899999999999999999999997753 2344444444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCH-----HHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSF-----TEIARRL 845 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa-----~ELLe~L 845 (867)
.. ...+..+++.+.+||.+||+.+|.+||++ .+|+.+.
T Consensus 408 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 408 QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence 43 34456789999999999999999999965 7777654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=333.90 Aligned_cols=263 Identities=23% Similarity=0.369 Sum_probs=185.1
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHH-HHHhCCCCceeeEe
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFY 649 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEie-iLk~L~HPNIVrL~ 649 (867)
..+.+..++|++.+.||+|+||.||+|.+. ++.||||+++... . .....++..|+. +++.++||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~---~~~~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV----D---EKEQKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC----C---HHHHHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc----C---chHHHHHHHHHHHHHHcCCCCcEeeee
Confidence 445677889999999999999999999995 8889999997532 1 112234555665 67778999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhc----ccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceEeccCCC
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~----~~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNILLd~dg~ 724 (867)
+++.... ..++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++
T Consensus 88 ~~~~~~~--~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~- 163 (327)
T 3aln_A 88 GALFREG--DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG- 163 (327)
T ss_dssp EEEECSS--EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-
T ss_pred eEEEeCC--ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-
Confidence 9998754 8999999996 477776642 246789999999999999999999998 999999999999998665
Q ss_pred CCCcEEEeecCCcccccCccccCCcCCCCCccCcccccc--CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 002908 725 IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG--SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG-AIIG 801 (867)
Q Consensus 725 ~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g--~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~-e~l~ 801 (867)
.+||+|||++.............||+.|+|||++.+ ....++.++|||||||++|+|++|..||...... ....
T Consensus 164 ---~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (327)
T 3aln_A 164 ---NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240 (327)
T ss_dssp ---EEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C
T ss_pred ---CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence 469999999986554444444568999999999842 1345788999999999999999999999865432 2222
Q ss_pred hHhhcCC---CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 802 GIVNNTL---RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 802 ~iv~~~l---r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.+..... .......+++.+.+||.+||+.+|.+|||+.+++++.+-..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 2221111 11112357899999999999999999999999998766543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.35 Aligned_cols=253 Identities=22% Similarity=0.239 Sum_probs=199.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
....+|++.+.||+|+||+||+|.+. +..||+|.+..... ...+|+.+++.++||||++++++|...
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------------~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------FKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------------hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 34567999999999999999999984 55699998864321 112689999999999999999998542
Q ss_pred ----CCCeEEEEEEeecCCchhhhhh--cccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEec-cCCCCCCc
Q 002908 656 ----PGGTLATVTEFMVNGSLRHVLL--SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-LKDPIRPI 728 (867)
Q Consensus 656 ----~~~~l~LVmEy~~ggSL~d~L~--~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd-~dg~~~~~ 728 (867)
....+++||||++++.+..... .....+++..++.++.||+.||+|||++||+||||||+|||++ .++ .
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~----~ 180 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG----V 180 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT----E
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC----c
Confidence 2235889999996654333221 2346799999999999999999999999999999999999998 444 5
Q ss_pred EEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC
Q 002908 729 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l 808 (867)
+||+|||+++............+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 181 ~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG-ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEEeeCCCcccccCCCCCcccccCcCccCHHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 69999999987655444455678999999999975 34578999999999999999999999998876655544433110
Q ss_pred C---------------C------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 809 R---------------P------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 809 r---------------~------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
. . ..+..+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 0 0 012347889999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=344.84 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=189.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||.||+|.+ +|+.||||++.... ........+.+|+.+|+.++||||+++++++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 47899999999999999999987 47889999986432 12233467889999999999999999999986531
Q ss_pred ----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
....++||+++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~----~kL~ 174 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKIL 174 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC----EEEC
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC----EEEe
Confidence 24679999999 8899988753 56999999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC--
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP-- 810 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~-- 810 (867)
|||+++..... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..+......+
T Consensus 175 DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 175 DFGLARHTADE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp C-----------------CCCTTCCHHHHTT-CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ecccccccccc--CCCcCcCcCccChHHHcC-CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865432 234568999999999974 2467899999999999999999999999877665544433211000
Q ss_pred ---------------------C------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 811 ---------------------P------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 811 ---------------------~------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+ ....+++.+.+||.+||+.||.+|||+.+++++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 0 01245788999999999999999999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.26 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=201.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|.+.+.||+|+||.||+|.+. |+.||||++.... ..+.....+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 468999999999999999999984 8899999996532 12334567889999999999999999999987653
Q ss_pred C----CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 G----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ~----~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
. ...++||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~----~kl~ 168 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE----LKIL 168 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC----EEEC
T ss_pred ccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc----EEEe
Confidence 2 23599999995 68887763 34899999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-----
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----- 807 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~----- 807 (867)
|||++...... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+......+..+....
T Consensus 169 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 169 DFGLARHADAE--MTGYVVTRWYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSC-CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred ecccccCCCCC--ccccccCcCcCCHHHHhC-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865432 234568999999999874 2457889999999999999999999998877655444332210
Q ss_pred ---------------------CC---CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 808 ---------------------LR---PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 808 ---------------------lr---~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+ ......+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00 11234578999999999999999999999999987653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.98 Aligned_cols=258 Identities=19% Similarity=0.211 Sum_probs=202.0
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC--C-ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc-----
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR--G-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN----- 644 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~--G-~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN----- 644 (867)
.+..+..++|++.+.||+|+||.||+|.+. + ..||||+++.. ......+.+|+.+++.++|++
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---------GKYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---------ccchhHHHHHHHHHHHHhhcCCCCce
Confidence 344556789999999999999999999984 3 67999999632 122356778999999887655
Q ss_pred -eeeEecccccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccC
Q 002908 645 -VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 722 (867)
Q Consensus 645 -IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~d 722 (867)
++.+++++.... ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 83 ~~~~~~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 83 LCVLMSDWFNFHG--HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159 (355)
T ss_dssp CBCCEEEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCC
T ss_pred eEEEeeeeeeeCC--eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecc
Confidence 899999888754 899999999 667766665443 569999999999999999999999999999999999999543
Q ss_pred C---------------CCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhC
Q 002908 723 D---------------PIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787 (867)
Q Consensus 723 g---------------~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTG 787 (867)
+ .....++|+|||++....... ....||+.|+|||++. ...++.++|||||||++|+|++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g 235 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH--TTIVATRHYRPPEVIL--ELGWAQPCDVWSIGCILFEYYRG 235 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC--CSSCSCGGGCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccccccccccccccCCCcEEEeecCccccccccc--cCCcCCCcccCCeeee--cCCCCCccchHHHHHHHHHHHhC
Confidence 2 234567999999998654332 3456899999999998 45688999999999999999999
Q ss_pred CCCCCCCChhHHHHhHhhcCCCC------------------------------------------CCCCCCcHHHHHHHH
Q 002908 788 EEPYANMHYGAIIGGIVNNTLRP------------------------------------------PVPGFCDSEWRLLME 825 (867)
Q Consensus 788 k~PF~~~~~~e~l~~iv~~~lr~------------------------------------------~ip~~~s~eL~dLI~ 825 (867)
..||........+..+....... ......+..+.+||.
T Consensus 236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 315 (355)
T 2eu9_A 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315 (355)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence 99998877654433222111000 001122457899999
Q ss_pred HhhcCCCCCCCCHHHHHHHHH
Q 002908 826 QCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 826 kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+||+.||.+|||+.+++++.+
T Consensus 316 ~~L~~dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 316 RMLEFDPAQRITLAEALLHPF 336 (355)
T ss_dssp HHTCSSTTTSCCHHHHTTSGG
T ss_pred HHhcCChhhCcCHHHHhcChh
Confidence 999999999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=336.92 Aligned_cols=257 Identities=23% Similarity=0.206 Sum_probs=193.6
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
...++|++.+.||+|+||.||+|.+. +..||||++...... ...+.+++..+..++||||++++++|..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---------RNRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---------CCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---------cHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 44578999999999999999999984 788999998653211 1234567788888999999999999854
Q ss_pred CC-----CCeEEEEEEeecCCchhhhhh---cccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCCcceEecc-CC
Q 002908 655 GP-----GGTLATVTEFMVNGSLRHVLL---SKERHLDRRKRLIIAMDAAFGMEYLH--SKNIVHFDLKCDNLLVNL-KD 723 (867)
Q Consensus 655 ~~-----~~~l~LVmEy~~ggSL~d~L~---~~~~~Lse~~~l~Ia~QIa~ALayLH--s~GIIHrDLKPsNILLd~-dg 723 (867)
.. ...+++||||+.+ +|...+. .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT
T ss_pred cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC
Confidence 22 2348899999965 5544332 24467899999999999999999999 999999999999999985 33
Q ss_pred CCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH
Q 002908 724 PIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 803 (867)
Q Consensus 724 ~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i 803 (867)
.+||+|||++.............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||........+..+
T Consensus 170 ----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 170 ----TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp ----EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ----cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 579999999987665555556678999999999874 334789999999999999999999999988776655554
Q ss_pred hhcCCC------------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 804 VNNTLR------------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 804 v~~~lr------------------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
...... ......+++.+.+||.+||+.||.+|||+.+++++.+--
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 319 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence 431110 111223578899999999999999999999999876543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.75 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=201.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|.+.+.||+|+||.||+|.+. ++.||||++.... ..+.....+.+|+.+++.++||||+++++++....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc------cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 468999999999999999999984 8899999997532 12344567889999999999999999999997654
Q ss_pred CC----eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 657 GG----TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 657 ~~----~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
.. ..++||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~----~kL~ 186 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE----LKIL 186 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC----EEEC
T ss_pred CcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC----EEEE
Confidence 21 2489999995 68877763 34899999999999999999999999999999999999997664 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC---
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR--- 809 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr--- 809 (867)
|||+++..... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 187 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 187 DFGLARHADAE--MTGYVVTRWYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSC-CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCcccccccC--cCCcccCccccCHHHhcC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99999865433 234568999999999974 246789999999999999999999999987766555444321110
Q ss_pred --------------------CC------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 810 --------------------PP------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 810 --------------------~~------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.+ ....+++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 00 123468899999999999999999999999987653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=363.32 Aligned_cols=259 Identities=33% Similarity=0.591 Sum_probs=216.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..++|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.++||||+++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 458 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIG 458 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 566789999999999999999999984 3458999876421 2233467889999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.+ +..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 459 ~~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~----~vk 531 (656)
T 2j0j_A 459 VITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVK 531 (656)
T ss_dssp EECS---SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EEE
T ss_pred EEec---CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC----CEE
Confidence 9854 257899999999999999976666799999999999999999999999999999999999999765 469
Q ss_pred EeecCCcccccCccc--cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcC
Q 002908 731 VGDFGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 731 L~DFGLA~~~~~~~~--~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~ 807 (867)
|+|||+++....... .....+|+.|+|||++. ...++.++|||||||++|+|++ |..||...........+...
T Consensus 532 L~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~- 608 (656)
T 2j0j_A 532 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG- 608 (656)
T ss_dssp ECCCCCCCSCCC----------CCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-
T ss_pred EEecCCCeecCCCcceeccCCCCCcceeCHHHhc--CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-
Confidence 999999986543221 22334678999999998 4468999999999999999997 99999988877766655443
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
.+.+.+..+++.+.++|.+||+.+|.+|||+.++++.|+.+...
T Consensus 609 ~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 44566778999999999999999999999999999999998654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=351.00 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=206.1
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC-ceeeEecccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP-NVVAFYGVVQ 653 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP-NIVrL~g~~~ 653 (867)
+..++|++.++||+|+||.||+|.+. ++.||||++...... ..+.+|+.+++.+.|+ ++..+..++.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~il~~L~~~~~i~~i~~~~~ 73 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKIYRILQGGTGIPNVRWFGV 73 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----------CCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 34578999999999999999999984 888999998754322 2366899999999874 5555555555
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. ...+|||||+ +++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+.+. ....+||+|
T Consensus 74 ~~--~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~D 149 (483)
T 3sv0_A 74 EG--DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIID 149 (483)
T ss_dssp ET--TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTTCEEECC
T ss_pred eC--CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCC-CCCeEEEEe
Confidence 53 4889999999 9999999976677899999999999999999999999999999999999994211 123569999
Q ss_pred cCCcccccCccc--------cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh---hHHHHh
Q 002908 734 FGLSKIKRNTLV--------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY---GAIIGG 802 (867)
Q Consensus 734 FGLA~~~~~~~~--------~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~---~e~l~~ 802 (867)
||+++....... .....||+.|+|||++. ...++.++|||||||+||+|++|+.||..... ...+..
T Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (483)
T ss_dssp CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred CCcceeccCCccccccccccccccCCCccccCHHHhc--CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence 999986543221 22567999999999998 45689999999999999999999999987543 222222
Q ss_pred HhhcCCC---CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 803 IVNNTLR---PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 803 iv~~~lr---~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
+...... ..+...++.++.+||.+||+.+|.+||++.+|++.|+.+....
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 228 ISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 2221111 1122467899999999999999999999999999999987644
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=333.52 Aligned_cols=258 Identities=19% Similarity=0.242 Sum_probs=200.7
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-----------C
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-----------H 642 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-----------H 642 (867)
.+...+|++.+.||+|+||.||+|.+ .++.||||++... ......+.+|+.++++++ |
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---------ccchhhhhHHHHHHHHhhcccccchhcccc
Confidence 45668999999999999999999998 4788999998632 122345678888888876 8
Q ss_pred CceeeEecccccC--CCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCCcceE
Q 002908 643 PNVVAFYGVVQDG--PGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLL 718 (867)
Q Consensus 643 PNIVrL~g~~~~~--~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~-GIIHrDLKPsNIL 718 (867)
|||+++++++... ....+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence 9999999998753 223789999999 99999988653 34599999999999999999999998 9999999999999
Q ss_pred eccCC--CCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCh
Q 002908 719 VNLKD--PIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHY 796 (867)
Q Consensus 719 Ld~dg--~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~ 796 (867)
++.++ .....++|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 97554 23446899999999865443 233468999999999984 4578999999999999999999999976432
Q ss_pred ------hHHHHhHhhcCC----------------------------------------CCCCCCCCcHHHHHHHHHhhcC
Q 002908 797 ------GAIIGGIVNNTL----------------------------------------RPPVPGFCDSEWRLLMEQCWAP 830 (867)
Q Consensus 797 ------~e~l~~iv~~~l----------------------------------------r~~ip~~~s~eL~dLI~kCLq~ 830 (867)
...+..+..... ....+..++..+.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 111111111000 0112234567899999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 002908 831 DPVVRPSFTEIARRLRV 847 (867)
Q Consensus 831 DPeeRPSa~ELLe~Lq~ 847 (867)
||.+|||+.+++++.+-
T Consensus 321 dP~~Rpt~~ell~hp~f 337 (373)
T 1q8y_A 321 DPRKRADAGGLVNHPWL 337 (373)
T ss_dssp STTTCBCHHHHHTCGGG
T ss_pred CccccCCHHHHhhChhh
Confidence 99999999999987653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=330.29 Aligned_cols=257 Identities=24% Similarity=0.309 Sum_probs=180.3
Q ss_pred cccCCeeEEE-EeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 577 IKNEDLEELK-ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 577 I~~sdyqilk-~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
...++|++.+ .||+|+||.||+|.+. ++.||||++... . .... .....++.+.||||+++++++.
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~---~~~~---e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------P---KARQ---EVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------H---HHHH---HHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------H---HHHH---HHHHHHHhcCCCChHHHHHHHh
Confidence 3457899965 6999999999999995 889999998642 1 1111 1223456779999999999986
Q ss_pred cC--CCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 654 DG--PGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 654 ~~--~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
.. ....+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ...++
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~-~~~~k 171 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEK-DAVLK 171 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSST-TCCEE
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCC-CceEE
Confidence 52 2346899999999999999997554 46999999999999999999999999999999999999987553 34579
Q ss_pred EeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH----HhHhhc
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII----GGIVNN 806 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l----~~iv~~ 806 (867)
|+|||++....... .....+|+.|+|||++. ...++.++|||||||++|+|++|..||......... ..+...
T Consensus 172 l~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (336)
T 3fhr_A 172 LTDFGFAKETTQNA-LQTPCYTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248 (336)
T ss_dssp ECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred Eeccccceeccccc-cccCCCCcCccChhhhC--CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc
Confidence 99999998654332 23456899999999997 456788999999999999999999999765443321 111111
Q ss_pred CC--CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 807 TL--RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 807 ~l--r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
.. ..+....+++.+.+||.+||+.+|.+|||+.+++++.+-..
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 11 22233568999999999999999999999999999877543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.77 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=202.5
Q ss_pred CccccccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC--CCcee
Q 002908 571 ISTLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--HPNVV 646 (867)
Q Consensus 571 ~~~l~~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~--HPNIV 646 (867)
.........++|++.+.||+|+||.||+|.+ +++.||||+++.......... .....+.+|+.+++.++ ||||+
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh--hhhhHHHHHHHHHHhhccCCCCce
Confidence 3344556678999999999999999999998 578899999986543221000 01134557889999996 59999
Q ss_pred eEecccccCCCCeEEEEEEeecC-CchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEec-cCCC
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVN-GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-LKDP 724 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~g-gSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd-~dg~ 724 (867)
++++++.... ..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 112 ~~~~~~~~~~--~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~- 187 (320)
T 3a99_A 112 RLLDWFERPD--SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG- 187 (320)
T ss_dssp CEEEEEECSS--EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-
T ss_pred EEEEEEecCC--cEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC-
Confidence 9999998854 89999999976 899998854 45689999999999999999999999999999999999998 333
Q ss_pred CCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHh
Q 002908 725 IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804 (867)
Q Consensus 725 ~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv 804 (867)
.+||+|||++....... .....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.... . +.
T Consensus 188 ---~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~ 256 (320)
T 3a99_A 188 ---ELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----II 256 (320)
T ss_dssp ---EEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HH
T ss_pred ---CEEEeeCcccccccccc-ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hh
Confidence 46999999998665433 2345689999999998742 234788999999999999999999997532 1 12
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 805 ~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.. ....+..+++.+.+||.+||+.+|.+|||+.+++++.+
T Consensus 257 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 257 RG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp HC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred cc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 22 22345678999999999999999999999999988643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.61 Aligned_cols=253 Identities=24% Similarity=0.225 Sum_probs=200.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CC-----ceee
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HP-----NVVA 647 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HP-----NIVr 647 (867)
....++|++.+.||+|+||+||+|.+. ++.||||+++.. ......+.+|+.+++.++ |+ +|++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---------KAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---------HHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 344679999999999999999999984 778999999632 123455677888888875 44 4999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCCcceEeccCCC
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLH--SKNIVHFDLKCDNLLVNLKDP 724 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLH--s~GIIHrDLKPsNILLd~dg~ 724 (867)
+++++.... ..++||||+. ++|.+++.... ..+++..+..++.||+.||.||| ..||+||||||+|||++.++
T Consensus 121 ~~~~~~~~~--~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~- 196 (382)
T 2vx3_A 121 LKRHFMFRN--HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK- 196 (382)
T ss_dssp EEEEEEETT--EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT-
T ss_pred eeeeeccCC--ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC-
Confidence 999998854 8999999995 69999886543 56899999999999999999999 57999999999999996533
Q ss_pred CCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHh
Q 002908 725 IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804 (867)
Q Consensus 725 ~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv 804 (867)
...+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+.
T Consensus 197 -~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 197 -RSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp -SCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -CCcEEEEeccCceecccc--cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 235799999999866433 234568999999999984 458899999999999999999999999877766555444
Q ss_pred hcCCCCC-----------------------------------CCC---------------------------CCcHHHHH
Q 002908 805 NNTLRPP-----------------------------------VPG---------------------------FCDSEWRL 822 (867)
Q Consensus 805 ~~~lr~~-----------------------------------ip~---------------------------~~s~eL~d 822 (867)
.....++ .+. ...+.+.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 351 (382)
T 2vx3_A 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351 (382)
T ss_dssp HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence 3211000 000 00147899
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 823 LMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 823 LI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
||.+||+.||.+|||+.+++++.+
T Consensus 352 li~~mL~~dP~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 352 LILRMLDYDPKTRIQPYYALQHSF 375 (382)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred HHHHhcCCChhhCCCHHHHhcCcc
Confidence 999999999999999999988644
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.53 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=194.5
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC----CCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL----HHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L----~HPNIVrL~ 649 (867)
....++|++.+.||+|+||.||+|.+ .++.||||++.......... ......+.+|+.++.++ +||||++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP--LSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccccc--chhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 44567899999999999999999988 47889999997543221110 11123455788899888 899999999
Q ss_pred cccccCCCCeEEEEEEe-ecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEec-cCCCCCC
Q 002908 650 GVVQDGPGGTLATVTEF-MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-LKDPIRP 727 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy-~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd-~dg~~~~ 727 (867)
+++.... ..++|||+ +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 105 ~~~~~~~--~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---- 177 (312)
T 2iwi_A 105 DWFETQE--GFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG---- 177 (312)
T ss_dssp EEC-------CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT----
T ss_pred EEEecCC--eEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC----
Confidence 9998754 78999999 788999999865 34689999999999999999999999999999999999998 444
Q ss_pred cEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC
Q 002908 728 ICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~ 807 (867)
.++|+|||++....... .....|+..|+|||++.+. ...+.++|||||||++|+|++|+.||.... .+...
T Consensus 178 ~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~- 248 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA- 248 (312)
T ss_dssp EEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT-
T ss_pred eEEEEEcchhhhcccCc-ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh-
Confidence 46999999998665433 2345689999999998742 223568999999999999999999997532 11222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....+..++..+.++|.+||+.+|.+|||+.+++++.+
T Consensus 249 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 249 -ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred -ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 23455678999999999999999999999999998654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=343.04 Aligned_cols=256 Identities=29% Similarity=0.403 Sum_probs=195.3
Q ss_pred cccccCCeeEEEEeeecCcEEE-EEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTV-YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~V-Yka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~ 652 (867)
..+...+|++.+.||+|+||+| |++..+++.||||++...... .+.+|+.+|+.+ +|||||++++++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----------~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----------FADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----------ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----------HHHHHHHHHHhccCCCCcCeEEEEE
Confidence 3566678999999999999984 556668999999999653221 234789999999 799999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCC-CCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg-~~~~~vKL 731 (867)
.+.. ..++|||||. ++|.+++......+.+..++.++.||+.||.|||++||+||||||+|||++.++ .....++|
T Consensus 88 ~~~~--~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 88 KDRQ--FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EETT--EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred ecCC--EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 8754 8999999994 699999976665666667789999999999999999999999999999996533 23456799
Q ss_pred eecCCcccccCc----cccCCcCCCCCccCccccccC-CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 732 GDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 732 ~DFGLA~~~~~~----~~~s~~~GT~~Y~APEvl~g~-~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
+|||+++..... .......||+.|+|||++.+. ...++.++|||||||++|+|++ |..||..............
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~ 244 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTC
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhcc
Confidence 999999865432 223446699999999999742 3456789999999999999999 9999976544333221111
Q ss_pred cCCC-CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 806 NTLR-PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 806 ~~lr-~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
.... .......+..+.+||.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111 11122345668999999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=334.86 Aligned_cols=253 Identities=28% Similarity=0.365 Sum_probs=189.6
Q ss_pred cccCCeeEEEEeeecCcEEEEEE-EECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHG-KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka-~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~ 654 (867)
...+.|.+.+.||+|+||+||.+ ..+|+.||||++.... ...+.+|+.+|..+ +||||+++++++.+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 80 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----------CDIALMEIKLLTESDDHPNVIRYYCSETT 80 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred hhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----------HHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 34456777899999999999754 4478999999986421 13467899999876 89999999999987
Q ss_pred CCCCeEEEEEEeecCCchhhhhhccccc------CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCC-----
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERH------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD----- 723 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~------Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg----- 723 (867)
.. .+++||||| +++|.+++...... .++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~--~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 81 DR--FLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp SS--EEEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSC
T ss_pred CC--eEEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccc
Confidence 54 899999999 46999998654321 12334578999999999999999999999999999998653
Q ss_pred ----CCCCcEEEeecCCcccccCcc-----ccCCcCCCCCccCccccccC-----CCCCChhhHHHHHHHHHHHHHh-CC
Q 002908 724 ----PIRPICKVGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGS-----SSKVSEKVDVFSFGIVLWEILT-GE 788 (867)
Q Consensus 724 ----~~~~~vKL~DFGLA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~-----~~~~S~kSDVWSLGvLLyELLT-Gk 788 (867)
.....+||+|||++....... ......||+.|+|||++.+. ...++.++|||||||++|+|+| |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 344578999999998654322 12245699999999999752 2568899999999999999999 99
Q ss_pred CCCCCCChhHHHHhHhhcCCCCCCC-----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 789 EPYANMHYGAIIGGIVNNTLRPPVP-----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 789 ~PF~~~~~~e~l~~iv~~~lr~~ip-----~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.||....... ..+.......+.. ..+++.+.+||.+||+.||.+|||+.+++++.
T Consensus 238 ~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 238 HPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp CTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 9997654332 2233332222211 12457899999999999999999999998753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.21 Aligned_cols=234 Identities=14% Similarity=0.081 Sum_probs=186.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
+..++|++.+.||+|+||.||+|.+. ++.||||++...... .+.....+.+|+.++..++||||+++++++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-----PDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-----CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 55678999999999999999999995 789999999754322 23345678899999999999999999999988
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++||||+++++|.+++.. . .....+..|+.||+.||.|||++||+||||||+|||++.+|. ++|+++
T Consensus 103 ~~--~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~----~kl~~~ 173 (286)
T 3uqc_A 103 RA--GGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD----VVLAYP 173 (286)
T ss_dssp TT--EEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC----EEECSC
T ss_pred CC--cEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC----EEEEec
Confidence 54 89999999999999999843 2 356678899999999999999999999999999999997764 477744
Q ss_pred CCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHH---hHhhcCCCC-
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIG---GIVNNTLRP- 810 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~---~iv~~~lr~- 810 (867)
| |++| ++.++|||||||++|+|+||+.||........+. .........
T Consensus 174 ~-------------------~~~~---------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T 3uqc_A 174 A-------------------TMPD---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225 (286)
T ss_dssp C-------------------CCTT---------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH
T ss_pred c-------------------ccCC---------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh
Confidence 3 3332 5789999999999999999999998755432111 001111110
Q ss_pred -CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 811 -PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 811 -~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
.....+++.+.++|.+||+.||.+| |+.++++.|+.+.....
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 1224678999999999999999999 99999999999876544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.49 Aligned_cols=235 Identities=26% Similarity=0.366 Sum_probs=183.6
Q ss_pred cCCeeEE-EEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHH-HhCCCCceeeEeccccc
Q 002908 579 NEDLEEL-KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL-SKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 579 ~sdyqil-k~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiL-k~L~HPNIVrL~g~~~~ 654 (867)
.++|.+. +.||+|+||.||++.+ +++.||||+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3567777 7899999999999998 4788999999642 3456788887 56689999999999865
Q ss_pred --CCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 655 --GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 655 --~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
......++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+. ...++|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~~~kl 161 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP-NAILKL 161 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSST-TCCEEE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCC-CCcEEE
Confidence 22347899999999999999997543 46999999999999999999999999999999999999997432 246799
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC--C
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL--R 809 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l--r 809 (867)
+|||++.... ...++.++|||||||++|+|++|..||................. .
T Consensus 162 ~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 162 TDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp CCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred eccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 9999986432 12357799999999999999999999977554332221111111 1
Q ss_pred CCCC----CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 810 PPVP----GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 810 ~~ip----~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
...+ ..+++.+.+||.+||+.||.+|||+.+++++.+-...
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 1111 4578999999999999999999999999998776543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.30 Aligned_cols=255 Identities=17% Similarity=0.168 Sum_probs=187.9
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---------C-----
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---------H----- 642 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~---------H----- 642 (867)
+..++|++.+.||+|+||+||+|+++++.||||+++.................+.+|+.+++.++ |
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45678999999999999999999999999999999875432110011112345677888888775 5
Q ss_pred ------------CceeeEecccccC-----------CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHH
Q 002908 643 ------------PNVVAFYGVVQDG-----------PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 699 (867)
Q Consensus 643 ------------PNIVrL~g~~~~~-----------~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~AL 699 (867)
|||+++++++... ....+++||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 4455555555430 13589999999999987776633 5689999999999999999
Q ss_pred HHHH-HCCeeccCCCCcceEeccCCCC----------------CCcEEEeecCCcccccCccccCCcCCCCCccCccccc
Q 002908 700 EYLH-SKNIVHFDLKCDNLLVNLKDPI----------------RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLN 762 (867)
Q Consensus 700 ayLH-s~GIIHrDLKPsNILLd~dg~~----------------~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~ 762 (867)
.||| ++||+||||||+|||++.++.. ...+||+|||+|+..... ...||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 9999999999999999977621 126899999999866543 236999999999998
Q ss_pred cCCCCCChhhHHHHHHHH-HHHHHhCCCCCCCCCh-hHHHHhHhhcC-CCCC----CCCCCcHHHHHHHHHhhcCCCCCC
Q 002908 763 GSSSKVSEKVDVFSFGIV-LWEILTGEEPYANMHY-GAIIGGIVNNT-LRPP----VPGFCDSEWRLLMEQCWAPDPVVR 835 (867)
Q Consensus 763 g~~~~~S~kSDVWSLGvL-LyELLTGk~PF~~~~~-~e~l~~iv~~~-lr~~----ip~~~s~eL~dLI~kCLq~DPeeR 835 (867)
+.. +.++|||||+++ .+++++|..||..... ......+.... .... .+..+++++.+||.+||+.+
T Consensus 251 g~~---~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 251 GDG---DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp CCS---SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred CCC---ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 533 789999998877 7778889999854322 11222222111 1111 12246788999999999976
Q ss_pred CCHHHHH-HHH
Q 002908 836 PSFTEIA-RRL 845 (867)
Q Consensus 836 PSa~ELL-e~L 845 (867)
|+.+++ ++.
T Consensus 324 -sa~e~l~~Hp 333 (336)
T 2vuw_A 324 -SATDLLCQHS 333 (336)
T ss_dssp -SHHHHHHHCG
T ss_pred -CHHHHHhcCC
Confidence 999998 653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=344.34 Aligned_cols=245 Identities=20% Similarity=0.228 Sum_probs=193.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
.+..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.++..++||||++++++|
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 148 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------DAEAQAMAMAERQFLAEVVHPSIVQIFNFV 148 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-------CHHHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence 455689999999999999999999983 6889999986421 122345688999999999999999999998
Q ss_pred ccCCC---CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 653 QDGPG---GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 653 ~~~~~---~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
..... ...|+||||+++++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+|||++.+ .+
T Consensus 149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-----~~ 220 (681)
T 2pzi_A 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-----QL 220 (681)
T ss_dssp EEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-----CE
T ss_pred eecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-----cE
Confidence 76432 126999999999999987643 69999999999999999999999999999999999999853 46
Q ss_pred EEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 730 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
||+|||+++..... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||...... ....
T Consensus 221 kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~ 286 (681)
T 2pzi_A 221 KLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPE 286 (681)
T ss_dssp EECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCT
T ss_pred EEEecccchhcccC---CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcccccc--------cccc
Confidence 99999999865443 345699999999999742 388999999999999999999888652210 0000
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLRVMS 849 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRP-Sa~ELLe~Lq~l~ 849 (867)
.......++.+.+||.+||+.+|.+|| +++++...|..+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000011357899999999999999999 5666766666654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=323.90 Aligned_cols=247 Identities=14% Similarity=0.031 Sum_probs=184.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC-CceeeEe------
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFY------ 649 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H-PNIVrL~------ 649 (867)
...|...+.||+|+||+||+|++. |+.||||+++..... .......+.+|+.+++.+.| +|...+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-----PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-----cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 345889999999999999999985 899999998743221 11223568889999999987 3221111
Q ss_pred ---------------cccccCC---CCeEEEEEEeecCCchhhhhh------cccccCCHHHHHHHHHHHHHHHHHHHHC
Q 002908 650 ---------------GVVQDGP---GGTLATVTEFMVNGSLRHVLL------SKERHLDRRKRLIIAMDAAFGMEYLHSK 705 (867)
Q Consensus 650 ---------------g~~~~~~---~~~l~LVmEy~~ggSL~d~L~------~~~~~Lse~~~l~Ia~QIa~ALayLHs~ 705 (867)
.++.... ...++++|+++ +++|.+++. .....+++..++.++.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 22457777766 789988883 2245688889999999999999999999
Q ss_pred CeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCcccccc--------CCCCCChhhHHHHH
Q 002908 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG--------SSSKVSEKVDVFSF 777 (867)
Q Consensus 706 GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g--------~~~~~S~kSDVWSL 777 (867)
||+||||||+||||+.++. +||+|||+++..... .....| +.|+|||++.+ ....++.++|||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~----~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGG----VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp TEECSCCCGGGEEECTTCC----EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred CcccCCcccceEEEecCCe----EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999999999997765 699999999865443 334567 99999999931 13457889999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 778 GIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 778 GvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
||++|+|++|+.||...........+.. ....+++.+.+||.+||+.+|.+||++.+++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999999987654433332222 123568999999999999999999998887654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=345.69 Aligned_cols=255 Identities=26% Similarity=0.343 Sum_probs=198.3
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc-
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD- 654 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~- 654 (867)
..++|++.+.||+|+||.||+|.+ .|+.||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-------SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-------CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 347899999999999999999987 47889999986431 12334678899999999999999999998765
Q ss_pred ---CCCCeEEEEEEeecCCchhhhhhccc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 655 ---GPGGTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 655 ---~~~~~l~LVmEy~~ggSL~d~L~~~~--~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
...+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++. ...+
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~-~~~v 163 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ-RLIH 163 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSS-SCEE
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCC-ceeE
Confidence 22457899999999999999987543 36899999999999999999999999999999999999997764 3568
Q ss_pred EEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH------
Q 002908 730 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI------ 803 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i------ 803 (867)
+|+|||++.............||+.|+|||++. ...++.++|||||||++|+|++|..||........+...
T Consensus 164 KL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 164 KIIDLGYAKELDQGELCTEFVGTLQYLAPELLE--QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp EECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSC--CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred EEcccccccccccccccccccCCcccCChHHhc--cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 999999998766555555677999999999998 456789999999999999999999999764332211000
Q ss_pred --------hhcCC----C----CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHH
Q 002908 804 --------VNNTL----R----PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 842 (867)
Q Consensus 804 --------v~~~l----r----~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELL 842 (867)
..... . ......+++.+.+||.+||..||.+|||+.+++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00000 0 111223578899999999999999999998854
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=278.50 Aligned_cols=190 Identities=16% Similarity=0.071 Sum_probs=131.4
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccccCCC--ChHHHHHHHHHHHHHHHHHhC-CCCceeeEecccccCCCCeEE
Q 002908 587 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGR--SSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 587 ~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~--~~~~e~~~~eflrEieiLk~L-~HPNIVrL~g~~~~~~~~~l~ 661 (867)
.++.|+.|.+..++. -|..+|||++........ ....+....+|.+|+++|+++ .|+||+++++++.+.. ..|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~--~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ--SGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS--EEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC--EEE
Confidence 467777777665544 589999999986543322 233455667899999999999 6999999999998854 999
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
|||||++|++|.+.+... .++++. .|+.||+.||+|||++|||||||||+||||+.+|. +||+|||+|+...
T Consensus 319 LVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~----vKL~DFGlAr~~~ 390 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH----ARLIDFGSIVTTP 390 (569)
T ss_dssp EEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC----EEECCCTTEESCC
T ss_pred EEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC----EEEeecccCeeCC
Confidence 999999999999999644 456654 47899999999999999999999999999997765 5999999998654
Q ss_pred Cc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCC
Q 002908 742 NT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE 789 (867)
Q Consensus 742 ~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~ 789 (867)
.. ......+||+.|||||++.+. +..++|+|++|+++++|.++..
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g~---~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAEN---KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred CCCccccCceechhhccHHHhCCC---CCCcccccccccchhhhccccc
Confidence 32 233456799999999999853 4667999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.8e-26 Score=260.38 Aligned_cols=191 Identities=19% Similarity=0.153 Sum_probs=146.8
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEEEE
Q 002908 584 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~LV 663 (867)
..+.||+|+||.||+|.+.+..+++|...................++.+|+.+|++++||||+++..++.... ..++|
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NKRIM 417 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TTEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--ccEEE
Confidence 3568999999999999889999999988654433222233334567899999999999999995444444432 56999
Q ss_pred EEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc
Q 002908 664 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743 (867)
Q Consensus 664 mEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~ 743 (867)
|||+++++|.+++.. ++.++.|++.||.|||++||+||||||+|||++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~------~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK------DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS------SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC------eEEEEECccCEECCCc
Confidence 999999999999854 5689999999999999999999999999999995 5799999999976543
Q ss_pred cc--------cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 002908 744 LV--------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791 (867)
Q Consensus 744 ~~--------~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF 791 (867)
.. .....||+.|+|||++.+....|+..+|+|+..+-..+.+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21 1245699999999999853345778899999999888888777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=200.01 Aligned_cols=152 Identities=18% Similarity=0.033 Sum_probs=115.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCC--ChHH--------HHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 580 EDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGR--SSEQ--------ERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~--~~~~--------e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
..|.+.+.||+|+||.||+|.+ .|+.||||+++....... .... ......+.+|+.+++.++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3466779999999999999999 478999999975322111 0000 123467889999999999 4 666
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCc
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~ 728 (867)
++++.. +..++||||+++++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++ .
T Consensus 167 ~~~~~~---~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~----~ 230 (282)
T 1zar_A 167 PKVYAW---EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE----G 230 (282)
T ss_dssp CCEEEE---ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT----E
T ss_pred CeEEec---cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC----c
Confidence 665543 25699999999999988 421 22446999999999999999999999999999999 54 4
Q ss_pred EEEeecCCcccccCccccCCcCCCCCccCccccc
Q 002908 729 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLN 762 (867)
Q Consensus 729 vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~ 762 (867)
++|+|||+|+ .+..|+|||++.
T Consensus 231 vkl~DFG~a~------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSV------------EVGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCE------------ETTSTTHHHHHH
T ss_pred EEEEECCCCe------------ECCCCCHHHHHH
Confidence 6999999986 234578899875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-18 Score=180.08 Aligned_cols=143 Identities=17% Similarity=0.083 Sum_probs=105.3
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCce--EEEEEeeccccCCCC----------------hHHHHHHHHHHHHHHHHHhCC
Q 002908 582 LEELKELGSGTFGTVYHGKW--RGTD--VAIKRIKKSCFTGRS----------------SEQERLTLEFWREAEILSKLH 641 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~--~G~~--VAVKv~k~~~~sd~~----------------~~~e~~~~eflrEieiLk~L~ 641 (867)
|++.+.||+|+||.||+|.+ .|+. ||||+++........ .........+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67899999999999999998 7888 999998654211000 001122346788999999998
Q ss_pred CCce--eeEecccccCCCCeEEEEEEeecC-C----chhhhhhcccccCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCC
Q 002908 642 HPNV--VAFYGVVQDGPGGTLATVTEFMVN-G----SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH-SKNIVHFDLK 713 (867)
Q Consensus 642 HPNI--VrL~g~~~~~~~~~l~LVmEy~~g-g----SL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLH-s~GIIHrDLK 713 (867)
|+++ +.++.+ . ..+|||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.||+|||||
T Consensus 129 ~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred hCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 8754 333332 1 45899999942 3 55554321 234567789999999999999 9999999999
Q ss_pred CcceEeccCCCCCCcEEEeecCCcccc
Q 002908 714 CDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 714 PsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
|.|||++. .++|+|||+|...
T Consensus 199 p~NILl~~------~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID------KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS------SEEECCCTTCEET
T ss_pred HHHEEEcC------cEEEEECcccccC
Confidence 99999985 4699999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.3e-15 Score=167.05 Aligned_cols=147 Identities=14% Similarity=0.038 Sum_probs=99.9
Q ss_pred eeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCC------------ChHHHHHH--HHHHHHHHHHHhCCCCcee
Q 002908 582 LEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGR------------SSEQERLT--LEFWREAEILSKLHHPNVV 646 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~------------~~~~e~~~--~eflrEieiLk~L~HPNIV 646 (867)
|++...||.|++|.||+|.. .|+.||||+++....... ........ ....+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999987 589999999875432211 01111111 1123455666666443332
Q ss_pred eEecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCC-
Q 002908 647 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI- 725 (867)
Q Consensus 647 rL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~- 725 (867)
...-+... ..+|||||++|.+|.++.. ......++.||+.+|.+||.+|||||||||.|||++.+|..
T Consensus 177 vp~p~~~~----~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQS----RHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEEE----TTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCeeeecc----CceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 11111111 2369999999888876542 12345678999999999999999999999999999877642
Q ss_pred -----CCcEEEeecCCccc
Q 002908 726 -----RPICKVGDFGLSKI 739 (867)
Q Consensus 726 -----~~~vKL~DFGLA~~ 739 (867)
...+.|+||+.+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 12368999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=120.16 Aligned_cols=139 Identities=17% Similarity=0.063 Sum_probs=106.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~~ 658 (867)
..|++...++.|+.+.||++...+..+++|+........ ...+.+|+.+++.+. +..+.++++++... +
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~ 83 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHD--G 83 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--------HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--C
Confidence 357788889989999999998778899999986532111 123667888998884 66778888888764 4
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS---------------------------------- 704 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs---------------------------------- 704 (867)
..++||||++|.+|.+.+. +......++.+++.+|+.||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred ceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 8899999999999877531 112234678899999999998
Q ss_pred -------------------------CCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 705 -------------------------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 705 -------------------------~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..++|+|++|.|||++.++ .+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~----~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK----VSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE----EEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc----EEEEEEchhcc
Confidence 4489999999999997432 34699999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.3e-09 Score=116.01 Aligned_cols=145 Identities=20% Similarity=0.259 Sum_probs=107.0
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEee--ccccCCCChHHHHHHHHHHHHHHHHHhCC--CCceeeEecccccCCC-C
Q 002908 584 ELKELGSGTFGTVYHGKWRGTDVAIKRIK--KSCFTGRSSEQERLTLEFWREAEILSKLH--HPNVVAFYGVVQDGPG-G 658 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~~G~~VAVKv~k--~~~~sd~~~~~e~~~~eflrEieiLk~L~--HPNIVrL~g~~~~~~~-~ 658 (867)
.++.|+.|.++.||+....+..+++|+.. ..... .....+.+|..+++.|. +..+++++.++.+... +
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-------PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-------CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 35678999999999998877889999875 32110 01235667899999887 4457888888766421 4
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS---------------------------------- 704 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs---------------------------------- 704 (867)
..++||||++|..+.+.. ...++......++.+++..|+.||.
T Consensus 115 ~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 678999999988875422 1246788888999999999999997
Q ss_pred ------------------------CCeeccCCCCcceEeccCCCCCCcEEEeecCCcccc
Q 002908 705 ------------------------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740 (867)
Q Consensus 705 ------------------------~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~ 740 (867)
.++||+|+++.|||++.++. ..+.|+||+.+...
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~--~v~~viDwe~a~~g 249 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP--RVLAVLDWELSTLG 249 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS--CEEEECCCTTCEEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC--cEEEEECccccccC
Confidence 35999999999999997653 23589999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.89 E-value=3.5e-09 Score=107.23 Aligned_cols=132 Identities=18% Similarity=0.056 Sum_probs=91.3
Q ss_pred eeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc--eeeEecccccCCCC
Q 002908 582 LEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQDGPGG 658 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN--IVrL~g~~~~~~~~ 658 (867)
+.+....+.|..+.||++... |..++||+..... ...+.+|+.+++.+.+.+ +.+++++.... +
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~ 88 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--G 88 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--S
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--C
Confidence 444333345666999998764 6779999975431 123557888888885444 45678777653 4
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN-------------------------------- 706 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~G-------------------------------- 706 (867)
..++||||++|.+|. ... .. ...++.+++..|+.||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp CEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 689999999998884 211 12 1246677788888888643
Q ss_pred --------------------------eeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 707 --------------------------IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 707 --------------------------IIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
++|+|++|.|||++.++ .+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~----~~~liD~~~a~~ 214 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR----FSGFIDCGRLGV 214 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE----EEEECCCTTCEE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc----EEEEEcchhccc
Confidence 99999999999997432 346999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.75 E-value=7.7e-09 Score=109.45 Aligned_cols=187 Identities=20% Similarity=0.183 Sum_probs=120.1
Q ss_pred EeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCc--eeeEecccccCC-CCeEEE
Q 002908 587 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPN--VVAFYGVVQDGP-GGTLAT 662 (867)
Q Consensus 587 ~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPN--IVrL~g~~~~~~-~~~l~L 662 (867)
.++.|.+..||+.. ..++||+.... .....+.+|..+|+.+. +.. +.+++....... ....++
T Consensus 27 ~~~~G~~n~v~~v~---~~~vlR~~~~~----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN---RDFIFKFPKHS----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp EEEECSSEEEEEST---TSEEEEEESSH----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred ecCCCCcceEEEEC---CEEEEEecCCc----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 48999999999753 67899986421 22356778999998873 332 344444433221 124578
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-------------------------------------- 704 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-------------------------------------- 704 (867)
||++++|.+|..... ..++..+...++.+++..|+.||+
T Consensus 94 vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999998875432 346777888888899999988886
Q ss_pred --------------------CCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCcccccc-
Q 002908 705 --------------------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG- 763 (867)
Q Consensus 705 --------------------~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g- 763 (867)
..++|+|++|.||+++.+. ...+.|+||+.+.................-..|+....
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~--~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK--NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT--TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC--CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence 1379999999999998641 12358999999876443221111111000012221110
Q ss_pred --CCC---------CCChhhHHHHHHHHHHHHHhCCCCC
Q 002908 764 --SSS---------KVSEKVDVFSFGIVLWEILTGEEPY 791 (867)
Q Consensus 764 --~~~---------~~S~kSDVWSLGvLLyELLTGk~PF 791 (867)
... ......+.|+++.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 0122368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=8.9e-06 Score=86.74 Aligned_cols=139 Identities=21% Similarity=0.173 Sum_probs=92.9
Q ss_pred EEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC---ceeeEecccccCCCCeEEE
Q 002908 586 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP---NVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 586 k~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP---NIVrL~g~~~~~~~~~l~L 662 (867)
+.++.|....||+. +..++||+... ......+.+|..+|+.+.+. .+.+++.+... ..+..++
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~ 90 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFV 90 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEE
Confidence 45788999999987 67899998531 11235677899999999752 35566655542 2456789
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK------------------------------------- 705 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~------------------------------------- 705 (867)
||+|++|.++..... ..++......++.+++..|+.||+.
T Consensus 91 v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp EEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred EEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 999999988876321 1234445555555555555555532
Q ss_pred -----------------------CeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 706 -----------------------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 706 -----------------------GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
.++|+|+++.|||++.++.....+.|+||+.+....
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 359999999999998632112234799999887543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=3.3e-05 Score=79.33 Aligned_cols=131 Identities=20% Similarity=0.123 Sum_probs=86.1
Q ss_pred EeeecCcE-EEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCCCeEEE
Q 002908 587 ELGSGTFG-TVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 587 ~LG~GafG-~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~~~l~L 662 (867)
.+..|.+| .||+.... +..+.||+.... ....+.+|..+|+.+. +--+.++++++.+. +..++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~l 97 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWL 97 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----------CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEE
Confidence 34556665 68887653 567999987532 1245678888888874 22366777777764 37899
Q ss_pred EEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 002908 663 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK------------------------------------- 705 (867)
Q Consensus 663 VmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~------------------------------------- 705 (867)
||++++|.++.+..... ......++.+++..|+.||..
T Consensus 98 vme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 99999988776644211 112223444555555555521
Q ss_pred ---------------------CeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 706 ---------------------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 706 ---------------------GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.++|+|+.+.|||++.++ .+-|+||+.+..
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~----~~~viDwe~a~~ 223 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK----LIGCIDVGRVGI 223 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE----EEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCe----EEEEEECccccc
Confidence 179999999999998543 346899998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=2.1e-05 Score=84.53 Aligned_cols=85 Identities=9% Similarity=-0.047 Sum_probs=52.6
Q ss_pred eEEEEe-eecCcEEEEEEEEC--------CceEEEEEeecccc-CCCChHHHHHHHHHHHHHHHHHhCC-C--CceeeEe
Q 002908 583 EELKEL-GSGTFGTVYHGKWR--------GTDVAIKRIKKSCF-TGRSSEQERLTLEFWREAEILSKLH-H--PNVVAFY 649 (867)
Q Consensus 583 qilk~L-G~GafG~VYka~~~--------G~~VAVKv~k~~~~-sd~~~~~e~~~~eflrEieiLk~L~-H--PNIVrL~ 649 (867)
...+.| +.|.+..+|+.... +..+++|+...... .... ...+.+|..+++.|. + -.+.+++
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~------~~~~~~E~~~l~~L~~~~~vpvP~v~ 96 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP------TYRLDHQFEVIRLVGELTDVPVPRVR 96 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS------CCCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc------hhHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 345678 88999999988765 67789998654220 0000 012345666776663 2 2456677
Q ss_pred cccccCC-CCeEEEEEEeecCCchh
Q 002908 650 GVVQDGP-GGTLATVTEFMVNGSLR 673 (867)
Q Consensus 650 g~~~~~~-~~~l~LVmEy~~ggSL~ 673 (867)
.++.+.. .+..++||||++|.++.
T Consensus 97 ~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 97 WIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EEECSSTTTSSCEEEEECCCCBCCC
T ss_pred EEccCCCccCCceEEEEecCCCChh
Confidence 7665431 13568899999887654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00024 Score=74.78 Aligned_cols=30 Identities=23% Similarity=0.213 Sum_probs=25.2
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
.++||+|+++.|||++.++ .+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~----~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE----QIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGG----CEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCC----cEEEEehhhcc
Confidence 5799999999999997554 35899999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00016 Score=79.08 Aligned_cols=81 Identities=17% Similarity=0.077 Sum_probs=46.7
Q ss_pred EEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC--C-ceeeEecccccCCCCe
Q 002908 585 LKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--P-NVVAFYGVVQDGPGGT 659 (867)
Q Consensus 585 lk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H--P-NIVrL~g~~~~~~~~~ 659 (867)
.+.||.|.++.||++.. .++.++||........... .......++..|.++|+.+.. + .+.+++.+..+ .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~-~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~----~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-SWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE----M 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT----T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC-CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCC----c
Confidence 45799999999999964 4678999987532110000 000011234567788877632 3 34455544322 3
Q ss_pred EEEEEEeecCC
Q 002908 660 LATVTEFMVNG 670 (867)
Q Consensus 660 l~LVmEy~~gg 670 (867)
.++|||++++.
T Consensus 110 ~~lvmE~l~g~ 120 (397)
T 2olc_A 110 AVTVMEDLSHL 120 (397)
T ss_dssp TEEEECCCTTS
T ss_pred cEEEEEeCCCc
Confidence 47899999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00053 Score=76.04 Aligned_cols=79 Identities=16% Similarity=0.190 Sum_probs=47.3
Q ss_pred HCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccCCcCC--CCCccCccccccCC-CCCChhhHHHHHHHH
Q 002908 704 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG--TLPWMAPELLNGSS-SKVSEKVDVFSFGIV 780 (867)
Q Consensus 704 s~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~G--T~~Y~APEvl~g~~-~~~S~kSDVWSLGvL 780 (867)
...++|+|++|.|||++.++ +.|+||+.+.............. ...|++|+...... ........+..+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-----~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-----TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-----EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-----CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 46799999999999998654 58999999875443221111111 13456665543111 111234555677777
Q ss_pred HHHHHhC
Q 002908 781 LWEILTG 787 (867)
Q Consensus 781 LyELLTG 787 (867)
+|+.+++
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7777664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0025 Score=66.31 Aligned_cols=140 Identities=12% Similarity=0.093 Sum_probs=93.7
Q ss_pred CCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCccccC
Q 002908 669 NGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747 (867)
Q Consensus 669 ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s 747 (867)
..+|.+.|...+.++++.++|.++.|.+.+|.-+-. ..-..+=+.|..|+|..+|.+ .+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V----~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAV----TLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCE----EECC-C------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCce----eccc-cccc---------
Confidence 348999999999999999999999999999877622 122233455789999988865 2221 1110
Q ss_pred CcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHh
Q 002908 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQC 827 (867)
Q Consensus 748 ~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kC 827 (867)
.....+.|||... ...+.+.=|||||+++|..+--..| ...+..+++.|.+||..|
T Consensus 98 --~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 98 --AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHM 153 (229)
T ss_dssp -----------CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHH
T ss_pred --ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHH
Confidence 1223466888763 3457889999999999988763332 223456789999999999
Q ss_pred hcC-------------------------CCCCCCCHHHHHHHHH
Q 002908 828 WAP-------------------------DPVVRPSFTEIARRLR 846 (867)
Q Consensus 828 Lq~-------------------------DPeeRPSa~ELLe~Lq 846 (867)
... .+..|+++++|++.-.
T Consensus 154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp TTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred HhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 765 2457889999876544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0029 Score=68.40 Aligned_cols=76 Identities=22% Similarity=0.192 Sum_probs=57.1
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---CCceeeEecccccCCCCeE
Q 002908 584 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDGPGGTL 660 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~---HPNIVrL~g~~~~~~~~~l 660 (867)
-.+.|+.|.+..+|+....+..++||+..... ...+.+|...|+.|. ...+++++.++... +..
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~ 106 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERSY-----------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHS 106 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEE
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCccc-----------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--Cce
Confidence 35678999999999988778889999876320 245677888888874 24577787776653 478
Q ss_pred EEEEEeecCCch
Q 002908 661 ATVTEFMVNGSL 672 (867)
Q Consensus 661 ~LVmEy~~ggSL 672 (867)
++||||+++..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999988754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0035 Score=65.53 Aligned_cols=79 Identities=18% Similarity=0.117 Sum_probs=53.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC---ceeeEeccccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP---NVVAFYGVVQD 654 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP---NIVrL~g~~~~ 654 (867)
..+..-++.+|.|..+.||+.+. +|+.|.||+........ ...|.+|...|+.|.-. -+.+++++.
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-- 83 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--------DGLFRAEALGLDWLGRSFGSPVPQVAGWD-- 83 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--------TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--------hhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence 34566678899999999999998 58899999875432111 12356788888887421 244555432
Q ss_pred CCCCeEEEEEEeecCCc
Q 002908 655 GPGGTLATVTEFMVNGS 671 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggS 671 (867)
.-++||||+++..
T Consensus 84 ----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 84 ----DRTLAMEWVDERP 96 (288)
T ss_dssp ----TTEEEEECCCCCC
T ss_pred ----CceEEEEeecccC
Confidence 2268999997663
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0027 Score=66.98 Aligned_cols=143 Identities=13% Similarity=0.093 Sum_probs=76.1
Q ss_pred eEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc--eeeEeccccc----CC
Q 002908 583 EELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQD----GP 656 (867)
Q Consensus 583 qilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN--IVrL~g~~~~----~~ 656 (867)
.-++.|+.|....+|+....+..+++|++..... ...+..|+.++..|.... +.+++..... ..
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCCCC----------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 3456788899999999887666899999864210 012334566665553211 2333322111 01
Q ss_pred CCeEEEEEEeecCCchhh--------------hhhccc----cc----CC---HHHHHH------------HHHHHHHHH
Q 002908 657 GGTLATVTEFMVNGSLRH--------------VLLSKE----RH----LD---RRKRLI------------IAMDAAFGM 699 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d--------------~L~~~~----~~----Ls---e~~~l~------------Ia~QIa~AL 699 (867)
.+..++||+|++|..+.. .++... .. .. |...+. +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 235789999998765321 011110 00 01 111000 001234455
Q ss_pred HHHHH-------CCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 700 EYLHS-------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 700 ayLHs-------~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
.+|+. .++||+|+.+.|||++.++ .+.|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~----~~~lIDf~~a~~ 217 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDE----LSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTE----EEEECCCTTCEE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCc----eEEEecchhccC
Confidence 66653 3699999999999998542 236999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0089 Score=62.87 Aligned_cols=72 Identities=17% Similarity=0.077 Sum_probs=41.8
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce-eeEecccccCCCCeEEEE
Q 002908 585 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAFYGVVQDGPGGTLATV 663 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI-VrL~g~~~~~~~~~l~LV 663 (867)
++.|+.|....+|+. ..+++|+........ ....+|..+++.+...++ .++++++.+ .-++|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~---------~~r~~E~~~l~~l~~~g~~P~~~~~~~~----~~~~v 85 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY---------INRANEAVAAREAAKAGVSPEVLHVDPA----TGVMV 85 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C---------CCHHHHHHHHHHHHHTTSSCCEEEECTT----TCCEE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce---------eCHHHHHHHHHHHHHcCCCCceEEEECC----CCEEE
Confidence 457889999999998 678999886421100 011245556655532111 455555433 23579
Q ss_pred EEee-cCCchh
Q 002908 664 TEFM-VNGSLR 673 (867)
Q Consensus 664 mEy~-~ggSL~ 673 (867)
++|+ +|.++.
T Consensus 86 ~e~i~~g~~l~ 96 (301)
T 3dxq_A 86 TRYIAGAQTMS 96 (301)
T ss_dssp EECCTTCEECC
T ss_pred EeecCCCccCC
Confidence 9999 665553
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0045 Score=69.45 Aligned_cols=72 Identities=13% Similarity=0.298 Sum_probs=47.1
Q ss_pred EEEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce-eeEeccccc
Q 002908 585 LKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAFYGVVQD 654 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI-VrL~g~~~~ 654 (867)
++.|+.|....||++... +..+++|+.... .. . ..+.+|..+++.|...++ .++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~--~----~~li~E~~~l~~L~~~g~~P~l~~~~~~ 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET--E----SHLVAESVIFTLLSERHLGPKLYGIFSG 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC--H----HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc--H----HHHHHHHHHHHHHHhCCCCCcEEEEeCC
Confidence 456888999999999874 467999988431 11 0 123367778877743333 566666543
Q ss_pred CCCCeEEEEEEeecCCch
Q 002908 655 GPGGTLATVTEFMVNGSL 672 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL 672 (867)
++||+|++|.+|
T Consensus 148 ------g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 ------GRLEEYIPSRPL 159 (429)
T ss_dssp ------EEEECCCCEEEC
T ss_pred ------CEEEEEeCCccc
Confidence 379999987554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.00085 Score=80.05 Aligned_cols=55 Identities=15% Similarity=0.211 Sum_probs=47.4
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPST 515 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs~ 515 (867)
+|+|.||+.|++++.|+.|++|+|+|+ |. ||..+.|..+...+|.+|+.+||+..
T Consensus 691 ~l~g~ip~~l~~l~~L~~L~ls~N~l~--g~-iP~~~~~~~~~~~~~~gN~~Lcg~~l 745 (768)
T 3rgz_A 691 KLDGRIPQAMSALTMLTEIDLSNNNLS--GP-IPEMGQFETFPPAKFLNNPGLCGYPL 745 (768)
T ss_dssp CCEECCCGGGGGCCCCSEEECCSSEEE--EE-CCSSSSGGGSCGGGGCSCTEEESTTS
T ss_pred cccCcCChHHhCCCCCCEEECcCCccc--cc-CCCchhhccCCHHHhcCCchhcCCCC
Confidence 567788888888888888888888888 84 99999999999999999999999753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.01 Score=65.91 Aligned_cols=139 Identities=13% Similarity=0.117 Sum_probs=76.6
Q ss_pred EEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccC
Q 002908 586 KELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDG 655 (867)
Q Consensus 586 k~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~ 655 (867)
+.|..|-...+|++... +..+.+|+.-.. .. . .....+|..+++.|. +.-..++++++.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~--~------~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ--G------VDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C--C------HHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc--h------HHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 35667888889998763 367899986321 10 1 123347888887774 2223566666543
Q ss_pred CCCeEEEEEEeecCCchhhh-----------------hhcc----cccCC--HHHHHHHHHHHH----------------
Q 002908 656 PGGTLATVTEFMVNGSLRHV-----------------LLSK----ERHLD--RRKRLIIAMDAA---------------- 696 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~-----------------L~~~----~~~Ls--e~~~l~Ia~QIa---------------- 696 (867)
.+||||++|.+|... ++.. .+... +.++.++..++.
T Consensus 126 -----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 126 -----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp -----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred -----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 289999988765421 0111 11122 344444443332
Q ss_pred ---HHHHHHH----H----CCeeccCCCCcceEeccCCCCCCcEEEeecCCccc
Q 002908 697 ---FGMEYLH----S----KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739 (867)
Q Consensus 697 ---~ALayLH----s----~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~ 739 (867)
..+..|. . ..++|+|+.+.|||++.+......+.|+||..+..
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1233333 2 24999999999999987622223568999998763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0065 Score=65.80 Aligned_cols=73 Identities=15% Similarity=0.201 Sum_probs=40.8
Q ss_pred EEEeeecCcEEEEEEEECC----------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCc-eeeEecccc
Q 002908 585 LKELGSGTFGTVYHGKWRG----------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQ 653 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G----------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPN-IVrL~g~~~ 653 (867)
.+.|+.|....+|+....+ ..+++|+.......- .....|..+++.+...+ ..++++.+.
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~---------~~~~~E~~~l~~L~~~g~~P~~~~~~~ 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL---------YNTISEFEVYKTMSKYKIAPQLLNTFN 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT---------SCHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce---------ecHHHHHHHHHHHHhcCCCCceEEecC
Confidence 4567888889999988754 678888875321000 01235666666664222 335555432
Q ss_pred cCCCCeEEEEEEeecCCch
Q 002908 654 DGPGGTLATVTEFMVNGSL 672 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL 672 (867)
+ ++||+|++|.++
T Consensus 109 ----~--~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 ----G--GRIEEWLYGDPL 121 (369)
T ss_dssp ----T--EEEEECCCSEEC
T ss_pred ----C--cEEEEEecCCcC
Confidence 1 579999987644
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.013 Score=62.25 Aligned_cols=38 Identities=26% Similarity=0.170 Sum_probs=28.0
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccC
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 742 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~ 742 (867)
..+||||+.+.|||++.+......+.|+||+.+.....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 46999999999999986421112468999999875443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.16 E-value=0.024 Score=59.81 Aligned_cols=75 Identities=15% Similarity=0.061 Sum_probs=44.2
Q ss_pred EeeecCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCC--ceeeEecccccC----CCCe
Q 002908 587 ELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQDG----PGGT 659 (867)
Q Consensus 587 ~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HP--NIVrL~g~~~~~----~~~~ 659 (867)
.|+ |....||+... .|+.+++|++...... ...+..|..++..|... .+++++.. ... ..+.
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---------~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~ 101 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGF 101 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCC---------HHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCE
Confidence 466 88889998776 3667999998633211 12344566666666321 23444443 110 1346
Q ss_pred EEEEEEeecCCch
Q 002908 660 LATVTEFMVNGSL 672 (867)
Q Consensus 660 l~LVmEy~~ggSL 672 (867)
.++||+|++|..+
T Consensus 102 ~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 102 YFAVFPSVGGRQF 114 (328)
T ss_dssp EEEEEECCCCEEC
T ss_pred EEEEEEecCCCCC
Confidence 6889999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.029 Score=63.74 Aligned_cols=73 Identities=18% Similarity=0.155 Sum_probs=46.6
Q ss_pred EEEeeecCcEEEEEEEECC--ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce-eeEecccccCCCCeEE
Q 002908 585 LKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAFYGVVQDGPGGTLA 661 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~G--~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI-VrL~g~~~~~~~~~l~ 661 (867)
++.|+.|-...+|++...+ ..+++|++.... . ...+ -.+|..++..|...++ .++++++.. .
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~--~~id------R~~E~~vl~~L~~~gl~P~ll~~~~~------G 177 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D--EIIN------REREKKISCILYNKNIAKKIYVFFTN------G 177 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C--SCSC------HHHHHHHHHHHTTSSSBCCEEEEETT------E
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h--hhcC------HHHHHHHHHHHHhcCCCCCEEEEeCC------e
Confidence 4568889999999998865 789999874321 1 0000 1357778888864444 567776632 3
Q ss_pred EEEEeecCCch
Q 002908 662 TVTEFMVNGSL 672 (867)
Q Consensus 662 LVmEy~~ggSL 672 (867)
+||+|++|.+|
T Consensus 178 ~v~e~I~G~~l 188 (458)
T 2qg7_A 178 RIEEFMDGYAL 188 (458)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEeeCCccC
Confidence 59999987654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=95.71 E-value=3.8e-05 Score=87.17 Aligned_cols=30 Identities=10% Similarity=-0.096 Sum_probs=25.8
Q ss_pred HHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 627 TLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 627 ~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..+|..|++.+.+++|+|||+++|||....
T Consensus 323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 323 SETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 357999999999999999999999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.47 E-value=0.095 Score=56.48 Aligned_cols=33 Identities=18% Similarity=0.270 Sum_probs=26.6
Q ss_pred CCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 705 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 705 ~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
..+||+|+.+.||+++.++. +.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~----~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES----IYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC----EEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCe----EEEEECCCCeeCC
Confidence 36999999999999986543 4899999887543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.88 E-value=0.18 Score=56.80 Aligned_cols=73 Identities=12% Similarity=0.087 Sum_probs=44.2
Q ss_pred EEEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEeccccc
Q 002908 585 LKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 654 (867)
Q Consensus 585 lk~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~ 654 (867)
++.|..|-...+|+.... +..+++|+..... . ...+ -.+|..+++.+. +.-..++++.+..
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~--~~id------R~~E~~~l~~L~~~gi~P~l~~~~~~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-G--KFYD------SKVELDVFRYLSNINIAPNIIADFPE 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCC------HHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-c--hhcC------HHHHHHHHHHHHhcCCCCCEEEEcCC
Confidence 455777889999998875 5779999864321 1 0001 124666666663 2223455554321
Q ss_pred CCCCeEEEEEEeecCCch
Q 002908 655 GPGGTLATVTEFMVNGSL 672 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL 672 (867)
++||+|++|.+|
T Consensus 146 ------~~I~efI~G~~l 157 (424)
T 3mes_A 146 ------GRIEEFIDGEPL 157 (424)
T ss_dssp ------EEEEECCCSEEC
T ss_pred ------CEEEEEeCCccC
Confidence 679999988764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=93.85 E-value=0.073 Score=51.76 Aligned_cols=70 Identities=9% Similarity=0.033 Sum_probs=53.2
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCC--CcccccccccccCCCCccCCCC-CCCCCCCccccccCCc
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGNE 531 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s--~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn~ 531 (867)
++++..|..|+++++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|.+...|.. ....+.+....+.+|.
T Consensus 44 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~----~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 116 (174)
T 2r9u_A 44 QITKLEPGVFDHLVNLQQLYFNSNKLT----AIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNP 116 (174)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSC
T ss_pred CccccCHHHhcCCcCCCEEECCCCCCC----ccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCC
Confidence 355666888999999999999999999 46653 3467888888888888877764 5666777777777774
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=93.74 E-value=0.022 Score=60.29 Aligned_cols=54 Identities=20% Similarity=0.305 Sum_probs=49.4
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPS 514 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs 514 (867)
++++.+|..|+++++|+.|+|++|+|+ |. +|..+.+.++..+.+.+|+.+|++.
T Consensus 255 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~-ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 255 RIYGTLPQGLTQLKFLHSLNVSFNNLC--GE-IPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CCEECCCGGGGGCTTCCEEECCSSEEE--EE-CCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred cccCcCChHHhcCcCCCEEECcCCccc--cc-CCCCccccccChHHhcCCCCccCCC
Confidence 567789999999999999999999999 95 9998888999999999999999863
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=93.36 E-value=0.1 Score=50.41 Aligned_cols=70 Identities=13% Similarity=0.077 Sum_probs=54.0
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCC--CcccccccccccCCCCccCCCC-CCCCCCCccccccCCc
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGNE 531 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s--~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn~ 531 (867)
++++..|..|+.+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|.+...|.. ....+.+....+.+|.
T Consensus 41 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~----~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 113 (170)
T 3g39_A 41 QITKLEPGVFDRLTQLTRLDLDNNQLT----VLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNP 113 (170)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cCCccChhhhcCcccCCEEECCCCCcC----ccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCC
Confidence 455666888999999999999999999 45553 3467888888899988877664 5667778788888874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.47 E-value=0.69 Score=50.99 Aligned_cols=33 Identities=21% Similarity=0.163 Sum_probs=25.1
Q ss_pred eeccCCCCcceEeccCC--CCCCcEEEeecCCccc
Q 002908 707 IVHFDLKCDNLLVNLKD--PIRPICKVGDFGLSKI 739 (867)
Q Consensus 707 IIHrDLKPsNILLd~dg--~~~~~vKL~DFGLA~~ 739 (867)
+||+|+.+.|||+..+. .....+.|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999995421 1234579999999864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=91.32 E-value=0.11 Score=60.19 Aligned_cols=65 Identities=12% Similarity=0.064 Sum_probs=27.7
Q ss_pred CCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccC--CCCCCCCCCCccccccCC
Q 002908 462 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVG--PSTMETHPDYSRSELKGN 530 (867)
Q Consensus 462 ~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~g--Ps~~~~~P~l~k~~Lagn 530 (867)
.||+.|++|++|+.|+|++|+|+ .+|..+.+.++..+.+.+|.+... |......+.+....+.+|
T Consensus 477 ~lp~~~~~l~~L~~L~Ls~N~l~----~lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N 543 (567)
T 1dce_A 477 ALPPALAALRCLEVLQASDNALE----NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543 (567)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCC----CCGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTS
T ss_pred ccchhhhcCCCCCEEECCCCCCC----CCcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCC
Confidence 34444444444444444444444 244333334444444444444333 333333333433333333
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=90.81 E-value=0.19 Score=59.95 Aligned_cols=66 Identities=15% Similarity=0.139 Sum_probs=56.4
Q ss_pred CCCcccccCCCccccCCCCCCCCCCCCCCCCC-CcccccccccccCCCCccCCCCCCCCCCCccccccCCc
Q 002908 462 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS-GSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNE 531 (867)
Q Consensus 462 ~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s-~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn~ 531 (867)
.||+.|++|++|+.|+|++|+|+ .||.. +.+.++..+.+.+|.+...|......+.+....+.+|.
T Consensus 261 ~lp~~~~~l~~L~~L~Ls~N~l~----~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 261 ELPAEIKNLSNLRVLDLSHNRLT----SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp CCCGGGGGGTTCCEEECTTSCCS----SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSC
T ss_pred ccChhhhCCCCCCEEeCcCCcCC----ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCc
Confidence 79999999999999999999999 57654 44568888999999988888888888888888888884
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=90.39 E-value=0.16 Score=60.54 Aligned_cols=70 Identities=11% Similarity=0.058 Sum_probs=36.1
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCc-cCCCCCCCCCCCccccccCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSI-VGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l-~gPs~~~~~P~l~k~~Lagn 530 (867)
+|+|.+|+.|++|+.|+.|+||+|+|+ |. +|. .+.+.++..+-+..|... ..|......+.+....+..|
T Consensus 643 ~l~g~ip~~l~~l~~L~~L~Ls~N~l~--g~-ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 643 MLSGYIPKEIGSMPYLFILNLGHNDIS--GS-IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp CCBSCCCGGGGGCTTCCEEECCSSCCC--SC-CCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred cccccCCHHHhccccCCEEeCcCCccC--CC-CChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 345566666666666666666666666 64 443 233345555555555544 23444444444444444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=90.27 E-value=0.16 Score=53.81 Aligned_cols=65 Identities=12% Similarity=-0.047 Sum_probs=30.5
Q ss_pred CCcccccCCCccccCCCCCCCCCCCCCCCCC-CcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 463 FSSPLTNIEEGATVDYSYPPLKPDGSVMPQS-GSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 463 LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s-~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
.|..|++|++|+.|+|++|+|+ | ..|.. ..+.++..+.+.+|.+...|........+....+..|
T Consensus 48 ~~~~~~~l~~L~~L~l~~N~l~--~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N 113 (347)
T 2ifg_A 48 ELRDLRGLGELRNLTIVKSGLR--F-VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113 (347)
T ss_dssp CGGGSCSCCCCSEEECCSSCCC--E-ECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSS
T ss_pred ChhHhccccCCCEEECCCCccc--e-eCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCC
Confidence 3345555666666666666655 3 12221 2344555555555555544433222222444444444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=90.14 E-value=0.24 Score=48.55 Aligned_cols=71 Identities=8% Similarity=-0.056 Sum_probs=53.3
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCccC-CCCCCCCCCCccccccCCc
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSIVG-PSTMETHPDYSRSELKGNE 531 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l~g-Ps~~~~~P~l~k~~Lagn~ 531 (867)
++++..|..|+.+++|+.|+|++|+|+ +- .|. ...+.++..+.+.+|.+... |......+.+....+.+|.
T Consensus 65 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 137 (192)
T 1w8a_A 65 QLTGIEPNAFEGASHIQELQLGENKIK--EI-SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP 137 (192)
T ss_dssp CCCCBCTTTTTTCTTCCEEECCSCCCC--EE-CSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred CCCCcCHhHcCCcccCCEEECCCCcCC--cc-CHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCC
Confidence 456777899999999999999999999 42 332 34467888888888887755 5566677777777777774
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.54 E-value=0.41 Score=47.13 Aligned_cols=70 Identities=16% Similarity=0.099 Sum_probs=51.2
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCC--CCcccccccccccCCCCccCCCC-CCCCCCCccccccCCc
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ--SGSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGNE 531 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~--s~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn~ 531 (867)
++++..|..|+.+++|+.|+|++|+|+ + +|. ...+.++..+.+.+|.+...|.. ....+.+....+.+|.
T Consensus 65 ~i~~i~~~~f~~l~~L~~L~Ls~N~l~--~--i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 137 (193)
T 2wfh_A 65 RISTLSNQSFSNMTQLLTLILSYNRLR--C--IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANP 137 (193)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC--B--CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred cCCEeCHhHccCCCCCCEEECCCCccC--E--eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCC
Confidence 455566678889999999999999998 3 443 34456788888888888877664 4556677777777774
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=89.37 E-value=0.15 Score=47.32 Aligned_cols=67 Identities=12% Similarity=0.032 Sum_probs=49.5
Q ss_pred CCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCcc-CCCCCCCCCCCccccccCCc
Q 002908 461 LGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIV-GPSTMETHPDYSRSELKGNE 531 (867)
Q Consensus 461 ~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~-gPs~~~~~P~l~k~~Lagn~ 531 (867)
+.+|..++.|++|+.|++++|+|+ + ++..+.+.++..+.+.+|.... .|......+.+....+.+|.
T Consensus 32 ~~~~~~~~~l~~L~~L~l~~n~l~--~--~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~ 99 (149)
T 2je0_A 32 GKLEGLTDEFEELEFLSTINVGLT--S--IANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK 99 (149)
T ss_dssp TBCCSCCTTCTTCCEEECTTSCCC--C--CTTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSC
T ss_pred hHHHHHHhhcCCCcEEECcCCCCC--C--chhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCc
Confidence 688998999999999999999999 3 4566667788888888887766 44443445666666666663
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.18 E-value=0.42 Score=47.87 Aligned_cols=70 Identities=11% Similarity=-0.083 Sum_probs=44.7
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCccC-CCCCCCCCCCccccccCCc
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSIVG-PSTMETHPDYSRSELKGNE 531 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l~g-Ps~~~~~P~l~k~~Lagn~ 531 (867)
+++..|..|+.|++|+.|+|++|+|+ +- .|. ...+.++..+.+.+|.+... |......+.+....+.+|.
T Consensus 93 l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 164 (220)
T 2v70_A 93 LENVQHKMFKGLESLKTLMLRSNRIT--CV-GNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANP 164 (220)
T ss_dssp CCCCCGGGGTTCSSCCEEECTTSCCC--CB-CTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred cCccCHhHhcCCcCCCEEECCCCcCC--eE-CHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcC
Confidence 44555666778888888888888887 41 232 23345677777777776665 4555566666666666663
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=88.91 E-value=0.56 Score=47.16 Aligned_cols=69 Identities=12% Similarity=-0.029 Sum_probs=44.6
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCC--CcccccccccccCCCCccCCCC-CCCCCCCccccccCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGN 530 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s--~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn 530 (867)
++++..|..|+.|++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|.+...|.. ....+.+....+..|
T Consensus 51 ~i~~~~~~~~~~l~~L~~L~L~~N~l~----~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N 122 (229)
T 3e6j_A 51 QITKLEPGVFDSLINLKELYLGSNQLG----ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCN 122 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ccCccCHHHhhCccCCcEEECCCCCCC----CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCC
Confidence 455556777788888888888888887 45542 3456777777777776655543 345556665555555
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=88.69 E-value=0.41 Score=47.92 Aligned_cols=68 Identities=6% Similarity=-0.067 Sum_probs=41.0
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCCCC--CcccccccccccCCCCccCC-CCCCCCCCCccccccCC
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGP-STMETHPDYSRSELKGN 530 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s--~~~~~l~~lSl~~N~~l~gP-s~~~~~P~l~k~~Lagn 530 (867)
+++..|..|+.+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|.+...+ ......+.+....+.+|
T Consensus 68 i~~~~~~~~~~l~~L~~L~Ls~N~l~----~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 138 (220)
T 2v9t_B 68 ISELAPDAFQGLRSLNSLVLYGNKIT----ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN 138 (220)
T ss_dssp CCEECTTTTTTCSSCCEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCcCHHHhhCCcCCCEEECCCCcCC----ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCC
Confidence 44556777778888888888888887 45553 23456667777777665553 23334444444444444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=88.69 E-value=0.43 Score=48.02 Aligned_cols=62 Identities=15% Similarity=0.163 Sum_probs=37.7
Q ss_pred cccccCCCccccCCCCCCCCCCCCCCCCC--CcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 465 SPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 465 ~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s--~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
..|+.+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|.+...|......+.+....+.+|
T Consensus 82 ~~~~~l~~L~~L~Ls~N~l~----~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N 145 (229)
T 3e6j_A 82 GVFDSLTQLTVLDLGTNQLT----VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN 145 (229)
T ss_dssp TTTTTCTTCCEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSS
T ss_pred hhcccCCCcCEEECCCCcCC----ccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCC
Confidence 44677777777777777777 34432 3455666677777776666655555555555444444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=88.42 E-value=0.27 Score=52.17 Aligned_cols=53 Identities=6% Similarity=-0.010 Sum_probs=42.3
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCC-CcccccccccccCCCCccCCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS-GSRINFDEGSQRESSSIVGPS 514 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s-~~~~~l~~lSl~~N~~l~gPs 514 (867)
+|++..|..|++|++|+.|+|++|+|+ + +|.. .....+..+.+.+|...|...
T Consensus 67 ~l~~~~~~~~~~l~~L~~L~l~~N~l~--~--~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 67 GLRFVAPDAFHFTPRLSRLNLSFNALE--S--LSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp CCCEECTTGGGSCSCCCEEECCSSCCS--C--CCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred ccceeCHHHhcCCcCCCEEeCCCCccc--e--eCHHHcccCCceEEEeeCCCccCCCc
Confidence 577888889999999999999999999 4 5543 333458888889998887643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.06 E-value=0.63 Score=45.74 Aligned_cols=65 Identities=14% Similarity=0.061 Sum_probs=48.4
Q ss_pred CCCcccccCCCccccCCCCCCCCCCCCCCCC--CCcccccccccccCCCCccCCC-CCCCCCCCccccccCC
Q 002908 462 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ--SGSRINFDEGSQRESSSIVGPS-TMETHPDYSRSELKGN 530 (867)
Q Consensus 462 ~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~--s~~~~~l~~lSl~~N~~l~gPs-~~~~~P~l~k~~Lagn 530 (867)
.||+.|+++++|+.|+|++|+|+ + ++. ...+.++..+.+.+|.+...+. .....+.+....+.+|
T Consensus 45 ~ip~~~~~l~~L~~L~Ls~N~i~--~--i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N 112 (193)
T 2wfh_A 45 LVPKELSNYKHLTLIDLSNNRIS--T--LSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGN 112 (193)
T ss_dssp SCCGGGGGCTTCCEEECCSSCCC--C--CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS
T ss_pred hhHHHhhcccCCCEEECCCCcCC--E--eCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCC
Confidence 68899999999999999999999 3 543 3445688888889998777654 3445555555555555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=87.66 E-value=0.31 Score=56.79 Aligned_cols=71 Identities=7% Similarity=0.090 Sum_probs=56.6
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCC----------------CCCCCC---cccccccccccCCCCc-cCCCCCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGS----------------VMPQSG---SRINFDEGSQRESSSI-VGPSTME 517 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs----------------~IP~s~---~~~~l~~lSl~~N~~l-~gPs~~~ 517 (867)
+++| ||+.|++|++|+.|+|++|+|+ |. .+|..- .+.++..+.+.+|... ..|....
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~--~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~ 270 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFV--AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCC--GGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccc--cccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence 7888 9999999999999999999999 61 055544 3678888888888743 4577777
Q ss_pred CCCCCccccccCCc
Q 002908 518 THPDYSRSELKGNE 531 (867)
Q Consensus 518 ~~P~l~k~~Lagn~ 531 (867)
..+.+....+.++.
T Consensus 271 ~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 271 ALPEMQLINVACNR 284 (636)
T ss_dssp TCSSCCEEECTTCT
T ss_pred cCCCCCEEECcCCC
Confidence 88888888888886
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=87.05 E-value=0.17 Score=47.89 Aligned_cols=47 Identities=4% Similarity=-0.150 Sum_probs=25.6
Q ss_pred CCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCcc
Q 002908 461 LGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIV 511 (867)
Q Consensus 461 ~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~ 511 (867)
+.||..++.|++|+.|+|++|.|+ + ++....+.++..+.+.+|....
T Consensus 39 ~~i~~~~~~l~~L~~L~l~~n~l~--~--~~~~~~l~~L~~L~Ls~N~l~~ 85 (168)
T 2ell_A 39 GKIEGLTAEFVNLEFLSLINVGLI--S--VSNLPKLPKLKKLELSENRIFG 85 (168)
T ss_dssp TBCSSCCGGGGGCCEEEEESSCCC--C--CSSCCCCSSCCEEEEESCCCCS
T ss_pred hhHHHHHHhCCCCCEEeCcCCCCC--C--hhhhccCCCCCEEECcCCcCch
Confidence 455655666666666666666665 2 3344444555555555555444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=86.98 E-value=0.84 Score=43.54 Aligned_cols=69 Identities=9% Similarity=0.033 Sum_probs=46.3
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCCCC--CcccccccccccCCCCccCCCCC-CCCCCCccccccCCc
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGPSTM-ETHPDYSRSELKGNE 531 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s--~~~~~l~~lSl~~N~~l~gPs~~-~~~P~l~k~~Lagn~ 531 (867)
+++..|..|+.+++|+.|+|++|+|+ + +|.. ..+.++..+.+.+|.....|... ...+.+....+.+|.
T Consensus 64 l~~~~~~~~~~l~~L~~L~l~~N~l~--~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 135 (177)
T 2o6r_A 64 IQSLPDGVFDKLTKLTILYLHENKLQ--S--LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC--C--CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred ceEeChhHccCCCccCEEECCCCCcc--c--cCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCC
Confidence 44444556788888888888888888 3 4432 34567777788888777666543 455666666777764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=86.95 E-value=0.43 Score=46.25 Aligned_cols=52 Identities=8% Similarity=-0.071 Sum_probs=40.9
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCCC--CCcccccccccccCCCCccCCC
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ--SGSRINFDEGSQRESSSIVGPS 514 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~--s~~~~~l~~lSl~~N~~l~gPs 514 (867)
|++..|..|+++++|+.|+|++|+|+ .+|. ...+.++..+.+.+|+..|.+.
T Consensus 69 l~~i~~~~~~~l~~L~~L~L~~N~l~----~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 69 LTAIPTGVFDKLTQLTQLDLNDNHLK----SIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC----CCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CCccChhHhCCcchhhEEECCCCccc----eeCHHHhccccCCCEEEeCCCCcccccc
Confidence 44444445799999999999999999 4655 3456788999999999888765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=86.43 E-value=0.48 Score=45.58 Aligned_cols=53 Identities=9% Similarity=-0.045 Sum_probs=41.8
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCC--CCcccccccccccCCCCccCCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ--SGSRINFDEGSQRESSSIVGPS 514 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~--s~~~~~l~~lSl~~N~~l~gPs 514 (867)
+|++..|..|+.+++|+.|+|++|+|+ .+|. ...+.++..+.+.+|+..|.+.
T Consensus 65 ~l~~l~~~~f~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 65 QLTVLPAGVFDKLTQLTQLSLNDNQLK----SIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CcCccChhhccCCCCCCEEECCCCccC----EeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 355555566899999999999999999 4554 3456788899999999888764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.99 E-value=0.93 Score=47.38 Aligned_cols=67 Identities=12% Similarity=0.143 Sum_probs=43.1
Q ss_pred cccCCCCcccccC---CCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 458 QDHLGFSSPLTNI---EEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 458 ~ls~~LP~~Lg~~---~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
++++.+|+.++.| ++|+.|+|++|+|+ .+|... +.++..+.+..|.+...|. ....+.+....+.+|
T Consensus 235 ~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~----~lp~~~-~~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L~~N 304 (310)
T 4glp_A 235 SLRATVNPSAPRCMWSSALNSLNLSFAGLE----QVPKGL-PAKLRVLDLSSNRLNRAPQ-PDELPEVDNLTLDGN 304 (310)
T ss_dssp CCCCCCCSCCSSCCCCTTCCCEECCSSCCC----SCCSCC-CSCCSCEECCSCCCCSCCC-TTSCCCCSCEECSST
T ss_pred CCCccchhhHHhccCcCcCCEEECCCCCCC----chhhhh-cCCCCEEECCCCcCCCCch-hhhCCCccEEECcCC
Confidence 3455567777777 58888888888888 566643 3677777777777665444 344455555555544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=85.71 E-value=1 Score=42.88 Aligned_cols=68 Identities=9% Similarity=0.039 Sum_probs=45.4
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCCCC--CcccccccccccCCCCccCCCC-CCCCCCCccccccCC
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGN 530 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s--~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn 530 (867)
+++..|..|+.+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|.+...|.. ....+.+....+..|
T Consensus 40 l~~~~~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 110 (177)
T 2o6r_A 40 LQSLPHGVFDKLTQLTKLSLSQNQIQ----SLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110 (177)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ccEeCHHHhcCcccccEEECCCCcce----EeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCC
Confidence 44445567889999999999999999 35542 4567888888888877655543 234444544444444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=85.50 E-value=0.31 Score=47.68 Aligned_cols=65 Identities=8% Similarity=0.016 Sum_probs=34.3
Q ss_pred cCCCCcccccCCCccccCCCCCC-CCCCCCCCCCCCcccccccccccCCCCccCCCCCCCCCCCccccccC
Q 002908 460 HLGFSSPLTNIEEGATVDYSYPP-LKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKG 529 (867)
Q Consensus 460 s~~LP~~Lg~~~~L~~LdLS~N~-Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lag 529 (867)
++.+|..|+.|++|+.|++++|+ +. .+|....+.++..+.+.+|.....+ .....+.+....+.+
T Consensus 125 ~~~~~~~l~~l~~L~~L~L~~n~~i~----~~~~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 125 DDSILTKINTLPKVNSIDLSYNGAIT----DIMPLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp BGGGHHHHTTCSSCCEEECCSCTBCC----CCGGGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECB
T ss_pred CcHhHHHHhhCCCCCEEEccCCCCcc----ccHhhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeC
Confidence 33455666666666666666666 44 3554444555666666666544433 333334444433333
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=85.41 E-value=0.32 Score=45.98 Aligned_cols=63 Identities=10% Similarity=-0.013 Sum_probs=26.8
Q ss_pred cccccCCCccccCCCCCCCCCCCCCCCCCCc-ccccccccccCCCCccCC--CCCCCCCCCccccccCC
Q 002908 465 SPLTNIEEGATVDYSYPPLKPDGSVMPQSGS-RINFDEGSQRESSSIVGP--STMETHPDYSRSELKGN 530 (867)
Q Consensus 465 ~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~-~~~l~~lSl~~N~~l~gP--s~~~~~P~l~k~~Lagn 530 (867)
..++.|++|+.|+|++|+|+ +. +|.... +.++..+.+.+|.+...| ......+.+....+.++
T Consensus 65 ~~~~~l~~L~~L~Ls~N~l~--~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N 130 (168)
T 2ell_A 65 SNLPKLPKLKKLELSENRIF--GG-LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130 (168)
T ss_dssp SSCCCCSSCCEEEEESCCCC--SC-CCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSS
T ss_pred hhhccCCCCCEEECcCCcCc--hH-HHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCC
Confidence 34444555555555555555 21 333222 334444444444443332 23333444444444444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=85.31 E-value=1 Score=47.13 Aligned_cols=69 Identities=17% Similarity=0.008 Sum_probs=46.4
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCCCCC--cccccccccccCCCCccCCCCCCCCCCCccccccCCc
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSG--SRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNE 531 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~--~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn~ 531 (867)
+++..|..|..+++|+.|+|++|+|+ .+|... .+.++..+.+.+|.+...|......+.+....+.+|.
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~----~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np 206 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLT----ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNP 206 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCS----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCC
T ss_pred CCccChhhcccccCCCEEECCCCcCC----ccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCC
Confidence 44445566777888888888888887 455432 3456777777777777777766666666666666664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=85.18 E-value=0.56 Score=55.94 Aligned_cols=65 Identities=9% Similarity=-0.022 Sum_probs=55.6
Q ss_pred CCCcccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 462 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 462 ~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
.||..+++|++|+.|+|++|+|+ .+|. .+.+.++..+.+.+|.+...|......+.+..+.+..|
T Consensus 238 ~l~~~~~~l~~L~~L~Ls~N~l~----~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N 303 (727)
T 4b8c_D 238 NISANIFKYDFLTRLYLNGNSLT----ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDN 303 (727)
T ss_dssp CCCGGGGGCCSCSCCBCTTSCCS----CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSS
T ss_pred CCChhhcCCCCCCEEEeeCCcCc----ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCC
Confidence 68999999999999999999999 6775 34567889999999999988888888888888888777
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=85.04 E-value=0.86 Score=46.79 Aligned_cols=130 Identities=14% Similarity=0.127 Sum_probs=62.9
Q ss_pred ecCCcCccchHHHHHhhhhhccccccccccCCCCceEEeecccCCCcchhhhh---hhhhhhhhhccchhhccccCCCCc
Q 002908 389 DINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFR---NLAQDEFSRKDVSLMDQDHLGFSS 465 (867)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ls~~LP~ 465 (867)
+|++-||.+.+.++.........+..+.+...=-.+-..++.+-....+..+. +|....++.- ++++ + +
T Consensus 8 ~i~~i~~~~~~~~l~~l~l~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~l~~l~~L~~L~l~~n------~l~~-~-~ 79 (272)
T 3rfs_A 8 PIKQIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGN------KLHD-I-S 79 (272)
T ss_dssp EHHHHSCSHHHHHHHHHHHTCSCTTSEECHHHHTTCCEEECTTSCCCCCTTGGGCTTCCEEECTTS------CCCC-C-G
T ss_pred cHHHhcCCchHHHHHHHHhcCcccccccccccccceeeeeeCCCCcccccccccCCCCcEEECCCC------CCCC-c-h
Confidence 56777888888877755543333333322211112333344443333333222 2222222211 1222 2 3
Q ss_pred ccccCCCccccCCCCCCCCCCCCCCCC--CCcccccccccccCCCCccCCCC-CCCCCCCccccccCC
Q 002908 466 PLTNIEEGATVDYSYPPLKPDGSVMPQ--SGSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGN 530 (867)
Q Consensus 466 ~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~--s~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn 530 (867)
.++.|++|+.|+|++|+|+ + +|. ...+.++..+.+.+|.....+.. ....+.+....+.++
T Consensus 80 ~l~~l~~L~~L~L~~n~l~--~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 143 (272)
T 3rfs_A 80 ALKELTNLTYLILTGNQLQ--S--LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHN 143 (272)
T ss_dssp GGTTCTTCCEEECTTSCCC--C--CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hhcCCCCCCEEECCCCccC--c--cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCC
Confidence 6677777777777777777 3 333 23445666666666665544432 344445554444444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=85.02 E-value=0.29 Score=51.58 Aligned_cols=70 Identities=10% Similarity=-0.027 Sum_probs=49.8
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCc-cCCCCCCCCCCCccccccCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSI-VGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l-~gPs~~~~~P~l~k~~Lagn 530 (867)
++++.+|..|+.+++|+.|+|++|+|+ |. +|....+.++..+.+.+|.+. ..|......+.+....+.+|
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 278 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLA--FD-LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEEC--CB-GGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred cccCcCCHHHhcCCCCCEEECCCCcee--ee-cCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence 345667888888888888888888888 63 666666677777777877776 55666666666666666665
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=84.68 E-value=0.35 Score=51.53 Aligned_cols=66 Identities=6% Similarity=0.123 Sum_probs=36.3
Q ss_pred CCCcccccCCCccccCCCCCCCCCCCCCCCCCCc----------ccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 462 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGS----------RINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 462 ~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~----------~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
.||+.|++|++|+.|+|++|++. |. +|.... +.++..+.+.+|.....|......+.+....+.++
T Consensus 141 ~lp~~l~~l~~L~~L~L~~n~~~--~~-~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N 216 (328)
T 4fcg_A 141 ALPASIASLNRLRELSIRACPEL--TE-LPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNS 216 (328)
T ss_dssp CCCGGGGGCTTCCEEEEEEETTC--CC-CCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESS
T ss_pred cCcHHHhcCcCCCEEECCCCCCc--cc-cChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCC
Confidence 55666666666666666666555 53 554332 44555555556655555554444455554444444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=84.36 E-value=0.5 Score=49.45 Aligned_cols=67 Identities=10% Similarity=-0.033 Sum_probs=43.8
Q ss_pred cCCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 460 HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 460 s~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
++..|..|+.+++|+.|+|++|+|+ .+|..+.+.++..+.+.+|.+...|......+.+....+..|
T Consensus 44 ~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N 110 (290)
T 1p9a_G 44 YTFSLATLMPYTRLTQLNLDRAELT----KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110 (290)
T ss_dssp SEEEGGGGTTCTTCCEEECTTSCCC----EEECCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSS
T ss_pred CccCHHHhhcCCCCCEEECCCCccC----cccCCCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCC
Confidence 3344566777777777777777777 355556666777777777777666665555555555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.34 E-value=0.79 Score=45.84 Aligned_cols=68 Identities=6% Similarity=-0.132 Sum_probs=41.2
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCCC--CCcccccccccccCCCCccC-CCCCCCCCCCccccccCC
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ--SGSRINFDEGSQRESSSIVG-PSTMETHPDYSRSELKGN 530 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~--s~~~~~l~~lSl~~N~~l~g-Ps~~~~~P~l~k~~Lagn 530 (867)
+++..|..|+.+++|+.|+|++|+|+ + +|. ...+.++..+.+.+|.+... |......+.+....+.+|
T Consensus 69 i~~i~~~~~~~l~~L~~L~Ls~N~l~--~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 139 (220)
T 2v70_A 69 ITDIEEGAFEGASGVNEILLTSNRLE--N--VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139 (220)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCC--C--CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTS
T ss_pred CCEECHHHhCCCCCCCEEECCCCccC--c--cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCC
Confidence 34444567788888888888888887 3 443 23345667777777776655 334444455544444444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=84.26 E-value=1.3 Score=43.36 Aligned_cols=68 Identities=7% Similarity=0.031 Sum_probs=37.7
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCCCC--CcccccccccccCCCCccCCCC-CCCCCCCccccccCC
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGN 530 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s--~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn 530 (867)
+++..|..|+++++|+.|+|++|+|+ + +|.. ..+.++..+.+.+|.....|.. ....+.+....+.+|
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~--~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 158 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQ--S--LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC--C--CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSC
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCc--c--cCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCC
Confidence 33334445667777777777777777 3 3332 3345666666666665544443 344455555555555
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=83.63 E-value=1.3 Score=44.71 Aligned_cols=21 Identities=14% Similarity=0.207 Sum_probs=8.9
Q ss_pred CcccccCCCccccCCCCCCCC
Q 002908 464 SSPLTNIEEGATVDYSYPPLK 484 (867)
Q Consensus 464 P~~Lg~~~~L~~LdLS~N~Ls 484 (867)
|..|+.+++|+.|+|++|+|+
T Consensus 76 ~~~~~~l~~L~~L~L~~n~l~ 96 (251)
T 3m19_A 76 AGVFDDLTELGTLGLANNQLA 96 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCC
T ss_pred HhHhccCCcCCEEECCCCccc
Confidence 333444444444444444444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=83.58 E-value=0.84 Score=52.91 Aligned_cols=63 Identities=13% Similarity=0.064 Sum_probs=50.8
Q ss_pred CCCcccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 462 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 462 ~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
.||. |+.|++|+.|+|++|+|+ .+|. .+.+.++..+.+.+|.+...| .....+.+....+.+|
T Consensus 455 ~lp~-~~~l~~L~~L~Ls~N~l~----~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N 518 (567)
T 1dce_A 455 VLCH-LEQLLLVTHLDLSHNRLR----ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNN 518 (567)
T ss_dssp SCCC-GGGGTTCCEEECCSSCCC----CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSS
T ss_pred CCcC-ccccccCcEeecCccccc----ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCC
Confidence 4887 999999999999999999 5764 344568888888999888777 6677777877777777
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=83.05 E-value=1.2 Score=46.88 Aligned_cols=68 Identities=7% Similarity=-0.126 Sum_probs=46.7
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCCC--CCcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ--SGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~--s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
+++..|..|+.|++|+.|+|++|+|+ + ++. ...+.++..+.+.+|.....|......+.+....+.+|
T Consensus 205 i~~~~~~~l~~l~~L~~L~L~~N~l~--~--~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N 274 (332)
T 2ft3_A 205 IQAIELEDLLRYSKLYRLGLGHNQIR--M--IENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTN 274 (332)
T ss_dssp CCCCCTTSSTTCTTCSCCBCCSSCCC--C--CCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSS
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCC--c--CChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCC
Confidence 44555677888888888888888888 4 332 34446777777778877777776666666666666655
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=83.00 E-value=1.5 Score=44.34 Aligned_cols=68 Identities=13% Similarity=0.088 Sum_probs=40.3
Q ss_pred cCCCCcccccCCCccccCCCCCCCCCCCCCCCC--CCcccccccccccCCCCccCCC-CCCCCCCCccccccCCc
Q 002908 460 HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ--SGSRINFDEGSQRESSSIVGPS-TMETHPDYSRSELKGNE 531 (867)
Q Consensus 460 s~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~--s~~~~~l~~lSl~~N~~l~gPs-~~~~~P~l~k~~Lagn~ 531 (867)
++..|..|+.+++|+.|+|++|+|+ + +|. ...+.++..+.+.+|.....|. .....+.+....+.+|.
T Consensus 120 ~~~~~~~~~~l~~L~~L~Ls~N~l~--~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 190 (251)
T 3m19_A 120 KSLPSGVFDRLTKLKELRLNTNQLQ--S--IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCC--C--CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCC
T ss_pred CCcChhHhccCCcccEEECcCCcCC--c--cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCc
Confidence 3333444677777777777777777 3 443 3344566667777776665544 34445556666666663
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=82.84 E-value=0.53 Score=55.12 Aligned_cols=26 Identities=15% Similarity=0.354 Sum_probs=15.9
Q ss_pred ecCCcCccchHHHHHhhhhhcccccc
Q 002908 389 DINDRFPRDFLSDIFTKARISENIAG 414 (867)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (867)
-|++-||..-|........-...+..
T Consensus 10 ~i~~ifpd~~l~~l~~l~l~~~~i~~ 35 (605)
T 1m9s_A 10 PIKQIFPDDAFAETIKDNLKKKSVTD 35 (605)
T ss_dssp EHHHHCCSHHHHHHHHHHTTCSCTTS
T ss_pred CHHHHCCcHHHHHHHHHhccCCCccc
Confidence 35667888888777665543333333
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=82.80 E-value=1.4 Score=42.95 Aligned_cols=62 Identities=11% Similarity=0.052 Sum_probs=41.9
Q ss_pred ccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCccCCCC-CCCCCCCccccccCC
Q 002908 466 PLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGN 530 (867)
Q Consensus 466 ~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn 530 (867)
.|+.+++|+.|+|++|+|+ + ..|. ...+.++..+.+.+|.+...+.. ....+.+....+.+|
T Consensus 49 ~~~~l~~L~~L~Ls~N~l~--~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 112 (192)
T 1w8a_A 49 LFGRLPHLVKLELKRNQLT--G-IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112 (192)
T ss_dssp SGGGCTTCCEEECCSSCCC--C-BCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS
T ss_pred ccccCCCCCEEECCCCCCC--C-cCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence 4888999999999999998 5 2343 34456778888888877666543 444555555555555
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=82.56 E-value=1.6 Score=42.54 Aligned_cols=46 Identities=11% Similarity=0.133 Sum_probs=23.9
Q ss_pred CcccccCCCccccCCCCCCCCCCCCCCCCC--CcccccccccccCCCCccCC
Q 002908 464 SSPLTNIEEGATVDYSYPPLKPDGSVMPQS--GSRINFDEGSQRESSSIVGP 513 (867)
Q Consensus 464 P~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s--~~~~~l~~lSl~~N~~l~gP 513 (867)
|..|+.+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|.+...|
T Consensus 69 ~~~~~~l~~L~~L~Ls~n~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~ 116 (208)
T 2o6s_A 69 NGVFNKLTSLTYLNLSTNQLQ----SLPNGVFDKLTQLKELALNTNQLQSLP 116 (208)
T ss_dssp TTTTTTCTTCCEEECCSSCCC----CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred hhhcCCCCCcCEEECCCCcCC----ccCHhHhcCccCCCEEEcCCCcCcccC
Confidence 334566666666666666666 23332 23445555555555544433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=82.41 E-value=0.49 Score=50.35 Aligned_cols=65 Identities=6% Similarity=0.065 Sum_probs=48.3
Q ss_pred CCCcccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 462 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 462 ~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
.||+.+++|++|+.|+|++|+|+ .+|. .+.+.++..+.+.+|.....|......+.+....+.++
T Consensus 95 ~lp~~l~~l~~L~~L~L~~n~l~----~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n 160 (328)
T 4fcg_A 95 QFPDQAFRLSHLQHMTIDAAGLM----ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRAC 160 (328)
T ss_dssp SCCSCGGGGTTCSEEEEESSCCC----CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEE
T ss_pred hcChhhhhCCCCCEEECCCCCcc----chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCC
Confidence 78888899999999999999988 5665 34567788888888887766666666666655555543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=82.25 E-value=0.93 Score=47.56 Aligned_cols=69 Identities=12% Similarity=0.066 Sum_probs=43.1
Q ss_pred ccCCCCcccccCCCccccCCCCCCCCCCCCCCC-CCCcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 459 DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMP-QSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 459 ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP-~s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
+++..|..|+.|++|+.|+|++|+|+ +- .+ ....+.++..+.+.+|.....|......+.+....+.+|
T Consensus 204 l~~~~~~~~~~l~~L~~L~Ls~n~l~--~~-~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N 273 (330)
T 1xku_A 204 ITKVDAASLKGLNNLAKLGLSFNSIS--AV-DNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 273 (330)
T ss_dssp CCEECTGGGTTCTTCCEEECCSSCCC--EE-CTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSS
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCc--ee-ChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCC
Confidence 34445667777777777777777777 31 22 233345666777777777766666666666666555555
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=81.87 E-value=1.7 Score=44.52 Aligned_cols=67 Identities=12% Similarity=0.116 Sum_probs=36.4
Q ss_pred cCCCCcccccCCCccccCCCCCCCCCCCCCCCC--CCcccccccccccCCCCccCCCC-CCCCCCCccccccCC
Q 002908 460 HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ--SGSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGN 530 (867)
Q Consensus 460 s~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~--s~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn 530 (867)
++..|..|+.|++|+.|+|++|+|+ + +|. .+.+.++..+.+.+|.....+.. ....+.+....+.+|
T Consensus 146 ~~~~~~~~~~l~~L~~L~l~~n~l~--~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 215 (272)
T 3rfs_A 146 QSLPKGVFDKLTNLTELDLSYNQLQ--S--LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCC--C--CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CccCHHHhccCccCCEEECCCCCcC--c--cCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCC
Confidence 3344445566666666666666666 3 332 13345666666666665544432 344555555555555
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=81.62 E-value=2 Score=42.86 Aligned_cols=64 Identities=8% Similarity=-0.118 Sum_probs=36.5
Q ss_pred cccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCccCCCC-CCCCCCCccccccCCc
Q 002908 465 SPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSIVGPST-METHPDYSRSELKGNE 531 (867)
Q Consensus 465 ~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l~gPs~-~~~~P~l~k~~Lagn~ 531 (867)
..|..+++|+.|+|++|+|+ +- .|. ...+.++..+.+.+|.+...+.. ....+.+....+.+|.
T Consensus 98 ~~f~~l~~L~~L~L~~N~l~--~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 163 (220)
T 2v9t_B 98 SLFEGLFSLQLLLLNANKIN--CL-RVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNP 163 (220)
T ss_dssp TTTTTCTTCCEEECCSSCCC--CC-CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred hHccCCCCCCEEECCCCCCC--Ee-CHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCC
Confidence 34566777777777777777 31 222 22345666666667766555442 4445555555666663
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=81.13 E-value=0.8 Score=56.14 Aligned_cols=71 Identities=7% Similarity=0.088 Sum_probs=52.1
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCC----------------CCCCCC---cccccccccccCCC-CccCCCCCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGS----------------VMPQSG---SRINFDEGSQRESS-SIVGPSTME 517 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs----------------~IP~s~---~~~~l~~lSl~~N~-~l~gPs~~~ 517 (867)
+|++ ||+.|++|++|+.|+|++|+|+ |. .+|... .+.++..+.+.+|. .-..|....
T Consensus 436 ~L~~-IP~~l~~L~~L~~L~Ls~N~Ls--g~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~ 512 (876)
T 4ecn_A 436 RITF-ISKAIQRLTKLQIIYFANSPFT--YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512 (876)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCC--GGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGG
T ss_pred cccc-hhHHHhcCCCCCEEECcCCcCC--CCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHh
Confidence 5666 8999999999999999999998 51 166554 46677778887776 334466667
Q ss_pred CCCCCccccccCCc
Q 002908 518 THPDYSRSELKGNE 531 (867)
Q Consensus 518 ~~P~l~k~~Lagn~ 531 (867)
..+.+....+.+|.
T Consensus 513 ~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 513 DLPELQSLNIACNR 526 (876)
T ss_dssp GCSSCCEEECTTCT
T ss_pred CCCCCCEEECcCCC
Confidence 77778877787775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 867 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-75 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-68 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-67 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-62 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-58 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-56 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-45 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 7e-75
Identities = 90/283 (31%), Positives = 145/283 (51%), Gaps = 22/283 (7%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
I + + + +GSG+FGTVY GKW G DVA+K + + T + + F E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ------AFKNEVGV 57
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
L K H N++ F G LA VT++ SL H L E + K + IA A
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---RNTLVTGGVRGTL 753
GM+YLH+K+I+H DLK +N+ ++ + K+GDFGL+ +K + + G++
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTV----KIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 754 PWMAPELLNG-SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP- 811
WMAPE++ + S + DV++FGIVL+E++TG+ PY+N++ I +V P
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 812 ---VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851
V C + LM +C RP F +I + +++ +
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-69
Identities = 94/272 (34%), Positives = 136/272 (50%), Gaps = 22/272 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ ++L+ L+ +G G FG V G +RG VA+K IK + F EA +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----------DATAQAFLAEASV 53
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDA 695
+++L H N+V GV+ + GG L VTE+M GSL L S+ R L L ++D
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 755
MEYL N VH DL N+LV+ + + KV DFGL+K +T TG + + W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDTG--KLPVKW 166
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 814
APE L K S K DV+SFGI+LWEI + G PY + ++ + + P
Sbjct: 167 TAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD 223
Query: 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
C +M+ CW D +RPSF ++ +L
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 3e-68
Identities = 92/274 (33%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I +DL LKELG+G FG V +GKWR DVAIK IK+ S E EF EA+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------SMSED---EFIEEAK 51
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
++ L H +V YGV + +TE+M NG L + L ++ L + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTL 753
MEYL SK +H DL N LVN + + KV DFGLS+ + G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812
W PE+L S K S K D+++FG+++WEI + G+ PY I LR
Sbjct: 166 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 222
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
P + +M CW RP+F + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 8e-68
Identities = 88/281 (31%), Positives = 127/281 (45%), Gaps = 24/281 (8%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEF 630
+I +DL L++LG G+FG V G+W VA+K +K + + +F
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DF 58
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
RE + L H N++ YGVV P + VTE GSL L + H
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVT 746
A+ A GM YL SK +H DL NLL+ +D + K+GDFGL + + ++
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV----KIGDFGLMRALPQNDDHYVMQ 171
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805
+ W APE L S D + FG+ LWE+ T G+EP+ ++ I+ I
Sbjct: 172 EHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
R P P C + +M QCWA P RP+F + L
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (572), Expect = 3e-67
Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 22/279 (7%)
Query: 570 DISTLQIIKNEDLEE----LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQ 623
D ++ +D E+ L+E+G G+FG VY + VAIK++ S Q
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 624 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 683
+ +E L KL HPN + + G T V E+ + + + + K + L
Sbjct: 61 D-----IIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHK-KPL 112
Query: 684 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743
+ + A G+ YLHS N++H D+K N+L++ + K+GDFG + I
Sbjct: 113 QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPA 168
Query: 744 LVTGGVRGTLPWMAPELLNGSS-SKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG 802
GT WMAPE++ + KVDV+S GI E+ + P NM+ + +
Sbjct: 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 803 IVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
I N G +R ++ C P RP+ +
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 8e-67
Identities = 77/263 (29%), Positives = 123/263 (46%), Gaps = 21/263 (7%)
Query: 586 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 643
E+G G+F TVY G T VA ++ T ++ F EAE+L L HP
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR------FKEEAEMLKGLQHP 68
Query: 644 NVVAFYGVVQDGP--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
N+V FY + + VTE M +G+L+ L + + + + G+++
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 702 LHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 759
LH++ I+H DLKCDN+ + K+GD GL+ +KR + V GT +MAPE
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASF-AKAVIGTPEFMAPE 183
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP-VPGFCDS 818
+ K E VDV++FG+ + E+ T E PY+ A I V + ++P
Sbjct: 184 MYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 819 EWRLLMEQCWAPDPVVRPSFTEI 841
E + ++E C + R S ++
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 2e-66
Identities = 92/294 (31%), Positives = 131/294 (44%), Gaps = 27/294 (9%)
Query: 576 IIKNEDLEELK-ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEF 630
+K ++L ELG G FG+V G +R DVAIK +K+ ++ T E
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEM 56
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
REA+I+ +L +P +V GV Q L V E G L L+ K +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVT 746
+ + GM+YL KN VH DL N+L+ R K+ DFGLSK
Sbjct: 114 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVN----RHYAKISDFGLSKALGADDSYYTAR 169
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805
+ L W APE +N K S + DV+S+G+ +WE L+ G++PY M ++ I
Sbjct: 170 SAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
Query: 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTKSHGH 859
R P C E LM CW RP F + +R+R + +K GH
Sbjct: 228 G-KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 3e-66
Identities = 82/273 (30%), Positives = 124/273 (45%), Gaps = 22/273 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
+ E L+ ++ LG+G FG V+ G + T VA+K +K+ + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEAN 60
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMD 694
++ +L H +V Y VV P + +TE+M NGSL L + L K L +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGT 752
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+++ G +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
+ W APE +N + K DV+SFGI+L EI+T + + R
Sbjct: 174 IKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C E LM CW P RP+F + L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-65
Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 20/274 (7%)
Query: 576 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+I +L ++E+GSG FG V+ G W VAIK I++ + +F EA
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---------DFIEEA 51
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
E++ KL HP +V YGV + + V EFM +G L L ++ L + +D
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGT 752
GM YL ++H DL N LV + KV DFG+++ + G +
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
+ W +PE+ + S + S K DV+SFG+++WE+ + + + + ++ R
Sbjct: 166 VKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
P + +M CW P RP+F+ + R+L
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 3e-65
Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 24/273 (8%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED E L +G+G++G + + + K + T + E +L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM------LVSEVNLL 57
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRKRLIIAMD 694
+L HPN+V +Y + D TL V E+ G L V+ + +LD L +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 695 AAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGG 748
++ H ++ ++H DLK N+ ++ K + K+GDFGL++ + +T
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV----KLGDFGLARILNHDTSFAKA 173
Query: 749 VRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL 808
GT +M+PE +N +EK D++S G +L+E+ P+ + G I
Sbjct: 174 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK- 230
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+P E ++ + RPS EI
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 2e-64
Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 19/264 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED E + LG G FG VY + + + +A+K + K+ E+ + + RE EI
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQ 60
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
S L HPN++ YG D + + E+ G++ L K D ++ + A
Sbjct: 61 SHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYR-ELQKLSKFDEQRTATYITELAN 117
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
+ Y HSK ++H D+K +NLL+ + K+ DFG S ++ + GTL ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGEL----KIADFGWSVHAPSSR-RTTLCGTLDYLP 172
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817
PE++ G EKVD++S G++ +E L G+ P+ Y I + P F
Sbjct: 173 PEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVT 228
Query: 818 SEWRLLMEQCWAPDPVVRPSFTEI 841
R L+ + +P RP E+
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREV 252
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 4e-64
Identities = 74/278 (26%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 575 QIIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTL 628
+ ++ + E+ + ELG G FG VY + + T A K I SE+E
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK------SEEELE-- 54
Query: 629 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 688
++ E +IL+ HPN+V L + EF G++ V+L ER L +
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQI 112
Query: 689 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTG 747
++ + YLH I+H DLK N+L L I K+ DFG+S R
Sbjct: 113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDI----KLADFGVSAKNTRTIQRRD 168
Query: 748 GVRGTLPWMAPELLNGSSSK---VSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804
GT WMAPE++ +SK K DV+S GI L E+ E P+ ++ ++ I
Sbjct: 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
Query: 805 NN-TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ P S ++ +++C + R + +++
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 6e-64
Identities = 84/274 (30%), Positives = 122/274 (44%), Gaps = 27/274 (9%)
Query: 582 LEELKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
LE+ KELGSG FGTV G ++ VA+K +K + L E EA ++
Sbjct: 10 LED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE------ANDPALKDELLAEANVM 62
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+L +P +V G+ + V E G L L + RH+ + + + +
Sbjct: 63 QQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNK-YLQQNRHVKDKNIIELVHQVSM 118
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTGGVRGTL 753
GM+YL N VH DL N+L+ + K+ DFGLSK + + +
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812
W APE +N K S K DV+SFG+++WE + G++PY M + + R
Sbjct: 175 KWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGC 231
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
P C E LM CW D RP F + RLR
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 4e-63
Identities = 79/287 (27%), Positives = 133/287 (46%), Gaps = 27/287 (9%)
Query: 572 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQER 625
+ L+I+K + +++K LGSG FGTVY G W VAIK ++++ +
Sbjct: 1 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPK 53
Query: 626 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR 685
E EA +++ + +P+V G+ T+ +T+ M G L + + ++
Sbjct: 54 ANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGS 110
Query: 686 RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRN 742
+ L + A GM YL + +VH DL N+LV K+ DFGL+K+ +
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEK 166
Query: 743 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIG 801
G + + WMA E + + + DV+S+G+ +WE++T G +PY + I
Sbjct: 167 EYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 224
Query: 802 GIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
I+ R P P C + ++M +CW D RP F E+ M
Sbjct: 225 -ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-62
Identities = 89/306 (29%), Positives = 129/306 (42%), Gaps = 49/306 (16%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 629
E+LE K LGSG FG V + G VA+K +K+ ++ ER
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-----KADSSERE--A 86
Query: 630 FWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------ 682
E +++++L H N+V G G + + E+ G L + L SK
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 683 ----------------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 726
L L A A GME+L K+ VH DL N+LV
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK--- 201
Query: 727 PICKVGDFGLSKI---KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWE 783
+ K+ DFGL++ N +V G R + WMAPE L + K DV+S+GI+LWE
Sbjct: 202 -VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWE 258
Query: 784 ILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIA 842
I + G PY + A ++ N + P + E ++M+ CWA D RPSF +
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 843 RRLRVM 848
L
Sbjct: 319 SFLGCQ 324
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 5e-62
Identities = 86/278 (30%), Positives = 132/278 (47%), Gaps = 25/278 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFW 631
I+ E +E + +G G FG V+ G + + VAIK K + + +F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFL 56
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
+EA + + HP++V GV+ + P + + E G LR L ++ LD ++
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 749
A + + YL SK VH D+ N+LV+ D K+GDFGLS+
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTL 808
+ + WMAPE +N + + DV+ FG+ +WEIL G +P+ + +IG I N
Sbjct: 170 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 226
Query: 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
R P+P C LM +CWA DP RP FTE+ +L
Sbjct: 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 4e-61
Identities = 87/273 (31%), Positives = 123/273 (45%), Gaps = 22/273 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
I E L +LG G FG V+ G W GT VAIK +K + F +EA+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------AFLQEAQ 64
Query: 636 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMD 694
++ KL H +V Y VV + P + VTE+M GSL + ++L + + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGT 752
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ G +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812
+ W APE + + K DV+SFGI+L E+ T + V R P
Sbjct: 178 IKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
P C LM QCW +P RP+F + L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 6e-61
Identities = 89/280 (31%), Positives = 133/280 (47%), Gaps = 25/280 (8%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEF 630
I + K +G+G FG VY G + + VAIK +K +E++R+ +F
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-----YTEKQRV--DF 56
Query: 631 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 690
EA I+ + H N++ GV+ + +TE+M NG+L L K+ + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 691 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVT 746
+ A GM+YL + N VH DL N+LVN +CKV DFGLS++ T T
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLEDDPEATYTT 170
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806
G + + W APE ++ K + DV+SFGIV+WE++T E + +N+
Sbjct: 171 SGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
R P P C S LM QCW + RP F +I L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 1e-60
Identities = 86/277 (31%), Positives = 124/277 (44%), Gaps = 22/277 (7%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
++ D+ +LG G +G VY G W+ VA+K +K+ EF +EA
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------EFLKEA 64
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAM 693
++ ++ HPN+V GV P +TEFM G+L L R + L +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN--TLVTGGVRG 751
+ MEYL KN +H DL N LV + KV DFGLS++ G +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
+ W APE L + K S K DV++FG++LWEI T + + ++ R
Sbjct: 179 PIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
P C + LM CW +P RPSF EI + M
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 3e-60
Identities = 95/296 (32%), Positives = 135/296 (45%), Gaps = 32/296 (10%)
Query: 565 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGR 619
A+ F + I ++ + +G+G FG V G + VAIK +K
Sbjct: 15 AVREFA----KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----- 65
Query: 620 SSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK 679
+E++R +F EA I+ + HPNV+ GVV + +TEFM NGSL L
Sbjct: 66 YTEKQRR--DFLSEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQN 121
Query: 680 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 739
+ + + + A GM+YL N VH DL N+LVN +CKV DFGLS+
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL----VCKVSDFGLSRF 177
Query: 740 ------KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYA 792
G + + W APE + K + DV+S+GIV+WE+++ GE PY
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 793 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+M +I I + R P P C S LM CW D RP F +I L M
Sbjct: 236 DMTNQDVINAIEQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-59
Identities = 92/298 (30%), Positives = 132/298 (44%), Gaps = 37/298 (12%)
Query: 572 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGT----DVAIKRIKKSCFTGRSSEQERLT 627
+ ++ D++ +G G FG V + + D AIKR+K+ S + R
Sbjct: 2 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHR-- 55
Query: 628 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------- 677
+F E E+L KL HHPN++ G + G L E+ +G+L L
Sbjct: 56 -DFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 112
Query: 678 ------SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731
S L ++ L A D A GM+YL K +H DL N+LV + K+
Sbjct: 113 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKI 168
Query: 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP 790
DFGLS+ + + R + WMA E LN S + DV+S+G++LWEI++ G P
Sbjct: 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTP 226
Query: 791 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
Y M + + R P CD E LM QCW P RPSF +I L M
Sbjct: 227 YCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 2e-59
Identities = 88/315 (27%), Positives = 140/315 (44%), Gaps = 51/315 (16%)
Query: 568 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRS 620
N + +L+ +N ++E ++++G G FG V+ + T VA+K +K+ S
Sbjct: 2 NPKLLSLEYPRN-NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----AS 56
Query: 621 SEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE 680
++ + +F REA ++++ +PN+V GV G + + E+M G L L S
Sbjct: 57 ADMQA---DFQREAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMS 111
Query: 681 RH-----------------------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 717
H L ++L IA A GM YL + VH DL N
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171
Query: 718 LVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDV 774
LV + K+ DFGLS+ G + WM PE + ++ + + DV
Sbjct: 172 LVGENM----VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDV 225
Query: 775 FSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPV 833
+++G+VLWEI + G +PY M + +I + + P C E LM CW+ P
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPA 284
Query: 834 VRPSFTEIARRLRVM 848
RPSF I R L+ M
Sbjct: 285 DRPSFCSIHRILQRM 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-59
Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 62/310 (20%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+K++D E++ ELG+G G V+ + + +A K I + + + RE
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIREL 55
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
++L + + P +V FYG G ++ E M GSL +L K + + +++
Sbjct: 56 QVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIA 112
Query: 695 AAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 753
G+ YL K+ I+H D+K N+LVN + I K+ DFG+S +++ V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV-GTR 167
Query: 754 PWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY---------------------- 791
+M+PE L G+ S + D++S G+ L E+ G P
Sbjct: 168 SYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 792 --------------------ANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPD 831
M ++ IVN G E++ + +C +
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 832 PVVRPSFTEI 841
P R ++
Sbjct: 286 PAERADLKQL 295
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 22/267 (8%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ +++G G GTVY G +VAI+++ + ++E E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKEL----IINEILV 70
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+ + +PN+V + G L V E++ GSL V+ E +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPW 755
+E+LHS ++H D+K DN+L+ + + K+ DFG I + GT W
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPG 814
MAPE++ KVD++S GI+ E++ GE PY N + + I N T P
Sbjct: 183 MAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
Query: 815 FCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ +R + +C D R S E+
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-58
Identities = 83/295 (28%), Positives = 119/295 (40%), Gaps = 38/295 (12%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLE 629
L K LG+G FG V VA+K +K S + ER
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTERE--A 72
Query: 630 FWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--------- 679
E ++LS L +H N+V G G G +TE+ G L + L K
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 680 --------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731
E LD L + A GM +L SKN +H DL N+L+ I IC
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDF 189
Query: 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP- 790
G K N +V G R + WMAPE + + + DV+S+GI LWE+ +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSP 247
Query: 791 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845
Y M + ++ R P +E +M+ CW DP+ RP+F +I + +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 202 bits (514), Expect = 1e-58
Identities = 53/267 (19%), Positives = 110/267 (41%), Gaps = 18/267 (6%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
+ + L+ELGSG FG V+ + T K I ++ E I
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYT----VKNEISI 79
Query: 637 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+++LHHP ++ + +D + + EF+ G L + +++ + + + A
Sbjct: 80 MNQLHHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
G++++H +IVH D+K +N++ K K+ DFGL+ + T +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPDEIVKVTTATAEFA 195
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF- 815
APE+++ V D+++ G++ + +L+G P+A + + F
Sbjct: 196 APEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 816 -CDSEWRLLMEQCWAPDPVVRPSFTEI 841
E + ++ +P R + +
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 3e-58
Identities = 78/274 (28%), Positives = 129/274 (47%), Gaps = 26/274 (9%)
Query: 586 KELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+ +G G FG VYHG D A+K + + G S+ F E I+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-------FLTEGIIMKDF 85
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
HPNV++ G+ G + V +M +G LR+ + ++ + + + + A GM+
Sbjct: 86 SHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-----TLVTGGVRGTLPW 755
+L SK VH DL N +++ + KV DFGL++ + G + + W
Sbjct: 145 FLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPG 814
MA E L K + K DV+SFG++LWE++T G PY +++ I ++ R P
Sbjct: 201 MALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPE 257
Query: 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848
+C +M +CW P +RPSF+E+ R+ +
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 201 bits (511), Expect = 3e-58
Identities = 57/266 (21%), Positives = 106/266 (39%), Gaps = 18/266 (6%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ + +ELG+G FG V+ R T A K + S++E +E + +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKET----VRKEIQTM 77
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
S L HP +V + +D + + EFM G L + + + + +
Sbjct: 78 SVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
G+ ++H N VH DLK +N++ K K+ DFGL+ GT + A
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF-- 815
PE+ G V D++S G++ + +L+G P+ + + + + F
Sbjct: 194 PEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ + + + DP R + +
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-58
Identities = 72/268 (26%), Positives = 110/268 (41%), Gaps = 21/268 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED + ++ LG G +G V R T+ VA+K + R+ + +E I
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPE---NIKKEICIN 57
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
L+H NVV FYG + G E+ G L + + +
Sbjct: 58 KMLNHENVVKFYGHRR--EGNIQYLFLEYCSGGELFD-RIEPDIGMPEPDAQRFFHQLMA 114
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR---NTLVTGGVRGTLP 754
G+ YLH I H D+K +NLL++ +D + K+ DFGL+ + R + + GTLP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNL----KISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE-EPYANMHYGAIIGGIVNNTLRPPVP 813
++APELL +E VDV+S GIVL +L GE
Sbjct: 171 YVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229
Query: 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
DS L+ + +P R + +I
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (499), Expect = 4e-57
Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 21/272 (7%)
Query: 578 KNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 631
+ ED+ + LG+G F V + + T VAIK I K G+
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-------ME 55
Query: 632 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
E +L K+ HPN+VA + + G G L + + + G L + ++ R +
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESG--GHLYLIMQLVSGGELFD-RIVEKGFYTERDASRL 112
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 751
++YLH IVH DLK +NLL D I + DFGLSK++ V G
Sbjct: 113 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACG 171
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
T ++APE+L S+ VD +S G++ + +L G P+ + + + I+
Sbjct: 172 TPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229
Query: 812 VPGF--CDSEWRLLMEQCWAPDPVVRPSFTEI 841
P + + + DP R + +
Sbjct: 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-57
Identities = 70/278 (25%), Positives = 116/278 (41%), Gaps = 21/278 (7%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 634
+ ED + K LG G+F TV + T AIK ++K R +E RE
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTRER 59
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
+++S+L HP V Y QD L + NG L + K D +
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAE 116
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRG 751
+EYLH K I+H DLK +N+L+N I ++ DFG +K+ + G
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHI----QITDFGTAKVLSPESKQARANSFVG 172
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
T +++PELL + D+++ G ++++++ G P+ + I I+ L
Sbjct: 173 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYD 228
Query: 812 VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849
P + R L+E+ D R E+ + +
Sbjct: 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 194 bits (493), Expect = 1e-56
Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 17/272 (6%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEI 636
E+ E + LG G V + T A+K I + S+E+ + L +E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 637 LSKLH-HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 695
L K+ HPN++ + V + M G L L+++ L ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRAL 119
Query: 696 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 755
+ LH NIVH DLK +N+L++ I K+ DFG S V GT +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNI----KLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 756 MAPELLNGS----SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP 811
+APE++ S ++VD++S G++++ +L G P+ + ++ I++ +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 812 VPGFCD--SEWRLLMEQCWAPDPVVRPSFTEI 841
P + D + L+ + P R + E
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-56
Identities = 71/309 (22%), Positives = 120/309 (38%), Gaps = 54/309 (17%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 639
+ + +G G FG V+ GKWRG +VA+K +E + E
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS---------REERSWFREAEIYQTVM 53
Query: 640 LHHPNVVAFYGVVQ--DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
L H N++ F +G L V+++ +GSL L + + +A+ A
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTAS 111
Query: 698 GMEYLHS--------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-----TL 744
G+ +LH I H DLK N+LV C + D GL+ + +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDSATDTIDI 167
Query: 745 VTGGVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTG----------EEP 790
GT +MAPE+L+ S + + ++ D+++ G+V WEI + P
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 791 YANMHYG-----AIIGGIVNNTLRPPVPGFCDS-----EWRLLMEQCWAPDPVVRPSFTE 840
Y ++ + + LRP +P S +M +CW + R +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 841 IARRLRVMS 849
I + L +S
Sbjct: 288 IKKTLSQLS 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-56
Identities = 51/266 (19%), Positives = 105/266 (39%), Gaps = 19/266 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E ++LG G FG V+ + K +K + ++Q +E IL
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVL----VKKEISIL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+ H N++ + + L + EF+ + + + L+ R+ +
Sbjct: 56 NIARHRNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
+++LHS NI HFD++ +N++ + K+ +FG ++ + + + A
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF-- 815
PE+ VS D++S G +++ +L+G P+ II I+N F
Sbjct: 172 PEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEI 841
E +++ + R + +E
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 15/274 (5%)
Query: 576 IIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLE 629
+ + E++++ +ELGSG F V + + T A K IKK SS + +
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK--SSRRGVSRED 59
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
RE IL ++ HPNV+ + V ++ + + E + G L L KE +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 749
+ G+ YLHS I HFDLK +N+++ ++ +P K+ DFGL+ +
Sbjct: 118 FLKQ-ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI--VNNT 807
GT ++APE++N + + D++S G++ + +L+G P+ + + VN
Sbjct: 177 FGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ + + + DP R + +
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 191 bits (487), Expect = 7e-56
Identities = 62/275 (22%), Positives = 119/275 (43%), Gaps = 15/275 (5%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 636
++ E + LG G V+ + DVA+K ++ + L F REA+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-----LARDPSFYLRFRREAQN 60
Query: 637 LSKLHHPNVVAFYGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
+ L+HP +VA Y + G V E++ +LR ++ E + ++ + + D
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIAD 119
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
A + + H I+H D+K N++++ + ++ + ++ + T V GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--V 812
+++PE G V + DV+S G VL+E+LTGE P+ ++ V PP
Sbjct: 180 YLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 813 PGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLR 846
++ ++ + A +P R + E+ L
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-55
Identities = 81/300 (27%), Positives = 123/300 (41%), Gaps = 39/300 (13%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLT 627
+ + L K LG G FG V + G D VA+K +K ++E++
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLS- 63
Query: 628 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---------- 676
+ E E++ + H N++ G G L + E+ G+LR L
Sbjct: 64 -DLISEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 677 -----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731
+ E L + + A A GMEYL SK +H DL N+LV +D + I
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADF 179
Query: 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEP 790
G T R + WMAPE L + + DV+SFG++LWEI T G P
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 791 YANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850
Y + + ++ R P C +E ++M CW P RP+F ++ L + A
Sbjct: 238 YPGVPVEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-53
Identities = 85/297 (28%), Positives = 124/297 (41%), Gaps = 41/297 (13%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 629
+ L+ K LG G FG V G D VA+K +K+ G + + R
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHR---A 62
Query: 630 FWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------ 682
E +IL HH NVV G PGG L + EF G+L L SK
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 121
Query: 683 ---------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733
L + + A GME+L S+ +H DL N+L++ K+ + K+ D
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKICD 177
Query: 734 FGLSKI---KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE- 789
FGL++ + + G R L WMAPE + + + DV+SFG++LWEI +
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 790 PYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
PY + + R P + E M CW +P RP+F+E+ L
Sbjct: 236 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-53
Identities = 81/287 (28%), Positives = 121/287 (42%), Gaps = 30/287 (10%)
Query: 577 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 629
+ E + +ELG G+FG VY G +G VAIK + ++ +S +ER+ E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-----ASMRERI--E 69
Query: 630 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---------LSKE 680
F EA ++ + + +VV GVV G + E M G L+ L
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 681 RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 740
K + +A + A GM YL++ VH DL N +V ++ I G
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK-IGDFGMTRDIYET 186
Query: 741 RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE-PYANMHYGAI 799
G + WM+PE L + DV+SFG+VLWEI T E PY + +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244
Query: 800 IGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
+ ++ P C LM CW +P +RPSF EI ++
Sbjct: 245 LRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 9e-53
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 20/269 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
ED K LG G+FG V+ +++ T+ AIK +KK + E +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC-----TMVEKRVL 56
Query: 638 SK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
S HP + + Q L V E++ G L + + D + A +
Sbjct: 57 SLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMY-HIQSCHKFDLSRATFYAAEII 113
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPW 755
G+++LHSK IV+ DLK DN+L++ K+ DFG+ K T GT +
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGH----IKIADFGMCKENMLGDAKTNTFCGTPDY 169
Query: 756 MAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815
+APE+L G K + VD +SFG++L+E+L G+ P+ + I + P P +
Sbjct: 170 IAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRW 225
Query: 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARR 844
+ E + L+ + + +P R R+
Sbjct: 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-50
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 21/261 (8%)
Query: 585 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH- 641
LGSG FG+VY G + VAIK ++K + E +L K+
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT--RVPMEVVLLKKVSS 66
Query: 642 -HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
V+ + + + E +++ L +
Sbjct: 67 GFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPEL 760
+ H+ ++H D+K +N+L++L R K+ DFG + ++T+ T GT + PE
Sbjct: 125 HCHNCGVLHRDIKDENILIDLN---RGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 180
Query: 761 LNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEW 820
+ V+S GI+L++++ G+ P+ + II G + SE
Sbjct: 181 IRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQRVSSEC 231
Query: 821 RLLMEQCWAPDPVVRPSFTEI 841
+ L+ C A P RP+F EI
Sbjct: 232 QHLIRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 6e-50
Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 32/284 (11%)
Query: 574 LQIIKN---EDLEELKE-LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 627
LQI KN +D + + LG G G V + T A+K ++
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------- 48
Query: 628 LEFWREAEILSKL-HHPNVVAFYGVVQDG--PGGTLATVTEFMVNGSLRHVLLSK-ERHL 683
+ RE E+ + P++V V ++ L V E + G L + + ++
Sbjct: 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 684 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 743
R+ I ++YLHS NI H D+K +NLL K P I K+ DFG +K +
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP-NAILKLTDFGFAKETTSH 167
Query: 744 LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 803
T ++APE+L K + D++S G++++ +L G P+ + H AI G+
Sbjct: 168 NSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225
Query: 804 VNN------TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P E ++L+ +P R + TE
Sbjct: 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 5e-49
Identities = 59/278 (21%), Positives = 105/278 (37%), Gaps = 31/278 (11%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 642
+++GSG+FG +Y G G +VAIK ++ + E++I +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQ----LHIESKIYKMMQG 61
Query: 643 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 702
+ G V E + SL + R + L++A +EY+
Sbjct: 62 GVGIPTIRWCGA-EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--------LVTGGVRGTLP 754
HSKN +H D+K DN L+ L + + DFGL+K R+ + GT
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT---LRPP 811
+ + G + S + D+ S G VL G P+ + + + P
Sbjct: 179 YASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 812 VPGFCD---SEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
+ C SE+ + C + +P ++ + + R
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (442), Expect = 1e-48
Identities = 59/261 (22%), Positives = 98/261 (37%), Gaps = 14/261 (5%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D + +G G FG VY + G A+K + K + + E L L ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLV 61
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
S P +V L+ + + M G L + L + R A
Sbjct: 62 STGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IIL 118
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
G+E++H++ +V+ DLK N+L++ + ++ D GL+ GT +MA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHV----RISDLGLACDFSKKK-PHASVGTHGYMA 173
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPGFC 816
PE+L D FS G +L+++L G P+ T+ +P
Sbjct: 174 PEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 817 DSEWRLLMEQCWAPDPVVRPS 837
E R L+E D R
Sbjct: 233 SPELRSLLEGLLQRDVNRRLG 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (438), Expect = 1e-48
Identities = 67/260 (25%), Positives = 126/260 (48%), Gaps = 20/260 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+D + L+ LG+G+FG V+ + R G A+K +KK + E +L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-----TNDERLML 58
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
S + HP ++ +G QD + + +++ G L +L +R + + A +
Sbjct: 59 SIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 115
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
+EYLHSK+I++ DLK +N+L++ I K+ DFG +K + T + GT ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHI----KITDFGFAKYVPDVTYT--LCGTPDYIA 169
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817
PE+++ ++ +D +SFGI+++E+L G P+ + + I+N P F +
Sbjct: 170 PEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFN 225
Query: 818 SEWRLLMEQCWAPDPVVRPS 837
+ + L+ + D R
Sbjct: 226 EDVKDLLSRLITRDLSQRLG 245
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 67/297 (22%), Positives = 112/297 (37%), Gaps = 46/297 (15%)
Query: 579 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 635
++ E + E+G G +G V+ + G VA+KR++ + +E + L RE
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVA 59
Query: 636 ILSKL---HHPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 689
+L L HPNVV + V L V E + ++ E +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 690 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 749
+ G+++LHS +VH DLK N+LV K+ DFGL++I + V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFGLARIYSFQMALTSV 175
Query: 750 RGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809
TL + APE+L S + VD++S G + E+ + + +G I++
Sbjct: 176 VVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 810 PP-------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
P D + L+ +C +P R S
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 167 bits (424), Expect = 5e-47
Identities = 50/280 (17%), Positives = 92/280 (32%), Gaps = 33/280 (11%)
Query: 585 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-H 641
+ +G G+FG ++ G VAIK + + E L
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----------RSDAPQLRDEYRTYKLLAG 59
Query: 642 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 701
+ Y Q+G + ++ SL +L R + + A ++
Sbjct: 60 CTGIPNVYYFGQEG---LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 702 LHSKNIVHFDLKCDNLLVNLKD-PIRPICKVGDFGLSKIKRNTLV--------TGGVRGT 752
+H K++V+ D+K DN L+ + + V DFG+ K R+ + + GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI------IGGIVNN 806
+M+ G + S + D+ + G V L G P+ + IG +
Sbjct: 177 ARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846
T + E+ M P + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 70/292 (23%), Positives = 114/292 (39%), Gaps = 43/292 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E+ ++++++G GT+G VY + + T VA+K+I+ +E E + RE +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TETEGVPSTAIREISLL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+L+HPN+V V+ L V EF+ + + S +
Sbjct: 56 KELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW-M 756
G+ + HS ++H DLK NLL+N + I K+ DFGL++ + T W
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAI----KLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP----- 811
APE+L G S VD++S G + E++T + + I P
Sbjct: 170 APEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 812 ----------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
V D + R L+ Q DP R S
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-45
Identities = 67/261 (25%), Positives = 109/261 (41%), Gaps = 19/261 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
D + LK LG GTFG V + + T A+K ++K + E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVL 59
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
HP + A Q L V E+ G L LS+ER + +
Sbjct: 60 QNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFF-HLSRERVFTEERARFYGAEIVS 116
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWM 756
+EYLHS+++V+ D+K +NL+++ I K+ DFGL K + GT ++
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHI----KITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
APE+L + VD + G+V++E++ G P+ N + + I+ P
Sbjct: 173 APEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTL 228
Query: 817 DSEWRLLMEQCWAPDPVVRPS 837
E + L+ DP R
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLG 249
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 9e-45
Identities = 67/288 (23%), Positives = 111/288 (38%), Gaps = 40/288 (13%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
E+L LG G F TVY + + T+ VAIK+IK RS ++ + RE ++L +L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQEL 57
Query: 641 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 700
HPN++ ++ V +FM + L + G+E
Sbjct: 58 SHPNIIGLLDAFGHK--SNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 701 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GTLPWMAPE 759
YLH I+H DLK +NLL++ + K+ DFGL+K + + T + APE
Sbjct: 115 YLHQHWILHRDLKPNNLLLDENGVL----KLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 760 LLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF---- 815
LL G+ VD+++ G +L E+L + I P +
Sbjct: 171 LLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 816 ----------------------CDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ L++ + +P R + T+
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-44
Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 21/268 (7%)
Query: 580 EDLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 634
E+ E LK LG+G +G V+ G G A+K +KK+ ++ E E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTER 79
Query: 635 EILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 693
++L + P +V + Q L + +++ G L LS+ + I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFT-HLSQRERFTEHEVQIYVG 136
Query: 694 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRG 751
+ +E+LH I++ D+K +N+L++ + + DFGLSK + T G
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV----LTDFGLSKEFVADETERAYDFCG 192
Query: 752 TLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-- 809
T+ +MAP+++ G S + VD +S G++++E+LTG P+ I L+
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252
Query: 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPS 837
PP P + + L+++ DP R
Sbjct: 253 PPYPQEMSALAKDLIQRLLMKDPKKRLG 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 159 bits (403), Expect = 2e-44
Identities = 61/290 (21%), Positives = 105/290 (36%), Gaps = 41/290 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
E L+++G GT+G VY + G A+K+I+ E E + RE IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE------KEDEGIPSTTIREISILK 55
Query: 639 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 698
+L H N+V Y V+ L ++ L+ +L E L+ + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL---VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAP 758
+ Y H + ++H DLK NLL+N + + K+ DFGL++ + W
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGEL----KIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 759 ELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF--- 815
+ S K S +D++S G + E++ G + + + I P +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 816 ------------------------CDSEWRLLMEQCWAPDPVVRPSFTEI 841
D L+ + DP R + +
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-43
Identities = 61/296 (20%), Positives = 111/296 (37%), Gaps = 51/296 (17%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
L +G G +G V VAIK+I E + RE +IL +
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRF 63
Query: 641 HHPNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 698
H N++ +++ + + ++ L +L K +HL G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRG 121
Query: 699 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTGGVRGTLP 754
++Y+HS N++H DLK NLL+N + K+ DFGL+++ +T T
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDL----KICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--- 811
+ APE++ S ++ +D++S G +L E+L+ + HY + I+ P
Sbjct: 178 YRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 812 --------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ DS+ L+++ +P R +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 59/305 (19%), Positives = 105/305 (34%), Gaps = 55/305 (18%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E+L ++G GTFG V+ + R T VA+K++ +E+E + RE +IL
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALREIKIL 63
Query: 638 SKLHHPNVVAFYGVVQDGP------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 691
L H NVV + + G++ V +F + + + + ++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 692 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----- 746
M G+ Y+H I+H D+K N+L+ + K+ DFGL++ +
Sbjct: 124 QM-LLNGLYYIHRNKILHRDMKAANVLITRDGVL----KLADFGLARAFSLAKNSQPNRY 178
Query: 747 GGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN 806
TL + PELL G +D++ G ++ E+ T + I
Sbjct: 179 TNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 807 TLRPP------------------------------VPGFCDSEWRLLMEQCWAPDPVVRP 836
D L+++ DP R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 837 SFTEI 841
+
Sbjct: 298 DSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 2e-42
Identities = 60/259 (23%), Positives = 110/259 (42%), Gaps = 20/259 (7%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ + +K LG+G+FG V K + + A+K + K + + + E IL
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
++ P +V +D L V E++ G + L + A
Sbjct: 96 QAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVL 152
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
EYLHS ++++ DLK +NLL++ + I+ V DFG +K + T + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQ----VTDFGFAKRVKGRTWT--LCGTPEALA 206
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFCD 817
PE++ ++ VD ++ G++++E+ G P+ I IV+ + P
Sbjct: 207 PEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFS 262
Query: 818 SEWRLLMEQCWAPDPVVRP 836
S+ + L+ D R
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-41
Identities = 60/296 (20%), Positives = 100/296 (33%), Gaps = 51/296 (17%)
Query: 581 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 638
+ K +G+G+FG VY K + VAIK++ + RE +I+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------------KRFKNRELQIMR 68
Query: 639 KLHHPNVVAFYGVVQDGP----GGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIA 692
KL H N+V L V +++ R ++ L +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 693 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGT 752
+ Y+HS I H D+K NLL++ + K+ DFG +K +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDT---AVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 753 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP- 811
+ APEL+ G ++ + +DV+S G VL E+L G+ + + I+ P
Sbjct: 186 RYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 812 --------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
E L + P R + E
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-40
Identities = 62/292 (21%), Positives = 109/292 (37%), Gaps = 43/292 (14%)
Query: 580 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
+ E+L+++G GT+GTV+ K R T VA+KR++ + E + RE +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLL 55
Query: 638 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 697
+L H N+V + V+ TL V EF ++ + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLK 112
Query: 698 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 757
G+ + HS+N++H DLK NLL+N K+ +FGL++ + W
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 758 PELLNGSSSKVSEKVDVFSFGIVLWEILTGEEP-YANMHYGAIIGGIVNNTLRPPVPGF- 815
P + + S +D++S G + E+ P + + I P +
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 816 --------------------------CDSEWRLLMEQCWAPDPVVRPSFTEI 841
++ R L++ +PV R S E
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 147 bits (371), Expect = 2e-39
Identities = 50/313 (15%), Positives = 109/313 (34%), Gaps = 58/313 (18%)
Query: 568 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQER 625
+++ ++ +D + +++LG G + V+ + V +K +K ++++
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKK 75
Query: 626 LTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 684
RE +IL L PN++ +V+D T A V E + N + + + L
Sbjct: 76 ----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLT 127
Query: 685 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 744
+ ++Y HS I+H D+K N++++ + ++ D+GL++
Sbjct: 128 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---RKLRLIDWGLAEFYHPGQ 184
Query: 745 VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIV 804
+ + PELL +D++S G +L ++ +EP+ + H +
Sbjct: 185 EYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
Query: 805 NNTLRPP------------------------------------VPGFCDSEWRLLMEQCW 828
L E +++
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 829 APDPVVRPSFTEI 841
D R + E
Sbjct: 304 RYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-38
Identities = 63/294 (21%), Positives = 108/294 (36%), Gaps = 51/294 (17%)
Query: 583 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+L+ +GSG +G V G VAIK++ + + E +RE +L +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHM 74
Query: 641 HHPNVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
H NV+ V T V FM + L K L + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQML 131
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
G+ Y+H+ I+H DLK NL VN K+ DFGL++ + + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP----- 811
APE++ + ++ VD++S G ++ E++TG+ + + + I+ T PP
Sbjct: 186 APEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 812 ------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
+ L+E+ D R + E
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-34
Identities = 55/265 (20%), Positives = 105/265 (39%), Gaps = 23/265 (8%)
Query: 583 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 640
+ LK +GSG G V D VAIK++ + +++ +RE ++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKCV 73
Query: 641 HHPNVVAFYGVVQDGP----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 696
+H N+++ V + V E M + + + LD + +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQML 129
Query: 697 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 756
G+++LHS I+H DLK N++V K+ DFGL++ + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 757 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816
APE++ G E VD++S G ++ E++ + + Y ++ L P P F
Sbjct: 186 APEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ-LGTPCPEFM 242
Query: 817 DSEWRLLMEQCWAPDPVVRPSFTEI 841
+ +F ++
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKL 267
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 49/296 (16%)
Query: 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 637
E + L +GSG +G+V G VA+K++ + + +++ +RE +L
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR------TYRELRLL 71
Query: 638 SKLHHPNVVAFYGVVQDGPG---GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
+ H NV+ V + ++ L + + K + L +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQ 129
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 754
G++Y+HS +I+H DLK NL VN K+ DFGL++ + + T
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMTG--YVATRW 183
Query: 755 WMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--- 811
+ APE++ ++ VD++S G ++ E+LTG + + + I+ P
Sbjct: 184 YRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 812 --------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEI 841
V + L+E+ D R + +
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (289), Expect = 1e-28
Identities = 43/224 (19%), Positives = 93/224 (41%), Gaps = 9/224 (4%)
Query: 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWR 632
+ K+ +++LG G F TV+ K T VA+K ++ ++E E L+
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 633 EAEI--LSKLHHPNVVAFYGVVQDGP--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 688
+A+ + +++ G + V E + L + + R +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 689 LIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 747
I+ G++Y+H + I+H D+K +N+L+ + D + ++ L
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 748 GVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY 791
T + +PE+L G + D++S +++E++TG+ +
Sbjct: 188 NSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 7e-18
Identities = 28/164 (17%), Positives = 52/164 (31%), Gaps = 30/164 (18%)
Query: 586 KELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLE----------FWREA 634
K +G G V++ + + +K K + + +++R + E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 635 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 694
L KL V Y + A + E + L V + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYRVRVENPDE--------VLDM 111
Query: 695 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738
+ + + IVH DL N+LV+ + + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 867 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.03 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 96.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.94 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.15 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 94.2 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 86.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 86.54 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 85.61 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 82.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 80.89 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-50 Score=421.47 Aligned_cols=264 Identities=34% Similarity=0.545 Sum_probs=218.4
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
|+|..++|++.+.||+|+||+||+|++++ .||||+++...... .....|.+|+.+|++++|||||++++++.+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP------QQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT------THHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH------HHHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 46778899999999999999999998765 59999997543221 124678899999999999999999998765
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
+ .+++|||||++|+|.+++......+++..++.|+.||+.||+|||+++||||||||+|||++.++. +||+||
T Consensus 76 ~---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~----~Kl~DF 148 (276)
T d1uwha_ 76 P---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT----VKIGDF 148 (276)
T ss_dssp S---SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS----EEECCC
T ss_pred c---EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC----EEEccc
Confidence 3 579999999999999999877778999999999999999999999999999999999999997654 599999
Q ss_pred CCcccccCc---cccCCcCCCCCccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 735 GLSKIKRNT---LVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 735 GLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~-~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
|+|+..... .......||+.|||||++.+. ...++.++|||||||+||||+||+.||.+......+...+......
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 999865332 223456799999999999753 2457999999999999999999999999877665555544444332
Q ss_pred ----CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 811 ----PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 811 ----~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
..+..+++.+.+||.+||+.+|.+|||+.+|+++|+.+....
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 245678999999999999999999999999999999887643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=408.52 Aligned_cols=256 Identities=32% Similarity=0.611 Sum_probs=210.5
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
|..++|++++.||+|+||+||+|.+. +..||||+++..... ..+|.+|+.++++++|||||+++|+|...
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---------HHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 56688999999999999999999994 677999998753211 24688999999999999999999999875
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. ..++||||+++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++.++. +||+|||
T Consensus 73 ~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~----~Kl~DFG 146 (263)
T d1sm2a_ 73 A--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV----IKVSDFG 146 (263)
T ss_dssp S--SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC----EEECSCC
T ss_pred C--ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC----eEecccc
Confidence 4 789999999999999998877778999999999999999999999999999999999999997664 5999999
Q ss_pred CcccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 736 LSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 736 LA~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
+++...... ......||+.|+|||++. ...++.++|||||||++|||+| |.+||...........+ ....+...
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~ 223 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYK 223 (263)
T ss_dssp ------------------CTTSCCHHHHT--TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH-HHTCCCCC
T ss_pred hheeccCCCceeecceecCcccCChHHhc--CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH-HhcCCCCC
Confidence 998654322 223456899999999998 4568999999999999999999 56667666665555554 44566777
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
|..+++.+.+||.+||+.||.+|||+++|+++|+++..
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 88899999999999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=408.66 Aligned_cols=259 Identities=33% Similarity=0.556 Sum_probs=218.7
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
-++|..++|++.+.||+|+||.||+|.++ ++.||||+++..... ...|.+|+.++++++|||||++++++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---------HHHHHHHHHHHHhCCCCCEeEEEeee
Confidence 45788899999999999999999999996 577999999753211 24688999999999999999999988
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.+. .+++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+||||+.++ .+||
T Consensus 78 ~~~---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~----~~Kl 150 (272)
T d1qpca_ 78 TQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL----SCKI 150 (272)
T ss_dssp CSS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----CEEE
T ss_pred ccC---CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc----ceee
Confidence 653 5689999999999998775443 4699999999999999999999999999999999999999665 4599
Q ss_pred eecCCcccccCc--cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCC-CCCCCCChhHHHHhHhhcCC
Q 002908 732 GDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE-EPYANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 732 ~DFGLA~~~~~~--~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk-~PF~~~~~~e~l~~iv~~~l 808 (867)
+|||+|+..... .......||+.|+|||++. ...++.++|||||||+||||+||. +||........... +....
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-i~~~~ 227 (272)
T d1qpca_ 151 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGY 227 (272)
T ss_dssp CCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTC
T ss_pred ccccceEEccCCccccccccCCcccccChHHHh--CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcC
Confidence 999999865432 2334556899999999998 446899999999999999999954 55555555555544 44556
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
+++.+..+++.+.+||.+||+.+|++|||+.+|++.|+.+..+
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 7778889999999999999999999999999999999998765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=410.96 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=205.6
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|+++ |+.||||++...... +.....+.+|+++|++++|||||++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC------HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC------HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 368999999999999999999984 788999999764321 223467889999999999999999999997665
Q ss_pred CCeEEEEEEeecCCchhhhhhc---ccccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCCcceEeccCCCCCCc
Q 002908 657 GGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPI 728 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~---~~~~Lse~~~l~Ia~QIa~ALayLHs~G-----IIHrDLKPsNILLd~dg~~~~~ 728 (867)
.+.+++|||||++|+|.+++.. ....+++..++.++.||+.||.|||+++ ||||||||+|||++.++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~---- 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---- 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC----
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc----
Confidence 6689999999999999998854 2357999999999999999999999876 999999999999997664
Q ss_pred EEEeecCCcccccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC
Q 002908 729 CKVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT 807 (867)
Q Consensus 729 vKL~DFGLA~~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~ 807 (867)
+||+|||+|+..... .......||+.|+|||++. ...++.++|||||||++|+|+||+.||......+....+....
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred EEEeeccceeecccCCCccccCCCCcccCCHHHHc--CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 599999999865432 2334567999999999998 4568999999999999999999999999988877777766654
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 808 LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 808 lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
. ...+..+++++.+||.+||+.||.+|||+.|++++.
T Consensus 231 ~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 231 F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 4 356678899999999999999999999999998763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=408.01 Aligned_cols=252 Identities=28% Similarity=0.471 Sum_probs=216.5
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|+++ ++.||||++...... .......+.+|+.+++.++|||||++++++.+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-----KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-----ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 368999999999999999999984 778999999754221 1122456789999999999999999999999854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++|||||++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 80 --~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~----~kl~DFG~ 152 (263)
T d2j4za1 80 --RVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE----LKIADFGW 152 (263)
T ss_dssp --EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----EEECCCCS
T ss_pred --EEEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC----Eeecccce
Confidence 89999999999999998864 456999999999999999999999999999999999999997764 59999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
|....... .....||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...........+.... ...+..+
T Consensus 153 a~~~~~~~-~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~ 227 (263)
T d2j4za1 153 SVHAPSSR-RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFV 227 (263)
T ss_dssp CSCCCCCC-CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTS
T ss_pred eeecCCCc-ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCccC
Confidence 98654432 234569999999999984 457899999999999999999999999888877777766544 3456778
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
++++.+||.+||+.||.+|||+.|++++.+-
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 9999999999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-48 Score=411.05 Aligned_cols=259 Identities=36% Similarity=0.596 Sum_probs=211.3
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--Cc---eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GT---DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~---~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..++|++.+.||+|+||+||+|+++ +. .||||.+.... .+....+|.+|+.+|++++|||||++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 466788999999999999999999984 32 48888875432 1233467899999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
+|.... .+++|||||++|+|.+++......+++..++.|+.||++||.|||+++|+||||||+||||+.++ .+|
T Consensus 95 ~~~~~~--~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~----~~K 168 (299)
T d1jpaa_ 95 VVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL----VCK 168 (299)
T ss_dssp EECSSS--SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEE
T ss_pred EEeeCC--EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC----cEE
Confidence 998754 88999999999999998877677899999999999999999999999999999999999999665 469
Q ss_pred EeecCCcccccCccc------cCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhH
Q 002908 731 VGDFGLSKIKRNTLV------TGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 803 (867)
Q Consensus 731 L~DFGLA~~~~~~~~------~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~i 803 (867)
|+|||+|+....... .....||+.|+|||++. ...++.++|||||||+||||+| |..||...........+
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i 246 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHh--cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999986543211 12245789999999998 4568999999999999999998 89999988877766654
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 804 v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
. ...+++.+..+++.+.+||.+||+.+|.+|||+.+|++.|+.+..
T Consensus 247 ~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 247 E-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp H-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred H-cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 4 456677788899999999999999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-48 Score=411.66 Aligned_cols=258 Identities=33% Similarity=0.546 Sum_probs=219.8
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
++|..++|++.+.||+|+||+||+|++. ++.||||+++.... . ..+|.+|+.+|++++|||||+++++|
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~----~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----E----VEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----C----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----h----HHHHHHHHHHHHhCCCCCEecCCccE
Confidence 5788899999999999999999999994 78899999864321 1 24688999999999999999999999
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.+.+ .+++|||||++|+|..++... ...+++..++.|+.||+.||+|||++||+||||||+||||+.++. +||
T Consensus 83 ~~~~--~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~----~Kl 156 (287)
T d1opja_ 83 TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL----VKV 156 (287)
T ss_dssp CSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC----EEE
T ss_pred eeCC--eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc----EEE
Confidence 8754 889999999999999998643 467899999999999999999999999999999999999997664 699
Q ss_pred eecCCcccccCc--cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 732 GDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 732 ~DFGLA~~~~~~--~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
+|||+|+..... .......|++.|+|||++. ...++.++|||||||++|||++|..||........+...+....+
T Consensus 157 ~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~ 234 (287)
T d1opja_ 157 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 234 (287)
T ss_dssp CCCCCTTTCCSSSSEEETTEEECGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ccccceeecCCCCceeeccccccccccChHHHc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC
Confidence 999999865432 2233455889999999998 456899999999999999999976665444444445556666778
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 002908 810 PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMS 849 (867)
Q Consensus 810 ~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~ 849 (867)
++.+..+++.+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 8888899999999999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=406.54 Aligned_cols=263 Identities=33% Similarity=0.552 Sum_probs=222.1
Q ss_pred ccccCCeeEEEE-eeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKE-LGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~-LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.+..++|.+.+. ||+|+||+||+|.++ +..||||+++... ......+|.+|+.+|++++|||||++++
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-------CHHHHHHHHHHHHHHHhCCCCCEeeEee
Confidence 356678888885 999999999999874 4469999997432 1223467899999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++... .+++|||||++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+|
T Consensus 77 ~~~~~---~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~----~~K 149 (285)
T d1u59a_ 77 VCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAK 149 (285)
T ss_dssp EEESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT----EEE
T ss_pred eeccC---eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC----cee
Confidence 98653 57899999999999999876667899999999999999999999999999999999999999765 469
Q ss_pred EeecCCcccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||+|+..... .......||+.|+|||++. ...++.++|||||||++|||+| |..||......+....+ .
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-~ 226 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-E 226 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-H
T ss_pred eccchhhhcccccccccccccccccCccccChHHHh--CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-H
Confidence 9999999865332 1223456889999999998 4468999999999999999998 99999988776665554 4
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcCC
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQTK 855 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s~~ 855 (867)
...+++.|..+++++.+||.+||+.+|++||||.+|++.|+.......+.
T Consensus 227 ~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 227 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 55667788899999999999999999999999999999999877655433
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=416.05 Aligned_cols=259 Identities=33% Similarity=0.495 Sum_probs=220.3
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCc
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 644 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPN 644 (867)
.-+++..++|++.++||+|+||+||+|++.+ ..||||++..... ......+.+|+.+|.++ +|||
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~Hpn 102 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSELKMMTQLGSHEN 102 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTT
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-------HHHHHHHHHHHHHHHHhcCCCc
Confidence 3467888999999999999999999999842 2589998864321 22235688999999998 8999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhccc----------------------ccCCHHHHHHHHHHHHHHHHHH
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------------------RHLDRRKRLIIAMDAAFGMEYL 702 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~----------------------~~Lse~~~l~Ia~QIa~ALayL 702 (867)
||+++++|.+.. .+++|||||++|+|.+++.... ..+++..++.|+.||+.||+||
T Consensus 103 Iv~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL 180 (325)
T d1rjba_ 103 IVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180 (325)
T ss_dssp BCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred EeEEEEEEeeCC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 999999998854 8999999999999999986542 3489999999999999999999
Q ss_pred HHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHH
Q 002908 703 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGI 779 (867)
Q Consensus 703 Hs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGv 779 (867)
|+++||||||||+|||++.++ .+||+|||+|+...... ......||+.|||||++. ...++.++|||||||
T Consensus 181 H~~~IiHRDlKp~Nill~~~~----~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwS~Gv 254 (325)
T d1rjba_ 181 EFKSCVHRDLAARNVLVTHGK----VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGI 254 (325)
T ss_dssp HHTTEEETTCSGGGEEEETTT----EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHH
T ss_pred HhCCeeeccCchhccccccCC----eEEEeeccccccccCCCceeeeccccCCCccCChHHHc--CCCCCcceeccchhH
Confidence 999999999999999999665 56999999998543322 223456899999999998 456899999999999
Q ss_pred HHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 780 VLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 780 LLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+||||+| |..||.+......+..++....+++.+..+++.+.+||.+||+.+|++|||+++|+++|.
T Consensus 255 il~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 255 LLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9999998 899999887777777888888888889999999999999999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=406.00 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=224.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|+++ |+.||||+++......... ......+.+|+.+|++++|||||+++++|.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 467999999999999999999984 7889999998765432221 112356889999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++|||||++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.....+||+|||+
T Consensus 87 --~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 87 --DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp --EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred --EEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999998643 46999999999999999999999999999999999999998887667789999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC--CCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~--ip~ 814 (867)
|.............||+.|+|||++. ...++.++|||||||+||+|++|+.||.+......+..+.......+ .+.
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~--~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhhcCCCccccccCCCCcccCHHHHc--CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 98766555556677999999999998 45678999999999999999999999999888887777766554433 235
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+++.+.+||.+||+.||.+|||+.+++++-+
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 67899999999999999999999999988643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=402.84 Aligned_cols=260 Identities=35% Similarity=0.598 Sum_probs=213.6
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
+|..++|++.++||+|+||.||+|.+++ ..||||+++... .+....+|.+|+.+|++++|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-------ChHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 5677899999999999999999998842 359999986432 122245789999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
|++.+.. ..++|||||.++++.+.+......+++..++.++.||+.||.|||+++|+||||||+||||+.++ .+
T Consensus 76 g~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~----~~ 149 (283)
T d1mqba_ 76 GVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VC 149 (283)
T ss_dssp EEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CE
T ss_pred EEEecCC--ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC----eE
Confidence 9998754 88999999999999998877777899999999999999999999999999999999999999765 46
Q ss_pred EEeecCCcccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCC-CCCCCChhHHHHhHh
Q 002908 730 KVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEE-PYANMHYGAIIGGIV 804 (867)
Q Consensus 730 KL~DFGLA~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~-PF~~~~~~e~l~~iv 804 (867)
||+|||+++..... .......||+.|+|||++. ...++.++|||||||+||||+++.. ||......... ..+
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~-~~i 226 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KAI 226 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHH--SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHH
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHc--cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH-HHH
Confidence 99999999864332 1223456899999999998 4578999999999999999999655 45555554444 445
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 805 NNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 805 ~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
....+++.+..++..+.+||.+||+.+|.+|||+.+|++.|+.+...
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 56677888888999999999999999999999999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=409.81 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=215.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
+.|++++.||+|+||+||+|++. +..||||+++..... ....+.+|+++|++++|||||++++++.+..
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--------ELEDYMVEIDILASCDHPNIVKLLDAFYYEN- 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--------GGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--------HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 56899999999999999999984 778999999754211 1246789999999999999999999998855
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+|
T Consensus 83 -~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~----~Kl~DFG~a 157 (288)
T d2jfla1 83 -NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD----IKLADFGVS 157 (288)
T ss_dssp -EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECCCTTC
T ss_pred -eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC----EEEEechhh
Confidence 899999999999999998776778999999999999999999999999999999999999997764 599999999
Q ss_pred ccccCc-cccCCcCCCCCccCccccccC---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCC-CCCC
Q 002908 738 KIKRNT-LVTGGVRGTLPWMAPELLNGS---SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTL-RPPV 812 (867)
Q Consensus 738 ~~~~~~-~~~s~~~GT~~Y~APEvl~g~---~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~l-r~~i 812 (867)
...... .......||+.|+|||++.+. ...++.++|||||||+||+|+||+.||........+..+..... ....
T Consensus 158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (288)
T d2jfla1 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237 (288)
T ss_dssp EECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS
T ss_pred hccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 754332 233456799999999998532 34578999999999999999999999998888777777666543 3344
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+..+++++.+||.+||+.||.+|||+.|++++-
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp 270 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 567899999999999999999999999998864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=400.47 Aligned_cols=252 Identities=35% Similarity=0.586 Sum_probs=219.3
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
..++|+++++||+|+||+||+|+++ ++.||||+++..... ..+|++|+.++++++||||++++|+|.+..
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---------HHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 4568888999999999999999995 568999999864321 246889999999999999999999998754
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++||||+++|+|..++......+++..++.|+.||++||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 73 --~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~----~~kl~DfG~ 146 (258)
T d1k2pa_ 73 --PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGL 146 (258)
T ss_dssp --SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC----CEEECCCSS
T ss_pred --ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC----cEEECcchh
Confidence 89999999999999999887778899999999999999999999999999999999999999665 459999999
Q ss_pred cccccCcc--ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 737 SKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 737 A~~~~~~~--~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
++...... ......+|+.|+|||++. ...++.++|||||||++|||+| |+.||......+....+. ...+.+.|
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p 223 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRP 223 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCC
T ss_pred heeccCCCceeecccCCCCCcCCcHHhc--CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCc
Confidence 98544322 223456899999999998 4568999999999999999998 899999998877776655 45677788
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..+++.+.+||.+||+.+|.+|||+.+++++|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 8999999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=410.05 Aligned_cols=258 Identities=25% Similarity=0.346 Sum_probs=216.5
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++++.||+|+||+||+|++. ++.||||++...... .+.....+.+|+.+|++++|||||+++++|.+.
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-----CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 4478999999999999999999984 788999999754221 112245688999999999999999999999885
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. .+++|||||++|+|.+++.. ...+++..++.++.|++.||+|||++|||||||||+|||++.++. +||+|||
T Consensus 81 ~--~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~----vkl~DFG 153 (288)
T d1uu3a_ 81 E--KLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH----IQITDFG 153 (288)
T ss_dssp S--EEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC----EEECCCT
T ss_pred C--EEEEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce----EEecccc
Confidence 4 89999999999999998754 456999999999999999999999999999999999999997764 5999999
Q ss_pred CcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 736 LSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 736 LA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
+|+..... .......||+.|+|||++. ...++.++|||||||+||+|++|+.||...+.......+.... ...
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~ 229 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLT--EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDF 229 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHH--TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CCC
T ss_pred cceecccCCcccccccccCCccccCceeec--cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--CCC
Confidence 99865422 2334567999999999998 4568999999999999999999999999888877777776654 345
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
+..+++.+.+||.+||+.||.+|||++|++.+.+-...+
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hp 268 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSG
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCC
Confidence 677899999999999999999999999987766544333
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=405.13 Aligned_cols=252 Identities=28% Similarity=0.366 Sum_probs=206.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|+++ |+.||||++...... .....+.+|+.+|++++|||||++++++.+..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-------hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 367999999999999999999984 788999999754221 12346789999999999999999999999855
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 77 --~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~----~KL~DFG~ 149 (271)
T d1nvra_ 77 --IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN----LKISDFGL 149 (271)
T ss_dssp --EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC----EEECCCTT
T ss_pred --eeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC----EEEccchh
Confidence 89999999999999999853 457999999999999999999999999999999999999997764 59999999
Q ss_pred cccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHH-HHhHhhcCCCCCC
Q 002908 737 SKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAI-IGGIVNNTLRPPV 812 (867)
Q Consensus 737 A~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~-l~~iv~~~lr~~i 812 (867)
|+.... ........||+.|+|||++.+.. .++.++|||||||+||+|+||+.||........ .............
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCC-CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence 986432 22334567999999999998432 246789999999999999999999977554333 3333333333334
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
...+++++.+||.+||+.||.+|||+.|++++-
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 261 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDR 261 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 456789999999999999999999999997754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=409.80 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=215.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
..|+.++.||+|+||+||+|++ +++.||||++..... ........+.+|+.+|++++|||||++++++.+..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-
Confidence 3599999999999999999998 478899999975422 22334567899999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|||||.+++|..++. ....+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|
T Consensus 89 -~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~----~~Kl~DFG~a 162 (309)
T d1u5ra_ 89 -TAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSA 162 (309)
T ss_dssp -EEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT----EEEECCCTTC
T ss_pred -EEEEEEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC----CEEEeecccc
Confidence 8999999999998876553 446799999999999999999999999999999999999999665 4699999999
Q ss_pred ccccCccccCCcCCCCCccCccccccC-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGS-SSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~-~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
...... ....||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+......+..+.........+..+
T Consensus 163 ~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (309)
T d1u5ra_ 163 SIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239 (309)
T ss_dssp BSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred cccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCC
Confidence 865443 345799999999999753 3458899999999999999999999999888877777777776655566678
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
++.+.+||.+||+.||.+|||+.+++++.
T Consensus 240 s~~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 99999999999999999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=408.75 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=213.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
.+|++++.||+|+||+||+|++ +|+.||||+++...... ...+.+|+.+|+.++|||||++++++.+..
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--------HHHHHHHHHHHHhCCCCCEeeEeEEEEECC-
Confidence 5799999999999999999997 48899999997643221 245789999999999999999999999855
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+|
T Consensus 91 -~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~----vkl~DFG~a 163 (293)
T d1yhwa1 91 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFC 163 (293)
T ss_dssp -EEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----EEECCCTTC
T ss_pred -EEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc----Eeeccchhh
Confidence 89999999999999987743 46999999999999999999999999999999999999997764 599999999
Q ss_pred ccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc-CCCCCCCCC
Q 002908 738 KIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-TLRPPVPGF 815 (867)
Q Consensus 738 ~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~-~lr~~ip~~ 815 (867)
+.... ........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.+......+..+... ....+.+..
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGG
T ss_pred eeeccccccccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 86543 334455679999999999984 45789999999999999999999999887776665555443 334555667
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
+++.+.+||.+||+.||.+|||+.|++++-+
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 8999999999999999999999999987644
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.6e-47 Score=413.93 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=219.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||+||+|++. |+.||||++.... ......+.+|+.+|++++|||||++++++.+..
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN- 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 58999999999999999999984 8899999996431 112356789999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|||||++|+|.+++......+++..+..|+.||+.||.|||++|||||||||+|||++.+.. ..+||+|||+|
T Consensus 97 -~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~--~~vkL~DFG~a 173 (350)
T d1koaa2 97 -EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLT 173 (350)
T ss_dssp -EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS--CCEEECCCTTC
T ss_pred -EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCC--CeEEEeecchh
Confidence 999999999999999999766677999999999999999999999999999999999999975432 35799999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC--CCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PGF 815 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i--p~~ 815 (867)
+............||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.......+. ...
T Consensus 174 ~~~~~~~~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 251 (350)
T d1koaa2 174 AHLDPKQSVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251 (350)
T ss_dssp EECCTTSCEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG
T ss_pred eecccccccceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 87666555556779999999999984 56789999999999999999999999998888888877776654433 245
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+++++.+||.+||+.||.+|||+.|++++-
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 789999999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-47 Score=407.16 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=201.3
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.+.|++.+.||+|+||+||+|+++ ++.||||++....... ....+.+|+.+|+.++|||||++++++.+..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-------KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 467999999999999999999984 7889999997643221 1245778999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++|||||+|++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+..... ...+||+|||+
T Consensus 81 --~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~-~~~vkl~DFG~ 156 (307)
T d1a06a_ 81 --HLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDE-DSKIMISDFGL 156 (307)
T ss_dssp --EEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSST-TCCEEECCC--
T ss_pred --EEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCC-CceEEEeccce
Confidence 89999999999999999864 456999999999999999999999999999999999999975321 24579999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC--CCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~--ip~ 814 (867)
|+............||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...........+.......+ .+.
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234 (307)
T ss_dssp ----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred eEEccCCCeeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence 987665555556779999999999984 4678999999999999999999999999888887777777665443 345
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.+++++.+||.+||+.||.+|||+.|++++.
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 6899999999999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-46 Score=410.95 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=218.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||+||+|++ +|+.||||+++... .. ....+.+|+.+|++++|||||+++++|.+..
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKY- 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 5799999999999999999998 48889999987531 11 1346789999999999999999999998854
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++|||||++++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+.... ..+||+|||+|
T Consensus 100 -~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~--~~vkL~DFGla 176 (352)
T d1koba_ 100 -EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLA 176 (352)
T ss_dssp -EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC--CCEEECCCTTC
T ss_pred -EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCC--CeEEEeecccc
Confidence 999999999999999988777778999999999999999999999999999999999999985432 35799999999
Q ss_pred ccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC--CCCC
Q 002908 738 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--VPGF 815 (867)
Q Consensus 738 ~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~--ip~~ 815 (867)
.............||+.|+|||++. ...++.++|||||||+||+|+||+.||.+......+..+.......+ ....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 254 (352)
T d1koba_ 177 TKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254 (352)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHT--TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred eecCCCCceeeccCcccccCHHHHc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 9776655555567999999999998 45689999999999999999999999999888888877777655433 3456
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
+++++.+||.+||+.||.+|||+.|++++
T Consensus 255 ~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999999886
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=394.92 Aligned_cols=260 Identities=33% Similarity=0.586 Sum_probs=211.6
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 649 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~-----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~ 649 (867)
++|..++|++.+.||+|+||.||+|.+. +..||||.++... .+.....|.+|+.+|++++|||||+++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 74 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLI 74 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3577899999999999999999999884 2357888875321 223346789999999999999999999
Q ss_pred cccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
+++.+ +.+++||||+++|+|..++......+++..++.++.||++||.|||+++|+||||||+|||++.++ .+
T Consensus 75 ~~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~----~~ 147 (273)
T d1mp8a_ 75 GVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CV 147 (273)
T ss_dssp EEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EE
T ss_pred EEEec---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC----cE
Confidence 99964 368999999999999998877777899999999999999999999999999999999999999765 46
Q ss_pred EEeecCCcccccCc--cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhc
Q 002908 730 KVGDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNN 806 (867)
Q Consensus 730 KL~DFGLA~~~~~~--~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~ 806 (867)
||+|||+|+..... .......||+.|+|||++. ...++.++|||||||++|||+| |.+||...........+..
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~--~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~- 224 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN- 224 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-
T ss_pred EEccchhheeccCCcceeccceecCcccchhhHhc--cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence 99999999864432 2233456889999999998 4568999999999999999998 8999998887777766554
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
..+.+.+..+++.+.+||.+||+.||.+|||+.+|+++|+.+...
T Consensus 225 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 445677888999999999999999999999999999999987543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=396.87 Aligned_cols=250 Identities=33% Similarity=0.554 Sum_probs=207.7
Q ss_pred EEeeecCcEEEEEEEEC----CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEE
Q 002908 586 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 586 k~LG~GafG~VYka~~~----G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~ 661 (867)
++||+|+||+||+|.++ ++.||||+++.... +.....+|.+|+.+|++++|||||+++++|... ..+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~ 83 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWM 83 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC------CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEE
Confidence 47999999999999873 35699999965321 223346789999999999999999999998653 468
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
+|||||++|+|.+++.. ...+++..++.|+.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 84 lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~----~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALR 158 (277)
T ss_dssp EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----EEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC----cccccchhhhhhcc
Confidence 99999999999998854 45699999999999999999999999999999999999999765 45999999998543
Q ss_pred Ccc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 742 NTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 742 ~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
... ......||+.|+|||++. ...++.++|||||||++|||+| |..||.+....+.... +....+++.+..+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-i~~~~~~~~p~~~ 235 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGC 235 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred ccccccccccccCCCceecCchhhc--CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-HHcCCCCCCCccc
Confidence 221 223356899999999998 4568899999999999999998 8999998877665554 4445677788899
Q ss_pred cHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 817 DSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
++++.+||.+||+.||.+|||+.+|++.|+.....+
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 999999999999999999999999999998876543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=408.63 Aligned_cols=254 Identities=27% Similarity=0.452 Sum_probs=206.1
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccc
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 653 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~ 653 (867)
++..++|++++.||+|+||+||+|++. |+.||||+++..... .....+.+|+.+|+.++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-------AIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-------THHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH-------HHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456789999999999999999999984 788999999754211 12356789999999999999999999999
Q ss_pred cCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 654 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 654 ~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
+.. .+++|||||++++|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+
T Consensus 75 ~~~--~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~----vkl~ 147 (322)
T d1s9ja_ 75 SDG--EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLC 147 (322)
T ss_dssp CSS--EEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC----EEEC
T ss_pred ECC--EEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC----EEEe
Confidence 855 899999999999999998644 469999999999999999999997 59999999999999997764 5999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH------------
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII------------ 800 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l------------ 800 (867)
|||+|+...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 148 DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 148 DFGVSGQLIDSM-ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCCCHHHHHHT-C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred eCCCccccCCCc-cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence 999998654322 234679999999999994 56889999999999999999999999764432110
Q ss_pred ------------------------------HhHhhcCCCCCCC-CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 801 ------------------------------GGIVNNTLRPPVP-GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 801 ------------------------------~~iv~~~lr~~ip-~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
..+... ..+..+ ..++.++.+||.+||+.||.+|||++|++++.+-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE-PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ---------------------CCCCHHHHHHHHHTS-CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cCCcccccccccccccccccccchhHHHHHhhhhcc-CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 000111 111111 2357899999999999999999999999997554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=394.29 Aligned_cols=256 Identities=35% Similarity=0.606 Sum_probs=214.9
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
|+|..++|++++.||+|+||.||+|.++|+.||||+++... ....|.+|+.++++++||||++++|+|.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 56788899999999999999999999999999999996431 12468899999999999999999999865
Q ss_pred CCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. +.+++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++.++. +||+|
T Consensus 72 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~----~kl~d 146 (262)
T d1byga_ 72 EK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV----AKVSD 146 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC----EEECC
T ss_pred cC-CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC----Eeecc
Confidence 42 36799999999999999996543 46899999999999999999999999999999999999997664 59999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
||+++...... ....+|..|+|||++.+ ..++.++|||||||++|||+| |++||...........+ ....+++.
T Consensus 147 fg~s~~~~~~~--~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~~~ 221 (262)
T d1byga_ 147 FGLTKEASSTQ--DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDA 221 (262)
T ss_dssp CCC--------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCCC
T ss_pred cccceecCCCC--ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCC
Confidence 99998654432 23458899999999984 568999999999999999998 78889888777766664 44567788
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+..+++.+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 88899999999999999999999999999999998864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=396.31 Aligned_cols=264 Identities=31% Similarity=0.492 Sum_probs=213.2
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCce
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 645 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNI 645 (867)
-++|.+++|++.++||+|+||.||+|++. ++.||||+++... .......+.+|..++.++ +|+||
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~e~~~l~~~~~h~~i 79 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNV 79 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-------CcHHHHHHHHHHHHHHhhcCCCeE
Confidence 45688899999999999999999999973 3569999986432 122235677888888877 68999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 710 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHr 710 (867)
+.+++++... ...+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++||||
T Consensus 80 v~~~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr 158 (299)
T d1ywna1 80 VNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158 (299)
T ss_dssp CCEEEEECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEeeeeeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 9999987654 347899999999999999986432 348999999999999999999999999999
Q ss_pred CCCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhC
Q 002908 711 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG 787 (867)
Q Consensus 711 DLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTG 787 (867)
||||+||||+.++. +||+|||+|+..... .......||+.|+|||++. ...++.++|||||||++|||+||
T Consensus 159 DlKp~NILl~~~~~----~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDiwS~Gvil~ellt~ 232 (299)
T d1ywna1 159 DLAARNILLSEKNV----VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSL 232 (299)
T ss_dssp CCCGGGEEECGGGC----EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cCCccceeECCCCc----EEEccCcchhhccccccccccCceeeCccccchhHhh--cCCCCcccceeehHHHHHHHHhC
Confidence 99999999997664 599999999854322 2334567999999999998 45689999999999999999996
Q ss_pred -CCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 788 -EEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 788 -k~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
..||........+...+....+++.+..+++++.+||.+||+.||.+|||+.+++++|+.+..+
T Consensus 233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 5688877766666666777778888889999999999999999999999999999999988654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=400.87 Aligned_cols=260 Identities=31% Similarity=0.582 Sum_probs=216.1
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC--Cc----eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceee
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 647 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~--G~----~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVr 647 (867)
++.+..++|+++++||+|+||+||+|.+. |+ .||||.++... ......+|.+|+.++++++|||||+
T Consensus 3 ~~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~ 75 (317)
T d1xkka_ 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCR 75 (317)
T ss_dssp SEECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEee
Confidence 34567788999999999999999999984 33 58888876432 1122467899999999999999999
Q ss_pred EecccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCC
Q 002908 648 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 727 (867)
Q Consensus 648 L~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~ 727 (867)
++++|.+. ..+++|+++.+++|.+++......+++..++.++.||+.||+|||+++||||||||+|||++.++
T Consensus 76 l~g~~~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~---- 148 (317)
T d1xkka_ 76 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---- 148 (317)
T ss_dssp EEEEEESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT----
T ss_pred EEEEEecC---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC----
Confidence 99999874 46788999999999999887778899999999999999999999999999999999999999665
Q ss_pred cEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhH
Q 002908 728 ICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGI 803 (867)
Q Consensus 728 ~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~i 803 (867)
.+||+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||+||||+| |.+||.+....+... .
T Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-~ 225 (317)
T d1xkka_ 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-I 225 (317)
T ss_dssp EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-H
T ss_pred CeEeeccccceecccccccccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-H
Confidence 46999999998653322 2233458999999999984 568999999999999999999 899998877666554 4
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 804 VNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 804 v~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
+....+++.+..+++.+.+||.+||+.+|.+|||+.+|+.+|+.+..
T Consensus 226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 45556777888899999999999999999999999999999988754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=393.08 Aligned_cols=251 Identities=29% Similarity=0.474 Sum_probs=206.0
Q ss_pred CCe-eEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC-
Q 002908 580 EDL-EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG- 655 (867)
Q Consensus 580 sdy-qilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~- 655 (867)
.+| ++.++||+|+||+||+|++. +..||||++...... +.....|.+|+++|++++|||||+++++|...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 344 67778999999999999984 678999999764321 22245788999999999999999999998642
Q ss_pred -CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCCcceEecc-CCCCCCcEEE
Q 002908 656 -PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNL-KDPIRPICKV 731 (867)
Q Consensus 656 -~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~G--IIHrDLKPsNILLd~-dg~~~~~vKL 731 (867)
....+++|||||++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++ .+||
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~----~~Kl 156 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----SVKI 156 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS----CEEE
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC----CEEE
Confidence 24578999999999999999854 456999999999999999999999998 999999999999974 33 4699
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHH-HhHhhcCCCC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAII-GGIVNNTLRP 810 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l-~~iv~~~lr~ 810 (867)
+|||+|+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+ ..+.......
T Consensus 157 ~DFGla~~~~~~~-~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 157 GDLGLATLKRASF-AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232 (270)
T ss_dssp CCTTGGGGCCTTS-BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred eecCcceeccCCc-cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc
Confidence 9999998654433 234679999999999974 4789999999999999999999999876554444 4444333334
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 811 PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 811 ~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..+..+++++.+||.+||+.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 44566789999999999999999999999998763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=396.95 Aligned_cols=259 Identities=34% Similarity=0.573 Sum_probs=214.9
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G-----~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
.|..++|++++.||+|+||.||+|++.+ ..||||+++..... .+....+|.+|+.+|++++|||||+++|
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-----CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 4667899999999999999999998732 35899998754322 2233467899999999999999999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
+|.+. ..++||||++++++.+.+......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+|
T Consensus 79 ~~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~----~vk 151 (273)
T d1u46a_ 79 VVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVK 151 (273)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT----EEE
T ss_pred EEeec---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc----cee
Confidence 99753 56899999999999998887777899999999999999999999999999999999999999765 469
Q ss_pred EeecCCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT-GEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT-Gk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|||+| |..||.+.+.......+..
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~ 229 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred eccchhhhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh
Confidence 99999998653321 2233457889999999984 568899999999999999998 8999999999888888888
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 806 NTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 806 ~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
...+++.+..+++.+.+||.+||+.||.+||||.+|++.|++.
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8888888889999999999999999999999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=395.96 Aligned_cols=259 Identities=34% Similarity=0.539 Sum_probs=211.4
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccc
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 652 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~ 652 (867)
-|+|..++|++.+.||+|+||.||+|+++ +..||||+++..... ...|.+|+.++++++|||||+++++|
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~g~~ 81 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVV 81 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---------HHHHHHHHHHHHhcccCCEeEEEEEE
Confidence 34577899999999999999999999995 457999999743211 24688999999999999999999998
Q ss_pred ccCCCCeEEEEEEeecCCchhhhhhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 653 QDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 653 ~~~~~~~l~LVmEy~~ggSL~d~L~~~-~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.+. .+++|||||++|+|..++... ...+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||
T Consensus 82 ~~~---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~----~~kl 154 (285)
T d1fmka3 82 SEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----VCKV 154 (285)
T ss_dssp CSS---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEEE
T ss_pred ecC---CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC----cEEE
Confidence 653 478999999999999888654 35699999999999999999999999999999999999999765 4699
Q ss_pred eecCCcccccCc--cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCC-CCCChhHHHHhHhhcCC
Q 002908 732 GDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPY-ANMHYGAIIGGIVNNTL 808 (867)
Q Consensus 732 ~DFGLA~~~~~~--~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF-~~~~~~e~l~~iv~~~l 808 (867)
+|||+++..... .......||+.|+|||++. ...++.++|||||||+||||+||..|| ......+.+. .+....
T Consensus 155 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~-~i~~~~ 231 (285)
T d1fmka3 155 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGY 231 (285)
T ss_dssp CCCCTTC--------------CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTC
T ss_pred cccchhhhccCCCceeeccccccccccChHHHh--CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH-HHHhcC
Confidence 999999865322 2233456899999999998 456899999999999999999965555 4444444444 444566
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 809 RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 809 r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
+.+.+..+++.+.+||.+||+.+|++||++++|++.|+.+...
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 7778889999999999999999999999999999999886643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-45 Score=390.25 Aligned_cols=260 Identities=23% Similarity=0.268 Sum_probs=222.7
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCCh-HHHHHHHHHHHHHHHHHhCC-CCceeeEeccccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSS-EQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 654 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~-~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~ 654 (867)
.++|++.+.||+|+||+||+|++ +++.||||+++......... ..+.....+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999998 57899999998765443332 23455567899999999997 9999999999998
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. ..++|||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 82 ~~--~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~----~kl~DF 154 (277)
T d1phka_ 82 NT--FFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN----IKLTDF 154 (277)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC----EEECCC
T ss_pred Cc--ceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC----eEEccc
Confidence 54 99999999999999999964 457999999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCccccCCcCCCCCccCcccccc----CCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 735 GLSKIKRNTLVTGGVRGTLPWMAPELLNG----SSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 735 GLA~~~~~~~~~s~~~GT~~Y~APEvl~g----~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
|+++............||+.|+|||++.+ ....++.++|||||||++|+|++|+.||...........+.......
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 99987665555556779999999999863 23456889999999999999999999999988877777777766544
Q ss_pred CC--CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 811 PV--PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 811 ~i--p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
+. ...+++++.+||.+||+.+|.+|||+.|++++-
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~ 271 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 271 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 33 346899999999999999999999999998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-45 Score=387.16 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=211.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++.+.||+|+||+||+|++ +++.||||+++..... +......|.+|+.+++.++|||||++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-----CHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 46899999999999999999998 4889999999764322 2334567899999999999999999999987543
Q ss_pred --CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 657 --GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 657 --~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
...+|+||||++|++|..++.. ...+++..++.++.||+.||+|||++|||||||||+|||++.++.. +|+||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~----~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV----KVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCE----EECCC
T ss_pred CCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccc----eeehh
Confidence 2458999999999999988754 4569999999999999999999999999999999999999977654 99999
Q ss_pred CCcccccCc----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCC
Q 002908 735 GLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRP 810 (867)
Q Consensus 735 GLA~~~~~~----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~ 810 (867)
|.+...... .......||+.|+|||++. ...++.++|||||||++|+|+||+.||...........++.....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp TTCEECC----------------TTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred hhhhhhccccccccccccccCcccccCHHHHc--CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC
Confidence 998743222 2333456999999999998 4568999999999999999999999999888777777666655443
Q ss_pred C--CCCCCcHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHHH
Q 002908 811 P--VPGFCDSEWRLLMEQCWAPDPVVRP-SFTEIARRLRVMS 849 (867)
Q Consensus 811 ~--ip~~~s~eL~dLI~kCLq~DPeeRP-Sa~ELLe~Lq~l~ 849 (867)
+ ....+++.+.+||.+||+.||.+|| |+++++..|.++.
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 2 3456899999999999999999998 8999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=402.77 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=217.8
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 654 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~ 654 (867)
|..++|++++.||+|+||.||+|++ +|+.||||++++..... ......+.+|+.+|+.++|||||+++++|.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-----KDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-----HHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 4567899999999999999999998 48889999997643211 1124567899999999999999999999998
Q ss_pred CCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
.. .+++|||||++|+|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|. +||+||
T Consensus 77 ~~--~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~----vkl~DF 149 (337)
T d1o6la_ 77 HD--RLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH----IKITDF 149 (337)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC----EEECCC
T ss_pred cc--ccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC----EEEeec
Confidence 55 99999999999999998854 456899999999999999999999999999999999999997764 599999
Q ss_pred CCcccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 735 GLSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 735 GLA~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
|+|+.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.... ...|
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p 225 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFP 225 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCC
T ss_pred ccccccccCCcccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCC
Confidence 99986433 334456779999999999984 467899999999999999999999999988888777777665 4456
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRL 845 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~L 845 (867)
..+++++.+||.+||+.||.+||+ +.++++|-
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence 789999999999999999999994 89998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-46 Score=393.35 Aligned_cols=257 Identities=32% Similarity=0.556 Sum_probs=216.7
Q ss_pred ccccCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 002908 576 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 648 (867)
Q Consensus 576 ~I~~sdyqilk~LG~GafG~VYka~~~G-------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL 648 (867)
+++.++|++++.||+|+||+||+|++.+ +.||||+++... ......+|.+|+.+|++++||||+++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~~ 81 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKL 81 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-------ChHHHHHHHHHHHHHHhcCCCCcccc
Confidence 4567899999999999999999999853 579999986432 12234678999999999999999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhccc-----------------------ccCCHHHHHHHHHHHHHHHHHHHHC
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------------------RHLDRRKRLIIAMDAAFGMEYLHSK 705 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-----------------------~~Lse~~~l~Ia~QIa~ALayLHs~ 705 (867)
+++|.... ..++||||+++++|.+++.... ..+++..++.|+.|++.||+|||++
T Consensus 82 ~~~~~~~~--~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 159 (301)
T d1lufa_ 82 LGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159 (301)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeeeccCC--ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence 99998754 8899999999999999885321 3488999999999999999999999
Q ss_pred CeeccCCCCcceEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHH
Q 002908 706 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLW 782 (867)
Q Consensus 706 GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLy 782 (867)
+||||||||+|||++.++ .+||+|||+|+..... .......+|+.|+|||.+. ...++.++|||||||+||
T Consensus 160 ~ivHrDlKp~NILld~~~----~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~t~ksDVwS~Gvvl~ 233 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENM----VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLW 233 (301)
T ss_dssp TCCCSCCSGGGEEECGGG----CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHH
T ss_pred CeEeeEEcccceEECCCC----cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc--cCCCChhhhhccchhhHH
Confidence 999999999999999765 4699999999854322 2233456889999999998 456899999999999999
Q ss_pred HHHhCC-CCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 002908 783 EILTGE-EPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVM 848 (867)
Q Consensus 783 ELLTGk-~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l 848 (867)
||++|. +||......+....+... ..++.+..+++++.+||.+||+.+|.+||||.+|+++|+++
T Consensus 234 ell~~~~~p~~~~~~~e~~~~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 234 EIFSYGLQPYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 999985 688888887777665544 46677888999999999999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=399.33 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=219.2
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|.+. ++.||||+++... .+ ...+.+|+.+|+.++|||||+++++|.+..
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TD---QVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------cc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 367999999999999999999984 7889999997532 11 234778999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+|+|||||+|++|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||++.++. ..++|+|||+
T Consensus 75 --~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~--~~ikl~DFG~ 150 (321)
T d1tkia_ 75 --ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS--STIKIIEFGQ 150 (321)
T ss_dssp --EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC--CCEEECCCTT
T ss_pred --EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCc--eEEEEcccch
Confidence 899999999999999999776667999999999999999999999999999999999999986543 3679999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC--CC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV--PG 814 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i--p~ 814 (867)
++............+|+.|+|||.+. ...++.++|||||||++|+|++|..||...+....+..+.......+. ..
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~--~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHT--TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred hhccccCCcccccccccccccchhcc--CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc
Confidence 98765554445567899999999998 456889999999999999999999999998888888887776654432 23
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
.+++++.+||.+||+.||.+|||+.|++++-+
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 57899999999999999999999999998765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=394.99 Aligned_cols=262 Identities=34% Similarity=0.530 Sum_probs=218.9
Q ss_pred ccccccCCeeEEEEeeecCcEEEEEEEEC--Cc--eEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCceeeE
Q 002908 574 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAF 648 (867)
Q Consensus 574 l~~I~~sdyqilk~LG~GafG~VYka~~~--G~--~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPNIVrL 648 (867)
.+.|.+++|++.++||+|+||+||+|+++ +. .||||.++.... ......|.+|+.+|.++ +|||||++
T Consensus 4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv~~ 76 (309)
T d1fvra_ 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINL 76 (309)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred CCccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-------hHHHHHHHHHHHHHHhccCCCCEeeE
Confidence 45678899999999999999999999984 43 477887754321 11235688999999998 79999999
Q ss_pred ecccccCCCCeEEEEEEeecCCchhhhhhcc---------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Q 002908 649 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLK 713 (867)
Q Consensus 649 ~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~---------------~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLK 713 (867)
+++|.+.. .+++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+|||||
T Consensus 77 ~~~~~~~~--~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlk 154 (309)
T d1fvra_ 77 LGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 154 (309)
T ss_dssp EEEEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EEEEecCC--eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccc
Confidence 99999854 899999999999999998643 3569999999999999999999999999999999
Q ss_pred CcceEeccCCCCCCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCC-CCCC
Q 002908 714 CDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGE-EPYA 792 (867)
Q Consensus 714 PsNILLd~dg~~~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk-~PF~ 792 (867)
|+|||++.++. +||+|||+++............||..|+|||.+. ...++.++|||||||++|||++|. +||.
T Consensus 155 p~NIL~~~~~~----~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 155 ARNILVGENYV----AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp GGGEEECGGGC----EEECCTTCEESSCEECCC----CCTTTCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cceEEEcCCCc----eEEccccccccccccccccceecCCcccchHHhc--cCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 99999997664 5999999998665554445567899999999998 456899999999999999999965 6788
Q ss_pred CCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 793 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 793 ~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
..........+.. ..+++.+..+++.+.+||.+||+.||++|||+.+|+++|+.+...
T Consensus 229 ~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 229 GMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp TCCHHHHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCHHHHHHHHHh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 8877777666544 566777888999999999999999999999999999999998653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-45 Score=395.79 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=215.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|+++ |+.||||+++..... .......+.+|+.+|+.++|||||++++++.+..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-----CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence 367999999999999999999984 888999999754321 1122456889999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++|||||+|++|..++. ....+++..+..++.||+.||+|||++|||||||||+||||+.+|. +||+|||+
T Consensus 78 --~~~ivmE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~----vkL~DFG~ 150 (316)
T d1fota_ 78 --QIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH----IKITDFGF 150 (316)
T ss_dssp --EEEEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC----EEECCCSS
T ss_pred --eeeeEeeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC----EEEecCcc
Confidence 9999999999999988775 4456889999999999999999999999999999999999997664 59999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
|+...... ...+||+.|+|||++.+ ..++.++|||||||+||+|+||+.||.+.+.......+..... ..+..+
T Consensus 151 a~~~~~~~--~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (316)
T d1fota_ 151 AKYVPDVT--YTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPFF 224 (316)
T ss_dssp CEECSSCB--CCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTTS
T ss_pred ceEecccc--ccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC--CCCCCC
Confidence 98765433 34679999999999984 4578899999999999999999999999888888887776654 455678
Q ss_pred cHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
++++.+++.+||+.||.+|+ |+++++++.+
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 99999999999999999995 8999988743
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=390.75 Aligned_cols=265 Identities=31% Similarity=0.493 Sum_probs=226.5
Q ss_pred ccccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCC
Q 002908 572 STLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 643 (867)
Q Consensus 572 ~~l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HP 643 (867)
...|++..++|++.++||+|+||.||+|++. ++.||||+++... ......+|.+|+.+++++ +||
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~~~~~l~~Hp 87 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLGNHM 87 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-------CHHHHHHHHHHHHHHHhccCCC
Confidence 3456788999999999999999999999873 3569999997532 122245788999999999 699
Q ss_pred ceeeEecccccCCCCeEEEEEEeecCCchhhhhhccc-----------------ccCCHHHHHHHHHHHHHHHHHHHHCC
Q 002908 644 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------------RHLDRRKRLIIAMDAAFGMEYLHSKN 706 (867)
Q Consensus 644 NIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~-----------------~~Lse~~~l~Ia~QIa~ALayLHs~G 706 (867)
|||+++++|.+.. .+++|||||++++|.+++.... ..+++..++.++.||+.||+|||+++
T Consensus 88 nIv~~~g~~~~~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ 165 (311)
T d1t46a_ 88 NIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165 (311)
T ss_dssp TBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEEEEEeeCC--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999998855 7899999999999999986432 25899999999999999999999999
Q ss_pred eeccCCCCcceEeccCCCCCCcEEEeecCCcccccC---ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHH
Q 002908 707 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWE 783 (867)
Q Consensus 707 IIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~---~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyE 783 (867)
|+||||||+|||++.++ .++++|||+++.... ........||+.|+|||++. ...++.++|||||||++||
T Consensus 166 ivHrDLKp~NIl~~~~~----~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DIwS~G~~l~e 239 (311)
T d1t46a_ 166 CIHRDLAARNILLTHGR----ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWE 239 (311)
T ss_dssp CCCSCCSGGGEEEETTT----EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHH
T ss_pred eeecccccccccccccC----cccccccchheeccCCCcceEeeecccChHHcCHHHhc--CCCCCCcccccchHHHHHH
Confidence 99999999999999665 459999999986443 22334567899999999998 4568999999999999999
Q ss_pred HHh-CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 784 ILT-GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 784 LLT-Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
|+| |.+||........+..++....++..+..+++.+.+||.+||+.||.+|||+.+|++.|++....
T Consensus 240 llt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 999 67777777776777778888888888889999999999999999999999999999999987655
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=388.89 Aligned_cols=262 Identities=31% Similarity=0.525 Sum_probs=217.8
Q ss_pred cccccCCeeEEEEeeecCcEEEEEEEECC---------ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC-CCCc
Q 002908 575 QIIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 644 (867)
Q Consensus 575 ~~I~~sdyqilk~LG~GafG~VYka~~~G---------~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L-~HPN 644 (867)
+.|..++|++.+.||+|+||.||+|++.+ ..||||+++... .+....++.+|...+.++ +|||
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-------ChHHHHHHHHHHHHHHHhcCCCe
Confidence 56888999999999999999999998632 369999986432 123346788899999888 7999
Q ss_pred eeeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------------ccCCHHHHHHHHHHHHHHHHHHHHCCeec
Q 002908 645 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 709 (867)
Q Consensus 645 IVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------------~~Lse~~~l~Ia~QIa~ALayLHs~GIIH 709 (867)
||+++++|.+.. ..++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++|||
T Consensus 81 Iv~~~~~~~~~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivH 158 (299)
T d1fgka_ 81 IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 158 (299)
T ss_dssp BCCEEEEECSSS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEecccccccCC--eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEe
Confidence 999999998754 8999999999999999996443 45899999999999999999999999999
Q ss_pred cCCCCcceEeccCCCCCCcEEEeecCCcccccCcc---ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHh
Q 002908 710 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILT 786 (867)
Q Consensus 710 rDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~~~~---~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLT 786 (867)
|||||+|||++.++. +||+|||+++...... ......+|+.|+|||.+. ...++.++|||||||++|+|++
T Consensus 159 rDiKp~NiLl~~~~~----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~--~~~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 159 RDLAARNVLVTEDNV----MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp SCCSGGGEEECTTCC----EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeecccceeecCCCC----eEeccchhhccccccccccccccCCCChhhhhhhHhc--CCCCCchhhhHHhHHHHHHhcc
Confidence 999999999997764 5999999998554322 223456889999999998 4568999999999999999998
Q ss_pred -CCCCCCCCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 002908 787 -GEEPYANMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAAC 852 (867)
Q Consensus 787 -Gk~PF~~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~ 852 (867)
|.+||........... +....+++.+..+++.+.+||.+||+.+|.+|||+.+|++.|+.+.+.+
T Consensus 233 ~g~~p~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp TSCCSSTTCCHHHHHHH-HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 7899988777665544 4556778888899999999999999999999999999999999986543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=384.17 Aligned_cols=252 Identities=25% Similarity=0.293 Sum_probs=199.5
Q ss_pred EEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCCeEE
Q 002908 584 ELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 661 (867)
Q Consensus 584 ilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~~l~ 661 (867)
.+++||+|+||+||+|++ +|+.||||+++...... ..+.....+.+|+.+|+.++|||||++++++.... .++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh---hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--cee
Confidence 467899999999999998 47889999997543221 11223356889999999999999999999998855 899
Q ss_pred EEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCccccc
Q 002908 662 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 741 (867)
Q Consensus 662 LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~~~~ 741 (867)
+||||+.++++.... .....+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~----~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV----LKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC----EEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc----cccccCccccccC
Confidence 999999877666554 45567999999999999999999999999999999999999997664 5999999998654
Q ss_pred Cc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC---------
Q 002908 742 NT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP--------- 811 (867)
Q Consensus 742 ~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~--------- 811 (867)
.. .......||+.|+|||++.+ ...++.++|||||||++|+|+||..||.+....+.+..+......+.
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTT-CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred CCcccccceecChhhccHHHHcc-CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 33 23345579999999999874 34579999999999999999999999998877766655543211100
Q ss_pred -----------------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 812 -----------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 812 -----------------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....+++.+.+||.+||+.||++|||+.|++++-+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 01245789999999999999999999999987643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.7e-45 Score=398.01 Aligned_cols=258 Identities=23% Similarity=0.292 Sum_probs=207.9
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
+.++|+++++||+|+||.||+|++ +|+.||||++........ ..+........|+.+++.++|||||+++++|.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~--~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH--TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh--hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 457899999999999999999998 488899999975432111 1122223334557778888999999999999885
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
. .+|+|||||++++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|. +||+|||
T Consensus 80 ~--~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~----iKl~DFG 152 (364)
T d1omwa3 80 D--KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH----VRISDLG 152 (364)
T ss_dssp S--EEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC----EEECCCT
T ss_pred C--EEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc----EEEeeec
Confidence 4 89999999999999999864 456899999999999999999999999999999999999997764 5999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH-hhcCCCCCCCC
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI-VNNTLRPPVPG 814 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i-v~~~lr~~ip~ 814 (867)
+|+...... .....||+.|+|||++.+ ...++.++|||||||+||+|+||+.||............ .........+.
T Consensus 153 la~~~~~~~-~~~~~GT~~y~APE~~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 153 LACDFSKKK-PHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp TCEECSSSC-CCSCCSCGGGCCHHHHST-TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred eeeecCCCc-ccccccccccchhHHhhc-CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 998655433 345679999999999963 345789999999999999999999999775433222111 12233455567
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCC-----HHHHHHHHH
Q 002908 815 FCDSEWRLLMEQCWAPDPVVRPS-----FTEIARRLR 846 (867)
Q Consensus 815 ~~s~eL~dLI~kCLq~DPeeRPS-----a~ELLe~Lq 846 (867)
.+++++.+||.+||+.||.+||| +++++++-+
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 88999999999999999999999 799988644
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=393.33 Aligned_cols=253 Identities=26% Similarity=0.344 Sum_probs=204.7
Q ss_pred cCCeeEEE-EeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHh-CCCCceeeEeccccc
Q 002908 579 NEDLEELK-ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQD 654 (867)
Q Consensus 579 ~sdyqilk-~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~-L~HPNIVrL~g~~~~ 654 (867)
.++|+++. .||+|+||+||+|++ +++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 36798875 599999999999998 4788999998642 345678988765 489999999999865
Q ss_pred --CCCCeEEEEEEeecCCchhhhhhccc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 655 --GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 655 --~~~~~l~LVmEy~~ggSL~d~L~~~~-~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
.....+|+|||||+||+|.+++...+ ..+++.+++.|+.||+.||+|||++||+||||||+|||++..+. ...+||
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~-~~~~Kl 155 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP-NAILKL 155 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSST-TCCEEE
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccc-cccccc
Confidence 23457899999999999999997643 57999999999999999999999999999999999999986543 356899
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhH----hhcC
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI----VNNT 807 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~i----v~~~ 807 (867)
+|||+|+............||+.|+|||++.+ ..++.++|||||||+||+|+||+.||.+.........+ ....
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred cccceeeeccCCCccccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence 99999987665555566789999999999984 45889999999999999999999999775543332222 2222
Q ss_pred CCCCCC--CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 808 LRPPVP--GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 808 lr~~ip--~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
+..+.+ ..+++++.+||.+||+.||.+|||+.+++.+-+-
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence 222221 2478899999999999999999999999987553
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-45 Score=395.67 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=214.9
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||.||+|+++ |+.||||++...... .......+.+|+.+|+.++|||||++++++....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-----CHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence 368999999999999999999984 889999999753221 1122356789999999999999999999998854
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+++||||+.+++|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|. +||+|||+
T Consensus 115 --~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~----ikL~DFG~ 187 (350)
T d1rdqe_ 115 --NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY----IQVTDFGF 187 (350)
T ss_dssp --EEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC----EEECCCTT
T ss_pred --ccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC----EEeeecee
Confidence 899999999999999988644 46999999999999999999999999999999999999997764 59999999
Q ss_pred cccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCCC
Q 002908 737 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGFC 816 (867)
Q Consensus 737 A~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~~ 816 (867)
|+...... ....||+.|||||++.+ ..++.++|||||||+||+|+||+.||.+.........+..... ..+..+
T Consensus 188 a~~~~~~~--~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 261 (350)
T d1rdqe_ 188 AKRVKGRT--WTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSHF 261 (350)
T ss_dssp CEECSSCB--CCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTC
T ss_pred eeeccccc--ccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC--CCCccC
Confidence 98765432 34679999999999984 5678999999999999999999999999888777777776654 445678
Q ss_pred cHHHHHHHHHhhcCCCCCC-----CCHHHHHHHHH
Q 002908 817 DSEWRLLMEQCWAPDPVVR-----PSFTEIARRLR 846 (867)
Q Consensus 817 s~eL~dLI~kCLq~DPeeR-----PSa~ELLe~Lq 846 (867)
++++.+||.+||+.||.+| ||++++++|-+
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 9999999999999999999 48999988643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=383.98 Aligned_cols=262 Identities=32% Similarity=0.505 Sum_probs=220.6
Q ss_pred cccccccCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce
Q 002908 573 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 645 (867)
Q Consensus 573 ~l~~I~~sdyqilk~LG~GafG~VYka~~~-------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI 645 (867)
.-++|..++|++.+.||+|+||.||+|.+. ++.||||+++... .......|.+|+.++++++||||
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-------~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-------ChHHHHHHHHHHHHHHHcCCCCE
Confidence 346889999999999999999999999874 3579999986421 12234578899999999999999
Q ss_pred eeEecccccCCCCeEEEEEEeecCCchhhhhhccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcc
Q 002908 646 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 716 (867)
Q Consensus 646 VrL~g~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~---------~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsN 716 (867)
|+++++|.... ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 86 v~~~~~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 86 VRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp CCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred eeeeeEEecCC--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCc
Confidence 99999998754 7899999999999999885432 346899999999999999999999999999999999
Q ss_pred eEeccCCCCCCcEEEeecCCcccccCc---cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhC-CCCCC
Q 002908 717 LLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTG-EEPYA 792 (867)
Q Consensus 717 ILLd~dg~~~~~vKL~DFGLA~~~~~~---~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTG-k~PF~ 792 (867)
||++.++ .+||+|||+|+..... .......+|+.|+|||.+. ...++.++|||||||++|||+|| ..||.
T Consensus 164 iLld~~~----~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~--~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 164 CMVAEDF----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp EEECTTC----CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred eeecCCc----eEEEeecccceeccCCcceeeccceecccccCCHHHHc--cCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 9999665 4699999999854332 2223345899999999998 45678999999999999999997 58898
Q ss_pred CCChhHHHHhHhhcCCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 002908 793 NMHYGAIIGGIVNNTLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSA 850 (867)
Q Consensus 793 ~~~~~e~l~~iv~~~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~ 850 (867)
.....+....+.. ..+++.+..+++.+.++|.+||+.+|.+|||+.+|+++|+....
T Consensus 238 ~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 238 GLSNEQVLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCHHHHHHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 8888777776554 44577778899999999999999999999999999999987543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=378.40 Aligned_cols=256 Identities=25% Similarity=0.316 Sum_probs=207.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhC---CCCceeeEeccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVV 652 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~---G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L---~HPNIVrL~g~~ 652 (867)
.++|++++.||+|+||+||+|++. ++.||||+++......... ..+.+|+.+|+.| +||||++++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~------~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP------LSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB------CTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH------HHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 478999999999999999999983 4569999997654332211 2344566666554 899999999998
Q ss_pred ccC---CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcE
Q 002908 653 QDG---PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 653 ~~~---~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
... ....++++|||+.++.+..........+++..++.++.||+.||+|||++|||||||||+|||++..+. +
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~----~ 155 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----I 155 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC----E
T ss_pred cccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC----e
Confidence 532 235789999999888776666566677999999999999999999999999999999999999997664 5
Q ss_pred EEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC
Q 002908 730 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR 809 (867)
Q Consensus 730 KL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr 809 (867)
||+|||++.............||+.|+|||++. ...++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~--~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHT--TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eecchhhhhhhcccccCCCcccChhhcCcchhc--CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 999999998766666666778999999999998 456899999999999999999999999988776665554321100
Q ss_pred -------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 810 -------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 810 -------------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
......+++.+.+||.+||+.||.+|||+.|++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 1123456889999999999999999999999988743
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=390.09 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=210.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHH-hCCCCceeeEecccccCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk-~L~HPNIVrL~g~~~~~~ 656 (867)
++|++++.||+|+||+||+|.+ +++.||||++++.... .+.....+..|..++. .++|||||++++++.++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-----~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc-----ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 6799999999999999999999 4888999999753211 1111244566777665 689999999999999855
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
.+|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 77 --~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~----~kl~DFG~ 149 (320)
T d1xjda_ 77 --NLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH----IKIADFGM 149 (320)
T ss_dssp --EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC----EEECCCTT
T ss_pred --ceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc----eeccccch
Confidence 89999999999999999864 456899999999999999999999999999999999999997765 49999999
Q ss_pred cccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCCCC
Q 002908 737 SKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVPGF 815 (867)
Q Consensus 737 A~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip~~ 815 (867)
++.... ........||+.|+|||++. ...++.++|||||||++|+|+||+.||.+.+.......+.... +..+..
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~ 225 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILL--GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRW 225 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTT
T ss_pred hhhcccccccccccCCCCCcCCHHHHc--CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcc
Confidence 985433 33334567999999999998 4568899999999999999999999999988888777776554 455677
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCHH-HHHHH
Q 002908 816 CDSEWRLLMEQCWAPDPVVRPSFT-EIARR 844 (867)
Q Consensus 816 ~s~eL~dLI~kCLq~DPeeRPSa~-ELLe~ 844 (867)
+++.+.+||.+||+.||.+||++. +++++
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 899999999999999999999995 77654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=380.51 Aligned_cols=252 Identities=27% Similarity=0.344 Sum_probs=202.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||+||+|++. ++.||||+++..... +.....+.+|+.+|++++|||||++++++.+..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~- 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN- 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC------hHHHHHHHHHHHHHHhCCCCcEEEecccccccc-
Confidence 58999999999999999999984 788999999754221 222357889999999999999999999999855
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
.+++||||+.++.+..........+++..+..++.||+.||.|||++|||||||||+|||++.++. +||+|||+|
T Consensus 75 -~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~----~kl~DFG~a 149 (298)
T d1gz8a_ 75 -KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA----IKLADFGLA 149 (298)
T ss_dssp -EEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC----EEECSTTHH
T ss_pred -ceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc----ceeccCCcc
Confidence 899999999655444443445567999999999999999999999999999999999999996654 599999999
Q ss_pred ccccC-ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC-------
Q 002908 738 KIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR------- 809 (867)
Q Consensus 738 ~~~~~-~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr------- 809 (867)
+.... ........||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred eeccCCcccceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 85533 2334455799999999998743 34588999999999999999999999987766655444321110
Q ss_pred ---------CCC-----------CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 002908 810 ---------PPV-----------PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARR 844 (867)
Q Consensus 810 ---------~~i-----------p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~ 844 (867)
... ...+++++.+||.+||+.||.+|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 12456889999999999999999999999886
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=382.07 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=209.4
Q ss_pred eEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 583 EELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 583 qilk~LG~GafG~VYka~~~G-----~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
+..++||+|+||+||+|++.. ..||||.++... ......+|.+|+++|++++|||||+++|++... .
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~ 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-E 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-T
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-C
Confidence 336789999999999999832 258999986421 233357799999999999999999999998654 3
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
+.+++|||||++++|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~----~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF----TVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC----CEEECSSGGG
T ss_pred CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC----CEEEecccch
Confidence 478999999999999999987777888999999999999999999999999999999999998654 4699999999
Q ss_pred ccccCc-----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCC
Q 002908 738 KIKRNT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPV 812 (867)
Q Consensus 738 ~~~~~~-----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~i 812 (867)
+..... .......||+.|+|||.+. ...++.++||||||++||||+||..||........+...+....++..
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~ 255 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC
T ss_pred hhccccccccceecccccccccccChHHHh--cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 854322 1223356899999999998 456899999999999999999977776553333222233344566777
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 813 PGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 813 p~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
+..+++.+.+||.+||+.||.+||++.||+++|+.+.....
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 88899999999999999999999999999999999976544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=377.24 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=201.4
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC--CCceeeEeccccc
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--HPNVVAFYGVVQD 654 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~--HPNIVrL~g~~~~ 654 (867)
.++|++.+.||+|+||+||+|++. |+.||||+++.......... ....++.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~--~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh--hHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 468999999999999999999984 78899999986544321110 01123567999999986 8999999999988
Q ss_pred CCCCeEEEEEEeecC-CchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 655 GPGGTLATVTEFMVN-GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 655 ~~~~~l~LVmEy~~g-gSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
.. ..++||||+.+ +++.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.+. ..+||+|
T Consensus 81 ~~--~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~---~~vkl~D 154 (273)
T d1xwsa_ 81 PD--SFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR---GELKLID 154 (273)
T ss_dssp SS--EEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT---TEEEECC
T ss_pred CC--eEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC---CeEEECc
Confidence 55 89999999976 46666654 445799999999999999999999999999999999999998543 3579999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCCCC
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPPVP 813 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~ip 813 (867)
||+|+...... .....||+.|+|||++.+. ..++.++|||||||++|+|+||+.||.... .+... ....+
T Consensus 155 FG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~~~~ 224 (273)
T d1xwsa_ 155 FGSGALLKDTV-YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFFR 224 (273)
T ss_dssp CTTCEECCSSC-BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCCS
T ss_pred cccceeccccc-ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--ccCCC
Confidence 99998654433 3456799999999999853 234678999999999999999999997532 22222 23455
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 814 GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 814 ~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
..+++++.+||.+||+.||.+|||++|++++.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 67899999999999999999999999998864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-43 Score=369.99 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=202.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~~ 658 (867)
++|+++++||+|+||+||+|+++ |+.||||+++..... +.....+.+|+.+|++++|||||++++++....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-- 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED------EGIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC------hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--
Confidence 68999999999999999999984 788999999764322 112357889999999999999999999999855
Q ss_pred eEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCcc
Q 002908 659 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 738 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA~ 738 (867)
..+++|+++.++.+..+ ......+++..+..++.||+.||.|||++|||||||||+|||++.++. +||+|||.+.
T Consensus 74 ~~~i~~e~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~----~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE----LKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC----EEECCTTHHH
T ss_pred ceeEEEEeehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC----EEecccccce
Confidence 89999999966555544 455677999999999999999999999999999999999999997765 5999999998
Q ss_pred cccCc-cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC--------
Q 002908 739 IKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-------- 809 (867)
Q Consensus 739 ~~~~~-~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr-------- 809 (867)
..... .......+++.|+|||.+.+ ...++.++|||||||++|+|++|+.||........+..+......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ecccCccccceecccchhhhHHHHhC-CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 65432 22344568999999999975 345689999999999999999999999887766655443321100
Q ss_pred -------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 810 -------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 810 -------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
......+++.+.+||++||+.||++|||+.|++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp 282 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 011234678999999999999999999999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=372.39 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=201.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC--
Q 002908 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG-- 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~-- 657 (867)
.+|.+.+.||+|+||.||+|+++|+.||||+++... ... ..+..|+..+..++|||||++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-------~~~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-------HHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-------hhH--HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 578899999999999999999999999999986421 111 112245555567899999999999975432
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHH--------CCeeccCCCCcceEeccCCCCCCcE
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS--------KNIVHFDLKCDNLLVNLKDPIRPIC 729 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs--------~GIIHrDLKPsNILLd~dg~~~~~v 729 (867)
..+++|||||++|+|.+++.. ..+++..++.++.|++.||+|||+ +|||||||||+||||+.++ .+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~----~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS----CE
T ss_pred eEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC----Ce
Confidence 368999999999999999964 368999999999999999999996 5999999999999999765 45
Q ss_pred EEeecCCcccccCcc-----ccCCcCCCCCccCccccccCCC----CCChhhHHHHHHHHHHHHHhCCCCCCCC------
Q 002908 730 KVGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSSS----KVSEKVDVFSFGIVLWEILTGEEPYANM------ 794 (867)
Q Consensus 730 KL~DFGLA~~~~~~~-----~~s~~~GT~~Y~APEvl~g~~~----~~S~kSDVWSLGvLLyELLTGk~PF~~~------ 794 (867)
||+|||+++...... ......||+.|+|||++.+... .++.++|||||||+||||+||..||...
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 999999998543321 2234679999999999874321 2577999999999999999998876321
Q ss_pred ---------ChhHHHHhHhhcCCCCCCCCC-----CcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 795 ---------HYGAIIGGIVNNTLRPPVPGF-----CDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 795 ---------~~~e~l~~iv~~~lr~~ip~~-----~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
..............++.++.. ....+.+|+.+||+.||.+|||+.||++.|+++.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 112233344444555555443 23468999999999999999999999999999876544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=373.20 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=199.3
Q ss_pred ccCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC
Q 002908 578 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 655 (867)
Q Consensus 578 ~~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~ 655 (867)
..++|++++.||+|+||+||+|.+. |+.||||+++.... .+.....+.+|+.+|+.++|||||+++++|...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc------ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 3679999999999999999999984 88899999975321 233456788999999999999999999998754
Q ss_pred C----CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEE
Q 002908 656 P----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 731 (867)
Q Consensus 656 ~----~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL 731 (867)
. ...+++||||+ +.+|..... ...+++..++.++.||+.||.|||++|||||||||+|||++.++. +||
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~----~kl 162 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE----LKI 162 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEE
T ss_pred ccccccceEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc----ccc
Confidence 2 23579999999 667776653 356999999999999999999999999999999999999997765 599
Q ss_pred eecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCC--
Q 002908 732 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLR-- 809 (867)
Q Consensus 732 ~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr-- 809 (867)
+|||+|+...... ....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 163 ~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 163 LDFGLARQADSEM--TGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp CCCTTCEECCSSC--CSSCSCGGGCCTHHHHT-TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccceeccCCcc--ccccccccccCHHHHcC-CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 9999998665433 34569999999999875 345688999999999999999999999887655443322211100
Q ss_pred ---------------------------CCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 810 ---------------------------PPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 810 ---------------------------~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
......+++.+.+||.+||..||.+|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp 302 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 112245688999999999999999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-42 Score=368.49 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=203.0
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~ 655 (867)
.++|+++++||+|+||+||+|++. ++.||||+++... ..++.+|+.+|+.++ ||||++++++|...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 468999999999999999999984 8889999986431 245778999999995 99999999999876
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecC
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 735 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFG 735 (867)
....+++|||||.+++|.... +.+++..+..++.||+.||.|||++||+||||||+|||++.++. .++|+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~---~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR---KLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT---EEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC---eeeecccc
Confidence 666899999999999987754 46899999999999999999999999999999999999986553 46999999
Q ss_pred CcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhH-HHHhHhh---------
Q 002908 736 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA-IIGGIVN--------- 805 (867)
Q Consensus 736 LA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e-~l~~iv~--------- 805 (867)
+|.............+|+.|+|||.+.+ ...++.++|||||||++|+|++|+.||....... ....+..
T Consensus 176 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 176 LAEFYHPGQEYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp GCEECCTTCCCCSCCSCGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred cceeccCCCcccccccCccccCcccccC-CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 9987766555666779999999999875 2347899999999999999999999997654321 1111000
Q ss_pred ----c----------------------CCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 806 ----N----------------------TLRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 806 ----~----------------------~lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
. .........+++++.+||++||+.||.+|||++|++++-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0 001111234678999999999999999999999998864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=373.20 Aligned_cols=249 Identities=24% Similarity=0.247 Sum_probs=200.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEeccccc----
Q 002908 581 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD---- 654 (867)
Q Consensus 581 dyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~---- 654 (867)
+|+.+++||+|+||+||+|++ +|+.||||+++.... .+.+|+.+|++++||||++++++|..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 699999999999999999999 478899999975421 12368999999999999999999853
Q ss_pred CCCCeEEEEEEeecCCchhhhhh--cccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEe
Q 002908 655 GPGGTLATVTEFMVNGSLRHVLL--SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 732 (867)
Q Consensus 655 ~~~~~l~LVmEy~~ggSL~d~L~--~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~ 732 (867)
....++++|||||+++.+..... .....+++..+..++.||+.||+|||++||+||||||+|||++.++. .+||+
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~---~~kl~ 165 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA---VLKLC 165 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC---CEEEC
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC---ceeEe
Confidence 23346899999997654433332 23457999999999999999999999999999999999999997653 36999
Q ss_pred ecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC-----
Q 002908 733 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT----- 807 (867)
Q Consensus 733 DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~----- 807 (867)
|||++.............||+.|+|||.+.+ ...++.++|||||||++|||++|+.||........+..+....
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccchhhccCCcccccccccccccChHHhhc-ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 9999987655555556679999999999874 3467999999999999999999999998877665554443210
Q ss_pred ----------CCC------------CCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 808 ----------LRP------------PVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 808 ----------lr~------------~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
... .....+++.+.+||.+||+.||.+|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 000 01234688999999999999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-42 Score=362.40 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=200.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeE-ecccccCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF-YGVVQDGP 656 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL-~g~~~~~~ 656 (867)
++|++.+.||+|+||+||+|++. ++.||||++...... .++.+|+++++.++|+|++.. ++++.+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~- 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEG- 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEET-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----------HHHHHHHHHHHHccCCCcccEEEEEEecC-
Confidence 57999999999999999999984 789999998754211 235679999999987765555 4444553
Q ss_pred CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCC
Q 002908 657 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 736 (867)
Q Consensus 657 ~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGL 736 (867)
...++||||+ +++|...+......+++..++.++.|++.||+|||++|||||||||+|||++..+. ...++|+|||+
T Consensus 76 -~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~-~~~vkl~DFG~ 152 (299)
T d1ckia_ 76 -DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK-GNLVYIIDFGL 152 (299)
T ss_dssp -TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGG-TTCEEECCCSS
T ss_pred -CEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCC-CceeeeeccCc
Confidence 4889999999 67777777666778999999999999999999999999999999999999975542 24679999999
Q ss_pred cccccCcc--------ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHh---Hhh
Q 002908 737 SKIKRNTL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGG---IVN 805 (867)
Q Consensus 737 A~~~~~~~--------~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~---iv~ 805 (867)
|+...... ......||+.|+|||++.+ ..++.++|||||||++|||+||..||........... ...
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 98654321 2234579999999999984 4589999999999999999999999977554332211 111
Q ss_pred cCC---CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 002908 806 NTL---RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAA 851 (867)
Q Consensus 806 ~~l---r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a 851 (867)
... .......+++++.+||.+||+.+|.+||++.++.+.|+.+...
T Consensus 231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 111 1122356889999999999999999999999999999887543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=360.49 Aligned_cols=256 Identities=22% Similarity=0.256 Sum_probs=198.8
Q ss_pred cCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|+++++||+|+||+||+|++. |+.||||++........ ...++.+|+.+|+.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH------HHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 378999999999999999999984 78899999876533221 2356779999999999999999999875532
Q ss_pred ------CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 657 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 657 ------~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
.+.+++||||+.++.+.. .......+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~----~k 157 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LK 157 (318)
T ss_dssp --------CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC----EE
T ss_pred ccccccCceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc----EE
Confidence 346899999997665554 4345567899999999999999999999999999999999999997664 59
Q ss_pred EeecCCcccccCc-----cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhh
Q 002908 731 VGDFGLSKIKRNT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVN 805 (867)
Q Consensus 731 L~DFGLA~~~~~~-----~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~ 805 (867)
|+|||++...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eeecceeeecccccccccccccceecCHHHhhHHHHcC-CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 9999999754321 12233569999999999875 33578999999999999999999999988776655444332
Q ss_pred cCCCCCCC------------------------------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 806 NTLRPPVP------------------------------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 806 ~~lr~~ip------------------------------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
........ ...++.+.+||.+||+.||++|||++|++++-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 21111000 012567889999999999999999999998765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=366.37 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=196.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|++++.||+|+||+||+|+++ |+.||||++.... .......+.+|+.+|++++||||+++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 57999999999999999999984 8889999986431 23334678899999999999999999999865421
Q ss_pred ---CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeec
Q 002908 658 ---GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 734 (867)
Q Consensus 658 ---~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DF 734 (867)
...++ |+++.+++|.+++.. ..+++..+..++.||+.||+|||++|||||||||+|||++.++. +||+||
T Consensus 81 ~~~~~~~l-~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~----~kl~Df 153 (345)
T d1pmea_ 81 EQMKDVYL-VTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD----LKICDF 153 (345)
T ss_dssp TTCCCEEE-EEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----EEECCC
T ss_pred cccceEEE-EEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC----EEEccc
Confidence 23444 555669999999853 46999999999999999999999999999999999999997664 599999
Q ss_pred CCcccccCcc----ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC---
Q 002908 735 GLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT--- 807 (867)
Q Consensus 735 GLA~~~~~~~----~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~--- 807 (867)
|++....... ......||+.|+|||++.. ...++.++||||+||++|+|++|+.||................
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT-BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred CceeeccCCCccceeeccccccceechHHHhhc-CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 9998543322 2344568999999999864 3457889999999999999999999998766543332221100
Q ss_pred -------------------C--CCC-----CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 808 -------------------L--RPP-----VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 808 -------------------l--r~~-----ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
. ... ....+++.+.+|+.+||+.||.+|||+.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0 000 1124578899999999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=353.00 Aligned_cols=252 Identities=25% Similarity=0.301 Sum_probs=202.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 657 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~~ 657 (867)
++|+++++||+|+||+||+|++ +++.||||+++..... +....++.+|+.+|+.++||||+++++++.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~- 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHSDK- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC------hHHHHHHHHHHHHHHhcCcCCEEeecccccccc-
Confidence 5899999999999999999998 4778999999764322 223467889999999999999999999998865
Q ss_pred CeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEeecCCc
Q 002908 658 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 737 (867)
Q Consensus 658 ~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~DFGLA 737 (867)
..++||+++.+++|..++. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||.+
T Consensus 75 -~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~----~kl~DFG~a 148 (292)
T d1unla_ 75 -KLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE----LKLANFGLA 148 (292)
T ss_dssp -EEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----EEECCCTTC
T ss_pred -ceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc----eeeeecchh
Confidence 8999999998888877664 5567899999999999999999999999999999999999996654 599999999
Q ss_pred ccccCcc-ccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCC-CChhHHHHhHhhcCC-------
Q 002908 738 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYAN-MHYGAIIGGIVNNTL------- 808 (867)
Q Consensus 738 ~~~~~~~-~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~-~~~~e~l~~iv~~~l------- 808 (867)
....... ......+++.|+|||.+.+ ...++.++|||||||++|+|++|+.||.. .+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred hcccCCCccceeeccccchhhhhHhcc-CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 8654432 3334457788999999874 23468999999999999999999998644 333333332221100
Q ss_pred --------------------CCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 002908 809 --------------------RPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRL 845 (867)
Q Consensus 809 --------------------r~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~L 845 (867)
.......+++.+.+||.+||+.||.+|||++|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence 1112234678899999999999999999999998763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-41 Score=355.32 Aligned_cols=260 Identities=18% Similarity=0.214 Sum_probs=210.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC-CceeeEecccccC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFYGVVQDG 655 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H-PNIVrL~g~~~~~ 655 (867)
.++|+++++||+|+||+||+|++ +|+.||||++...... ..+.+|+++++.|.| +|++.+++++...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----------HHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 57899999999999999999998 4788999998654211 235578888999975 8999999998875
Q ss_pred CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCC-CCCcEEEeec
Q 002908 656 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP-IRPICKVGDF 734 (867)
Q Consensus 656 ~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~-~~~~vKL~DF 734 (867)
. ..++||||+ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.... ....++|+||
T Consensus 74 ~--~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 74 L--HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp T--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred C--ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence 4 899999999 89999988777778999999999999999999999999999999999999986432 2346899999
Q ss_pred CCcccccCc--------cccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChh---HHHHhH
Q 002908 735 GLSKIKRNT--------LVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYG---AIIGGI 803 (867)
Q Consensus 735 GLA~~~~~~--------~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~---e~l~~i 803 (867)
|+|+..... .......||+.|||||++. ...++.++|||||||++|+|+||+.||.+.... .....+
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~--~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL--GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhc--CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 999864322 1233467999999999998 456899999999999999999999999764432 222222
Q ss_pred hhcC---CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc
Q 002908 804 VNNT---LRPPVPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRVMSAACQ 853 (867)
Q Consensus 804 v~~~---lr~~ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~l~~a~s 853 (867)
.... ........+++++.+++..|++.+|.+||+++.+.+.|+.+.....
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 2111 1112234678999999999999999999999999999998876554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=363.78 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=200.1
Q ss_pred cCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccCC
Q 002908 579 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 656 (867)
Q Consensus 579 ~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~~ 656 (867)
.++|++++.||+|+||+||+|++ +|+.||||+++.... ......++.+|+.+|+.++|||||++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc------ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 47899999999999999999998 488999999975421 1223456889999999999999999999886431
Q ss_pred ---CCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 657 ---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 657 ---~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
....++||+++.+++|.+++. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~----~kl~d 164 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKILD 164 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC----EEECC
T ss_pred ccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc----ccccc
Confidence 224456677788999999884 346999999999999999999999999999999999999997765 49999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcCCCCC--
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPP-- 811 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~lr~~-- 811 (867)
||++...... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 165 fg~a~~~~~~--~~~~~g~~~y~apE~~~~-~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 165 FGLARHTDDE--MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp C----CCTGG--GSSSCHHHHTSCHHHHTT-CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cchhcccCcc--cccccccccccCchhhcC-CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 9999865433 234568999999999874 33468899999999999999999999988776554444332211110
Q ss_pred ---------------------------CCCCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 002908 812 ---------------------------VPGFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLR 846 (867)
Q Consensus 812 ---------------------------ip~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq 846 (867)
....+++.+.+||.+||+.||.+|||+.|++++-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 01246888999999999999999999999998744
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=365.05 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=191.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCceeeEecccccC--
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG-- 655 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~--G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNIVrL~g~~~~~-- 655 (867)
++|+++++||+|+||+||+|++. |+.||||+++.... .+....++.+|+.+|+.++|||||+++++|...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc------CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 67999999999999999999984 88999999976432 133346788999999999999999999998643
Q ss_pred --CCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEEEee
Q 002908 656 --PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 733 (867)
Q Consensus 656 --~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vKL~D 733 (867)
....+|+|||||.++.+ +.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~----~kl~d 162 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILD 162 (355)
T ss_dssp TTTCCEEEEEEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC----EEECC
T ss_pred cccCceeEEEEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc----eeeec
Confidence 23589999999965544 444 246899999999999999999999999999999999999997765 49999
Q ss_pred cCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhcC------
Q 002908 734 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNT------ 807 (867)
Q Consensus 734 FGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~~------ 807 (867)
||+++............+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 163 f~~~~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp CCC---------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhhhhccccccccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 999987666555566779999999999984 567899999999999999999999998776554433322110
Q ss_pred ----------------CCCC------------CC------CCCcHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 002908 808 ----------------LRPP------------VP------GFCDSEWRLLMEQCWAPDPVVRPSFTEIARRLRV 847 (867)
Q Consensus 808 ----------------lr~~------------ip------~~~s~eL~dLI~kCLq~DPeeRPSa~ELLe~Lq~ 847 (867)
.... .+ ...++++.+||++||+.||++|||++|+|++-+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 0000 00 1135678999999999999999999999988543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=365.99 Aligned_cols=259 Identities=26% Similarity=0.388 Sum_probs=207.6
Q ss_pred cccCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC-CceeeEec
Q 002908 577 IKNEDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFYG 650 (867)
Q Consensus 577 I~~sdyqilk~LG~GafG~VYka~~-----~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H-PNIVrL~g 650 (867)
+..++|++++.||+|+||+||+|.. +|+.||||+++........ .....+.+|+.+|++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~----~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch----HHHHHHHHHHHHHHhccCCCeEEEeee
Confidence 4458899999999999999999987 3678999998754322110 112456789999999977 89999999
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
++.+.. .+++||||+.+++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++. ++
T Consensus 97 ~~~~~~--~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~----vk 169 (322)
T d1vzoa_ 97 AFQTET--KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH----VV 169 (322)
T ss_dssp EEEETT--EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC----EE
T ss_pred eeccCC--ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC----EE
Confidence 998865 899999999999999988543 45788999999999999999999999999999999999997764 59
Q ss_pred EeecCCcccccC--ccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCCChhHHHHhHhhc--
Q 002908 731 VGDFGLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNN-- 806 (867)
Q Consensus 731 L~DFGLA~~~~~--~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~~~~e~l~~iv~~-- 806 (867)
|+|||+++.... ........|++.|+|||.+.+....++.++|||||||+||+|++|+.||...........+...
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence 999999975432 2233456799999999999866667889999999999999999999999775543332222221
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhcCCCCCCC-----CHHHHHHHHH
Q 002908 807 TLRPPVPGFCDSEWRLLMEQCWAPDPVVRP-----SFTEIARRLR 846 (867)
Q Consensus 807 ~lr~~ip~~~s~eL~dLI~kCLq~DPeeRP-----Sa~ELLe~Lq 846 (867)
...++.+..+++.+.+||.+||++||.+|| |++|++++.+
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 224455667899999999999999999999 5899987644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-36 Score=324.07 Aligned_cols=259 Identities=19% Similarity=0.211 Sum_probs=190.5
Q ss_pred cccc-ccCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC---------
Q 002908 574 LQII-KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--------- 641 (867)
Q Consensus 574 l~~I-~~sdyqilk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~--------- 641 (867)
++.+ ...+|+++++||+|+||+||+|++ +|+.||||+++.. ......+.+|+.+++.++
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---------~~~~~~~~~Ei~~l~~l~~~~~~~~~~ 76 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDS 76 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---------ccchHHHHHHHHHHHHhcchhhhhhhh
Confidence 3443 346799999999999999999998 4889999999743 122345667888887775
Q ss_pred --CCceeeEecccccCCCCeEEEEEEeecCCchhhh--hhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCCcc
Q 002908 642 --HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV--LLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDN 716 (867)
Q Consensus 642 --HPNIVrL~g~~~~~~~~~l~LVmEy~~ggSL~d~--L~~~~~~Lse~~~l~Ia~QIa~ALayLHs-~GIIHrDLKPsN 716 (867)
|+||+++++++........+++|.++..+..... .......+++..+..++.||+.||+|||+ .||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 5789999998875444566777777655543322 22344678999999999999999999998 899999999999
Q ss_pred eEeccCCCC--CCcEEEeecCCcccccCccccCCcCCCCCccCccccccCCCCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 002908 717 LLVNLKDPI--RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANM 794 (867)
Q Consensus 717 ILLd~dg~~--~~~vKL~DFGLA~~~~~~~~~s~~~GT~~Y~APEvl~g~~~~~S~kSDVWSLGvLLyELLTGk~PF~~~ 794 (867)
|||+.++.. ...++++|||.+...... .....||+.|+|||++. ...++.++|||||||++++|++|+.||...
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL--GAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH--TCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeeeccCcccccceeeEeecccccccccc--cccccccccccChhhcc--ccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 999866532 234799999999865433 23456999999999998 456789999999999999999999999653
Q ss_pred Chh------HHHHhHhhc--------------------------CC--------------CCCCCCCCcHHHHHHHHHhh
Q 002908 795 HYG------AIIGGIVNN--------------------------TL--------------RPPVPGFCDSEWRLLMEQCW 828 (867)
Q Consensus 795 ~~~------e~l~~iv~~--------------------------~l--------------r~~ip~~~s~eL~dLI~kCL 828 (867)
... ..+...+.. .. ........++.+.+||.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 321 111100000 00 00111223577999999999
Q ss_pred cCCCCCCCCHHHHHHHH
Q 002908 829 APDPVVRPSFTEIARRL 845 (867)
Q Consensus 829 q~DPeeRPSa~ELLe~L 845 (867)
+.||.+|||++|+|++-
T Consensus 313 ~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVNHP 329 (362)
T ss_dssp CSSTTTCBCHHHHHTCG
T ss_pred CCChhHCcCHHHHhcCc
Confidence 99999999999998864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=5.6e-22 Score=195.57 Aligned_cols=171 Identities=16% Similarity=0.013 Sum_probs=119.9
Q ss_pred eeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccccCCCC----------hHHHHHHHHHHHHHHHHHhCCCCceeeEec
Q 002908 582 LEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS----------SEQERLTLEFWREAEILSKLHHPNVVAFYG 650 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~-~G~~VAVKv~k~~~~sd~~----------~~~e~~~~eflrEieiLk~L~HPNIVrL~g 650 (867)
+.+.++||+|+||+||+|.+ +|+.||||+++........ .........+.+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35788999999999999987 6889999998643221000 011122344567899999999999998876
Q ss_pred ccccCCCCeEEEEEEeecCCchhhhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCCcceEeccCCCCCCcEE
Q 002908 651 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 730 (867)
Q Consensus 651 ~~~~~~~~~l~LVmEy~~ggSL~d~L~~~~~~Lse~~~l~Ia~QIa~ALayLHs~GIIHrDLKPsNILLd~dg~~~~~vK 730 (867)
+.. .+++|||+++..+.+ ++...+..++.|++.+|+|||++||+||||||+|||++.++ ++
T Consensus 82 ~~~------~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-----~~ 142 (191)
T d1zara2 82 WEG------NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-----IW 142 (191)
T ss_dssp EET------TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-----EE
T ss_pred ecC------CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-----EE
Confidence 532 268999997765543 34445567899999999999999999999999999998543 58
Q ss_pred EeecCCcccccCccccCCcCCCCCccCc------cccccCCCCCChhhHHHHHHHHH
Q 002908 731 VGDFGLSKIKRNTLVTGGVRGTLPWMAP------ELLNGSSSKVSEKVDVFSFGIVL 781 (867)
Q Consensus 731 L~DFGLA~~~~~~~~~s~~~GT~~Y~AP------Evl~g~~~~~S~kSDVWSLGvLL 781 (867)
|+|||+|......... .|... +.+. ..|+.++|+||+.--+
T Consensus 143 liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR-------EILERDVRNIITYFS---RTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcH-------HHHHHHHHHHHHHHc---CCCCCcccHHHHHHHH
Confidence 9999999754432111 12111 1221 2356778999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.98 E-value=1e-05 Score=80.28 Aligned_cols=86 Identities=13% Similarity=0.014 Sum_probs=55.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEecccccCCCC
Q 002908 580 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 658 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~g~~~~~~~~ 658 (867)
+.|+..+..+-++.+.||+....+..+.||+........ ...+.+|..++..+. +--+.+++.++... +
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHD--G 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--------hhhHHHHHHHHHHHhccCCCCcEEEEEecC--C
Confidence 356666655545557899988778888999876432211 123456777777663 32345666666553 4
Q ss_pred eEEEEEEeecCCchhhh
Q 002908 659 TLATVTEFMVNGSLRHV 675 (867)
Q Consensus 659 ~l~LVmEy~~ggSL~d~ 675 (867)
..++||++++|.++...
T Consensus 84 ~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEE 100 (263)
T ss_dssp EEEEEEECCSSEEHHHH
T ss_pred ceEEEEEeccccccccc
Confidence 78999999988877544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.24 E-value=0.0004 Score=68.13 Aligned_cols=74 Identities=19% Similarity=0.078 Sum_probs=46.5
Q ss_pred EeeecCc-EEEEEEEEC-CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCC--CceeeEecccccCCCCeEEE
Q 002908 587 ELGSGTF-GTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--PNVVAFYGVVQDGPGGTLAT 662 (867)
Q Consensus 587 ~LG~Gaf-G~VYka~~~-G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~H--PNIVrL~g~~~~~~~~~l~L 662 (867)
.+..|.+ +.||+.... +..+.||....... ..+.+|...|+.+.. -.+.+++.+..+. +..++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----------NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----------SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----------hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEE
Confidence 3455654 678988775 45588898754321 123456666666532 2356667666553 47889
Q ss_pred EEEeecCCchh
Q 002908 663 VTEFMVNGSLR 673 (867)
Q Consensus 663 VmEy~~ggSL~ 673 (867)
||++++|.++.
T Consensus 84 v~~~i~G~~~~ 94 (255)
T d1nd4a_ 84 LLGEVPGQDLL 94 (255)
T ss_dssp EEECCSSEETT
T ss_pred EEEeeeccccc
Confidence 99999877653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.03 E-value=0.00066 Score=72.55 Aligned_cols=83 Identities=18% Similarity=0.077 Sum_probs=46.6
Q ss_pred EEEeeecCcEEEEEEEE--CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-C--CceeeEecccccCCCCe
Q 002908 585 LKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-H--PNVVAFYGVVQDGPGGT 659 (867)
Q Consensus 585 lk~LG~GafG~VYka~~--~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-H--PNIVrL~g~~~~~~~~~ 659 (867)
.+.||.|....||++.. .++.++||.-.......+.... ....+...|.+.|+.+. + ..+.+++.+..+ .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~-~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~----~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP-LTIDRARIESSALIRQGEHVPHLVPRVFYSDTE----M 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC-CCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT----T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCC-CCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC----C
Confidence 45689999999999875 3667999976432111000000 00112335666676552 2 345666655433 3
Q ss_pred EEEEEEeecCCch
Q 002908 660 LATVTEFMVNGSL 672 (867)
Q Consensus 660 l~LVmEy~~ggSL 672 (867)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 4789999976543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=96.72 E-value=0.00021 Score=72.76 Aligned_cols=54 Identities=20% Similarity=0.305 Sum_probs=49.9
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPS 514 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs 514 (867)
+++|.||+.|++|++|+.|+|++|+|+ |. ||+.+.+.++..+.+.+|+.+||..
T Consensus 255 ~l~g~iP~~l~~L~~L~~L~Ls~N~l~--g~-iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 255 RIYGTLPQGLTQLKFLHSLNVSFNNLC--GE-IPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CCEECCCGGGGGCTTCCEEECCSSEEE--EE-CCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred eecccCChHHhCCCCCCEEECcCCccc--cc-CCCcccCCCCCHHHhCCCccccCCC
Confidence 688999999999999999999999999 95 9998888999999999999999853
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.17 E-value=0.007 Score=62.38 Aligned_cols=71 Identities=14% Similarity=0.021 Sum_probs=40.6
Q ss_pred cCcEEEEEEEE-CCceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCCCCce--eeEecc---cccCCCCeEEEEE
Q 002908 591 GTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV--VAFYGV---VQDGPGGTLATVT 664 (867)
Q Consensus 591 GafG~VYka~~-~G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~HPNI--VrL~g~---~~~~~~~~l~LVm 664 (867)
+..-.||+++. +|..+++|+.+....+ ..++..|...+..|....+ +..+.. ......+..+.++
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCC---------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 34468999887 5888999998754322 1334556666666642221 111111 0001134678899
Q ss_pred EeecCC
Q 002908 665 EFMVNG 670 (867)
Q Consensus 665 Ey~~gg 670 (867)
+++.|.
T Consensus 104 ~~~~G~ 109 (325)
T d1zyla1 104 PSVGGR 109 (325)
T ss_dssp ECCCCE
T ss_pred eecCCc
Confidence 998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.94 E-value=0.015 Score=61.31 Aligned_cols=77 Identities=14% Similarity=0.242 Sum_probs=48.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccccCCCChHHHHHHHHHHHHHHHHHhCC-CCceeeEe
Q 002908 580 EDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFY 649 (867)
Q Consensus 580 sdyqilk~LG~GafG~VYka~~~---------G~~VAVKv~k~~~~sd~~~~~e~~~~eflrEieiLk~L~-HPNIVrL~ 649 (867)
+++++ +.|+.|-.-.+|++... ...|.++++-.. . .. ....+|..+++.+. +.-..+++
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~--~~------idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TE------SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CH------HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c--hh------hHHHHHHHHHHHHHhCCCCCeEE
Confidence 44544 46888999999998863 234777766321 1 11 12235777777774 33345777
Q ss_pred cccccCCCCeEEEEEEeecCCchh
Q 002908 650 GVVQDGPGGTLATVTEFMVNGSLR 673 (867)
Q Consensus 650 g~~~~~~~~~l~LVmEy~~ggSL~ 673 (867)
+++.+ ++||+|++|.++.
T Consensus 112 ~~~~~------g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPSRPLS 129 (395)
T ss_dssp EEETT------EEEECCCCEEECC
T ss_pred EEcCC------ceEEEEeccccCC
Confidence 77754 5799999876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.15 E-value=0.037 Score=55.80 Aligned_cols=32 Identities=13% Similarity=0.124 Sum_probs=22.4
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeec
Q 002908 582 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKK 613 (867)
Q Consensus 582 yqilk~LG~GafG~VYka~~~G~~VAVKv~k~ 613 (867)
+.-.+.|..|-.-+.|+....+..+++|++..
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~ 51 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEK 51 (316)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC
T ss_pred ceEeecCCCCcccCeEEEEECCCcEEEEEcCC
Confidence 44456677888889999988777799999854
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.20 E-value=0.015 Score=51.89 Aligned_cols=67 Identities=12% Similarity=0.071 Sum_probs=47.6
Q ss_pred CCCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCC--CCCCCCCCccccccCCc
Q 002908 461 LGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPS--TMETHPDYSRSELKGNE 531 (867)
Q Consensus 461 ~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs--~~~~~P~l~k~~Lagn~ 531 (867)
+.||+.++.|++|+.|++++|+|+ .+|....+.++..+.+.+|.+...+. .....|.+....+.+|.
T Consensus 33 ~~lp~~~~~l~~L~~L~l~~N~i~----~l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 33 RALPPALAALRCLEVLQASDNALE----NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp CCCCGGGGGCTTCCEEECCSSCCC----CCGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred Ccchhhhhhhhccccccccccccc----ccCccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCc
Confidence 357888888888888888888888 57766677788888888887765553 34455666655565553
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.55 E-value=0.15 Score=47.11 Aligned_cols=65 Identities=9% Similarity=0.032 Sum_probs=45.8
Q ss_pred CCCcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCCCC-CCCCCCccccccCC
Q 002908 462 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTM-ETHPDYSRSELKGN 530 (867)
Q Consensus 462 ~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs~~-~~~P~l~k~~Lagn 530 (867)
.||..+..|++|+.|+||+|+|+ .++....+.++..+.+.+|.....|... ...|.+....+.+|
T Consensus 32 ~i~~~~~~l~~L~~L~Ls~N~i~----~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N 97 (162)
T d1a9na_ 32 VIENLGATLDQFDAIDFSDNEIR----KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 97 (162)
T ss_dssp SCCCGGGGTTCCSEEECCSSCCC----EECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSC
T ss_pred ccCccccccccCCEEECCCCCCC----ccCCcccCcchhhhhcccccccCCCccccccccccccceeccc
Confidence 46666677888888888888888 5666666677788888888777665432 34566666666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=86.54 E-value=0.22 Score=43.90 Aligned_cols=63 Identities=13% Similarity=0.067 Sum_probs=49.8
Q ss_pred CCCcccccCCCccccCCCCCCCCCCCCCCCC-CCcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 462 GFSSPLTNIEEGATVDYSYPPLKPDGSVMPQ-SGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 462 ~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~-s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
.+| .|+.|+.|+.|++++|+|+ .+|. .+.+.++..+.+.+|.+...|. ....|.+....+..|
T Consensus 12 ~l~-~l~~l~~L~~L~ls~N~l~----~lp~~~~~l~~L~~L~l~~N~i~~l~~-~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 12 VLC-HLEQLLLVTHLDLSHNRLR----ALPPALAALRCLEVLQASDNALENVDG-VANLPRLQELLLCNN 75 (124)
T ss_dssp SCC-CGGGGTTCCEEECCSSCCC----CCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSS
T ss_pred CCc-ccccCCCCCEEECCCCccC----cchhhhhhhhcccccccccccccccCc-cccccccCeEECCCC
Confidence 455 4899999999999999999 6774 4556788889999998877654 566777777777666
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.61 E-value=0.2 Score=49.11 Aligned_cols=63 Identities=11% Similarity=0.025 Sum_probs=44.3
Q ss_pred CcccccCCCccccCCCCCCCCCCCCCCCCCCcccccccccccCCCCccCCCCCCCCCCCccccccCC
Q 002908 464 SSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 530 (867)
Q Consensus 464 P~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn 530 (867)
|..|+++++|+.|+|++|+|+ .+|..+.+.++..+.+..|.....+......+.+....+..+
T Consensus 48 ~~~f~~l~~L~~L~L~~N~l~----~l~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~ 110 (266)
T d1p9ag_ 48 LATLMPYTRLTQLNLDRAELT----KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110 (266)
T ss_dssp GGGGTTCTTCCEEECTTSCCC----EEECCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSS
T ss_pred HHHhhcccccccccccccccc----cccccccccccccccccccccccccccccccccccccccccc
Confidence 356788888888888888888 577767777788888888877666665555555555555444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.40 E-value=0.45 Score=43.35 Aligned_cols=63 Identities=10% Similarity=-0.034 Sum_probs=36.2
Q ss_pred cccccCCCccccCCCCCCCCCCCCCCCCCC--cccccccccccCCCCccCCCCCCCCCCCccccccCCc
Q 002908 465 SPLTNIEEGATVDYSYPPLKPDGSVMPQSG--SRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNE 531 (867)
Q Consensus 465 ~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~--~~~~l~~lSl~~N~~l~gPs~~~~~P~l~k~~Lagn~ 531 (867)
..|..+++|+.|+|++|+|+ .|+... .+.+++.+.+.+|.+...|...-....+....+.+|.
T Consensus 50 ~~f~~l~~L~~L~Ls~N~l~----~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np 114 (156)
T d2ifga3 50 RDLRGLGELRNLTIVKSGLR----FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNP 114 (156)
T ss_dssp GGSCSCCCCSEEECCSSCCC----EECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSC
T ss_pred hhhccccccCcceeeccccC----CcccccccccccccceeccCCCCcccChhhhccccccccccCCCc
Confidence 45666666666666666666 344322 2345666666666666655554444455555666663
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.89 E-value=0.48 Score=43.20 Aligned_cols=52 Identities=6% Similarity=-0.020 Sum_probs=39.9
Q ss_pred cccCCCCcccccCCCccccCCCCCCCCCCCCCCCCCCc-ccccccccccCCCCccCC
Q 002908 458 QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGS-RINFDEGSQRESSSIVGP 513 (867)
Q Consensus 458 ~ls~~LP~~Lg~~~~L~~LdLS~N~Ls~~Gs~IP~s~~-~~~l~~lSl~~N~~l~gP 513 (867)
+|++--|..|..+++|+.|+|++|+|+ .+|.... ..++..+.+.+|+..|.-
T Consensus 67 ~l~~i~~~~f~~l~~L~~L~Ls~N~l~----~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 67 GLRFVAPDAFHFTPRLSRLNLSFNALE----SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CCCEECTTGGGSCSCCCEEECCSSCCS----CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred ccCCcccccccccccccceeccCCCCc----ccChhhhccccccccccCCCcccCCc
Confidence 345555788999999999999999999 6776543 346777888899877643
|